PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Arnqvist, G; Rowe, L				Arnqvist, G; Rowe, L			Antagonistic coevolution between the sexes in a group of insects	NATURE			English	Article							SEXUAL CONFLICT; WATER STRIDERS; ARMS RACES; MATE CHOICE; EVOLUTION; COSTS; ADAPTATION; SPECIATION; SELECTION; MODEL	In coevolutionary 'arms races' between the sexes, the outcome of antagonistic interactions may remain at an evolutionary standstill. The advantage gained by one sex, with any evolutionary exaggeration of arms, is expected to be matched by analogous counteradaptations in the other sex(1,2). This fundamental coevolutionary process may thus be hidden from the evolutionist's eye(3,4), and no natural examples are known. We have studied the effects of male and female armament (clasping and anti-clasping morphologies) on the outcome of antagonistic mating interactions in 15 species of water strider, using a combination of experimental and phylogenetic comparative methods. Here we present, by assessing the independent effects of both species-specific level of arms escalation and small imbalances in the amounts of arms between the sexes within species, the consequences of a sexual arms race. Evolutionary change in the balance of armament between males and females, but not in the species-specific level of escalation, has resulted in evolutionary change in the outcome of sexually antagonistic interactions such as mating rate.	Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Toronto, Dept Zool, Toronto, ON M5S 1A1, Canada	Uppsala University; University of Toronto	Arnqvist, G (corresponding author), Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.		Arnqvist, Göran/E-6782-2015	Arnqvist, Göran/0000-0002-3501-3376				ARNQVIST G, 1989, OIKOS, V56, P344, DOI 10.2307/3565619; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; ARNQVIST G, IN PRESS EVOLUTION; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; Damgaard J, 2001, SYST ENTOMOL, V26, P241, DOI 10.1046/j.1365-3113.2001.00141.x; FELSENSTEIN J, 2001, PHYLOGENY INFERENCE; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hardling R, 1999, J THEOR BIOL, V196, P163, DOI 10.1006/jtbi.1998.0828; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; PARKER GA, 1983, J THEOR BIOL, V101, P619, DOI 10.1016/0022-5193(83)90019-X; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; ROWE L, IN PRESS EVOLUTION; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101	30	366	369	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					787	789		10.1038/415787a	http://dx.doi.org/10.1038/415787a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845208				2022-12-01	WOS:000173833900045
J	Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K				Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K			Lateral relocation of auxin efflux regulator PIN3 mediates tropism in Arabidopsis	NATURE			English	Article							TRANSPORT; GRAVITROPISM; THALIANA; ROOTS; SEEDLINGS	Long-standing models propose that plant growth responses to light or gravity are mediated by asymmetric distribution of the phytohormone auxin(1-3). Physiological studies implicated a specific transport system that relocates auxin laterally, thereby effecting differential growth(4); however, neither the molecular components of this system nor the cellular mechanism of auxin redistribution on light or gravity perception have been identified. Here, we show that auxin accumulates asymmetrically during differential growth in an efflux-dependent manner. Mutations in the Arabidopsis gene PIN3, a regulator of auxin efflux, alter differential growth. PIN3 is expressed in gravity-sensing tissues, with PIN3 protein accumulating predominantly at the lateral cell surface. PIN3 localizes to the plasma membrane and to vesicles that cycle in an actin-dependent manner. In the root columella, PIN3 is positioned symmetrically at the plasma membrane but rapidly relocalizes laterally on gravity stimulation. Our data indicate that PIN3 is a component of the lateral auxin transport system regulating tropic growth. In addition, actin-dependent relocalization of PIN3 in response to gravity provides a mechanism for redirecting auxin flux to trigger asymmetric growth.	Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Konstanz, Lehrstuhl Phytopathol, D-78457 Constance, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Nicolaus Copernicus University; University of Konstanz; University of Freiburg	Friml, J (corresponding author), Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany.	jiri.friml@zmbp.uni-tuebingen.de; palme@mpiz-koeln.mpg.de	Wisniewska, Justyna/D-4351-2009; Palme, Klaus/A-9524-2013; Friml, Jiri/D-9511-2012; Benkova, Eva/E-2910-2012	Palme, Klaus/0000-0002-2728-3835; Friml, Jiri/0000-0002-8302-7596; 				BJORKMAN T, 1988, PLANTA, V176, P513, DOI 10.1007/BF00397658; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Collings DA, 2001, PLANTA, V212, P392, DOI 10.1007/s004250000406; Darwin C., 1881, DARWINS GESAMMELTE W, V13; EPEL BL, 1992, J PLANT PHYSIOL, V140, P310, DOI 10.1016/S0176-1617(11)81084-9; FRIML J, IN PRESS CELL; FRIML J, IN PRESS PLANT MOL B; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hart JW., 1990, PLANT TROPISM OTHER; Hasenstein KH, 1999, ADV SPACE RES-SERIES, V24, P677, DOI 10.1016/S0273-1177(99)00399-3; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; LI Y, 1991, PLANT CELL, V3, P1167, DOI 10.1105/tpc.3.11.1167; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Monshausen GB, 1996, PLANT CELL ENVIRON, V19, P1408, DOI 10.1111/j.1365-3040.1996.tb00019.x; MORRIS DA, 1978, J EXP BOT, V29, P147, DOI 10.1093/jxb/29.1.147; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Palme K, 1999, CURR OPIN PLANT BIOL, V2, P375, DOI 10.1016/S1369-5266(99)00008-4; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; SIEVERS A, 1995, PLANTA, V197, P392, DOI 10.1007/BF00202662; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; [No title captured]	26	1006	1071	9	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					806	809		10.1038/415806a	http://dx.doi.org/10.1038/415806a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845211	Green Published			2022-12-01	WOS:000173833900050
J	Feldbaum, C				Feldbaum, C			Biotechnology - Some history should be repeated	SCIENCE			English	Editorial Material									Biotechnol Ind Org, Washington, DC 20006 USA		Feldbaum, C (corresponding author), Biotechnol Ind Org, Washington, DC 20006 USA.								0	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					975	975		10.1126/science.1069614	http://dx.doi.org/10.1126/science.1069614			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834802				2022-12-01	WOS:000173793000027
J	Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D				Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D			Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; CIGARETTE-SMOKING; NATURAL-HISTORY; BLOOD-PRESSURE; MORTALITY; POPULATION; DISEASE; WOMEN; MEN; DYSFUNCTION	Background: Although excessive alcohol consumption can promote cardiomyopathy, little is known about the association between alcohol consumption and risk for congestive heart failure in the community. Objective: To determine the relation between alcohol consumption and risk for congestive heart failure in the community. Design: Community-based, prospective observational study. Setting: Framingham, Massachusetts. Participants: Participants in the Framingham Heart Study who were free of congestive heart failure and coronary heart disease. Measurements: Self-reported alcohol consumption; sex-specific rates of congestive heart failure per 1000 person-years of follow-up by level of alcohol consumption. Results: In men, 99 cases of congestive heart failure occurred during 26 035 person-years of follow-up. In women, 120 cases of congestive heart failure occurred during 35 563 person-years of follow-up. After adjustment for multiple confounders, risk for congestive heart failure was lower among men at all levels of alcohol consumption compared with men who consumed less than 1 drink/wk. The hazard ratio for congestive heart failure was lowest among men who consumed 8 to 14 drinks/wk (0.41 [95% CI, 0.21 to 0.81]) compared with those who consumed less than 1 drink/wk. In women, the age-adjusted hazard ratio for congestive heart failure was lowest among those who consumed 3 to 7 drinks/wk (0.49 [CI, 0.25 to 0.96]) compared with those who consumed less than 1 drink/wk. However, after adjustment for multiple predictors of congestive heart failure, this association was no longer statistically significant. Conclusions: In the community, alcohol consumption is not associated with increased risk for congestive heart failure, even among heavy drinkers (greater than or equal to15 drinks/wk in men and greater than or equal to8 drinks/wk in women). To the contrary, when consumed in moderation, alcohol appears to protect against congestive heart failure.	NHLBI, Framingham Heart Study, NIH, Framingham, MA 01702 USA; Boston Univ, Sch Med, Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02118 USA; Harvard Univ, Sch Med, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Harvard University; Harvard Medical School	Levy, D (corresponding author), NHLBI, Framingham Heart Study, NIH, 5 Thurber St, Framingham, MA 01702 USA.		Ramachandran, Vasan/Y-2527-2019; Djousse, Luc/F-5033-2017; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Ramachandran, Vasan/0000-0001-7357-5970; Djousse, Luc/0000-0002-9902-3047; Levy, Daniel/0000-0003-1843-8724; Ellison, Robert Curtis/0000-0002-0582-7467; Larson, Martin/0000-0002-9631-1254	NHLBI NIH HHS [N01-HC-38038, 1K24 HL04334] Funding Source: Medline; NIAMS NIH HHS [AR/AG 41398] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; ALEXANDE.CS, 1972, AM J MED, V53, P395, DOI 10.1016/0002-9343(72)90136-2; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; BERTOLET BD, 1991, DRUG ALCOHOL DEPEN, V28, P113, DOI 10.1016/0376-8716(91)90067-9; Black HR, 1997, ARCH INTERN MED, V157, P2413; BYRNEQUINN E, 1969, BMJ-BRIT MED J, V4, P25, DOI 10.1136/bmj.4.5674.25; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Cooper HA, 2000, J AM COLL CARDIOL, V35, P1753, DOI 10.1016/S0735-1097(00)00625-2; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1987, AM J EPIDEMIOL, V126, P629, DOI 10.1093/oxfordjournals.aje.a114702; DANCY M, 1985, LANCET, V1, P1122; Dawber, 1959, J CHRON DIS, V10, P186, DOI 10.1016/0021-9681(59)90002-5; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8; FRIEDMAN LA, 1986, AM J EPIDEMIOL, V124, P481, DOI 10.1093/oxfordjournals.aje.a114418; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; HARRIS M, 1979, DIABETES, V28, P1039; HASKELL WL, 1984, NEW ENGL J MED, V310, P805, DOI 10.1056/NEJM198403293101301; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1993, AM J CARDIOL, V72, P1418, DOI 10.1016/0002-9149(93)90190-N; MANOLIO TA, 1991, J AM COLL CARDIOL, V17, P717, DOI 10.1016/S0735-1097(10)80189-5; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKenna CJ, 1998, AM HEART J, V135, P833, DOI 10.1016/S0002-8703(98)70042-0; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; National Institute on Alcohol Abuse and Alcoholism, 1995, PUBL NIH; PATEL VB, 1995, BIOCHEM SOC T, V23, pS461, DOI 10.1042/bst023461s; Prazak P, 1996, EUR HEART J, V17, P251; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P807; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SUH I, 1992, ANN INTERN MED, V116, P881, DOI 10.7326/0003-4819-116-11-881; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; *USDA, 1999, USDA NUTR DAT STAND; WU CF, 1976, AM HEART J, V91, P281, DOI 10.1016/S0002-8703(76)80209-8	47	150	155	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					181	191		10.7326/0003-4819-136-3-200202050-00005	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827493				2022-12-01	WOS:000173637400001
J	Elinav, E; Chajek-Shaul, TA; Stern, M				Elinav, E; Chajek-Shaul, TA; Stern, M			Improvement in cholesterol emboli syndrome after iloprost therapy	BRITISH MEDICAL JOURNAL			English	Article									Hadassah Univ Hosp, Dept Med, IL-91240 Jerusalem, Israel; Hadassah Univ Hosp, Med Day Care Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Chajek-Shaul, TA (corresponding author), Hadassah Univ Hosp, Dept Med, Mt Scopus, IL-91240 Jerusalem, Israel.		Elinav, Eran/C-8077-2011; Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				GRANT SM, 1992, DRUGS, V43, P889, DOI 10.2165/00003495-199243060-00008; KARA HVK, 1993, J VASC SURG, V17, P328; OKEEFFE ST, 1992, ARCH INTERN MED, V152, P2197, DOI 10.1001/archinte.152.11.2197	3	46	50	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					268	269		10.1136/bmj.324.7332.268	http://dx.doi.org/10.1136/bmj.324.7332.268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823357	Bronze, Green Published			2022-12-01	WOS:000173728300016
J	Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC				Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC			Structure of the reovirus membrane-penetration protein, mu 1, in a complex with its protector protein, sigma 3	CELL			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN REOVIRUSES; CHROMIUM RELEASE; CAPSID PROTEIN; SUBVIRION PARTICLES; M2 GENE; BINDING; SEQUENCE; ENTRY; CRYSTALLOGRAPHY	Cell entry by nonenveloped animal viruses requires membrane penetration without membrane fusion. The reovirus penetration agent is the outer-capsid protein, mu1. The structure of mu1, complexed with its "protector" protein, sigma3, and the fit of this mu1(3)sigma3(3) heterohexameric complex into the cryoEM image of an intact virion, reveal molecular events essential for viral penetration. Autolytic cleavage divides mu1 into myristoylated mu1N and mu1C. A long hydrophobic pocket can receive the myristoyl group. Dissociation of mu1N, linked to a major conformational change of the entire mu1 trimer, must precede myristoyl-group insertion into the cellular membrane. A myristoyl switch, coupling exposure of the fatty acid chain, autolytic cleavage of mu1N, and long-range molecular rearrangement of mu1C, thus appears to be part of the penetration mechanism.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Chandran, Kartik/I-2232-2012	, Timothy/0000-0001-6543-8968	NATIONAL CANCER INSTITUTE [R37CA013202, R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045976, R01AI046440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050, R01GM033050] Funding Source: NIH RePORTER; NCI NIH HHS [CA-13202, R37 CA013202, R01 CA013202] Funding Source: Medline; NIAID NIH HHS [R01 AI046440, AI-46440, P01 AI045976] Funding Source: Medline; NIGMS NIH HHS [R37 GM033050, GM-33050, R01 GM033050] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran K, 1998, J VIROL, V72, P467, DOI 10.1128/JVI.72.1.467-475.1998; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; CHANDRAN K, 2001, THESIS U WISCONSIN M; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; CHEN WY, 1991, J BIOL CHEM, V266, P9355; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; FIELDS BN, 1971, VIROLOGY, V43, P569, DOI 10.1016/0042-6822(71)90282-0; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooper JW, 1996, J VIROL, V70, P672, DOI 10.1128/JVI.70.1.672-677.1996; Hooper JW, 1996, J VIROL, V70, P459, DOI 10.1128/JVI.70.1.459-467.1996; HUISMANS H, 1976, VIROLOGY, V70, P411, DOI 10.1016/0042-6822(76)90282-8; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; JAYASURIYA AK, 1988, VIROLOGY, V163, P591, DOI 10.1016/0042-6822(88)90300-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; LUCIAJANDRIS P, 1993, J VIROL, V67, P5339, DOI 10.1128/JVI.67.9.5339-5345.1993; Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485; MOSCUFO N, 1993, J VIROL, V67, P5075, DOI 10.1128/JVI.67.8.5075-5078.1993; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHIFF LA, 1988, MOL CELL BIOL, V8, P273, DOI 10.1128/MCB.8.1.273; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; SHATKIN AJ, 1972, J VIROL, V10, P698, DOI 10.1128/JVI.10.4.698-706.1972; Shing M, 1996, VIRUS RES, V46, P19, DOI 10.1016/S0168-1702(96)01372-X; SILVERSTEIN SC, 1970, P NATL ACAD SCI USA, V67, P275, DOI 10.1073/pnas.67.1.275; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; TOSTESON MT, 1993, P NATL ACAD SCI USA, V90, P10549, DOI 10.1073/pnas.90.22.10549; WIENER JR, 1988, VIROLOGY, V163, P603, DOI 10.1016/0042-6822(88)90301-7; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6; [No title captured]	59	179	202	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					283	295		10.1016/S0092-8674(02)00612-8	http://dx.doi.org/10.1016/S0092-8674(02)00612-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832217	Green Accepted, Bronze			2022-12-01	WOS:000173521300014
J	Hyde, PS; Knudsen, EI				Hyde, PS; Knudsen, EI			The optic tectum controls visually guided adaptive plasticity in the owl's auditory space map	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; FREQUENCY-SPECIFIC ADJUSTMENTS; SUPERIOR COLLICULAR MAP; BARN OWL; INFERIOR COLLICULUS; NEURAL REPRESENTATION; LOCALIZATION CUES; GUINEA-PIG; CALIBRATION; DEPRIVATION	The midbrain contains an auditory map of space that is shaped by visual experience(1-3). When barn owls are raised wearing spectacles that horizontally displace the visual field, the auditory space map in the external nucleus of the inferior colliculus (ICX) shifts according to the optical displacement of the prisms(4). Topographic visual activity in the optic tectum could serve as the template that instructs the auditory space map(5). We studied the effects of a restricted, unilateral lesion in the portion of the optic tectum that represents frontal space. Here we show that such a lesion eliminates adaptive adjustments specifically in the portion of the auditory map that represents frontal space on the same side of the brain, while the rest of the map continues to adjust adaptively. Thus, activity in the tectum calibrates the auditory space map in a location-specific manner. Because the site of adaptive changes is the ICX4,6,7, the results also indicate that the tectum provides a topographic instructive signal that controls adaptive auditory plasticity in the ICX.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.							Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; HYDE PS, IN PRESS J NEUROSCI; KING AJ, 1993, EXP BRAIN RES, V94, P444; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; KNUDSEN EI, 1983, J COMP NEUROL, V218, P187, DOI 10.1002/cne.902180206; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; LUSCH H, 2000, J NEUROSCI, V20, P1; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Stein BE., 1993, MERGING SENSES; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	30	45	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					73	76		10.1038/415073a	http://dx.doi.org/10.1038/415073a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780119				2022-12-01	WOS:000173028800042
J	Phillips, DP; Liu, GC; Kwok, K; Jarvinen, JR; Zhang, N; Abramson, IS				Phillips, DP; Liu, GC; Kwok, K; Jarvinen, JR; Zhang, N; Abramson, IS			The Hound of the Baskervilles effect: natural experiment on the influence of psychological stress on timing of death	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY DISEASE; MENTAL STRESS	Objective To determine whether cardiac mortality is abnormally high on days considered unlucky: Chinese and Japan se people consider the number 4 unlucky, white Americans do not. Design Examination of cardiac and non-cardiac mortality on and around the fourth of each month in Chinese and Japanese subjects and white controls. Setting United States. Subjects All Chinese and Japanese (n = 209 908) and white (n = 47 328 762) Americans whose computerised death certificates were recorded between the beginning of January 1973 and the end of December 1998. Main outcome measures Ratio of observed to expected numbers of deaths on the fourth day of the month (expected number was estimated from mortality on other days of the month). Results Cardiac mortality in Chinese and Japanese people peaked on the fourth of the month. The peak was particularly large for deaths from chronic heart disease (ratio of observed to expected deaths = 1.13, 95% confidence interval 1.06 to 1.21) and still larger for deaths from chronic heart disease in California (1.27,1.15 to 1.39). Within this group. inpatients showed a particularly large peak on the fourth day(1.45, 1.19 to 1.81). The peak was not followed by a compensatory drop in number of deaths. White controls, matched on age, sex, marital status, hospital status, location, and cause of death, showed no similar peak in cardiac mortality. Conclusions Our findings of excess cardiac mortality on "unlucky" days are consistent with the hypothesis that cardiac mortality increases on psychologically stressful occasions. The results are inconsistent with nine other possible explanations for the findings-for example, the fourth day peak does not seem to occur because of changes in the patient's diet, alcohol intake, exercise, or drug regimens.	Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Phillips, DP (corresponding author), Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA.							*CA DEP HLTH SERV, MORT FIL; DOYLE AC, 1964, HOUND BASKERVILLES; Gardner M. J., 1989, STAT CONFIDENCE; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; *NAT CTR HLTH STAT, 1997, VIT STAT US 1994 A, V2; *NAT CTR HLTH STAT, 1976, VIT STAT US 1973 1 A, V2; Philips DP, 1999, NEW ENGL J MED, V341, P93, DOI 10.1056/NEJM199907083410206; PHILLIPS DF, 1995, JAMA-J AM MED ASSOC, V273, P1221, DOI 10.1001/jama.273.15.1221; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; PHILLIPS DP, 1993, LANCET, V342, P1142, DOI 10.1016/0140-6736(93)92124-C; PHILLIPS DP, 2000, ENCY PSYCHOL; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Soufer R, 1998, P NATL ACAD SCI USA, V95, P6454, DOI 10.1073/pnas.95.11.6454; STEPTOE A, 1991, CIRCULATION, V83, P14; *US NAT CTR HLTH S, MORT DET FIL; Witte DR, 2000, BMJ-BRIT MED J, V321, P1552, DOI 10.1136/bmj.321.7276.1552; 2000, W CALENDAR CALENDAR; 2000, SCHAUWECKERS GUIDE J	19	53	54	1	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1443	1446		10.1136/bmj.323.7327.1443	http://dx.doi.org/10.1136/bmj.323.7327.1443			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506PA	11751347	Green Published			2022-12-01	WOS:000172979900006
J	Fored, CM; Ejerblad, E; Lindblad, P; Fryzek, JP; Dickman, PW; Signorello, LB; Lipworth, L; Elinder, C; Blot, WJ; McLaughlin, JK; Zack, MM; Nyren, O				Fored, CM; Ejerblad, E; Lindblad, P; Fryzek, JP; Dickman, PW; Signorello, LB; Lipworth, L; Elinder, C; Blot, WJ; McLaughlin, JK; Zack, MM; Nyren, O			Acetaminophen, aspirin, and chronic renal failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANALGESIC USE; DISEASE; NEPHROPATHY; KIDNEY; PARACETAMOL; RISK	Background: Several epidemiologic studies have demonstrated an association between heavy consumption of nonnarcotic analgesics and the occurrence of chronic renal failure, but it is unclear which is the cause and which is the effect. Methods: In a nationwide, population-based, case-control study of early-stage chronic renal failure in Sweden, face-to-face interviews were conducted with 926 patients with newly diagnosed renal failure and 998 control subjects, of whom 918 and 980, respectively, had complete data. We used logistic-regression models to estimate the relative risks of disease-specific types of chronic renal failure associated with the use of various analgesics. Results: Aspirin and acetaminophen were used regularly by 37 percent and 25 percent, respectively, of the patients with renal failure and by 19 percent and 12 percent, respectively, of the controls. Regular use of either drug in the absence of the other was associated with an increase by a factor of 2.5 in the risk of chronic renal failure from any cause. The relative risks rose with increasing cumulative lifetime doses, rose more consistently with acetaminophen use than with aspirin use, and were increased for most disease-specific types of chronic renal failure. When we disregarded the recent use of analgesics, which could have occurred in response to antecedents of renal disease, the associations were only slightly attenuated. Conclusions: Our results are consistent with the existence of exacerbating effects of acetaminophen and aspirin on chronic renal failure. However, we cannot rule out the possibility of bias due to the triggering of analgesic consumption by predisposing conditions. (N Engl J Med 2001;345:1801-8.) Copyright (C) 2001 Massachusetts Medical Society.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Huddinge Univ Hosp, Dept Renal Med, S-14186 Huddinge, Sweden; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; Int Epidemiol Inst, Rockville, MD USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Karolinska Institutet; Karolinska Institutet; Vanderbilt University; Centers for Disease Control & Prevention - USA	Fored, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.		Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380				BUCKALEW VM, 1986, MEDICINE, V65, P291, DOI 10.1097/00005792-198609000-00002; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delzell E, 1998, MEDICINE, V77, P383; ELSEVIERS M, 1994, THESIS U ANTWERP DEP; Elseviers MM, 1999, DRUG SAFETY, V20, P15, DOI 10.2165/00002018-199920010-00003; Feinstein AR, 2000, KIDNEY INT, V58, P2259, DOI 10.1046/j.1523-1755.2000.00410.x; Goldfarb S, 1998, ANN INTERN MED, V129, P636, DOI 10.7326/0003-4819-129-8-199810150-00012; GRIMLUND K, 1963, ACTA MED SCAND, V405, P1; Henrich WL, 1996, AM J KIDNEY DIS, V27, P162, DOI 10.1016/S0272-6386(96)90046-3; *INT AG RES CANC, 1980, STAT METH CANC RES; MCCREDIE M, 1988, NEPHRON, V49, P296, DOI 10.1159/000185079; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MOULTON LH, 1991, J CLIN EPIDEMIOL, V44, P915, DOI 10.1016/0895-4356(91)90054-D; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; NANRA RS, 1993, ANALGESIC NSAID INDU, P17; PERNEGER TV, 1995, AM J KIDNEY DIS, V25, P722, DOI 10.1016/0272-6386(95)90548-0; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; POMMER W, 1989, AM J NEPHROL, V9, P403, DOI 10.1159/000168002; Rexrode KM, 2001, JAMA-J AM MED ASSOC, V286, P315, DOI 10.1001/jama.286.3.315; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Sabatini S, 1996, AM J KIDNEY DIS, V28, pS34, DOI 10.1016/S0272-6386(96)90567-3; Salas M, 1999, AM J EPIDEMIOL, V149, P981; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SEGASOTHY M, 1988, NEPHRON, V50, P50, DOI 10.1159/000185116; SPUHLER O, 1953, Z KLIN MED, V151, P1; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; *USRDS COORD CTR, 2001, 2001 USRDS ADR REF T; WEST SL, 1994, PHARMACOEPIDEM DR S, P549; WING AJ, 1989, TOXICOL LETT, V46, P281, DOI 10.1016/0378-4274(89)90136-7	31	173	180	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1801	1808		10.1056/NEJMoa010323	http://dx.doi.org/10.1056/NEJMoa010323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752356				2022-12-01	WOS:000172794800003
J	He, L; Fong, J; von Zastrow, M; Whistler, JL				He, L; Fong, J; von Zastrow, M; Whistler, JL			Regulation of opioid receptor trafficking and morphine tolerance by receptor oligornerization	CELL			English	Article							RAT-BRAIN; G-PROTEINS; DOWN-REGULATION; UP-REGULATION; GABA RELEASE; MICE LACKING; NEURONS; DEPENDENCE; DESENSITIZATION; ENDOCYTOSIS	The utility of morphine for the treatment of chronic pain is hindered by the development of tolerance to the analgesic effects of the drug. Morphine is unique among opiates in its ability to activate the mu opioid receptor (MOR) without promoting its desensitization and endocytosis. Here we demonstrate that [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) can facilitate the ability of morphine to stimulate MOR endocytosis. As a consequence, rats treated chronically with both drugs show reduced analgesic tolerance compared to rats treated with morphine alone. These results demonstrate that endocytosis of the MOR can reduce the development of tolerance, and hence suggest an approach for the development of opiate analogs with enhanced efficacy for the treatment of chronic pain.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Psychiat & Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	shooz2@itsa.ucsf.edu						Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; ABDELHAMID EE, 1991, EUR J PHARMACOL, V198, P157, DOI 10.1016/0014-2999(91)90615-W; ADVOKAT C, 1993, PHARMACOL BIOCHEM BE, V45, P871, DOI 10.1016/0091-3057(93)90134-F; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.97.7.3684; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bernstein MA, 1998, MOL BRAIN RES, V55, P237, DOI 10.1016/S0169-328X(98)00005-9; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bonci A, 1997, J NEUROSCI, V17, P796; BRADY LS, 1989, BRAIN RES, V477, P382, DOI 10.1016/0006-8993(89)91432-7; Chieng B, 1998, J NEUROSCI, V18, P7033; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; Connor M, 1999, BRIT J PHARMACOL, V126, P1553, DOI 10.1038/sj.bjp.0702457; DEVRIES TJ, 1993, LIFE SCI, V52, P1685, DOI 10.1016/0024-3205(93)90476-J; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; GOUARDERES C, 1990, PROG CLIN BIOL RES, V328, P175; HUGHES J, 1983, BRIT MED BULL, V39, P1; Jolas T, 2000, NEUROSCIENCE, V95, P433; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P264; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mitchell JM, 2000, NAT NEUROSCI, V3, P47, DOI 10.1038/71120; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REZVANI A, 1983, J PHARMACOL EXP THER, V225, P251; ROTHMAN RB, 1991, PEPTIDES, V12, P151, DOI 10.1016/0196-9781(91)90182-O; Selley DE, 1997, BRAIN RES, V746, P10, DOI 10.1016/S0006-8993(96)01125-0; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; SIMANTOV R, 1984, NEUROPEPTIDES, V5, P197, DOI 10.1016/0143-4179(84)90061-1; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; STEVENS CW, 1989, J PHARMACOL EXP THER, V250, P1; Tao PL, 1998, EUR J PHARMACOL, V344, P137, DOI 10.1016/S0014-2999(97)01596-3; Tejwani GA, 1998, BRAIN RES, V797, P305, DOI 10.1016/S0006-8993(98)00416-8; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Trafton JA, 2000, J NEUROSCI, V20, P8578; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; WERLING LL, 1989, P NATL ACAD SCI USA, V86, P6393, DOI 10.1073/pnas.86.16.6393; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 1999, TRENDS PHARMACOL SCI, V20, P329, DOI 10.1016/S0165-6147(99)01370-X; YAKSH TL, 1986, PHARMACOL BIOCHEM BE, V25, P483, DOI 10.1016/0091-3057(86)90028-6; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	57	264	276	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					271	282		10.1016/S0092-8674(02)00613-X	http://dx.doi.org/10.1016/S0092-8674(02)00613-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832216	Bronze			2022-12-01	WOS:000173521300013
J	del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F				del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F			A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIDROTIC ECTODERMAL DYSPLASIA; SENSORINEURAL DEAFNESS; CHILDHOOD DEAFNESS; RAT COCHLEA; MUTATIONS; EXPRESSION; GJB2; POPULATION; FREQUENCY; DFNB1	Background: Inherited hearing impairment affects about 1 in 2000 newborns. Up to 50 percent of all patients with autosomal recessive nonsyndromic prelingual deafness in different populations have mutations in the gene encoding the gap-junction protein connexin 26 (GJB2) at locus DFNB1 on chromosome 13q12. However, a large fraction (10 to 42 percent) of patients with GJB2 mutations have only one mutant allele; the accompanying mutation has not been identified. DFNB1-linked familial cases with no mutation in GJB2 have also been reported. Methods: We evaluated 33 unrelated probands with nonsyndromic prelingual deafness who had only one GJB2 mutant allele. Nine subjects had evidence of linkage to DFNB1. We used haplotype analysis for markers on 13q12 to search for mutations other than the one involving GJB2. Results: We identified a 342-kb deletion in the gene encoding connexin 30 (GJB6), a protein that is reported to be expressed with connexin 26 in the inner ear. The deletion extended distally to GJB2, which remained intact. The break-point junction of the deletion was isolated and sequenced, and a specific diagnostic test was developed for this common mutation. Twenty-two of the 33 subjects were heterozygous for both the GJB6 and GJB2 mutations, including all 9 with evidence of linkage to DFNB1. Two subjects were homozygous for the GJB6 mutation. Conclusions: A 342-kb deletion in GJB6 is the second most frequent mutation causing prelingual deafness in the Spanish population. Our data suggest that mutations in the complex locus DFNB1, which contains two genes (GJB2 and GJB6), can result in a monogenic or a digenic pattern of inheritance of prelingual deafness. (N Engl J Med 2002;346:243-9.) Copyright (C) 2002 Massachusetts Medical Society.	Hosp Ramon y Cajal, Unite Genet Mol, E-28034 Madrid, Spain; Hosp Pediat William Soler, Dept Genet, Havana, Cuba	Hospital Universitario Ramon y Cajal	Moreno, F (corresponding author), Hosp Ramon y Cajal, Unite Genet Mol, Carretera Colmenar Km 9, E-28034 Madrid, Spain.		del Castillo, Francisco J./A-6467-2013; Villamar, Manuela/AAD-3842-2020; del Castillo, Ignacio/B-4314-2013	del Castillo, Francisco J./0000-0003-0467-4320; Villamar, Manuela/0000-0002-5115-4937; del Castillo, Ignacio/0000-0003-1188-3665; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098				Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; COHEN MM, 1995, OXFORD MONOGRAPHS ME, V28, P9; Dahl E, 1996, J BIOL CHEM, V271, P26444; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAJIWARA K, 1994, SCIENCE, V264, P1064; KEEN J, 1991, TRENDS GENET, V7, P5; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelley PM, 1999, GENOMICS, V62, P172, DOI 10.1006/geno.1999.6002; Kibar Z, 2000, EUR J HUM GENET, V8, P372, DOI 10.1038/sj.ejhg.5200471; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Loffler J, 2001, EUR J HUM GENET, V9, P226, DOI 10.1038/sj.ejhg.5200607; MAW MA, 1995, AM J HUM GENET, V57, P629; Murgia A, 1999, J MED GENET, V36, P829; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.0.CO;2-8; Sobe T, 2000, HUM GENET, V106, P50, DOI 10.1007/s004390051009; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wilcox SA, 1999, J MED GENET, V36, P383	33	426	445	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					243	U1		10.1056/NEJMoa012052	http://dx.doi.org/10.1056/NEJMoa012052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807148	Bronze			2022-12-01	WOS:000173398900004
J	Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA				Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA			Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTES; INFECTED RHESUS-MONKEYS; TYPE-1 INFECTION; DISEASE PROGRESSION; DNA VACCINATION; RESPONSES; VIREMIA; MAMU-A-ASTERISK-01; DOMINANT; EPITOPES	Recent studies of human immunodeficiency virus type 1 (HIV-1) infection in humans and of simian immunodeficiency virus (SIV) in rhesus monkeys have shown that resolution of the acute viral infection and control of the subsequent persistent infection are mediated by the antiviral cellular immune response(1-11). We comparatively assessed several vaccine vector delivery systems-three formulations of a plasmid DNA vector, the modified vaccinia Ankara (MVA) virus, and a replication incompetent adenovirus type 5 (Ad5) vector-expressing the SIV gag protein for their ability to elicit such immune responses in monkeys. The vaccines were tested either as a single modality or in combined modality regimens. Here we show that the most effective responses were elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector. After challenge with a pathogenic HIV-SIV hybrid virus (SHIV), the animals immunized with Ad5 vector exhibited the most pronounced attenuation of the virus infection. The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine.	Merck Res Labs, W Point, PA 19486 USA; Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC 27710 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Viral Pathogenesis, Boston, MA 02215 USA	Merck & Company; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Emini, EA (corresponding author), Merck Res Labs, W Point, PA 19486 USA.		Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922				Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; GALLIMORE A, 1995, NAT MED, V1, P1167, DOI 10.1038/nm1195-1167; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; MILLER MD, 1991, J IMMUNOL, V147, P320; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Newman MJ, 1998, CRIT REV THER DRUG, V15, P89, DOI 10.1615/CritRevTherDrugCarrierSyst.v15.i2.10; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2	20	1036	1091	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					331	335		10.1038/415331a	http://dx.doi.org/10.1038/415331a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797011				2022-12-01	WOS:000173293500046
J	Chao, W; Huynh, KD; Spencer, RJ; Davidow, LS; Lee, JT				Chao, W; Huynh, KD; Spencer, RJ; Davidow, LS; Lee, JT			CTCF, a candidate trans-acting factor for X-inactivation choice	SCIENCE			English	Article							ENHANCER-BLOCKING ACTIVITY; XIST EXPRESSION; CHROMOSOME; GENE; METHYLATION; MOUSE; TSIX; INSULATOR; REGION; PARENT	In mammals, X-inactivation silences one of two female X chromosomes. Silencing depends on the noncoding gene, Xist ((i) under bar nactive (X) under bar-(s) under bar pecific (t) under bar ranscript), and is blocked by the antisense gene, Tsix. Deleting the choice/imprinting center in Tsix affects X-chromosome selection. Here, we identify the insulator and transcription factor, CTCF, as a candidate trans-acting factor for X-chromosome selection. The choice/imprinting center contains tandem CTCF binding sites that function in an enhancer-blocking assay. In vitro binding is reduced by CpG methylation and abolished by including non-CpG methylation. We postulate that Tsix and CTCF together establish a regulatable epigenetic switch for X-inactivation.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Genet, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Genet, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA.			Chao, Wendy/0000-0002-9418-8723				Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Prissette M, 2001, HUM MOL GENET, V10, P31, DOI 10.1093/hmg/10.1.31; Sado T, 2001, DEVELOPMENT, V128, P1275; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0	27	220	239	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					345	347		10.1126/science.1065982	http://dx.doi.org/10.1126/science.1065982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11743158				2022-12-01	WOS:000173278600055
J	Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN				Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN			Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo	NATURE			English	Article							DEVELOPING MOUSE AORTA; FIBRILLIN-1; FIBER; ORGANIZATION; TROPOELASTIN; MATRIX	Extracellular elastic fibres provide mechanical elasticity to tissues and contribute towards the processes of organ remodelling by affecting cell-cell signalling(1,2). The formation of elastic fibres requires the assembly and crosslinking of tropoelastin monomers, and organization of the resulting insoluble elastin matrix into functional fibres. The molecules and mechanisms involved in this process are unknown. Fibulin-5 (also known as EVEC/DANCE) is an extracellular matrix protein abundantly expressed in great vessels and cardiac valves during embryogenesis, and in many adult tissues including the aorta, lung, uterus and skin, all of which contain abundant elastic fibres(3,4). Here we show that fibulin-5 is a calcium-dependent, elastin-binding protein that localizes to the surface of elastic fibres in vivo. fibulin-5(-/-) mice develop marked elastinopathy owing to the disorganization of elastic fibres, with resulting loose skin, vascular abnormalities and emphysematous lung. This phenotype, which resembles the cutis laxa syndrome in humans(5), reveals a critical function for fibulin-5 as a scaffold protein that organizes and links elastic fibres to cells. This function may be mediated by the RGD motif in fibulin-5, which binds to cell surface integrins, and the Ca2+-binding epidermal growth factor (EGF) repeats, which bind elastin.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas Hlth Ctr, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Davis, Elaine/F-3449-2012; Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186				Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; DAVIS EC, 1994, J CELL SCI, V107, P727; DAVIS EC, 1993, LAB INVEST, V68, P89; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200	18	466	493	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					168	171		10.1038/415168a	http://dx.doi.org/10.1038/415168a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805834				2022-12-01	WOS:000173159300041
J	Pack, CC; Berezovskii, VK; Born, RT				Pack, CC; Berezovskii, VK; Born, RT			Dynamic properties of neurons in cortical area MT in alert and anaesthetized macaque monkeys	NATURE			English	Article							PRIMARY VISUAL-CORTEX; MOTION PERCEPTION; SEGREGATION; SELECTIVITY; COHERENCE; MODEL	In order to see the world with high spatial acuity, an animal must sample the visual image with many detectors that restrict their analyses to extremely small regions of space. The visual cortex must then integrate the information from these localized receptive fields to obtain a more global picture of the surrounding environment. We studied this process in single neurons within the middle temporal visual area (MT) of macaques using stimuli that produced conflicting local and global information about stimulus motion. Neuronal responses in alert animals initially reflected predominantly the ambiguous local motion features, but gradually converged to an unambiguous global representation. When the same animals were anaesthetized, the integration of local motion signals was markedly impaired even though neuronal responses remained vigorous and directional tuning characteristics were intact. Our results suggest that anaesthesia preferentially affects the visual processing responsible for integrating local signals into a global visual representation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019; Berezovskii, Vladimir/B-9866-2013; Berezovskii, Vladimir/AAB-5253-2022	Born, Richard/0000-0003-4360-427X; Berezovskii, Vladimir/0000-0003-4077-3940; 				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Alais D, 1997, VISION RES, V37, P143, DOI 10.1016/0042-6989(95)00320-7; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7066, DOI 10.1073/pnas.88.16.7066; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hildreth E., 1984, MEASUREMENT VISUAL M; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	27	108	108	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					905	908		10.1038/414905a	http://dx.doi.org/10.1038/414905a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780062				2022-12-01	WOS:000172813300045
J	Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ				Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ			Horses damp the spring in their step	NATURE			English	Article							MUSCLE; LOCOMOTION; SIMULATION; ENERGY; STRAIN; GASTROCNEMIUS; BEHAVIOR; STORAGE; MODEL	The muscular work of galloping in horses is halved by storing and returning elastic strain energy in spring-like muscle-tendon units(1,2). These make the legs act like a child's pogo stick that is tuned to stretch and recoil at 2.5 strides per second. This mechanism is optimized by unique musculoskeletal adaptations: the digital flexor muscles have extremely short fibres and significant passive properties, whereas the tendons are very long and span several joints(3,4). Length change occurs by a stretching of the spring-like digital flexor tendons rather than through energetically expensive length changes in the muscle(5). Despite being apparently redundant for such a mechanism(5), the muscle fibres in the digital flexors are well developed. Here we show that the mechanical arrangement of the elastic leg permits it to vibrate at a higher frequency of 30-40 Hz that could cause fatigue damage to tendon and bone. Furthermore, we show that the digital flexor muscles have minimal ability to contribute to or regulate significantly the 2.5-Hz cycle of movement, but are ideally arranged to damp these high-frequency oscillations in the limb.	Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA	University of London; University of London Royal Veterinary College; Cleveland Clinic Foundation	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	van den Bogert, Antonie J/A-7809-2009; Su, Anne/M-3246-2013	van den Bogert, Antonie J/0000-0002-3791-3749; Su, Anne/0000-0002-6924-6899; Wilson, Alan/0000-0001-9914-3455				ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Alexander RM., 1988, ELASTIC MECH ANIMAL; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, J EXP BIOL, V201, P1681; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; CHENEY JA, 1973, MED BIOL ENG, V11, P613, DOI 10.1007/BF02477408; DIMERY NJ, 1986, J ZOOL, V210, P415; DOW SM, 1991, EQUINE VET J, V23, P266, DOI 10.1111/j.2042-3306.1991.tb03715.x; ETTEMA GJC, 1994, J BIOMECH, V27, P1015, DOI 10.1016/0021-9290(94)90218-6; GERRITSEN KGM, 1995, J BIOMECH, V28, P661, DOI 10.1016/0021-9290(94)00127-P; GRANDAGE J, 1981, J ANAT, V132, P318; HERMANSON JW, 1992, J MORPHOL, V212, P269, DOI 10.1002/jmor.1052120306; HERRICK WC, 1978, J BIOMED MATER RES, V12, P877, DOI 10.1002/jbm.820120610; Hof AL, 1998, J BIOMECH, V31, P793, DOI 10.1016/S0021-9290(98)00062-1; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; Kurokawa S, 2001, J APPL PHYSIOL, V90, P1349, DOI 10.1152/jappl.2001.90.4.1349; LAKE MJ, 2001, P 18 C INT SOC BIOM, P200; Minetti AE, 1999, J EXP BIOL, V202, P2329; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 1996, J MUSCLE RES CELL M, V17, P45, DOI 10.1007/BF00140323; PRATT GA, 1995, P 4 INT S EXP ROB IS, P173; STEPHENS PR, 1989, AM J VET RES, V50, P1089; van den Bogert AJ, 1998, J ELECTROMYOGR KINES, V8, P119, DOI 10.1016/S1050-6411(97)00028-X; VANDENBOGERT AJ, 1993, ACTA ANAT, V146, P95; VANDENBOGERT AJ, 1989, THESIS U UTRECHT NET; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANWEEREN PR, 1993, ACTA ANAT, V146, P154, DOI 10.1159/000147438; WANG XT, 1995, J EXP BIOL, V198, P847	30	174	174	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					895	899		10.1038/414895a	http://dx.doi.org/10.1038/414895a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780059	Green Submitted			2022-12-01	WOS:000172813300042
J	Bateman, DN; Clark, R; Azuara-Blanco, A; Bain, M; Forrest, J				Bateman, DN; Clark, R; Azuara-Blanco, A; Bain, M; Forrest, J			The impact of new drugs on management of glaucoma in Scotland: observational study	BRITISH MEDICAL JOURNAL			English	Article							OPEN-ANGLE GLAUCOMA		Royal Edinburgh & Associated Hosp, Scottish Poisons Informat Bur, Natl Poisons Informat Serv Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland; Common Serv Agcy NHS, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Aberdeen Royal Infirm, Dept Ophthalmol, Aberdeen AB25 2ZN, Scotland	Royal Infirmary of Edinburgh; University of Aberdeen	Bateman, DN (corresponding author), Royal Edinburgh & Associated Hosp, Scottish Poisons Informat Bur, Natl Poisons Informat Serv Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland.			Bateman, David Nicholas/0000-0002-8971-862X; Azuara-Blanco, Augusto/0000-0002-4805-9322				Evans J., 1996, HEALTH TRENDS, V28, P5; Harley K, 1996, Health Bull (Edinb), V54, P410; HARRISON RJ, 1988, BRIT MED J, V297, P1162, DOI 10.1136/bmj.297.6657.1162; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83	5	37	38	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2001	323	7326					1401	1402		10.1136/bmj.323.7326.1401	http://dx.doi.org/10.1136/bmj.323.7326.1401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505EX	11744564	Bronze, Green Published			2022-12-01	WOS:000172900400017
J	Oh, J; Takahashi, R; Kondo, S; Mizoguchi, A; Adachi, E; Sasahara, RM; Nishimura, S; Imamura, Y; Kitayama, H; Alexander, DB; Ide, C; Horan, TP; Arakawa, T; Yoshida, H; Nishikawa, SI; Itoh, Y; Seiki, M; Itohara, S; Takahashi, C; Noda, M				Oh, J; Takahashi, R; Kondo, S; Mizoguchi, A; Adachi, E; Sasahara, RM; Nishimura, S; Imamura, Y; Kitayama, H; Alexander, DB; Ide, C; Horan, TP; Arakawa, T; Yoshida, H; Nishikawa, SI; Itoh, Y; Seiki, M; Itohara, S; Takahashi, C; Noda, M			The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis	CELL			English	Article							BLOOD-VESSEL FORMATION; TISSUE INHIBITOR; SUPPRESSOR GENE; MESSENGER-RNA; IN-VIVO; METALLOPROTEINASES; RAS; ACTIVATION; EXPRESSION; CELLS	Matrix metalloproteinases (MMPs) are essential for proper extracellular matrix remodeling. We previously found that a membrane-anchored glycoprotein, RECK, negatively regulates MMP-9 and inhibits tumor invasion and metastasis. Here we show that RECK regulates two other MMPs, MMP-2 and MT1-MMP, known to be involved in cancer progression, that mice lacking a functional RECK gene die around E10.5 with defects in collagen fibrils, the basal lamina, and vascular development, and that this phenotype is partially suppressed by MMP-2 null mutation. Also, vascular sprouting is dramatically suppressed in tumors derived from RECK,expressing fibrosarcoma cells grown in nude mice. These results support a role for RECK in the regulation of MMP-2 in vivo and implicate RECK downregulation in tumor angiogenesis.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068501, Japan; Kitasato Univ, Grad Sch Med Sci, Dept Mol Morphol, Kanagawa 2288555, Japan; RIKEN, Brain Res Inst, Wako, Saitama 3510198, Japan; Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA; Univ Tokyo, Inst Med Sci, Dept Canc Res, Tokyo 1080071, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kitasato University; RIKEN; Amgen; University of Tokyo	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.		Itohara, Shigeyoshi/I-8769-2012; Seiki, Motoharu/K-9443-2015	Itohara, Shigeyoshi/0000-0002-2410-9989; Itoh, Yoshifumi/0000-0002-2128-2823; Oh, Junseo/0000-0002-0754-4946				BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; CANETESOLER R, 1995, DEV DYNAM, V204, P30, DOI 10.1002/aja.1002040105; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DAVIES B, 1993, CANCER RES, V53, P5365; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.0.CO;2-J; FAGAN JB, 1981, J BIOL CHEM, V256, P520; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; GARBISA S, 1987, CANCER RES, V47, P1523; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; HOWARD BH, 1978, J BIOL CHEM, V253, P5869; Ikeda M, 2000, CLIN CANCER RES, V6, P3290; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kahari VM, 1999, ANN MED, V31, P34, DOI 10.3109/07853899909019260; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; Nothnick WB, 1997, BIOL REPROD, V56, P1181, DOI 10.1095/biolreprod56.5.1181; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; REPONEN P, 1992, J BIOL CHEM, V267, P7856; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Takahashi C, 1996, ONCOGENE, V12, P2137; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Thant AA, 1997, FEBS LETT, V406, P28, DOI 10.1016/S0014-5793(97)00230-5; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamamoto M, 1996, CANCER RES, V56, P384; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	48	538	580	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					789	800		10.1016/S0092-8674(01)00597-9	http://dx.doi.org/10.1016/S0092-8674(01)00597-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747814	Bronze, Green Submitted			2022-12-01	WOS:000172771800011
J	Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D				Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D			Impact of high-normal blood pressure on the risk of cardiovascular disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; ISOLATED SYSTOLIC HYPERTENSION; REGRESSION DILUTION; MEN; MORTALITY; WOMEN; RECOMMENDATIONS; METAANALYSIS; POPULATION; PREVENTION	Background: Information is limited regarding the risk of cardiovascular disease in persons with high-normal blood pressure (systolic pressure of 130 to 139 mm Hg, diastolic pressure of 85 to 89 mm Hg, or both). Methods: We investigated the association between blood-pressure category at base line and the incidence of cardiovascular disease on follow-up among 6859 participants in the Framingham Heart Study who were initially free of hypertension and cardiovascular disease. Results: A stepwise increase in cardiovascular event rates was noted in persons with higher base-line blood-pressure categories. The 10-year cumulative incidence of cardiovascular disease in subjects 35 to 64 years of age who had high-normal blood pressure was 4 percent (95 percent confidence interval, 2 to 5 percent) for women and 8 percent (95 percent confidence interval, 6 to 10 percent) for men; in older subjects (those 65 to 90 years old), the incidence was 18 percent (95 percent confidence interval, 12 to 23 percent) for women and 25 percent (95 percent confidence interval, 17 to 34 percent) for men. As compared with optimal blood pressure, high-normal blood pressure was associated with a risk-factor-adjusted hazard ratio for cardiovascular disease of 2.5 (95 percent confidence interval, 1.6 to 4.1) in women and 1.6 (95 percent confidence interval, 1.1 to 2.2) in men. Conclusions: High-normal blood pressure is associated with an increased risk of cardiovascular disease. Our findings emphasize the need to determine whether lowering high-normal blood pressure can reduce the risk of cardiovascular disease. (N Engl J Med 2001;345:1291-7.) Copyright (C) 2001 Massachusetts Medical Society.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, K24 HL 04334-01A1] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chalmers J, 1999, J HYPERTENS, V17, P151; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOK RJ, 1995, BRIT MED J, V310, P1056; Cox DR., 1984, ANAL SURVIVAL DATA; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Escudero E, 1996, CAN J CARDIOL, V12, P959; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Kannel W., 1987, SOME RISK FACTORS RE; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kimura Y, 1999, HYPERTENS RES-CLIN E, V22, P291, DOI 10.1291/hypres.22.291; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; Lloyd-Jones DM, 1999, ARCH INTERN MED, V159, P2206, DOI 10.1001/archinte.159.18.2206; LONATI L, 1993, CARDIOLOGY, V83, P298, DOI 10.1159/000175985; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Neaton James D., 1995, P127; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rodgers A, 1998, LANCET, V352, P1801; SAGIE A, 1993, NEW ENGL J MED, V329, P1912, DOI 10.1056/NEJM199312233292602; SAS Institute, 1996, SAS STAT SOFTW CHANG; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wood D, 1998, J HYPERTENS, V16, P1407, DOI 10.1097/00004872-199816100-00003	34	1345	1396	1	77	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1291	1297		10.1056/NEJMoa003417	http://dx.doi.org/10.1056/NEJMoa003417			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794147				2022-12-01	WOS:000171896300001
J	Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX				Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX			Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits	NATURE			English	Article							RAT SPINAL-CORD; BINDING-SITE; XENOPUS OOCYTES; AMINO-ACIDS; ANTAGONIST; POTENT; IDENTIFICATION; MEMANTINE; RESPONSES; CLONING	The N-methyl-D-aspartate subtype of glutamate receptor (NMDAR) serves critical functions in physiological and pathological processes in the central nervous system, including neuronal development, plasticity and neurodegeneration(1,2). Conventional heteromeric NMDARs composed of NR1 and NR2A-D subunits(3,4) require dual agonists, glutamate and glycine, for activation. They are also highly permeable to Ca2+, and exhibit voltage-dependent inhibition by Mg2+. Coexpression of NR3A with NR1 and NR2 subunits modulates NMDAR activity(5-7). Here we report the cloning and characterization of the final member of the NMDAR family, NR3B, which shares high sequence homology with NR3A. From in situ and immunocytochemical analyses, NR3B is expressed predominantly in motor neurons, whereas NR3A is more widely distributed(5,6). Remarkably, when co-expressed in Xenopus oocytes, NR3A or NR3B co-assembles with NR1 to form excitatory glycine receptors that are unaffected by glutamate or NMDA, and inhibited by D-serine, a co-activator of conventional NMDARs. Moreover, NR1/NR3A or -3B receptors form relatively Ca2+-impermeable cation channels that are resistant to Mg2+, MK-801, memantine and competitive antagonists. In cerebrocortical neurons containing NR3 family members, glycine triggers a burst of firing, and membrane patches manifest glycine-responsive single channels that are suppressible by D-serine. By itself, glycine is normally thought of as an inhibitory neurotransmitter. In contrast, these NR1/NR3A or -3B 'NMDARs' constitute a type of excitatory glycine receptor.	Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; Kanazawa Univ, Grad Sch Med, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06030 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Southern Illinois University System; Southern Illinois University; Kanazawa University; University of Connecticut; University of California System; University of California San Diego	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259				Anson LC, 1998, J NEUROSCI, V18, P581; BARON BM, 1990, MOL PHARMACOL, V38, P554; BORMANN J, 1989, EUR J PHARMACOL, V166, P591, DOI 10.1016/0014-2999(89)90385-3; CHEN HSV, 1992, J NEUROSCI, V12, P4427; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; CURTIS DR, 1967, NATURE, V215, P1502, DOI 10.1038/2151502a0; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Ishimaru H, 1996, RECEPTOR CHANNEL, V4, P31; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN CJ, 1989, MOL PHARMACOL, V36, P556; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Palecek J, 1999, EUR J NEUROSCI, V11, P827, DOI 10.1046/j.1460-9568.1999.00489.x; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Soloviev MM, 1997, J MOL BIOL, V273, P14, DOI 10.1006/jmbi.1997.1272; Souverbie F, 1996, EUR J PHARMACOL, V307, P347, DOI 10.1016/0014-2999(96)00273-7; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; vonEuler M, 1997, J NEUROTRAUM, V14, P53, DOI 10.1089/neu.1997.14.53; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	30	483	528	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					793	798		10.1038/nature715	http://dx.doi.org/10.1038/nature715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823786				2022-12-01	WOS:000173833900047
J	Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS				Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS			Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer coning	SCIENCE			English	Article							CLONED TRANSGENIC CALVES; SOMATIC-CELLS	The presence of galactose alpha-1,3-galactose residues on the surface of pig cells is a major obstacle to successful xenotransplantation. Here, we report the production of four live pigs in which one allele of the alpha-1,3-galactosyltransferase locus has been knocked out. These pigs were produced by nuclear transfer technology; clonal fetal fibroblast cell lines were used as nuclear donors for embryos reconstructed with enucleated pig oocytes.	Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Immerge BioTherapeut Inc, Charlestown, MA 02129 USA; Kangwon Natl Univ, Coll Anim Resource Sci, Dept Vet Med, Chunchon 200701, South Korea; Natl Livestock Res Inst, Suwon 441350, South Korea	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Kangwon National University	Prather, RS (corresponding author), Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA.	pratherR@missouri.edu	Prather, Randall S/B-4528-2012; Lai, Liangxue/H-4545-2011	Prather, Randall/0000-0002-6012-4035	NCRR NIH HHS [T32 RR07004, R44 RR15198] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R44RR015198, T32RR007004] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bondioli K, 2001, MOL REPROD DEV, V60, P189, DOI 10.1002/mrd.1076; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Costa C, 1999, FASEB J, V13, P1762, DOI 10.1096/fasebj.13.13.1762; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Evans RW, 2001, XENOTRANSPLANTATION, P29; GALILI U, 2001, CURR OPIN ORGAN T, V6; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; LAI L, UNPUB; Lambrigts D, 1998, TRANSPLANTATION, V66, P547, DOI 10.1097/00007890-199809150-00001; Martin Michael J., 1994, P315; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Miyagawa S, 2001, J BIOL CHEM, V276, P39310, DOI 10.1074/jbc.M104359200; OLDMIXON BA, UNPUB; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; POLGE C, 1966, J REPROD FERTIL, V12, P395, DOI 10.1530/jrf.0.0120395; POLGE C, 1981, CONTROL PIG REPROD, P283; Pope W F, 1990, J Reprod Fertil Suppl, V40, P251; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Tao T, 2000, ZYGOTE, V8, P69, DOI 10.1017/S0967199400000848; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996	24	1020	1252	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1089	1092		10.1126/science.1068228	http://dx.doi.org/10.1126/science.1068228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11778012				2022-12-01	WOS:000173793000071
J	Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC				Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC			Linking breeding and wintering ranges of a migratory songbird using stable isotopes	SCIENCE			English	Article							CARBON; GROUNDS; POPULATIONS; BEHAVIOR; RATIOS; TRENDS	We used the natural abundance of stable isotopes (carbon and hydrogen) in the feathers of a neotropical migrant songbird to determine where birds from particular breeding areas spend the winter and the extent to which breeding populations mix in winter quarters. We show that most birds wintering on western Caribbean islands come from the northern portion of the species' North American breeding range, whereas those on more easterly islands are primarily from southern breeding areas. Although segregated by breeding latitude, birds within local wintering areas derive from a wide range of breeding longitudes, indicating considerable population mixing with respect to breeding Longitude. These results are useful for assessing the effects of wintering habitat Loss on breeding population abundances and for predicting whether the demographic consequences will be concentrated or diffuse.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; Smithsonian Inst, Dept Systemat Biol, Washington, DC 20560 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Dartmouth College; Dartmouth College; Smithsonian Institution; Smithsonian Institution; Smithsonian National Museum of Natural History	Rubenstein, DR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	drr24@cornell.edu	Rubenstein, Dustin R/A-3451-2015; Rubenstein, Dustin R./N-9302-2019; Ayres, Matthew/AAI-6873-2020; Graves, Gary R/P-1003-2017	Rubenstein, Dustin R/0000-0002-4999-3723; Rubenstein, Dustin R./0000-0002-4999-3723; Ayres, Matthew/0000-0001-6120-9068; Graves, Gary R/0000-0003-1406-5246				Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P365, DOI 10.1016/0016-7037(94)90470-7; DANSGAARD W, 1964, TELLUS, V16, P436; DEWOLFE BB, 1995, CONDOR, V97, P376, DOI 10.2307/1369024; GREENBERG R, 1980, MIGRANT BIRDS NEOTRO, P593; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 2001, ECOL APPL, V11, P1545, DOI 10.2307/3060938; HOLMES RT, 1994, BIRDS N AM, V87; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; James FC, 1996, ECOLOGY, V77, P13, DOI 10.2307/2265650; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; PELLEK R, 1990, J FOREST, V88, P15; Ramos M.A., 1980, P173; SAUER JR, 2001, N AM BREEDING BIRD S; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Sherry Thomas W., 1995, P85; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove D.S., 1984, American Birds, V38, P10; ZIEGLER H, 1988, STABLE ISOTOPES ECOL, P105	25	208	216	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1062	1065		10.1126/science.1067124	http://dx.doi.org/10.1126/science.1067124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834833				2022-12-01	WOS:000173793000063
J	Brugha, R; Starling, M; Walt, G				Brugha, R; Starling, M; Walt, G			GAVI, the first steps: lessons for the Global Fund	LANCET			English	Article								The Global Alliance for Vaccines and Immunization (GAVI) Is seen as a model for the new Global Fund to Fight AIDS, Tuberculosis and Malaria, to be launched early in 2002. We did an assessment in four African countries to report the experiences of ministries of health and their partners in applying to GAVI for funds to strengthen health systems and for new vaccines. Countries welcomed the introduction of hepatitis B vaccine, safe Injection equipment, and the financial support to strengthen Immunisation programmes. All reported that the pace of the application process was too rapid. District visits revealed low staffing levels, insufficient transport and fuel, poorly functioning cold chains, and infrequent supervision. Information systems were unreliable, which will be an obstacle to GAVI when monitoring and rewarding improvements in Immunisation coverage. Also, the high cost of expensive new vaccines will be difficult to sustain if GAVI funding stops at the end of its 5 year commitment. Our study suggests that applications for support and planning for AIDS, tuberculosis, and malaria control under the new Global Fund, will be more complex and demanding on already overstretched ministries of health. Further, the rapid onset of activities, coupled with uncertainty about the time-scale of donor commitment, could be problematic. A limited and carefully assessed set of initial activities, focusing on where and how to strengthen existing country systems, is more likely to be successful and could provide useful models for scaling-up to larger programmes in different contexts.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Brugha, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.		Ayres, Jose Ricardo C. M./G-2618-2012; Brugha, Ruairi/C-8420-2012	Ayres, Jose Ricardo C. M./0000-0002-5225-6492; Brugha, Ruairi/0000-0003-0729-0197				Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; *GAVI, 2002, UPD COUNTR LEV GAV V; *GAVI, 2002, PROP CALC GAVI REW S; *LATH CONS, 2001, IMM DAT QUAL AUD EV; LEVIN A, 2001, CASE STUDY COSTS FIN; Starling M., 2002, NEW PRODUCTS OLD SYS; *TRANS WORK GROUP, 2002, IN PRESS FRAM DOC GL; Walt G, 2000, TROP MED INT HEALTH, V5, P467, DOI 10.1046/j.1365-3156.2000.00596.x; WHO, 2002, MACR HLTH INV HLTH E	9	76	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					435	438		10.1016/S0140-6736(02)07607-9	http://dx.doi.org/10.1016/S0140-6736(02)07607-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844535				2022-12-01	WOS:000173686500035
J	McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM				McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM			Asthma in exercising children exposed to ozone: a cohort study	LANCET			English	Article							AIR-POLLUTION; BRONCHIAL RESPONSIVENESS; SCHOOL CHILDREN; PREVALENCE; POLLUTANTS; CHILDHOOD; ASSOCIATION; SYMPTOMS	Background Little is known about the effect of exposure to air pollution during exercise or time spent outdoors on the development of asthma. We investigated the relation between newly-diagnosed asthma and team sports in a cohort of children exposed to different concentrations and mixtures of air pollutants. Methods 3535 children with no history of asthma were recruited from schools in 12 communities in southern California and were followed up for up to 5 years. 265 children reported a new diagnosis of asthma during follow-up. We assessed risk of asthma in children playing team sports at study entry in six communities with high daytime ozone concentrations, six with lower concentrations, and in communities with high or low concentrations of nitrogen dioxide, particulate matter, and inorganic-acid vapour. Findings In communities with high ozone concentrations, the relative risk of developing asthma in children playing three or more sports was 3.3 (95% CI 1.9-5.8), compared with children playing no sports. Sports had no effect in areas of low ozone concentration (0.8, 0.4-1.6). Time spent outside was associated with a higher incidence of asthma in areas of high ozone (1.4, 1.0-2.1), but not in areas of low ozone. Exposure to pollutants other than ozone did not alter the effect of team sports. Interpretation Incidence of new diagnoses of asthma is associated with heavy exercise in communities with high concentrations of ozone, thus, air pollution and outdoor exercise could contribute to the development of asthma in children.	Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Calif Air Resources Board, Sacramento, CA USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McConnell, R (corresponding author), Univ So Calif, Sch Med, Dept Prevent Med, 1540 Alcazar St,CHP 236, Los Angeles, CA 90089 USA.	rmcconne@hsc.usc.edu	, Talat/AAV-6834-2020; London, Stephanie/C-3734-2019	, Talat/0000-0002-2837-865X; London, Stephanie/0000-0003-4911-5290	NHLBI NIH HHS [1R01HL61768] Funding Source: Medline; NIEHS NIH HHS [5P30ES07048-05, 1PO1ES0939581-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049019, P30ES007048] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Asher MI, 1998, EUR RESPIR J, V12, P315; Avol EL, 1998, ENVIRON SCI TECHNOL, V32, P463, DOI 10.1021/es970351m; Baldi I, 1999, EUR RESPIR J, V14, P132, DOI 10.1034/j.1399-3003.1999.14a22.x; Becklake MR, 1997, LANCET, V350, P10; BRUNEKREEF B, 1994, AM J RESP CRIT CARE, V150, P962, DOI 10.1164/ajrccm.150.4.7921470; BURR ML, 1992, CLIN EXP ALLERGY, V22, P509, DOI 10.1111/j.1365-2222.1992.tb00158.x; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; Corrao W, 1996, CHEST, V109, P298, DOI 10.1378/chest.109.2.298; Ehrlich RI, 1995, INT J EPIDEMIOL, V24, P1138, DOI 10.1093/ije/24.6.1138; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P1001, DOI 10.1289/ehp.991071001; Heir T., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P94; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; HORSTMAN DH, 1990, AM REV RESPIR DIS, V142, P1158, DOI 10.1164/ajrccm/142.5.1158; Jenkins HS, 1999, AM J RESP CRIT CARE, V160, P33, DOI 10.1164/ajrccm.160.1.9808119; Kehrl HR, 1999, J ALLERGY CLIN IMMUN, V104, P1198, DOI 10.1016/S0091-6749(99)70013-8; KOREN HS, 1995, ENVIRON HEALTH PERSP, V103, P235, DOI 10.2307/3432379; MCARDLE WD, 1996, EXERCISE PHYSL ENERG, P228; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; Miller FJ, 1995, TOXICOL LETT, V82-3, P277, DOI 10.1016/0378-4274(95)03562-1; OSEBOLD JW, 1988, P SOC EXP BIOL MED, V188, P259; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; RUPP NT, 1992, AM J DIS CHILD, V146, P941, DOI 10.1001/archpedi.1992.02160200063028; SAMET JM, 1987, CHEST, V91, pS74, DOI 10.1378/chest.91.6.74S; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; SueChu M, 1996, RESP MED, V90, P99, DOI 10.1016/S0954-6111(96)90206-1; TAGER IB, 1998, RES REP HLTH EFF I, V81, P27; Wang TN, 1999, ENVIRON RES, V81, P239, DOI 10.1006/enrs.1999.3985; WICHMANN HE, 1995, ENVIRON HEALTH PERSP, V103, P29, DOI 10.2307/3432446	32	531	542	5	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					386	391		10.1016/S0140-6736(02)07597-9	http://dx.doi.org/10.1016/S0140-6736(02)07597-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844508				2022-12-01	WOS:000173686500008
J	Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN				Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN			Antarctic climate cooling and terrestrial ecosystem response	NATURE			English	Article							TAYLOR-VALLEY; DRY VALLEYS; COMMUNITIES; TEMPERATURE	The average air temperature at the Earth's surface has increased by 0.06degreesC per decade during the 20th century(1), and by 0.19degreesC per decade from 1979 to 1998(2). Climate models generally predict amplified warming in polar regions(3,4), as observed in Antarctica's peninsula region over the second half of the 20th century(5-9). Although previous reports suggest slight recent continental warming(9,10), our spatial analysis of Antarctic meteorological data demonstrates a net cooling on the Antarctic continent between 1966 and 2000, particularly during summer and autumn. The McMurdo Dry Valleys have cooled by 0.7degreesC per decade between 1986 and 2000, with similar pronounced seasonal trends. Summer cooling is particularly important to Antarctic terrestrial ecosystems that are poised at the interface of ice and water. Here we present data from the dry valleys representing evidence of rapid terrestrial ecosystem response to climate cooling in Antarctica, including decreased primary productivity of lakes (6-9% per year) and declining numbers of soil invertebrates (more than 10% per year). Continental Antarctic cooling, especially the seasonality of cooling, poses challenges to models of climate and ecosystem change.	Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; Montana State Univ, Bozeman, MT 59717 USA; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Portland State Univ, Dept Geol, Portland, OR 97207 USA; Univ Toledo, Dept Earth Ecol & Environm Sci, Toledo, OH 43606 USA; Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Geol Survey, Climate Program, Denver, CO 80225 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89512 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Portland State University; University System of Ohio; University of Toledo; Dartmouth College; Colorado State University; United States Department of the Interior; United States Geological Survey; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Doran, PT (corresponding author), Univ Illinois, Dept Earth & Environm Sci, 845 W Taylor St, Chicago, IL 60607 USA.		Wall, Diana H/F-5491-2011	MCKNIGHT, DIANE/0000-0002-4171-1533; Walsh, John/0000-0001-9541-5927				Bromley A. M., 1985, INFORMATION PUBLICAT, V11; BROMWICH DH, 1998, ANTARCTICA BAROMETER; CATTLE H, 1995, PHILOS T R SOC A, V352, P201, DOI 10.1098/rsta.1995.0064; CHEN CTA, 1986, ANNU REV EARTH PL SC, V14, P201, DOI 10.1146/annurev.ea.14.050186.001221; Chinn T.J., 1993, ANTARCT RES SER, V59, P1, DOI DOI 10.1029/AR059P0001; Clow GD, 1988, J CLIMATE, V1, P715, DOI 10.1175/1520-0442(1988)001<0715:COAPSR>2.0.CO;2; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; DORAN P. T., 1995, ANTARCT J US, V30, P276; DORAN PT, UNPUB J CLIM; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jacka TH, 1998, ANN GLACIOL, V27, P553; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; MCKAY CP, 1993, ANTARCT RES SER, V61, P201; McKnight DM, 1999, BIOSCIENCE, V49, P985, DOI 10.2307/1313732; National Research Council, 2000, REC OBS GLOB TEMP CH; Parish TR, 2001, J APPL METEOROL, V40, P810, DOI 10.1175/1520-0450(2001)040<0810:FOTWAB>2.0.CO;2; PORAZINSKA DL, IN PRESS ARCTIC ANTA; Powers LE, 1998, ARCTIC ALPINE RES, V30, P133, DOI 10.2307/1552128; PRISCU JC, 1995, FRESHWATER BIOL, V34, P215, DOI 10.1111/j.1365-2427.1995.tb00882.x; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; RIORDAN A. J, 1973, CLIMATE ARCTIC, P268; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Virginia RA, 1999, BIOSCIENCE, V49, P973, DOI 10.2307/1313731; Weller G, 1998, ANN GLACIOL, V27, P543; WHARTON RA, 1992, J GEOPHYS RES-OCEANS, V97, P3503, DOI 10.1029/91JC03106	29	335	346	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					517	520		10.1038/nature710	http://dx.doi.org/10.1038/nature710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793010				2022-12-01	WOS:000173564300044
J	Lobachev, KS; Gordenin, DA; Resnick, MA				Lobachev, KS; Gordenin, DA; Resnick, MA			The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements	CELL			English	Article							DNA DOUBLE-STRAND; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE AMPLIFICATION; MEIOTIC RECOMBINATION; PROTEIN COMPLEX; INVERTED REPEAT; HUMAN GENOME; YEAST-CELLS; MEIOSIS	Inverted repeats (IRs) that can form a hairpin or cruciform structure are common in the human genome and may be sources of instability. An IR involving the human Alu sequence (Alu-IR) has been studied as a model of such structures in yeast. We found that an Alu-IR is a mitotic recombination hotspot requiring MRE11/RAD50/XRS2 and SAE2. Using a newly developed approach for mapping rare double-strand breaks (DSBs), we established that induction of recombination results from breaks that are terminated by hairpins. Failure of the mre11, rad50, xrs2, and sae2 mutants to process the hairpins blocks recombinational repair of the DSBs and leads to generation of chromosome inverted duplications. Our results suggest an additional role for the Mre11 complex in maintaining genome stability.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.		Dmitry, Gordenin/C-3907-2018; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073, Z01ES021122, ZIAES065073] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Catasti P, 1999, GENETICA, V106, P15, DOI 10.1023/A:1003716509180; CHALKER AF, 1988, GENE, V71, P201, DOI 10.1016/0378-1119(88)90092-3; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; DASGUPTA U, 1987, GENETICS, V115, P41; Delidakis C, 1989, CURR OPIN CELL BIOL, V1, P488, DOI 10.1016/0955-0674(89)90010-0; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; ERLICH DS, 1989, MOBILE DNA, P799; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Galli A, 1998, GENETICS, V149, P1235; GIBSON FP, 1992, J BACTERIOL, V174, P1222, DOI 10.1128/jb.174.4.1222-1228.1992; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; HUANG T, 1995, J BIOL CHEM, V270, P9607, DOI 10.1074/jbc.270.16.9607; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jankowski C, 2000, P NATL ACAD SCI USA, V97, P2134, DOI 10.1073/pnas.040460297; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Malagon F, 1998, MOL GEN GENET, V259, P639, DOI 10.1007/s004380050858; Malkova A, 1996, GENETICS, V143, P741; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; McKee AHZ, 1997, GENETICS, V146, P797; MEUTH M, 1989, MOBILE DNA, P833; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Prinz S, 1997, GENETICS, V146, P781; Qin ZJ, 2000, GENE DEV, V14, P1789; Rattray AJ, 2001, GENETICS, V158, P109; Schar P, 2001, CELL, V104, P329, DOI 10.1016/S0092-8674(01)00220-3; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4	64	319	324	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					183	193		10.1016/S0092-8674(02)00614-1	http://dx.doi.org/10.1016/S0092-8674(02)00614-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832209	Bronze			2022-12-01	WOS:000173521300006
J	Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC				Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC			RIM1 alpha is required for presynaptic long-term potentiation	NATURE			English	Article							MOSSY FIBER SYNAPSES; CYCLIC-AMP; SYNAPTIC TRANSMISSION; CAMP; LTP; HIPPOCAMPUS; MICE; RAB3; ENHANCEMENT; ACTIVATION	Two main forms of long-term potentiation (LTP)-a prominent model for the cellular mechanism of learning and memory-have been distinguished in the mammalian brain(1). One requires activation of postsynaptic NMDA (N-methyl D-aspartate) receptors, whereas the other, called mossy fibre LTP, has a principal presynaptic component. Mossy fibre LTP is expressed in hippocampal mossy fibre synapses(1,2), cerebellar parallel fibre synapses(3,4) and corticothalamic synapses(5), where it apparently operates by a mechanism that requires activation of protein kinase A. Thus, presynaptic substrates of protein kinase A are probably essential in mediating this form of long-term synaptic plasticity. Studies of knockout mice have shown that the synaptic vesicle protein Rab3A is required for mossy fibre LTP6, but the protein kinase A substrates rabphilin, synapsin I and synapsin II are dispensable(7,8). Here we report that mossy fibre LTP in the hippocampus and the cerebellum is abolished in mice lacking RIM1alpha, an active zone protein that binds to Rab3A and that is also a protein kinase A substrate(9,10). Our results indicate that the long-term increase in neurotransmitter release during mossy fibre LTP may be mediated by a unitary mechanism that involves the GTP-dependent interaction of Rab3A with RIM1alpha at the interface of synaptic vesicles and the active zone.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Linden DJ, 1999, J NEUROSCI, V19, P10221; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	29	287	301	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					327	330		10.1038/415327a	http://dx.doi.org/10.1038/415327a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797010				2022-12-01	WOS:000173293500045
J	Zhang, S; Xu, L; Lee, J; Xu, T				Zhang, S; Xu, L; Lee, J; Xu, T			Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes	CELL			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; EVEN-SKIPPED PROTEIN; REPRESSES TRANSCRIPTION; GENE-PRODUCT; EMBRYO; PATTERN; SEGMENTATION; EXPRESSION; REPEAT; HAIRY	Dentatorubral-pallidoluysian atrophy is a progressive neurodegenerative disease caused by the expansion of a polyglutamine repeats within the Atrophin-1 protein. The In vivo function of Atrophin-1 is unknown. We have characterized a Drosophila gene encoding an Atrophin family protein. Analysis of mutant phenotypes indicates that Drosophila Atrophin is required in diverse developmental processes including early embryonic patterning. Drosophila Atrophin genetically interacts with the transcription repressor even-skipped and is required for its repressive function in vivo. Drosophila Atrophin directly binds to Even-skipped in vitro. Furthermore, both human Atrophin-1 and Drosophila Atrophin repress transcription in vivo when tethered to DNA, and poly-Q expansion in Atrophin-1 reduces this repressive activity. We propose that Atrophin proteins function as versatile transcriptional corepressors and discuss a model that deregulation of transcription may contribute to the pathogenesis of neurodegeneration.	Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.				NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; CHOU TB, 1992, GENETICS, V131, P643; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; FRASCH M, 1988, GENE DEV, V2, P1824, DOI 10.1101/gad.2.12b.1824; Fujioka M, 1999, DEVELOPMENT, V126, P2527; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LA SA, 1991, NATURE, V352, P77; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MANOUKIAN AS, 1992, GENE DEV, V6, P1740, DOI 10.1101/gad.6.9.1740; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Seki N, 1997, DNA Res, V4, P345, DOI 10.1093/dnares/4.5.345; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; STJOHNSTON D, 1992, CELL, V68, P201; WEIGEL D, 1990, SCIENCE, V248, P495, DOI 10.1126/science.2158673; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; XU TA, 1995, DEVELOPMENT, V121, P1053; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; ZHENG L, 1995, DEVELOPMENT, V121, P3045; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	35	119	119	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					45	56		10.1016/S0092-8674(01)00630-4	http://dx.doi.org/10.1016/S0092-8674(01)00630-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792320	Bronze			2022-12-01	WOS:000173280700007
J	Ischenko, AA; Saparbaev, MK				Ischenko, AA; Saparbaev, MK			Alternative nucleotide incision repair pathway for oxidative DNA damage	NATURE			English	Article							COLI ENDONUCLEASE-IV; BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; STRUCTURAL GENE; GLYCOSYLASE; ENZYMES; RECONSTITUTION; SUBSTRATE; ADDUCT; SITE	The DNA glycosylase pathway(1), which requires the sequential action of two enzymes for the incision of DNA(2), presents a serious problem for the efficient repair of oxidative DNA damage, because it generates genotoxic intermediates such as abasic sites and/or blocking 3'-end groups that must be eliminated by additional steps before DNA repair synthesis can be initiated. Besides the logistical problems, biological evidence hints at the existence of an alternative repair pathway. Mutants of Escherichia coli(3) and mice (ref. 4 and M. Takao et al., personal communication) that are deficient in DNA glycosylases that remove oxidized bases are not sensitive to reactive oxygen species, and the E. coli triple mutant nei, nth, fpg is more radioresistant than the wild-type strain(5). Here we show that Nfo-like endonucleases nick DNA on the 5' side of various oxidatively damaged bases, generating 3'-hydroxyl and 5'-phosphate termini. Nfo-like endonucleases function next to each of the modified bases that we tested, including 5,6-dihydrothymine, 5,6-dihydrouracil, 5-hydroxyuracil and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine residues. The 3'-hydroxyl terminus provides the proper end for DNA repair synthesis; the dangling damaged nucleotide on the 5' side is then a good substrate for human flap-structure endonuclease(6) and for DNA polymerase I of E. coli.	Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, F-94805 Villejuif, France; Russian Acad Sci, Novosibirsk Bioorgan Chem Inst, Siberian Div, Novosibirsk 630090, Russia	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Saparbaev, MK (corresponding author), Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, Rue Camille Desmoulins, F-94805 Villejuif, France.		Saparbaev, Murat K/N-3225-2015; Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat/AAC-5478-2020	Saparbaev, Murat K/0000-0002-4630-1074; Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat/0000-0002-4630-1074				Alleva JL, 2000, BIOCHEMISTRY-US, V39, P2659, DOI 10.1021/bi992751n; BAILLY V, 1989, BIOCHEM J, V259, P761, DOI 10.1042/bj2590761; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P10450; FURLONG EA, 1986, BIOCHEMISTRY-US, V25, P4344, DOI 10.1021/bi00363a025; Gonzalez-Flecha B, 2000, ANN NY ACAD SCI, V899, P69; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LAVAL J, 1977, NATURE, V269, P829, DOI 10.1038/269829a0; LINDAHL T, 1976, NATURE, V259, P64, DOI 10.1038/259064a0; Maksimenko AV, 1999, NUCLEOS NUCLEOT, V18, P2071, DOI 10.1080/07328319908044865; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; RAMOTAR D, 1991, MOL MICROBIOL, V5, P149, DOI 10.1111/j.1365-2958.1991.tb01835.x; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROGERS SG, 1980, GENE, V11, P187, DOI 10.1016/0378-1119(80)90059-1; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Yasui A, 1998, BIOESSAYS, V20, P291, DOI 10.1002/(SICI)1521-1878(199804)20:4<291::AID-BIES5>3.0.CO;2-T	29	205	222	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					183	187		10.1038/415183a	http://dx.doi.org/10.1038/415183a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805838				2022-12-01	WOS:000173159300045
J	Chang, D; Markman, BS				Chang, D; Markman, BS			Spontaneous resolution of a pubic-symphysis diastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									San Francisco Orthopaed Residency Program, San Francisco, CA 94117 USA		Chang, D (corresponding author), San Francisco Orthopaed Residency Program, San Francisco, CA 94117 USA.								0	4	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					39	39		10.1056/NEJMicm980471	http://dx.doi.org/10.1056/NEJMicm980471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11778001				2022-12-01	WOS:000173033600006
J	Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL				Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL			Meiotic silencing by unpaired DNA	CELL			English	Article							DIRECTED RNA-POLYMERASE; INDUCED POINT MUTATION; DOUBLE-STRANDED-RNA; NEUROSPORA-CRASSA; MATING-TYPE; GENETIC INTERFERENCE; EXPRESSION; TRANSVECTION; RECOGNITION; INSTABILITY	The silencing of gene expression by segments of DNA present in excess of the normal number is called cosuppression in plants and quelling in fungi. We describe a related process, meiotic silencing by unpaired DNA (MSUD). DNA unpaired in meiosis causes silencing of all DNA homologous to it, including genes that are themselves paired. A semidominant Neurospora mutant, Sad-1, fails to perform MSUD. Sad-1 suppresses the sexual phenotypes of many ascus-dominant mutants. MSUD may provide insights into the function of genes necessary for meiosis, including genes for which ablation in vegetative life would be lethal. It may also contribute to reproductive isolation of species within the genus Neurospora. The wild-type allele, sad-1(+), encodes a putative RNA-directed RNA polymerase.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France	Stanford University; UDICE-French Research Universities; Universite Paris Saclay	Shiu, PKT (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	ktshiu@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM008995, R01GM008995] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 08995] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1990, FUNGAL GENET NEWSL, DOI [10.4148/1941-4765.1472, DOI 10.4148/1941-4765.1472]; Aramayo R, 1996, GENETICS, V144, P991; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; BUTLER DK, 1993, CHROMOSOMA, V102, P519, DOI 10.1007/BF00368345; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Coppin E, 2000, GENETICS, V155, P657; CRISP TM, 1992, MUTAT RES, V296, P89, DOI 10.1016/0165-1110(92)90034-7; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Mitchell M. B, 1966, NEUROSPORA NEWSL, V10, P6; Noubissi FK, 2000, FUNGAL GENET BIOL, V31, P91, DOI 10.1006/fgbi.2000.1235; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PERKINS DD, 1988, EXP MYCOL, V12, P91, DOI 10.1016/0147-5975(88)90001-1; Perkins DD, 1997, GENETICS, V147, P125; Perkins DD, 1997, ADV GENET, V36, P239, DOI 10.1016/S0065-2660(08)60311-9; PERKINS DD, 2001, NEUROSPORA COMPENDIU, P92; RAJU NB, 1977, EXP MYCOL, V1, P152, DOI 10.1016/S0147-5975(77)80040-6; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAJU NB, 1978, CAN J GENET CYTOL, V20, P41, DOI 10.1139/g78-007; RANDALL TA, 1995, GENETICS, V141, P119; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHROEDER AL, 1986, CURR GENET, V10, P381, DOI 10.1007/BF00418410; SCHROEDER AL, 1975, MOL MECHANISMS REP B, P567; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Shiu PKT, 2000, CURR OPIN MICROBIOL, V3, P183, DOI 10.1016/S1369-5274(00)00073-4; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THOMPSONCOFFE C, 1994, DEV BIOL, V165, P257, DOI 10.1006/dbio.1994.1251; Tinsley JH, 1998, MOL GEN GENET, V259, P601, DOI 10.1007/s004380050853; TOPPER VM, 1972, THESIS CORNELL U; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	54	339	360	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					905	916		10.1016/S0092-8674(01)00609-2	http://dx.doi.org/10.1016/S0092-8674(01)00609-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779466	Bronze			2022-12-01	WOS:000173024200011
J	Clarfield, AM				Clarfield, AM			In grandfather's room	BRITISH MEDICAL JOURNAL			English	Article									Soroka Hosp Ctr, Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University	Clarfield, AM (corresponding author), Soroka Hosp Ctr, Beer Sheva, Israel.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1496	1497		10.1136/bmj.323.7327.1496	http://dx.doi.org/10.1136/bmj.323.7327.1496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751369	Green Published			2022-12-01	WOS:000172979900030
J	Redelmeier, DA; Singh, SM				Redelmeier, DA; Singh, SM			Longevity of screenwriters who win an academy award: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC-STATUS; HEALTH; MORTALITY; STRESS	Objective To determine whether the link between high success and longevity extends to academy award winning screenwriters. Design Retrospective cohort analysis. Participants All screenwriters ever nominated for an academy award. Main outcome measures Life expectancy and all cause mortality Results A total of 850 writers were nominated; the median duration of follow up from birth was 68 years; and 428 writers died. On average, winners were more successful than nominees, as indicated by a 14% longer career (27.7 v 24.2, P = 0.004), 34% more total films (23.2 v 17.3, P < 0.001), 58% more four star films (4.8 v 3.1, P < 0.001), and 62% more nominations (2.1 v, 1.3, P < 0.001). However, life expectancy was 3.6 years shot-ter for winners than for nominees (74.1 v, 77.7 years. P = 0.004), equivalent to a 37% relative increase in death rates (95% confidence interval 10 to 70). After adjustment for year of birth, sex, and other factors, a 35% relative increase in death rates was found (7%, to 70%). Additional wins were associated with a 22% relative increase in death rates (31% to 44%). Additional nominations and additional other films in a career otherwise caused no significant increase in death rates. Conclusion The link between occupational achievement and longevity is reversed in screenwriters who win academy awards. Doubt is cast on simple biological theories for the survival gradients found for other members of society.	Sunnybrook & Womens Hosp, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Sunnybrook & Womens Hosp, Toronto, ON M4N 3M5, Canada.							Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; [Anonymous], 1994, WHY ARE SOME PEOPLE; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Detsky AS, 1998, NEW ENGL J MED, V339, P402, DOI 10.1056/NEJM199808063390611; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; GARBER AM, 1989, PATHWAYS HLTH ROLE S, P271; Katz Ephraim, 1998, FILM ENCY; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1984, LANCET, V1, P1003; MYERS J, 1968, DECADE LATER FOLLOW; SAPOLSKY RM, 1990, SCI AM, V262, P116, DOI 10.1038/scientificamerican0190-116; STEWART WT, 1981, INT FILM NECROLOGY; Syme SL, 1998, MILBANK Q, V76, P493, DOI 10.1111/1468-0009.00100; Thomas Nicholas, 1990, INT DICT FILMS FILMM; Vincendeau G., 1995, ENCY EUROPEAN CINEMA; WALKER J, 1997, HALLIWELLS FILMGOERS	20	25	25	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1491	1496		10.1136/bmj.323.7327.1491	http://dx.doi.org/10.1136/bmj.323.7327.1491			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751368	Green Published			2022-12-01	WOS:000172979900029
J	Weijers, D; Geldner, N; Offringa, R; Jurgens, G				Weijers, D; Geldner, N; Offringa, R; Jurgens, G			Seed development - Early paternal gene activity in Arabidopsis	NATURE			English	Article							PATTERN-FORMATION; EMBRYO; PROTEIN		Leiden Univ, Inst Mol Plant Sci, NL-2333 AL Leiden, Netherlands; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Leiden University; Leiden University - Excl LUMC; Eberhard Karls University of Tubingen	Weijers, D (corresponding author), Leiden Univ, Inst Mol Plant Sci, NL-2333 AL Leiden, Netherlands.		Geldner, Niko/Y-2481-2019; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Offringa, Remko/0000-0002-3293-5295				Hamann T, 1999, DEVELOPMENT, V126, P1387; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; MAYER U, 1993, DEVELOPMENT, V117, P149; Springer PS, 2000, DEVELOPMENT, V127, P1815; SURANI MA, 1990, DEVELOPMENT, P89; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2	9	93	98	2	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					709	710		10.1038/414709a	http://dx.doi.org/10.1038/414709a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742384				2022-12-01	WOS:000172676200032
J	Rycroft, B				Rycroft, B			My adventure with breast cancer	LANCET			English	Article											Rycroft, B (corresponding author), POB 24002, ZA-7735 Claremont, South Africa.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S6	S6		10.1016/S0140-6736(01)07019-2	http://dx.doi.org/10.1016/S0140-6736(01)07019-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784555				2022-12-01	WOS:000172907200006
J	Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P				Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P			Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR; ANEMIA; CDNA	Background: Within a period of three years, we identified 13 patients in whom pure red-cell aplasia developed during treatment with recombinant human erythropoietin (epoetin). We investigated whether there was an immunologic basis for the anemia in these patients. Methods: Serum samples from the 13 patients with pure red-cell aplasia were tested for neutralizing antibodies that could inhibit erythroid-colony formation by normal bone marrow cells in vitro. The presence of antierythropoietin antibodies was identified by means of binding assays with the use of radiolabeled intact, deglycosylated, or denatured epoetin. Results: Serum from all 13 patients blocked the formation of erythroid colonies by normal bone marrow cells. The inhibition was reversed by epoetin. Antibodies from 12 of the 13 patients bound only conformational epitopes in the protein moiety of epoetin; serum from the remaining patient bound to both conformational and linear epitopes in erythropoietin. In all the patients, the antibody titer slowly decreased after the discontinuation of treatment with epoetin. Conclusions: Neutralizing antierythropoietin antibodies and pure red-cell aplasia can develop in patients with the anemia of chronic renal failure during treatment with epoetin. (N Engl J Med 2002;346:469-75.) Copyright (C) 2002 Massachusetts Medical Society.	Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France; Hop Hotel Dieu, Dept Nucl Med, Paris, France; INSERM, U362, Paris, France; Hop Bichat, Dept Nephrol, F-75877 Paris, France; Hop Bichat, Dept Internal Med, F-75877 Paris, France; Assoc Utilisat Rein Artificiel Reg Parisienne, St Ouen, France; Hop Beaujon, Dept Hematol, Clichy, France; Ctr Treitement Malad Renales St Augustin, Bordeaux, France; Polyclin Lagny, Lagny Sur Marne, France; Univ Paris 05, Ctr Hosp Univ Necker Enfants Malad, Dept Hematol, Paris, France; Inst Cochin Genet Mol, INSERM, U363, F-75014 Paris, France; Inst Cochin Genet Mol, Dept Hematol, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Casadevall, N (corresponding author), Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France.		Kiladjian, Jean-Jacques/K-5345-2019	Kiladjian, Jean-Jacques/0000-0002-8121-438X; Ugo, Valerie/0000-0002-4678-2138				Casadevall N, 1996, NEW ENGL J MED, V334, P630, DOI 10.1056/NEJM199603073341004; DESSYPRIS EN, 1991, SEMIN HEMATOL, V28, P275; ESCHBACH JW, 1985, KIDNEY INT, V28, P1, DOI 10.1038/ki.1985.109; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; MAYEUX P, 1990, FEBS LETT, V269, P167, DOI 10.1016/0014-5793(90)81145-E; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Storring PL, 1998, BRIT J HAEMATOL, V100, P79; Stridsberg M., 1993, ERYTHROPOIETIN MOL P, P266; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1	15	862	922	0	22	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					469	475		10.1056/NEJMoa011931	http://dx.doi.org/10.1056/NEJMoa011931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844847				2022-12-01	WOS:000173815300002
J	Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG				Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG			Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor	SCIENCE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; HISTONE DEACETYLASE; RAR-ALPHA; FUSION PROTEINS; DIFFERENTIATION; METHYLATION; CANCER; GENE; EPIGENETICS; REPRESSION	DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.	European Inst Oncol, Dept Expt Oncol, Milan, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy; Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; Univ Cambridge, Wellcome CRC Inst, Cambridge, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Camerino, Dept Morphol Sci, I-62032 Camerino, Italy; Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); Sapienza University Rome; Sapienza University Rome; University of Cambridge; University of Cambridge; University of Camerino; IFOM - FIRC Institute of Molecular Oncology	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.		Fanelli, Mirco/F-2665-2011; Di Croce, Luciano/E-7759-2015; Faretta, Mario/H-8946-2012; Minucci, Saverio/J-9669-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; Fazi, Francesco/K-5304-2018	Fanelli, Mirco/0000-0002-9649-8661; Di Croce, Luciano/0000-0003-3488-6228; Faretta, Mario/0000-0003-1678-5781; Fazi, Francesco/0000-0003-2910-7912; NERVI, Clara/0000-0001-9341-0188; Kouzarides, Tony/0000-0002-8918-4162				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Benedetti L, 1996, BLOOD, V87, P1939; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Casini T, 1999, ONCOGENE, V18, P3235, DOI 10.1038/sj.onc.1202630; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DICROCE L, UNPUB; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PELICCI PG, UNPUB; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ruthardt M, 1997, MOL CELL BIOL, V17, P4859, DOI 10.1128/MCB.17.8.4859; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826	25	619	638	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1079	1082		10.1126/science.1065173	http://dx.doi.org/10.1126/science.1065173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834837	Green Submitted			2022-12-01	WOS:000173793000068
J	Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B				Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B			Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion	NATURE			English	Article							PHOSPHOLIPID-BINDING; SPEED LIMIT; SYNAPTOTAGMIN; PROTEIN; COMPLEX; SYNAPTOPHYSIN; EXOCYTOSIS; VESICLES; TETANUS; RELEASE	Release of neurotransmitter occurs when synaptic vesicles fuse with the plasma membrane. This neuronal exocytosis is triggered by calcium and requires three SNARE (soluble-N-ethylmaleimide-sensitive factor attachment protein receptors) proteins: synaptobrevin (also known as VAMP) on the synaptic vesicle, and syntaxin and SNAP-25 on the plasma membrane(1-4). Neuronal SNARE proteins form a parallel four-helix bundle that is thought to drive the fusion of opposing membranes(5,6). As formation of this SNARE complex in solution does not require calcium, it is not clear what function calcium has in triggering SNARE-mediated membrane fusion. We now demonstrate that whereas syntaxin and SNAP-25 in target membranes are freely available for SNARE complex formation, availability of synaptobrevin on synaptic vesicles is very limited. Calcium at micromolar concentrations triggers SNARE complex formation and fusion between synaptic vesicles and reconstituted target membranes. Although calcium does promote interaction of SNARE proteins between opposing membranes, it does not act by releasing synaptobrevin from synaptic vesicle restriction. Rather, our data suggest a mechanism in which calcium-triggered membrane apposition enables syntaxin and SNAP-25 to engage synaptobrevin, leading to membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	baz@mrc-lmb.cam.ac.uk	Davletov, Bazbek/ABA-8569-2021; Fedorovich, Sergei/N-4315-2013	Rickman, Colin/0000-0001-8938-524X				Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Capogna M, 1997, J NEUROSCI, V17, P7190; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Elferink LA, 1995, PROG BRAIN RES, V105, P79; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; KELLY RB, 1999, FR MOLEC B, V23, P1; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; McCammon JA, 1996, P NATL ACAD SCI USA, V93, P11426, DOI 10.1073/pnas.93.21.11426; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meyuhas D, 1996, BIOPHYS J, V71, P2602, DOI 10.1016/S0006-3495(96)79452-3; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; PERIN MS, 1991, J BIOL CHEM, V266, P615; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schikorski T, 1997, J NEUROSCI, V17, P5858; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tolar LA, 1998, J NEUROSCI, V18, P10250; VIGUERA AR, 1993, BIOCHEMISTRY-US, V32, P3708, DOI 10.1021/bi00065a024; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wittung-Stafshede P, 1999, P NATL ACAD SCI USA, V96, P6587, DOI 10.1073/pnas.96.12.6587; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	30	149	152	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					646	650		10.1038/415646a	http://dx.doi.org/10.1038/415646a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832947				2022-12-01	WOS:000173709100048
J	Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H				Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H			S-Cdk-dependent phosphorylation of Sld2 essential for chromosomal DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; POLYMERASE-ALPHA; SHUTTLE VECTORS; KINASE; PHASE; ORIGINS; COMPLEX; PROTEIN; CDC45P	Cyclin-dependent protein kinases (Cdks) in eukaryotic cells work as a key enzyme at various points in the cell cycle(1,2). At the onset of S phase, active S-phase Cdks (S-Cdks) are essential for chromosomal DNA replication(3). Although several replication proteins are phosphorylated in a Cdk-dependent manner(3), the biological effects of phosphorylation of these proteins on the activation of DNA replication have not been elucidated. Here we show that Sld2 (ref. 4) (also known as Drc1; ref. 5), one of the replication proteins of budding yeast (Saccharomyces cerevisiae), is phosphorylated in S phase in an S-Cdk-dependent manner, and mutant Sld2 lacking all the preferred Cdk phosphorylation sites (All-A) is defective in chromosomal DNA replication. Moreover, the complex that contains, at least, Sld2 and Dpb11 (ref. 6) (the Sld2-Dpb11 complex(4)) is formed predominantly in S phase; the All-A protein is defective in this complex formation. Because this complex is suggested to be essential for chromosomal DNA replication 4,5, it seems likely that S-Cdk positively regulates formation of the Sld2-Dpb11 complex and, consequently, chromosomal DNA replication.	Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Yata 1111, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Kamimura, Yoichiro/M-2585-2017					Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Diffley JFX, 1995, J CELL SCI, P67; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PONDAVEN P, 1990, GENE DEV, V4, P9, DOI 10.1101/gad.4.1.9; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	30	164	169	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					651	655		10.1038/nature713	http://dx.doi.org/10.1038/nature713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11807498				2022-12-01	WOS:000173709100049
J	Fraser, PJ; Shelmerdine, RL				Fraser, PJ; Shelmerdine, RL			Fish physiology - Dogfish hair cells sense hydrostatic pressure	NATURE			English	Article									Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Aberdeen	Fraser, PJ (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.			Shelmerdine, Richard L./0000-0003-2135-3326				BLAXTER JHS, 1980, ENV PHYSL FISHES, P369; Conradi P, 1999, ORL J OTO-RHINO-LARY, V61, P57, DOI 10.1159/000027642; DIGBY PS, 1961, NATURE, V191, P366, DOI 10.1038/191366a0; DOWSE HB, 1994, BIOL RHYTHM RES, V25, P1; FRASER PJ, 1994, NATURE, V371, P383, DOI 10.1038/371383b0; HARDY AC, 1951, NATURE, V168, P327; LOWENSTEIN O, 1978, PROC R SOC SER B-BIO, V202, P313, DOI 10.1098/rspb.1978.0070; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Pavlov DS, 2000, J FISH BIOL, V57, P69, DOI 10.1006/jfbi.2000.1287	9	31	31	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					495	496		10.1038/415495a	http://dx.doi.org/10.1038/415495a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823850				2022-12-01	WOS:000173564300036
J	Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H				Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H			Complete development of mosquito phases of the malaria parasite in vitro	SCIENCE			English	Article							PLASMODIUM-BERGHEI; SPOROGONIC DEVELOPMENT; ANOPHELES-STEPHENSI; IN-VITRO; TRANSMISSION; GALLINACEUM; INVITRO; EXPRESSION; HEMOLYMPH; PROTEINS	Methods for reproducible in vitro development of the mosquito stages of malaria parasites to produce infective sporozoites have been elusive for over 40 years. We have cultured gametocytes of Plasmodium berghei through to infectious sporozoites with efficiencies similar to those recorded in vivo and without the need for salivary gland invasion. Oocysts developed extracellularly in a system whose essential elements include co-cultured Drosophila S2 cells, basement membrane matrix, and insect tissue culture medium. Sporozoite production required the presence of para-aminobenzoic acid. The entire life cycle of P. berghei, a useful model malaria parasite, can now be achieved in vitro.	Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England	Keele University; Imperial College London	Hurd, H (corresponding author), Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.							Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; ALOLAYAN EM, UNPUB J CELL BIOL; Arrighi RBG, 2002, INT J PARASITOL, V32, P91, DOI 10.1016/S0020-7519(01)00298-3; BALL GH, 1964, J PARASITOL, V50, P3, DOI 10.2307/3276018; Billingsley PF, 1997, PARASITOL TODAY, V13, P297, DOI 10.1016/S0169-4758(97)01094-6; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; BOULANGER N, 1995, PARASITOL RES, V81, P58, DOI 10.1007/BF00932418; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; MACK SR, 1978, J PARASITOL, V64, P918, DOI 10.2307/3279531; PETERS W, 1980, ANN TROP MED PARASIT, V74, P275, DOI 10.1080/00034983.1980.11687345; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shahabuddin M, 1998, P NATL ACAD SCI USA, V95, P3385, DOI 10.1073/pnas.95.7.3385; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; SINDEN RE, 1987, PROC R SOC SER B-BIO, V230, P443, DOI 10.1098/rspb.1987.0028; SYAFRUDDIN RA, 1992, J PROTOZOOL, V39, P333; UCHIDA K, 1990, J MED ENTOMOL, V27, P302, DOI 10.1093/jmedent/27.3.302; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1977, B WORLD HEALTH ORGAN, V55, P377; VARMA MGR, 1969, J MED ENTOMOL, V6, P432, DOI 10.1093/jmedent/6.4.432; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; WARBURG A, 1993, EXP PARASITOL, V76, P121, DOI 10.1006/expr.1993.1014; WARBURG A, 1992, SCIENCE, V255, P448, DOI 10.1126/science.1734521; WINGER LA, 1992, PARASITOL RES, V78, P427, DOI 10.1007/BF00931700; YEON SH, 2000, EMBO J, V19, P6030; Yuda M, 1999, J EXP MED, V189, P1947, DOI 10.1084/jem.189.12.1947; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	31	80	86	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					677	679		10.1126/science.1067159	http://dx.doi.org/10.1126/science.1067159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809973				2022-12-01	WOS:000173560900045
J	Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ				Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ			Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila	CELL			English	Article							EMBRYONIC VENTRAL ECTODERM; GROWTH-FACTOR RECEPTOR; ZINC-FINGER DOMAIN; EGF RECEPTOR; NEUROTRANSMITTER RELEASE; MULTIVESICULAR BODY; PROTEIN; ENDOCYTOSIS; MELANOGASTER; INTERACTS	Signaling through tyrosine kinase receptors (TKRs) is thought to be modulated by receptor-mediated endocytosis and degradation of the receptor in the lysosome. However, factors that regulate endosomal sorting of TKRs are largely unknown. Here, we demonstrate that Hrs ((H) under bar epatocyte growth factor-(r) under bar egulated tyrosine kinase (s) under bar ubstrate) is one such factor. Electron microscopy studies of hrs mutant larvae reveal an impairment in endosome membrane invagination and formation of multivesicular bodies (MVBs). hrs mutant animals fail to degrade active epidermal growth factor (EGF) and Torso TKRs, leading to enhanced signaling and altered embryonic patterning. These data suggest that Hrs and MVB formation function to downregulate TKR signaling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.			Lloyd, Thomas/0000-0003-4756-3700; Bellen, Hugo/0000-0001-5992-5989				Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; CHOU TB, 1993, DEVELOPMENT, V119, P1359; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DOYLE HJ, 1993, GENE DEV, V7, P633, DOI 10.1101/gad.7.4.633; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, DEVELOPMENT, V124, P3535; Ghiglione C, 1999, DEV BIOL, V205, P181, DOI 10.1006/dbio.1998.9102; Golembo M, 1996, DEVELOPMENT, V122, P3363; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; KOENIG JH, 1990, CELL TISSUE RES, V262, P233, DOI 10.1007/BF00309878; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kwong J, 2000, J CELL SCI, V113, P2273; LEPTIN M, 1992, DEVELOPMENT, P23; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; LITTLETON JT, 1994, GENETICS, V138, P111; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; NARITA K, 1989, J CELL PHYSIOL, V141, P383, DOI 10.1002/jcp.1041410220; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; PERRIMON N, 1986, GENETICS, V113, P695; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SPRENGER F, 1992, CELL, V71, P987, DOI 10.1016/0092-8674(92)90394-R; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; WIDES RJ, 1990, EUR J BIOCHEM, V189, P637, DOI 10.1111/j.1432-1033.1990.tb15532.x; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129	53	359	363	2	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					261	269		10.1016/S0092-8674(02)00611-6	http://dx.doi.org/10.1016/S0092-8674(02)00611-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832215	Bronze			2022-12-01	WOS:000173521300012
J	Pluk, H; Dorey, K; Superti-Furga, G				Pluk, H; Dorey, K; Superti-Furga, G			Autoinhibition of c-Abl	CELL			English	Article							TYROSINE KINASE-ACTIVITY; BCR-ABL; SH3 DOMAINS; SRC-FAMILY; POSITIVE CELLS; HUMAN LEUKEMIA; PROTEIN; GROWTH; TRANSFORMATION; INHIBITOR	Despite years of investigation, the molecular mechanism responsible for regulation of the c-Abl tyrosine kinase has remained elusive. We now report inhibition of the catalytic activity of purified c-Abl in vitro, demonstrating that regulation is an intrinsic property of the molecule. We show that the interaction of the N-terminal 80 residues with the rest of the protein mediates autoregulation. This N-terminal "cap" is required to achieve and maintain inhibition, and its loss turns c-Abl into an oncogenic protein and contributes to deregulation of BCR-Abl.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH	Superti-Furga, G (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Dorey, Karel/0000-0003-0846-5286				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Dorey K, 1999, BIOL CHEM, V380, P223; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hardin JD, 1996, ONCOGENE, V12, P2669; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Koegl M, 1995, ONCOGENE, V11, P2317; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; McCormick F, 2001, NATURE, V412, P281, DOI 10.1038/35085665; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; RENSHAW MW, 1992, EMBO J, V11, P3941, DOI 10.1002/j.1460-2075.1992.tb05488.x; SAWYERS CL, 1992, CANCER SURV, V15, P37; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Walkenhorst J, 1996, ONCOGENE, V12, P1513; WANG JYJ, 1988, ONCOGENE RES, V3, P293; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200	48	184	200	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					247	259		10.1016/S0092-8674(02)00623-2	http://dx.doi.org/10.1016/S0092-8674(02)00623-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832214	Bronze			2022-12-01	WOS:000173521300011
J	Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM				Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM			Estimating the human health risk from possible BSE infection of the British sheep flock	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; GREAT-BRITAIN; PRION PROTEIN; SCRAPIE; EPIDEMIOLOGY; TRANSMISSION; ACCUMULATION; DYNAMICS; VCJD	Following the controversial failure of a recent study(1) and the small numbers of animals yet screened for infection(2), it remains uncertain whether bovine spongiform encephalopathy (BSE) was transmitted to sheep in the past via feed supplements and whether it is still present. Well grounded mathematical and statistical models are therefore essential to integrate the limited and disparate data, to explore uncertainty, and to define data-collection priorities. We analysed the implications of different scenarios of BSE spread in sheep for relative human exposure levels and variant Creutzfeldt-Jakob disease (vCJD) incidence. Here we show that, if BSE entered the sheep population and a degree of transmission occurred, then ongoing public health risks from ovine BSE are likely to be greater than those from cattle, but that any such risk could be reduced by up to 90% through additional restrictions on sheep products entering the food supply. Extending the analysis to consider absolute risk, we estimate the 95% confidence interval for future vCJD mortality to be 50 to 50,000 human deaths considering exposure to bovine BSE alone, with the upper bound increasing to 150,000 once we include exposure from the worst-case ovine BSE scenario examined.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@ic.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Ghani, Azra/0000-0002-0007-4910; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; d'Aignaux JNH, 2001, SCIENCE, V294, P1729, DOI 10.1126/science.1064748; DONNELLY CA, 2000, STAT ASPECTS BSE VCI; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Frankish H, 2001, LANCET, V358, P1436, DOI 10.1016/S0140-6736(01)06544-8; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hart R. J, 1997, AUDIT BOVINE OVINE S; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hoinville LJ, 2000, VET REC, V146, P455, DOI 10.1136/vr.146.16.455; Hunter N, 2000, ARCH VIROL, P181; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; JEFFREY M, UNPUB J COMP PATHOL; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; *MEAT LIV COMM, 1998, C782506 MEAT LIV COM; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; van Keulen LJM, 2000, ARCH VIROL, P57; WELLS GAH, 1994, VET REC, V135, P40, DOI 10.1136/vr.135.2.40; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427	29	81	82	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					420	424		10.1038/nature709	http://dx.doi.org/10.1038/nature709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11786878				2022-12-01	WOS:000173433600047
J	Matsumoto, Y; Maller, JL				Matsumoto, Y; Maller, JL			Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts	SCIENCE			English	Article							PROTEIN-KINASE-II; MAMMALIAN-CELLS	Aberrant centrosome duplication is observed in many tumor cells and may contribute to genomic instability through the formation of multipolar mitotic spindles. Cyclin-dependent kinase 2 (Cdk2) is required for multiple rounds of centrosome duplication in Xenopus egg extracts but not for the initial round of replication. Egg extracts undergo periodic oscillations in the level of free calcium. We show here that chelation of calcium in egg extracts or specific inactivation of calcium/calmodulin-dependent protein kinase 11 (CaMKII) blocks even initial centrosome duplication, whereas inactivation of Cdk2 does not. Duplication can be restored to inhibited extracts by addition of CaMKII and calmodulin. These results indicate that calcium, calmodulin, and CaMKII are required for an essential step in initiation of centrosome duplication. Our data suggest that calcium oscillations in the cell cycle may be linked to centrosome duplication.	Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.				NCI NIH HHS [CA46934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Kim SH, 1999, DEV BIOL, V212, P381, DOI 10.1006/dbio.1999.9361; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y., UNPUB; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; OHTA Y, 1990, P NATL ACAD SCI USA, V87, P5341, DOI 10.1073/pnas.87.14.5341; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PIETROMONACO SF, 1995, BLOOD CELL MOL DIS, V21, P34, DOI 10.1006/bcmd.1995.0006; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; Swanson CA, 1997, P NATL ACAD SCI USA, V94, P1194, DOI 10.1073/pnas.94.4.1194; Tokmakov AA, 2001, J CELL BIOCHEM, V82, P89, DOI 10.1002/jcb.1140.abs; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	27	79	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					499	502		10.1126/science.1065693	http://dx.doi.org/10.1126/science.1065693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799245				2022-12-01	WOS:000173350700051
J	Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD				Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD			Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; PDGF ALPHA-RECEPTOR; ADULT HUMAN CNS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; SPINAL-CORD; REMYELINATION; SURVIVAL; BRAIN	Background: Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination. Methods: Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes. Results: Thirty-four of the 48 chronic lesions of multiple sclerosis contained oligodendrocytes with multiple extended processes that associated with demyelinated axons but failed to myelinate them. These axons were dystrophic and contained multiple swellings. In some regions, the densities of premyelinating oligodendrocytes (25 per square millimeter of tissue) were similar to those in the developing rodent brain (23 per square millimeter). In the patients with disease of long duration (more than 20 years), there were fewer lesions with premyelinating oligodendrocytes (P<0.001). Conclusions: Premyelinating oligodendrocytes are present in chronic lesions of multiple sclerosis, so remyelination is not limited by an absence of oligodendrocyte progenitors or their failure to generate oligodendrocytes. Our findings suggest that in the chronic lesions of multiple sclerosis, the axons are not receptive for remyelination. Understanding the cellular interactions between premyelinating oligodendrocytes, axons, and the microenvironment of lesions of multiple sclerosis may lead to effective strategies for enhancing remyelination. (N Engl J Med 2002;346:165-73.) Copyright (C) 2002 Massachusetts Medical Society.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44195 USA; W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Trapp, BD (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Calabrese, Massimiliano/I-6195-2012; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS035058] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35058, P01 NS38667] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BRUCK W, 1994, ANN NEUROL, V35, P65, DOI 10.1002/ana.410350111; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Duncan ID, 1997, MOL MED TODAY, V3, P554, DOI 10.1016/S1357-4310(97)01162-3; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; GOGATE N, 1994, J NEUROSCI, V14, P4571; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Murray PD, 2001, BRAIN, V124, P1403, DOI 10.1093/brain/124.7.1403; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1989, LAB INVEST, V61, P489; PRINEAS JW, 1984, ANN NY ACAD SCI, V436, P11, DOI 10.1111/j.1749-6632.1984.tb14773.x; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi JY, 1998, J NEUROSCI, V18, P4627; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Ueda H, 1999, J CELL BIOL, V146, P1365, DOI 10.1083/jcb.146.6.1365; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387	38	729	779	1	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					165	173		10.1056/NEJMoa010994	http://dx.doi.org/10.1056/NEJMoa010994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796850				2022-12-01	WOS:000173273600004
J	Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC				Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC			HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; UNITED-STATES; WOMEN; PREVALENCE; DISEASE; TRENDS; DISORDERS; CARCINOMA; CANCERS	Background Information about vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia in women infected with HIV-1 is needed to develop guidelines for clinical care. Our aim was to investigate the incidence of these lesions in HIV-1-positive and HIV-1-negative women and to examine risk factors for disease. Methods In a prospective cohort study, 925 women had a gynaecological examination twice yearly-including colposcopy and tests for human papillomavirus DNA in cervicovaginal lavage-for a median follow-up of 3.2 years (IQR 0.98-4.87). Findings Vulvovaginal and perianal condylomata acuminata or intraepithelial neoplasia were present in 30 (6%) of 481 HIV-1-positive and four (1%) of 437 HIV-1-negative women (p < 0.0001) at enrolment. Women without lesions at enrolment were included in an incidence analysis. 33 (9%) of 385 HIV-1-positive and two (1%) of 341 HIV-1-negative women developed vulvovaginal or perianal lesions, resulting in an incidence of 2.6 and 0.16 cases per 100 person-years, respectively (relative risk 16, 95% Cl 12.9-20.5; p < 0.0001). Risk factors for incident lesions included HIV-1 infection (p = 0.013), human papillomavirus infection (p = 0.0013), lower CD4 T lymphocyte count (p = 0.0395), and history of frequent injection of drugs (P = 0.0199). Interpretation Our results suggest that HIV-1-positive women are at increased risk of development of invasive vulvar carcinoma. Thus, we recommend that, as part of every gynaecological examination, HIV-1-positive women should have a thorough inspection of the vulva and perianal region, and women with abnormalities-except for typical, exophytic condylomata acuminata-should undergo colposcopy and biopsy.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Publ Hlth Serv,US Dept Hlth & Human Serv, Atlanta, GA USA; New York City Dept Hlth, Bur Dis Intervent Res, New York, NY 10013 USA	Columbia University; Centers for Disease Control & Prevention - USA; United States Public Health Service; New York City Department of Health & Mental Hygiene	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-402,630 W 168th St, New York, NY 10032 USA.				ODCDC CDC HHS [U64/CCU206822] Funding Source: Medline	ODCDC CDC HHS		Bersoff-Matcha SJ, 1998, J INFECT DIS, V178, P1174, DOI 10.1086/515678; BLOHME I, 1985, TRANSPLANTATION, V39, P23; BYRNE MA, 1989, AIDS, V3, P379, DOI 10.1097/00002030-198906000-00007; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P1; CHIASSON M, 1998, P 2 AIDS MAL C APR B; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Chin KM, 1998, OBSTET GYNECOL, V92, P83, DOI 10.1016/S0029-7844(98)00140-9; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FENNEMA JSA, 1995, AIDS, V9, P1071, DOI 10.1097/00002030-199509000-00014; Frankel RE, 1997, CLIN INFECT DIS, V25, P706, DOI 10.1086/513775; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; GHYS PD, 1995, J INFECT DIS, V172, P1371, DOI 10.1093/infdis/172.5.1371; JONES RW, 1995, BRIT J OBSTET GYNAEC, V102, P764, DOI 10.1111/j.1471-0528.1995.tb10839.x; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; JONES RW, 1994, OBSTET GYNECOL, V84, P741; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; KAUFMAN RH, 1995, GYNECOL ONCOL, V56, P8, DOI 10.1006/gyno.1995.1003; KOULOS JP, 1993, GYNECOL ONCOL, V48, P364, DOI 10.1006/gyno.1993.1064; KURMAN RJ, 1994, BLAUSTEINS PATHOLOGY, P229; LAGA M, 1992, INT J CANCER, V50, P45, DOI 10.1002/ijc.2910500110; MAIMAN M, 1990, GYNECOL ONCOL, V38, P377, DOI 10.1016/0090-8258(90)90077-X; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; PENN I, 1986, CANCER-AM CANCER SOC, V58, P611, DOI 10.1002/1097-0142(19860801)58:3<611::AID-CNCR2820580303>3.0.CO;2-M; STURGEON SR, 1992, AM J OBSTET GYNECOL, V166, P1482, DOI 10.1016/0002-9378(92)91623-I; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P681; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	28	119	127	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					108	113		10.1016/S0140-6736(02)07368-3	http://dx.doi.org/10.1016/S0140-6736(02)07368-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809252				2022-12-01	WOS:000173212400009
J	Balasubramanian, M; Schwartz, EL				Balasubramanian, M; Schwartz, EL			The Isomap algorithm and topological stability	SCIENCE			English	Editorial Material									Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; Boston Univ, Dept Elect & Comp Syst, Boston, MA 02215 USA	Boston University; Boston University	Balasubramanian, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.							Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; SCHWARTZ EL, 1988, IEEE COMPUT GRAPH, V8, P13, DOI 10.1109/38.7745; SCHWARTZ EL, 1989, IEEE T PATTERN ANAL, V11, P1005, DOI 10.1109/34.35506; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; WOLFSON E, 1989, IEEE T PATTERN ANAL, V11, P1001, DOI 10.1109/34.35505	5	465	540	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778013				2022-12-01	WOS:000173143100001
J	Yacubova, E; Komuro, H				Yacubova, E; Komuro, H			Stage-specific control of neuronal migration by somatostatin	NATURE			English	Article							CEREBELLAR GRANULE CELLS; RAT CEREBELLUM; RECEPTORS; EXPRESSION; CORTEX; K+; PATTERNS; BLOCKS; SYSTEM	Developing neurons transiently express somatostatin and its receptors(1-3), but little is known about their function at these early stages. As we thought that endogenous somatostatin might control the migratory behaviour of immature neurons, we have examined the effects of somatostatin in cerebellar granule cells of early postnatal mice, because these cells express all five types of somatostatin receptors before the initiation of their migration(4,5). Here we show that somatostatin has opposite and stage-specific effects on the migration of cerebellar granule cells. Activation of somatostatin receptors increases the rate of granule cell migration near their birthplace, but decreases the rate near their final destination. Furthermore, somatostatin enhances the size and frequency of spontaneous Ca2+ fluctuations in the early phase of migration, whereas it eliminates spike-like Ca2+ transients in the late phase. Somatostatin-induced changes at both early and late phases are reversed by a blockade of K+ channel activity. These results indicate that somatostatin may provide an essential cue for accelerating the movement of granule cells in the early phase and for terminating the movement in the late phase through altering intracellular Ca2+ concentrations and K+ channel activity.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Komuro, H (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Baumbach WR, 1998, MOL PHARMACOL, V54, P864, DOI 10.1124/mol.54.5.864; Bologna E, 2000, J COMP NEUROL, V420, P466, DOI 10.1002/(SICI)1096-9861(20000515)420:4<466::AID-CNE5>3.0.CO;2-W; DAngelo E, 1997, J NEUROPHYSIOL, V78, P1631, DOI 10.1152/jn.1997.78.3.1631; GONZALEZ B, 1992, P NATL ACAD SCI USA, V89, P9627, DOI 10.1073/pnas.89.20.9627; GONZALEZ BJ, 1988, DEV BRAIN RES, V40, P154, DOI 10.1016/0165-3806(88)90018-1; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; INAGAKI S, 1989, MOL BRAIN RES, V6, P289, DOI 10.1016/0169-328X(89)90074-0; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Komuro H, 1998, J NEUROSCI, V18, P1478; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KUHAR SG, 1993, DEVELOPMENT, V117, P97; MAUBERT E, 1994, NEUROSCIENCE, V62, P317, DOI 10.1016/0306-4522(94)90335-2; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Patel YC, 1997, J ENDOCRINOL INVEST, V20, P348, DOI 10.1007/BF03350317; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; Rhie DJ, 1999, DEV BRAIN RES, V112, P267, DOI 10.1016/S0165-3806(98)00175-8; Schindler M, 1996, PROG NEUROBIOL, V50, P9; Shibata R, 2000, J NEUROSCI, V20, P4145; SIMS SM, 1991, J PHYSIOL-LONDON, V441, P615, DOI 10.1113/jphysiol.1991.sp018770; TANIWAKI T, 1995, DEV BRAIN RES, V88, P109, DOI 10.1016/0165-3806(95)00090-Z; Thoss VS, 1996, EUR J PHARMACOL, V297, P145, DOI 10.1016/0014-2999(95)00736-9; VILLAR MJ, 1989, ANAT EMBRYOL, V179, P257, DOI 10.1007/BF00326591; Viollet C, 1997, J NEUROCHEM, V68, P2263	28	87	87	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					77	81		10.1038/415077a	http://dx.doi.org/10.1038/415077a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780120				2022-12-01	WOS:000173028800043
J	Chaudhari, N; Kinnamon, SC				Chaudhari, N; Kinnamon, SC			Molecular basis of the sweet tooth?	LANCET			English	Editorial Material							RECEPTOR GENE; TASTE; SACCHARIN; IDENTIFICATION; TRANSDUCTION; MICE; SAC		Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Colorado, Hlth Sci Ctr, Rocky Mt Taste & Smell Ctr, Denver, CO USA; Colorado State Univ, Dept Anat & Neurobiol, Ft Collins, CO 80523 USA	University of Miami; University of Miami; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University	Chaudhari, N (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA.	NChaudhari@miami.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, P315; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Masters-Harte LD, 2001, ANN PHARMACOTHER, V35, P947; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	13	6	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2101	2102		10.1016/S0140-6736(01)07233-6	http://dx.doi.org/10.1016/S0140-6736(01)07233-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784621				2022-12-01	WOS:000172905800006
J	Seo, HC; Kube, M; Edvardsen, RB; Jensen, MF; Beck, A; Spriet, E; Gorsky, G; Thompson, EM; Lehrach, H; Reinhardt, R; Chourrout, D				Seo, HC; Kube, M; Edvardsen, RB; Jensen, MF; Beck, A; Spriet, E; Gorsky, G; Thompson, EM; Lehrach, H; Reinhardt, R; Chourrout, D			Miniature genome in the marine chordate Oikopleura dioica	SCIENCE			English	Article									Sara Ctr Marine Mol Biol, N-5020 Bergen, Norway; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Observ Oceanol, LOV, UPMC, CNRS,INSU, F-06234 Villefranche, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Chourrout, D (corresponding author), Sara Ctr Marine Mol Biol, Thormohlensgt 55, N-5020 Bergen, Norway.			Reinhardt, Richard/0000-0001-9376-2132; Edvardsen, Rolf/0000-0001-8430-8042				Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Fraser CM, 1997, ELECTROPHORESIS, V18, P1207, DOI 10.1002/elps.1150180803; Monaghan P, 2000, TRENDS GENET, V16, P331, DOI 10.1016/S0168-9525(00)02051-5; Nishino A, 2001, GENESIS, V29, P36, DOI 10.1002/1526-968X(200101)29:1<36::AID-GENE1003>3.0.CO;2-J; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437	5	134	139	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2506	2506		10.1126/science.294.5551.2506	http://dx.doi.org/10.1126/science.294.5551.2506			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752568				2022-12-01	WOS:000172927700045
J	Bhoo, SH; Davis, SJ; Walker, J; Karniol, B; Vierstra, RD				Bhoo, SH; Davis, SJ; Walker, J; Karniol, B; Vierstra, RD			Bacteriophytochromes are photochromic histidine kinases using a biliverdin chromophore	NATURE			English	Article							EUKARYOTIC PHYTOCHROMES; BIOSYNTHESIS; PROTEIN; GENE; SIMILARITY	Phytochromes comprise a principal family of red/far-red light sensors in plants(1). Although phytochromes were thought originally to be confined to photosynthetic organisms(2,3), we have recently detected phytochrome-like proteins in two heterotrophic eubacteria, Deinococcus radiodurans and Pseudomonas aeruginosa(4). Here we show that these form part of a widespread family of bacteriophytochromes (BphPs) with homology to two-component sensor histidine kinases. Whereas plant phytochromes use phytochromobilin as the chromophore, BphPs assemble with biliverdin, an immediate breakdown product of haem, to generate photochromic kinases that are modulated by red and far-red light. In some cases, a unique haem oxygenase responsible for the synthesis of biliverdin is part of the BphP operon. Co-expression of this oxygenase with a BphP apoprotein and a haem source is sufficient to assemble holo-BphP in vivo. Both their presence in many diverse bacteria and their simplified assembly with biliverdin suggest that BphPs are the progenitors of phytochrome-type photoreceptors.	Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vierstra, RD (corresponding author), Univ Wisconsin, Mol & Cellular Biol Program, 1575 Linden Dr, Madison, WI 53706 USA.							BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; ELICH TD, 1989, J BIOL CHEM, V264, P12902; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Herdman M, 2000, J MOL EVOL, V51, P205, DOI 10.1007/s002390010082; Hughes O, 1999, PLANT PHYSIOL, V121, P1059; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000	19	232	253	1	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					776	779		10.1038/414776a	http://dx.doi.org/10.1038/414776a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742406				2022-12-01	WOS:000172676200054
J	Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW				Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW			Melanopsin-containing retinal. ganglion cells: Architecture, projections, and intrinsic photosensitivity	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; SUPRACHIASMATIC NUCLEUS; INTERGENICULATE LEAFLET; BODY-TEMPERATURE; LIGHT REFLEX; RAT; OLIVARY; PACAP; EEG	The primary circadian pacemaker, in the suprachiasmatic nucleus (SCN) of the mammalian brain, is photoentrained by light signals from the eyes through the retinohypothalamic tract. Retinal rod and cone cells are not required for photoentrainment. Recent evidence suggests that the entraining photoreceptors are retinal ganglion cells (RGCs) that project to the SCN. The visual pigment for this photoreceptor may be melanopsin, an opsin-like protein whose coding messenger RNA is found in a subset of mammalian RGCs. By cloning rat melanopsin and generating specific antibodies, we show that melanopsin is present in cell bodies, dendrites, and proximal axonal segments of a subset of rat RGCs. In mice heterozygous for tau-lacZ targeted to the melanopsin gene locus, P-galactosidase-positive RGC axons projected to the SCN and other brain nuclei involved in circadian photoentrainment or the pupillary light reflex. Rat RGCs that exhibited intrinsic photosensitivity invariably expressed melanopsin. Hence, melanopsin is most likely the visual pigment of phototransducing RGCs that set the circadian clock and initiate other non-image-forming visual functions.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Brown University	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	kwyau@mail.jhmi.edu	Jansen, Heiko T./A-5770-2008; Hattar, Samer/W-6927-2019	Jansen, Heiko T./0000-0003-0178-396X; 	NEI NIH HHS [R37 EY006837-15S1, R37 EY006837, R37 EY006837-13, R37 EY006837-14, R37 EY006837-15] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CAJOCHEN C, 1992, SLEEP, V15, P337; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DUNN FA, COMMUNICATION; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; KLEIND C, 1991, SUPRACHIASMATIC NUCL; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	29	1725	1778	7	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1065	1070		10.1126/science.1069609	http://dx.doi.org/10.1126/science.1069609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834834	Green Accepted			2022-12-01	WOS:000173793000064
J	Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ				Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ			Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels	LANCET			English	Article								In a subset of high-altitude dwellers, the appropriate erythrocytotic response becomes excessive and can result in chronic mountain sickness. We studied men with (study group) and without excessive erythrocytosis (packed-cell volume >65%) living in Cerro de Pasco, Peru (altitude 4300 m), and compared them with controls living in Lima, Peru (at sea-level). Toxic serum cobalt concentrations were detected in 11 of 21 (52%) study participants with excessive erythrocytosis, but were undetectable in high altitude or sea-level controls. In the mining community of Cerro de Pasco, cobalt toxicity might be an important contributor to excessive erythrocytosis.	Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; Univ Washington, Med Ctr, Div Nephrol, Seattle, WA 98195 USA; Univ Peruana Cayetano Heredia, Div Nephrol, Hosp Loayza, Carlos Monge Cassinelli Nephrol Ctr, Lima, Peru; Scios, Sunnyvale, CA USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Scios	Johnson, RJ (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Smith 1273,6550 Fannin St, Houston, TX 77030 USA.		Jefferson, Jonathan/AAA-9679-2019	Hurtado, Abdias/0000-0001-8850-7903	BLRD VA [I01 BX002586] Funding Source: Medline	BLRD VA		ALIPPI RM, 1992, HAEMATOLOGICA, V77, P446; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; MONGE CARLOS, 1942, SCIENCE, V95, P79, DOI 10.1126/science.95.2456.79; NORDBERG G, 1994, SCI TOTAL ENVIRON, V150, P201, DOI 10.1016/0048-9697(94)90151-1; Winslow RM, 1987, HYPOXIA POLYCYTHEMIA	5	58	61	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					407	408		10.1016/S0140-6736(02)07594-3	http://dx.doi.org/10.1016/S0140-6736(02)07594-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844517				2022-12-01	WOS:000173686500017
J	Spiegelhalter, DJ				Spiegelhalter, DJ			Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							IN-HOSPITAL MORTALITY; TRANSPLANTATION CENTERS; LIVER-TRANSPLANTATION	Objectives To determine whether mortality between 1991 and 1995 in hospitals in England carrying out surgery for congenital heart disease in children was associated with the annual volume of cases and to estimate the extent to which an association could explain the apparent divergent mortality at Bristol Royal Infirmary. Design Retrospective analysis of data from two sources, a register of returns by surgeons to their professional society and an administrative database. Setting 12 hospitals in England carrying out surgery for congenital heart disease over the period April 1991 to March 1995. Main outcome measure 30 day mortality. Results For open heart operations in children under 1 year old, and in particular for arterial switches and repair of atrioventricular septal defect, there is strong and consistent evidence of an inverse association between mortality and volume of cases (not taking into account any data from Bristol). A hospital carrying out 120 open operations per year in 1991-5 on children aged under 1 year would be expected to have a mortality 25% lower than that in a hospital carrying out 40 operations. If the children in the hospitals had the same mix of operations, this reduction is 34%. Stratifying for types of operation or including the results from Bristol strengthens this association. It was also estimated that less than a fifth of the excess mortality at Bristol Royal Infirmary in open operations in children less than 1 year old was due to the hospital's lower volume of surgery. Conclusions Using appropriate methods, this study showed that mortality in paediatric cardiac surgery was inversely related to the Volume of surgery. Considerable caution is needed in interpreting these results, and it does not necessarily follow that concentrating resources in fewer centres would reduce mortality.	Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Spiegelhalter, DJ (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England.							Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; *BRIST ROYAL INF I, 2001, INQ ISS LIST 1; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Kennedy I, 2001, INQUIRY MANAGEMENT C; Laks MP, 2000, NEW ENGL J MED, V342, P1527; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X	10	62	65	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					261	264		10.1136/bmj.324.7332.261	http://dx.doi.org/10.1136/bmj.324.7332.261			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823355	Green Published, Bronze			2022-12-01	WOS:000173728300013
J	Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D				Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D			Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors	SCIENCE			English	Article							RETROVIRAL VECTORS; HIGH-TITER; MICE; MOUSE; METHYLATION; ELEMENT; VIRUS; CELLS; LINE; DNA	Single-cell mouse embryos were infected in vitro with recombinant lentiviral vectors to generate transgenic mice carrying the green fluorescent protein (GFP) gene driven by a ubiquitously expressing promoter. Eighty percent of founder mice carried at least one copy of the transgene, and 90% of these expressed GFP at high levels. Progeny inherited the transgene(s) and displayed green fluorescence. Mice generated using lentiviral vectors with muscle-specific and T lymphocyte-specific promoters expressed high levels of GFP only in the appropriate cell types. We have also generated transgenic rats that express GFP at high levels, suggesting that this technique can be used to produce other transgenic animal species.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Coffin J.M., 1997, RETROVIRUSES; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hogan B., 2014, MANIPULATING MOUSE E; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; NAITO K, 1992, HUM REPROD, V7, P281, DOI 10.1093/oxfordjournals.humrep.a137633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; YEE JK, 1994, METHOD CELL BIOL, V43, P99; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	22	1525	1688	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					868	872		10.1126/science.1067081	http://dx.doi.org/10.1126/science.1067081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11786607				2022-12-01	WOS:000173733000049
J	McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH				McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH			Plankton blooms - Lysogeny in marine Synechococcus	NATURE			English	Article							VIRUSES; ABUNDANCE; MORTALITY; SEAWATER		Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	McDaniel, L (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.							Ackermann H., 1987, VIRUSES PROKARYOTES, V1; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; SUTTLE CA, 1992, MAR ECOL PROG SER, V87, P105, DOI 10.3354/meps087105; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weinbauer MG, 1996, APPL ENVIRON MICROB, V62, P4374, DOI 10.1128/AEM.62.12.4374-4380.1996; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	10	97	105	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					496	496		10.1038/415496a	http://dx.doi.org/10.1038/415496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823851	Bronze			2022-12-01	WOS:000173564300037
J	Higashi, H; Tsutsumi, R; Muto, S; Sugiyama, T; Azuma, T; Asaka, M; Hatakeyama, M				Higashi, H; Tsutsumi, R; Muto, S; Sugiyama, T; Azuma, T; Asaka, M; Hatakeyama, M			SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein	SCIENCE			English	Article							GASTRIC EPITHELIAL-CELLS; SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; SH2 DOMAINS; FOCAL ADHESION; IV SECRETION; TRANSLOCATION; SH-PTP2; INVOLVEMENT; ANTIGEN	Helicobacter pylori CagA protein is associated with severe gastritis and gastric carcinoma. CagA is injected from the attached Helicobacter pylori into host cells and undergoes tyrosine phosphorylation. Wild-type but not phosphorylation-resistant CagA induced a growth factor-like response in gastric epithelial cells. Furthermore, CagA formed a physical complex with the SRC homology 2 domain (SH2)-containing tyrosine phosphatase SHP-2 in a phosphorylation-dependent manner and stimulated the phosphatase activity. Disruption of the CagA-SHP-2 complex abolished the CagA-dependent cellular response. Conversely, the CagA effect on cells was reproduced by constitutively active SHP-2. Thus, upon translocation, CagA perturbs cellular functions by deregulating SHP-2.	Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido 0600815, Japan; Fukui Med Univ, Dept Internal Med 2, Fukui 9101193, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Fukui	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan.	mhata@imm.hokudai.ac.jp	Asaka, Masahiro/A-5948-2012; Higashi, Hideaki/F-6872-2012	Tsutsumi, Ryouhei/0000-0002-1704-0362				AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BLASER MJ, 1995, CANCER RES, V55, P2111; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; DECHERT U, 1994, J BIOL CHEM, V269, P5602; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; HIGASHI H, UNPUB; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Manes S, 1999, MOL CELL BIOL, V19, P3125; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	27	766	804	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					683	686		10.1126/science.1067147	http://dx.doi.org/10.1126/science.1067147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11743164				2022-12-01	WOS:000173560900047
J	Cardinale, BJ; Palmer, MA; Collins, SL				Cardinale, BJ; Palmer, MA; Collins, SL			Species diversity enhances ecosystem functioning through interspecific facilitation	NATURE			English	Article							CHANGING BIODIVERSITY; PARTICLE CAPTURE; PLANT DIVERSITY; FLOW; CONSEQUENCES; PRODUCTIVITY; SEDIMENTS	Facilitation between species is thought to be a key mechanism by which biodiversity affects the rates of resource use that govern the efficiency and productivity of ecosystems(1-4); however, there is no direct empirical evidence to support this hypothesis. Here we show that increasing the species diversity of a functional group of aquatic organisms induces facilitative interactions, leading to non-additive changes in resource consumption. We increased the richness and evenness of suspension-feeding caddisfly larvae (Insecta, Trichoptera) in stream mesocosms and found that the increased topographical complexity of the benthic habitat alters patterns of near-bed flow such that the feeding success of individuals is enhanced. Species diversity reduces 'current shading' (that is, the deceleration of flow from upstream to downstream neighbours), allowing diverse assemblages to capture a greater fraction of suspended resources than is caught by any species monoculture. The fundamental nature of this form of hydrodynamic facilitation suggests that it is broadly applicable to freshwater and marine habitats; in addition, it has several analogues in terrestrial ecosystems where fluxes of energy and matter can be influenced by biophysical complexity(3,5,6). Thus, changes in species diversity may alter the probability of positive species interactions, resulting in disproportionately large changes in the functioning of ecosystems.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Cardinale, BJ (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.		Palmer, Margaret A/F-9648-2013; Collins, Scott L/P-7742-2014; Cardinale, Bradley J/I-7076-2013	Palmer, Margaret A/0000-0003-1468-7993; Collins, Scott L/0000-0002-0193-2892; 				[Anonymous], 1997, PHYSL ECOLOGY TROPIC; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; CARDINALE BJ, IN PRESS ECOLOGY; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; ECKMAN JE, 1981, J MAR RES, V39, P361; ENGLUND G, 1991, FRESHWATER BIOL, V26, P425, DOI 10.1111/j.1365-2427.1991.tb01409.x; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; HART DD, 1986, OIKOS, V46, P88, DOI 10.2307/3565384; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JOHNSON AS, 1990, LIMNOL OCEANOGR, V35, P1395, DOI 10.4319/lo.1990.35.6.1395; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LOUDON C, 1990, AM NAT, V135, P360, DOI 10.1086/285051; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; OKAMURA B, 1992, ECOLOGY, V73, P1502, DOI 10.2307/1940693; Palmer M, 1997, AMBIO, V26, P571; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vogel S., 1994, LIFE MOVING FLUIDS; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	30	568	624	5	508	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					426	429		10.1038/415426a	http://dx.doi.org/10.1038/415426a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807553				2022-12-01	WOS:000173433600049
J	Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR				Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR			Prediction of central nervous system embryonal tumour outcome based on gene expression	NATURE			English	Article							HUMAN HOMOLOG; CEREBELLAR MEDULLOBLASTOMA; SONIC HEDGEHOG; RECEPTOR TRKC; CELL LINEAGE; GERM-LINE; MUTATIONS; CANCER; PATTERNS	Embryonal tumours of the central nervous system (CNS) represent a heterogeneous group of tumours about which little is known biologically, and whose diagnosis, on the basis of morphologic appearance alone, is controversial. Medulloblastomas, for example, are the most common malignant brain tumour of childhood, but their pathogenesis is unknown, their relationship to other embryonal CNS tumours is debated(1,2), and patients' response to therapy is difficult to predict(3). We approached these problems by developing a classification system based on DNA microarray gene expression data derived from 99 patient samples. Here we demonstrate that medulloblastomas are molecularly distinct from other brain tumours including primitive neuroectodermal tumours (PNETs), atypical teratoid/rhabdoid tumours (AT/RTs) and malignant gliomas. Previously unrecognized evidence supporting the derivation of medulloblastomas from cerebellar granule cells through activation of the Sonic Hedgehog (SHH) pathway was also revealed. We show further that the clinical outcome of children with medulloblastomas is highly predictable on the basis of the gene expression profiles of their tumours at diagnosis.	Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol & Neurosurg Serv, Boston, MA 02115 USA; MIT, Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02139 USA; MIT, McGovern Inst, Ctr Biol & Computat Learning, AI Lab, Cambridge, MA 02139 USA; Baylor Coll Med, Div Pediat Oncol, Houston, TX 77030 USA; Beth Israel Deaconess Med Ctr, New York, NY 10128 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Human Genet, Philadelphia, PA 19104 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; New York University; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Massachusetts Institute of Technology (MIT); International Business Machines (IBM)	Pomeroy, SL (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA.	scott.pomeroy@tch.harvard.edu; golub@genome.wi.mit.edu	Curran, Tom/C-1164-2008; Curran, Tom/F-5234-2018; Mesirov, Jill/AGF-7626-2022; Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Califano, Andrea/F-7239-2012	Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Califano, Andrea/0000-0003-4742-3679; Mukherjee, Sayan/0000-0002-6715-3920; Allen, Jeffrey/0000-0001-9957-6664				ARUGA J, 1994, J NEUROCHEM, V63, P1880; Biegel JA, 1999, CANCER RES, V59, P74; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CALIFANO, 2000, P 8 INT C INT SYST M, P75; DASARATHY VB, 1991, NEAREST NEIGHBOOR NN; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GIANGASPERO F, 2000, WHO CLASSIFICATION T, P129; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KADIN ME, 1970, J NEUROPATH EXP NEUR, V29, P583, DOI 10.1097/00005072-197010000-00005; Kim JYH, 1999, CANCER RES, V59, P711; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mardia K.V., 1979, MULTIVARIATE ANAL; MUKHERJEE S, 1999, 182AI CBCL MIT; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Pietsch T, 1997, CANCER RES, V57, P2085; Raffel C, 1997, CANCER RES, V57, P842; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; RORKE LB, 1983, J NEUROPATH EXP NEUR, V42, P1, DOI 10.1097/00005072-198301000-00001; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; SLONIM DK, 2000, P 4 ANN INT C COMP M, P263; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2000, CANCER RES, V60, P2239; XIE J, 1997, CANCER RES, V57, P2397; Yokota N, 1996, CANCER RES, V56, P377	30	1708	1778	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					436	442		10.1038/415436a	http://dx.doi.org/10.1038/415436a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807556				2022-12-01	WOS:000173433600052
J	Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG				Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG			Fertility after intact ovary transplantation	NATURE			English	Article							KIDNEYS		Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada; McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98105 USA	Universite de Montreal; McGill University; Royal Victoria Hospital; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada.							CORNIER E, 1985, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V14, P567; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GUTTMAN FM, 1977, CRYOBIOLOGY, V14, P559, DOI 10.1016/0011-2240(77)90166-3; JACOBSEN IA, 1984, CRYOBIOLOGY, V21, P637, DOI 10.1016/0011-2240(84)90223-2; LEE S, 1974, J RES I MED SCI KORE, V6, P112; Picton HM, 2000, BRIT MED BULL, V56, P603, DOI 10.1258/0007142001903418; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Song YC, 2000, NAT BIOTECHNOL, V18, P296, DOI 10.1038/73737	8	163	180	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					385	385		10.1038/415385a	http://dx.doi.org/10.1038/415385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807540				2022-12-01	WOS:000173433600035
J	Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C				Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C			Regulation of life-span by germ-line stem cells in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; GENE; GLP-1; SPERMATOGENESIS; DROSOPHILA; RECEPTORS; EMBRYOS; MUTANT; STRESS; LAG-2	The germ line of the nematode Caenorhabditis elegans influences life-span; when the germ-line precursor cells are removed, life-span is increased dramatically. We find that neither sperm, nor oocytes, nor meiotic precursor cells are responsible for this effect. Rather life-span is influenced by the proliferating germ-line stem cells. These cells, as well as a downstream transcriptional regulator, act in the adult to influence aging, indicating that the aging process remains plastic during adulthood. We propose that the germ-line stem cells affect life-span by influencing the production of, or the response to, a steroid hormone that promotes longevity.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Apfeld, Javier/0000-0001-9897-5671; Kenyon, Cynthia/0000-0003-3446-2636				Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1990, GENETICS, V125, P29; Berry LW, 1997, DEVELOPMENT, V124, P925; ELLIS RE, 1995, GENETICS, V139, P561; FRANCIS R, 1995, GENETICS, V139, P579; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Karashima T, 2000, DEVELOPMENT, V127, P1069; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; SCHEDL T, 1988, GENETICS, V119, P43; SCHEDL T, 1997, C ELEGANS, V2, P241; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; STROME S, 1995, DEVELOPMENT, V121, P2961; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605	24	334	350	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					502	505		10.1126/science.1065768	http://dx.doi.org/10.1126/science.1065768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799246				2022-12-01	WOS:000173350700052
J	Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN				Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN			Spider silk fibers spun from soluble recombinant silk produced in mammalian cells	SCIENCE			English	Article							FORCE-ELONGATION BEHAVIOR; DRAGLINE SILK; FIBROIN; PROTEIN; EXPRESSION; PURIFICATION; SEQUENCE; DESIGN	Spider silks are protein-based "biopolymer" filaments or threads secreted by specialized epithelia[ cells as concentrated soluble precursors of highly repetitive primary sequences. Spider dragline silk is a flexible, lightweight fiber of extraordinary strength and toughness comparable to that of synthetic high-performance fibers. We sought to "biomimic" the process of spider silk production by expressing in mammalian cells the dragline silk genes (ADF-3/MaSpll and MaSpl) of two spider species. We produced soluble recombinant (rc)-dragline silk proteins with molecular masses of 60 to 140 kilodaltons. We demonstrated the wet spinning of silk monofilaments spun from a concentrated aqueous solution of soluble rc-spider silk protein (ADF-3; 60 kilodaltons) under modest shear and coagulation conditions. The spun fibers were water insoluble with a fine diameter (10 to 40 micrometers) and exhibited toughness and modulus values comparable to those of native dragline silks but with tower tenacity. Dope solutions with rc-silk protein concentrations >20% and postspinning draw were necessary to achieve improved mechanical properties of the spun fibers. Fiber properties correlated with finer fiber diameter and increased birefringence.	Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada; USA, Soldier Biol Chem Command, Mat Sci Team, Natick, MA 01760 USA		Lazaris, A (corresponding author), Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada.	alazaris@nexiabiotech.com						Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U; DENNY M, 1976, J EXP BIOL, V65, P483; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; FAHNESTOCK SR, 1994, Patent No. 9429450; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN M, 1992, BIOPOLYMERS, P227; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; KAPLAN D, 1994, ACS SYM SER, V544, P2; KOOVER J, 1987, ECOPHYSIOLOGY SPIDER, P160; Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060; LILVAK O, 1998, MACROMOLECULES, V31, P2947; LIZARDI PM, 1979, P NATL ACAD SCI USA, V76, P6211, DOI 10.1073/pnas.76.12.6211; Lock, 1993, Process for Making Silk Fibroin Fibers, Patent No. [US5252285A, 5252285]; LUCAS FRED, 1964, DISCOVERY, V25, P20; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j; TERMONIA Y, 2000, PERG MAT SER, V4, P271; TERMONIA Y, 2000, PERG MAT SER, V4, P337; Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860; Viney C., 1994, SILK POLYM MAT SCI B, P120; VINEY C, 2000, PERG MAT SER, V4, P295; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; ZEMLIN JC, 1968, 6929CM US ARM NAT LA	38	497	602	11	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					472	476		10.1126/science.1065780	http://dx.doi.org/10.1126/science.1065780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799236				2022-12-01	WOS:000173350700042
J	Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME				Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME			Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASES; SMOOTH-MUSCLE; RESPONSES; ARTERIES; CLONING	Blood vessels express estrogen receptors, but their rote in cardiovascular physiology is not wet[ understood. We show that vascular smooth muscle cells and blood vessels from estrogen receptor beta (ERbeta)-deficient mice exhibit multiple functional abnormalities. In wild-type mouse blood vessels, estrogen attenuates vasoconstriction by an ERbeta-mediated increase in inducible nitric oxide synthase expression. In contrast, estrogen augments vasoconstriction in blood vessels from ERbeta-deficient mice. Vascular smooth muscle cells isolated from ERbeta-deficient mice show multiple abnormalities of ion channel function. Furthermore, ERbeta-deficient mice develop sustained systolic and diastolic hypertension as they age. These data support an essential role for ERbeta in the regulation of vascular function and blood pressure.	Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Huddinge Univ Hosp, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Novum, Ctr Biotechnol, S-14186 Huddinge, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA	Tufts Medical Center; Tufts University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mendelsohn, ME (corresponding author), Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056235, R01HL061298, R01HL056069, P50HL063494, R01HL053546, R01HL055309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020069, R01GM020069] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56235, R01 HL55309, R01 HL56069, R01 HL61298, P50 HL63494, HL53546] Funding Source: Medline; NICHD NIH HHS [HD30276] Funding Source: Medline; NIGMS NIH HHS [GM20069] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; Binko J, 1998, AM J PHYSIOL-HEART C, V274, pH853, DOI 10.1152/ajpheart.1998.274.3.H853; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Guetta V, 1997, CIRCULATION, V96, P2795, DOI 10.1161/01.CIR.96.9.2795; Kauser K, 1997, J VASC RES, V34, P229, DOI 10.1159/000159227; Kolyada AY, 1996, BIOCHEM BIOPH RES CO, V220, P600, DOI 10.1006/bbrc.1996.0449; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LANTINHERMOSO RL, 1997, AM J PHYSIOL, V273, P119; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0; Mendelsohn ME, 2000, CIRC RES, V87, P956, DOI 10.1161/01.RES.87.11.956; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mugge A, 1997, PHARMACOLOGY, V54, P162, DOI 10.1159/000139483; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; WILLIAMS JK, 1992, J AM COLL CARDIOL, V20, P452, DOI 10.1016/0735-1097(92)90116-5; [No title captured]	24	388	402	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					505	508		10.1126/science.1065250	http://dx.doi.org/10.1126/science.1065250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799247				2022-12-01	WOS:000173350700053
J	Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH				Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH			A longitudinal study of abnormalities on MRI and disability from multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPTIC NEURITIS; FOLLOW-UP; SPINAL-CORD; NATURAL-HISTORY; CLINICAL COURSE; AXONAL DAMAGE; BRAIN-STEM; EARLY RISK; LESIONS; PROGRESSION	Background: In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T(2)-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods: Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke's Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results: Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions: In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance imaging of the brain in the first five years correlate with the degree of long-term disability from multiple sclerosis. This relation is only moderate, so the volume of the lesions alone may not be an adequate basis for decisions about the use of disease-modifying treatment. (N Engl J Med 2002;346:158-64.) Copyright (C) 2002 Massachusetts Medical Society.	UCL Inst Neurol, NMR Res Unit, London WC1N 3BG, England; Ninewells Hosp, Tayside Multiple Sclerosis Res Unit, Dundee DD1 9SY, Scotland; Otto Von Guericke Univ, Magdeburg, Germany	University of London; University College London; University of Dundee; Otto von Guericke University	Miller, DH (corresponding author), UCL Inst Neurol, NMR Res Unit, Queen Sq, London WC1N 3BG, England.		Calabrese, Massimiliano/I-6195-2012; Thompson, Alan J/C-2654-2008	Thompson, Alan J/0000-0002-4333-8496; O'Riordan, Jonathan/0000-0001-6774-2488	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		ALTMAN DG, 1991, PRACTICAL STAT MED R, P293; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brodsky M, 1997, NEUROLOGY, V49, P1404; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; CONFAVREUX C, 1980, BRAIN, V103, P281, DOI 10.1093/brain/103.2.281; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 1997, NEUROLOGY, V49, P371, DOI 10.1212/WNL.49.2.371; FRANCIS DA, 1987, J NEUROL NEUROSUR PS, V50, P758, DOI 10.1136/jnnp.50.6.758; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Ghezzi A, 1999, J NEUROL, V246, P770, DOI 10.1007/s004150050453; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; KURTZKE JF, 1977, J CHRON DIS, V30, P819, DOI 10.1016/0021-9681(77)90010-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LASSMANN H, 1994, ANN NEUROL, V36, pS42, DOI 10.1002/ana.410360713; LECHNERSCOTT J, IN PRESS CAN EXPANDE; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1988, J NEUROL NEUROSUR PS, V51, P1569, DOI 10.1136/jnnp.51.12.1569; MILLER DH, 1989, ANN NEUROL, V26, P635, DOI 10.1002/ana.410260508; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; MILLER DH, 1987, ANN NEUROL, V22, P714, DOI 10.1002/ana.410220607; Molyneux PD, 1998, AM J NEURORADIOL, V19, P1715; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P124, DOI 10.1136/jnnp.49.2.124; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P737, DOI 10.1136/jnnp.49.7.737; PATY DW, 1993, NEUROLOGY, V43, P6627; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Riordan T, 1998, EPIDEMIOL INFECT, V121, P495, DOI 10.1017/S0950268898001496; RIZZO JF, 1988, NEUROLOGY, V38, P185, DOI 10.1212/WNL.38.2.185; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sailer M, 1999, NEUROLOGY, V52, P599, DOI 10.1212/WNL.52.3.599; SANDBERG-WOLLHEIM M, 1990, Annals of Neurology, V27, P386, DOI 10.1002/ana.410270406; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STEWART WA, 1984, LANCET, V2, P412; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419	42	630	653	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					158	164		10.1056/NEJMoa011341	http://dx.doi.org/10.1056/NEJMoa011341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796849	Green Published, Bronze			2022-12-01	WOS:000173273600003
J	Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N				Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N			Outcomes in young adulthood for very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN BORN; FOLLOW-UP; HEALTH; RISK; AGE; INTELLIGENCE; ABILITIES; COHORT; BOYS; SEX	Background: Very-low-birth-weight infants (those weighing less than 1500 g) born during the initial years of neonatal intensive care have now reached young adulthood. Methods: We compared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979 (mean birth weight, 1179 g; mean gestational age at birth, 29.7 weeks) with 233 controls from the same population in Cleveland who had normal birth weights. We assessed the level of education, cognitive and academic achievement, and rates of chronic illness and risk-taking behavior at 20 years of age. Outcomes were adjusted for sex and sociodemographic status. Results: Fewer very-low-birth-weight young adults than normal-birth-weight young adults had graduated from high school (74 percent vs. 83 percent, P=0.04). Very-low-birth-weight men, but not women, were significantly less likely than normal-birth-weight controls to be enrolled in postsecondary study (30 percent vs. 53 percent, P=0.002). Very-low-birth-weight participants had a lower mean IQ (87 vs. 92) and lower academic achievement scores (P<0.001 for both comparisons). They had higher rates of neurosensory impairments (10 percent vs. <1 percent, P<0.001) and subnormal height (10 percent vs. 5 percent, P=0.04). The very-low-birth-weight group reported less alcohol and drug use and had lower rates of pregnancy than normal-birth-weight controls; these differences persisted when comparisons were restricted to the participants without neurosensory impairment. Conclusions: Educational disadvantage associated with very low birth weight persists into early adulthood. (N Engl J Med 2002;346:149-57.) Copyright (C) 2002 Massachusetts Medical Society.	Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Special Educ, Cleveland, OH 44115 USA; Kent State Univ, Inst Study & Prevent Violence, Kent, OH 44242 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Hack, M (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@po.cwru.edu	Fahimifar, Sepideh/M-5303-2019; Borawski, Elaine/R-9959-2019	Borawski, Elaine/0000-0001-7629-6889	NCRR NIH HHS [M01 RR00080] Funding Source: Medline; NICHD NIH HHS [R01 HD34177] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS PF, 1994, VITAL HLTH STAT, V10; ARAM DM, 1991, J SPEECH HEAR RES, V34, P1169, DOI 10.1044/jshr.3405.1169; AYLWARD GP, 1985, J DEV BEHAV PEDIATR, V6, P3; Bacharach VR, 1998, J PEDIATR PSYCHOL, V23, P197, DOI 10.1093/jpepsy/23.3.197; Belcher HME, 1998, ARCH PEDIAT ADOL MED, V152, P952; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; CHILCOAT HD, 1995, AM J EPIDEMIOL, V141, P25, DOI 10.1093/oxfordjournals.aje.a117340; Chilcoat HD, 1999, J AM ACAD CHILD PSY, V38, P1347, DOI 10.1097/00004583-199911000-00008; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; *FED INT FOR CHILD, 2000, AM CHILDR KEY NAT IN; Flannery D. J., 1993, J ADOLESCENT RES, V8, P21, DOI DOI 10.1177/074355489381003; Flannery DJ, 1999, AM J ORTHOPSYCHIAT, V69, P247, DOI 10.1037/h0080426; FLANNERY DJ, 1994, J YOUTH ADOLESCENCE, V23, P195, DOI 10.1007/BF01537445; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; Hack M, 1996, ARCH PEDIAT ADOL MED, V150, P1122, DOI 10.1001/archpedi.1996.02170360012002; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403; Halpern CT, 2000, J ADOLESCENT HEALTH, V26, P213, DOI 10.1016/S1054-139X(99)00061-0; Hardy JB, 1997, PEDIATRICS, V99, P80, DOI 10.1542/peds.99.1.80; HESS JH, 1953, PEDIATRICS, V11, P425; Johnson EO, 2000, BIOL PSYCHIAT, V47, P490, DOI 10.1016/S0006-3223(99)00223-1; KANN L, 2000, CDC SURVEILLANCE SUM, V49, P1; KUCZMARSKI RJ, 2000, DHHS PUBLICATION; MACKAY AP, 2000, DHHS PUBLICATION; Mazurier E, 1999, PEDIATR RES, V45, p250A, DOI 10.1203/00006450-199904020-01487; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; Moss N, 1997, AM J PUBLIC HEALTH, V87, P1411, DOI 10.2105/AJPH.87.9.1411; Piecuch RE, 1998, CLIN PEDIATR, V37, P537, DOI 10.1177/000992289803700903; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2000, Semin Neonatol, V5, P107, DOI 10.1053/siny.1999.0003; Sattler JM, 1992, ASSESSMENT CHILDREN; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; *US C, 1987, OTA PUBL; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 1981, WAIS R MANUAL WECHSL; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5; Woodcock R. W., 1989, WJ R TESTS ACHIEVEME; Xu BZ, 1998, EPIDEMIOLOGY, V9, P662, DOI 10.1097/00001648-199811000-00017; 1994, MMWR MORB MORTAL WKL, V43, P231	45	775	792	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					149	157		10.1056/NEJMoa010856	http://dx.doi.org/10.1056/NEJMoa010856			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511NZ	11796848				2022-12-01	WOS:000173273600002
J	Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA				Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA			Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability	NATURE			English	Article							ENGINEERING SUBSTRATE-SPECIFICITY; LINEAR EXTRAPOLATION METHOD; HYDROGEN-EXCHANGE; INFLUENZA HEMAGGLUTININ; CONFORMATIONS; CORE	During the evolution of proteins the pressure to optimize biological activity is moderated by a need for efficient folding. For most proteins, this is accomplished through spontaneous folding to a thermodynamically stable and active native state. However, in the extracellular bacterial alpha-lytic protease (alphaLP) these two processes have become decoupled. The native state of alphaLP is thermodynamically unstable, and when denatured, requires millennia (t(1/2), similar to 1,800 years)(1) to refold. Folding is made possible by an attached folding catalyst, the pro-region, which is degraded on completion of folding, leaving alphaLP trapped in its native state by a large kinetic unfolding barrier (t(1/2) similar to1.2 years)(1). alphaLP faces two very different folding landscapes: one in the presence of the pro-region controlling folding, and one in its absence restricting unfolding. Here we demonstrate that this separation of folding and unfolding pathways has removed constraints placed on the folding of thermodynamically stable proteins, and allowed the evolution of a native state having markedly reduced dynamic fluctuations. This, in turn, has led to a significant extension of the functional lifetime of alphaLP by the optimal suppression of proteolytic sensitivity.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chamberlain AK, 1997, STRUCTURE, V5, P859, DOI 10.1016/S0969-2126(97)00240-2; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Halfon S, 1996, J AM CHEM SOC, V118, P1227, DOI 10.1021/ja9533813; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; MACE JE, 1995, J MOL BIOL, V254, P720, DOI 10.1006/jmbi.1995.0650; Orosz A, 1996, MOL CELL BIOL, V16, P7018; PERONA JJ, 1995, PROTEIN SCI, V4, P337; RUPLEY JA, 1967, METHOD ENZYMOL, V11, P905; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wang L, 1998, PROTEIN SCI, V7, P2460, DOI 10.1002/pro.5560071124; 1988, J MOL GRAPH, V6, P13; [No title captured]	24	144	146	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					343	346		10.1038/415343a	http://dx.doi.org/10.1038/415343a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797014				2022-12-01	WOS:000173293500049
J	Motani, R				Motani, R			Scaling effects in caudal fin propulsion and the speed of ichthyosaurs	NATURE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; LARGE WATER TUNNEL; TUNA SWIMMING PERFORMANCE; POWER OUTPUT; ENERGY-EXPENDITURE; OSCILLATING FOILS; FISH PROPULSION; KINEMATICS; MACKEREL; SIZE	Four unrelated groups of large cruising vertebrates (tunas, whales, lamnid sharks and parvipelvian ichthyosaurs) evolved tuna-shaped (thunniform) body plans(1,2). Stringent physical constraints, imposed by the surrounding fluids, are probably responsible for this example of evolutionary convergence(1,2). Here I present a mathematical model of swimming kinematics and fluid mechanics that specifies and quantifies such constraints, and test the model with empirical data. The test shows quantitatively that morphology, kinematics, and physiology indeed covary tightly in large cruisers. The model enables calculations of optimal cruising speed from external measurements, and also predicts that wide caudal fin spans, typical of thunniform swimmers, are necessary for large cruisers. This finding is contrary to a popular yet rather teleological view that thunniform tails were selected for their high aspect ratios that increased propulsive efrciency(1,2). I also show by calculation that Stenopterygius, a Jurassic ichthyosaur, probably had optimal cruising speeds and basal metabolic rates similar to living tunas.	Royal Ontario Museum, Dept Paleobiol, Toronto, ON M5S 2C6, Canada	Royal Ontario Museum	Motani, R (corresponding author), Royal Ontario Museum, Dept Paleobiol, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.		Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053				ALTRINGHAM JD, 1990, J EXP BIOL, V151, P453; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; Arata Jr G. F, 1954, B MAR SCI GULF CARIB, V4, P183; Barrett DS, 1999, J FLUID MECH, V392, P183, DOI 10.1017/S0022112099005455; BLIX AS, 1995, ACTA PHYSIOL SCAND, V153, P61, DOI 10.1111/j.1748-1716.1995.tb09834.x; BLOCK BA, 1992, J EXP BIOL, V166, P267; BOSE N, 1990, P ROY SOC B-BIOL SCI, V242, P163, DOI 10.1098/rspb.1990.0120; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; DEWAR H, 1994, J EXP BIOL, V192, P13; DEWAR H, 1994, J EXP BIOL, V192, P45; Drucker EG, 1996, AM ZOOL, V36, P555; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1993, J EXP BIOL, V185, P179; Gibb AC, 1999, J EXP BIOL, V202, P2433; GRAHAM JB, 1990, J EXP BIOL, V151, P175; Hind AT, 1997, J EXP BIOL, V200, P531; HUNTER JR, 1971, FISH BULL NATL OC AT, V69, P253; Martill D.M., 1987, Modern Geology, V11, P265; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MCGOWAN C, 1991, DINOAURS SPITFIRES S; MOTANI R, UNPUB PALEOBIOLOGY; Nakamura I., 1985, FAO FISH SYNOPSIS, V125, P1; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Vogel S., 1994, LIFE MOVING FLUIDS; WEBB PW, 1984, J EXP BIOL, V109, P77; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303; Yazdi P, 1999, MAR BIOL, V134, P601, DOI 10.1007/s002270050575	30	54	55	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					309	312		10.1038/415309a	http://dx.doi.org/10.1038/415309a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797005				2022-12-01	WOS:000173293500040
J	Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J				Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J			Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina	CELL			English	Article							CYTOPLASMIC DYNEIN; FUNCTIONAL-ORGANIZATION; ENDOPLASMIC-RETICULUM; PHOSPHORYLATION SITES; MEMBRANE-PROTEIN; SEA-URCHIN; MITOSIS; CELL; INTERPHASE; DYNAMICS	The mechanism of nuclear envelope breakdown (NEBD) was investigated in live cells. Early spindle microtubules caused folds and invaginations in the NE up to one hour prior to NEBD, creating mechanical tension in the nuclear lamina. The first gap in the NE appeared before lamin B depolymerization, at the site of maximal tension, by a tearing mechanism. Gap formation relaxed this tension and dramatically accelerated the rate of chromosome condensation. The hole produced in the NE then rapidly expanded over the nuclear surface. NE fragments remaining on chromosomes were removed toward the centrosomes in a microtubule-dependent manner, suggesting a mechanism mediated by a minus-end-directed motor.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Biophys Programme, D-69117 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany.	jan.ellenberg@embl-heidelberg.de	Gerlich, Daniel Wolfram W/A-6991-2016; Eils, Roland/B-6121-2009; Ellenberg, Jan/I-4688-2014	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Eils, Roland/0000-0002-0034-4036; Ellenberg, Jan/0000-0001-5909-701X				Alberts B., 1994, MOL BIOL CELL 2, V3rd ed.; BAJER A, 1969, CHROMOSOMA, V27, P448, DOI 10.1007/BF00325682; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Buendia B, 1997, EXP CELL RES, V230, P133, DOI 10.1006/excr.1996.3395; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; ELLENBERG J, 1997, CELLS LAB MANUAL; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; FOLSNER R, 1993, CELL, V73, P1267; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HAMAGUCHI Y, 1993, BIOIMAGES, V1, P129; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Marshall ICB, 1997, TRENDS CELL BIOL, V7, P69, DOI 10.1016/S0962-8924(96)10047-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; PAWELETZ N, 1988, EUR J CELL BIOL, V47, P334; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; YE Q, 1994, J BIOL CHEM, V269, P11306; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; ZATSEPINA OV, 1977, CYTOBIOLOGIE, V16, P130	54	337	348	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					83	96		10.1016/S0092-8674(01)00627-4	http://dx.doi.org/10.1016/S0092-8674(01)00627-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792323	Bronze			2022-12-01	WOS:000173280700010
J	Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K				Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K			Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter	CELL			English	Article							DNA-BINDING DOMAIN; V-MYB; TRANSCRIPTIONAL ACTIVATION; MIM-1 GENE; IN-VITRO; SYNERGISTIC ACTIVATION; PROTOONCOGENE PRODUCT; MYELOMONOCYTIC CELLS; ONCOGENE PRODUCT; HYDROPHOBIC CORE	c-Myb, but not avian myeloblastosis virus (AMV) v-Myb, cooperates with C/EBPbeta to regulate transcription of myeloid-specific genes. To assess the structural basis for that difference, we determined the crystal structures of complexes comprised of the c-Myb or AMV v-Myb DNA-binding domain (DBD), the C/EBPbeta DBD, and a promoter DNA fragment. Within the c-Myb complex, a DNA-bound C/EBPbeta interacts with R2 of c-Myb bound to a different DNA fragment; point mutations in v-Myb R2 eliminate such interaction within the v-Myb complex. GST pull-down assays, luciferase trans-activation assays, and atomic force microscopy confirmed that the interaction of c-Myb and C/EBPbeta observed in crystal mimics their long range interaction on the promoter, which is accompanied by intervening DNA looping.	Kanagawa Acad Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biol Struct, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; Japan Sci & Technol Corp, CREST Res Project, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Adv Ind Sci & Technol, Prot Dynam Grp, Cent 6, Tsukuba, Ibaraki 3058566, Japan; RIKEN, Harima Inst, SPring 8, Biocrystallog Technol Div, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst, SPring 8, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan	Kanagawa Academy Science & Technology; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; RIKEN; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN	Tahirov, TH (corresponding author), Kanagawa Acad Sci & Technol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.		Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Ishii, Shunsuke/A-5271-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Ishii, Shunsuke/0000-0002-6530-2478; Tahirov, Tahir/0000-0002-1238-0069; Watanabe, Shioka/0000-0003-2411-1891				BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brendeford EM, 1998, FEBS LETT, V425, P52, DOI 10.1016/S0014-5793(98)00196-3; Brendeford EM, 1997, J BIOL CHEM, V272, P4436, DOI 10.1074/jbc.272.7.4436; BRISTOSBRAY M, 1997, MOL CELL BIOL, V17, P5127; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DINI PW, 1993, MOL CELL BIOL, V13, P7334, DOI 10.1128/MCB.13.12.7334; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Fong IC, 2000, MOL IMMUNOL, V37, P391, DOI 10.1016/S0161-5890(00)00056-0; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Ganter B, 1999, FEBS LETT, V460, P401, DOI 10.1016/S0014-5793(99)01373-3; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; KaneiIshii C, 1997, SCIENCE, V277, P246, DOI 10.1126/science.277.5323.246; KANEIISHII C, 1990, J BIOL CHEM, V265, P19990; KLEMPNAUER KH, 1993, ONCOGENE, V8, P111; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Lutz PG, 2001, BLOOD, V97, P2449, DOI 10.1182/blood.V97.8.2449; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mink S, 1996, MOL CELL BIOL, V16, P1316; Morii H, 1999, J MOL BIOL, V292, P909, DOI 10.1006/jmbi.1999.3099; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oda M, 1997, PROTEIN ENG, V10, P1407, DOI 10.1093/protein/10.12.1407; OELGESCHLAGER M, 1996, EMBO J, V15, P277; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Ording E, 1996, ONCOGENE, V13, P1043; ORDING E, 1994, EUR J BIOCHEM, V222, P113, DOI 10.1111/j.1432-1033.1994.tb18848.x; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sasaki M, 2000, J BIOCHEM-TOKYO, V127, P945, DOI 10.1093/oxfordjournals.jbchem.a022710; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; Zhang XH, 1997, J BIOL CHEM, V272, P29272, DOI 10.1074/jbc.272.46.29272	54	131	137	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					57	70		10.1016/S0092-8674(01)00636-5	http://dx.doi.org/10.1016/S0092-8674(01)00636-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792321	Bronze			2022-12-01	WOS:000173280700008
J	Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW				Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW			Parasitic Cape honeybee workers, Apis mellifera capensis, evade policing	NATURE			English	Article							BEE; REMOVAL	Relocation of the Cape honeybee, Apis mellifera capensis, by bee-keepers from southern to northern South Africa in 1990 has caused widespread death of managed African honeybee, A. m. scutellata, colonies(1). Apis mellifera capensis worker bees are able to lay diploid, female eggs without mating by means of automictic thelytoky(2) (meiosis followed by fusion of two meiotic products to restore egg diploidy), whereas workers of other honeybee subspecies are able to lay only haploid, male eggs. The A. m. capensis workers, which are parasitizing and killing A. m. scutellata colonies in northern South Africa, are the asexual offspring of a single, original worker in which the small amount of genetic variation observed is due to crossing over during meiosis(3) (P. Kryger, personal communication). Here we elucidate two principal mechanisms underlying this parasitism. Parasitic A. m. capensis workers activate their ovaries in host colonies that have a queen present (queenright colonies), and they lay eggs that evade being killed by other workers (worker policing)-the normal fate of worker-laid eggs in colonies with a queen(4-8). This unique parasitism by workers is an instance in which a society is unable to control the selfish actions of its members.	Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Sheffield; University of Pretoria	Ratnieks, FLW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	F.Ratnieks@Shefreld.ac.uk	Beekman, Madeleine/AAF-8574-2019; Beekman, Madeleine/A-3983-2011; martin, stephen/B-5254-2009	Beekman, Madeleine/0000-0002-9040-3756; Beekman, Madeleine/0000-0002-9040-3756; Wossler, Theresa/0000-0003-3725-6133				ALLSOPP MH, 1993, AM BEE J, V133, P121; Barron AB, 2001, BEHAV ECOL SOCIOBIOL, V50, P199, DOI 10.1007/s002650100362; BEEKMAN M, UNPUB INSECTES SOCIA; Downs SG, 2001, BEHAV ECOL, V12, P47, DOI 10.1093/oxfordjournals.beheco.a000377; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; KRYGER P, 2001, P 13 ENT C S AFR, P38; MARTIN S, IN PRESS APIDOLOGIE; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Nunney L, 1999, MG BEH ECOL, P238; Oldroyd BP, 2000, BEHAV ECOL SOCIOBIOL, V47, P268, DOI 10.1007/s002650050665; OLDROYD BP, 1994, NATURE, V371, P749, DOI 10.1038/371749a0; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1993, BEHAV ECOL SOCIOBIOL, V32, P191, DOI 10.1007/BF00173777; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Visscher PK, 1996, BEHAV ECOL SOCIOBIOL, V39, P237, DOI 10.1007/s002650050286	18	101	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					163	165		10.1038/415163a	http://dx.doi.org/10.1038/415163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805832	Green Accepted			2022-12-01	WOS:000173159300039
J	Crutzen, PJ				Crutzen, PJ			Geology of mankind	NATURE			English	Editorial Material									Max Planck Inst Chem, D-55020 Mainz, Germany; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego; Scripps Institution of Oceanography	Crutzen, PJ (corresponding author), Max Planck Inst Chem, POB 3060, D-55020 Mainz, Germany.		Crutzen, Paul J/F-6044-2012; Quinn, Patrick/B-5489-2010					Berger A, 1996, CR ACAD SCI II A, V323, P1; CLARK WC, 1986, SUSTAINABLE DEV BIOS, pCH1; Crutzen P. J, 2000, IGBP NEWSLETTER, V41; Houghton J. T., 2001, CLIMATE CHANGE 2001; Marsh G. P., 1864, MAN NATURE; McNeill John R, 2000, FACE NATURAL HIST; Sack RD., 1990, EARTH TRANSFORMED HU, P659; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; VERNADSKI VI, 1998, BIOSPHERE	9	2181	2273	32	618	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					23	23		10.1038/415023a	http://dx.doi.org/10.1038/415023a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780095	Bronze			2022-12-01	WOS:000173028800020
J	Hoang, C; Ferre-D'Amare, AR				Hoang, C; Ferre-D'Amare, AR			Cocrystal structure of a tRNA Psi 55 pseudouridine synthase: Nucleotide flipping by an RNA-modifying enzyme	CELL			English	Article							CRYSTAL-STRUCTURE; DYSKERATOSIS-CONGENITA; ESCHERICHIA-COLI; RESOLUTION; PROTEINS; BASE; RECOGNITION; SYNTHETASE; TRNA(PHE); MUTATIONS	Pseudouridine (Psi) synthases catalyze the isomerization of specific uridines in cellular RNAs to pseudouridines and may function as RNA chaperones. TruB is responsible for the Psi residue present in the T loops of virtually all tRNAs. The close homolog Cbf5/dyskerin is the catalytic subunit of box H/ACA snoRNPs. These carry out the pseudouridylation of eukaryotic rRNA and snRNAs. The 1.85 Angstrom resolution structure of TruB bound to RNA reveals that this enzyme recognizes the preformed three-dimensional structure of the T loop, primarily through shape complementarity. It accesses its substrate uridyl residue by flipping out the nucleotide and disrupts the tertiary structure of tRNA. Structural comparisons with TruB demonstrate that all Psi synthases are descended from a common molecular ancestor.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			NCRR NIH HHS [RR 15943] Funding Source: Medline; NIGMS NIH HHS [GM 63576] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BENESCH RE, 1953, SCIENCE, V118, P447, DOI 10.1126/science.118.3068.447; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUSACK S, 1998, MANY FACES RNA, P55; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Dirheimer G., 1995, P93; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Koshlap KM, 1999, BIOCHEMISTRY-US, V38, P8647, DOI 10.1021/bi990118w; MAIZELS N, 1993, RNA WORLD, P577; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NURSE K, 1995, RNA, V1, P102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; VIDHYASHANKAR R, 1999, J BIOL CHEM, V274, P22225; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Watanabe Y, 2000, NUCLEIC ACIDS RES, V28, P2342, DOI 10.1093/nar/28.12.2342; Yang XJ, 2001, NAT STRUCT BIOL, V8, P968, DOI 10.1038/nsb1101-968; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	48	228	233	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					929	939		10.1016/S0092-8674(01)00618-3	http://dx.doi.org/10.1016/S0092-8674(01)00618-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779468	Bronze			2022-12-01	WOS:000173024200013
J	Kramer, A; Yang, FC; Snodgrass, P; Li, XD; Scammell, TE; Davis, FC; Weitz, CJ				Kramer, A; Yang, FC; Snodgrass, P; Li, XD; Scammell, TE; Davis, FC; Weitz, CJ			Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling	SCIENCE			English	Article							GROWTH-FACTOR-ALPHA; SUPRACHIASMATIC NUCLEUS; CIRCADIAN PACEMAKERS; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; PROJECTIONS; EXPRESSION; MASKING; TEMPERATURE; HAMSTERS	The circadian clock in the suprachiasmatic nucleus (SCN) is thought to drive daily rhythms of behavior by secreting factors that act locally within the hypothalamus. in a systematic screen, we identified transforming growth factor-alpha (TGF-alpha) as a likely SCN inhibitor of locomotion. TGF-alpha is expressed rhythmically in the SCN, and when infused into the third ventricle it reversibly inhibited locomotor activity and disrupted circadian sleep-wake cycles. These actions are mediated by epidermal growth factor (EGF) receptors on neurons in the hypothalamic subparaventricular zone. Mice with a hypomorphic EGF receptor mutation exhibited excessive daytime locomotor activity and failed to suppress activity when exposed to light. These results implicate EGF receptor signaling in the daily control of locomotor activity, and identify a neural circuit in the hypothalamus that likely mediates the regulation of behavior both by the SCN and the retina.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Kramer, Achim/0000-0001-9671-6078	NICHD NIH HHS [HD-18686] Funding Source: Medline; NIMH NIH HHS [MH62589] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD018686, R01HD018686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062589] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBERS HE, 1991, J NEUROSCI, V11, P846; DAVIS FC, 1980, AM J PHYSIOL, V239, pR149, DOI 10.1152/ajpregu.1980.239.1.R149; Decoursey PJ, 1998, PHYSIOL BEHAV, V65, P457, DOI 10.1016/S0031-9384(98)00187-5; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KITA H, 1982, BRAIN RES BULL, V8, P249, DOI 10.1016/0361-9230(82)90055-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; KRAMER A, UNPUB; LEE DC, 1995, PHARMACOL REV, V47, P51; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MA YJ, 1992, NEURON, V9, P657; Miller JD, 1996, SLEEP, V19, P641, DOI 10.1093/sleep/19.8.641; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PATEL B, 1994, BRIT J OPHTHALMOL, V78, P714, DOI 10.1136/bjo.78.9.714; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; ROKAL RR, 1995, BIOMETRY; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440	40	388	399	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2511	2515		10.1126/science.1067716	http://dx.doi.org/10.1126/science.1067716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752569				2022-12-01	WOS:000172927700047
J	Narla, G; Heath, KE; Reeves, HL; Li, D; Giono, LE; Kimmelman, AC; Glucksman, MJ; Narla, J; Eng, FJ; Chan, AM; Ferrari, AC; Martignetti, JA; Friedman, SL				Narla, G; Heath, KE; Reeves, HL; Li, D; Giono, LE; Kimmelman, AC; Glucksman, MJ; Narla, J; Eng, FJ; Chan, AM; Ferrari, AC; Martignetti, JA; Friedman, SL			KLF6, a candidate tumor suppressor gene mutated in prostate cancer	SCIENCE			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; ALLELIC LOSS; DNA; PROMOTER	Kruppel-like factor 6 (KLF6) is a zinc finger transcription factor of unknown function. Here, we show that the KLF6 gene is mutated in a subset of human prostate cancer. Loss-of-heterozygosity analysis revealed that one KLF6 allele is deleted in 77% (17 of 22) of primary prostate tumors. Sequence analysis of the retained KLF6 allele revealed mutations in 71% of these tumors. Functional studies confirm that whereas wild-type KLF6 up-regulates p21 (WAF1/CIP1) in a p53-independent manner and significantly reduces cell proliferation, tumor-derived KLF6 mutants do not. Our data suggest that KLF6 is a tumor suppressor gene involved in human prostate cancer.	CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, Div Med Oncol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Reg Med Ctr, San Jose, CA 95116 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Friedman, SL (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, 1425 Madison Ave,Room 1170F,Box 1123, New York, NY 10029 USA.		Heath, Karen Elise/K-7760-2014; Chan, Andrew Man-Lok/J-9497-2013; Narla, Goutham/AAZ-5710-2020; Heath, K. E./ABG-4658-2020; Chan, Andrew/AAC-1145-2020	Heath, Karen Elise/0000-0002-5816-7044; Chan, Andrew Man-Lok/0000-0001-9923-5464; Narla, Goutham/0000-0003-4098-4203; Heath, K. E./0000-0002-5816-7044; Chan, Andrew/0000-0001-9923-5464; Giono, Luciana/0000-0001-6958-6044; Reeves, Helen/0000-0003-0359-9795	NCI NIH HHS [CA79918, CA78207] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [DK37340] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA079918, T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037340] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Gumerlock PH, 1997, J NATL CANCER I, V89, P66, DOI 10.1093/jnci/89.1.66; Ittmann M, 1996, CANCER RES, V56, P2143; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kojima S, 2000, BLOOD, V95, P1309; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Latil A, 1998, VIRCHOWS ARCH, V432, P389, DOI 10.1007/s004280050183; MIRCHANDANI D, 1995, AM J PATHOL, V147, P92; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Suzuki T, 1998, J BIOCHEM, V124, P389, DOI 10.1093/oxfordjournals.jbchem.a022124; Trybus TM, 1996, CANCER RES, V56, P2263	15	360	392	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2563	2566		10.1126/science.1066326	http://dx.doi.org/10.1126/science.1066326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752579				2022-12-01	WOS:000172927700063
J	Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J				Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J			The DNA sequence and comparative analysis of human chromosome 20	NATURE			English	Article							COMMON DELETED REGION; HUMAN-GENOME; PHYSICAL MAPS; GENE; CHROMOSOME-20; IDENTIFICATION; PROGRAM; NUMBER; LOCUS; MOUSE	The finished sequence of human chromosome 20 comprises 59,187,298 base pairs (bp) and represents 99.4% of the euchromatic DNA. A single contig of 26 megabases (Mb) spans the entire short arm, and five contigs separated by gaps totalling 320 kb span the long arm of this metacentric chromosome. An additional 234,339 bp of sequence has been determined within the pericentromeric region of the long arm. We annotated 727 genes and 168 pseudogenes in the sequence. About 64% of these genes have a 59 and a 39 untranslated region and a complete open reading frame. Comparative analysis of the sequence of chromosome 20 to whole-genome shotgun-sequence data of two other vertebrates, the mouse Mus musculus and the puffer fish Tetraodon nigroviridis, provides an independent measure of the efficiency of gene annotation, and indicates that this analysis may account for more than 95% of all coding exons and almost all genes.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Deloukas, P (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	panos@sanger.ac.uk	Hubbard, Tim J/C-2567-2008; Durbin, Richard/AAE-7178-2019; Deloukas, Panos/B-2922-2013; Johnson, David/A-3907-2011; Hubbard, Tim J.P./AAT-4571-2020	Hubbard, Tim J/0000-0002-1767-9318; Durbin, Richard/0000-0002-9130-1006; Deloukas, Panos/0000-0001-9251-070X; Johnson, David/0000-0003-0887-3343; Hubbard, Tim J.P./0000-0002-1767-9318; Davidson, Claire/0000-0002-4910-8202; Howe, Kerstin/0000-0003-2237-513X; Martin, Sancha/0000-0001-6213-5259; Hunt, Adrienne/0000-0002-1227-0310; Hunt, Sarah/0000-0002-8350-1235; Gilbert, James/0000-0001-8079-3159; Steward, Charles/0000-0001-8829-5349; Wilming, Laurens/0000-0002-4154-7358; Kay, Mike/0000-0002-3282-0834; Fosker, Christine/0000-0002-3799-9474				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bench AJ, 1998, GENOMICS, V49, P351, DOI 10.1006/geno.1998.5231; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHUTE I, 1997, GENOMICS, V41, P51; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenfeld A, 1999, GENOME RES, V9, P1; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Rigaud G, 2001, CANCER RES, V61, P285; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zheng SL, 2001, HUM GENET, V108, P430, DOI 10.1007/s004390100513; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	38	166	736	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					865	U3		10.1038/414865a	http://dx.doi.org/10.1038/414865a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780052	Bronze			2022-12-01	WOS:000172813300035
J	Ohta, A; Sitkovsky, M				Ohta, A; Sitkovsky, M			Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage	NATURE			English	Article							T-CELL-ACTIVATION; RELEASE; MECHANISMS; INHIBITOR; ARTHRITIS	Inappropriate or prolonged inflammation is the main cause of many diseases(1); for this reason it is important to understand the physiological mechanisms that terminate inflammation in vivo(2). Agonists for several G(s)-protein-coupled receptors(3), including cell-surface adenosine purinergic receptors(4-7), can increase levels of immunosuppressive cyclic AMP in immune cells(8-15); however, it was unknown whether any of these receptors regulates inflammation in vivo. Here we show that A2a adenosine receptors have a non-redundant role in the attenuation of inflammation and tissue damage in vivo. Sub-threshold doses of an inflammatory stimulus(16,17) that caused minimal tissue damage in wild-type mice were sufficient to induce extensive tissue damage, more prolonged and higher levels of pro-inflammatory cytokines, and death of male animals deficient in the A2a adenosine receptor. Similar observations were made in studies of three different models of inflammation and liver damage as well as during bacterial endotoxin-induced septic shock. We suggest that A2a adenosine receptors are a critical part of the physiological negative feedback mechanism for limitation and termination of both tissue-specific and systemic inflammatory responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sitkovsky, M (corresponding author), NIAID, Immunol Lab, NIH, 10 Ctr Dr,Room 10-11N311, Bethesda, MD 20892 USA.	mvsitkov@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000626] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apasov SG, 2000, BRIT J PHARMACOL, V131, P43, DOI 10.1038/sj.bjp.0703532; Armstrong JM, 2001, BIOCHEM J, V354, P123, DOI 10.1042/0264-6021:3540123; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Cheng P, 1999, J POROUS MEDIA, V2, P19, DOI 10.1615/JPorMedia.v2.i1.20; CRONSTEIN BN, 1995, J INVEST MED, V43, P50; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Eigler A, 1997, SCAND J IMMUNOL, V45, P132, DOI 10.1046/j.1365-3083.1997.d01-377.x; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; FIRESTEIN GS, 1994, J IMMUNOL, V152, P5853; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; HOSKIN DW, 1994, INT J CANCER, V59, P854, DOI 10.1002/ijc.2910590625; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ji X D, 1999, Drug Des Discov, V16, P217; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Luster MI, 2001, TOXICOL LETT, V120, P317, DOI 10.1016/S0378-4274(01)00284-3; Malfait AM, 1999, J IMMUNOL, V162, P6278; MARQUARDT DL, 1984, P NATL ACAD SCI-BIOL, V81, P6192, DOI 10.1073/pnas.81.19.6192; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Schumann J, 1998, J IMMUNOL, V161, P5745; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; Tarkowski A, 1998, MOL MED TODAY, V4, P15, DOI 10.1016/S1357-4310(97)80540-0; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; van der Pouw Kraan TCTM, 1998, J CLIN INVEST, V102, P1866, DOI 10.1172/JCI3692; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; WINN HR, 1981, AM J PHYSIOL, V241, pH235, DOI 10.1152/ajpheart.1981.241.2.H235	30	966	1009	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					916	920		10.1038/414916a	http://dx.doi.org/10.1038/414916a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780065	Green Published			2022-12-01	WOS:000172813300048
J	Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK				Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK			Structural basis of water-specific transport through the AQP1 water channel	NATURE			English	Article							ELECTRON CRYSTALLOGRAPHY; PROTEIN; GLYCEROL; CONDUCTION; CHAIN; CHIP; PORE	Water channels facilitate the rapid transport of water across cell membranes in response to osmotic gradients. These channels are believed to be involved in many physiological processes that include renal water conservation, neuro-homeostasis, digestion, regulation of body temperature and reproduction. Members of the water channel superfamily have been found in a range of cell types from bacteria to human. In mammals, there are currently 10 families of water channels, referred to as aquaporins (AQP): AQP0-AQP9. Here we report the structure of the aquaporin 1 (AQP1) water channel to 2.2 Angstrom resolution. The channel consists of three topological elements, an extracellular and a cytoplasmic vestibule connected by an extended narrow pore or selectivity filter. Within the selectivity filter, four bound waters are localized along three hydrophilic nodes, which punctuate an otherwise extremely hydrophobic pore segment. This unusual combination of a long hydrophobic pore and a minimal number of solute binding sites facilitates rapid water transport. Residues of the constriction region, in particular histidine 182, which is conserved among all known water-specific channels, are critical in establishing water specificity. Our analysis of the AQP1 pore also indicates that the transport of protons through this channel is highly energetically unfavourable.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Comparat Biochem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Walian, P (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	PJWalian@lbl.gov; BKJap@lbl.gov	Sui, Haixin/L-4265-2017; Han, Bong-Gyoon/J-9120-2012	Sui, Haixin/0000-0002-5560-4325; 				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; AGRE P, 1993, AM J PHYSIOL, V265, pF463; BACIOU L, 1995, BIOCHEMISTRY-US, V34, P7967, DOI 10.1021/bi00025a001; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Pomes R, 1998, BIOPHYS J, V75, P33, DOI 10.1016/S0006-3495(98)77492-2; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERKMAN AS, 1992, ANNU REV PHYSIOL, V54, P97, DOI 10.1146/annurev.physiol.54.1.97; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	39	863	916	9	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					872	878		10.1038/414872a	http://dx.doi.org/10.1038/414872a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780053	Green Submitted			2022-12-01	WOS:000172813300036
J	Bansal, A				Bansal, A			Trends in reporting of SNP associations	LANCET			English	Editorial Material							CALPAIN-10		Gemini Genom UK Ltd, Dept Stat, Cambridge CB4 0GH, England		Bansal, A (corresponding author), Gemini Genom UK Ltd, Dept Stat, Cambridge CB4 0GH, England.	Aruna.Bansal@gemini-genomics.com						Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; HOLM S, 1979, SCAND J STAT, V6, P65; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467	8	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2016	2016		10.1016/S0140-6736(01)07139-2	http://dx.doi.org/10.1016/S0140-6736(01)07139-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755606				2022-12-01	WOS:000172722800008
J	Walldius, G; Jungner, I; Holme, I; Aastveit, AH; Kolar, W; Steiner, E				Walldius, G; Jungner, I; Holme, I; Aastveit, AH; Kolar, W; Steiner, E			High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study	LANCET			English	Article							CHEMISTRY STANDARDIZATION PROJECT; CORONARY-ARTERY DISEASE; ISCHEMIC-HEART-DISEASE; INTERNATIONAL-FEDERATION; PLASMA APOLIPOPROTEINS; REFERENCE INTERVALS; SWEDISH MALES; RISK; CHOLESTEROL; VALUES	Background Apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) are thought to be better predictors of acute myocardial infarction than total cholesterol and LDL-cholesterol. We investigated whether apoB and apoA-I are predictors of risk of fatal myocardial infarction. We also aimed to establish whether apoB and apoA-I add further information about risk of fatal myocardial infarction to that obtained with total cholesterol, triglycerides, and LDL-cholesterol. Methods We recruited 175 553 individuals mainly from screening programmes. We measured concentrations of apoB, apoA-I, total cholesterol, and triglycerides, and calculated apoB/apoA-I ratio and concentrations of LDL-cholesterol and HDL-cholesterol. The relation between death from acute myocardial infarction and initial values for apoB, apoA-I, and the other lipids was examined. Findings Mean follow-up was 66.8 months (SD 41.3) for 98 722 men and 64.4 months (41.4) for 76 831 women. 864 men and 359 women had fatal myocardial infarction. In univariate analyses adjusted for age and in multivariate analyses adjusted for age, total cholesterol, and triglycerides, the values for apoB and apoB/apoA-I ratio were strongly and positively related to increased risk of fatal myocardial infarction in men and in women. ApoA-I was noted to be protective. In multivariate analysis, apoB was a stronger predictor of risk than LDL-cholesterol in both sexes. Interpretation Although LDL-cholesterol and HDL-cholesterol are known risk factors, we suggest that apoB, apoB/apoA-I, and apoA-I should also be regarded as highly predictive in evaluation of cardiac risk. Although increased throughout the range of values of LDL-cholesterol, apoB and apoA-I might be of greatest value in diagnosis and treatment in men and women who have common lipid abnormalities, but have normal or low concentrations of LDL-cho le sterol.	AstraZeneca, S-43183 Molndal, Sweden; Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden; St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden; Ulleval Hosp, Ctr Prevent Med, Oslo, Norway; Agr Univ Norway, Dept Math Sci, As, Norway	AstraZeneca; Karolinska Institutet; Saint Goran's Hospital; University of Oslo; Norwegian University of Life Sciences	Walldius, G (corresponding author), AstraZeneca, S-43183 Molndal, Sweden.	goran.walldius@astrazeneca.com						Bachorik PS, 1997, CLIN CHEM, V43, P2364; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Connelly PW, 1999, CAN J CARDIOL, V15, P409; Contois JH, 1996, CLIN CHEM, V42, P515; Contois JH, 1996, CLIN CHEM, V42, P507; Crouse JR, 2000, ARTERIOSCL THROM VAS, V20, P2333, DOI 10.1161/01.ATV.20.11.2333; Francis MC, 2001, ATHEROSCLEROSIS, V155, P165, DOI 10.1016/S0021-9150(00)00528-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GARFAGNINI A, 1995, EUR HEART J, V16, P465, DOI 10.1093/oxfordjournals.eurheartj.a060937; GOTTO A, 2000, ILIB LIPID HDB CLIN; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Graziani MS, 1998, CLIN CHEM, V44, P134; JUNGNER I, 1992, INT J CLIN LAB RES, V21, P247, DOI 10.1007/BF02591655; Jungner I, 1998, CLIN CHEM, V44, P1641; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LEINO A, 1995, CLIN CHEM, V41, P1633; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Mykkanen L, 1999, ARTERIOSCL THROM VAS, V19, P2742, DOI 10.1161/01.ATV.19.11.2742; OBRIEN T, 1995, ARTERIOSCL THROM VAS, V15, P228, DOI 10.1161/01.ATV.15.2.228; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; RADER DJ, 1994, ANN INTERN MED, V120, P1012, DOI 10.7326/0003-4819-120-12-199406150-00008; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Sniderman AD, 1996, CLIN CHEM, V42, P489; Sniderman AD, 2001, CAN MED ASSOC J, V164, P44; Sniderman AD, 1997, CLIN CHEM, V43, P1310; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; WALLDIUS G, 1992, BLOOD PRESS S4, V1, P35; Warnick GR, 2000, CLIN CHEM LAB MED, V38, P287, DOI 10.1515/CCLM.2000.041; Westedt ML, 1998, RHEUMATOL INT, V18, P1, DOI 10.1007/s002960050045; Wood D, 1998, EUR HEART J, V19, P1434	35	919	970	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2026	2033		10.1016/S0140-6736(01)07098-2	http://dx.doi.org/10.1016/S0140-6736(01)07098-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755609				2022-12-01	WOS:000172722800011
J	Colman-Lerner, A; Chin, TE; Brent, R				Colman-Lerner, A; Chin, TE; Brent, R			Yeast Cbk1 and Mob2 activate daughter-specific genetic programs to induce asymmetric cell fates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; HO GENE; TRANSCRIPTION FACTOR; CYCLE CONTROL; EXPRESSION; SWI5; IDENTIFICATION; REGULATORS; INHIBITOR	In Saccharomyces cerevisiae, mothers and daughters have distinct fates. We show that Cbk1 kinase and its interacting protein Mob2 regulate this asymmetry by inducing daughter-specific genetic programs. Daughter-specific expression is due to Cbk1/Mob2-dependent activation and localization of the Ace2 transcription factor to the daughter nucleus. Ectopic localization of active Ace2 to mother nuclei is sufficient to activate daughter-specific genes in mothers. Eight genes are daughter-specific under the tested conditions, while two are daughter-specific only in saturated cultures. Some daughter-specific gene products contribute to cell separation by degrading the cell wall. These experiments define programs of gene expression specific to daughters and describe how those programs are controlled.	Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Colman-Lerner, A (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	colman-lerner@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020	Colman-Lerner, Alejandro/0000-0002-2557-8883				Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dohrmann PR, 1996, MOL CELL BIOL, V16, P1746; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Futcher Bruce, 1999, Methods in Cell Science, V21, P79, DOI 10.1023/A:1009872403440; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geyer CR, 1999, P NATL ACAD SCI USA, V96, P8567, DOI 10.1073/pnas.96.15.8567; Guthrie C., 1991, METHODS ENZYMOLOGY G; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jacobs C, 1998, CURR OPIN GENET DEV, V8, P386, DOI 10.1016/S0959-437X(98)80107-X; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NASMYTH K, 1993, CURR OPIN GENET DEV, V3, P286, DOI 10.1016/0959-437X(93)90036-O; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1983, NATURE, V302, P670, DOI 10.1038/302670a0; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; OSHIMA Y, 1971, GENETICS, V67, P327; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; SIKORSKI RS, 1989, GENETICS, V122, P19; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; SLOAT BF, 1978, SCIENCE, V200, P1171, DOI 10.1126/science.349694; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; TEBB G, 1993, GENE DEV, V7, P517, DOI 10.1101/gad.7.3.517; Toyn JH, 1997, GENETICS, V145, P85; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	50	261	268	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					739	750		10.1016/S0092-8674(01)00596-7	http://dx.doi.org/10.1016/S0092-8674(01)00596-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747810	Bronze			2022-12-01	WOS:000172771800007
J	Stemmann, O; Zou, H; Gerber, SA; Gygi, SP; Kirschner, MW				Stemmann, O; Zou, H; Gerber, SA; Gygi, SP; Kirschner, MW			Dual inhibition of sister chromatid separation at metaphase	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; XENOPUS EGG EXTRACTS; CELL-CYCLE EXTRACTS; MAP KINASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ALIGNMENT; ANAPHASE TRANSITION; CENP-E; YEAST; DESTRUCTION	Separation of sister chromatids in anaphase is mediated by separase, an endopeptidase that cleaves the chromosomal cohesin SCC1. Separase is inhibited by securin, which is degraded at the metaphase-anaphase transition. Using Xenopus egg extracts, we demonstrate that high CDC2 activity inhibits anaphase but not securin degradation. We show that separase is kept inactive under these conditions by a mechanism independent of binding to securin. Mutation of a single phosphorylation site on separase relieves the inhibition and rescues chromatid separation in extracts with high CDC2 activity. Using quantitative mass spectrometry, we show that, in intact cells, there is complete phosphorylation of this site in metaphase and significant dephosphorylation in anaphase. We propose that separase activation at the metaphase-anaphase transition requires the removal of both securin and an inhibitory phosphate.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.			Gerber, Scott/0000-0002-2964-5051; Stemmann, Olaf/0000-0003-3044-2515	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026875, R01GM039023, R01GM026875] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00041] Funding Source: Medline; NIGMS NIH HHS [GM26875-17, GM39023-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; ENG J, 1994, J AM SOC MASS SPECTR, V5, P1579; Fang CH, 1998, INT J MOL MED, V1, P163; Foley E, 2001, CURR BIOL, V11, P151, DOI 10.1016/S0960-9822(01)00050-1; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; IMIGER S, 1995, CELL, V81, P269; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; KUMAGAI A, 1991, COLD SPRING HARB SYM, V56, P585; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Meyn MA, 2000, CURR BIOL, V10, P1599, DOI 10.1016/S0960-9822(00)00863-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	46	372	394	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					715	726		10.1016/S0092-8674(01)00603-1	http://dx.doi.org/10.1016/S0092-8674(01)00603-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747808	Bronze			2022-12-01	WOS:000172771800005
J	Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G				Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G			Loss of sex discrimination and male-male aggression in mice deficient for TRP2	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MUS-MUSCULUS; OLFACTORY CONTROL; MULTIGENE FAMILY; BEHAVIOR; CHANNEL; TESTOSTERONE; ORGANIZATION; NEURONS; VISION	The mouse vomeronasal organ (VNO) is thought to mediate social behaviors and neuroendocrine changes elicited by pheromonal cues. The molecular mechanisms underlying the sensory response to pheromones and the behavioral repertoire induced through the VNO are not fully characterized. Using the tools of mouse genetics and multielectrode recording, we demonstrate that the sensory activation of VNO neurons requires TRP2, a putative ion channel of the transient receptor potential family that is expressed exclusively in these neurons. Moreover, we show that mate mice deficient in TRP2 expression fail to display mate-mate aggression, and they initiate sexual and courtship behaviors toward both males and females. Our study suggests that, in the mouse, sensory activation of the VNO is essential for sex discrimination of conspecifics and thus ensures gender-specific behavior.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Oka, Yoshitaka/C-9670-2010; Stowers, Lisa/K-6137-2015	Oka, Yoshitaka/0000-0002-3482-3051; Stowers, Lisa/0000-0002-4403-1269; Dulac, Catherine/0000-0001-5024-5418; Meister, Markus/0000-0003-2136-6506	NIDCD NIH HHS [DC03903] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; BARKLEY MS, 1977, HORM BEHAV, V9, P32, DOI 10.1016/0018-506X(77)90048-4; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONNOR J, 1972, PSYCHON SCI, V27, P1; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DRIVER PM, 1970, NATURE, V226, P968, DOI 10.1038/226968a0; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; FARBMAN AI, 1992, CELL BIOL OLFACTION; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hofmann T, 2000, BIOCHEM J, V351, P115, DOI 10.1042/0264-6021:3510115; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; LEE CT, 1972, PSYCHON SCI, V27, P287; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 1996, J NEUROSCI, V16, P4625; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARUNIAK JA, 1986, PHYSIOL BEHAV, V37, P655, DOI 10.1016/0031-9384(86)90300-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MEREDITH M, 1986, PHYSIOL BEHAV, V36, P737, DOI 10.1016/0031-9384(86)90362-8; Meredith M, 2001, CHEM SENSES, V26, P433, DOI 10.1093/chemse/26.4.433; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; VANNIER B, 1996, P NATL ACAD SCI USA, V93, P571; VANOORTMERSSEN GA, 1971, BEHAVIOUR, V38, P1, DOI 10.1163/156853971X00014; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1979, NEUROSCI BIOBEHAV R, V3, P301, DOI 10.1016/0149-7634(79)90015-0; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zann R.A., 1996, ZEBRA FINCH SYNTHESI; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	45	616	633	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1493	1500		10.1126/science.1069259	http://dx.doi.org/10.1126/science.1069259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11823606				2022-12-01	WOS:000173981300044
J	Chou, KM; Cheng, YC				Chou, KM; Cheng, YC			An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3 ' mispaired DNA	NATURE			English	Article							BASE EXCISION-REPAIR; HUMAN APURINIC ENDONUCLEASE; POLYMERASE-BETA; L-CONFIGURATION; CELLS; MUTAGENESIS; EXPRESSION; MUTATIONS; HOMOLOGY; ANALOGS	Human apurinic/apyrimidinic endonuclease (APE1) is an essential enzyme in DNA base excision repair that cuts the DNA backbone immediately adjacent to the 5' side of abasic sites to facilitate repair synthesis by DNA polymerase beta (ref. 1). Mice lacking the murine homologue of APE1 die at an early embryonic stage(2). Here we report that APE1 has a DNA exonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules. The efficiency of this activity is inversely proportional to the gap size in DNA. In a base excision repair system reconstituted in vitro, the rejoining of nicked mismatched DNA depended on the presence of APE1, indicating that APE1 may increase the fidelity of base excision repair and may represent a new 3' mispaired DNA repair mechanism. The exonuclease activity of APE1 can remove the anti-HIV nucleoside analogues 3'-azido-3'-deoxythymidine and 2',3'-didehydro-2', 3'-dideoxythymidine from DNA, suggesting that APE1 might have an impact on the therapeutic index of antiviral compounds in this category.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,Sterling Hall Med B-315, New Haven, CT 06520 USA.							Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Bouayadi K, 1997, CANCER RES, V57, P110; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; CHENG YC, 1990, ANN NY ACAD SCI, V616, P217; Chou KM, 2000, J BIOL CHEM, V275, P31009, DOI 10.1074/jbc.M004082200; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; GROVE KL, 1995, CANCER RES, V55, P3008; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1087, DOI 10.1093/nar/19.5.1087; SKALSKI V, 1995, BIOCHEM PHARMACOL, V50, P815, DOI 10.1016/0006-2952(95)00205-E; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zhu QY, 1996, AIDS RES HUM RETROV, V12, P507, DOI 10.1089/aid.1996.12.507	25	182	195	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					655	659		10.1038/415655a	http://dx.doi.org/10.1038/415655a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832948				2022-12-01	WOS:000173709100050
J	Golz, J; MacLeod, DIA				Golz, J; MacLeod, DIA			Influence of scene statistics on colour constancy	NATURE			English	Article							MUTUAL ILLUMINATION; NATURAL IMAGES; APPEARANCE; CHROMATICITY; PERCEPTION; MECHANISMS; MODEL	The light reflected from an object depends not only on the surface properties of this object but also on the illuminant. The same is true for the excitations of the photoreceptors, which serve as the basis for the perceived colour. However, our visual system has the ability to perceive constant surface colours despite changes in illumination(1). The average chromaticity of the retinal image of a scene depends on the illumination, and thus might be used by the visual system to estimate the illumination and to modulate the correction that subserves colour constancy(2-4). But this measure is not sufficient: a reddish scene under white light can produce the same mean stimulation as a neutral scene in red light. Higher order scene statistics-for example, the correlation between redness and luminance within the image-allow these cases to be distinguished. Here we report that the human visual system does exploit such a statistic when estimating the illuminant, and gives it a weight that is statistically appropriate for the natural environment.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Calif San Diego, Dept Psychol, La Jolla, CA 93093 USA	University of Kiel; University of California System; University of California San Diego	Golz, J (corresponding author), Univ Kiel, Dept Psychol, Olshaussenstr 40, D-24098 Kiel, Germany.							BAUML KH, 1994, J OPT SOC AM A, V11, P531, DOI 10.1364/JOSAA.11.000531; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Brown RO, 1997, CURR BIOL, V7, P844, DOI 10.1016/S0960-9822(06)00372-1; BUCHSBAUM G, 1980, J FRANKLIN I, V310, P1, DOI 10.1016/0016-0032(80)90058-7; DZMURA M, 1986, J OPT SOC AM A, V3, P1662, DOI 10.1364/JOSAA.3.001662; DZMURA M, 1995, GEOMETRIC REPRESENTATIONS OF PERCEPTUAL PHENOMENA, P187; Eskew R. T., 1999, COLOR VISION GENES P, P345, DOI DOI 10.1016/B978-012370880-9.00302-9; FORSYTH DA, 1990, INT J COMPUT VISION, V5, P5, DOI 10.1007/BF00056770; FORSYTH DA, 1990, AI AND THE EYE, P201; FUNT BV, 1993, IEEE T PATTERN ANAL, V15, P1319, DOI 10.1109/34.250838; FUNT BV, 1991, INT J COMPUT VISION, V6, P5, DOI 10.1007/BF00127123; GERSHON R, 1989, COLOR RES APPL, V14, P325, DOI 10.1002/col.5080140610; GILCHRIST AL, 1992, INVEST OPHTH VIS SCI, V33, P756; Golz J, 1999, INVEST OPHTH VIS SCI, V40, pS749; JENNESS JW, 1995, VISION RES, V35, P797, DOI 10.1016/0042-6989(94)00169-M; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; LAND EH, 1986, VISION RES, V26, P7, DOI 10.1016/0042-6989(86)90067-2; LEE HC, 1986, J OPT SOC AM A, V3, P1694, DOI 10.1364/JOSAA.3.001694; MACLEOD DI, IN PRESS COLOUR PERC; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MALONEY TM, IN PRESS COLOUR PERC; Mausfeld R, 1998, PERCEPTION, V27, P42; MAUSFELD R, IN PRESS PERCEPTION; Mausfeld R., 1998, COLOR VISION PERSPEC, P219; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; TOMINAGA S, 1989, J OPT SOC AM A, V6, P576, DOI 10.1364/JOSAA.6.000576; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WYSZECKI G, 1982, COLOR SCI CONCEPTS M, P145	30	93	95	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					637	640		10.1038/415637a	http://dx.doi.org/10.1038/415637a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832945				2022-12-01	WOS:000173709100045
J	Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB				Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB			Genome shuffling leads to rapid phenotypic improvement in bacteria	NATURE			English	Article							STREPTOMYCES-FRADIAE; PROTOPLAST FUSION; GENETIC-RECOMBINATION; REGENERATION; BIOSYNTHESIS; EVOLUTION; TYLOSIN	For millennia, selective breeding, on the basis of biparental mating, has led to the successful improvement of plants and animals to meet societal needs(1). At a molecular level, DNA shuffling mimics, yet accelerates, evolutionary processes, and allows the breeding and improvement of individual genes and subgenomic DNA fragments. We describe here whole-genome shuffling; a process that combines the advantage of multi-parental crossing allowed by DNA shuffling with the recombination of entire genomes normally associated with conventional breeding. We show that recursive genomic recombination within a population of bacteria can efficiently generate combinatorial libraries of new strains. When applied to a population of phenotypically selected bacteria, many of these new strains show marked improvements in the selected phenotype. We demonstrate the use of this approach through the rapid improvement of tylosin production from Streptomyces fradiae. This approach has the potential to facilitate cell and metabolic engineering and provide a non-recombinant alternative to the rapid production of improved organisms.	Maxygen, Redwood City, CA 94063 USA; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	Eli Lilly	del Cardayre, SB (corresponding author), Maxygen, 515 Galveston Dr, Redwood City, CA 94063 USA.							AHARONOWITZ Y, 1981, SCI AM, V245, P141, DOI 10.1038/scientificamerican0981-140; BALTZ RH, 1981, ANTIMICROB AGENTS CH, V20, P214, DOI 10.1128/AAC.20.2.214; BALTZ RH, 1988, ANNU REV MICROBIOL, V42, P547; BALTZ RH, 1978, J GEN MICROBIOL, V107, P93, DOI 10.1099/00221287-107-1-93; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; Hamlyn P.F., 1979, GENETICS IND MICROOR, P185; HOPWOOD DA, 1980, PHILOS T R SOC B, V290, P313, DOI 10.1098/rstb.1980.0097; HOPWOOD DA, 1979, J GEN MICROBIOL, V111, P137, DOI 10.1099/00221287-111-1-137; HOPWOOD DA, 1978, MOL GEN GENET, V162, P307, DOI 10.1007/BF00268856; HOPWOOD DA, 1977, NATURE, V268, P171, DOI 10.1038/268171a0; IKEDA H, 1983, J ANTIBIOT, V36, P283, DOI 10.7164/antibiotics.36.283; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Vinci V, 1999, MANUAL IND MICROBIOL, V2, P103; [No title captured]; [No title captured]; [No title captured]	17	409	518	7	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					644	646		10.1038/415644a	http://dx.doi.org/10.1038/415644a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832946				2022-12-01	WOS:000173709100047
J	Schwetz, BA				Schwetz, BA			Congenital heart defect devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-01	WOS:000173686700006
J	Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E				Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E			The effect of controlled drinking in alcoholic cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR MASS; NATURAL-HISTORY; NUTRITIONAL-STATUS; HEART-FAILURE; LIVER-DISEASE; MYOPATHY; ETHANOL; CONSUMPTION; MEN	Background: Cardiomyopathy is a potentially fatal complication of alcohol abuse. In alcoholic persons who develop cardiac dysfunction, abstinence is thought to be essential to halt further deterioration of cardiac contractility. Some evidence indicates that reducing alcohol intake may also be beneficial. Objective: To evaluate the effect of moderate "controlled" drinking on cardiac function in patients with alcoholic cardiomyopathy. Design: 4-year prospective cohort study. Setting: A university hospital in Barcelona, Spain. Patients: 55 alcoholic men with cardiomyopathy who had been drinking a minimum of 100 g of ethanol per day for at least 10 years. Measurements: Evaluation of ethanol intake and nutrition, clinical assessment of cardiac status, and sequential echocardiography and radionuclide cardiac angiography. Results: After the first year of evaluation, all patients with cardiomyopathy who abstained from alcoholic beverages demonstrated significant improvement in left ventricular function (average increase in left ventricular ejection fraction, 0.131 [95% Cl, 0.069 to 0.193]). Patients who drank 20 to 60 g of ethanol per day showed a comparable mean improvement of 0.125 (CI, 0.082 to 0.168). In contrast, left ventricular election fraction deteriorated further in most patients who continued to abuse alcohol (>80 g/d). After 4 years, left ventricular ejection fraction had continued to improve in both abstinent patients and those who controlled their drinking. Ten patients who had continued to consume more than 80 g of ethanol per day died during the study. Conclusion: In patients with alcoholic cardiomyopathy, both abstinence and controlled drinking of up to 60 g of ethanol per day (four standard drinks) were comparably effective in promoting improvement in cardiac function.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Jefferson University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Rubin, E (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 279, Philadelphia, PA 19107 USA.		SOLA, JOAQUIM FERNANDEZ/K-3991-2019	SOLA, JOAQUIM FERNANDEZ/0000-0002-3218-0582				ASKANAS A, 1980, AM HEART J, V99, P9, DOI 10.1016/0002-8703(80)90309-9; BORY M, 1977, NOUV PRESSE MED, V6, P3295; Christakis GT, 1996, ANN THORAC SURG, V62, P1084, DOI 10.1016/0003-4975(96)00533-4; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; De Vries JHM, 1999, HLTH ISSUES RELATED, P27; DEMAKIS JG, 1974, ANN INTERN MED, V80, P293, DOI 10.7326/0003-4819-80-3-293; ESTRUCH R, 1993, ALCOHOL ALCOHOLISM, V28, P543; ESTRUCH R, 1989, MED CLIN-BARCELONA, V92, P69; ESTRUCH R, 1995, HEPATOLOGY, V22, P532, DOI 10.1016/0270-9139(95)90576-6; Estruch R, 1998, ALCOHOL CLIN EXP RES, V22, P2023, DOI 10.1111/j.1530-0277.1998.tb05911.x; Fernandez-Sola J, 2000, QJM-MON J ASSOC PHYS, V93, P35, DOI 10.1093/qjmed/93.1.35; FERNANDEZSOLA J, 1994, ANN INTERN MED, V120, P529, DOI 10.7326/0003-4819-120-7-199404010-00001; FernandezSola J, 1997, ADDICT BIOL, V2, P9, DOI 10.1080/13556219772822; FILLMORE KM, 1991, BRIT J ADDICT, V86, P1203, DOI 10.1111/j.1360-0443.1991.tb01700.x; FOY A, 1988, ALCOHOL CLIN EXP RES, V12, P360, DOI 10.1111/j.1530-0277.1988.tb00208.x; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOULD L, 1971, J AMER MED ASSOC, V218, P1799, DOI 10.1001/jama.218.12.1799; Guillo P, 1997, AM J CARDIOL, V79, P1276, DOI 10.1016/S0002-9149(97)00101-X; JOHNSON RA, 1982, NEW ENGL J MED, V307, P1119, DOI 10.1056/NEJM198210283071804; KALANT H, 1999, HLTH ISSUES RELATED, P1; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1984, POSTGRAD MED J, V60, P151, DOI 10.1136/pgmj.60.700.151; LANGER RD, 1992, CIRCULATION, V85, P910, DOI 10.1161/01.CIR.85.3.910; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MOUSHMOUSH B, 1991, ARCH INTERN MED, V151, P36, DOI 10.1001/archinte.151.1.36; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Nie N.H., 1975, STAT PACKAGE SOCIAL; Oren S, 1996, AM J CARDIOL, V77, P93, DOI 10.1016/S0002-9149(97)89144-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; REDFIELD MM, 1993, J AM COLL CARDIOL, V22, P1921, DOI 10.1016/0735-1097(93)90780-5; SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x; Sobell LC, 1996, AM J PUBLIC HEALTH, V86, P966, DOI 10.2105/AJPH.86.7.966; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VANDENBERG BF, 1989, CURR OPIN CARDIOL, V4, P815, DOI 10.1097/00001573-198912000-00011; WYNNE J, 1998, HARRISONS PRINCIPLES, P1328	39	79	81	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					192	200		10.7326/0003-4819-136-3-200202050-00007	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827495				2022-12-01	WOS:000173637400002
J	Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV				Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV			Association between functional polymorphism in EGF gene and malignant melanoma	LANCET			English	Article							EPIDERMAL GROWTH-FACTOR; RECEPTOR; SUSCEPTIBILITY	Background Malignant melanoma, the most serious cutaneous malignancy, has attracted substantial attention because of its rapidly increasing incidence and the poor prognosis of some tumours. Little is known of the genetic factors that mediate susceptibility to, and outcome of, sporadic malignant melanoma. Because of its role in mitogenesis, which is especially relevant to wound healing, tumorigenesis, and proliferation of epidermal tissues, epidermal growth factor (EGF) is an attractive candidate in which to look for genetic polymorphisms. Methods We enrolled 135 white European patients with malignant melanoma and 99 healthy white European controls, and screened a selection of DNA samples for polymorphisms in the promoter and 5' untranslated region of the EGF gene by single-stranded conformational polymorphism (SSCP) analysis. We then screened DNA samples from all participants for the identified polymorphism by restriction-fragment-length polymorphism (RFLP) analysis. In-vitro EGF production was measured in peripheral-blood mononuclear cells from 34 controls, and the results were compared with the individuals' EGF genotypes. Findings We identified a single nucleotide substitution (G to A) at position 61 of the EGF gene. Allele frequencies in the controls were 56% EGF 61*A and 44% EGF 61*G. Cells from individuals homozygous for the 61*A allele produced significantly less EGF than cells from 61*G homozygotes (p=0.0004) or heterozygous A/G individuals (p=0.001). Compared with the A/A genotype, G/G was significantly associated with Breslow thickness (p=0.045) and with risk of malignant melanoma (odds ratio 4.9 [95% Cl 2.3-10.2], P<0.0001). Interpretation This study suggests that high EGF production might be important in the development of malignant melanoma.	Univ Manchester, Sch Biol Sci, Immunol Res Grp, Manchester M13 9PT, Lancs, England; Keele Univ, N Staffordshire Hosp, Postgrad Med Sch, Ctr Cell & Mol Med, Stoke On Trent, Staffs, England; Leicester Royal Infirm, Dept Dermatol, Leicester, Leics, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent, Staffs, England	University of Manchester; Keele University; University Hospital of North Staffordshire NHS Trust; University of Leicester; Keele University; University Hospital of North Staffordshire NHS Trust	Pravica, V (corresponding author), Univ Manchester, Sch Biol Sci, Immunol Res Grp, Stopford Bldg, Manchester M13 9PT, Lancs, England.		Shahbazi, Majid/E-1452-2012; Fakhoury, Hana/F-6457-2017; lear, john/I-5465-2015	Fakhoury, Hana/0000-0001-9974-2108; Fryer, Anthony/0000-0001-8678-0404; lear, john/0000-0002-2969-9922; Shahbazi, Majid/0000-0002-4143-8282				BOYLE P, 1995, BRIT MED BULL, V51, P523, DOI 10.1093/oxfordjournals.bmb.a072978; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hutchinson PE, 2000, CLIN CANCER RES, V6, P498; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; LAFUENTE A, 1995, BRIT J CANCER, V72, P324, DOI 10.1038/bjc.1995.332; LAURENCE DJR, 1990, TUMOR BIOL, V11, P229, DOI 10.1159/000217659; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lear JT, 1998, INT J CLIN PRACT, V52, P145; Ma D, 1998, INVEST OPHTH VIS SCI, V39, P1067; MACKIE RM, 1995, BRIT J CANCER, V71, P173, DOI 10.1038/bjc.1995.35; MORTON CC, 1986, CYTOGENET CELL GENET, V41, P245, DOI 10.1159/000132237; Rivers JK, 1996, LANCET, V347, P803, DOI 10.1016/S0140-6736(96)90873-9; Rodeck U, 1988, Cancer Treat Res, V43, P3; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Strange RC, 1999, PHARMACOGENETICS, V9, P269, DOI 10.1097/00008571-199906000-00001; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wagner SN, 1998, BRIT J DERMATOL, V138, P13; WOLF CR, 1992, TOHOKU J EXP MED, V168, P73, DOI 10.1620/tjem.168.73; WORM M, 1995, EXP DERMATOL, V4, P305	20	226	242	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					397	401		10.1016/S0140-6736(02)07600-6	http://dx.doi.org/10.1016/S0140-6736(02)07600-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844511				2022-12-01	WOS:000173686500011
J	Sisodia, SS				Sisodia, SS			Biomedicine - A cargo receptor mystery APParently solved?	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; AXONAL-TRANSPORT; GAMMA-SECRETASE; KINESIN; APP; PHOSPHORYLATION; LOCALIZATION; PRESENILIN-1; MICE		Ctr Mol Neurobiol, Chicago, IL 60637 USA		Sisodia, SS (corresponding author), Ctr Mol Neurobiol, Chicago, IL 60637 USA.	ssisodia@drugs.bsd.uchicago.edu						Ando K, 1999, J NEUROSCI, V19, P4421; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heber S, 2000, J NEUROSCI, V20, P7951; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Matsuda S, 2001, J NEUROSCI, V21, P6597; Mattson M P, 2001, Trends Neurosci, V24, P441, DOI 10.1016/S0166-2236(00)01936-6; Muresan V, 2001, MOL BIOL CELL, V12, p311A; SCHEINFELD MH, 2001, J BIOL CHEM     1127; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6	27	25	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					805	807		10.1126/science.1069661	http://dx.doi.org/10.1126/science.1069661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823626				2022-12-01	WOS:000173733000028
J	Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB				Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB			Alcohol consumption and risk of dementia: the Rotterdam Study	LANCET			English	Article							APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; ACETYLCHOLINE; VALIDATION; DIAGNOSIS; DRINKING; ETHANOL; HEALTH; WINE	Background Light-to-moderate alcohol consumption reduces the risk of coronary heart disease and stroke. Because vascular disease is associated with cognitive impairment and dementia, we hypothesised that alcohol consumption might also affect the risk of dementia. Methods We examined the relation between alcohol consumption and risk of dementia in individuals taking part in the Rotterdam Study-a prospective population-based study of 7983 individuals aged 55 years and older. We studied all participants who did not have dementia at baseline (1990-93) and who had complete data on alcohol consumption (n=5395). Through follow-up examinations in 1993-94 and 1997-99 and an extensive monitoring system, we obtained nearly complete follow-up (99.7%) until the end of 1999. We used proportional hazards regression analysis, adjusted for age, sex, systolic blood pressure, education, smoking, and body-mass index, to compare the risk of developing dementia between individuals who regularly consumed alcohol and individuals who did not consume alcohol. Findings The average follow-up was 6.0 years. During this period, 197 individuals developed dementia (146 Alzheimer's disease, 29 vascular dementia, 22 other dementia). The median alcohol consumption was 0.29 drinks per day. Light-to-moderate drinking (one to three drinks per day) was significantly associated with a lower risk of any dementia (hazard ratio 0.58 [95% CI 0.38-0.90]) and vascular dementia (hazard ratio 0.29 [0.09-0.93]). We found no evidence that the relation between alcohol and dementia varied by type of alcoholic beverage. Interpretation These findings suggest that light-to-moderate alcohol consumption is associated with a reduced risk of dementia in individuals aged 55 years or older. The effect seems to be unchanged by the source of alcohol.	Eramus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Netherlands Inst Hlth Sci, NL-3000 DR Rotterdam, Netherlands		Breteler, MMB (corresponding author), Eramus Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	breteler@epib.fgg.eur.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305; van Swieten, John/0000-0001-6278-6844; Van Duijn, Cornelia/0000-0002-2374-9204				American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; BYERS T, 1987, AM J EPIDEMIOL, V125, P999, DOI 10.1093/oxfordjournals.aje.a114638; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; FENN CG, 1982, THROMB HAEMOSTASIS, V48, P49; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GOLDBERG DM, 1995, CLIN CHIM ACTA, V237, P155, DOI 10.1016/0009-8981(95)06069-P; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Hebert R, 2000, STROKE, V31, P1487, DOI 10.1161/01.STR.31.7.1487; Henn C, 1998, N-S ARCH PHARMACOL, V357, P640, DOI 10.1007/PL00005219; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JOYCE EM, 1994, BRIT MED BULL, V50, P99, DOI 10.1093/oxfordjournals.bmb.a072888; KLATSKY AL, 1986, CIRCULATION, V73, P628, DOI 10.1161/01.CIR.73.4.628; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER NE, 1988, J EPIDEMIOL COMMUN H, V42, P220, DOI 10.1136/jech.42.3.220; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; RUITENBERG A, IN PRESS NEUROBIOL A; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Skoog I, 1998, NEUROEPIDEMIOLOGY, V17, P2, DOI 10.1159/000026147; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 1993, NEVO TABLE DUTCH FOO	34	358	366	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					281	286		10.1016/S0140-6736(02)07493-7	http://dx.doi.org/10.1016/S0140-6736(02)07493-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830193				2022-12-01	WOS:000173588100007
J	Mellor, J; Nicoll, RA; Schmitz, D				Mellor, J; Nicoll, RA; Schmitz, D			Mediation of hippocampal mossy fiber long-term potentiation by presynaptic I-h channels	SCIENCE			English	Article							INWARD RECTIFYING CURRENT; GYRUS GRANULE CELLS; SYNAPTIC TRANSMISSION; ADENYLATE-CYCLASE; CATION CURRENT; CYCLIC-AMP; 2 FORMS; NEURONS; EXPRESSION; PACEMAKER	Hippocampal mossy fiber long-term potentiation (LTP) is expressed presynaptically, but the exact mechanisms remain unknown. Here, we demonstrate the involvement of the hyperpolarization-activated cation channel (I-h) in the expression of mossy fiber LTP. Established LTP was blocked and reversed by I-h. channel antagonists. Whole-cell recording from granule cells revealed that repetitive stimulation causes a calcium- and I-h-dependent long-lasting depolarization mediated by protein kinase A. Depolarization at the terminals would be expected to enhance transmitter release, whereas somatic depolarization would enhance the responsiveness of granule cells to afferent input. Thus, I-h channels play an important rote in the long-lasting control of transmitter release and neuronal excitability.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CASTILLO PE, 2000, SOC NEUR ABSTR, V27; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Chen CF, 1997, J NEUROSCI, V17, P8687; FROEMKE RC, 2000, SOC NEUR ABSTR, V27; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; KOCSIS JD, 1983, J PHYSIOL-LONDON, V334, P225, DOI 10.1113/jphysiol.1983.sp014491; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; STABEL J, 1992, NEUROSCI LETT, V135, P231, DOI 10.1016/0304-3940(92)90443-B; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	41	128	134	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					143	147		10.1126/science.1064285	http://dx.doi.org/10.1126/science.1064285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778053				2022-12-01	WOS:000173143100054
J	Haas, W; Shepard, BD; Gilmore, MS				Haas, W; Shepard, BD; Gilmore, MS			Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction	NATURE			English	Article							MEMBRANE-PROTEINS; TOXIN; IDENTIFICATION; ACTIVATION; PREDICTION	Bacteria of the genus Enterococcus are the main causes of highly antibiotic-resistant infections that are acquired in hospitals(1,2). Many clinical isolates of Enterococcus faecalis produce an exotoxin called cytolysin that contributes to bacterial virulence(3). In addition to its toxin activity, the cytolysin is bactericidal for nearly all Gram-positive organisms(4). An understanding of conditions that regulate cytolysin expression has advanced little since its initial description(5). Here we show that the products of two genes, cylR1 and cylR2, which lack homologues of known function, work together to repress transcription of cytolysin genes. Derepression occurs at a specific cell density when one of the cytolysin subunits reaches an extracellular threshold concentration. These observations form the basis of a model for the autoinduction of the cytolysin by a quorum-sensing mechanism involving a two-component regulatory system.	Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gilmore, MS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, 975 NE 10th St, Oklahoma City, OK 73104 USA.							Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BROCK TD, 1963, J BACTERIOL, V86, P702, DOI 10.1128/JB.86.4.702-707.1963; Coburn PS, 1999, INFECT IMMUN, V67, P3339, DOI 10.1128/IAI.67.7.3339-3347.1999; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; DUNNY GM, 1999, CELL CELL SIGNALING; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GILMORE MS, 1990, INFECT IMMUN, V58, P3914, DOI 10.1128/IAI.58.12.3914-3923.1990; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1111/j.1574-6968.1997.tb12726.x; Sambrook J., 2001, MOL CLONING; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shepard BD, 1999, APPL ENVIRON MICROB, V65, P1470; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; [No title captured]	24	159	168	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					84	87		10.1038/415084a	http://dx.doi.org/10.1038/415084a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780122				2022-12-01	WOS:000173028800045
J	McConnachie, A; Hunt, K; Emslie, C; Hart, C; Watt, G				McConnachie, A; Hunt, K; Emslie, C; Hart, C; Watt, G			"Unwarranted survivals" and "anomalous deaths" from coronary heart disease: prospective survey of general population	BRITISH MEDICAL JOURNAL			English	Article							LAY EPIDEMIOLOGY; HEALTH-EDUCATION; LIFE-STYLE; RISK; PREVENTION; RENFREW; WOMEN; MEN	Objectives To assess survival in people who are at apparent high risk who do not develop coronary heart disease ("unwarranted survivals") and mortality in people at low risk who die from the disease ("anomalous deaths") and the extent to which these outcomes are explained by other, less visible, risk factors. Design Prospective general population survey. Setting Renfrew and Paisley, Scotland. Participants 6068 men aged 45-64 years at screening in 1972-6, allocated to "visible" risk groups on the basis of body mass index and smoking. Main outcome measures Survival and death from coronary heart disease by age 70 years. Results Visible risk was a good predictor of mortality: 13% (45) of men at low risk and 45% (86) of men at high risk had died by age 70 years. Of these deaths, 12 (4%) and 44 (23%), respectively, were from coronary heart disease. In the group at low visible risk other less visible risk factors accounted for increased risk in 83% (10/12) of men who died from coronary heart disease and 29% (84/292) of men who survived. In the high risk group 81/107 who survived (76%) and 19/44 (43%) who died from coronary heart disease had lower risk after other factors were considered. Different risk factors modified risk (beyond smoking and body mass index) in the two groups. Among men at low visible risk, poor respiratory function, diabetes, previous coronary heart disease, and socioeconomic deprivation modified risk. Among men at high visible risk, height and cholesterol concentration modified risk. Conclusions Differences in survival between these extreme risk groups are dramatic. Health promotion messages would be more credible if they discussed anomalies and the limits of prediction of coronary disease at an individual level.	Univ Glasgow, MRC, Social & Publ Hlth Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Hunt, K (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Unit, Glasgow G12 8RZ, Lanark, Scotland.			Emslie, Carol/0000-0003-2170-2039				Blaxter M., 1990, HLTH LIFESTYLES; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DAVISON C, 1989, Health Education Research, V4, P329, DOI 10.1093/her/4.3.329; DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DONG W, 1997, SCOTLANDS HLTH SCOTT, V1; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; Emslie C, 2001, SOCIOL HEALTH ILL, V23, P203, DOI 10.1111/1467-9566.00248; EMSLIE C, 2001, CORONARY HLTH CARE, V4, P1; FRANKEL S, 1991, BRIT J GEN PRACT, V41, P428; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Hunt K, 2001, INT J EPIDEMIOL, V30, P442, DOI 10.1093/ije/30.3.442; Hunt K, 2001, LANCET, V357, P1168, DOI 10.1016/S0140-6736(00)04334-8; MARTEAU TM, 1995, BRIT J GEN PRACT, V45, P5; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; The Scottish Office, 1999, HLTH SCOTL WHIT PAP; [No title captured]	21	13	13	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1487	1491		10.1136/bmj.323.7327.1487	http://dx.doi.org/10.1136/bmj.323.7327.1487			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751367	Green Accepted, Green Published			2022-12-01	WOS:000172979900028
J	Wyrick, JJ; Aparicio, JG; Chen, T; Barnett, JD; Jennings, EG; Young, RA; Bell, SP; Aparicio, OM				Wyrick, JJ; Aparicio, JG; Chen, T; Barnett, JD; Jennings, EG; Young, RA; Bell, SP; Aparicio, OM			Genome-wide distribution of ORC and MCM proteins in S-cerevisiae: High-resolution mapping of replication origins	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME-VI; DNA-REPLICATION; ARS ELEMENTS; YEAST; IDENTIFICATION; RECOGNITION; INITIATION; EUKARYOTES; SEQUENCE	DNA replication origins are fundamental to chromosome organization and duplication, but understanding of these elements is limited because only a small fraction of these sites have been identified in eukaryotic genomes. Origin Recognition Complex (ORC) and minichromosome maintenance (MCM) proteins form prereplicative complexes at origins of replication. Using these proteins as molecular landmarks for origins, we identified ORC- and MCM-bound sites throughout the yeast genome. Four hundred twenty-nine sites in the yeast genome were predicted to contain replication origins, and similar to 80% of the loci identified on chromosome X demonstrated origin function. A substantial fraction of the predicted origins are associated with repetitive DNA sequences, including subtelomeric elements (X and Y') and transposable element-associated sequences (tong terminal repeats). These findings identify the global set of yeast replication origins and open avenues of investigation into the role(s) ORC and MCM proteins play in chromosomal architecture and dynamics.	Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of Southern California; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Aparicio, OM (corresponding author), Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.	oaparici@usc.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Aparicio, Oscar/0000-0002-5591-0277; Aparicio, Jennifer/0000-0002-6442-3032; Bell, Stephen/0000-0002-2876-610X	NIGMS NIH HHS [GM52339, GM34365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1999, CURRENT PROTOCOLS MO, V4; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Boeke J.D., 1991, MOL CELLULAR BIOL YE, V1, P193; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; Friedman KL, 1995, J CELL SCI, P51; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HSIAO CL, 1979, P NATL ACAD SCI USA, V76, P3829, DOI 10.1073/pnas.76.8.3829; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Newlon C. S., 1996, DNA REPLICATION EUKA, P873; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; NEWLON CS, 1991, GENETICS, V129, P343; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	28	318	328	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2357	2360		10.1126/science.1066101	http://dx.doi.org/10.1126/science.1066101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743203				2022-12-01	WOS:000172817200048
J	Glorieux, FH				Glorieux, FH			A disease of the osteoblast	LANCET			English	Article									Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; McGill Univ, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Glorieux, FH (corresponding author), Shriners Hosp Children, Genet Unit, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.								0	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S45	S45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784594				2022-12-01	WOS:000172907200045
J	He, GS; Markowicz, PP; Lin, TC; Prasad, PN				He, GS; Markowicz, PP; Lin, TC; Prasad, PN			Observation of stimulated emission by direct three-photon excitation	NATURE			English	Article							OPTICAL-DATA STORAGE; 2-PHOTON ABSORPTION; 2-PHOTON-ABSORBING CHROMOPHORES; FLUORESCENCE; DESIGN; PHOTON; DYES	Multiphoton processes, predicted(1) theoretically in 1931, were for a long time considered to be mainly of academic interest. This view changed when it was shown(2,3) that a two-photon absorption process could, because of a quadratic dependence of excitation on intensity, produce a spatially confined excitation useful for three-dimensional data storage and imaging. Two-photon absorption has received considerable attention recently because of the development of highly efficient two-photon-sensitive materials, leading to numerous technological applications(4-28). These successes have created interest in exploring applications based on three-photon excitations(29). For a three-photon process, a longer excitation wavelength such as those common in optical communications can be used. Also, the cubic dependence of the three-photon process on the input light intensity provides a stronger spatial confinement, so that a higher contrast in imaging can be obtained. Here we report the observation of a highly directional and up-converted stimulated emission as an amplified spontaneous emission, produced in an organic chromophore solution by a strong simultaneous three-photon absorption at 1.3 mum. This achievement suggests opportunities for a three-photon process in frequency-upconversion lasing, short-pulse optical communications, and the emerging field of biophotonics.	SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Prasad, PN (corresponding author), SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA.	pnprasad@acsu.buffalo.edu	Prasad, Paras N/U-2269-2019					Adronov A, 2000, CHEM MATER, V12, P2838, DOI 10.1021/cm000586o; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Belfield KD, 2000, J ORG CHEM, V65, P4475, DOI 10.1021/jo991950+; Bhawalkar J D, 1997, J Clin Laser Med Surg, V15, P201; Bhawalkar JD, 1997, POLYMER, V38, P4551, DOI 10.1016/S0032-3861(97)00125-0; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dvornikov AS, 1997, OPT COMMUN, V136, P1, DOI 10.1016/S0030-4018(96)00645-1; Ehrlich JE, 1997, OPT LETT, V22, P1843, DOI 10.1364/OL.22.001843; GOPPERTMEYER M, 1931, ANN PHYS, V9, P275; Gura T, 1997, SCIENCE, V276, P1988, DOI 10.1126/science.276.5321.1988; HE GS, 1995, OPT LETT, V20, P1524, DOI 10.1364/OL.20.001524; He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303; He GS, 1998, IEEE J QUANTUM ELECT, V34, P7, DOI 10.1109/3.655001; He GS, 1998, IEEE J QUANTUM ELECT, V34, P2279, DOI 10.1109/3.736090; He GS, 1997, J OPT SOC AM B, V14, P1079, DOI 10.1364/JOSAB.14.001079; HE GS, 1995, OPT LETT, V20, P435, DOI 10.1364/OL.20.000435; HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393; Joshi MP, 1999, APPL PHYS LETT, V74, P170, DOI 10.1063/1.123283; Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kim OK, 2000, CHEM MATER, V12, P284, DOI 10.1021/cm990662r; PARTHENOPOULOS DA, 1990, J APPL PHYS, V68, P5814, DOI 10.1063/1.346953; PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843; Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543; Reinhardt BA, 1998, CHEM MATER, V10, P1863, DOI 10.1021/cm980036e; STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780; Wang XP, 1999, P NATL ACAD SCI USA, V96, P11081, DOI 10.1073/pnas.96.20.11081; ZHAO CF, 1995, CHEM MATER, V7, P1979, DOI 10.1021/cm00058a032	29	364	376	9	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					767	770		10.1038/415767a	http://dx.doi.org/10.1038/415767a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845202				2022-12-01	WOS:000173833900039
J	Bond, AB; Kamil, AC				Bond, AB; Kamil, AC			Visual predators select for crypticity and polymorphism in virtual prey	NATURE			English	Article							SEARCH IMAGE; BLUE JAYS; REFLEXIVE SELECTION; APOSTATIC SELECTION; CYANOCITTA-CRISTATA; NATURAL-SELECTION; HYPOTHESIS; ATTENTION; PATTERNS; STIMULI	Cryptically coloured animals commonly occur in several distinct pattern variants. Such phenotypic diversity may be promoted by frequency-dependent predation, in which more abundant variants are attacked disproportionately often, but the hypothesis has never been explicitly tested. Here we report the first controlled experiment on the effects of visual predators on prey crypticity and phenotypic variance, in which blue jays (Cyanocitta cristata) searched for digital moths on computer monitors. Moth phenotypes evolved via a genetic algorithm in which individuals detected by the jays were much less likely to reproduce. Jays often failed to detect atypical cryptic moths, confirming frequency-dependent selection and suggesting the use of searching images, which enhance the detection of common prey. Over successive generations, the moths evolved to become significantly harder to detect, and they showed significantly greater phenotypic variance than non-selected or frequency-independent selected controls.	Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA.							ALLEN JA, 1988, PHILOS T R SOC B, V319, P485, DOI 10.1098/rstb.1988.0061; ALLEN JA, 1988, OIKOS, V51, P251, DOI 10.2307/3565651; Back T, 1996, EVOLUTIONARY ALGORIT; Barnes W., 1918, Mem Amer mus NH New York, V3; Bond AB, 1998, NATURE, V395, P594, DOI 10.1038/26961; BOND AB, 1983, J EXP PSYCHOL ANIM B, V9, P292, DOI 10.1037/0097-7403.9.3.292; BOND AB, 1991, ETHOLOGY, V87, P203; Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Clarke B., 1962, TAXONOMY GEOGRAPHY, P47; COMMON IFB, 1954, AUST J ZOOL, V2, P223, DOI 10.1071/ZO9540223; Cott HB., 1957, ADAPTIVE COLOURATION; DARLINGTON CD, 1950, ELEMENTS GENETICS; Dearn J.M., 1990, P517; Edmunds M., 1990, P3; Endler J.A., 1991, P169; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Fleishman LJ, 1998, ANIM BEHAV, V56, P1035, DOI 10.1006/anbe.1998.0894; FORD EB, 1961, INSECT POLYMORPHISM, V1, P11; GUILDORD T, 1987, ANIM BEHAV, V35, P1838, DOI 10.1016/S0003-3472(87)80076-3; HALKKA O, 1990, EVOL BIOL, V24, P149; Kaufman L, 2009, FINDING GROUPS DATA; Kono H, 1998, ANIM BEHAV, V56, P963, DOI 10.1006/anbe.1998.0847; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P152, DOI 10.1037/0097-7403.22.2.152; MOMENT GB, 1962, SCIENCE, V136, P262, DOI 10.1126/science.136.3512.262; Nabours RK, 1933, GENETICS, V18, P0159; Nijhout HF, 1991, DEV EVOLUTION BUTTER; OWEN DF, 1986, OIKOS, V47, P117, DOI 10.2307/3565927; PIETREWICZ AT, 1977, SCIENCE, V195, P580, DOI 10.1126/science.195.4278.580; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; PLAISTED KC, 1995, ANIM BEHAV, V50, P1219, DOI 10.1016/0003-3472(95)80039-5; Poulton E.B., 1890, COLOUR ANIMALS; PRUESS KP, 1967, ANN ENTOMOL SOC AM, V60, P910, DOI 10.1093/aesa/60.5.910; Rand AS, 1967, ATAS S SOBRE BIOTA A, V5, P73; REID PJ, 1992, J EXP PSYCHOL ANIM B, V18, P273, DOI 10.1037/0097-7403.18.3.273; RICKLEFS RE, 1975, EVOLUTION, V29, P313, DOI 10.1111/j.1558-5646.1975.tb00211.x; Robinson M. H., 1969, EVOL BIOL, VIII, P225; ROBINSON R, 1971, LEPIDOPTERAN GENETIC; SARGENT T.D., 1976, LEGION NIGHT UNDERWI; SARGENT TD, 1978, EVOLUTION, V32, P424, DOI 10.1111/j.1558-5646.1978.tb00657.x; SNEATH P. H. A., 1973, NUMERICAL TAXONOMY; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; WALLACE AR, 1891, DARWINISM EXPOSITION; Whiteley DAA, 1997, BIOL J LINN SOC, V62, P475, DOI 10.1006/bijl.1997.0168	47	212	221	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					609	613		10.1038/415609a	http://dx.doi.org/10.1038/415609a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	519DC	11832937	Green Published			2022-12-01	WOS:000173709100037
J	Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM				Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM			Sex differences in emigration and mortality affect optimal management of deer populations	NATURE			English	Article							DENSITY-RELATED CHANGES; FEMALE RED DEER; CERVUS-ELAPHUS; HABITAT SEGREGATION; RATIO; HIGHLANDS; SHEEP	Populations of red deer that are limited by food, like those of many other ungulates(1-3), commonly include more females than males(4-7). We assessed the contribution of variation in sex- and age-specific rates of mortality and emigration to density-dependent changes in the adult sex ratio, using long-term observations and demographic experiments involving the red deer population on Rum, Scotland(4,5). We incorporated these effects in a stochastic model of local populations under different management regimes to show here that, when female numbers are allowed to increase to more than 60% of the ecological carrying capacity, the sustainable annual harvest of males from local deer populations will fall. Because males are typically culled by fee-paying hunters and generate more income than females(5,8,9), income will decrease as the male harvest falls. Because numbers of female deer throughout much of the Highlands probably exceed the threshold at which male density starts to be affected(5), many managers might be able to raise income from local deer populations by reducing female numbers, with potential benefits to the vegetation of Scottish Highland environments(10).	Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge CB2 3EJ, England; Univ London Imperial Coll Sci Technol & Med, Royal Sch Mines, TH Huxley Sch Environm Earth Sci & Engn, London SW7 2BP, England; Scottish Nat Heritage, Edinburgh EH6 5NP, Midlothian, Scotland	University of Cambridge; Imperial College London	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England.		Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003				Buckland ST, 1996, J APPL ECOL, V33, P118, DOI 10.2307/2405021; CHARLES WN, 1977, J APPL ECOL, V14, P55, DOI 10.2307/2401826; CLUTTONBROCK TH, 1987, J ZOOL, V211, P275, DOI 10.1111/j.1469-7998.1987.tb01534.x; CLUTTONBROCK TH, 1985, J ANIM ECOL, V54, P831, DOI 10.2307/4381; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CLUTTONBROCK TH, 1994, J APPL ECOL, V31, P521, DOI 10.2307/2404447; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; CLUTTONBROCK TH, 1992, NATURE, V358, P11; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Conradt L, 2000, ANIM BEHAV, V59, P1049, DOI 10.1006/anbe.2000.1409; Conradt L, 1999, OECOLOGIA, V119, P367, DOI 10.1007/s004420050797; KLEIN DR, 1968, J WILDLIFE MANAGE, V32, P350, DOI 10.2307/3798981; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; LOWE VPW, 1969, J ANIM ECOL, V38, P425, DOI 10.2307/2782; Lubow BC, 1996, J WILDLIFE MANAGE, V60, P787, DOI 10.2307/3802378; McCullough D. R., 1990, WILDLIFE MONOGR, V112, P1; McCullough DR, 2001, WILDLIFE BIOL, V7, P161, DOI 10.2981/wlb.2001.020; OSBORNE BC, 1984, J APPL ECOL, V21, P497, DOI 10.2307/2403424; [No title captured]; [No title captured]; [No title captured]; [No title captured]	23	120	132	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					633	637		10.1038/415633a	http://dx.doi.org/10.1038/415633a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832944				2022-12-01	WOS:000173709100044
J	Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH				Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH			Phospholipase C gamma 1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE	NATURE			English	Article							NERVE GROWTH-FACTOR; SH3 DOMAINS; CELL-DIFFERENTIATION; STRUCTURAL BASIS; FRIEND-CELLS; PROTEIN 4.1N; PC12 CELLS; C-GAMMA; RAS; ACTIVATION	Phospholipase Cgamma1 (PLC-gamma1) hydrolyses phosphatidylinositol-4,5-bisphosphate to the second messengers inositol-1,4,5-trisphosphate and diacylglycerol. PLC-gamma1 also has mitogenic activity upon growth-factor-dependent tyrosine phophorylation(1,2); however, this activity is not dependent on the phospholipase activity of PLC-gamma1, but requires an SH3 domain(3,4). Here, we demonstrate that PLC-gamma1 acts as a guanine nucleotide exchange factor (GEF) for PIKE (phosphatidylinositol-3-OH kinase (PI(3)K) enhancer). PIKE is a nuclear GTPase that activates nuclear PI(3)K activity, and mediates the physiological activation by nerve growth factor (NGF) of nuclear PI(3)K activity(5). This enzymatic activity accounts for the mitogenic properties of PLC-gamma1.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Pohang Univ Sci & Technol, Dept Life Sci, Div Mol Life Sci, Pohang 790784, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pohang University of Science & Technology (POSTECH)	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Suh, Pann-Ghill/F-3610-2010; Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X				Bae SS, 1998, J NEUROCHEM, V71, P178; Bertagnolo V, 1998, FEBS LETT, V441, P480, DOI 10.1016/S0014-5793(98)01593-2; BERTAGNOLO V, 1995, CELL SIGNAL, V7, P669, DOI 10.1016/0898-6568(95)00036-O; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HUANG KJ, 1995, CHINESE J CHEM ENG, V3, P1; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kim MJ, 2000, BIOCHEMISTRY-US, V39, P8674, DOI 10.1021/bi992558t; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; MARMIROLI S, 1994, J BIOL CHEM, V269, P13; MARTELLI AM, 1994, CANCER RES, V54, P2536; MUNDER T, 1992, MOL CELL BIOL, V12, P2091, DOI 10.1128/MCB.12.5.2091; Neri LM, 1998, J BIOL CHEM, V273, P29738, DOI 10.1074/jbc.273.45.29738; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pei ZD, 1997, ARCH BIOCHEM BIOPHYS, V345, P103, DOI 10.1006/abbi.1997.0245; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Scholler JK, 2000, EUR J IMMUNOL, V30, P2378, DOI 10.1002/1521-4141(2000)30:8<2378::AID-IMMU2378>3.0.CO;2-E; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Smith MR, 1996, BIOCHEM BIOPH RES CO, V222, P186, DOI 10.1006/bbrc.1996.0719; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZINI N, 1995, EUR J CELL BIOL, V68, P25	28	137	143	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					541	544		10.1038/415541a	http://dx.doi.org/10.1038/415541a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823862				2022-12-01	WOS:000173564300050
J	Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R				Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R			Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR	CELL			English	Article							DOUBLE-STRANDED-RNA; DSRNA-BINDING DOMAIN; SECONDARY STRUCTURE; CELLS; PHOSPHORYLATION; RECOGNITION; REGION	PKR, an interferon (IFN)-inducible protein kinase activated by double-stranded RNA, inhibits translation by phosphorylating the initiation factor eIF2alpha chain. We show that human IFN-gamma mRNA uses local activation of PKR in the cell to control its own translation yield. IFN-gamma mRNA activates PKR through a pseudoknot in its 5' untranslated region. Mutations that impair pseudoknot stability reduce the ability to activate PKR and strongly increase the translation efficiency of IFN-gamma mRNA. Nonphosphorylatable mutant eIF2alpha, knockout of PKR and PKR inhibitors 2-aminopurine, transdominant-negative PKR, or vaccinia E3L correspondingly enhances translation of IFN-gamma mRNA. The potential to form the pseudoknot is phylogenetically conserved. We propose that the RNA pseudoknot acts to adjust translation of IFN-gamma mRNA to the PKR level expressed in the cell.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kaempfer, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel.	kaempfer@cc.huji.ac.il		Kaempfer, Raymond/0000-0002-5865-4619				Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Ben-Asouli Y, 2000, NUCLEIC ACIDS RES, V28, P1011, DOI 10.1093/nar/28.4.1011; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Circle DA, 1997, RNA, V3, P438; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; DIRKS W, 1994, GENE, V149, P389, DOI 10.1016/0378-1119(94)90187-2; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; EFRAT S, 1982, NATURE, V297, P236, DOI 10.1038/297236a0; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HARROD R, 1994, GENE, V140, P79, DOI 10.1016/0378-1119(94)90734-X; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jarrous N, 1996, MOL CELL BIOL, V16, P2814; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; ROSEN H, 1982, J BIOL CHEM, V257, P946; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; SCHMEDT C, 1995, J MOL BIOL, V249, P29, DOI 10.1006/jmbi.1995.0278; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	39	165	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					221	232		10.1016/S0092-8674(02)00616-5	http://dx.doi.org/10.1016/S0092-8674(02)00616-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832212	Bronze			2022-12-01	WOS:000173521300009
J	Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T				Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T			Penetrance of 845G -> A (C282Y) HFE hereditary haemochromatosis mutation in the USA	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CALIFORNIA	Amer Soc Hematol			HEMOCHROMATOSIS GENE; HOMOZYGOTES; DISEASE; POPULATION; ALLELE; COST; H63D	Background There has been much interest in screening populations for disease-associated mutations. A favoured candidate has been the HFE gene, mutations of which are the most common cause of haemochromatosis in the European population. About five people in 1000 are homozygotes for the 845G-->A mutation, but little is known of how many have mutation-caused clinical manifestations. Methods We screened 41038 individuals attending a health appraisal clinic in the USA for the 845G-->A and 187C-->G HFE mutations, and analysed laboratory data and data on signs and symptoms of haemochromatosis as elicited by questionnaire. Findings The most common symptoms of haemochromatosis, including poor general health, diabetes, arthropathies, arrhythmias, impotence, and skin pigmentation were no more prevalent among the 152 identified homozygotes than among the controls. The age distribution of homozygotes and compound heterozygotes did not differ significantly from that of controls: there was no measurable loss of such individuals from the population during ageing. However, there was a significantly increased prevalence of a history of hepatitis or "liver trouble" among homozygotes and in the proportion of homozygotes with increased concentrations of serum aspartate aminotransferase and collagen IV; these changes were not related to iron burden or to age. Only one of the 152 homozygotes had signs and symptoms that would suggest a diagnosis of haemochromatosis. Interpretation The normal age distribution of people with the haemochromatosis genotype, and the lack of symptoms in patients of all ages, indicate that the penetrance of hereditary haemochromatosis is much lower than generally thought. The clinical penetrance of a disorder is an essential consideration in screening for genetic disease; disorders with low penetrance are more expensive candidates for screening than disorders with high penetrance. Our best estimate is that less than 1% of homozygotes develop frank clinical haemochromatosis.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Biomath, La Jolla, CA 92037 USA; Kaiser Permanente, Dept Prevent Med, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Kaiser Permanente	Beutler, E (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Gelbart, Terri/0000-0002-7863-1262	NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK53505-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 1995, HEPATOLOGY, V22, P1720, DOI 10.1016/0270-9139(95)90197-3; Adams PC, 2000, MOL GENET METAB, V71, P81, DOI 10.1006/mgme.2000.3037; Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO;2-0; Barton JC, 1996, NAT MED, V2, P394, DOI 10.1038/nm0496-394; Beutler E, 1997, AM J HUM GENET, V61, P762; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Beutler E, 2000, GENET TEST, V4, P131, DOI 10.1089/10906570050114830; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Bradley L A, 1996, J Med Screen, V3, P178; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Edwards CQ, 1998, SEMIN HEMATOL, V35, P72; Fairbanks VF, 1998, GUT, V43, P441, DOI 10.1136/gut.43.3.441; Fasouliotis S J, 2000, Obstet Gynecol Surv, V55, P373, DOI 10.1097/00006254-200006000-00023; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; George DK, 1999, J HEPATOL, V31, P47, DOI 10.1016/S0168-8278(99)80162-7; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; LINDMARK B, 1985, ACTA MED SCAND, V218, P299; Lubin IM, 1999, ARCH PATHOL LAB MED, V123, P1177; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Sheldon J. H., 1935, HAEMOCHROMATOSIS; STEINBERG MH, 1989, BRIT J HAEMATOL, V71, P297, DOI 10.1111/j.1365-2141.1989.tb04274.x; WILK MB, 1968, BIOMETRIKA, V55, P1; Willis G, 2000, GUT, V46, P401, DOI 10.1136/gut.46.3.401; Willis G, 1999, LANCET, V354, P221, DOI 10.1016/S0140-6736(99)02195-9; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Yang QH, 1998, ANN INTERN MED, V129, P946, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00005; Yapp TR, 2001, INTERN MED J, V31, P48, DOI 10.1046/j.1445-5994.2001.00005.x	33	629	643	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					211	218		10.1016/S0140-6736(02)07447-0	http://dx.doi.org/10.1016/S0140-6736(02)07447-0			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812557				2022-12-01	WOS:000173350800013
J	Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE				Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE			Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA; DIAGNOSIS	Objective To examine referral pathways from primary care for patients with epithelial ovarian cancer and to identify, factors related to survival at 18 months. Design Retrospective,e review of patient notes. Setting General practices and receiving hospitals within Mersey region. Subjects 135 patients with epithelial ovarian cancer identified from an audit in the Mersey area between 1992 and 1994. Main outcome measures Delays between onset of symptoms and treatment attributable to patient, general practitioner, and hospital. Results 105 (78%) women first presented to their general practitioner, within four weeks of the onset of symptoms. 99 (73%) women were referred to hospital by their general practitioners within four weeks of presentation, mad 95 (70%) were seen in hospital within two weeks of referral. Multivariate analysis With survival as the dependent variable identified age (odds ratio 0.96, 95% confidence interval 0.93 to 0.99) cancer stage III or more (0.15, 0.05 to 0.43), and non-specific symptoms (0.36, 0.14 to 0.89) as significant variables. Conclusion Most patients attended their general practitioner within four weeks and were referred within two weeks. No evidence was found that delays in referral or diagnosis adversely affected survival at IS months. Stage of disease at surgery was the most important adverse factor. An effective screening programme is the most likely method to improve survival.	Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; Univ Liverpool, Dept Obstet & Gynaecol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Kirwan, JMJ (corresponding author), Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England.							Bell R, 1998, BRIT J OBSTET GYNAEC, V105, P1136, DOI 10.1111/j.1471-0528.1998.tb09966.x; Berrino F, 1999, SURVIVAL CANC PATIEN; FIGO Cancer Committee, 1986, GYNECOL ONCOL, V25, P383; FLAM F, 1988, EUR J OBSTET GYN R B, V27, P53, DOI 10.1016/S0028-2243(88)80010-8; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Kjellgren O, 1977, Lakartidningen, V74, P3333; LEIDERKEN BMJ, 1997, BR J GEN PRACT, V47, P505; LYNN RB, 1995, MED CLIN N AM, V79, P373, DOI 10.1016/S0025-7125(16)30074-8; *NCI, 1998, SEER STAT CANC INC P; *OFF NAT STAT, 1999, CANC 1971 1997; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Secretary of State for Health, 1997, CM380; SUMMERTON N, 1999, DIAGNOSING CANC PRIM; Wikborn C, 1996, INT J GYNECOL OBSTET, V52, P263, DOI 10.1016/0020-7292(95)02588-X; WIKBORN C, 1993, INT J GYNECOL OBSTET, V42, P261, DOI 10.1016/0020-7292(93)90222-I	17	47	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					148	151		10.1136/bmj.324.7330.148	http://dx.doi.org/10.1136/bmj.324.7330.148			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799032	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000173470600019
J	Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL				Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL			Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MHC CLASS-I; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; VIREMIA; VARIANTS; SELECTION; PEPTIDE; EPITOPE; PROGRESSION	Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to control viral replication and prevent clinical disease progression after pathogenic viral challenges in rhesus monkeys(1-4). Here we show that viral escape from CTL recognition can result in the eventual failure of this partial immune protection. Viral mutations that escape from CTL recognition have been previously described in humans infected with human immunodeficiency virus (HIV)(5-10) and monkeys infected with simian immunodeficiency virus (SIV)(11-13). In a cohort of rhesus monkeys that were vaccinated and subsequently infected with a pathogenic hybrid simian-human immunodeficiency virus (SHIV), the frequency of viral sequence mutations within CTL epitopes correlated with the level of viral replication. A single nucleotide mutation within an immunodominant Gag CTL epitope in an animal with undetectable plasma viral RNA resulted in viral escape from CTLs, a burst of viral replication, clinical disease progression, and death from AIDS-related complications. These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; So Res Inst, Frederick, MD 21701 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Duke University	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Res E Room 113,330 Brookline Ave, Boston, MA 02215 USA.		Schmitz, Joern/A-4929-2018; Wolinsky, Steven/B-2893-2012; Barouch, Dan/Y-3918-2019	Schmitz, Joern/0000-0001-8803-0922; Wolinsky, Steven/0000-0002-9625-6697	NATIONAL CANCER INSTITUTE [R01CA050139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035351, P01AI035351] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA050139] Funding Source: Medline; NIAID NIH HHS [P01 AI035351, U01 AI035351] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; MILLER MD, 1991, J IMMUNOL, V147, P320; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Polacino P, 1999, J VIROL, V73, P618, DOI 10.1128/JVI.73.1.618-630.1999; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	27	576	608	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					335	339		10.1038/415335a	http://dx.doi.org/10.1038/415335a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797012				2022-12-01	WOS:000173293500047
J	Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL				Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL			Direct determination of the timing of sea level change during termination II	SCIENCE			English	Article							PENULTIMATE DEGLACIATION; HUON PENINSULA; DEVILS-HOLE; CLIMATE; RECORD; TEMPERATURE; BARBADOS; TERRACES; ISOTOPES; CALCITE	An outcrop within the last interglacial terrace on Barbados contains corals that grew during the penultimate deglaciation, or Termination II. We used combined Th-230 and Pa-231 dating to determine that they grew 135.8+/-0.8 thousand years ago, indicating that sea level was 18+/-3 meters below present sea level at the time. This suggests that sea level had risen to within 20% of its peak last-interglacial value by 136 thousand years ago, in conflict with Milankovitch theory predictions. Orbital forcing may have played a rote in the deglaciation, as may have isostatic adjustments due to large ice sheets, Other corals in the same outcrop grew during oxygen isotope (delta(18)O) substage 6e, indicating that sea level was 38+/-5 meters below present sea level, about 168.0 thousand years ago. When compared to the delta(18)O signal in the benthic V19-30/V19-28 record at that time, the coral data extend to the previous glacial cycle the conclusion that deep-water temperatures were colder during glacial periods.	Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA; Univ Texas, Inst Geophys, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin	Gallup, CD (corresponding author), Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA.	cgallup@d.umn.edu	Taylor, Frederick/A-2195-2009; Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458				BENDER ML, 1979, GEOL SOC AM BULL, V90, P577, DOI 10.1130/0016-7606(1979)90<577:UDOTPR>2.0.CO;2; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; JOHNSON RG, 1991, GEOLOGY, V19, P686, DOI 10.1130/0091-7613(1991)019<0686:MNHDCB>2.3.CO;2; Karner DB, 2000, SCIENCE, V288, P2143, DOI 10.1126/science.288.5474.2143; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; MUHS DR, QUAT SCI REV; PELTIER WR, 1986, J ATMOS SCI, V44, P1351; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; TAYLOR FW, 1991, GEOLOGY, V19, P103, DOI 10.1130/0091-7613(1991)019<0103:LQFOCR>2.3.CO;2; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918; [No title captured]	32	175	185	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					310	313		10.1126/science.1065494	http://dx.doi.org/10.1126/science.1065494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786639				2022-12-01	WOS:000173278600044
J	Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L				Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L			Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface	NATURE			English	Article							CROSS-LINKING ENZYMES; FACTOR-XIII; TRANSGLUTAMINASES; ACTIVATION; TRYPTOPHAN; CONVULXIN; COLLAGEN; RECEPTOR; TISSUES; BINDING	Activated platelets bind numerous adhesive and procoagulant proteins by receptor-mediated processes(1). Although there is little evidence to suggest that these processes are heterogeneous in platelets, we previously found that platelets co-stimulated with collagen and thrombin express functional alpha -granule factor V only on a subpopulation of cells(2). Here we show that these cells, referred to as 'COAT-platelets', bind additional alpha -granule proteins, including fibrinogen, von Willebrand factor, thrombospondin, fibronectin and alpha (2)-antiplasmin. These proteins are all transglutaminase substrates, and inhibitors of transglutaminase prevent the production of COAT-platelets. A synthetic transglutaminase substrate (CP15) also binds to COAT-platelets, and analysis by high performance liquid chromatography/mass spectrometry shows that a product is formed with a relative molecular mass (M-r) equal to CP15 plus 176. Serotonin, an abundant component of platelet-dense granules(3), has an M-r of 176, and fibrinogen isolated from COAT-platelets contains covalently linked serotonin. Synthetic bovine serum albumin-(serotonin)(6) binds selectively to COAT-platelets and also inhibits the retention of procoagulant proteins on COAT-platelets. These data indicate that COAT-platelets use serotonin conjugation to augment the retention of procoagulant proteins on their cell surface through an as yet unidentified serotonin receptor.	Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73104 USA; Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Bern	Dale, GL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA.			Alberio, Lorenzo/0000-0001-9686-9920				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; CLARKE DD, 1959, ARCH BIOCHEM BIOPHYS, V79, P338, DOI 10.1016/0003-9861(59)90413-8; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; LAAKSO JT, 1983, SCAND J CLIN LAB INV, V43, P463; Lorand L, 1998, EXP EYE RES, V66, P531, DOI 10.1006/exer.1997.0463; MAEDA K, 1984, H-S Z PHYSIOL CHEM, V365, P1183, DOI 10.1515/bchm2.1984.365.2.1183; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Mousa SA, 1998, J CARDIOVASC PHARM, V32, P169, DOI 10.1097/00005344-199808000-00001; Muszbek L, 1996, CRIT REV CL LAB SCI, V33, P357, DOI 10.3109/10408369609084691; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012; REED GL, 1992, THROMB HAEMOSTASIS, V68, P315; REED GL, 1995, THROMB HAEMOSTASIS, V74, P680; SHATTIL SJ, 1987, BLOOD, V70, P307; WAGNER A, 1990, J AFFECT DISORDERS, V20, P101, DOI 10.1016/0165-0327(90)90123-P; [No title captured]	22	245	254	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					175	179		10.1038/415175a	http://dx.doi.org/10.1038/415175a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805836				2022-12-01	WOS:000173159300043
J	Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS				Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS			Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GS-ALPHA GENE; ALBRIGHT HEREDITARY OSTEODYSTROPHY; STIMULATORY G-PROTEIN; SUBUNIT; LOCUS; OSSIFICATION	Background Progressive osseous heteroplasia (POH), an autosomal dominant disorder, is characterized by extensive dermal ossification during childhood, followed by disabling and widespread heterotopic ossification of skeletal muscle and deep connective tissue. Occasional reports of mild heterotopic ossification in Albright's hereditary osteodystrophy (AHO) and a recent report of two patients with AHO who had atypically extensive heterotopic ossification suggested a common genetic basis for the two disorders. AHO is caused by heterozygous inactivating mutations in the GNAS1 gene that result in decreased expression or function of the alpha subunit of the stimulatory G protein (G(s)alpha) of adenylyl cyclase. Methods We tested the hypothesis that GNAS1 mutations cause POH, using the polymerase chain reaction to amplify GNAS1 exons and exon-intron boundaries in 18 patients with sporadic or familial POH. Results Heterozygous inactivating GNAS1 mutations were identified in 13 of the 18 probands with POH. The defective allele in POH is inherited exclusively from fathers, a result consistent with a model of imprinting for GNAS1. Direct evidence that the same mutation can cause either POH or AHO was observed within a single family, in which the phenotype correlated with the parental origin of the mutant allele. Conclusions Paternally inherited inactivating GNAS1 mutations cause POH. This finding extends the range of phenotypes derived from haploinsufficiency of GNAS1, provides evidence that imprinting is a regulatory mechanism for GNAS1 expression, and suggests that G,a is a critical negative regulator of osteogenic commitment in nonosseous connective tissues. (N Engl J Med 2002;346:99-106.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Ilyssa Ctr Mol & Cellular Endocrinol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Royal Childrens Hosp, Victoria & Murdoch Childrens Res Inst, Genet Hlth Serv, Melbourne, Vic, Australia; Washington Univ, Sch Med, Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA; Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Washington University (WUSTL); Washington University (WUSTL)	Shore, EM (corresponding author), Univ Penn, Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th & Hamilton Walk, Philadelphia, PA 19104 USA.		Shore, Eileen/D-2593-2009	Levine, Michael/0000-0003-0036-7809	NIAMS NIH HHS [R01-AR46831, R01 AR046831, R01-AR41916] Funding Source: Medline; NIDDK NIH HHS [R01-DK34281] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046831, R01AR041916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034281] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATHANASOU NA, 1994, BONE, V15, P471, DOI 10.1016/8756-3282(94)90269-0; CAMPBELL R, 1994, J MED GENET, V31, P607, DOI 10.1136/jmg.31.8.607; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DEBEUR SMJ, 2001, PARATHYROIDS BASIC C, P807; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; GARDNER RJM, 1988, J MED GENET, V25, P113, DOI 10.1136/jmg.25.2.113; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Kaplan FS, 1996, ARCH DERMATOL, V132, P815, DOI 10.1001/archderm.132.7.815; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; McKusick V.A., 1998, MENDELIAN INHERITANC; MIRIC A, 1993, J CLIN ENDOCR METAB, V76, P1560, DOI 10.1210/jc.76.6.1560; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; PISANI V, 1985, PEDIAT DERMATOL NEWS, V4, P170; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RODRIGUEZJURADO R, 1995, PEDIATR PATHOL LAB M, V15, P813, DOI 10.3109/15513819509027017; ROSENFELD SR, 1995, CLIN ORTHOP RELAT R, P243; SCHMIDT AH, 1994, J BONE JOINT SURG AM, V76A, P907, DOI 10.2106/00004623-199406000-00016; Shapira H, 1996, HUM GENET, V97, P73; Urtizberea JA, 1998, J BONE JOINT SURG BR, V80B, P768, DOI 10.1302/0301-620X.80B5.8626; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; WHYTE MP, 1999, PRIMER METABOLIC BON, P384; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	31	211	220	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					99	106		10.1056/NEJMoa011262	http://dx.doi.org/10.1056/NEJMoa011262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784876				2022-12-01	WOS:000173133400005
J	Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K				Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K			XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; ACTIVATION; PROTEOLYSIS; INDUCTION; PATHWAY; BINDS	In yeast, the transmembrane protein kinase/endoribonuclease Ire1p activated by endoplasmic reticulum stress cleaves HAC1 mRNA, leading to production of the transcription factor Hac1p that activates the unfolded protein response (UPR). In mammals, no Hac1p counterpart has yet been discovered despite the presence of Ire1p homologs in the endoplasmic reticulum. Instead, the transcription factor ATF6 specific to the mammalian UPR is regulated by intramembrane proteolysis. Here, we identified the transcription factor XBP1, a target of ATF6, as a mammalian substrate of such an unconventional mRNA splicing system and showed that only the spliced form of XBP1 can activate the UPR efficiently. Our results reveal features of the UPR conserved during evolution and clarify the relationship between IRE1- and ATF6-dependent pathways.	Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan	Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan.		Longo, Kenneth A/A-5631-2010; Mori, Kazutoshi/K-6106-2015	Yoshida, Hiderou/0000-0002-5773-1408				Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J., 1989, MOL CLONING LAB MANU; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x	27	2803	2930	12	241	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					881	891		10.1016/S0092-8674(01)00611-0	http://dx.doi.org/10.1016/S0092-8674(01)00611-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779464	Bronze			2022-12-01	WOS:000173024200009
J	Manning, SW; Kromer, B; Kuniholm, PI; Newton, MW				Manning, SW; Kromer, B; Kuniholm, PI; Newton, MW			Anatolian tree rings and a new chronology for the east Mediterranean bronze-iron ages	SCIENCE			English	Article							ICE CORE; BC; C-14; CALIBRATION; TELECONNECTIONS; TERRESTRIAL; SANTORINI; MINOAN; GREECE; BP	We report an extensive program of high-precision radiocarbon dating to establish the best date for a floating 1599-year Anatolian tree ring chronology that spans the later third millennium B.C. through the earlier first millennium B.C. This chronology is directly associated with a number of key sites and ancient personages. A previously suggested dating is withdrawn and is replaced by a robust new date fix 22 (+ 4 or -7) years earlier. These new radiocarbon wiggle-matched dates offer a unique independent resource for establishing the precise chronology of the ancient Near East and Aegean and help resolve, among others, a tong-standing debate in favor of the so-called Middle Mesopotamian chronology.	Univ Reading, Dept Archaeol, Reading RG6 6AA, Berks, England; Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany; Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY 14853 USA	University of Reading; Ruprecht Karls University Heidelberg; Cornell University	Manning, SW (corresponding author), Univ Reading, Dept Archaeol, POB 218 Whiteknights, Reading RG6 6AA, Berks, England.							BRAZIUNAS TF, 1995, GLOBAL BIOGEOCHEM CY, V9, P565, DOI 10.1029/95GB01725; BRONKRAMSEY C, 1995, RADIOCARBON, V37, P425; CHARPIN D, 1985, ANN RECH INTERDISCIP, V4, P293; CILINGIROGLU A., 2001, AYANIS 1 10 YEARS EX; Clausen HB, 1997, J GEOPHYS RES-OCEANS, V102, P26707, DOI 10.1029/97JC00587; Cole-Dai JH, 2000, J GEOPHYS RES-ATMOS, V105, P24431, DOI 10.1029/2000JD900254; Gasche H., 1998, DATING FALL BABYLON; HAAS V., 1986, REICH URARTU ALTORIE; HAMMER CU, 1987, NATURE, V328, P517, DOI 10.1038/328517a0; HAMMER CU, 2000, SYNCHRONISATION CIVI, P35; HAMMER CU, 2001, SCIEM2000EUR HAIND L; KROMER B, 1993, RADIOCARBON, V35, P125, DOI 10.1017/S0033822200013862; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kromer B, 2001, SCIENCE, V294, P2529, DOI 10.1126/science.1066114; Kuniholm P. I., 1992, SYRIA, V69, P379; Kuniholm P.I., 1993, STUDIES HONOR N OZGU, P371; Kuniholm P. I., 1977, THESIS U PENNSYLVANI; Kuniholm PI, 1996, NATURE, V381, P780, DOI 10.1038/381780a0; KUNIHOLM PI, 1993, TILLE HOYUK, V4, P179; Manning S. W., 1999, TEST TIME VOLCANO TH; McCormac FG, 1995, RADIOCARBON, V37, P395, DOI 10.1017/S0033822200030873; Michaud V, 2000, J VOLCANOL GEOTH RES, V99, P195, DOI 10.1016/S0377-0273(00)00173-6; MICHEL C., 1997, JEOL, V35-36, P111; NEWTON M, IN PRESS KAMAN KALEH; Nimet Ozguc, 2001, KULTEPE KANIS SEALED; ozguc N., 1980, ANCIENT ART SEALS, P61; PEARSON GW, 1986, RADIOCARBON, V28, P911, DOI 10.1017/S0033822200060197; PEARSON GW, 1993, RADIOCARBON, V35, P105, DOI 10.1017/S0033822200013850; Prag AJNW, 1989, ANATOLIAN STUDIES, V39, P159; SPARKS RJ, COMMUNICATION; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Stuiver M, 1998, GEOPHYS RES LETT, V25, P329, DOI 10.1029/97GL03694; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; TUNCA O, 1989, ANATOLIA ANCIENT NEA, P481; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; VanGeel B, 1996, J QUATERNARY SCI, V11, P451, DOI 10.1002/(SICI)1099-1417(199611/12)11:6<451::AID-JQS275>3.0.CO;2-9; VEENHOF KR, 2000, AKKADICA, V119, P137; VOIGT MJA, COMMUNICATION; Whiting R. M. J., 1990, TALL AL HAMIDIYA, P167; YOUNG RS, 1981, 3 GREAT EARLY TUMULI	40	80	83	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2532	2535		10.1126/science.1066112	http://dx.doi.org/10.1126/science.1066112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11743159				2022-12-01	WOS:000172927700054
J	Alekseev, V; Lampert, W				Alekseev, V; Lampert, W			Maternal control of resting-egg production in Daphnia	NATURE			English	Article							SEXUAL REPRODUCTION; DIAPAUSING EGGS	Many planktonic organisms produce 'resting' stages when the environmental conditions deteriorate. Like seeds, resting stages can survive unfavourable conditions. The crustacean Daphnia normally reproduces by means of parthenogenetically produced normal, not resting, eggs-but occasionally switches to bisexual reproduction, which results in two resting eggs encased in a robust structure carried on the back of the female. This 'ephippium' is shed with the next moult, and can survive dormant for many years. The induction of resting-egg production requires multiple environmental stimuli, one of them being photoperiod(1,2). The switch from production of parthenogenetic eggs to resting eggs in Daphnia has recently been shown to be influenced by a maternal food effect(3). Here we present evidence that female Daphnia transmit information not only about food but also on photoperiod to their offspring, and influence the production of resting eggs in the next generation. The combined maternal effects can be relevant for the correct timing of resting-egg production-for example, in discriminating between spring and autumn conditions.	Max Planck Inst Limnol, Dept Physiol Ecol, D-24302 Plon, Germany	Max Planck Society	Alekseev, V (corresponding author), Max Planck Inst Limnol, Dept Physiol Ecol, Postfach 165, D-24302 Plon, Germany.		Alekseev, Victor/X-7437-2019; alekseev, victor r/C-7086-2014	Alekseev, Victor/0000-0002-1968-2609; alekseev, victor r/0000-0002-1968-2609				Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.2307/176789; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Hill J.C., 1965, SCIENCE, V150, P1463; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; LAMPERT W, 1988, B MAR SCI, V43, P620; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, OECOLOGIA, V104, P501, DOI 10.1007/BF00341348; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Webb MLZ, 1998, PHYSIOL ENTOMOL, V23, P184, DOI 10.1046/j.1365-3032.1998.232073.x	17	157	168	2	67	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					899	901		10.1038/414899a	http://dx.doi.org/10.1038/414899a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780060				2022-12-01	WOS:000172813300043
J	Cobelens, F; Borgdorff, M				Cobelens, F; Borgdorff, M			Boosting, BCG, and time of reading in tuberculin skin testing	LANCET			English	Editorial Material									Royal Netherlands TB Assoc KNCV, NL-2501 CC The Hague, Netherlands	KNCV Tuberculosis Foundation	Cobelens, F (corresponding author), Royal Netherlands TB Assoc KNCV, NL-2501 CC The Hague, Netherlands.			Cobelens, Frank/0000-0002-4367-1133				BASS JB, 1981, AM REV RESPIR DIS, V123, P394; COMSTOCK G W, 1960, Bull World Health Organ, V23, P683; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Singh D, 2001, AM J RESP CRIT CARE, V164, P962, DOI 10.1164/ajrccm.164.6.2102076; *WHO TUB RES OFF, 1955, B WORLD HEALTH ORGAN, V12, P189; *WHO TUB RES OFF, 1955, B WORLD HEALTH ORGAN, V12, P197	8	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2014	2014		10.1016/S0140-6736(01)07137-9	http://dx.doi.org/10.1016/S0140-6736(01)07137-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755604				2022-12-01	WOS:000172722800006
J	Welburn, SC; Picozzi, K; Fevre, EM; Coleman, PG; Odiit, M; Carrington, M; Maudlin, I				Welburn, SC; Picozzi, K; Fevre, EM; Coleman, PG; Odiit, M; Carrington, M; Maudlin, I			Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene	LANCET			English	Article							BRUCEI-RHODESIENSE; EXPRESSION; GAMBIENSE; PCR	Background The expansion of sleeping sickness caused by Trypanosoma brucei rhodesiense beyond its traditional focus in southeast Uganda has been linked with large-scale livestock restocking. To assess the risk presented to the human population by domestic livestock, human-infective T b rhodesiense must be distinguished from non-human-infective T brucei brucei, since both parasites can be present in cattle. We investigated the use of a simple genetic marker to characterise parasites collected from cattle in villages within the new sleeping sickness focus in Soroti District, Uganda. Methods 70 T brucei sl samples of known human infectivity status collected from human beings and cattle in Tororo District, Uganda, from 1989 to 1991 were screened for the presence of the human-serum-resistance-associated (SRA) gene by conventional PCR. In 2000-01, blood samples from 200 randomly selected cattle in six villages and two markets in Soroti District were screened for T brucei sl parasites (ie, both T b brucei and T b rhodesiense) by PCR; positive samples were screened for the presence of the SRA gene. Findings The SRA gene was present in all 29 samples from patients with sleeping sickness in Tororo District. Of the 41 samples collected from cattle at the same time, the SRA gene was present in the eight samples that tested resistant to human serum in vitro, whereas it was absent from all 33 isolates that were sensitive to human serum in vitro. Of the 200 cattle sampled in Soroti District, we estimated that up to 18% (95% CI 12-23) were infected with T b rhodesiense. Interpretation Detection of the SRA gene could provide the basis for a simple diagnostic test to enable targeted control of T b rhodesiense in the domestic livestock reservoir, thereby reducing the public-health burden of sleeping sickness in east Africa.	Univ Edinburgh, Ctr Trop Vet Med, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Livestock Hlth Res Inst, Torono, Uganda; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Welburn, SC (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland.		Carrington, Mark/N-4892-2018; Carrington, Mark/N-3653-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Welburn, Susan/0000-0002-9903-7086; Fevre, Eric/0000-0001-8931-4986				ARTAMA WT, 1992, PARASITOLOGY, V104, P67, DOI 10.1017/S0031182000060819; Barrett MP, 2001, LANCET, V358, P603, DOI 10.1016/S0140-6736(01)05817-2; BRUN R, 1987, Z PARASITENKD, V73, P218; de Almeida PP, 1998, ACTA TROP, V70, P269, DOI 10.1016/S0001-706X(98)00031-X; DEGREEF C, 1989, MOL BIOCHEM PARASIT, V36, P169, DOI 10.1016/0166-6851(89)90189-8; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Hide G, 1998, EXP PARASITOL, V89, P21, DOI 10.1006/expr.1998.4265; HIDE G, 1991, EXPERIENTIA, V47, P128, DOI 10.1007/BF01945413; HIDE G, 1990, MOL BIOCHEM PARASIT, V39, P213, DOI 10.1016/0166-6851(90)90060-Y; HIDE G, 1994, PARASITOLOGY, V109, P95, DOI 10.1017/S0031182000077805; Kabiri M, 1999, TROP MED INT HEALTH, V4, P658, DOI 10.1046/j.1365-3156.1999.00465.x; KOERNER T, 1995, PARASITOL TODAY, V11, P303, DOI 10.1016/0169-4758(95)80046-8; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; Milner JD, 1999, MOL BIOCHEM PARASIT, V104, P271, DOI 10.1016/S0166-6851(99)00151-6; Odiit M, 1997, E AFR MED J, V74, P792; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; VANNIEUWENHOVE S, 1999, PROGR HUMAN AFRICAN, P235; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	20	165	168	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2017	2019		10.1016/S0140-6736(01)07096-9	http://dx.doi.org/10.1016/S0140-6736(01)07096-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755607				2022-12-01	WOS:000172722800009
J	Trumpp, A; Refaeli, Y; Oskarsson, T; Gasser, S; Murphy, M; Martin, GR; Bishop, JM				Trumpp, A; Refaeli, Y; Oskarsson, T; Gasser, S; Murphy, M; Martin, GR; Bishop, JM			c-Myc regulates mammalian body size by controlling cell number but not cell size	NATURE			English	Article							DROSOPHILA MYC; MICE; GENE; INACTIVATION; EXPRESSION; GROWTH	Overexpression of the proto-oncogene c-myc has been implicated in the genesis of diverse human tumours. c-Myc seems to regulate diverse biological processes, but its role in tumorigenesis and normal physiology remains enigmatic(1). Here we report the generation of an allelic series of mice in which c-myc expression is incrementally reduced to zero. Fibroblasts from these mice show reduced proliferation and after complete loss of c-Myc function they exit the cell cycle. We show that Myc activity is not needed for cellular growth but does determine the percentage of activated T cells that re-enter the cell cycle. In vivo, reduction of c-Myc levels results in reduced body mass owing to multiorgan hypoplasia, in contrast to Drosophila dmyc mutants, which are smaller as a result of hypotrophy(2). We rnd that dmyc substitutes for c-myc in fibroblasts, indicating they have similar biological activities. This suggests there may be fundamental differences in the mechanisms by which mammals and insects control body size. We propose that in mammals c-Myc controls the decision to divide or not to divide and thereby functions as a crucial mediator of signals that determine organ and body size.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Trumpp, A (corresponding author), Swiss Inst Expt Canc Res, Ch des Boveresses 155, CH-1066 Epalinges, Switzerland.		Trumpp, Andreas/Z-2141-2019; Oskarsson, Thordur/HBP-9601-2022; gasser, stephan/A-2309-2013	Trumpp, Andreas/0000-0002-6212-3466; Oskarsson, Thordur/0000-0002-0983-6969; Gasser, Stephan/0000-0002-5616-0914				Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HOLZEL M, 2001, 21 EMBO; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; STEVENSON RD, 1995, P ROY SOC B-BIOL SCI, V259, P105, DOI 10.1098/rspb.1995.0016; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TRUMPP A, 1992, GENE DEV, V6, P14, DOI 10.1101/gad.6.1.14; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x	27	356	378	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					768	773		10.1038/414768a	http://dx.doi.org/10.1038/414768a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742404				2022-12-01	WOS:000172676200052
J	Morris, RH				Morris, RH			Thriving with chronic myeloid leukaemia	LANCET			English	Article											Morris, RH (corresponding author), 492 Fulton Court, W New York, NJ 07093 USA.	RMorris@aol.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S12	S12		10.1016/S0140-6736(01)07025-8	http://dx.doi.org/10.1016/S0140-6736(01)07025-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784561				2022-12-01	WOS:000172907200012
J	Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S				Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S			Nuclear weapons tests and human germline mutation rate	SCIENCE			English	Article									Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Kazakh State Natl Univ, Almaty 480121, Kazakhstan; Inst Gen Genet & Cytol, Almaty 480060, Kazakhstan; STUK Radiat & Nucl Safety Author, Helsinki 00881, Finland; Univ Warwick, Dept Biol Sci, Coventry CV4 7A1, W Midlands, England	University of Leicester; Al-Farabi Kazakh National University; Institute of General Genetics & Cytology; Radiation & Nuclear Safety Authority (STUK); University of Warwick	Dubrova, YE (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Dubrova, Yuri/ABA-7148-2020; Leyla, Djansugurova/AAZ-1063-2020	Leyla, Djansugurova/0000-0002-6745-9903; Dubrova, Yuri/0000-0001-5281-7539				Dubrova YE, 1997, MUTAT RES-FUND MOL M, V381, P267; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Gusev BI, 1997, RADIAT ENVIRON BIOPH, V36, P201, DOI 10.1007/s004110050072; MATSUSCHENKO M, 1998, NUCL TESTS LONG TERM, P89	4	108	123	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1037	1037		10.1126/science.1068102	http://dx.doi.org/10.1126/science.1068102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834827				2022-12-01	WOS:000173793000055
J	Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM				Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM			Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease	SCIENCE			English	Article							LEWY BODIES; HSP70; EXPRESSION; NEURODEGENERATION; DEGENERATION; INCLUSIONS; DEMENTIA; MUTATION; NEURONS; HSP104	Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in Drosophila melanogaster upon directed expression of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease and a major component of proteinaceous Lewy bodies. We report that directed expression of the molecular chaperone, Hsp70 prevented dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and that interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. Furthermore, Lewy bodies in human postmortem tissue immunostained for molecular chaperones, also suggesting that chaperones may play a role in Parkinson's disease progression.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.		Auluck, Pavan K/A-1160-2010; Chan, Edwin/A-9478-2011	Chan, Edwin/0000-0003-4307-474X				Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3	21	994	1057	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					865	868		10.1126/science.1067389	http://dx.doi.org/10.1126/science.1067389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823645				2022-12-01	WOS:000173733000048
J	Dawson, CR; Schachter, J				Dawson, CR; Schachter, J			Should trachoma be treated with antibiotics?	LANCET			English	Editorial Material									Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, Chlamydia Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dawson, CR (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.							Dawson C., 1990, CHLAMYDIAL INFECT, P271; DAWSON CR, 1981, GUIDE TRACHOMA CONTR, P1; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; TIELSCH JM, 1987, BRIT J OPHTHALMOL, V71, P371, DOI 10.1136/bjo.71.5.371	7	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					184	185		10.1016/S0140-6736(02)07463-9	http://dx.doi.org/10.1016/S0140-6736(02)07463-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812548				2022-12-01	WOS:000173350800004
J	Hack, M; Shah, D				Hack, M; Shah, D			Periventricular haemorrhage and tocolytic therapies	LANCET			English	Editorial Material							OUTCOMES; NETWORK		Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Hack, M (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA.							Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HORBAR JD, 1995, SEMIN PERINATOL, V19, P124, DOI 10.1016/S0146-0005(05)80032-1; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; KEIRSE MJN, 1989, EFFECTIVE CARE PREGN, V1; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; PHILIP AGS, 1995, J PEDIATR-US, V126, P427, DOI 10.1016/S0022-3476(95)70463-9; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Weintraub Z, 2001, ARCH DIS CHILD-FETAL, V85, pF13, DOI 10.1136/fn.85.1.F13	10	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					185	186		10.1016/S0140-6736(02)07464-0	http://dx.doi.org/10.1016/S0140-6736(02)07464-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812549				2022-12-01	WOS:000173350800005
J	Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R				Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R			X-ray structure of a CIC chloride channel at 3.0 angstrom reveals the molecular basis of anion selectivity	NATURE			English	Article							ELECTRON-DENSITY MAPS; TORPEDO ELECTROPLAX; ION-CHANNEL; CLC-0; PERMEATION; TRANSMEMBRANE; CONDUCTION; EXPRESSION; MUTATIONS; PORES	The ClC chloride channels catalyse the selective flow of Cl- ions across cell membranes, thereby regulating electrical excitation in skeletal muscle and the flow of salt and water across epithelial barriers. Genetic defects in ClC Cl- channels underlie several familial muscle and kidney diseases. Here we present the X-ray structures of two prokaryotic ClC Cl- channels from Salmonella enterica serovar typhimurium and Escherichia coli at 3.0 and 3.5 Angstrom, respectively. Both structures reveal two identical pores, each pore being formed by a separate subunit contained within a homodimeric membrane protein. Individual subunits are composed of two roughly repeated halves that span the membrane with opposite orientations. This antiparallel architecture defines a selectivity filter in which a Cl- ion is stabilized by electrostatic interactions with a-helix dipoles and by chemical coordination with nitrogen atoms and hydroxyl groups. These findings provide a structural basis for further understanding the function of ClC Cl- channels, and establish the physical and chemical basis of their anion selectivity.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANDERSEN OS, 1975, BIOPHYS J, V15, P795, DOI 10.1016/S0006-3495(75)85856-5; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; DELAFORTELLE E, 1997, METHODS ENZYMOLOGY; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN PC, 1983, BIOPHYS J, V41, P189, DOI 10.1016/S0006-3495(83)84419-1; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vonrhein C, 1999, ACTA CRYSTALLOGR D, V55, P225, DOI 10.1107/S0907444998007914; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; WHITE MM, 1981, J GEN PHYSIOL, V78, P1, DOI 10.1085/jgp.78.1.1; WHITE MM, 1979, J BIOL CHEM, V254, P161; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	49	1255	1290	1	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					287	294		10.1038/415287a	http://dx.doi.org/10.1038/415287a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796999				2022-12-01	WOS:000173293500034
J	Tong, AHY; Drees, B; Nardelli, G; Bader, GD; Brannetti, B; Castagnoli, L; Evangelista, M; Ferracuti, S; Nelson, B; Paoluzi, S; Quondam, M; Zucconi, A; Hogue, CWV; Fields, S; Boone, C; Cesareni, G				Tong, AHY; Drees, B; Nardelli, G; Bader, GD; Brannetti, B; Castagnoli, L; Evangelista, M; Ferracuti, S; Nelson, B; Paoluzi, S; Quondam, M; Zucconi, A; Hogue, CWV; Fields, S; Boone, C; Cesareni, G			A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules	SCIENCE			English	Article							DOMAINS; BINDING; SPECIFICITY; ACTIVATION; BEE1P	Peptide recognition modules mediate many protein-protein interactions critical for the assembly of macromolecular complexes. Complete genome sequences have revealed thousands of these domains, requiring improved methods for identifying their physiologically relevant binding partners. We have developed a strategy combining computational prediction of interactions from phage-display ligand consensus sequences with large-scale two-hybrid physical interaction tests. Application to yeast SH3 domains generated a phage-display network containing 394 interactions among 206 proteins and a two-hybrid network containing 233 interactions among 145 proteins. Graph theoretic analysis identified 59 highly likely interactions common to both networks, Las17 (Bee1), a member of the Wiskott-Aldrich Syndrome protein (WASP) family of actin-assembly proteins, showed multiple SH3 interactions, many of which were confirmed in vivo by coimmunoprecipitation.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L6, Canada; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University of Rome Tor Vergata; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Queens University - Canada; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	fields@u.washington.edu; charlie.boone@utoronto.ca; giovanni.cesareni@uniroma2.it	Hogue, Christopher W V/AAZ-3934-2020; Bader, Gary/C-1176-2009; Cesareni, Gianni/AAW-1382-2020; Hogue, Christopher/B-6726-2008	Hogue, Christopher W V/0000-0002-3107-5246; Bader, Gary/0000-0003-0185-8861; , Barbara/0000-0001-9436-0362; Castagnoli, Luisa/0000-0001-5283-8671	NCRR NIH HHS [P41 RR11823] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Colwill K, 1999, GENETICS, V152, P881; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Lechler T, 1997, J CELL BIOL, V138, P95, DOI 10.1083/jcb.138.1.95; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mayer BJ, 2001, J CELL SCI, V114, P1253; MOCHIDA J, COMMUNICATION; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	21	531	555	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					321	324		10.1126/science.1064987	http://dx.doi.org/10.1126/science.1064987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11743162				2022-12-01	WOS:000173278600048
J	Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A				Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A		Swiss HIV Cohort Study	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study	LANCET			English	Article							HIV PROTEASE INHIBITORS; PERFORMANCE LIQUID-CHROMATOGRAPHY; P-GLYCOPROTEIN; EXPRESSION; MICE; GENES; MDR1; NELFINAVIR; METABOLISM; THYMOCYTES	Background HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes. Methods In 123 patients, we did PCR analyses of the gene for the multidrug-resistance transporter (MDR1), which codes for P-glycoprotein, of genes coding for isoenzymes of cytochrome P450, CYP3A4, CYP3A5, CYP2D6, and CYP2C19, and of the gene for the chemokine receptor CCR5. We measured concentrations in plasma of the antiretroviral agents efavirenz and nelfinavir by high-performance liquid-chromatography, and measured levels of P-glycoprotein expression, CD4-cell count, and HIV-1 viraemia. Findings Median drug concentrations in patients with the MDR1 3435 TT, CT, and CC genotypes were at the 30th, 50th, and 75th percentiles, respectively (p=0.0001). In patients with CYP2D6 extensive-metaboliser or poor-metaboliser alleles, median drug concentrations were at percentiles 45 and 62.5, respectively (p=0.04). Patients with the MDR1 TT genotype 6 months after starting treatment had a greater rise in CD4-cell count (257 cells/muL) than patients with the CT (165 cells/muL) and CC (121 cells/muL) genotype (p=0.0048), and the best recovery of naive CD4-cells. Interpretation The polymorphism MDR1 3435 C/T predicts immune recovery after initiation of antiretroviral treatment. This finding suggests that P-glycoprotein has an important role in admittance of antiretroviral drugs to restricted compartments in vivo.	Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland; Univ Lausanne Hosp, Div Immunol, Lausanne, Switzerland; Univ Lausanne Hosp, Unit Biochem & Clin Psychopharmacol, Lausanne, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Hosp La Source, Lausanne, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Univ Hosp Germans Trias & Pujol, Retrovirol Lab, Barcelona, Spain; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Liverpool; Netherlands Cancer Institute	Telenti, A (corresponding author), CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Marzolini, Catia/C-8253-2019; Fellay, Jacques/A-6681-2009; Pantaleo, Giuseppe/K-6163-2016; Furrer, Hansjakob/G-6768-2013; VALLET, Yannick/F-9979-2011; Buclin, Thierry/P-1640-2014; Decosterd, Laurent/E-8494-2019; Telenti, Amalio/AAY-1674-2021	Fellay, Jacques/0000-0002-8240-939X; Furrer, Hansjakob/0000-0002-1375-3146; Buclin, Thierry/0000-0003-0639-5536; Decosterd, Laurent/0000-0002-9840-1325; Eap, Chin/0000-0002-5439-0230				Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Bardsley-Elliot A, 2000, DRUGS, V59, P581, DOI 10.2165/00003495-200059030-00014; Carrillo JA, 1998, THER DRUG MONIT, V20, P319, DOI 10.1097/00007691-199806000-00013; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Gutmann H, 1999, MOL PHARMACOL, V56, P383, DOI 10.1124/mol.56.2.383; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; Huisman MT, 2000, AIDS, V14, P237, DOI 10.1097/00002030-200002180-00005; Johansson I, 1996, PHARMACOGENETICS, V6, P351, DOI 10.1097/00008571-199608000-00008; Jones K, 2001, AIDS, V15, P675, DOI 10.1097/00002030-200104130-00002; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lavie Y, 2000, GLYCOCONJUGATE J, V17, P253, DOI 10.1023/A:1026553626537; Lee CGL, 2000, FASEB J, V14, P516, DOI 10.1096/fasebj.14.3.516; Li XL, 1999, ADV DRUG DELIVER REV, V39, P81, DOI 10.1016/S0169-409X(99)00021-6; MACDONALD HR, 1995, EUR J IMMUNOL, V25, P1457, DOI 10.1002/eji.1830250549; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; PILARSKI LM, 1995, AM J HEMATOL, V49, P323, DOI 10.1002/ajh.2830490411; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 2000, MOL PHARMACOL, V57, P188; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Smit JW, 1998, BRIT J PHARMACOL, V124, P416, DOI 10.1038/sj.bjp.0701845; Srinivas RV, 1998, ANTIMICROB AGENTS CH, V42, P3157, DOI 10.1128/AAC.42.12.3157; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009	34	533	561	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					30	36		10.1016/S0140-6736(02)07276-8	http://dx.doi.org/10.1016/S0140-6736(02)07276-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809184				2022-12-01	WOS:000173143500013
J	Horsey, P				Horsey, P			Albumin and hypovolaemia: is the Cochrane evidence to be trusted?	LANCET			English	Editorial Material							PRESSURE; TRAUMA; TRIAL				Horsey, P (corresponding author), Old Manor, Stockbridge SO20 6RH, Berks, England.							Bell Ewan, 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P149; CASH JD, 1981, HAEMOSTASIS THROMBOS, P475; Chalmers I, 1998, BRIT MED J, V317, P885; Drummond G, 1999, LANCET, V354, P1038, DOI 10.1016/S0140-6736(05)76653-8; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; GRUNDMANN R, 1982, INTENS CARE MED, V8, P179, DOI 10.1007/BF01725735; Horsey PJ, 1997, ANAESTHESIA, V52, P1027, DOI 10.1111/j.1365-2044.1997.266-az0392.x; LEDGERWOOD AM, 1974, ARCH SURG-CHICAGO, V108, P531; LOWE RJ, 1977, SURGERY, V81, P676; LUCAS CE, 1978, J TRAUMA, V18, P564, DOI 10.1097/00005373-197808000-00002; McClelland B, 1998, BRIT MED J, V317, P829, DOI 10.1136/bmj.317.7162.829; Offringa M, 1998, BMJ-BRIT MED J, V317, P223, DOI 10.1136/bmj.317.7153.223; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; So KW, 1997, ARCH DIS CHILD-FETAL, V76, pF43, DOI 10.1136/fn.76.1.F43; WOITTIEZ AJ, 1998, COCHRANE LIB; WOODS MS, 1993, AM SURGEON, V59, P758; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P133, DOI 10.1111/j.1399-6576.1981.tb01623.x	17	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					70	72		10.1016/S0140-6736(02)07285-9	http://dx.doi.org/10.1016/S0140-6736(02)07285-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809206				2022-12-01	WOS:000173143500035
J	Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA				Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA			Gene defect in ectodermal dysplasia implicates a death domain adapter in development	NATURE			English	Article							NF-KAPPA-B; TNF RECEPTOR; EDA GENE; PROTEIN; HOMOLOG; MOUSE; FAMILY; INVOLVEMENT; APOPTOSIS; MUTATIONS	Members of the tumour-necrosis factor receptor (TNFR) family that contain an intracellular death domain initiate signalling by recruiting cytoplasmic death domain adapter proteins(1,2). Edar is a death domain protein of the TNFR family that is required for the development of hair, teeth and other ectodermal derivatives(3,4). Mutations in Edar-or its ligand, Eda-cause hypohidrotic ectodermal dysplasia in humans and mice(3-7). This disorder is characterized by sparse hair, a lack of sweat glands and malformation of teeth(8). Here we report the identification of a death domain adapter encoded by the mouse crinkled locus. The crinkled mutant has an hypohidrotic ectodermal dysplasia phenotype identical to that of the edar (downless) and eda (Tabby) mutants(9). This adapter, which we have called Edaradd (for Edar-associated death domain), interacts with the death domain of Edar and links the receptor to downstream signalling pathways. We also identify a missense mutation in its human orthologue, EDARADD, that is present in a family affected with hypohidrotic ectodermal dysplasia. Our findings show that the death receptor/adapter signalling mechanism is conserved in developmental, as well as apoptotic, signalling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Guys Hosp, Univ London Kings Coll, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Guys Hosp, Univ London Kings Coll, GKT Dent Inst, Dept Craniofacial Dev, London SE1 9RT, England	Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Overbeek, PA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Tucker, Abigail S/K-1788-2016	Tucker, Abigail S/0000-0001-8871-6094; Sharpe, Paul/0000-0003-2116-9561; Overbeek, Paul/0000-0001-9784-2084	Medical Research Council [G9800001] Funding Source: Medline; MRC [G9800001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; FALCONER DS, 1951, J GENET, V50, P324, DOI 10.1007/BF02996227; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LYON MF, 1996, GENETIC VARIANTS STR; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Munoz F, 1997, AM J HUM GENET, V61, P94; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perou CM, 1997, GENOMICS, V39, P136, DOI 10.1006/geno.1996.4478; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	28	268	282	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					913	916		10.1038/414913a	http://dx.doi.org/10.1038/414913a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780064				2022-12-01	WOS:000172813300047
J	Reneman, L; Booij, J; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GL; van den Brink, W				Reneman, L; Booij, J; de Bruin, K; Reitsma, JB; de Wolff, FA; Gunning, WB; den Heeten, GL; van den Brink, W			Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons	LANCET			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BETA-CIT BINDING; IN-VIVO; DOPAMINE TRANSPORTERS; NONHUMAN-PRIMATES; PARTIAL RECOVERY; 52-WEEK PERIOD; NEUROTOXICITY; METHYLENEDIOXYMETHAMPHETAMINE; HUMANS	Background 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug that has been shown to damage brain serotonin neurons in high doses. However, effects of moderate MDMA use on serotonin neurons have not been studied, and sex differences and the longterm effects of MDMA use on serotonin neurons have not been identified. We investigated the effects of moderate and heavy MDMA use, sex differences, and long-term effects of MDMA use on serotonin neurons in different brain regions. Methods By means of flyers posted in "rave" venues in Amsterdam, the Netherlands, we recruited 15 moderate MDMA users, 23 heavy MDMA users, 16 ex-MDMA users who had stopped using MDMA for more than 1 year, and 15 controls who claimed never to have used MDMA. We studied the effects of MDMA on brain serotonin neurons using (123)iodine-2 beta -carbomethoxy-3 beta-(4-iodophenyl) tropane ([I-123][beta -CIT)-a radioligand that binds with high affinity to serotonin transporters. Density of binding (expressed as a ratio of region-of-interest binding over binding in the cerebellum) was calculated by single-photon-emission computed tomography (SPELT). Findings We saw significant effects of group and group by sex (p=0.041 and p=0.022, respectively) on overall [I-123])beta -CIT binding ratios. In heavy MDMA users, significant decreases in overall binding ratios were seen in women (p<0.01) but not men (p=0.587). In female ex-MDMA users, overall densities of serotonin transporters were significantly higher than in heavy MDMA users (p=0.004), but not higher than in controls (p=0.524). Interpretation Our results indicate that heavy use of MDMA is associated with neurotoxic effects on serotonin neurons, that women might be more susceptible than men, and that MDMA-induced neurotoxic changes in several brain regions of female ex-MDMA users are reversible.	Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Toxicol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Child & Adolescent Psychiat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Toxicol Lab, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Reneman, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Booij, Jan/AAD-7159-2019	Reneman, Liesbeth/0000-0002-5912-9971				*ADD RES I US, 1998, ECST DUTCH RAV SCEN; Booij J, 1999, EUR J NUCL MED, V26, P171, DOI 10.1007/s002590050374; Boot BP, 2000, LANCET, V355, P1818, DOI 10.1016/S0140-6736(00)02276-5; Chang L, 1999, AM J PSYCHIAT, V156, P716; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; FARDE L, 1994, SYNAPSE, V16, P93, DOI 10.1002/syn.890160203; Gerra G, 2000, BIOL PSYCHIAT, V47, P127, DOI 10.1016/S0006-3223(99)00180-8; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Hegadoren KM, 1999, NEUROSCI BIOBEHAV R, V23, P539, DOI 10.1016/S0149-7634(98)00046-3; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; INSEL TR, 1989, J PHARMACOL EXP THER, V249, P713; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; LARUELLE M, 1994, J CEREBR BLOOD F MET, V14, P982, DOI 10.1038/jcbfm.1994.131; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Malison RT, 1998, BIOL PSYCHIAT, V44, P1090, DOI 10.1016/S0006-3223(98)00272-8; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; NELSON HE, 1991, REV NATL ADULT READI; Pirker W, 2000, J NUCL MED, V41, P36; PIRKER W, 1995, J NEURAL TRANSM-GEN, V100, P247, DOI 10.1007/BF01276462; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; Sabol KE, 1996, J PHARMACOL EXP THER, V276, P846; Scheffel U, 1998, SYNAPSE, V29, P183, DOI 10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.3.CO;2-M; SCHIFANO F, 1994, BIOL PSYCHIAT, V36, P763, DOI 10.1016/0006-3223(94)90088-4; SCHMIDT CJ, 1987, J PHARMACOL EXP THER, V240, P1; Semple DM, 1999, BRIT J PSYCHIAT, V175, P63, DOI 10.1192/bjp.175.1.63; SWAAB DF, 1985, SCIENCE, V228, P1112, DOI 10.1126/science.3992248	30	172	172	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1864	1869		10.1016/S0140-6736(01)06888-X	http://dx.doi.org/10.1016/S0140-6736(01)06888-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741626				2022-12-01	WOS:000172463000012
J	in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC				in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC			Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCUPATIONAL EPIDEMIOLOGY; RHEUMATOID-ARTHRITIS; VASCULAR DEMENTIA; RECEPTOR-GAMMA; MENTAL STATE; ROTTERDAM; POPULATION; DIAGNOSIS; INFLAMMATION; ASSOCIATION	Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease. The results, however, have been inconsistent. Methods: We studied the association between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 years of age or older who were free of dementia at base line. The risk of Alzheimer's disease was estimated in relation to the use of NSAIDs as documented in pharmacy records. We defined four mutually exclusive categories of use: nonuse, short-term use (1 month or less of cumulative use), intermediate-term use (more than 1 but less than 24 months of cumulative use), and long-term use (24 months or more of cumulative use). Adjustments were made by Cox regression analysis for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H(sub 2)-receptor antagonists, antihypertensive agents, and hypoglycemic agents. Results: During an average follow-up period of 6.8 years, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia. The relative risk of Alzheimer's disease was 0.95 (95 percent confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95 percent confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95 percent confidence interval, 0.05 to 0.83) in those with long-term use. The risk did not vary according to age. The use of NSAIDs was not associated with a reduction in the risk of vascular dementia. Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia. (N Engl J Med 2001;345:1515-21.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; NIA, Epidemiol Demog & Biometry Program, NIH, Bethesda, MD 20892 USA; Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stricker, BHC (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305				Aisen PS, 1996, MOL CHEM NEUROPATHOL, V28, P83, DOI 10.1007/BF02815208; Aisen PS, 1997, GERONTOLOGY, V43, P143; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; BEARD CM, 1991, LANCET, V337, P1426, DOI 10.1016/0140-6736(91)93122-P; Beard CM, 1998, MAYO CLIN PROC, V73, P951, DOI 10.4065/73.10.951; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BROOKS W, 1998, NEUROBIOL AGING, V19, pS140; CHECKOWAY H, 1990, ARCH ENVIRON HEALTH, V45, P95, DOI 10.1080/00039896.1990.9935932; CHECKOWAY H, 1989, AM J IND MED, V15, P375, DOI 10.1002/ajim.4700150403; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; CORNELIUS C, 1998, NEUROBIOL AGING, V19, pS28; COX DR, 1972, J R STAT SOC B, V34, P187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 1996, J CLIN EPIDEMIOL, V49, P1201, DOI 10.1016/0895-4356(96)00202-8; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GILBERT ES, 1979, RADIAT RES, V79, P122, DOI 10.2307/3575027; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HENDERSON AS, 1992, PSYCHOL MED, V22, P429, DOI 10.1017/S0033291700030373; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P926, DOI 10.1002/(SICI)1099-1166(199709)12:9<926::AID-GPS665>3.0.CO;2-Y; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; KUKULL WA, 1994, NEUROLOGY, V44, pA237; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEVEUGLE B, 1994, MOL NEUROBIOL, V9, P25, DOI 10.1007/BF02816102; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; *WHO, 1994, AN THER CLASS ATC IN	46	955	1008	2	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1515	1521		10.1056/NEJMoa010178	http://dx.doi.org/10.1056/NEJMoa010178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794217	Green Published, Bronze			2022-12-01	WOS:000172265200001
J	Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R				Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R			Structure, function, and activator-induced conformations of the CRSP coactivator	SCIENCE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; COFACTOR COMPLEX; CHROMATIN; MEDIATOR; PROTEIN; DOMAIN; SMCC; SP1	The human cofactor complexes ARC (activator-recruited cofactor) and CRSP (cofactor required for Sp1 activation) mediate activator-dependent transcription in vitro. Although these complexes share several common subunits, their structural and functional relationships remain unknown. Here, we report that affinity-purified ARC consists of two distinct multisubunit complexes: a larger complex, denoted ARC-L, and a smaller coactivator, CRSP. Reconstituted in vitro transcription with biochemically separated ARC-L and CRSP reveals differential cofactor functions. The ARC-L complex is transcriptionally inactive, whereas the CRSP complex is highly active. Structural determination by electron microscopy (EM) and three-dimensional reconstruction indicate substantial differences in size and shape between ARC-L and CRSP. Moreover, EM analysis of independently derived CRSP complexes reveals distinct conformations induced by different activators. These results suggest that CRSP may potentiate transcription via specific activator-induced conformational changes.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 401 Barker Hall, Berkeley, CA 94720 USA.		Taatjes, Dylan J/G-2027-2011					Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; NAAR AM, UNPUB; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8	19	209	217	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1058	1062		10.1126/science.1065249	http://dx.doi.org/10.1126/science.1065249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834832				2022-12-01	WOS:000173793000062
J	Walraven, G				Walraven, G			Rural Africa	LANCET			English	Editorial Material									MRC Labs, Farafenni Field Stn, Farafenni, Gambia	MRC Laboratory Molecular Biology	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, Farafenni, Gambia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					401	401		10.1016/S0140-6736(02)07601-8	http://dx.doi.org/10.1016/S0140-6736(02)07601-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844512				2022-12-01	WOS:000173686500012
J	Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR				Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR			Extreme responses to climate change in Antarctic lakes	SCIENCE			English	Article							AIR-TEMPERATURE; ICE		British Antarctic Survey, NERC, Cambridge CB3 0ET, England; BC Ctr Excellence, Vancouver, BC V6Z 1Y6, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; B.C. Centre for Excellence in HIV/AIDS	Peck, LS (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.		QUAYLE, WENDY/Q-3719-2016; Peat, Helen J/E-9666-2015; QUAYLE, Wendy/D-4634-2011	QUAYLE, WENDY/0000-0003-0622-1915; Peat, Helen/0000-0003-2017-8597				CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; HAWES I, 1985, HYDROBIOLOGIA, V123, P69, DOI 10.1007/BF00006616; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Roberts EC, 1999, FRESHWATER BIOL, V41, P737, DOI 10.1046/j.1365-2427.1999.00401.x; Smith R.I.L., 1990, ANTARCTIC ECOSYSTEMS, P30; Vincent W.F., 1988, MICROBIAL ECOSYSTEMS	7	223	233	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					645	645		10.1126/science.1064074	http://dx.doi.org/10.1126/science.1064074			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809962				2022-12-01	WOS:000173560900034
J	Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F				Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F			The nucleoporin RanBP2 has SUMO1 E3 ligase activity	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR-PORE COMPLEX; UBIQUITIN; RANGAP1; YEAST; TRANSPORT; SUBSTRATE; HOMOLOG; IMPORT; NUP358	Posttranslational modification with SUMO1 regulates protein/protein interactions, localization, and stability. SUMOylation requires the E1 enzyme Aos1/Uba2 and the E2 enzyme Ubc9. A family of E3-like factors, PIAS proteins, was discovered recently. Here we show that the nucleoporin RanBP2/Nup358 also has SUMO1 E3-like activity. RanBP2 directly interacts with the E2 enzyme Ubc9 and strongly enhances SUMO1-transfer from Ubc9 to the SUMO1 target Sp100. The E3-like activity is contained within a 33 kDa domain of RanBP2 that lacks RING finger motifs and does not resemble PIAS family proteins. Our findings place SUMOylation at the cytoplasmic filaments of the NPC and suggest that, at least for some substrates, modification and nuclear import are linked events.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Inst Pasteur, INSERM, U163, Unite Recombinaison & Express Genet, F-75724 Paris 15, France	Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Melchior, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Dejean, Anne/L-5145-2018; Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797; Seeler, Jacob-Sebastian/0000-0001-8209-8555				Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 1998, METH MOL B, V88, P265; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SAITOH H, 2001, IN PRESS J BIOL CHEM; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; STACHDEV S, 2001, GENE DEV, V15, P3088; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	38	626	652	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					109	120		10.1016/S0092-8674(01)00633-X	http://dx.doi.org/10.1016/S0092-8674(01)00633-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792325	Bronze			2022-12-01	WOS:000173280700012
J	Kirchner, JW				Kirchner, JW			Evolutionary speed limits inferred from the fossil record	NATURE			English	Article							TIME-SERIES ANALYSIS; SPECTRAL-ANALYSIS; EXTINCTION; RECOVERY; BIODIVERSITY; END	The dynamics of extinction and diversification determine the long-term effects of extinction episodes(1). If rapid bursts of extinction are offset by equally rapid bursts of diversification, their biodiversity consequences will be transient. But if diversification rates cannot accelerate rapidly enough, pulses of extinction will lead to long-lasting depletion of biodiversity(2,3). Here I use spectral analysis of the fossil record to test whether diversification rates can accelerate as much as extinction rates, over both short and long spans of geological time. I show that although the long-wavelength variability of diversification rates equals or exceeds that of extinctions, diversification rates are markedly less variable than extinction rates at wavelengths shorter than roughly 25 million years. This implies that there are intrinsic speed limits that constrain how rapidly diversification rates can accelerate in response to pulses of extinction.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kirchner, JW (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.		Kirchner, James W/B-6126-2009; Kirchner, James/AAC-4707-2019	Kirchner, James W/0000-0001-6577-3619; Kirchner, James/0000-0001-6577-3619				Cartwright M, 1990, FOURIER METHODS MATH; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; FOOTE M, 1994, PALEOBIOLOGY, V20, P424, DOI 10.1017/S0094837300012914; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Foster G, 1996, ASTRON J, V111, P541, DOI 10.1086/117805; GILINSKY NL, 1991, ANAL PALEOBIOLOGY, P157; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Jablonski David, 1995, P25; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 1998, NATURE, V395, P337, DOI 10.1038/26384; Miller AI, 1998, SCIENCE, V281, P1157, DOI 10.1126/science.281.5380.1157; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; NEWELL ND, 1967, GEOL SOC AM SPEC PAP, V89, P63; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAUP DM, 1992, PALEOBIOLOGY, V18, P80, DOI 10.1017/S0094837300012227; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Sepkoski J. J., 1996, GLOBAL EVENTS EVENT, DOI DOI 10.1007/978-3-642-79634-0_4; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Wilson EO, 1999, DIVERSITY LIFE	26	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					65	68		10.1038/415065a	http://dx.doi.org/10.1038/415065a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780116				2022-12-01	WOS:000173028800039
J	Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA				Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA			p53 mutant mice that display early ageing-associated phenotypes	NATURE			English	Article							REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; STRESS-RESPONSE; DEFICIENT MICE; DNA-BINDING; FIBROBLASTS; CANCER; TUMORS; BONE; SUPPRESSION	The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53(+/m)) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53(+/+)) littermates. As p53(+/)m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.	Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Sanger Ctr, Cambridge CB10 1SA, Cambs, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Heinrich Pette Institute; University of Hamburg; Wellcome Trust Sanger Institute	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	larryd@bcm.tmc.edu		Bradley, Allan/0000-0002-2349-8839				ARKING R, 1998, BIOL AGING; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bond J, 1996, ONCOGENE, V13, P2097; BOND JA, 1994, ONCOGENE, V9, P1885; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chuttani Anjali, 1995, P309; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; GERSTEIN AD, 1993, DERMATOL CLIN, V11, P749, DOI 10.1016/S0733-8635(18)30227-4; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; HARRISON DE, 1988, EXP GERONTOL, V23, P309, DOI 10.1016/0531-5565(88)90034-4; HARRISON DE, 1992, CURR TOP MICROBIOL, V177, P13; Harvey RC, 1999, VET CLIN N AM-SMALL, V29, P683, DOI 10.1016/S0195-5616(99)50055-7; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hogan B., 1994, MANIPULATING MOUSE E, P189; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Kalu Dike N., 1995, P395; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Muravchick Stanley, 1997, P1125; PURDIE CA, 1994, ONCOGENE, V9, P603; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; SHOCK NW, 1983, J CHRON DIS, V36, P137, DOI 10.1016/0021-9681(83)90053-X; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; WEISS A, 1991, BONE, V12, P165, DOI 10.1016/8756-3282(91)90039-L; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000	44	1117	1176	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					45	53		10.1038/415045a	http://dx.doi.org/10.1038/415045a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780111				2022-12-01	WOS:000173028800034
J	Habas, R; Kato, Y; He, X				Habas, R; Kato, Y; He, X			Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1	CELL			English	Article							PLANAR CELL POLARITY; CONVERGENT EXTENSION MOVEMENTS; SIGNALING SPECIFICITY; TISSUE POLARITY; DORSAL CLOSURE; BETA-CATENIN; SMALL GTPASE; WNT; DROSOPHILA; KINASE	Wnt signaling via the Frizzled (Fz) receptor controls cell polarity and movement during development, but the molecular nature of Wnt/Fz polarity signal transduction remains poorly defined. Here we report that in human cells and during Xenopus embryogenesis, Wnt/Fz signaling activates the small GTPase Rho, a key regulator of cytoskeleton architecture. Wnt/Fz activation of Rho requires the cytoplasmic protein Dishevelled (Dvl) and a novel Formin homology protein Daam1. Daam1 binds to both DvI and Rho, and mediates Wnt-induced DvI-Rho complex formation. Inhibition or depletion of Daam1 prevents Wnt/Fz activation of Rho and of Xenopus gastrulation, but not of beta -catenin signaling. Our study illustrates a molecular pathway from Wnt/Fz signaling to Rho activation in cell polarity signal transduction.	Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; NICHHD, Genet Mol Lab, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	He, X (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.	xi.he@tch.harvard.edu						ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Djiane A, 2000, DEVELOPMENT, V127, P3091; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GUBB D, 1993, DEVELOPMENT, P269; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kato Y, 1999, J NEUROSCI, V19, P9364; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	61	635	643	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					843	854		10.1016/S0092-8674(01)00614-6	http://dx.doi.org/10.1016/S0092-8674(01)00614-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779461	Bronze			2022-12-01	WOS:000173024200006
J	Brown, R; Chaloner, E; Mannion, S; Cheatle, T				Brown, R; Chaloner, E; Mannion, S; Cheatle, T			10-year experience of injuries sustained during clearance of anti-personnel mines	LANCET			English	Article								Clearance of anti-personnel mines and unexploded ordnance In countries recovering from war usually continues long after conflict has ceased. We prospectively recorded 92 traumatic injuries sustained by 73 mineclearers working In seven countries over a period of 10 years. 15% of Injuries were fatal, with an incidence of 116 injuries per 100 000 workers per year. Limb Injury occurred in 59% of cases, with an overall amputation rate of 30%. 44% of Injuries were sustained by workers handling a mine, resulting In severe upper limb and facial Injuries. The Incidence of facial Injuries fell after the Introduction of visors.	Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; Univ Coll Hosp NHS Trust, London, England; Lilongwe Cent Hosp, Lilingwe, Malawi; Malawi Polio, Lilingwe, Malawi	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London	Brown, R (corresponding author), Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.							ASCERIO A, 1995, LANCET, V346, P721; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; *UN MIN ACT SERV, 1997, INT STAND HUM MIN CL	3	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2048	2049		10.1016/S0140-6736(01)07141-0	http://dx.doi.org/10.1016/S0140-6736(01)07141-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755615				2022-12-01	WOS:000172722800016
J	Pawliuk, R; Westerman, KA; Fabry, ME; Payen, E; Tighe, R; Bouhassira, EE; Acharya, SA; Ellis, J; London, IM; Eaves, CJ; Humphries, RK; Beuzard, Y; Nagel, RL; Leboulch, P				Pawliuk, R; Westerman, KA; Fabry, ME; Payen, E; Tighe, R; Bouhassira, EE; Acharya, SA; Ellis, J; London, IM; Eaves, CJ; Humphries, RK; Beuzard, Y; Nagel, RL; Leboulch, P			Correction of sickle cell disease in transgenic mouse models by gene therapy	SCIENCE			English	Article							HUMAN BETA-GLOBIN; LOCUS-CONTROL REGION; ERYTHROID-CELLS; RETROVIRUS VECTORS; MESSENGER-RNA; KNOCKOUT MICE; HEMOGLOBIN-S; EXPRESSION; ELEMENTS; ANEMIA	Sickle Cell disease (SCD) is caused by a single point mutation in the human beta (A) globin gene that results in the formation of an abnormal hemoglobin [HbS (alpha (2)beta (S)(2))]. We designed a beta (A) globin gene variant that prevents HbS polymerization and introduced it into a lentiviral vector we optimized for transfer to hematopoietic stem cells and gene expression in the adult red blood cell lineage. Long-term expression (up to 10 months) was achieved, without preselection, in all transplanted mice with erythroid-specific accumulation of the antisickling protein in up to 52% of total hemoglobin and 99% of circulating red blood cells. In two mouse SCD models, Berkeley and SAD, inhibition of red blood cell dehydration and sickling was achieved with correction of hematological parameters, splenomegaly, and prevention of the characteristic urine concentration defect.	Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Genetix Pharmaceut, Cambridge, MA 02139 USA; Yeshiva Univ Albert Einstein Coll Med, Div Hematol, Bronx, NY 10461 USA; Hop St Louis, INSERM, EMI 0111, F-75010 Paris, France; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ British Columbia, Terry Fox Lab, Vancouver, BC V5Z 3L6, Canada; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Massachusetts Institute of Technology (MIT); University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Leboulch, P (corresponding author), Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.		Ellis, James/F-4789-2011; Payen, Emmanuel/S-5357-2018; Bouhassira, Eric/AAZ-4184-2021	Ellis, James/0000-0002-4400-0091; Payen, Emmanuel/0000-0002-1329-2327; Humphries, Richard/0000-0003-0540-7005	NHLBI NIH HHS [HL554352] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alami R, 1999, BLOOD CELL MOL DIS, V25, P110, DOI 10.1006/bcmd.1999.0235; ALKAN O, 2000, 3 AM SOC GEN THER DE; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Blouin MJ, 2000, NAT MED, V6, P177, DOI 10.1038/72279; BOOKCHIN RM, 1971, J MOL BIOL, V60, P263, DOI 10.1016/0022-2836(71)90292-0; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; BUNN HF, 1994, MOL BASIS BLOOD DIS, P207; Chang JC, 1998, P NATL ACAD SCI USA, V95, P14886, DOI 10.1073/pnas.95.25.14886; CHANG JC, 1992, P NATL ACAD SCI USA, V89, P3107, DOI 10.1073/pnas.89.7.3107; Emery DW, 1999, HUM GENE THER, V10, P877, DOI 10.1089/10430349950018283; Fabry ME, 2001, BLOOD, V97, P410, DOI 10.1182/blood.V97.2.410; GELINAS R, 1992, BONE MARROW TRANSPL, V9, P157; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Kalberer CP, 2000, P NATL ACAD SCI USA, V97, P5411, DOI 10.1073/pnas.100082597; LEBOULCH P, 1994, EMBO J, V13, P3065, DOI 10.1002/j.1460-2075.1994.tb06605.x; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; MILLER JL, 1994, P NATL ACAD SCI USA, V91, P10183, DOI 10.1073/pnas.91.21.10183; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; Nagel RL, 2001, BRIT J HAEMATOL, V112, P19, DOI 10.1046/j.1365-2141.2001.02286.x; Nagel RL, 2001, DISORDERS HEMOGLOBIN, P711; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; PLAVEC I, 1993, BLOOD, V81, P1384; Raftopoulos H, 1997, BLOOD, V90, P3414, DOI 10.1182/blood.V90.9.3414; Rubin JE, 2000, BLOOD, V95, P3242; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sabatino DE, 2000, P NATL ACAD SCI USA, V97, P13294, DOI 10.1073/pnas.230453097; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; TAKEKOSHI KJ, 1995, P NATL ACAD SCI USA, V92, P3014, DOI 10.1073/pnas.92.7.3014; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	33	424	454	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2368	2371		10.1126/science.1065806	http://dx.doi.org/10.1126/science.1065806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743206				2022-12-01	WOS:000172817200051
J	Sleutels, F; Zwart, R; Barlow, DP				Sleutels, F; Zwart, R; Barlow, DP			The non-coding Air RNA is required for silencing autosomal imprinted genes	NATURE			English	Article							X-INACTIVATION; ANTISENSE RNA; CPG ISLAND; TRANSCRIPT; LOCUS; METHYLATION; EXPRESSION; CHROMOSOME; OVERLAPS; IGF2	In genomic imprinting, one of the two parental alleles of an autosomal gene is silenced epigenetically by a cis-acting mechanism(1,2). A bidirectional silencer for a 400-kilobase region that contains three imprinted, maternally expressed protein-coding genes (Igf2r/Slc22a2/Slc22a3) has been shown by targeted deletion to be located in a sequence of 3.7 kilobases(3-5), which also contains the promoter for the imprinted, paternally expressed non-coding Air RNA(6). Expression of Air is correlated with repression of all three genes on the paternal allele(5); however, Air RNA overlaps just one of these genes in an antisense orientation(6). Here we show, by inserting a polyadenylation signal that truncates 96% of the RNA transcript, that Air RNA is required for silencing. The truncated Air allele maintains imprinted expression and methylation of the Air promoter, but shows complete loss of silencing of the Igf2r/Slc22a2/Slc22a3 gene cluster on the paternal chromosome. Our results indicate that non-coding RNAs have an active role in genomic imprinting.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Netherlands Canc Inst, Dept Mol Genet, NL-1066 CX Amsterdam, Netherlands	Austrian Academy of Sciences; Netherlands Cancer Institute	Barlow, DP (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.							Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BEECHEY CV, 2000, MRC MAMMALIAN GENETI; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hogan B., 2014, MANIPULATING MOUSE E; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Lyon Mary F., 1999, Results and Problems in Cell Differentiation, V25, P73; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Sleutels F, 2001, MOL CELL BIOL, V21, P5008, DOI 10.1128/MCB.21.15.5008-5017.2001; SLEUTELS F, IN PRESS HOMOLOGY EF; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2001, DEVELOPMENT, V128, P1881; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	27	827	876	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					810	813		10.1038/415810a	http://dx.doi.org/10.1038/415810a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845212				2022-12-01	WOS:000173833900051
J	Berson, DM; Dunn, FA; Takao, M				Berson, DM; Dunn, FA; Takao, M			Phototransduction by retinal ganglion cells that set the circadian clock	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; LIGHT; PHOTORECEPTORS; ENTRAINMENT; OPSIN; RAT; EYE; INTEGRATION; SENSITIVITY; PATHWAY	Light synchronizes mammalian circadian rhythms with environmental time by modulating retinal input to the circadian pacemaker-the suprachiasmatic nucleus (SCN) of the hypothalamus. Such photic entrainment requires neither rods nor cones, the only known retinal photoreceptors. Here, we show that retinal ganglion cells innervating the SCN are intrinsically photosensitive. Unlike other ganglion cells, they depolarized in response to tight even when all synaptic input from rods and cones was blocked. The sensitivity, spectral tuning, and slow kinetics of this tight response matched those of the photic entrainment mechanism, suggesting that these ganglion cells may be the primary photoreceptors for this system.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NEI NIH HHS [EY12793] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012793] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; DANIOLOS A, 1990, PIGM CELL RES, V3, P38, DOI 10.1111/j.1600-0749.1990.tb00260.x; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; DODT E, 1961, J NEUROPHYSIOL, V24, P427, DOI 10.1152/jn.1961.24.4.427; DUNN FA, UNPUB; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Kojima D, 2000, J NEUROSCI, V20, P2845; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Meijer JH, 1998, J NEUROSCI, V18, P9078; MOORE MAS, 1995, CLIN CANCER RES, V1, P3; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Pu M, 2000, J BIOL RHYTHM, V15, P31, DOI 10.1177/074873040001500104; PU M, 1992, J NEUROSCI METH, V41, P45, DOI 10.1016/0165-0270(92)90122-T; Pu ML, 1999, J COMP NEUROL, V414, P267; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; von Schantz M, 2000, INVEST OPHTH VIS SCI, V41, P1605	29	2183	2276	27	461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1070	1073		10.1126/science.1067262	http://dx.doi.org/10.1126/science.1067262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834835				2022-12-01	WOS:000173793000065
J	Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR				Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR			A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes	SCIENCE			English	Article							INTRACELLULAR GROWTH; LEGIONNAIRES-DISEASE; HOST-CELLS; HELICOBACTER-PYLORI; HUMAN-MONOCYTES; PNEUMOPHILA; IDENTIFICATION; ESTABLISHMENT; ORGANELLE; GTPASES	The intracellular pathogen Legionella pneumophila subverts vesicle traffic in eukaryotic host cells to create a vacuole that supports replication. The dot/icm genes encode a protein secretion apparatus that L. pneumophila require for biogenesis of this vacuole. Here we show that L. pneumophila produce a protein called RalF that functions as an exchange factor for the ADP ribosylation factor (ARF) family of guanosine triphosphatases (GTPases). The RalF protein is required for the localization of ARF on phagosomes containing L. pneumophila. Translocation of RalF protein through the phagosomal membrane is a dot/km-dependent process. Thus, RalF is a substrate of the Dot/Icm secretion apparatus.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Yale University; Emory University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.		Nagai, Hiroki/GXZ-7815-2022; Kahn, Richard/ABD-2666-2020; Nagai, Hiroki/G-4113-2015	Kahn, Richard/0000-0002-0259-0601; Nagai, Hiroki/0000-0003-1659-2197; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [R01 AI44371, R29 AI41699] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044371, R29AI041699] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Breiman R F, 1998, Semin Respir Infect, V13, P84; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jones S, 1999, GENETICS, V152, P1543; KAGAN J, UNPUB; Matthews M, 2000, INFECT IMMUN, V68, P3971, DOI 10.1128/IAI.68.7.3971-3982.2000; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	32	439	454	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					679	682		10.1126/science.1067025	http://dx.doi.org/10.1126/science.1067025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809974				2022-12-01	WOS:000173560900046
J	Altabet, MA; Higginson, MJ; Murray, DW				Altabet, MA; Higginson, MJ; Murray, DW			The effect of millennial-scale changes in Arabian Sea denitrification on atmospheric CO2	NATURE			English	Article							INDIAN-OCEAN; ICE CORE; CYCLE; MONSOON; OSCILLATIONS; VARIABILITY; ATLANTIC; METHANE; RATIOS	Most global biogeochemical processes are known to respond to climate change, some of which have the capacity to produce feedbacks through the regulation of atmospheric greenhouse gases(1). Marine denitrification-the reduction of nitrate to gaseous nitrogen-is an important process in this regard, affecting greenhouse gas concentrations directly through the incidental production of nitrous oxide, and indirectly through modification of the marine nitrogen inventory and hence the biological pump for CO2. Although denitrification has been shown to vary with glacial-interglacial cycles(2,3), its response to more rapid climate change has not yet been well characterized. Here we present nitrogen isotope ratio, nitrogen content and chlorin abundance data from sediment cores with high accumulation rates on the Oman continental margin that reveal substantial millennial-scale variability in Arabian Sea denitrification and productivity during the last glacial period. The detailed correspondence of these changes with Dansgaard-Oeschger events recorded in Greenland ice cores(4) indicates rapid, century-scale reorganization of the Arabian Sea ecosystem in response to climate excursions, mediated through the intensity of summer monsoonal upwelling. Considering the several-thousand-year residence time of fixed nitrogen in the ocean, the response of global marine productivity to changes in denitrification would have occurred at lower frequency and appears to be related to climatic and atmospheric CO2 oscillations observed in Antarctic ice cores between 20 and 60 kyr ago(5).	Univ Massachusetts, Sch Marine Sci & Technol, New Bedford, MA 02744 USA; Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	University of Massachusetts System; Brown University	Altabet, MA (corresponding author), Univ Massachusetts, Sch Marine Sci & Technol, 706 S Rodney French Blvd, New Bedford, MA 02744 USA.							ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Altabet MA, 1999, PALEOCEANOGRAPHY, V14, P732, DOI 10.1029/1999PA900035; ANDERSON DM, 1991, FORAMINIFER EVIDENCE; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; DANSGAARD W, 1982, SCIENCE, V218, P1273, DOI 10.1126/science.218.4579.1273; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HIGGINSON MJ, 2000, THESIS U BRISTOL; Honjo S, 1999, DEEP-SEA RES PT II, V46, P1859, DOI 10.1016/S0967-0645(99)00047-8; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; KROM MD, 1993, DEEP-SEA RES PT I, V40, P805, DOI 10.1016/0967-0637(93)90073-C; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Suthhof A, 2001, GLOBAL BIOGEOCHEM CY, V15, P637, DOI 10.1029/2000GB001337; Upstill-Goddard RC, 1999, J GEOPHYS RES-OCEANS, V104, P30067, DOI 10.1029/1999JC900232; von Rad U, 1999, PALAEOGEOGR PALAEOCL, V152, P129, DOI 10.1016/S0031-0182(99)00042-5; WARREN BA, 1994, BIOGEOCHEMISTRY ARAB, P301	30	332	351	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					159	162		10.1038/415159a	http://dx.doi.org/10.1038/415159a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805831				2022-12-01	WOS:000173159300038
J	Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ				Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ			Endothelin-1 synthesis reduced by red wine - Red wines confer extra benefit when it comes to preventing coronary heart disease.	NATURE			English	Article							MORTALITY; CONSUMPTION; ALCOHOL		Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Corder, R (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.		Corder, Roger/H-2588-2012	Corder, Roger/0000-0003-1712-6841; Lees, Delphine M/0000-0002-2119-3978				Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; CORDER R, 2001, HANDB EXP PHARM, V152, P35; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Goldberg IJ, 2001, CIRCULATION, V103, P472; Kinlay S, 2001, CIRCULATION, V104, P1114, DOI 10.1161/hc3501.095707; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	11	237	258	5	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					863	864		10.1038/414863a	http://dx.doi.org/10.1038/414863a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780050				2022-12-01	WOS:000172813300033
J	Srivatsa, B; Srivatsa, S; Johnson, KL; Samura, O; Lee, SL; Bianchi, DW				Srivatsa, B; Srivatsa, S; Johnson, KL; Samura, O; Lee, SL; Bianchi, DW			Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study	LANCET			English	Article							BONE-MARROW; CELLS; IMMUNOLOGY; PREGNANCY; DNA	Background Some so-called autoimmune diseases in women might be alloimmune and represent a chronic graft-versus-host response attributable to transplacentally acquired fetal cells. Thyroid disease is more common in women than men, and post partum exacerbation of thyroiditis is common. Our aim was to investigate whether there is an association between fetal cell microchimerism and thyroid disease in women. Methods Surgical specimens were obtained from 29 women who underwent thyroidectomy for various thyroid disorders. Control specimens were taken from clinically and histologically normal thyroids obtained at necropsy from eight women who died from unrelated conditions. Medical records and pregnancy histories were reviewed. Fluorescence in-situ hybridisation analysis was done with probes specific for X and Y chromosomes. Slides were examined with a fluorescence microscope to detect the presence of male cells-with one X and one Y signal in the nucleus-among maternal cells containing two X signals. Findings Male cells were seen in thyroid sections from 16 patients but not in those from controls (p=0.01). Male cells (1-165 per slide) were seen individually or in clusters in all thyroid diseases and were not restricted to inflammatory thyroid diseases. In one patient with a progressively enlarging goitre, we noted fully differentiated male thyroid follicles closely attached to and indistinguishable from the rest of the thyroid. Interpretation Our findings suggest a relation between fetal cell microchimerism and thyroid disease. Furthermore, fetal stem cells might be capable of differentiation into mature thyroid follicles in their mothers with favourable environmental and developmental factors.	Tufts Univ, New England Med Ctr,Sch Med, Dept Paediat,Div Genet, Floating Hosp Children, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr,Sch Med, Div Endocrinol Diabet Metab & Mol Med, Dept Med, Boston, MA 02111 USA	Floating Hospital For Children; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Bianchi, DW (corresponding author), Tufts Univ, New England Med Ctr,Sch Med, Dept Paediat,Div Genet, Floating Hosp Children, Box 394,750 Washington St, Boston, MA 02111 USA.	DBianchi@Lifespan.org	Samura, Osamu/AAD-1079-2020	Samura, Osamu/0000-0002-7249-1537	NICHD NIH HHS [HD07492, HD43204] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDO T, 2001, 83 ANN M END SOC JUN; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 2000, AM J MED GENET, V91, P22, DOI 10.1002/(SICI)1096-8628(20000306)91:1<22::AID-AJMG4>3.0.CO;2-3; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Davies TF, 1999, THYROID, V9, P675, DOI 10.1089/thy.1999.9.675; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; DEMOOR G, 1988, ACTA CLIN BELG, V43, P231; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HUTCHINSON DL, 1967, AM J OBSTET GYNECOL, V99, P702, DOI 10.1016/0002-9378(67)90418-8; Johnson KL, 2001, ARTHRITIS RHEUM-US, V44, P1848, DOI 10.1002/1529-0131(200108)44:8<1848::AID-ART323>3.0.CO;2-L; Johnson TC, 2000, AMBIO, V29, P2, DOI 10.1639/0044-7447(2000)029[0002:THHOLV]2.0.CO;2; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Nath J, 1998, BIOTECH HISTOCHEM, V73, P6, DOI 10.3109/10520299809140502; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Schmorl G, 1893, PATHOLOGISCHE ANATOM; SCHRODER J, 1974, TRANSPLANTATION, V17, P346, DOI 10.1097/00007890-197404000-00003; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Tyndall A, 1998, NAT MED, V4, P386, DOI 10.1038/nm0498-386; Vietor HE, 2000, BLOOD, V95, P2709; ZHENG YL, 1995, PRENATAL DIAG, V15, P897, DOI 10.1002/pd.1970151004	23	199	204	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2001	358	9298					2034	2038		10.1016/S0140-6736(01)07099-4	http://dx.doi.org/10.1016/S0140-6736(01)07099-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755610				2022-12-01	WOS:000172722800012
J	Beroukas, T; Hiscock, J; Jonsson, R; Waterman, SA; Gordon, TP				Beroukas, T; Hiscock, J; Jonsson, R; Waterman, SA; Gordon, TP			Subcellular distribution of aquaporin 5 in salivary glands in primary Sjogren's syndrome	LANCET			English	Article								Secretions from salivary and lacrimal glands are reduced in patients with primary Sjogren's syndrome (PSS). Since aquaporin 5 is involved in transport of water and is present in salivary and lacrimal glands, this protein was thought to have a major role in the pathogenesis of PSS. We used indirect immunofluorescence and an immunoperoxidase technique to assess expression and subcellular localisation of aquaporin 5 in patients and controls. Our results suggest that the distribution and density of aquaporin 5 in salivary glands does not differ between patients with PSS and those without. Thus, the role of aquaporin 5 in the pathogenesis of PSS needs to be reassessed and alternative pathogenetic mechanisms investigated.	Flinders Med Ctr, Dept Immunol Allergy & Arthritis, Bedford Pk, SA 5042, Australia; Univ Bergen, Broegelmann Res Lab, Bergen, Norway	Flinders Medical Centre; University of Bergen	Gordon, TP (corresponding author), Flinders Med Ctr, Dept Immunol Allergy & Arthritis, Bedford Pk, SA 5042, Australia.	imtg@flinders.edu.au		Waterman, Sally/0000-0003-2579-3636; Gordon, Thomas/0000-0003-3232-8249				Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Jonsson R., 2001, ARTHRITIS ALLIED CON, Vp, P1736; NIELSEN S, 1997, AM J PHYSIOL, V42, pC1549; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4	5	75	79	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1875	1876		10.1016/S0140-6736(01)06900-8	http://dx.doi.org/10.1016/S0140-6736(01)06900-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741631				2022-12-01	WOS:000172463000017
J	Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH				Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH			Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE INDUSTRIAL-STATE; HIGH-RESOLUTION CT; EOSINOPHILIC GRANULOMA; MULTIPLE-MYELOMA; ACUTE-LEUKEMIA; LUNG; ASSOCIATION; MALIGNANCY; LYMPHOMAS; MICHIGAN	Background: Pulmonary Langerhans'-cell histiocytosis is an uncommon interstitial lung disease in adults. It has an unpredictable course and may be associated with an increased susceptibility to the development of malignant neoplasms. Methods: We reviewed the records of 102 adults with histopathologically confirmed pulmonary Langerhans'-cell histiocytosis to ascertain their vital status and whether cancer had been diagnosed. The health status of surviving patients was quantified with the use of the 36-Item Short-Form General Health Survey. Factors potentially associated with survival after the diagnosis of pulmonary Langerhans'-cell histiocytosis were analyzed with the Cox proportional-hazards model. Results: The median follow-up period was 4 years (range, 0 to 23). There were 33 deaths, 15 of which were attributable to respiratory failure. Six hematologic cancers were diagnosed. The overall median survival was 12.5 years, which was significantly shorter than that expected for persons of the same sex and calendar year of birth (P<0.001). In a univariate analysis, variables predictive of shorter survival included an older age (P=0.003), a lower forced expiratory volume in one second (FEV1 (P=0.004), a higher residual volume (P=0.007), a lower ratio of FEV1 to forced vital capacity (P=0.03), and a reduced carbon monoxide diffusing capacity (P=0.001). Conclusions: The survival of adults with pulmonary Langerhans'-cell histiocytosis is shorter than that in the general population, and respiratory failure accounts for a substantial proportion of deaths among such patients. (N Engl J Med 2002;346:484-90.) Copyright (C) 2002 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Vassallo, R (corresponding author), Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Stable Bldg 8-54,200 1st St SW, Rochester, MN 55905 USA.		Vassallo, Robert/R-7752-2019	Vassallo, Robert/0000-0003-2328-0255; Ryu, Jay/0000-0002-9576-2272				American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; BASSET F, 1978, AM REV RESPIR DIS, V118, P811; BENEZRA JM, 1993, AM J CLIN PATHOL, V99, P464, DOI 10.1093/ajcp/99.4.464; Bernstrand C, 2000, ACTA PAEDIATR, V89, P1389, DOI 10.1080/080352500300002642; Bonelli FS, 1998, AM J ROENTGENOL, V170, P1507, DOI 10.2214/ajr.170.6.9609163; BRAUNER MW, 1989, RADIOLOGY, V172, P255, DOI 10.1148/radiology.172.1.2787036; Brauner MW, 1997, RADIOLOGY, V204, P497, DOI 10.1148/radiology.204.2.9240543; BURNS BF, 1983, AM J SURG PATHOL, V7, P529, DOI 10.1097/00000478-198309000-00003; Chang JA, 1999, CHEST, V116, P1175, DOI 10.1378/chest.116.5.1175; COLBY TV, 1983, HUM PATHOL, V14, P847, DOI 10.1016/S0046-8177(83)80160-9; Collins J, 2001, RADIOL CLIN N AM, V39, P1115, DOI 10.1016/S0033-8389(05)70334-1; de Andres CI, 1999, VIRCHOWS ARCH, V434, P259, DOI 10.1007/s004280050338; DECAMARGO B, 1993, MED PEDIATR ONCOL, V21, P451, DOI 10.1002/mpo.2950210612; Delobbe K, 1996, EUR RESPIR J, V9, P2002; EGELER RM, 1993, CANCER, V71, P865, DOI 10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0; Egeler RM, 1998, HEMATOL ONCOL CLIN N, V12, P369, DOI 10.1016/S0889-8588(05)70516-5; EGELER RM, 1994, MED PEDIATR ONCOL, V23, P81, DOI 10.1002/mpo.2950230204; EMILE JF, 1995, AM J SURG PATHOL, V19, P636, DOI 10.1097/00000478-199506000-00003; FRIEDMAN PJ, 1981, MEDICINE, V60, P385, DOI 10.1097/00005792-198111000-00001; HOUSINI I, 1994, ARCH PATHOL LAB MED, V118, P523; KRENACS L, 1993, J PATHOL, V171, P99, DOI 10.1002/path.1711710206; LOMBARD CM, 1987, ARCH PATHOL LAB MED, V111, P339; Malpas JS, 1996, MED PEDIATR ONCOL, V27, P540; Michetti G, 1996, Minerva Med, V87, P243; MILLER A, 1986, B EUR PHYSIOPATH RES, V22, P589; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Nagai S, 2000, Curr Opin Pulm Med, V6, P415, DOI 10.1097/00063198-200009000-00005; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; *SURV EP END RES, 2000, SEER PROGR PUBL US D; Therneau TMSJ, 1994, TECHNICAL REPORT SER, V52; TRAVIS WD, 1993, AM J SURG PATHOL, V17, P971, DOI 10.1097/00000478-199310000-00002; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Ware J. E, 1994, PHYS MENTAL HLTH SUM; YAMASHITA H, 1992, CLIN EXP DERMATOL, V17, P275, DOI 10.1111/j.1365-2230.1992.tb02167.x; Yousem SA, 2001, AM J SURG PATHOL, V25, P630, DOI 10.1097/00000478-200105000-00010	35	272	295	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					484	490		10.1056/NEJMoa012087	http://dx.doi.org/10.1056/NEJMoa012087			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844849				2022-12-01	WOS:000173815300004
J	Lowenstein, E; Wanzer, SH				Lowenstein, E; Wanzer, SH			Sounding board - The US Attorney General's intrusion into medical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Lowenstein, E (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							*ACOG, 1999, ACOG PRACT B, V10; *ACOG, 1999, 228 ACOG; ASHCROFT J, 2001, COMMUNICATION   1106; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; *MED EC, 2002, PHYS DESK REF, P3202; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	7	6	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					447	448		10.1056/NEJM200202073460613	http://dx.doi.org/10.1056/NEJM200202073460613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832536				2022-12-01	WOS:000173686400011
J	Schwetz, BA				Schwetz, BA			New contraceptive patch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-01	WOS:000173686700005
J	Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ				Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ			Dynamic brain sources of visual evoked responses	SCIENCE			English	Article							ALPHA-BAND; SPATIAL ATTENTION; RHYTHMS; EEG; POTENTIALS	It has been long debated whether averaged electrical responses recorded from the scalp result from stimulus-evoked brain events or stimulus-induced changes in ongoing brain dynamics. In a human visual selective attention task, we show that nontarget event-related potentials were mainly generated by partial stimulus-Induced phase resetting of multiple electroencephalographic processes. Independent component analysis applied to the single-trial data identified at least eight classes of contributing components, including those producing central and lateral posterior alpha, left and right mu, and frontal midline theta rhythms. Scalp topographies of these components were consistent with their generation in compact cortical domains.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Inst Neural Computat, San Diego, CA 92093 USA; Univ Calif San Diego, Dept Biol, San Diego, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Makeig, S (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Sejnowski, Terrence/AAV-5558-2021		NIMH NIH HHS [2RO1-MH36840] Funding Source: Medline; NINDS NIH HHS [1RO1-NS34155] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034155] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrew C, 1997, NEUROSCI LETT, V222, P103, DOI 10.1016/S0304-3940(97)13358-4; Barry RJ, 2000, INT J PSYCHOPHYSIOL, V39, P39, DOI 10.1016/S0167-8760(00)00114-8; Basar E., 1980, EEG BRAIN DYNAMICS R; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BELL AJ, INPRESS HDB NEURAL N; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; BRANDT ME, 1991, ELECTROENCEPHALOGR C, V80, P241; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; CHAPMAN R, 2001, 7 ANN M ORG HUM BRAI; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fellous JM, 2001, NEUROCOMPUTING, V38, P587, DOI 10.1016/S0925-2312(01)00422-2; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.0.CO;2-R; Kolev V, 2001, INT J PSYCHOPHYSIOL, V39, P159, DOI 10.1016/S0167-8760(00)00139-2; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lutzenberger W, 1997, INT J PSYCHOPHYSIOL, V26, P273, DOI 10.1016/S0167-8760(97)00770-8; Makeig S, 1999, PHILOS T ROY SOC B, V354, P1135, DOI 10.1098/rstb.1999.0469; Makeig S, 2000, IEEE T REHABIL ENG, V8, P208, DOI 10.1109/86.847818; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; MANGUN R, 1992, INDUCED RHYTHMS BRAI, P219; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TOWNSEND J, 1994, J COGNITIVE NEUROSCI, V6, P220, DOI 10.1162/jocn.1994.6.3.220; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Worden MS, 2000, J NEUROSCI, V20	35	1178	1237	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					690	694		10.1126/science.1066168	http://dx.doi.org/10.1126/science.1066168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809976				2022-12-01	WOS:000173560900049
J	Germain, P; Iyer, J; Zechel, C; Gronemeyer, H				Germain, P; Iyer, J; Zechel, C; Gronemeyer, H			Co-regulator recruitment and the mechanism of retinoic acid receptor synergy	NATURE			English	Article							NUCLEAR HORMONE RECEPTORS; LIGAND-BINDING DOMAINS; HETERODIMERIC COMPLEX; RESPONSE PATHWAYS; X-RECEPTOR; RAR; RXR; ACTIVATION; TIF2; TRANSACTIVATION	Crystal structure and co-regulator interaction studies have led to a general mechanistic view of the initial steps of nuclear receptor (NR) action. Agonist-induced transconformation of the ligand-binding domain (holo-LBD) leads to the formation of co-activator complexes, and destabilizes the co-repressor complexes bound to the ligand-free (apo) LBD1-3. However, the molecular basis of retinoid-X receptor (RXR) 'subordination' in heterodimers, an essential mechanism to avoid signalling pathway promiscuity, has remained elusive. RXR, in contrast to its heterodimer partner, cannot autonomously induce transcription on binding of cognate agonists(4-7). Here we show that RXR can bind ligand and recruit co-activators as a heterodimer with apo-retinoic-acid receptor (apo-RAR). However, in the usual cellular environment co-repressors do not dissociate and they prohibit co-activator access because co-regulator binding is mutually exclusive. Accordingly, RXR subordination can be overcome in heterodimers that bind co-repressor weakly or in cells with a high co-activator content. We identify two types of RAR antagonists that differentially modulate co-regulator interaction, and we demonstrate that synergy between RAR ligands and RXR agonists(6,8) results from increased interaction efficiency of a single p160 with the heterodimer, requiring two intact receptor-binding surfaces on the co-activator.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gronemeyer, H (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	hg@igbmc.u-strasbg.fr	Gronemeyer, Hinrich/H-7002-2016; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/G-6240-2011	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Germain, Pierre/0000-0003-2962-9593				Alen P, 1999, MOL CELL BIOL, V19, P6085; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Bourguet W, 2000, PROTEIN EXPRES PURIF, V19, P284, DOI 10.1006/prep.2000.1248; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Iyer J, 1999, PROTEIN EXPRES PURIF, V16, P308, DOI 10.1006/prep.1999.1053; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Vivat V, 1997, EMBO J, V16, P5697, DOI 10.1093/emboj/16.18.5697; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yang W, 1999, J BIOL CHEM, V274, P16838, DOI 10.1074/jbc.274.24.16838	30	248	256	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					187	192		10.1038/415187a	http://dx.doi.org/10.1038/415187a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805839				2022-12-01	WOS:000173159300046
J	Schwetz, BA				Schwetz, BA			Drug for severe adult sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fushers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-01	WOS:000172978500004
J	Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM				Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM			Posttranslational mechanisms regulate the mammalian circadian clock	CELL			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NUCLEAR ENTRY; DOUBLE-TIME; PHOSPHORYLATION; PROTEIN; PERIOD; RHYTHMS; MUTATION	We have examined posttranslational regulation of clock proteins in mouse liver in vivo. The mouse PERIOD proteins (mPER1 and mPER2), CLOCK, and BMAL1 undergo robust circadian changes in phosphorylation. These proteins, the cryptochromes (mCRY1 and mCRY2), and casein kinase I epsilon (CKI epsilon) form multimeric complexes that are bound to DNA during negative transcriptional feedback. CLOCK:BMAL1 heterodimers remain bound to DNA over the circadian cycle. The temporal increase in mPER abundance controls the negative feedback interactions. Analysis of clock proteins in mCRY-deficient mice shows that the mCRYs are necessary for stabilizing phosphorylated mPER2 and for the nuclear accumulation of mPER1, mPER2, and CKI epsilon. We also provide in vivo evidence that casein kinase I delta is a second clock relevant kinase.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Massachusetts System; University of Massachusetts Worcester; University of Manchester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 55 Lake Ave N, Worcester, MA 01655 USA.	steven.reppert@umassmed.edu	Cagampang, Felino/AAG-5141-2019	Cagampang, Felino/0000-0003-4404-9853; Loudon, Andrew/0000-0003-3648-445X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD 14427] Funding Source: Medline; NINDS NIH HHS [R01 NS 39303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P758, DOI 10.1210/en.140.2.758; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Park SK, 2000, ARCH BIOCHEM BIOPHYS, V381, P302, DOI 10.1006/abbi.2000.1999; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, GENE DEV, V14, P1353; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zhang JH, 2000, J BIOL CHEM, V275, P8895, DOI 10.1074/jbc.275.12.8895; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	45	862	886	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					855	867		10.1016/S0092-8674(01)00610-9	http://dx.doi.org/10.1016/S0092-8674(01)00610-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779462	Bronze			2022-12-01	WOS:000173024200007
J	Tulina, N; Matunis, E				Tulina, N; Matunis, E			Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling	SCIENCE			English	Article							GENE-EXPRESSION; GERMLINE; PROTEIN; DIFFERENTIATION; PROLIFERATION; ENCODES; PATHWAY; KINASE	Stem cells, which regenerate tissue by producing differentiating cells, also produce cells that renew the stem cell population. Signals from regulatory microenvironments (niches) are thought to cause stem cells to retain self-renewing potential. However, the molecular characterization of niches remains an important goat. In Drosophila testes, germ tine and somatic stem cells attach to a cluster of support cells called the hub. The hub specifically expresses Unpaired, a ligand activating the JAK-STAT (Janus kinase-signal transducer and activator of transcription) signaling cascade. Without JAK-STAT signaling, germ line stem cells differentiate but do not self-renew. Conversely, ectopic JAK-STAT signaling greatly expands both stem cell populations. We conclude that the support cells of the hub signal to adjacent stem cells by activation of the JAK-STAT pathway, thereby defining a niche for stem cell self-renewal.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Matunis, E (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD040307, R01HD40307] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Boyle M, 1997, DEVELOPMENT, V124, P971; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GONCZY P, 1992, DEVELOPMENT, V114, P89; GONCZY P, 1995, THESIS ROCKEFELLER U; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hime GR, 1996, J CELL SCI, V109, P2779; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LIN HF, 1994, DEVELOPMENT, V120, P947; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Smith AG, 2001, DEV BIOL, V235, P289; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; TSAI YC, 2001, A DROS RES C, V42, pC585; Van Doren M, 1998, CURR BIOL, V8, P243; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	24	478	497	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2546	2549		10.1126/science.1066700	http://dx.doi.org/10.1126/science.1066700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752575				2022-12-01	WOS:000172927700058
J	Roberts, R				Roberts, R			Muscular dystrophy through an evolutionary lens	LANCET			English	Article									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Roberts, R (corresponding author), Guys Hosp, GKT Med Sch, Div Med & Mol Genet, 8th Floor,Guys Tower, London SE1 9RT, England.	roland.roberts@kcl.ac.uk	Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S25	S25		10.1016/S0140-6736(01)07038-6	http://dx.doi.org/10.1016/S0140-6736(01)07038-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784574				2022-12-01	WOS:000172907200025
J	MacInnis, BL; Campenot, RB				MacInnis, BL; Campenot, RB			Retrograde support of neuronal survival without retrograde transport of nerve growth factor	SCIENCE			English	Article							RAT SYMPATHETIC NEURONS; AXONAL-TRANSPORT; TRKA; BINDING; KINASE; SIGNAL; PHOSPHORYLATION; INTERNALIZATION; ENDOCYTOSIS	Application of nerve growth factor (NGF) covalently cross-linked to beads increased the phosphorylation of TrkA and Akt, but not of mitogen-activated protein kinase, in cultured rat sympathetic neurons. NGF beads or iodine-125-labeled NGF beads supplied to distal axons resulted in the survival of over 80% of the neurons for 30 hours, with little or no retrograde transport of iodine-125-labeled NGF; whereas application of free iodine-125-labeled NGF (0.5 nanograms per milliliter) produced 20-fold more retrograde transport, but only 29% of the neurons survived. Thus, in contrast to widely accepted theory, a neuronal survival signal can reach the cell bodies unaccompanied by the NGF that initiated it.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Campenot, RB (corresponding author), Univ Alberta, Dept Cell Biol, 6-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	bob.campenot@ualberta.ca						CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; CAMPENOT RB, 2001, PROTOCOLS NEURAL CEL, P49; CLAUDE P, 1982, J NEUROSCI, V2, P431; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1991, NEUROSCI LETT, V133, P29, DOI 10.1016/0304-3940(91)90049-Y; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; PALMATIER MA, 1984, J NEUROSCI, V4, P751; POPOV S, 1992, J NEUROSCI, V12, P77; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; URE DR, 1994, DEV BIOL, V162, P339, DOI 10.1006/dbio.1994.1091; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Viahos CJ, 1994, J BIOL CHEM, V269, P5241; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	26	211	214	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1536	1539		10.1126/science.1064913	http://dx.doi.org/10.1126/science.1064913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11799202				2022-12-01	WOS:000173981300057
J	Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD				Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD			Existence of an O-16-rich gaseous reservoir in the solar nebula	SCIENCE			English	Article							REFRACTORY INCLUSION; ORDINARY CHONDRITES; CHONDRULE FORMATION; CONSTRAINTS; SYSTEM; AL-26; CONDENSATION; METEORITES; ALLENDE; MODELS	Carbonaceous chondrite condensate olivine grains from two distinct petrographic settings, calcium-aluminum-rich inclusion (CAI) accretionary rims and amoeboid olivine aggregates (AOAs), are oxygen-16 (O-16) enriched at the level, previously observed inside CAIs. This requires that the gas in the nebular region where these grains condensed was O-16-rich. This contrasts with an O-16-poor gas present during the formation of chondrules, suggesting that CAIs and AOAs formed in a spatially restricted region of the solar nebula containing O-16-rich gas. The O-16-rich gas composition may have resulted either from mass-independent isotopic chemistry or from evaporation of regions with enhanced dust/gas ratios, possibly in an X-wind environment near the young Sun.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Smithsonian Inst, US Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA	University of Hawaii System; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; Smithsonian National Museum of Natural History	Krot, AN (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	sasha@higp.hawaii.edu	McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X; Scott, Edward/0000-0002-5137-3830				BREARLEY AJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2081, DOI 10.1016/0016-7037(89)90326-8; Cassen P, 2001, METEORIT PLANET SCI, V36, P671, DOI 10.1111/j.1945-5100.2001.tb01908.x; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; DAVIS AM, 1994, METEORITICS, V29, P458; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; Fagan TJ, 2001, METEORIT PLANET SCI, V36, P223, DOI 10.1111/j.1945-5100.2001.tb01866.x; Guan Y, 2000, EARTH PLANET SC LETT, V181, P271, DOI 10.1016/S0012-821X(00)00218-1; Hewins R., 1996, CHONDRULES PROTOPLAN, P55; Hiyagon H, 1999, SCIENCE, V283, P828, DOI 10.1126/science.283.5403.828; IMAI H, 2001, LUNAR PLANET SCI, V32, P1580; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Komatsu M, 2001, METEORIT PLANET SCI, V36, P629, DOI 10.1111/j.1945-5100.2001.tb01905.x; Krot AN, 1999, METEORIT PLANET SCI, V34, pA68; Krot AN, 2001, METEORIT PLANET SCI, V36, P611, DOI 10.1111/j.1945-5100.2001.tb01904.x; LESHIN LA, 2000, LUNAR PLANET SCI, V31, P1918; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2267, DOI 10.1016/0016-7037(85)90227-3; MACPHERSON GJ, 1993, GEOCHIM COSMOCHIM AC, V57, P231, DOI 10.1016/0016-7037(93)90481-B; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Petaev MI, 1998, METEORIT PLANET SCI, V33, P1123, DOI 10.1111/j.1945-5100.1998.tb01717.x; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; RUZICKA A, 1995, METEORITICS, V30, P570; Scott ERD, 2001, METEORIT PLANET SCI, V36, P1307, DOI 10.1111/j.1945-5100.2001.tb01826.x; Shu FH, 1996, SCIENCE, V271, P1545, DOI 10.1126/science.271.5255.1545; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wark D. A., 1977, LUNAR PLANETARY SCI, P95; WOOD JA, 1981, EARTH PLANET SC LETT, V56, P32, DOI 10.1016/0012-821X(81)90115-1; Wood JA, 1998, ASTROPHYS J, V503, pL101, DOI 10.1086/311517; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 2001, METEORIT PLANET SCI, V36, pA230	33	96	97	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1051	1054		10.1126/science.1068200	http://dx.doi.org/10.1126/science.1068200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834830				2022-12-01	WOS:000173793000060
J	Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR				Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR			RanGAP mediates GTP hydrolysis without an arginine finger	NATURE			English	Article							ACTIVATING PROTEIN; CRYSTAL-STRUCTURE; TRANSITION-STATE; RAN/TC4 GTPASE; BINDING; TRANSPORT; COMPLEX; DOMAIN; GAP; RESIDUES	GTPase-activating proteins (GAPs) increase the rate of GTP hydrolysis on guanine nucleotide-binding proteins by many orders of magnitude. Studies with Ras and Rho have elucidated the mechanism of GAP action by showing that their catalytic machinery is both stabilized by GAP binding and complemented by the insertion of a so-called 'arginine finger' into the phosphate-binding pocket(1,2). This has been proposed as a universal mechanism for GAP-mediated GTP hydrolysis. Ran is a nuclear Ras-related protein that regulates both transport between the nucleus and cytoplasm during interphase, and formation of the mitotic spindle and/or nuclear envelope in dividing cells(3). RanGTP is hydrolysed by the combined action of Ran-binding proteins (RanBPs) and RanGAP(4). Here we present the three-dimensional structure of a Ran-RanBP1-RanGAP ternary complex in the ground state and in a transition-state mimic. The structure and biochemical experiments show that RanGAP does not act through an arginine finger, that the basic machinery for fast GTP hydrolysis is provided exclusively by Ran and that correct positioning of the catalytic glutamine is essential for catalysis.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44026 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Postfach 102664, D-44026 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Ding, Cheng-Qiang/B-6287-2011	Seewald, Michael/0000-0001-6967-8993				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Haberland J, 1999, BIOCHEM J, V343, P653, DOI 10.1042/0264-6021:3430653; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	30	150	153	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					662	666		10.1038/415662a	http://dx.doi.org/10.1038/415662a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832950				2022-12-01	WOS:000173709100052
J	Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV				Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV			Environment - Frontier governance in Amazonia	SCIENCE			English	Article							FOREST		Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; Fed Univ Para, BR-66059 Belem, Para, Brazil	Woods Hole Research Center; Universidade Federal do Para	Nepstad, D (corresponding author), Woods Hole Res Ctr, POB 296, Woods Hole, MA 02543 USA.		/AAX-3684-2020	/0000-0001-5605-7469				Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; *BRAZ I NAT STAT G, 2000, PROD AGR MUN 1999; Carvalho G, 2001, NATURE, V409, P131, DOI 10.1038/35051794; Costa MH, 2000, J CLIMATE, V13, P18, DOI 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2; *GOV EST M GROSS F, 2001, SIST CONTR AMB PROPR; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Schmink Marianne, 1992, CONTESTED FRONTIERS; SCHNEIDER RR, 2000, PARTNERSHIP SERIES, V1; Webb Steven, 1999, 2121 WORLD BANK; Zimmer Kevin J., 1997, Ornithological Monographs, V48, P887; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	12	145	151	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					629	+		10.1126/science.1067053	http://dx.doi.org/10.1126/science.1067053			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809955				2022-12-01	WOS:000173560900025
J	Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH				Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH			SIVcpz in wild chimpanzees	SCIENCE			English	Article							VIRUS		Univ Alabama, Birmingham, AL 35294 USA; Gombe Stream Res Ctr, Kigoma, Tanzania; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Nottingham, Nottingham NG7 2UH, England; Harvard Univ, Cambridge, MA 02138 USA; Ctr Pasteur Cameroun, Yaounde, Cameroon; Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Rijswijk ZH, Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands; Univ Minnesota, St Paul, MN 55108 USA; Max Planck Inst, D-04301 Leipzig, Germany; Jane Goodall Inst, Silver Spring, MD 20911 USA	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Nottingham; Harvard University; Centre Pasteur du Cameroun; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Hahn, BH (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.		Ayouba, Ahidjo/G-8775-2017; Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Sharp, Paul/Y-3787-2019	Ayouba, Ahidjo/0000-0002-5081-1632; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Kilby, J. Michael/0000-0003-3222-1003; Hahn, Beatrice/0000-0002-9400-9887; Pusey, Anne/0000-0002-2280-8954; Heeney, Jonathan/0000-0003-2702-1621; Santiago, Mario L./0000-0001-7792-2706				Butynski Thomas M., 2001, P3; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Teleki G., 1989, P312; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384	6	160	164	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					465	465		10.1126/science.295.5554.465	http://dx.doi.org/10.1126/science.295.5554.465			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799233				2022-12-01	WOS:000173350700039
J	Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH				Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH			Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet	SCIENCE			English	Article							HYPERRESPONSIVENESS; INFLAMMATION; CELLS; TH2	Human asthma is associated with airway infiltration by T helper 2 (T(H)2) lymphocytes. We observed reduced expression of the T(H)1 transcription factor, T-bet, in T cells from airways of patients with asthma compared with that in T cells from airways of nonasthmatic patients, suggesting that loss of T-bet might be associated with asthma. Mice with a targeted deletion of the T-bet gene and severe combined immunodeficient mice receiving CD4(+) cells from T-bet knockout mice spontaneously demonstrated multiple physiological and inflammatory features characteristic of asthma, Thus, T-bet deficiency, in the absence of allergen exposure, induces a murine phenotype reminiscent of both acute and chronic human asthma.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Millenium Pharmaceut, Cambridge, MA 02138 USA; Univ Mainz, Dept Pathol, D-55131 Mainz, Germany; Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada; Univ Mainz, Med Clin 1, D-55131 Mainz, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Johannes Gutenberg University of Mainz; University of Calgary; Johannes Gutenberg University of Mainz	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Drazen, Jeffrey M/E-5841-2012; Finotto, Susetta/H-2753-2019		NHLBI NIH HHS [HL-36110] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Cohn L, 1998, J IMMUNOL, V161, P3813; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Finotto S, 1999, DEVELOPMENT, V126, P2935; FINOTTO S, UNPUB; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; LI XM, 1996, J IMMUNOL, V157, P2316; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543	16	491	566	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					336	338		10.1126/science.1065544	http://dx.doi.org/10.1126/science.1065544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786643				2022-12-01	WOS:000173278600052
J	Thery, M; Casas, J				Thery, M; Casas, J			Predator and prey views of spider camouflage - Both hunter and hunted fail to notice crab-spiders blending with coloured petals	NATURE			English	Article							PERCEPTION; EVOLUTION; ECOLOGY		Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France; Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Thery, M (corresponding author), Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France.	thery@mnhn.fr	Casas, Jérôme/D-9620-2011	Casas, Jérôme/0000-0003-1666-295X				Bradbury Jack W., 1998, pi; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHEN DM, 1986, J COMP PHYSIOL A, V159, P473, DOI 10.1007/BF00604167; Chittka L, 2001, ENTOMOL GEN, V25, P181; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098	7	180	186	1	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					133	133		10.1038/415133a	http://dx.doi.org/10.1038/415133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805822				2022-12-01	WOS:000173159300028
J	Ascherio, A; Munger, KL; Lennette, ET; Spiegelman, D; Hernan, MA; Olek, MJ; Hankinson, SE; Hunter, DJ				Ascherio, A; Munger, KL; Lennette, ET; Spiegelman, D; Hernan, MA; Olek, MJ; Hankinson, SE; Hunter, DJ			Epstein-Barr virus antibodies and risk of multiple sclerosis - A prospective study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CD8(+) T-CELLS; NUCLEAR ANTIGEN; INFECTION; EBV; VARIANT; HUMAN-HERPESVIRUS-6; ASSOCIATION; AUTOIMMUNE; RESPONSES; DISEASE		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Multiple Sclerosis Unit, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Virolab Inc, Berkeley, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	Alberto.Ascherio@channing.harvard.edu		Olek, Michael/0000-0002-3840-2772	NCI NIH HHS [CA49449, CA67262] Funding Source: Medline; NINDS NIH HHS [NS35624] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA049449, R01CA049449, R01CA067262, U01CA067262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035624] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; COMPSTON DAS, 1986, BRAIN, V109, P325, DOI 10.1093/brain/109.2.325; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Diggle P., 2002, ANAL LONGITUDINAL DA; Flamand L, 1996, J VIROL, V70, P1784, DOI 10.1128/JVI.70.3.1784-1791.1996; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P00281; Haahr S, 1995, Mult Scler, V1, P73; Hafler DA, 1999, J CLIN INVEST, V104, P527, DOI 10.1172/JCI8193; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; HILTON DA, 1994, J NEUROL NEUROSUR PS, V57, P975, DOI 10.1136/jnnp.57.8.975; Hunter SF, 2000, NEUROLOGY, V55, P164, DOI 10.1212/WNL.55.2.164; Jabs WJ, 1999, CLIN EXP IMMUNOL, V116, P468; Knox KK, 2000, CLIN INFECT DIS, V31, P894, DOI 10.1086/318141; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; LENNETTE E, 2000, IMMUNE ADHERENCE HEM; LENNETTE ET, 1993, EUR J CANCER, V29A, P1584, DOI 10.1016/0959-8049(93)90299-U; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; LINDBERG C, 1991, NEUROEPIDEMIOLOGY, V10, P62, DOI 10.1159/000110248; Marrie RA, 2000, NEUROLOGY, V54, P2307, DOI 10.1212/WNL.54.12.2307; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; MARTYN CN, 1991, MCALPINES MULTIPLE S, P2; Morre SA, 2001, NEUROLOGY, V56, P692, DOI 10.1212/WNL.56.5.692; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; OPERSKALSKI EA, 1989, NEUROLOGY, V39, P825, DOI 10.1212/WNL.39.6.825; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Tan LC, 1999, J IMMUNOL, V162, P1827; van Sechel AC, 1999, J IMMUNOL, V162, P129; VAUGHAN JH, 1995, SPRINGER SEMIN IMMUN, V17, P203; Vaughan JH, 1996, J NEUROIMMUNOL, V69, P95; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; WARNER HB, 1981, LANCET, V2, P1290; Winer S, 2001, J IMMUNOL, V166, P4751, DOI 10.4049/jimmunol.166.7.4751	45	367	382	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3083	3088		10.1001/jama.286.24.3083	http://dx.doi.org/10.1001/jama.286.24.3083			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754673	Bronze			2022-12-01	WOS:000172927100025
J	Schlecht, NF; Kulaga, S; Robitaille, J; Ferreira, S; Santos, M; Miyamura, RA; Duarte-Franco, E; Rohan, TE; Ferenczy, A; Villa, LL; Franco, EL				Schlecht, NF; Kulaga, S; Robitaille, J; Ferreira, S; Santos, M; Miyamura, RA; Duarte-Franco, E; Rohan, TE; Ferenczy, A; Villa, LL; Franco, EL			Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATURAL-HISTORY; WOMEN; RISK; DNA; LESIONS	Context Human papillomavirus (HPV) infection is believed to be the central cause of cervical cancer, although most of the epidemiological evidence has come from retrospective, case-control studies, which do not provide information on the dynamics of cumulative or persistent exposure to HPV infection. Objective To assess the risks of cervical neoplasia related to prior persistent HPV infections. Design and Setting Longitudinal study of the natural history of HPV infection and cervical neoplasia in women residing in the city of Sao Paulo, Brazil, which was conducted between November 1993 and March 1997 and involved repeated measurements of HPV and lesions with follow-up until June 2000. Participants A total of 1611 women with no cytological lesions at enrollment and HPV test results available from the first 2 visits. Main Outcome Measure Cervical specimens taken for Papanicolaou cytology and HPV testing every 4 months in the first year and twice yearly thereafter. Incident cervical cancer precursor lesions ascertained by expert review of all cytology smears. Results The incidence rate of squamous intraepithelial lesions (SILs) was 0.73 per 1000 women-months (95% confidence interval [CII, 0.5-0.9) among women free of HPV at the 2 initial visits and 8.68 (95% Cl, 2.3-15.1) among women with HPV type 16 or 18 infections persisting over both visits. Relative to those negative for HPV oncogenic types at both initial visits, the relative risk (RR) of incident SIL was 10.19 (95% Cl, 5.9-17.6) for persistent infections with any known oncogenic HPV types. The equivalent RR of incident high-grade SIL was 11.67 (95% Cl, 4.1-33.3). The RRs of lesions were considerably higher for persistent infections with HPV type 16 or 18. Conclusion A strong relationship exists between persistent HPV infections and SIL incidence, particularly for HPV types 16 and 18.	McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; McGill Univ, Dept Pathol, Montreal, PQ, Canada; Ludwig Inst Canc Res, Sao Paulo, Brazil; Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA	McGill University; McGill University; McGill University; Ludwig Institute for Cancer Research; Yeshiva University; Albert Einstein College of Medicine	Franco, EL (corresponding author), McGill Univ, Dept Oncol, 546 Pine Ave W, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	VILLA, LUISA/AAH-4761-2019; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Franco, Eduardo/0000-0002-4409-8084; Schlecht, Nicolas/0000-0003-2482-244X	NCI NIH HHS [CA70269] Funding Source: Medline; PHS HHS [MA13647] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070269] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FRANCO EL, 1994, JNCI-J NATL CANCER I, V86, P1558, DOI 10.1093/jnci/86.20.1558; Franco EL, 1999, JNCI-J NATL CANCER I, V91, P506, DOI 10.1093/jnci/91.6.506; FRANCO EL, 1999, PAN AM J PUBLIC HLTH, V6, P223; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; *IARC, 1995, IARC MON EV CARC RIS, V64; KATAJA V, 1989, EUR J EPIDEMIOL, V5, P1, DOI 10.1007/BF00145037; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Londesborough P, 1996, INT J CANCER, V69, P364; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; SOLOMON D, 1989, ACTA CYTOL, V33, P567; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8	22	401	439	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3106	3114		10.1001/jama.286.24.3106	http://dx.doi.org/10.1001/jama.286.24.3106			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754676	Bronze			2022-12-01	WOS:000172927100028
J	Kromer, B; Manning, SW; Kuniholm, PI; Newton, MW; Spurk, M; Levin, I				Kromer, B; Manning, SW; Kuniholm, PI; Newton, MW; Spurk, M; Levin, I			Regional (CO2)-C-14 offsets in the troposphere: Magnitude, mechanisms, and consequences	SCIENCE			English	Article							RADIOCARBON TIME SCALE; PRECISION BIDECADAL CALIBRATION; ANATOLIAN TREE-RINGS; AGE CALIBRATION; SOLAR; TERRESTRIAL; CHRONOLOGY; CYCLE	Radiocarbon dating methods typically assume that there are no significant tropospheric (CO2)-C-14 gradients within the low- to mid-latitude zone of the Northern Hemisphere. Comparison of tree ring C-14 data from southern Germany and Anatolia supports this assumption in general but also documents episodes of significant short-term regional (CO2)-C-14 offsets. We suggest that the offset is caused by an enhanced seasonal (CO2)-C-14. cycle, with seasonally peaked flux of stratospheric C-14 into the troposphere during periods of low solar magnetic activity, coinciding with substantial atmospheric cooling. Short-term episodes of regional (CO2)-C-14, offsets are important to palaeoclimate studies and to high-resolution archaeological dating.	Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany; Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany; Univ Reading, Dept Archaeol, Reading RG6 6AA, Berks, England; Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY 14853 USA; Univ Hohenheim, Inst Bot 210, D-70593 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Reading; Cornell University; University Hohenheim	Kromer, B (corresponding author), Heidelberger Akad Wissensch, Neuenheimer Feld 229, D-69120 Heidelberg, Germany.	bernd.kromer@iup.uni-heidelberg.de						BALACHANDRAN NK, 1995, J CLIMATE, V8, P2058, DOI 10.1175/1520-0442(1995)008<2058:MTEOUV>2.0.CO;2; Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; BOND G, 2001, SCIENCE         1115; BRAZIUNAS TF, 1995, GLOBAL BIOGEOCHEM CY, V9, P565, DOI 10.1029/95GB01725; BRIFF AKR, 2001, J GEOPHYS RES, V106, P2929; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; HESSHAIMER V, 1997, THESIS U HEIDELBERG; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; KROMER B, 1993, RADIOCARBON, V35, P125, DOI 10.1017/S0033822200013862; KROMER B, 1992, RADIOCARBON AFTER FOUR DECADES, P184; Kuniholm PI, 1996, NATURE, V381, P780, DOI 10.1038/381780a0; Lamb H. H., 1995, CLIMATE HIST MODERN; Lean J, 1998, J CLIMATE, V11, P3069, DOI 10.1175/1520-0442(1998)011<3069:CFBCSR>2.0.CO;2; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Manning S. W., 1999, TEST TIME VOLCANO TH; Manning SW, 2001, SCIENCE, V294, P2532, DOI 10.1126/science.1066112; Masarik J, 1999, J GEOPHYS RES-ATMOS, V104, P12099, DOI 10.1029/1998JD200091; McCormac FG, 1995, RADIOCARBON, V37, P395, DOI 10.1017/S0033822200030873; NESMERIBES E, 1994, NATO ASI SER, V1, P71; PEARSON GW, 1993, RADIOCARBON, V35, P25, DOI 10.1017/S0033822200013795; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Shindell DT, 2001, J GEOPHYS RES-ATMOS, V106, P7193, DOI 10.1029/2000JD900547; SPURK M, 1998, RADIOCARBON, V40, P1; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; STUIVER M, 1980, SCIENCE, V207, P11, DOI 10.1126/science.207.4426.11; Stuiver M, 1998, GEOPHYS RES LETT, V25, P329, DOI 10.1029/97GL03694; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; van Loon H, 1998, J CLIMATE, V11, P1529, DOI 10.1175/1520-0442(1998)011<1529:TGROTS>2.0.CO;2; VOGEL JC, 1993, RADIOCARBON, V35, P73, DOI 10.1017/S0033822200013825	32	62	62	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2529	2532		10.1126/science.1066114	http://dx.doi.org/10.1126/science.1066114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11743160				2022-12-01	WOS:000172927700053
J	Lemon, B; Inouye, C; King, DS; Tjian, R				Lemon, B; Inouye, C; King, DS; Tjian, R			Selectivity of chromatin-remodelling cofactors for ligand-activated transcription	NATURE			English	Article							IN-VITRO; GLUCOCORTICOID RECEPTOR; COMPLEX; COACTIVATOR; BINDING; ACETYLATION; ENHANCEMENT; REQUIRES; FAMILY; GENES	An array of regulatory protein and multi-subunit cofactors has been identified(1) that directs eukaryotic gene transcription. However, establishing the specific functions of various related cofactors has been difficult owing to the limitations inherent in assaying transcription in animals and cells indirectly. Here we describe, using an integrated chromatin-dependent reconstituted transcription reaction, the purification and identification of a multi-subunit cofactor (PBAF)(2) that is necessary for ligand-dependent transactivation by nuclear hormone receptors. A highly related cofactor, human SWI/SNF3, and the ISWI-containing chromatin-remodelling complex ACF(4) both fail to potentiate transcription. We also show that transcriptional activation mediated by nuclear hormone receptors requires TATA-binding protein (TBP)-associated factors (TAFs) as well as the multi-subunit cofactors ARC(5)/CRSP6. These studies demonstrate functional selectivity amongst highly related complexes involved in gene regulation and help define a more complete set of factors and cofactors required to activate transcription.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.							Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kal AJ, 2000, GENE DEV, V14, P1058; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	30	207	213	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					924	928		10.1038/414924a	http://dx.doi.org/10.1038/414924a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780067				2022-12-01	WOS:000172813300050
J	Kagawa-Singer, M; Blackhall, LJ				Kagawa-Singer, M; Blackhall, LJ			Negotiating cross-cultural issues at the end of life - "You got to go where he lives"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RACIAL-DIFFERENCES; DECISION-MAKING; HEALTH-CARE; CANCER; ATTITUDES; ETHNICITY; BLACK; PHYSICIANS; RACE; PREFERENCES	Culture fundamentally shapes how individuals make meaning out of illness, suffering, and dying. With increasing diversity in the United States, encounters between patients and physicians of different backgrounds are becoming more common. Thus the risk for cross-cultural misunderstandings surrounding care at the end of life is also increasing. Studies have shown cultural differences in attitudes toward truth telling, life-prolonging technology, and decision-making styles at the end of life. Using 2 case studies of patients, one of an African American couple in the southern United States and the other of a Chinese-American family in Hawaii, we outline some of the major issues involved in cross-cultural care and indicate how the patient, family, and clinician can navigate among differing cultural beliefs, values, and practices. Skilled use of cross-cultural understanding and communication techniques increases the likelihood that both the process and outcomes of care are satisfactory for all involved.	Univ Calif Los Angeles, Sch Publ Hlth & Asian Amer Studies, Los Angeles, CA 90095 USA; Univ Virginia, Ctr Palliat Care & Res, Charlottesville, VA USA; Univ Virginia, Ctr Biomed Eth, Charlottesville, VA USA	University of California System; University of California Los Angeles; University of Virginia; University of Virginia	Kagawa-Singer, M (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth & Asian Amer Studies, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.		Wang, Zi Dan/GZH-3012-2022					ABRAHAM J, 2000, PHYSICIANS GUIDE PAI; ANNAS GJ, 1979, AM J LAW MED, V4, P367; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; BARKER JC, 1992, WESTERN J MED, V157, P248; BERLIN EA, 1983, WESTERN J MED, V139, P934; BEYENE Y, 1992, W J MED, P328; Blackhall LJ, 2001, J URBAN HEALTH, V78, P59, DOI 10.1093/jurban/78.1.59; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; Braun K. L, 2000, CULTURAL ISSUES END; BUCHMAN R, 1992, BREAK BAD NEWS; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Chadwick G L, 1997, J Int Assoc Physicians AIDS Care, V3, P27; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Clinton WJ., 2000, OFF PRES FED REGIST, V65, P67249; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; *COUNC EC ADV, 1997, CHANG AM IND SOC EC, P40; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; CRAWLEY L, 2001, INNOVATIONS END LIFE; CRAWLEY L, 2001, RESPECTING CULTURAL; DALLAVORGIA P, 1992, J MED ETHICS, V18, P67, DOI 10.1136/jme.18.2.67; Dana R., 1993, MULTICULTURAL ASSESS; DAVIDSON MN, 1991, TRANSPLANT P, V23, P2531; DEVORE W, 1990, SOCIAL WORK PRACTICE; EMANUEL LL, 1993, HASTINGS CENT REP, V23, P6, DOI 10.2307/3562059; Emanuel LL, 2000, ARCH FAM MED, V9, P1181, DOI 10.1001/archfami.9.10.1181; Ersek M, 1998, Oncol Nurs Forum, V25, P1683; Fadiman A, 1997, SPIRIT CATCHES YOU Y; Fang J, 1996, NEW ENGL J MED, V335, P1545, DOI 10.1056/NEJM199611213352101; Fielding R, 1996, PSYCHO-ONCOL, V5, P321, DOI 10.1002/(SICI)1099-1611(199612)5:4<321::AID-PON226>3.0.CO;2-K; Francis CK, 2001, J NATL MED ASSOC, V93, P157; FRIEDMAN L C, 1988, Journal of Psychosocial Oncology, V6, P75; Gilbert Daniel Todd, 1998, HDB SOCIAL PSYCHOL, V2; Hallowell AI, 1955, CULTURE EXPERIENCE; Haynes MA, 1999, UNEQUAL BURDEN CANC; Hern HE, 1998, CAMB Q HEALTHC ETHIC, V7, P27, DOI 10.1017/S0963180198701045; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; IRISH D, 1993, ETHNIC VARIATIONS; Ishii S., 1984, CROSS CURR, V11, P49; Kagawa-Singer M., 1994, GERONTOLOGY GERIATRI, V15, P101; KAGAWASINGER M, 1994, J COMMUNITY PSYCHOL, P192; KATON W, 1980, WESTERN J MED, V133, P9; Kim MS, 1996, COMMUN MONOGR, V63, P29, DOI 10.1080/03637759609376373; Kleinman A., 1988, ILLNESS NARRATIVES S; Kleinman A., 1981, PATIENTS HEALERS CON; KOENIG BA, 1995, WESTERN J MED, V163, P244; KOENIG BA, 1993, I MED WORKSH DYING D; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lebra T.S., 1976, JAPANESE PATTERNS BE; LIKE RC, 2000, PATIENT CARE, P189; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Morrison RS, 1998, ARCH INTERN MED, V158, P2493, DOI 10.1001/archinte.158.22.2493; Mouton C., 2000, CULTURAL ISSUES END, P71; MULLER JH, 1992, WESTERN J MED, V157, P323; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, P250; *NAT BIOETH ADV CO, 2001, ENS VOL INF CONS PRO, P103; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.1979.03290350017012; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V263, P2344; PARRY JK, 1990, SOCIAL WORK PRACTICE; Paul Benjamin, 1955, HLTH CULTURE COMMUNI; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; ROTHENBERG LS, 1996, ANN REV LAW ETHICS, V4, P335; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Stuart M., 1993, 15 MINUTE HOUR APPL; Surbone A, 2000, ANN NY ACAD SCI, V913, P52; Takayama T, 2001, SOC SCI MED, V53, P1335, DOI 10.1016/S0277-9536(00)00413-5; THOMSEN OO, 1993, LANCET, V341, P473, DOI 10.1016/0140-6736(93)90218-6; Tong K L, 1994, J Palliat Care, V10, P26; Uba L., 1994, ASIAN AM PERSONALITY; Veatch, 2000, CROSS CULTURAL PERSP; Wellisch D, 1999, PSYCHO-ONCOL, V8, P207, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<207::AID-PON357>3.0.CO;2-B; YEO G, 2000, CULTURAL ISSUES END, P356; ZANE N, IN PRESS ASIAN AM ME	80	368	369	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					2993	3001		10.1001/jama.286.23.2993	http://dx.doi.org/10.1001/jama.286.23.2993			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502VY	11743841				2022-12-01	WOS:000172764500032
J	Joutel, A; Favrole, P; Labauge, P; Chabriat, H; Lescoat, C; Andreux, F; Domenga, V; Cecillon, M; Vahedi, K; Ducros, A; Cave-Riant, F; Bousser, MG; Tournier-Lasserve, E				Joutel, A; Favrole, P; Labauge, P; Chabriat, H; Lescoat, C; Andreux, F; Domenga, V; Cecillon, M; Vahedi, K; Ducros, A; Cave-Riant, F; Bousser, MG; Tournier-Lasserve, E			Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis	LANCET			English	Article								CADASIL (cerebral autosomal dominant arteriopathy with subcortical Infarcts and leucoencephalopathy) Is a small-artery disease of the brain caused by NOTCH3 mutations that lead to an abnormal accumulation of NOTCH3 within the vasculature. We aimed to establish whether immunostaining skin biopsy samples with a monoclonal antibody specific for NOTCH3 could form the basis of a reliable and easy diagnostic test. We compared the sensitivity and specificity of this method In two groups of patients suspected of having CADASIL with complete scanning of mutation-ca using exons of NOTCH3 (in a retrospective series of 39 patients) and with limited scanning of four exons that are mutation hotspots (prospective series of 42 patients). In the retrospective series skin biopsy was positive in 21 (96%) of the 22 CADASIL patients examined and negative In all others; In the prospective series, seven of the 42 patients had a positive skin biopsy whereas only four had a mutation detected by limited NOTCH3 scanning. Our Immunostaining technique Is highly sensitive (96%) and specific (100%) for diagnosis of CADASIL.	Fac Med Lariboisiere, INSERM, F-75010 Paris, France; Hop Lariboisiere, Lab Cytogenet, F-75475 Paris, France; Cent Hosp Univ Caremeau, Serv Neurol, Nimes, France; Hop Lariboisiere, Serv Neurol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Joutel, A (corresponding author), Fac Med Lariboisiere, INSERM, EPI 99-21,10 Ave Verdun, F-75010 Paris, France.		Tournier-Lasserve, Elisabeth/N-7134-2017; DUCROS, Anne/D-1899-2010; Joutel, Anne/K-5601-2017; Chabriat, Hugues/G-5699-2010	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; DUCROS, Anne/0000-0001-5560-5013; Joutel, Anne/0000-0003-3963-3860; Chabriat, Hugues/0000-0001-8436-6074				BAUDRIMONT M, 1998, NEUROPATHOL APPL NEU, V24, P148; Joutel A, 2000, ANN NEUROL, V47, P388, DOI 10.1002/1531-8249(200003)47:3<388::AID-ANA19>3.0.CO;2-Q; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500	5	161	180	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2049	2051		10.1016/S0140-6736(01)07142-2	http://dx.doi.org/10.1016/S0140-6736(01)07142-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755616				2022-12-01	WOS:000172722800017
J	Heard, E; Rougeulle, C; Arnaud, D; Avner, P; Allis, CD; Spector, DL				Heard, E; Rougeulle, C; Arnaud, D; Avner, P; Allis, CD; Spector, DL			Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation	CELL			English	Article							XIST RNA; DOSAGE COMPENSATION; H4 ACETYLATION; GENE; CHROMATIN; HYPOACETYLATION; INITIATION; MACROH2A1; PROMOTER; COMPLEX	Coating of the X chromosome by Xist RNA is an essential trigger for X inactivation. However, little is known about the early chromatin remodeling events: that transform this signal into transcriptional silencing. Here we report that methylation of histone H3 lysine 9 on the inactive X chromosome occurs immediately after Xist RNA coating and before transcriptional inactivation of X-linked genes. X-chromosomal H3 Lys-9 methylation occurs during the same window of time as H3 Lys-9 hypoacetylation and H3 Lys-4 hypomethylation. Histone H3 modifications thus represent the earliest known chromatin changes during X inactivation. We also identify a unique "hotspot" of H3 Lys-9 methylation 5' to Xist, and we propose that this acts as a nucleation center for Xist RNA-dependent spread of inactivation along the X chromosome via H3 Lys-9 methylation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Inst Pasteur, F-75724 Paris 15, France; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Virginia	Heard, E (corresponding author), Inst Curie, CNRS, UMR 218, 26 Rue Ulm, F-75248 Paris 05, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Rougeulle, Claire/0000-0003-3861-4940	NIGMS NIH HHS [GM42694, R01 GM042694, GM53512] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R01GM042694, R37GM053512] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BOGGS BA, 2001, IN PRESS NAT GENET; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Heard E, 1999, MOL CELL BIOL, V19, P3156; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hogan B., 2014, MANIPULATING MOUSE E; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCBURNEY MW, 1988, BIOESSAYS, V9, P85, DOI 10.1002/bies.950090211; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RIGGS AD, 1985, BIOCH BIOL DNA METHY, P211; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Smith AG., 1991, J TISSUE CULTURE MET, V13, P89, DOI [DOI 10.1007/BF01666137, 10.1007/BF01666137, 10.1007/bf01666137]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	46	401	412	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					727	738		10.1016/S0092-8674(01)00598-0	http://dx.doi.org/10.1016/S0092-8674(01)00598-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747809				2022-12-01	WOS:000172771800006
J	Navarro, M; Gull, K				Navarro, M; Gull, K			A pol I transcriptional body associated with VSG mono-allelic expression in Trypanosoma brucei	NATURE			English	Article							VARIANT SURFACE GLYCOPROTEIN; AMANITIN-RESISTANT TRANSCRIPTION; GENE-EXPRESSION; AFRICAN TRYPANOSOMES; RNA; SITES; DIFFERENTIATION; VISUALIZATION; LOCALIZATION; ORGANIZATION	In the mammalian host, African trypanosomes generate consecutive waves of parasitaemia by changing their antigenic coat. Because this coat consists of a single type of variant surface glycoprotein (VSG), the question arises of how a trypanosome accomplishes the transcription of only one of a multi-allelic family of VSG expression site loci to display a single VSG type on the surface at any one time(1). No major differences have been detected between the single active expression site and the cohort of inactive expression sites(2). Here we identify an extranucleolar body containing RNA polymerase I (pol I) that is transcriptionally active and present only in the bloodstream form of the parasite. Visualization of the active expression site locus by tagging with green fluorescent protein(3) shows that it is specifically located at this unique pol I transcriptional factory. The presence of this transcriptional body in postmitotic nuclei and its stability in the nucleus after DNA digestion provide evidence for a coherent structure. We propose that the recruitment of a single expression site and the concomitant exclusion of inactive loci from a discrete transcriptional body define the mechanism responsible for VSG mono-allelic expression.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Navarro, M (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		Navarro, Miguel/C-3685-2009	Navarro, Miguel/0000-0003-2301-2699				Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Borst P, 1999, TRENDS GENET, V15, P95, DOI 10.1016/S0168-9525(98)01680-1; Chaves I, 1998, P NATL ACAD SCI USA, V95, P12328, DOI 10.1073/pnas.95.21.12328; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; HARTSHORNE T, 1993, MOL CELL BIOL, V13, P144, DOI 10.1128/MCB.13.1.144; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Laufer G, 1999, MOL CELL BIOL, V19, P5466; MATTHEWS KR, 1994, J CELL BIOL, V125, P1147, DOI 10.1083/jcb.125.5.1147; Navarro M, 1996, MOL CELL BIOL, V16, P3615; Navarro M, 1998, MOL BIOCHEM PARASIT, V94, P53, DOI 10.1016/S0166-6851(98)00049-8; Navarro M, 1999, EMBO J, V18, P2265, DOI 10.1093/emboj/18.8.2265; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; RUDENKO G, 1992, NUCLEIC ACIDS RES, V20, P303, DOI 10.1093/nar/20.2.303; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZOMERDIJK JCBM, 1991, NATURE, V353, P772, DOI 10.1038/353772a0; ZOMERDIJK JCBM, 1990, EMBO J, V9, P2791, DOI 10.1002/j.1460-2075.1990.tb07467.x	30	247	247	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					759	763		10.1038/414759a	http://dx.doi.org/10.1038/414759a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742402				2022-12-01	WOS:000172676200050
J	Shaffer, LG; Heilstedt, HA				Shaffer, LG; Heilstedt, HA			Terminal deletion of 1p36	LANCET			English	Article									Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, Houston, TX 77030 USA	Baylor College of Medicine	Shaffer, LG (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, 1 Baylor Plaza,Room S801, Houston, TX 77030 USA.	lshaffer@bcm.tmc.edu							0	27	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S9	S9		10.1016/S0140-6736(01)07022-2	http://dx.doi.org/10.1016/S0140-6736(01)07022-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784558	Bronze			2022-12-01	WOS:000172907200009
J	Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M				Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M			Varicella disease after introduction of varicella vaccine in the United States, 1995-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTLICENSURE; IMMUNIZATION; SAFETY; SURVEILLANCE; EPIDEMIOLOGY; CHICKENPOX; LICENSURE	Context Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11000 hospitalizations, and 100 deaths every year. Objective To examine population-based disease surveillance data in 3 communities to document the impact of the varicella vaccination program. Design, Setting, and Subjects Active surveillance for varicella conducted among the populations of Antelope Valley, Calif; Travis County, Tex; and West Philadelphia, Pa; from January 1, 1995, to December 31, 2000. Reporting sites included child care centers, schools, universities, physicians, public health clinics, hospitals, emergency departments, and households. Main Outcome Measures Trends in number and rate of varicella cases and hospitalizations; varicella vaccine coverage. Results From 1995 through 1998, in each surveillance area, the number of verified varicella cases varied from year to year with marked springtime seasonality. In 1999, the number and rates of varicella cases and hospitalizations declined markedly. From 1995 through 2000, in Antelope Valley, Travis County, and West Philadelphia, varicella cases declined 71%, 84%, and 79%, respectively. Cases declined to the greatest extent among children aged 1 to 4 years, but cases declined in all age groups, including infants and adults. In the combined 3 surveillance areas, hospitalizations due to varicella declined from a range of 2.7 to 4.2 per 100000 population in 1995 through 1998 to 0.6 and 1.5 per 100000 population in 1999 and 2000, respectively (P=.15). By 2000, vaccine coverage among children aged 19 to 35 months was 82.1%, 73.6%, and 83.8% in Los Angeles County, Texas, and Philadelphia County, respectively. Conclusions Varicella disease has declined dramatically in surveillance areas with moderate vaccine coverage. Continued implementation of existing vaccine policies should lead to further reductions of varicella disease in these communities and throughout the United States.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Philadelphia Dept Publ Hlth, Philadelphia, PA USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Texas Department of State Health Services	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov	Goldman, Gary/D-1131-2016; Goldman, Gary/AAD-6289-2021	Goldman, Gary/0000-0002-6039-3921				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Black S, 1999, PEDIATR INFECT DIS J, V18, P1041, DOI 10.1097/00006454-199912000-00003; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; *CDCP, 1997, MMWR-MORBID MORTAL W, V47, P944; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P365; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P55; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P637; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P657; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P409; Chen RT, 1996, EPIDEMIOL REV, V18, P99, DOI 10.1093/oxfordjournals.epirev.a017931; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Comm Infect Dis, 2000, PEDIATRICS, V105, P136; Deguen S, 1998, J EPIDEMIOL COMMUN H, V52, p46S; FREED GL, 1994, PEDIATRICS, V93, P747; GALIL K, 2000, JOINT M PED AC SOC A; Gershon A, 1998, ARCH DIS CHILD, V79, P470, DOI 10.1136/adc.79.6.470; GORDON JE, 1962, AM J MED SCI, V244, P362, DOI 10.1097/00000441-196209000-00013; GUESS HA, 1986, PEDIATRICS, V78, P723; HALL CB, 1995, PEDIATRICS, V95, P791; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; PETERSON CL, 1997, 37 INT C ANT AG CHEM, P233; Plotkin SA, 1996, PEDIATRICS, V97, P251; Schaffer SJ, 1999, ARCH PEDIAT ADOL MED, V153, P357; Shapiro ED, 1997, JAMA-J AM MED ASSOC, V278, P1529, DOI 10.1001/jama.278.18.1529; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; SMITH PJ, 2001, AM J PREV MED, V20, P61; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; 1968, N ENGL J MED, V278, P275	37	380	406	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					606	611		10.1001/jama.287.5.606	http://dx.doi.org/10.1001/jama.287.5.606			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829699	Bronze			2022-12-01	WOS:000173686700029
J	van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH				van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH			Gene expression profiling predicts clinical outcome of breast cancer	NATURE			English	Article							SPORADIC BREAST; BRCA1; PATTERNS; TUMORS	Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour(1-3). Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however 70-80% of patients receiving this treatment would have survived without it(4,5). None of the signatures of breast cancer gene expression reported to date(6-12) allow for patient-tailored therapy strategies. Here we used DNA microarray analysis supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases ('poor prognosis' signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.	Rosetta Inpharmat, Kirkland, WA 98034 USA; Netherlands Canc Inst, Div Diagnost Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Merck & Company; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Friend, SH (corresponding author), Rosetta Inpharmat, 12040 115th Ave NE, Kirkland, WA 98034 USA.			van de Vijver, Marc/0000-0002-0385-4787; Bernards, Rene/0000-0001-8677-3423				Abe O, 1998, LANCET, V352, P930; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Clarke M, 1998, LANCET, V351, P1451; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Gruvberger S, 2001, CANCER RES, V61, P5979; He YDD, 2001, NAT MED, V7, P658, DOI 10.1038/89022; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Janicke F, 2001, J NATL CANCER I, V93, P913, DOI 10.1093/jnci/93.12.913; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Martin K, 2000, CANCER RES, V60, P2232; MCGUIRE WL, 1991, J NATL CANCER I, V83, P154, DOI 10.1093/jnci/83.3.154; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 1998, BREAST CANCER RES TR, V52, P17, DOI 10.1023/A:1006102916060; vanDiest PJ, 1997, AM J PATHOL, V150, P705; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	26	6991	7388	13	793	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					530	536		10.1038/415530a	http://dx.doi.org/10.1038/415530a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823860	Green Published			2022-12-01	WOS:000173564300048
J	Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H				Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H			Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity	SCIENCE			English	Article							ACETYLCHOLINE-RELEASE; DENDRITIC TRANSPORT; PROTEIN-SYNTHESIS; STRESS; RESPONSES; TRANSCRIPTS; EXPRESSION; STABILITY; MEMORY; SITES	To explore neuronal mechanisms underlying long-term consequences of stress, we studied stress-induced changes in the neuritic translocation of acetylcholinesterase (AChE) splice variants. Under normal conditions, we found the synaptic AChE-S mRNA and protein in neurites, Corticosterone, anticholinesterases, and forced swim, each facilitated a rapid (minutes), yet long-lasting (weeks), shift from AChE-S to the normally rare AChE-R mRNA, promoted AChE-R mRNA translocation into neurites, and induced enzyme secretion, Weeks after stress, electrophysiological measurements in hippocampus slices displayed apparently normal evoked synaptic responses but extreme hypersensitivity to both anticholinesterases and atropine. Our findings suggest that neuronal hypersensitivity under stress involves neuritic replacement of AChE-S with AChE-R.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Eric Roland Ctr Neurodegenerat Dis, IL-91904 Jerusalem, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	soreq@shum.huji.ac.il	Gazit, Roi/J-3352-2017; Pavlovsky, Lev/AAD-1348-2021; Ben-Arie, Nissim/K-4997-2012	Meshorer, Eran/0000-0003-4777-986X; Gazit, Roi/0000-0002-0548-2147; Pavlovsky, Lev/0000-0001-8400-9587; Soreq, Hermona/0000-0002-0955-526X				Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Chan RYY, 1998, J BIOL CHEM, V273, P9727, DOI 10.1074/jbc.273.16.9727; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DAVIS L, 1990, J NEUROSCI, V10, P3056; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Foster JA, 1996, J NEUROSCI RES, V46, P652; Friedman A, 1998, J PHYSIOLOGY-PARIS, V92, P329, DOI 10.1016/S0928-4257(98)80042-9; Galyam N, 2001, ANTISENSE NUCLEIC A, V11, P51, DOI 10.1089/108729001750072128; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; IMPERATO A, 1991, BRAIN RES, V538, P111, DOI 10.1016/0006-8993(91)90384-8; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Luo ZD, 1999, MOL PHARMACOL, V56, P886, DOI 10.1124/mol.56.5.886; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mezey G, 2001, BRIT MED J, V323, P561, DOI 10.1136/bmj.323.7312.561; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Shapira M, 2000, HUM MOL GENET, V9, P1273, DOI 10.1093/hmg/9.9.1273; SOREQ H, 1984, EMBO J, V3, P1371, DOI 10.1002/j.1460-2075.1984.tb01979.x; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wallace CS, 1998, J NEUROSCI, V18, P26; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	30	196	206	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					508	512		10.1126/science.1066752	http://dx.doi.org/10.1126/science.1066752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799248				2022-12-01	WOS:000173350700054
J	Sturm, R; Gresenz, CR				Sturm, R; Gresenz, CR			Relations of income inequality and family income to chronic medical conditions and mental health disorders: national survey in USA	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CIVIL-SERVANTS; MORTALITY; DETERMINANTS; DESIGN; CARE	Objectives To analyse the relation between geographical inequalities in income and the prevalence of common chronic medical conditions and mental health disorders, and to compare it with the relation between family income mid these health problems. Design Nationally representative household telephone survey conducted in 1997-8. Setting 60 metropolitan areas or economic areas of the United States. Participants 9585 adults who participated in the community tracking study. Main outcome measures Self report of 17 common chronic medical conditions; current depressive disorder or anxiety disorder assessed by clinical screeners. Results A strong continuous association was seen between health and education or family income. No relation was found between income inequality and the prevalence of chronic medical problems or depressive disorders and anxiety disorders, either across the whole population or among poorer people. Only self reported overall health, the measure used in previous studies, was significantly correlated with inequality at the population level, but this correlation disappeared after adjustment for individual characteristics. Conclusions This study provides no evidence for the hypothesis that income inequality is a major risk factor for common disorders of physical or mental health.	RAND Corp, Santa Monica, CA 90401 USA; RAND Corp, Arlington, VA 22202 USA	RAND Corporation; RAND Corporation	Sturm, R (corresponding author), RAND Corp, 1700 Main St, Santa Monica, CA 90401 USA.	sturm@rand.org			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062124] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH062124, R01-MH62124] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cowell F.A., 1977, MEASURING INEQUALITY; Daly MC, 1998, MILBANK Q, V76, P315, DOI 10.1111/1468-0009.00094; Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724; Fiscella K, 2000, HEALTH SERV RES, V35, P307; FLEGG AT, 1982, POP STUD-J DEMOG, V36, P441, DOI 10.2307/2174055; Jones A.F., 2000, CURRENT POPULATION R; Juster FT, 1997, J AM STAT ASSOC, V92, P1268, DOI 10.2307/2965397; Kahn RS, 2000, BRIT MED J, V321, P1311, DOI 10.1136/bmj.321.7272.1311; KAHN RS, 2000, BRIT MED J, V32, P1311; Kaplan GA, 1996, BRIT MED J, V312, P999; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kennedy BP, 1998, BRIT MED J, V317, P917; Kessler R.C., 1998, INT J METH PSYCH RES, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Mellor JM, 2001, J HEALTH POLIT POLIC, V26, P487, DOI 10.1215/03616878-26-3-487; MELLOR JM, IN PRESS J HUM RESOU; RODGERS GB, 1979, POP STUD-J DEMOG, V33, P343, DOI 10.2307/2173539; Sen A., 1973, EC INEQUALITY; Soobader MJ, 1999, SOC SCI MED, V48, P733, DOI 10.1016/S0277-9536(98)00401-8; Sturm R, 1999, INQUIRY-J HEALTH CAR, V36, P221; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weich S, 2001, BRIT J PSYCHIAT, V178, P222, DOI 10.1192/bjp.178.3.222; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; Wilkinson RG., 1996, UNHEALTHY SOC AFFLIC; World Health Organization, 1995, COMP INT DIAGN INT V	31	148	151	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2002	324	7328					20	+		10.1136/bmj.324.7328.20	http://dx.doi.org/10.1136/bmj.324.7328.20			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510JV	11777799	Bronze, Green Published			2022-12-01	WOS:000173205700018
J	Wang, W; Thornton, K; Berry, A; Long, MY				Wang, W; Thornton, K; Berry, A; Long, MY			Nucleotide variation along the Drosophila melanogaster fourth chromosome	SCIENCE			English	Article							DNA POLYMORPHISM; SELECTION; DIVERGENCE; PATTERNS; COMPLEX; MODEL; GENES	The Drosophila melanogaster fourth chromosome, believed to be nonrecombining and invariable, is a classic example of the effect of natural selection in eliminating genetic variation in linked loci. However, in a chromosome-wide assay of nucleotide variation in natural populations, we have observed a high level of polymorphism in a similar to 200-kilobase region and marked levels of polymorphism in several other fragments interspersed with regions of little variation, suggesting different evolutionary histories in different chromosomal domains. Statistical tests of neutral evolution showed that a few haplotypes predominate in the 200-kilobase polymorphic region. Finally, contrary to the expectation of no recombination, we identified six recombination events within the chromosome. Thus, positive Darwinian selection and recombination have affected the evolution of this chromosome.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Chicago; University of Chicago; Harvard University	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Wang, Wei/B-5617-2019; Wang, Wen/AAP-9873-2020	Wang, Wen/0000-0002-7801-2066; Thornton, Kevin/0000-0003-0743-4445				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2000, GENETICS, V156, P257; Ashburner M., 1989, LAB HDB; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1992, NATURE, V356, P475, DOI 10.1038/356475a0; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Dobzhansky T, 1943, GENETICS, V28, P162; Freeman S, 1998, EVOLUTIONARY ANAL; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1985, GENETICS, V111, P147; Kimura M., 1983, NEUTRAL THEORY MOL E; KREITMAN M, 1991, GENETICS, V127, P565; MAYANRDSMITH J, 1976, GENET RES, V23, P23; Nurminsky D, 2001, SCIENCE, V291, P128, DOI 10.1126/science.291.5501.128; Powell J.R., 1997, PROGR PROSPECTS EVOL; TAJIMA F, 1989, GENETICS, V123, P585; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413	24	66	74	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					134	137		10.1126/science.1064521	http://dx.doi.org/10.1126/science.1064521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778050				2022-12-01	WOS:000173143100051
J	Meden, T; St John-Larkin, C; Hermes, D; Sommerschield, S				Meden, T; St John-Larkin, C; Hermes, D; Sommerschield, S			Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSERVING SURGERY; PATIENT; WOMEN		Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Meden, T (corresponding author), Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA.							ABE O, 1995, NEW ENGL J MED, V333, P1444; Albain KS, 1996, J CLIN ONCOL, V14, P3009, DOI 10.1200/JCO.1996.14.11.3009; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Kotwall CA, 1996, ANN SURG, V224, P419, DOI 10.1097/00000658-199610000-00001; Lazovich D, 1997, ARCH SURG-CHICAGO, V132, P418; SAMET JM, 1994, CANCER, V73, P2344, DOI 10.1002/1097-0142(19940501)73:9<2344::AID-CNCR2820730917>3.0.CO;2-V; Stafford D, 1998, AM J SURG, V176, P515, DOI 10.1016/S0002-9610(98)00257-8	7	72	72	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					111	111		10.1001/jama.287.1.111	http://dx.doi.org/10.1001/jama.287.1.111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754721	hybrid			2022-12-01	WOS:000172978500037
J	Lee, SH; Fu, KK; Hui, JN; Richman, JM				Lee, SH; Fu, KK; Hui, JN; Richman, JM			Noggin and retinoic acid transform the identity of avian facial prominences	NATURE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; BONE MORPHOGENETIC PROTEIN-4; NEURAL CREST; CHICK-EMBRYOS; LIMB BUDS; SONIC HEDGEHOG; EXPRESSION; PRIMORDIA; OUTGROWTH; BMP-4	The signals that determine body part identity in vertebrate embryos are largely unknown, with some exceptions such as those for teeth and digits(1,2). The vertebrate face is derived from small buds of tissue, facial prominences, that surround the embryonic oral cavity(3). In chicken embryos, the skeleton of the upper beak is derived from the frontonasal mass and maxillary prominences(4). Here we show that bone morphogenetic proteins (Bmps) and the vitamin A derivative, retinoic acid (RA), are used to specify the identity of the frontonasal mass and maxillary prominences. Implanting two beads adjacent to the stage-15 presumptive maxillary field, one soaked in the Bmp antagonist Noggin(5) and one soaked in RA, induces a duplicate set of frontonasal mass skeletal elements in place of maxillary bones. We also show that the duplicated beak is due to transformation of the maxillary prominence into a second frontonasal mass and not due to ectopic migration of cells or splitting of the normal frontonasal mass. Thus the levels of Bmp and RA determine whether specific regions of the face form maxillary or frontonasal mass derivatives.	Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; Gyeongsang Natl Univ, Coll Med, Dept Dent, Chinju, South Korea	University of British Columbia; Gyeongsang National University	Richman, JM (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada.		Richman, Joy M./C-3111-2018; Richman, Joy/AAD-9445-2020	Richman, Joy M./0000-0002-1409-8163; Richman, Joy/0000-0002-1409-8163; /0000-0002-9438-2489				Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Barlow AJ, 1997, DEVELOPMENT, V124, P391; BROWN JM, 1993, DEVELOPMENT, V119, P41; Couly G, 1998, DEVELOPMENT, V125, P3445; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; EICHELE G, 1984, ANAL BIOCHEM, V142, P542, DOI 10.1016/0003-2697(84)90504-9; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FRANCISWEST PH, 1994, DEV DYNAM, V201, P168, DOI 10.1002/aja.1002010207; Haeckel E., 1886, EVOLUTION MAN POPULA; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu D, 1999, DEVELOPMENT, V126, P4873; LELIEVRE CS, 1978, J EMBRYOL EXP MORPH, V47, P17; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; WALL NA, 1995, MECH DEVELOP, V53, P383, DOI 10.1016/0925-4773(95)00453-X; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	26	98	101	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					909	912		10.1038/414909a	http://dx.doi.org/10.1038/414909a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780063				2022-12-01	WOS:000172813300046
J	Karol, KG; McCourt, RM; Cimino, MT; Delwiche, CF				Karol, KG; McCourt, RM; Cimino, MT; Delwiche, CF			The closest living relatives of land plants	SCIENCE			English	Article							GREEN-ALGAE; MESOSTIGMA VIRIDE; PHYLOGENY; ULTRASTRUCTURE; CHAROPHYCEAE; BRYOPHYTES; SEQUENCES; CHARA	The embryophytes (land plants) have long been thought to be related to the green algal group Charophyta, though the nature of this relationship and the origin of the land plants have remained unresolved. A four-gene phytogenetic analysis was conducted to investigate these relationships. This analysis supports the hypothesis that the land plants are placed phylogenetically within the Charophyta, identifies the Charales (stoneworts) as the closest living relatives of plants, and shows the Coleochaetales as sister to this Charales/land plant assemblage. The results also support the unicellular flagellate Mesostigma as the earliest branch of the charophyte lineage. These findings provide insight into the nature of the ancestor of plants, and have broad implications for understanding the transition from aquatic green algae to terrestrial plants.	Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Acad Nat Sci Philadelphia, Dept Bot, Philadelphia, PA 19103 USA	University System of Maryland; University of Maryland College Park; Drexel University	Karol, KG (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.		Delwiche, Charles F/C-6549-2008	Delwiche, Charles F/0000-0001-7854-8584				[Anonymous], 1993, ORIGIN LAND PLANTS; Bhattacharya D, 1998, J MOL EVOL, V47, P544, DOI 10.1007/PL00006410; Bower F. O., 1908, ORIGIN LAND FLORA TH; CHAPMAN RL, 1998, SYSTEMATICS PLANTS, V2, P508; Cook ME, 1997, AM J BOT, V84, P1169, DOI 10.2307/2446040; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11, DOI [10.2307/4119796, DOI 10.2307/4119796]; Duncan TM, 1997, PLANT SYST EVOL, V204, P125, DOI 10.1007/BF00989201; Feist M, 1997, NATURE, V385, P401, DOI 10.1038/385401a0; Feist M., 1991, CALCAREOUS ALGAE STR, V11, P189, DOI [10.1007/978-3-642-52335-9, DOI 10.1007/978-3-642-52335-9]; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FRITSCH F.E., 1935, STRUCTURE REPROD ALG, V1; Graham L.E., 2016, ALGAE-SEOUL, V3; GRAHAM LE, 1991, ADV BRYOL, V4, P213; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUELSENBECK JP, 2001, HDB STAT GENETICS; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; LEMIEUX C, IN PRESS; Marin B, 1999, PROTIST, V150, P399, DOI 10.1016/S1434-4610(99)70041-6; Mattox K.R., 1984, SYSTEMATICS GREEN AL, P29, DOI 10.1017/S0024282985000482; McCourt RM, 2000, J PHYCOL, V36, P747, DOI 10.1046/j.1529-8817.2000.99106.x; MISHLER B D, 1985, Cladistics, V1, P305, DOI 10.1111/j.1096-0031.1985.tb00431.x; MISHLER BD, 1984, BRITTONIA, V36, P406, DOI 10.2307/2806602; PICKETTHEAPS JD, 1972, CYTOBIOS, V6, P255; SLUIMAN HJ, 1985, PLANT SYST EVOL, V149, P217, DOI 10.1007/BF00983308; Sluiman HJ, 1999, J PHYCOL, V35, P395, DOI 10.1046/j.1529-8817.1999.3520395.x; Tappan H, 1980, PALEOBIOLOGY PLANT P	27	428	467	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2351	2353		10.1126/science.1065156	http://dx.doi.org/10.1126/science.1065156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743201				2022-12-01	WOS:000172817200046
J	Winston, WM; Molodowitch, C; Hunter, CP				Winston, WM; Molodowitch, C; Hunter, CP			Systemic RNAi in C-elegans requires the putative transmembrane protein SID-1	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE	Double-stranded RNA-mediated gene interference (RNAi) in Caenorhabditis elegans systemically inhibits gene expression throughout the organism. To investigate how gene-specific silencing information is transmitted between cells, we constructed a strain that permits visualization of systemic RNAi. We used this strain to identify systemic RNA interference-deficient (sid) loci required to spread gene-silencing information between tissues but not to initiate or maintain an RNAi response. One of these loci, sid-1, encodes a conserved protein with predicted transmembrane domains. SID-1 is expressed in cells sensitive to RNAi, is localized to the cell periphery, and is required cell-autonomously for systemic RNAi.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hunter, CP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							BUCH JP, 1985, UROL CLIN N AM, V12, P3; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, PLANT MOL BIOL, V43, P285, DOI 10.1023/A:1006404016494; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marathe R, 2000, PLANT MOL BIOL, V43, P295, DOI 10.1023/A:1006456000564; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parrish S, 2001, RNA, V7, P1397; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; WINSTON WM, UNPUB	21	590	654	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2456	2459		10.1126/science.1068836	http://dx.doi.org/10.1126/science.1068836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11834782				2022-12-01	WOS:000174712600057
J	Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC				Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC			A basal troodontid from the Early Cretaceous of China	NATURE			English	Article							REPUBLIC-OF-CHINA; INNER-MONGOLIA; THEROPOD; DINOSAUR; BIRDS; SKULL	Troodontid dinosaurs form one of the most avian-like dinosaur groups(1-5). Their phylogenetic position is hotly debated, and they have been allied with almost all principal coelurosaurian lineages(6-13). Here we report a basal troodontid dinosaur, Sinovenator changii gen. et sp. nov., from the lower Yixian Formation of China. This taxon has several features that are not found in more derived troodontids, but that occur in dromaeosaurids and avialans. The discovery of Sinovenator and the examination of character distributions along the maniraptoran lineage indicate that principal structural modifications toward avians were acquired in the early stages of maniraptoran evolution.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xxu@midwest.com.cn						BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, J PALEONTOL, V70, P536; KURZANOV S M, 1976, Paleontologicheskii Zhurnal, P127; Li JL, 2001, CHINESE SCI BULL, V46, P782, DOI 10.1007/BF03187223; MAKIVICKY P, 1998, AM MUS NOVIT, P1; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Osmolska H., 1990, P259; Perle A., 1999, NEW MANIRAPTORAN THE; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Saurornithoididae BarsboldR., 1974, PALAENTOL POL, V30, P5; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Walker A., 1985, P123; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; XU X, 2000, SPECIAL PUBLICATION, P179; Xu Xing, 2000, Vertebrata Palasiatica, V38, P318	30	160	176	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					780	784		10.1038/415780a	http://dx.doi.org/10.1038/415780a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845206				2022-12-01	WOS:000173833900043
J	Gallivan, S; Utley, M; Treasure, T; Valencia, S				Gallivan, S; Utley, M; Treasure, T; Valencia, S			Booked inpatient admissions and hospital capacity: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							SYSTEM; DESIGN	Objectives To investigate the variability of patients' length of stay in intensive care after cardiac surgery. To investigate potential interactions between such variability, booked admissions, and capacity requirements. Design Mathematical modelling study using routinely collected data. Setting A cardiac surgery department. Source of data Hospital records of 7014 people entering intensive care after cardiac surgery. Main outcome measures Length of stay in intensive care; capacity requirements of an intensive care unit for a hypothetical booked admission system. Results Although the vast majority of patients (89.5%) had a length of stay in intensive care of less than or equal to48 hours, there was considerable overall variability and the distribution of stays has a lengthy tail. A mathematical model of the operation of a hypothetical booking system indicates that such variability has a considerable impact on intensive care capacity requirements, indicating that a high degree of reserve capacity is required to avoid high rates of operation cancellation because of unavailability of suitable postoperative care. Conclusion Despite the considerable enthusiasm for booked admissions systems, queuing theory suggests that caution is required when considering such systems for inpatient admissions. Such systems may Well result in frequent operational difficulties if there is a high degree of variability in length of stay and where reserve capacity is limited. Both of these are common in the NHS.	UCL, Clin Operat Res Unit, London WC1E 6BT, England; Guys Hosp, Cardiothorac Unit, London SE1 9RT, England; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Gallivan, S (corresponding author), UCL, Clin Operat Res Unit, Mortimer St, London WC1E 6BT, England.	s.gallivan@ucl.ac.uk		Utley, Martin/0000-0001-9928-1516				BAILEY NTJ, 1952, J ROY STAT SOC B, V14, P185; Goodyear OM., 1998, CURRENT PERSPECTIVES, P345; GOODYEAR OM, 1997, CURRENT PERSPECTIVES, P316; HARRIS RA, 1986, EUR J OPER RES, V25, P121, DOI 10.1016/0377-2217(86)90121-9; JACKSON RRP, 1964, OPER RES QUART, V15, P219, DOI 10.2307/3007209; KIPPING R, 2000, BOOKING PATIENTS HOS; Mackay M, 1999, Aust Health Rev, V22, P118; Millard PH, 2000, ANN ROY COLL SURG, V82, P75; VISSERS J, 1979, EUR J OPER RES, V3, P459, DOI 10.1016/0377-2217(79)90245-5; WORTHINGTON D, 1991, J OPER RES SOC, V42, P833, DOI 10.1057/jors.1991.164; WORTHINGTON DJ, 1987, J OPER RES SOC, V38, P413, DOI 10.1057/jors.1987.69	11	64	64	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					280	282		10.1136/bmj.324.7332.280	http://dx.doi.org/10.1136/bmj.324.7332.280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823362	Bronze, Green Published			2022-12-01	WOS:000173728300021
J	Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M				Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M			The changing epidemiology of rubella in the 1990s - On the verge of elimination and new challenges for control and prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WORKPLACE	Context In 1989, the United States established a goal to eliminate indigenous rubella and congenital rubella syndrome (CRS) by 2000. Reported rubella cases are at record low levels; however, cases and outbreaks have occurred, primarily among unvaccinated foreign-born adults. Objective To evaluate the current epidemiology of rubella and CRS and assess progress toward elimination. Design, Setting, and Subjects Analysis of rubella cases reported to the National Notifiable Diseases Surveillance System from 1990 through 1999 and CRS cases reported to the National Congenital Rubella Syndrome Registry from 1990 through 1999. Since 1996, US and international viral isolates have been sequenced. Main Outcome Measures incidence and characteristics of rubella and CRS cases; molecular typing of virus isolates. Results Annually from 1990 through 1999, the median number of reported rubella cases was 232 (range, 128-1412), and between 1992 and 1999, fewer than 300 rubella cases were reported annually, except in 1998. During the 1990s, the incidence of rubella in children younger than 15 years decreased (0.63 vs 0.06 per 100000 in 1990 vs 1999), whereas the incidence in adults aged 15 to 44 years increased (0.13 vs 0.24 per 100000). In 1992, incidence among Hispanics was 0.06 per 100000 and increased to a high in 1998 of 0.97 per 100000. From 1997 through 1999, 20 (83%) of 24 CRS infants were born to Hispanic mothers, and 21 (91%) of 23 CRS infants were born to foreign-born mothers. Molecular typing identified 3 statistically distinct genotypic groups. In group 1, the close relatedness of viruses suggests that a single imported source seeded an outbreak that did not spread beyond the Northeast. Similarly, within groups 2 and 3, relatedness of viruses obtained from clusters of cases suggests that single imported sources seeded each one. Diversity of viruses found in 1 state is consistent with the conclusion that several viruses were imported. Moreover, the similarity of viruses found across the country, combined with a lack of epidemiologic evidence of endemic transmission, support the conclusion that some viruses that are common abroad, particularly in Latin America and the Carribean, were introduced into the United States on several separate occasions. Conclusions The epidemiology of rubella and CRS has changed significantly in the last decade. These changes and molecular typing suggest that the United States is on the verge of elimination of the disease. To prevent future rubella outbreaks and CRS, current strategies must be enhanced and new strategies developed.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Georgia State Univ, Atlanta, GA 30303 USA; Emory Univ, Sch Publ Hlth, Atlanta, GA USA; Utah Dept Hlth, Salt Lake City, UT 84116 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; Emory University	Reef, SE (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,MS E-61, Atlanta, GA 30333 USA.	sreef@cdc.gov						*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P30; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P560; *CDCP, 1985, MMWR-MORBID MORTAL W, V34, P228; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P225; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1137; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P770; Centers for Disease Control and Prevention, 1980, MMWR-MORBID MORTAL W, V29, P517; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P57; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1247; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P615; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P173; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P349; Centers for Disease Control & Prevention, 1991, MMWR-MORBID MORTAL W, V40, P93; Danovaro-Holliday MC, 2000, JAMA-J AM MED ASSOC, V284, P2733, DOI 10.1001/jama.284.21.2733; DOUGHERTY N, 1995, IMMUNICATION ACTION, V1, P2; Frey TK, 1998, J INFECT DIS, V178, P642, DOI 10.1086/515370; GOODMAN AK, 1987, AM J PUBLIC HEALTH, V77, P725, DOI 10.2105/AJPH.77.6.725; LEE SH, 1992, JAMA-J AM MED ASSOC, V267, P2616, DOI 10.1001/jama.267.19.2616; LINDEGREN ML, 1991, EPIDEMIOL REV, V13, P341, DOI 10.1093/oxfordjournals.epirev.a036077; MELLINGER AK, 1995, PEDIATR INFECT DIS J, V14, P573, DOI 10.1097/00006454-199507000-00004; *NAT CTR HLTH STAT, 1997, HLTH PEOPL 1996 97 I; *PAN AM HLTH ORG, 2001, EPI NEWSLETTER, V23, P3; *PHS, 1991, US DEP HHS PHS PUBLI; Preblud S R, 1980, Epidemiol Rev, V2, P171; Rangel Maria C., 1999, Ethnicity and Disease, V9, P230; REEF S, 1999, MANUAL SURVEILLIANCE; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928	27	94	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					464	472		10.1001/jama.287.4.464	http://dx.doi.org/10.1001/jama.287.4.464			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798368	Bronze			2022-12-01	WOS:000173401900023
J	Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM				Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM			DREAM is a critical transcriptional repressor for pain modulation	CELL			English	Article							KAPPA-OPIOID RECEPTOR; LONG-LASTING ALLODYNIA; SPINAL-CORD NEURONS; DYNORPHIN-A; NEUROPATHIC PAIN; ADMINISTERED DYNORPHIN; PRODYNORPHIN GENE; RAT; NMDA; MECHANISMS	Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Ctr Study Pain, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada; NeuroDetect Inc, Lethbridge, AB T1K 3M4, Canada; Amgen Inc, Dept Pharmacol & Pathol, Thousand Oaks, CA 91320 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Amgen	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jpenning@amgen.com	Woodgett, Jim/F-1087-2010; Penninger, Josef M/I-6860-2013	Woodgett, Jim/0000-0003-3731-5797; Penninger, Josef M/0000-0002-8194-3777				AKIL H, 1976, SCIENCE, V191, P961, DOI 10.1126/science.1251210; Akil H, 1996, NIDA Res Monogr, V161, P127; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Appleyard SM, 1997, J NEUROCHEM, V69, P2405; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CAUDLE RM, 1994, J NEUROSCI, V14, P5580; Chen L, 1998, J PHARMACOL EXP THER, V284, P826; CHEN L, 1995, J NEUROSCI, V15, P4602; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; DawsonBasoa ME, 1996, PAIN, V64, P607, DOI 10.1016/0304-3959(96)87175-2; DICKENSON AH, 1991, BRIT MED BULL, V47, P690, DOI 10.1093/oxfordjournals.bmb.a072501; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GRUDT TJ, 1993, P NATL ACAD SCI USA, V90, P11429, DOI 10.1073/pnas.90.23.11429; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Ho J, 1997, J PHARMACOL EXP THER, V281, P136; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; Jevtovic-Todorovic V, 1998, BRAIN RES, V781, P202, DOI 10.1016/S0006-8993(97)01247-X; Jo DG, 2001, FASEB J, V15, P589; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; Lai SL, 1998, NEUROSCI LETT, V247, P115, DOI 10.1016/S0304-3940(98)00293-6; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; LUCAS JJ, 1993, NEURON, V10, P599, DOI 10.1016/0896-6273(93)90163-L; Lutfy K, 1997, PAIN, V70, P31, DOI 10.1016/S0304-3959(96)03290-3; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Mason DJ, 1999, EUR J PHARMACOL, V378, P237, DOI 10.1016/S0014-2999(99)00479-3; MESSERSMITH DJ, 1994, MOL CELL NEUROSCI, V5, P238, DOI 10.1006/mcne.1994.1028; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; RANDIC M, 1995, J NEUROSCI, V15, P6809; Rusin KI, 1997, J NEUROSCI, V17, P6565; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; Spreafico F, 2001, MOL CELL NEUROSCI, V17, P1, DOI 10.1006/mcne.2000.0913; Suzuki R, 1999, PAIN, V80, P215, DOI 10.1016/S0304-3959(98)00208-5; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; TanNo K, 1996, EUR J PHARMACOL, V314, P61, DOI 10.1016/S0014-2999(96)00518-3; Vaccarino AL, 2000, PEPTIDES, V21, P1975, DOI 10.1016/S0196-9781(00)00345-4; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wickenden AD, 1999, CIRC RES, V85, P1067; Wiley JW, 1997, J NEUROPHYSIOL, V77, P1338, DOI 10.1152/jn.1997.77.3.1338; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zachariou V, 1997, EUR J PHARMACOL, V323, P159, DOI 10.1016/S0014-2999(97)00038-1	58	225	242	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					31	43		10.1016/S0092-8674(01)00629-8	http://dx.doi.org/10.1016/S0092-8674(01)00629-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792319	Bronze			2022-12-01	WOS:000173280700006
J	Schwetz, BA				Schwetz, BA			Rheumatoid arthritis treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-01	WOS:000172978500006
J	Obernosterer, A; Aschauer, M; Schnedl, W; Lipp, RW				Obernosterer, A; Aschauer, M; Schnedl, W; Lipp, RW			Anomalies of the inferior vena cava in patients with iliac venous thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; LOWER-EXTREMITIES; PELVIC VEINS; APLASIA; ABSENCE	Background: Cases of deep venous thrombosis in the lower extremities triggered by abnormalities of the vena cava have been reported. Objective: To describe anomalies of the inferior vena cava in patients with deep venous thrombosis. Design: Prospective, consecutive case series. Setting: University Hospital, Graz, Austria. Patients: 97 patients with deep venous thrombosis. Intervention: Sonography, venography, or both to diagnose deep venous thrombosis; magnetic resonance angiography to image the inferior vena cava. Measurements: Anomalies of the inferior vena cava imaged by magnetic resonance angiography. Results: 31 of 97 patients showed thrombotic occlusion of iliac veins (common and external iliac vein [n = 29] or external iliac vein [n = 2]). Five of 31 patients (3 men, 2 women) had an anomaly of the inferior vena cava. Anomalies were missing inferior vena cava, hypoplastic hepatic segment, and missing renal or postrenal segments. Patients with anomalies were significantly younger than the 92 patients without (mean age +/- SD, 25 +/- 6 years vs. 53 +/- 19 years; P = 0.002). In 2 patients with anomalies, the thrombotic occlusion was recurrent. Conclusions: An anomaly of the inferior vena cava should be suspected if thrombosis involving the iliac veins is seen in patients 30 years of age or younger. Patients with both an anomaly and thrombosis may be at higher risk for thrombotic recurrence.	Graz Univ, Dept Internal Med, Div Angiol, A-8036 Graz, Austria	University of Graz	Obernosterer, A (corresponding author), Graz Univ, Dept Internal Med, Div Angiol, Auenbruggerpl 15, A-8036 Graz, Austria.	andrea.obernosterer@kfunigraz.ac.at		Schnedl, Wolfgang/0000-0002-5212-5230				BALDRIDGE ED, 1987, ARCH SURG-CHICAGO, V122, P1184; Bergqvist D, 1997, ANN INTERN MED, V126, P454, DOI 10.7326/0003-4819-126-6-199703150-00006; BORUCHOW IB, 1972, SURG GYNECOL OBSTETR, V134, P115; CHUANG VP, 1974, BRIT J RADIOL, V47, P206, DOI 10.1259/0007-1285-47-556-206; Dougherty MJ, 1996, J VASC SURG, V23, P141, DOI 10.1016/S0741-5214(05)80044-8; Hach W, 1985, PHLEBOGRAPHIE BEIN B, P56; HALBMAYER WM, 1993, DEUT MED WOCHENSCHR, V118, P1561, DOI 10.1055/s-2008-1059485; Kellman G M, 1988, Radiographics, V8, P533; Klessen C, 1999, DEUT MED WOCHENSCHR, V124, P523, DOI 10.1055/s-2007-1024354; Mirzaie M, 1999, VASA-J VASCULAR DIS, V28, P293, DOI 10.1024/0301-1526.28.4.293; MUELHEIMS GH, 1962, AM J CARDIOL, V9, P945, DOI 10.1016/0002-9149(62)90225-4; Ordonez FS, 1998, ANGIOLOGY, V49, P951, DOI 10.1177/000331979804901113; POLAK JF, 1992, PERIPHERAL VASCULAR, P155; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; SAITO H, 1995, CARDIOVASC INTER RAD, V18, P410, DOI 10.1007/BF00338312; Shah NL, 1996, SURGERY, V120, P891, DOI 10.1016/S0039-6060(96)80100-0; Thornton MJ, 1999, AM J ROENTGENOL, V173, P999, DOI 10.2214/ajr.173.4.10511166; Tiesenhausen K, 1999, VASA-J VASCULAR DIS, V28, P289, DOI 10.1024/0301-1526.28.4.289; Timmers GJ, 1999, INT J CLIN PRACT, V53, P75; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297	20	129	140	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2002	136	1					37	41		10.7326/0003-4819-136-1-200201010-00009	http://dx.doi.org/10.7326/0003-4819-136-1-200201010-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510BF	11777362				2022-12-01	WOS:000173188300004
J	Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM				Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM			The genetic architecture of divergence between threespine stickleback species	NATURE			English	Article							GASTEROSTEUS-ACULEATUS; NATURAL-SELECTION; SPECIATION; ADAPTATION; EVOLUTION; PREDATION; ECOLOGY; PAIR; SIZE	The genetic and molecular basis of morphological evolution is poorly understood, particularly in vertebrates. Genetic studies of the differences between naturally occurring vertebrate species have been limited by the expense and difficulty of raising large numbers of animals and the absence of molecular linkage maps for all but a handful of laboratory and domesticated animals. We have developed a genome-wide linkage map for the three-spined stickleback (Gasterosteus aculeatus), an extensively studied teleost fish that has undergone rapid divergence and speciation since the melting of glaciers 15,000 years ago(1). Here we use this map to analyse the genetic basis of recently evolved changes in skeletal armour and feeding morphologies seen in the benthic and limnetic stickleback species from Priest Lake, British Columbia. Substantial alterations in spine length, armour plate number, and gill raker number are controlled by genetic factors that map to independent chromosome regions. Further study of these regions will help to define the number and type of genetic changes that underlie morphological diversification during vertebrate evolution.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biol, Eau Claire, WI 54702 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1ZT, Canada; Univ British Columbia, Ctr Biodivers, Vancouver, BC V6T 1ZT, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Wisconsin System; University of British Columbia; University of British Columbia	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.			Buerkle, Alex/0000-0003-4222-8858; Peichel, Catherine/0000-0002-7731-8944; Schluter, Dolph/0000-0003-1683-7836				Ahn DG, 1999, EVOL DEV, V1, P100, DOI 10.1046/j.1525-142x.1999.99009.x; Beavis William D., 1998, P145; Bell M.A., 1984, P431; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; CHEN TR, 1970, CYTOGENETICS, V9, P321, DOI 10.1159/000130102; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Largiader CR, 1999, MOL ECOL, V8, P342; Lynch M., 1998, AM J HUM GENET; McPhail J.D., 1994, P399; MOODIE GEE, 1972, HEREDITY, V28, P155, DOI 10.1038/hdy.1972.21; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Reimchen TE, 1995, BEHAVIOUR, V132, P1079, DOI 10.1163/156853995X00469; RICO C, 1993, MOL ECOL, V2, P271, DOI 10.1111/j.1365-294X.1993.tb00017.x; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROZEN S, 1997, PRIMER3; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Stam P., 1995, JOINMAP VERSION 2 0; SWAIN DP, 1992, EVOLUTION, V46, P998, DOI 10.1111/j.1558-5646.1992.tb00615.x; Taylor AC, 1998, MOL ECOL, V7, P925; Vamosi SM, 1999, EVOLUTION, V53, P874, DOI 10.1111/j.1558-5646.1999.tb05381.x; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; [No title captured]	30	401	414	1	189	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					901	905		10.1038/414901a	http://dx.doi.org/10.1038/414901a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780061	Green Accepted			2022-12-01	WOS:000172813300044
J	Grenfell, BT; Bjornstad, ON; Kappey, J				Grenfell, BT; Bjornstad, ON; Kappey, J			Travelling waves and spatial hierarchies in measles epidemics	NATURE			English	Article							PATTERN-FORMATION; DYNAMICS; PERSISTENCE; CHAOS; HETEROGENEITY; PERIODICITY; POPULATIONS; VACCINATION; SYNCHRONY; MODELS	Spatio-temporal travelling waves are striking manifestations of predator-prey and host-parasite dynamics. However, few systems are well enough documented both to detect repeated waves and to explain their interaction with spatio-temporal variations in population structure and demography. Here, we demonstrate recurrent epidemic travelling waves in an exhaustive spatio-temporal data set for measles in England and Wales. We use wavelet phase analysis, which allows for dynamical nonstationarity-a complication in interpreting spatio-temporal patterns in these and many other ecological time series. In the prevaccination era, conspicuous hierarchical waves of infection moved regionally from large cities to small towns; the introduction of measles vaccination restricted but did not eliminate this hierarchical contagion. A mechanistic stochastic model suggests a dynamical explanation for the waves-spread via infective 'sparks' from large 'core' cities to smaller 'satellite' towns. Thus, the spatial hierarchy of host population structure is a prerequisite for these infection waves.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Grenfell, BT (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	b.t.grenfell@zoo.cam.ac.uk	Bjornstad, Ottar N/I-4518-2012					ANDERSON R M, 1991; ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; [Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; BAK P, 1977, NATURE WORKS SCI ORG; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bjornstad ON, 2001, J ANIM ECOL, V70, P924, DOI 10.1046/j.0021-8790.2001.00560.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; BJORNSTAD ON, IN PRESS ECOL MONOGR; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; BRADSHAW GA, 1992, J ECOL, V80, P205, DOI 10.2307/2261007; Breiman L, 1992, PROBABILITY; BULMER MG, 1974, J ANIM ECOL, V43, P701, DOI 10.2307/3532; Cliff A, 1993, MEASLES HIST GEOGRAP, P1840; CLIFF AD, 1992, STAT MED, V11, P1409, DOI 10.1002/sim.4780111102; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; GRENFELL BT, 1995, P ROY SOC B-BIOL SCI, V259, P97, DOI 10.1098/rspb.1995.0015; Grenfell BT, 1998, ECOL LETT, V1, P63; GRENFELL BT, IN PRESS ECOL MONOGR; HALL P, 1994, PROBAB THEORY REL, V99, P399, DOI 10.1007/BF01199899; HANSKI I, 1993, AM NAT, V142, P17, DOI 10.1086/285527; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Jeltsch F, 1997, P ROY SOC B-BIOL SCI, V264, P495, DOI 10.1098/rspb.1997.0071; KENDALL BE, 1993, PHYS LETT A, V177, P13, DOI 10.1016/0375-9601(93)90366-8; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; MOLLISON D, 1986, PHILOS T R SOC B, V314, P675, DOI 10.1098/rstb.1986.0080; Murray J., 1993, MATH BIOL, V2nd, DOI DOI 10.1007/978-3-662-08539-4; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; NEUBERT MG, 1995, THEOR POPUL BIOL, V48, P7, DOI 10.1006/tpbi.1995.1020; Office of Population Censuses and Surveys, 1944, REG GEN WEEKL RET EN; Percival DB, 2000, CA ST PR MA, V4; Ranta E, 1997, NATURE, V390, P456, DOI 10.1038/37261; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; SCHWARTZ IB, 1989, BIOMEDICAL MODELLING, P201; Sherratt JA, 2001, ECOL LETT, V4, P30, DOI 10.1046/j.1461-0248.2001.00193.x; SOLE RV, 1992, PHYS LETT A, V166, P123, DOI 10.1016/0375-9601(92)90546-X; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2	50	639	651	0	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					716	723		10.1038/414716a	http://dx.doi.org/10.1038/414716a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742391				2022-12-01	WOS:000172676200039
J	Rodewald, HR; Paul, S; Haller, C; Bluethmann, H; Blum, C				Rodewald, HR; Paul, S; Haller, C; Bluethmann, H; Blum, C			Thymus medulla consisting of epithelial islets each derived from a single progenitor	NATURE			English	Article							CELL DIFFERENTIATION; STEM-CELLS; C-KIT; MICE; EXPANSION	The thymus is organized into medullary and cortical zones that support distinct stages of T-cell development. The formation of medulla and cortex compartments is thought to occur through invagination of an endodermal epithelial sheet into an ectodermal one at the third pharyngeal pouch and cleft, respectively(1-5). Epithelial stem/progenitor cells have been proposed to be involved in thymus development(6,7), but evidence for their existence has been elusive. We have constructed chimaeric mice by injecting embryonic stem (ES) cells into blastocysts using ES cells and blastocysts differing in their major histocompatibility complex (MHC) type. Here we show that the MHC class-II-positive medullary epithelium in these chimaeras is composed of cell clusters, most of which derive from either embryonic stem cell or blastocyst, but not mixed, origin. Thus, the medulla comprises individual epithelial 'islets' each arising from a single progenitor. One thymic lobe has about 300 medullary areas that originate from as few as 900 progenitors. Islet formation can be recapitulated after implantation of 'reaggregated fetal thymic organs'(8) into mice, which shows that medullary 'stem' cells retain their potential until at least day 16.5 in fetal development. Thus, medulla- cortex compartmentalization is established by formation of medullary islets from single progenitors.	Univ Ulm, Dept Immunol, D-89081 Ulm, Germany; Basel Inst Immunol, CH-4005 Basel, Switzerland; F Hoffmann La Roche & Co Ltd, Roche Genet, CH-4070 Basel, Switzerland	Ulm University; Roche Holding	Rodewald, HR (corresponding author), Univ Ulm, Dept Immunol, Albert Einstein Allee 11, D-89081 Ulm, Germany.							ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; BESCHORNER WE, 1987, CELL IMMUNOL, V110, P350, DOI 10.1016/0008-8749(87)90128-6; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; CRISAN C., 1935, ZEITSCHR ANAT U ENTUNCKLUNGSGESCH, V104, P327, DOI 10.1007/BF02118610; GOSGROVE D, 1991, CELL, V66, P1051; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lampert I. A., 1988, THYMUS UPDATE, P5; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; NORRIS EH, 1938, CONTRIB EMBRYOL, V166, P191; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Suniara RK, 1999, EUR J IMMUNOL, V29, P75, DOI 10.1002/(SICI)1521-4141(199901)29:01<75::AID-IMMU75>3.3.CO;2-3; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANEWIJK W, 1980, J HISTOCHEM CYTOCHEM, V28, P1089, DOI 10.1177/28.10.6999083; VONGAUDECKER B, 1991, ANAT EMBRYOL, V183, P1; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	21	159	163	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					763	768		10.1038/414763a	http://dx.doi.org/10.1038/414763a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742403				2022-12-01	WOS:000172676200051
J	Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P				Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P			The RAR1 interactor SGT1, an essential component of R gene-triggered disease resistance	SCIENCE			English	Article							COP9 SIGNALOSOME; PROTEIN; ARABIDOPSIS; EXPRESSION; BARLEY	Plant disease resistance (R) genes trigger innate immune responses upon pathogen attack. RAR1 is an early convergence: point in a signaling pathway engaged by multiple R genes. Here, vie show that RAR1 interacts with plant orthologs of the yeast protein SGT1, an essential regulator in the cell cycle. Silencing the barley gene Sgt1 reveals its role in R gene-triggered, Rar1-dependent disease resistance. SGT1 associates with SKP1 and CUL1, subunits of the SCF (Skp1-Cullin-F-box) ubiquitin ligase complex. Furthermore, the RAR1-SGT1 complex also interacts with two COP9 signalosome components. The interactions among RAR1, SGT1, SCF, and signalosome subunits indicate a link between disease resistance and ubiquitination.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Max Planck Inst Zuchtungsforsch, Biochem Abt, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; St Jude Children's Research Hospital; Max Planck Society	Shirasu, K (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	ken.shirasu@bbrsc.ac.uk	Azevedo, Cristina/Y-4296-2019; Shirasu, Ken/ABF-5306-2020; Shirasu, Ken/A-4455-2010; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008	Azevedo, Cristina/0000-0002-6997-1265; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; 				Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Schweizer P, 2000, PLANT J, V24, P895, DOI 10.1046/j.1365-313x.2000.00941.x; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	23	469	511	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2073	2076		10.1126/science.1067554	http://dx.doi.org/10.1126/science.1067554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847307				2022-12-01	WOS:000174450500049
J	Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD				Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD			Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas	NATURE			English	Article							B-CELL LINE; MSH2-DEFICIENT MICE; MISMATCH REPAIR; IMMUNE-RESPONSE; IN-VITRO; SEQUENCES; GENES; NUCLEOTIDE; INDUCTION; MUTATION	The production of high-affinity protective antibodies requires somatic hypermutation (SHM) of the antibody variable (V) region genes. SHM is characterized by a high frequency of point mutations that occur only during the centroblast stage of B-cell differentiation. Activation-induced cytidine deaminase (AID), which is expressed specifically in germinal-centre centroblasts(1), is required for this process, but its exact role is unknown(2). Here we show that AID is required for SHM in the centroblast-like Ramos cells, and that expression of AID is sufficient to induce SHM in hybridoma cells, which represent a later stage of B-cell differentiation that does not normally undergo SHM. In one hybridoma, mutations were exclusively in G.C base pairs that were mostly within RGYW or WRCY motifs, suggesting that AID has primary responsibility for mutations at these nucleotides. The activation of SHM in hybridomas indicates that AID does not require other centroblast-specific cofactors to induce SHM, suggesting either that it functions alone or that the factors it requires are expressed at other stages of B-cell differentiation.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave Chanin 403, Bronx, NY 10461 USA.		Martin, Alberto/B-1421-2008; Bardwell, Philip D./K-8442-2013; Bardwell, Philip/H-2219-2014	Bardwell, Philip D./0000-0002-3835-255X; Bardwell, Philip/0000-0002-3835-255X; Martin, Alberto/0000-0002-0795-0418				Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; CONNOR A, 1994, J BIOL CHEM, V269, P25178; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; KOBRIN BJ, 1990, SOMATIC HYPERMUTATIO, V5, P11; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lin MMQ, 1997, P NATL ACAD SCI USA, V94, P5284, DOI 10.1073/pnas.94.10.5284; Luria SE, 1943, GENETICS, V28, P491; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sack SZ, 2001, MOL IMMUNOL, V38, P303, DOI 10.1016/S0161-5890(01)00058-X; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Spencer J, 1999, J IMMUNOL, V162, P6596; TAO W, 1990, J IMMUNOL, V145, P3216; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang W, 2001, INT IMMUNOL, V13, P1175, DOI 10.1093/intimm/13.9.1175	27	211	226	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					802	806		10.1038/nature714	http://dx.doi.org/10.1038/nature714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823785				2022-12-01	WOS:000173833900049
J	Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB				Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB			Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha	NATURE			English	Article							ACTIVATED RECEPTOR-GAMMA; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; PROMYELOCYTIC LEUKEMIA; HORMONE RECEPTORS; BINDING; COACTIVATOR; RECOGNITION; SMRT; COREPRESSORS	Repression of gene transcription by nuclear receptors is mediated by interactions with co-repressor proteins such as SMRT and NCoR1,2, which in turn recruit histone deacetylases to the chromatin(3-5). Aberrant interactions between nuclear receptors and co-repressors contribute towards acute promyelocytic leukaemia and thyroid hormone resistance syndrome (6-8). The binding of co-repressors to nuclear receptors occurs in the unliganded state, and can be stabilized by antagonists(9). Here we report the crystal structure of a ternary complex containing the peroxisome proliferator-activated receptor-alpha ligand-binding domain bound to the antagonist GW6471 and a SMRT co-repressor motif. In this structure, the co-repressor motif adopts a three-turn alpha-helix that prevents the carboxy-terminal activation helix (AF-2) of the receptor from assuming the active conformation. Binding of the co-repressor motif is further reinforced by the antagonist, which blocks the AF-2 helix from adopting the active position. Biochemical analyses and structure-based mutagenesis indicate that this mode of co-repressor binding is highly conserved across nuclear receptors.	GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline	Xu, HE (corresponding author), GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA.	ex11957@gsk.com	feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014					Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; ONATE SA, 1995, SCIENCE, V270, P1354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	30	497	521	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					813	817		10.1038/415813a	http://dx.doi.org/10.1038/415813a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845213				2022-12-01	WOS:000173833900052
J	Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H				Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H			Psychobiology - Speech sounds learned by sleeping newborns	NATURE			English	Article							CHILDREN		Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland; Univ Turku, Dept Psychol, Turku 20100, Finland; Univ Turku, Dept Phonet, Turku 20100, Finland; Univ Helsinki, Cent Hosp, BioMag Lab, Helsinki 00029, Finland; Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Brain Res Ctr, FIN-00014 Helsinki, Finland; Turku Univ, Cent Hosp, Dept Obstet & Gynaecol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Child Neurol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Pediat, Turku 20100, Finland; Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Turku; University of Turku; University of Turku; Cornell University	Cheour, M (corresponding author), Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland.	marie.cheour@utu.fi	Sillanpaa, Matti L/G-4708-2015; Martynova, Olga V/K-3900-2012	Sillanpaa, Matti L/0000-0003-4190-3698; Martynova, Olga V/0000-0001-9047-2893; Sillanpaa, Matti/0000-0002-1521-3602				Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5	8	132	140	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					599	600		10.1038/415599b	http://dx.doi.org/10.1038/415599b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832930				2022-12-01	WOS:000173709100030
J	Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K				Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K			A role for interaction of the RNA polymerase flap domain with the sigma subunit in promoter recognition	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION; ACTIVATION; BINDING; PROTEIN; SITE	In bacteria, promoter recognition depends on the RNA polymerase sigma subunit, which combines with the catalytically proficient RNA polymerase core to form the holoenzyme. The major class of bacterial promoters is defined by two conserved elements (the -10 and -35 elements, which are 10 and 35 nucleotides upstream of the initiation point, respectively) that are contacted by sigma the holoenzyme. We show that recognition of promoters of this class depends on the "flexible flap" domain of the RNA polymerase beta subunit. The flap interacts with conserved region 4 of sigmaand triggers:a conformational change that moves region 4 into the correct position for interaction with the -35 element. Because the flexible flap is evolutionarily conserved, this domain may facilitate promoter recognition by specificity factors in eukaryotes as well.	Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Rutgers State University New Brunswick; Saint Louis University; Harvard University; Harvard Medical School	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, POB 759, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016; Nickels, Bryce/AAF-2549-2020	Nickels, Bryce/0000-0001-7449-8831	NIGMS NIH HHS [GM44025, GM50514] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Gerber JS, 1996, J BACTERIOL, V178, P6133, DOI 10.1128/jb.178.21.6133-6139.1996; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	16	147	151	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					855	857		10.1126/science.1066303	http://dx.doi.org/10.1126/science.1066303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823642				2022-12-01	WOS:000173733000045
J	Day, JJ; Norman, DB; Upchurch, P; Powell, HP				Day, JJ; Norman, DB; Upchurch, P; Powell, HP			Biomechanics - Dinosaur locomotion from a new trackway	NATURE			English	Article									Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Oxford, Museum Nat Hist, Oxford OXD1 3PW, England	University of Cambridge; University of Oxford	Day, JJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Upchurch, Paul/C-1654-2008	Day, Julia/0000-0002-6765-7782				ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1986, ZOOL J LINN SOC-LOND, V83, P1; Cope J.C.W., 1980, SPECIAL PUBLICATIONS, V15, P109; PADIAN K, 1984, COPEIA, P662, DOI 10.2307/1445147; Thulborn R.A., 1990, DINOSAUR TRACKS; THULBORN RA, 1981, NATURE, V292, P273, DOI 10.1038/292273c0	6	51	55	8	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					494	495		10.1038/415494a	http://dx.doi.org/10.1038/415494a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823849				2022-12-01	WOS:000173564300035
J	Griffiths, CEM				Griffiths, CEM			Immunotherapy for psoriasis: from serendipity to selectivity	LANCET			English	Editorial Material							PLAQUE-TYPE PSORIASIS; QUALITY-OF-LIFE; T-CELLS; ANTIBODY		Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England	University of Manchester	Griffiths, CEM (corresponding author), Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England.	christopher.griffiths@man.ac.uk	Griffiths, Christopher E.M./P-5448-2014	Griffiths, Christopher E.M./0000-0001-5371-4427				Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; Fortune DG, 1997, BRIT J DERMATOL, V137, P755; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger JG, 2000, J AM ACAD DERMATOL, V43, P448, DOI 10.1067/mjd.2000.106515; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Papp K, 2001, J AM ACAD DERMATOL, V45, P665, DOI 10.1067/mjd.2001.117850; Richards HL, 1999, J AM ACAD DERMATOL, V41, P581, DOI 10.1016/S0190-9622(99)70301-4; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x	16	21	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					279	280		10.1016/S0140-6736(02)07536-0	http://dx.doi.org/10.1016/S0140-6736(02)07536-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830192				2022-12-01	WOS:000173588100006
J	Aurelio, O; Hall, DH; Hobert, O				Aurelio, O; Hall, DH; Hobert, O			Immunoglobulin-domain proteins required for maintenance of ventral nerve cord organization	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; NEURONS; SYSTEM; UNC-6	During development, neurons extend axons along defined routes to specific target cells. We show that additional mechanisms ensure that axons maintain their correct positioning in defined axonal tracts. After termination of axonal outgrowth and target recognition, axons in the ventral nerve cord (VNC) of Caenorhabditis elegans require the presence of a specific VNC neuron, PVT, to maintain their correct positioning in the left and right fascicles of the VNC. PVT may exert its stabilizing function by the temporally tightly controlled secretion of 2-immunoglobulin (Ig)-domain proteins encoded by the zig genes. Dedicated axon maintenance mechanisms may be widely used to ensure the preservation of functional neuronal circuitries.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Ctr C Elegans Anat, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 722 W 168th St, New York, NY 10032 USA.			Hobert, Oliver/0000-0002-7634-2854	NCRR NIH HHS [RR12596, R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline; NINDS NIH HHS [5F32NS11107-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011107] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; DURBIN RM, 1987, THESIS U CAMBRIDGE; HALL DH, 1991, J NEUROSCI, V11, P1; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; LEWIS JA, 1980, GENETICS, V95, P905; MILLER DM, 1995, DEVELOPMENT, V121, P2877; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; SONDEREGGER P, 1998, IG SUPERFAMILY MOL N; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zallen JA, 1999, DEVELOPMENT, V126, P3679	13	88	105	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					686	690		10.1126/science.1066642	http://dx.doi.org/10.1126/science.1066642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809975				2022-12-01	WOS:000173560900048
J	Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA				Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA			Recent patterns of medication use in the ambulatory adult population of the United States - The Slone survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG-REACTIONS; SUPPLEMENT USE; PRESCRIPTION; MEDICINE; EPESE	Context Data on the range of prescription and over-the-counter drug use in the United States are not available. Objective To provide recent population-based information on use of all medications, including prescription and over-the-counter drugs, vitamins and minerals, and herbal preparations/natural supplements in the United States. Design, Setting, and Participants Ongoing telephone survey of a random sample of the noninstitutionalized US population in the 48 continental states and the District of Columbia; data analyzed here were collected from February 1998 through December 1999. Main Outcome Measure Use of medications, by type, during the preceding week, compared by demographic characteristics. Results Among 2590 participants aged at least 18 years, 81% used at least 1 medication in the preceding week; 50% took at least 1 prescription drug; and 7% took 5 or more. The highest overall prevalence of medication use was among women aged at least 65 years, of whom 12% took at least 10 medications and 23% took at least 5 prescription drugs. Herbals/supplements were taken by 14% of the population. Among prescription drug users, 16% also took an herbal/supplement; the rate of concurrent use was highest for fluoxetine users, at 22%. Reasons for drug use varied widely, with hypertension and headache mentioned most often (9% for each). Vitamins/minerals were frequently used for nonspecific reasons such as "health" (35%); herbals/supplements were also most commonly used for "health" (16%). Conclusions In any given week, most US adults take at least 1 medication, and many take multiple agents. The substantial overlap between use of prescription medications and herbals/supplements raises concern about unintended interactions. Documentation of usage patterns can provide a basis for improving the safety of medication use.	Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, Boston, MA 02215 USA	Boston University	Kaufman, DW (corresponding author), Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, 1010 Commonwealth Ave, Boston, MA 02215 USA.			Rosenberg, Lynn/0000-0003-2760-2987; Kaufman, David/0000-0002-2150-5070; Mitchell, Allen/0000-0003-0950-6799				Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Baugh DK, 1999, HEALTH CARE FINANC R, V20, P79; Caces MF, 1998, J SUBST ABUSE, V10, P115, DOI 10.1016/S0899-3289(99)80128-X; COPELAND C, 1999, EBRI ISSUE BRIEF, V208, P1; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Ervin RB., 1999, USE DIETARY SUPPLEME; Espino DV, 1998, J AM GERIATR SOC, V46, P1228, DOI 10.1111/j.1532-5415.1998.tb04538.x; Gotto Antonio M., 1999, American Journal of Medicine, V107, p36S; Gray SL, 1996, PHARMACOTHERAPY, V16, P715; Handa VL, 1996, J AM GERIATR SOC, V44, P1; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Lassila HC, 1996, ANN PHARMACOTHER, V30, P589, DOI 10.1177/106002809603000604; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Mehl B, 2000, AM J HEALTH-SYST PH, V57, P129, DOI 10.1093/ajhp/57.2.129; OROURKE D, 1999, SURVEY RES, V30, P1; Petrini J. R., 1999, Morbidity and Mortality Weekly Report, V48, P325; Pradel FG, 1999, ANN PHARMACOTHER, V33, P400, DOI 10.1345/aph.18247; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Stoehr GP, 1997, J AM GERIATR SOC, V45, P158, DOI 10.1111/j.1532-5415.1997.tb04501.x; THORNBERRY OT, 1987, VITAL HLTH STAT, V2, P106; *US CENS BUR, 2000, CURR POP REP 1998; *US CENS BUR, 2000, HOUS TYP SEL CHAR 19; *US CENS BUR, 2001, NAT POP PROJ 2000 HI; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; *US CENS BUR, 2000, CURR POP REP MON INC; *US DEP COMM EC ST, 1993, 1990 CENS POP HOUS S; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; 2000, SCOTTLEVINS SOURCE P; 2000, IMS AM NPA 20K MONTH	32	1292	1333	0	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					337	344		10.1001/jama.287.3.337	http://dx.doi.org/10.1001/jama.287.3.337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790213	Bronze			2022-12-01	WOS:000173294700028
J	Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N				Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N			beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs	CELL			English	Article							PROTEIN-KINASE-C; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; HIPPOCAMPAL SYNAPSES; PROBABILITY; UNC-13; POTENTIATION; VESICLES; CELLS; POOL	Munc13-1 is a presynaptic protein with an essential role in synaptic vesicle priming. It contains a diacylglycerol (DAG)/beta phorbol ester binding C-1 domain and is a potential target of the DAG second messenger pathway that may act in parallel with PKCs. Using genetically modified mice that express a DAG/beta phorbol ester binding-deficient Munc13-1(H567K) variant instead of the wild-type protein, we determined the relative contribution of PKCs and Munc13-1 to DAG/beta phorbol ester-dependent regulation of neurotransmitter release. We show that Munc13s are the main presynaptic DAG/beta phorbol ester receptors in hippocampal neurons. Modulation of Munc13-1 activity by second messengers via the DAG/beta phorbol ester binding C-1 domain is essential for use-dependent alterations of synaptic efficacy and survival.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan	Max Planck Society; Max Planck Society; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Varoqueaux, Frederique/AAC-1834-2021; Rosenmund, Christian/AAC-3596-2020; Pyott, Sonja/AAW-8789-2020	Varoqueaux, Frederique/0000-0002-3614-3121; Rosenmund, Christian/0000-0002-3905-2444; Pyott, Sonja/0000-0001-7750-2437				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; DEGRAAN PNE, 1994, NEUROTOXICOLOGY, V15, P41; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Goda Y, 1996, LEARN MEMORY, V3, P182, DOI 10.1101/lm.3.2-3.182; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Honda I, 2000, J PHYSIOL-LONDON, V529, P763, DOI 10.1111/j.1469-7793.2000.00763.x; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; NAYAK A, 1999, ADV NEUROL, V79, P6545; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Oleskevich S, 2000, J PHYSIOL-LONDON, V526, P349, DOI 10.1111/j.1469-7793.2000.t01-1-00349.x; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Redman RS, 1997, J PHYSIOL-LONDON, V501, P41, DOI 10.1111/j.1469-7793.1997.041bo.x; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROSENMUND C, 2002, IN PRESS NEURON; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; SKABA T, 2001, P NATL ACAD SCI USA, V98, P331; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Waters J, 2000, J NEUROSCI, V20, P7863; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Yawo H, 1999, J PHYSIOL-LONDON, V516, P461, DOI 10.1111/j.1469-7793.1999.0461v.x	48	364	376	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					121	133		10.1016/S0092-8674(01)00635-3	http://dx.doi.org/10.1016/S0092-8674(01)00635-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792326	Bronze			2022-12-01	WOS:000173280700013
J	Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R				Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R			Reduced nitrogen fixation in the glacial ocean inferred from changes in marine nitrogen and phosphorus inventories	NATURE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; ARABIAN SEA; INTERGLACIAL VARIABILITY; DENITRIFICATION; ACCUMULATION; PACIFIC; APATITE; PERU	To explain the lower atmospheric CO(2) concentrations during glacial periods, it has been suggested that the productivity of marine phytoplankton was stimulated by an increased flux of iron-bearing dust to the oceans(1,2). One component of this theory is that iron-an essential element/nutrient for nitrogen-fixing organisms-will increase the rate of marine nitrogen fixation, fuelling the growth of other marine phytoplankton and increasing CO(2) uptake. Here we present data that questions this hypothesis. From a sediment core off the northwestern continental margin of Mexico, we show that denitrification and phosphorite formation-processes that occur in oxygen-deficient upwelling regions, removing respectively nitrogen and phosphorus from the ocean-declined in glacial periods, thus increasing marine inventories of nitrogen and phosphorus. But increases in phosphorus were smaller and less rapid, leading to increased N/P ratios in the oceans. Acknowledging that phytoplankton require nitrogen and phosphorus in constant proportions, the Redfield ratio(3), and that N/P ratios greater than the Redfield ratio are likely to suppress nitrogen fixation(4,5), we suggest therefore that marine productivity did not increase in glacial periods in response to either increased nutrient inventories or greater iron supply.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02540 USA	University of Edinburgh; University of British Columbia; Woods Hole Oceanographic Institution	Ganeshram, RS (corresponding author), Univ Edinburgh, Dept Geol & Geophys, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	Raja.Ganeshram@glg.ed.ac.uk						ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BURNETT WC, 1980, J GEOL SOC LONDON, V137, P757, DOI 10.1144/gsjgs.137.6.0757; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; FALKOWSKI P. G., 1997, NATURE, V342, P637; Filippelli GM, 1997, MAR GEOL, V139, P231, DOI 10.1016/S0025-3227(96)00113-2; FROELICH PN, 1988, MAR GEOL, V80, P309, DOI 10.1016/0025-3227(88)90095-3; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 1998, PALEOCEANOGRAPHY, V13, P634, DOI 10.1029/98PA02508; Garrison R.E., 1990, P OCEAN DRILLING PRO, V112, P111, DOI DOI 10.2973/ODP.PROC.SR.112.145.1990.; Heggie D., 1988, EOS T AM GEOPHYS UN, V69, P2, DOI DOI 10.1029/88E000007; HOOD RR, 2000, EOS, V81, P1; JAHNKE RA, 1983, GEOCHIM COSMOCHIM AC, V47, P259, DOI 10.1016/0016-7037(83)90138-2; LAMBOURN L, 1991, 110 U WASH SCH OC; PRICE NB, 1978, CHEM GEOL, V23, P151, DOI 10.1016/0009-2541(78)90072-4; REDFIELD AC, 1963, SEA, V2, P36; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schenau S, 2000, MAR GEOL, V169, P1, DOI 10.1016/S0025-3227(00)00083-9; Schuffert JD, 1998, MAR GEOL, V146, P21, DOI 10.1016/S0025-3227(97)00122-9; SHIMMIELD G, 1991, P OCEAN DRILLING PRO, V0117; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	26	106	124	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					156	159		10.1038/415156a	http://dx.doi.org/10.1038/415156a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805830				2022-12-01	WOS:000173159300037
J	Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN				Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN			Prevalence of kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BISEXUAL MEN; SEXUAL TRANSMISSION; RISK-FACTORS; HUMAN-HERPESVIRUS-8; SEROCONVERSION; COHORT; HEALTH; ANTIBODIES; RATES	Context Some studies have inferred that an epidemic of Kaposi sarcoma-associated herpesvirus (KSHV) infection in homosexual men in the United States occurred concurrently with that of human immunodeficiency virus (HIV), but there have been no direct measurements of KSHV prevalence at the beginning of the HIV epidemic. Objectives To determine the prevalence of KSHV infection in homosexual men in San Francisco, Calif, at the beginning of the HIV epidemic in 1978 and 1979 and to examine changes in prevalence of KSHV at time points from 1978 through 1996 in light of changes in sexual behavior. Design, Setting, and Participants Analysis of a clinic-based sample (n=398) derived from the San Francisco City Clinic Cohort (ages 18-66 years) (n=2666 for analyses herein) and from population-based samples from the San Francisco Men's Health Study (MHS) (ages 25-54 years) (n=825 and 252) and the San Francisco Young Men's Health Study (YMHS) (ages 18-29 years) (n=428-976, and 557); behavioral studies were longitudinal and KSHV prevalence studies were cross-sectional. Main Outcome Measures Antibodies against KSHV and HIV; sexual behaviors. Results The prevalence of KSHV infection in 1978 and 1979 was 26.5% of 235 (a random sample) overall (weighted for HIV infection) vs 6.9% (128/1842) for HIV in the San Francisco City Clinic Cohort sample. The prevalence of KSHV infection remained essentially unchanged between an MHS sample of 252 in 1984 and 1985 (29.6%) and a YMHS sample of 557 in 1995 and 1996 (26.4%), while HIV prevalence dropped from 49.5% of 825 in 1984 and 1985 (MHS) to 17.6% of 428 in 1992 and 1993 (YMHS). The proportion of men practicing unprotected receptive anal intercourse with 1 or more partners declined from 54% to 11% during the 1984 through 1993 period (MHS) with similar though slightly higher values in the YMHS in 1992 and 1993; whereas for unprotected oral intercourse it ranged between 60% and 90% in the 1984 through 1996 period (PANS and YMHS). Conclusions Infection with KSHV was already highly prevalent in homosexual men when the HIV epidemic began in San Francisco, and its prevalence has been maintained at a nearly constant level. Any declines in the incidence of Kaposi sarcoma do not appear to be caused by a decline in KSHV transmission.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Calif Dept Hlth Serv, Div Communicable Dis Control, Viral & Rickettsial Dis Lab, Viral Immunoserol Sect, Richmond, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; California Department of Health Care Services	Osmond, DH (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Box 0886, San Francisco, CA 94143 USA.				NCI NIH HHS [U01 CA78124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA078124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Diamond C, 1997, J INFECT DIS, V176, P775, DOI 10.1086/517299; Dore GJ, 1996, AIDS, V10, P1401, DOI 10.1097/00002030-199610000-00013; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Fusaro RE, 1996, BIOMETRICS, V52, P211, DOI 10.2307/2533157; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Grulich AE, 1997, AM J EPIDEMIOL, V145, P673, DOI 10.1093/aje/145.8.673; Hayward GS, 1999, SEMIN CANCER BIOL, V9, P187, DOI 10.1006/scbi.1998.0116; Jacobson L.P., 2000, 3 INT WORKSH KAP SAR; Jones JL, 1999, J ACQ IMMUN DEF SYND, V21, pS11; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; MARTIN J, 2000, 3 INT WORKSH KAP SAR; Martin JN, 2000, J CLIN MICROBIOL, V38, P696, DOI 10.1128/JCM.38.2.696-701.2000; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; RUTHERFORD GW, 1990, BRIT MED J, V301, P1183, DOI 10.1136/bmj.301.6762.1183; RUTHERFORD GW, 1990, J ACQ IMMUN DEF SYND, V3, pS4; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; VEUGELERS PJ, 1995, EPIDEMIOLOGY, V6, P382, DOI 10.1097/00001648-199507000-00009; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	30	71	72	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					221	225		10.1001/jama.287.2.221	http://dx.doi.org/10.1001/jama.287.2.221			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779265				2022-12-01	WOS:000173114900025
J	Vecchione, M; Young, RE; Guerra, A; Lindsay, DJ; Clague, DA; Bernhard, JM; Sager, WW; Gonzalez, AF; Rocha, FJ; Segonzac, M				Vecchione, M; Young, RE; Guerra, A; Lindsay, DJ; Clague, DA; Bernhard, JM; Sager, WW; Gonzalez, AF; Rocha, FJ; Segonzac, M			Worldwide observations of remarkable deep-sea squids	SCIENCE			English	Article									Natl Museum Nat Hist, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20560 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; CSIC, Inst Invest Marinas, ECOBIOMAR, Vigo, Spain; Japan Marine Sci & Technol Ctr, Marine Ecosyst Res Dept, Yokosuka, Kanagawa, Japan; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ S Carolina, Dept Environm Hlth Sci, Columbia, SC 29208 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; IFREMER, CENTOB, Plouzane, France	National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Monterey Bay Aquarium Research Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station; Ifremer	Vecchione, M (corresponding author), Natl Museum Nat Hist, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20560 USA.	vecchione.michael@nmnh.si.edu	Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				ASUBEL J, 1999, OCEANOGRAPHY, V12, P4; Smith CR, 1998, DEEP-SEA RES PT II, V45, P1, DOI 10.1016/S0967-0645(97)00088-X; Vecchione M, 1998, S AFR J MARINE SCI, V20, P429	3	31	35	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2505	2506		10.1126/science.294.5551.2505	http://dx.doi.org/10.1126/science.294.5551.2505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752567	Green Submitted			2022-12-01	WOS:000172927700044
J	Murphy, WJ; Eizirik, E; O'Brien, SJ; Madsen, O; Scally, M; Douady, CJ; Teeling, E; Ryder, OA; Stanhope, MJ; de Jong, WW; Springer, MS				Murphy, WJ; Eizirik, E; O'Brien, SJ; Madsen, O; Scally, M; Douady, CJ; Teeling, E; Ryder, OA; Stanhope, MJ; de Jong, WW; Springer, MS			Resolution of the early placental mammal radiation using Bayesian phylogenetics	SCIENCE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCES; ORIGINS	Molecular phylogenetic studies have resolved placental. mammals into four major groups, but have not established the full hierarchy of interordinal relationships, including the position of the root. The latter is critical for understanding the early biogeographic history of placentals. We investigated placental phylogeny using Bayesian and maximum-likelihood methods and a 16.4-kilobase molecular data set. Interordinal. relationships are almost entirely resolved. The basal split is between Afrotheria and other placentals, at about 103 million years, and may be accounted for by the separation of South America and Africa in the Cretaceous. Crown-group Eutheria may have their most recent common ancestry in the Southern Hemisphere (Gondwana).	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; Queens Univ Belfast, Belfast, Antrim, North Ireland; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Glaxo SmithKline, Collegeville, PA 19426 USA; Inst Systemat & Populat Biol, Amsterdam, Netherlands	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Radboud University Nijmegen; Queens University Belfast; Zoological Society of San Diego; GlaxoSmithKline	O'Brien, SJ (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	obrien@ncifcr.gov; mark.springer@ucr.edu	Douady, Christophe J/N-1357-2014; Madsen, Ole/E-3730-2012; Eizirik, Eduardo/K-8034-2012; Douady, Christophe/N-3069-2019; OBRIEN, STEPHEN/ABD-1346-2020	Douady, Christophe J/0000-0002-4503-8040; Madsen, Ole/0000-0001-8082-7881; Eizirik, Eduardo/0000-0002-9658-0999; Douady, Christophe/0000-0002-4503-8040; OBRIEN, STEPHEN/0000-0001-7857-0757; Teeling, Emma/0000-0002-3309-1346				Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hay WW, 1999, GEOL S AM S, P1; Hillis David M., 1996, P515; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Matthew W. D., 1915, Annals of the New York Academy of Sciences, V24; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 2001, SCIENCE, V292, P2264, DOI 10.1126/science.1059393; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAINGER R, 1991, AGENDA ANTIQUITY HF; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Smith AG, 1994, ATLAS CENOZOIC MESOZ; Springer MS, 2001, MOL BIOL EVOL, V18, P132, DOI 10.1093/oxfordjournals.molbev.a003787; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wallace A. R, 1962, GEOGRAPHICAL DISTRIB; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; [No title captured]	29	975	1020	6	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2348	2351		10.1126/science.1067179	http://dx.doi.org/10.1126/science.1067179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743200				2022-12-01	WOS:000172817200045
J	Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C				Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C			Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein	SCIENCE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; TUBERCULOSIS; AHPC; ACETYLTRANSFERASE; DEHYDROGENASE; BACTERIAL	Mycobacterium tuberculosis (Mtb) mounts a stubborn defense against oxidative and nitrosative components of the immune response. Dihydrolipoamide dehydrogenase (Lpd) and dihydrolipoamide succinyltransferase (SucB) are components of alpha-ketoacid dehydrogenase complexes that are central to intermediary metabolism. We find that Lpd and SucB support Mtb's antioxidant defense. The peroxiredoxin alkyl hydroperoxide reductase (AhpC) is linked to Lpd and SucB by an adaptor protein, AhpD. The 2.0 angstrom AhpD crystal structure reveals a thioredoxin-like active site that is responsive to lipoamide. We propose that Lpd, SucB (the only lipoyl protein detected in Mtb), AhpD, and AhpC together constitute a nicotinamide adenine dinucleotide (reduced)-dependent peroxidase and peroxynitrite reductase. AhpD thus represents a class of thioredoxin-like molecules that enables an antioxidant defense.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Sloan Kettering Inst, Prot Ctr, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Struct Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, Box 65,1300 York Ave, New York, NY 10021 USA.			Tempst, Paul/0000-0002-6680-3987; Lima, Christopher/0000-0002-9163-6092; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA08748] Funding Source: Medline; NHLBI NIH HHS [HL61241] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argyrou A, 2001, BIOCHEMISTRY-US, V40, P11353, DOI 10.1021/bi010575o; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAN J, 1999, NITRIC OXIDE INFECT, P281; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DANSON MJ, 1988, BIOCHEM SOC T, V16, P87, DOI 10.1042/bst0160087; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; ERJUMENTBROMAGE H, 1998, J CHROMATOGR A, V826, P167; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MURTHY PS, 1973, AM REV RESPIR DIS, V108, P689; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989	23	299	327	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1073	1077		10.1126/science.1067798	http://dx.doi.org/10.1126/science.1067798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799204				2022-12-01	WOS:000173793000066
J	Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J				Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J		GRACE Investigators	Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)	LANCET			English	Article							THROMBOLYTIC THERAPY; COMBINATION THERAPY; NATIONAL REGISTRY; ELDERLY-PATIENTS; ANGIOPLASTY; INHIBITION; ELIGIBILITY; MANAGEMENT; BENEFIT	Background The benefits of reperfusion therapy for patients with acute coronary syndromes have been established, but there is much variation in the type of reperfusion given and decisions about which patients are eligible. This study assessed current practices in relation to reperfusion therapy of ST-segment-elevation myocardial infarction from data collected in the multinational, prospective Global Registry of Acute Coronary Events. Methods 94 hospitals in 14 countries are recruiting patients for the registry, Hospitals are organised into population-based clusters that reflect the population characteristics of the region. Information about patients' demographic characteristics, presenting symptoms, medical history, time between symptom onset and presentation, and clinical and electrocardiographic features is recorded in a standard case record. Findings Of the 9251 patients enrolled, 1763 presented within 12 h of symptom onset with ST-segment-elevation myocardial infarction. Of these, 30% did not receive reperfusion therapy. Elderly patients (75 years and older), those presenting without chest pain, and those with a history of diabetes, congestive heart failure, myocardial infarction, or coronary bypass surgery were less likely to receive reperfusion therapy. The rate of primary percutaneous coronary intervention was highest in the USA and lowest in Australia, New Zealand, and Canada. The rate at sites with a catheterisation laboratory was 19% compared with zero at sites without this facility. Interpretation A substantial proportion of patients who are eligible for reperfusion therapy still do not receive this treatment. These typically high-risk patients can be identified in advance, and reasons for the underuse of these beneficial treatments need to be clarified.	Univ Michigan Hosp, Div Cardiol, Ann Arbor, MI 48109 USA; Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada; CTIA Hosp Albert Einstein, Sao Paulo, Brazil; Grochowski Hosp, Dept Cardiol, Warsaw, Poland; Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA; Hosp Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain	University of Michigan System; University of Michigan; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hospital Israelita Albert Einstein; Centre of Postgraduate Medical Education - Poland; University of Massachusetts System; University of Massachusetts Worcester; General University Gregorio Maranon Hospital	Eagle, KA (corresponding author), Univ Michigan Hosp, Div Cardiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	keagle@umich.edu	Avezum, Alvaro/AAP-7687-2020; Avezum, Alvaro AA/K-6137-2016	Avezum, Alvaro AA/0000-0002-3073-6890; Budaj, Andrzej/0000-0002-6395-2098				Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Akkerhuis KM, 2000, EUR HEART J, V21, P371, DOI 10.1053/euhj.1999.1743; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Berger AK, 1999, JAMA-J AM MED ASSOC, V282, P341, DOI 10.1001/jama.282.4.341; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Califf RM, 2000, AM HEART J, V139, pS33, DOI 10.1067/mhj.2000.104090; Cannon CP, 2000, J THROMB THROMBOLYS, V9, P235, DOI 10.1023/A:1018714627681; Cariou A, 1997, EUR HEART J, V18, P1583; French WJ, 2000, AM J CARDIOL, V85, p5B; Gibson CM, 1999, ANN INTERN MED, V130, P841, DOI 10.7326/0003-4819-130-10-199905180-00019; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HIMBERT D, 1994, EUR HEART J, V15, P483, DOI 10.1093/oxfordjournals.eurheartj.a060531; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Holmes DR, 1997, LANCET, V349, P75, DOI 10.1016/S0140-6736(96)03031-0; Julian DG, 1996, EUR HEART J, V17, P43; Juliard JM, 1997, J AM COLL CARDIOL, V30, P157, DOI 10.1016/S0735-1097(97)00119-8; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; Tresch DD, 1996, ARCH INTERN MED, V156, P1089, DOI 10.1001/archinte.156.10.1089; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; White HD, 2000, LANCET, V356, P2028, DOI 10.1016/S0140-6736(00)03397-3; White HD, 1998, AM J CARDIOL, V82, p57P, DOI 10.1016/S0002-9149(98)00663-8; Zijlstra F, 2000, EUR HEART J, V21, P1487, DOI 10.1053/euhj.2000.2192	28	414	447	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					373	377		10.1016/S0140-6736(02)07595-5	http://dx.doi.org/10.1016/S0140-6736(02)07595-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844506				2022-12-01	WOS:000173686500006
J	Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R				Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R			Chromosomal congenital anomalies and residence near hazardous waste landfill sites	LANCET			English	Article							RISK	Previous findings of the EUROHAZCON study showed a 33% Increase In risk of non-chromosomal anomalies near hazardous waste landfill sites. Here, we studied 245 cases of chromosomal anomalies and 2412 controls who lived near 23 such sites In Europe, After adjustment for confounding by maternal age and socioeconomic status, we noted a higher risk of chromosomal anomalies In people who lived close to sites (0-3 km) than In those who lived further away (3-7 km; odds ratio 1.41, 95% CI 1.00-1.99). Our results suggest an increase in risk of chromosomal anomalies similar to that found for non-chromosomal anomalies.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, London WC1E 7HT, England; Univ Ulster, Fac Life & Hlth Sci, EUROCAT Registry, Belfast, Antrim, North Ireland; Northwick Pk Hosp & Clin Res Ctr, N Thames Perinatal Publ Hlth Unit, N Thames W Congenital Malformat Register, London, England; CNR, Inst Clin Physiol, Epidemiol Unit, Tuscany EUROCAT Register, I-56100 Pisa, Italy; Inst Publ Hlth, Ljubljana, Slovenia; Univ So Denmark, Inst Publ Hlth, Funen Cty Eurocat Register, Odense, Denmark; St Bartholomews & London Sch Med & Dent, Wolfson Inst Prevent Med, Natl Down Syndrome Cytogenet Register, London, England; Prov Inst Hyg, Antwerp Eurocat Register, Antwerp, Belgium; Inst Europeen Genomutat, France Cent E Register Congenital Malformat, Lyon, France; Univ Newcastle Upon Tyne, Matern Survey Off, No Congenital Abnormal Survey, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Glasgow, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow EUROCAT Register, Glasgow, Lanark, Scotland; Univ Padua, NE Italy Registry Congenital Malformat, Padua, Italy	University of London; London School of Hygiene & Tropical Medicine; Ulster University; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Southern Denmark; University of London; Queen Mary University London; Newcastle University - UK; University of Glasgow; University of Padua	Vrijheid, M (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, Keppel St, London WC1E 7HT, England.		Bianchi, Fabrizio/F-7900-2015; Vrijheid, Martine/H-2702-2014	Bianchi, Fabrizio/0000-0002-3459-9301; Vrijheid, Martine/0000-0002-7090-1758; armstrong, benedict/0000-0003-4407-0409				Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; DOLK H, 1999, DIS MAPPING RISK ASS; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; VJIJHEID M, 2000, THESIS U LONDON LOND; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349	5	53	55	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					320	322		10.1016/S0140-6736(02)07531-1	http://dx.doi.org/10.1016/S0140-6736(02)07531-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830202				2022-12-01	WOS:000173588100016
J	Huang, JK; Rozelle, S; Pray, C; Wang, QF				Huang, JK; Rozelle, S; Pray, C; Wang, QF			Plant biotechnology in China	SCIENCE			English	Article								A survey of China's plant biotechnologists shows that China is developing the largest plant biotechnology capacity outside of North America. The list of genetically modified plant technologies in trials, including rice, wheat, potatoes, and peanuts, is impressive and differs from those being worked on in other countries. Poor farmers in China are cultivating more area of genetically modified plants than are small farmers in any other developing country. A survey of agricultural producers in China demonstrates that Bacillus thuringiensis cotton adoption increases production efficiency and improves farmer health.	Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA; Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China	University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Rutgers State University New Brunswick; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Rozelle, S (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, 1 Shields Ave, Davis, CA 95616 USA.							BYLERLEE D, 2000, 4 INT C EC AGR BIOT; COURTMANCHE A, 2001, IMPROTANCE INTELLECT; HUANG J, 2000, CHINAS AGR RES INVES, P105; HUANG J, 2001, SMALL HOLDERS TRANSG; HUANG J, 2001, BIOTECHNOLOGY ALTERN; HUANG JK, 2001, AGR BIOTECHNOLOGY DE; JAMES C, 2000, ISAAA BRIEFS, V17, P65; PAARLBERG RL, 2001, 16 20 20 VIS PEAC EN; Pray C, 2001, WORLD DEV, V29, P813, DOI 10.1016/S0305-750X(01)00010-9; PRAY CE, 2001, 2001 AM AGR EC ASS A; PRAY CE, 2001, PRIVATE SECTOR INVES; QAIM M, 2001, SITUATION AGR BIOTEC; *WORLD BANK, 2000, ENT 21 CENT WORLD DE, P821; XU Z, 2000, BIOL ENG PROGR, V20, P20	14	273	329	7	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					674	677		10.1126/science.1067226	http://dx.doi.org/10.1126/science.1067226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809972				2022-12-01	WOS:000173560900044
J	Reynolds, T				Reynolds, T			Switching from prescription to over the counter	ANNALS OF INTERNAL MEDICINE			English	Article																			0	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					177	180		10.7326/0003-4819-136-2-200201150-00026	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790082				2022-12-01	WOS:000173333900019
J	Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B				Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B			Cytoplasmic dynein as a facilitator of nuclear envelope breakdown	CELL			English	Article							INTEGRAL MEMBRANE-PROTEINS; RAT KANGAROO CELLS; PHOSPHORYLATION SITES; MAMMALIAN-CELLS; CYSTEINE-RICH; LIVING CELLS; LAMIN-A; DYNACTIN; MITOSIS; END	During prophase in higher cells, centrosomes localize to deep invaginations in the nuclear envelope in a microtubule-dependent process. Loss of nuclear membranes In prometaphase commences in regions of the nuclear envelope that lie outside of these invaginations. Dynein and dynactin complex components concentrate on the nuclear envelope prior to any changes in nuclear envelope organization. These observations suggest a model in which dynein facilitates nuclear envelope breakdown by pulling nuclear membranes and associated proteins poleward along astral microtubules leading to nuclear membrane detachment. Support for this model is provided by the finding that interference with dynein function drastically alters nuclear membrane dynamics in prophase and prometaphase.	Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Calgary; Johns Hopkins University	Burke, B (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	bburke@anatomy.med.ufl.edu	Eckley, David Mark/I-9245-2019; Eckley, Mark/M-3526-2014	Eckley, Mark/0000-0003-2296-5164; Schroer, Trina/0000-0002-5065-1835	NIGMS NIH HHS [R01 GM044589] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879; ASH JF, 1977, P NATL ACAD SCI USA, V74, P5584, DOI 10.1073/pnas.74.12.5584; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bodoor K, 1999, J CELL SCI, V112, P2253; BURKE B, 1990, EXP CELL RES, V186, P169, DOI 10.1016/0014-4827(90)90223-W; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Collas P, 2000, TRENDS CELL BIOL, V10, P5, DOI 10.1016/S0962-8924(99)01697-9; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mack GJ, 1998, ARTHRITIS RHEUM, V41, P551; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NUSSE M, 1984, CELL TISSUE KINET, V17, P13, DOI 10.1111/j.1365-2184.1984.tb00564.x; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PFALLER R, 1995, J BIOL CHEM, V270, P19066, DOI 10.1074/jbc.270.32.19066; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; RATTNER JB, 1976, CYTOBIOS, V15, P37; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Vierula PJ, 1997, MOL MICROBIOL, V24, P331, DOI 10.1046/j.1365-2958.1997.3461704.x; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WATERMANSTORER CM, 1993, CELL MOTIL CYTOSKEL, V26, P19, DOI 10.1002/cm.970260104; Whitehead CM, 1996, ARTHRITIS RHEUM, V39, P1635, DOI 10.1002/art.1780391005; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; ZELIGS JD, 1979, J ULTRA MOL STRUCT R, V66, P53, DOI 10.1016/S0022-5320(79)80065-9	59	280	292	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					97	107		10.1016/S0092-8674(01)00628-6	http://dx.doi.org/10.1016/S0092-8674(01)00628-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792324	Bronze			2022-12-01	WOS:000173280700011
J	Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A				Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A			Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA BLOCKADE; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; NATIONAL REGISTRY; WOMEN; MORTALITY; MEN; SURVIVAL; REVASCULARIZATION; MANAGEMENT	Context A higher mortality risk for women with acute myocardial infarction (AMI) is a common finding in studies that compare the postinfarction outcome of women vs men. It is not clear, however, whether sex is an independent predictor of death among patients systematically treated with aggressive reperfusion and medical strategies. Objective To assess the impact of patient's sex on outcome in a consecutive series of patients with AMI treated with a reperfusion strategy largely based on percutaneous coronary interventions. Design, Setting, and Patients Inception cohort of 1937 patients (502 women and 1435 men) who were admitted with a diagnosis of AMI to a tertiary referral institution between January 1995 and December 2000. Main Outcome Measures Mortality at 1 year after AMI. Results Compared with men, women were older (70 vs 61 years; P<.001) and had known diabetes or hypertension more often. Both men and women received essentially identical therapy with the majority of patients (86%) receiving reperfusion therapy via percutaneous coronary interventions. There were no significant differences in 1-year Kaplan-Meier death rates with 13.8% (68 cases) among women and 12.9% (184 cases) among men (unadjusted hazard ratio, 1.06; 95% confidence interval, 0.80-1.39; P=.70). After age adjustment, women had a lower risk of death (hazard ratio, 0.65; 95% confidence interval, 0.49-0.87; P=.004). Conclusion Despite their more advanced age and greater prevalence of diabetes or hypertension, women with AMI who were treated with a reperfusion strategy largely based on percutaneous coronary interventions show a similar outcome as men.	Deutsch Herzzentrum Munich, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts Isar 1, D-8000 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Kastrati, A (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					*AM HEART ASS, 2000, 2001 HEART STROK STA, P6; [Anonymous], 1986, LANCET, V2, P57; Antoniucci D, 2001, AM J CARDIOL, V87, P289, DOI 10.1016/S0002-9149(00)01360-6; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BECKER RC, 1994, ANN INTERN MED, V120, P638, DOI 10.7326/0003-4819-120-8-199404150-00003; Bell DM, 2000, PHARMACOTHERAPY, V20, P1034, DOI 10.1592/phco.20.13.1034.35034; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; Cho L, 2000, J WOMEN HEALTH GEN-B, V9, P741, DOI 10.1089/15246090050147718; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; French JK, 1996, BMJ-BRIT MED J, V312, P1637, DOI 10.1136/bmj.312.7047.1637; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Hannan EL, 2000, J AM COLL CARDIOL, V36, P1194, DOI 10.1016/S0735-1097(00)00866-4; HARRELL FE, 1997, PREDICTING OUTCOMES, P290; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LINCOFF AM, 1993, J AM COLL CARDIOL, V22, P1780, DOI 10.1016/0735-1097(93)90757-R; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; STONE GW, 1995, AM J CARDIOL, V75, P987, DOI 10.1016/S0002-9149(99)80709-7; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; VACEK JL, 1995, AM J CARDIOL, V76, P226, DOI 10.1016/S0002-9149(99)80070-8; VACEK JL, 1993, AM HEART J, V126, P521, DOI 10.1016/0002-8703(93)90399-T; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; WHITE HD, 1993, CIRCULATION, V88, P2097, DOI 10.1161/01.CIR.88.5.2097	40	124	130	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					210	215		10.1001/jama.287.2.210	http://dx.doi.org/10.1001/jama.287.2.210			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779263				2022-12-01	WOS:000173114900023
J	Montgomery, SM; Ekbom, A				Montgomery, SM; Ekbom, A			Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort	BRITISH MEDICAL JOURNAL			English	Article									Karolinska Sjukuset, Klin Epidemiol, SE-17176 Stockholm, Sweden		Montgomery, SM (corresponding author), Karolinska Sjukuset, Klin Epidemiol, SE-17176 Stockholm, Sweden.		Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; EKINSMYTH C, 1992, INTEGRATED APPROACH; FERRI E, 1993, LIFE 33 5 FOLLOW UP; ORAHILLY S, 1987, BRIT MED J, V294, P923, DOI 10.1136/bmj.294.6577.923; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/BF00403383	5	159	165	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2002	324	7328					26	27		10.1136/bmj.324.7328.26	http://dx.doi.org/10.1136/bmj.324.7328.26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510JV	11777801	Bronze, Green Published			2022-12-01	WOS:000173205700020
J	Tregenza, T; Wedell, N				Tregenza, T; Wedell, N			Polyandrous females avoid costs of inbreeding	NATURE			English	Article							GRYLLUS-BIMACULATUS; FIELD CRICKET; GENETIC INCOMPATIBILITY; SPERM SELECTION; CHOICE; EVOLUTION; BENEFITS; RECOGNITION; CONFLICT; SUCCESS	Why do females typically mate with more than one male? Female mating patterns have broad implications for sexual selection(1,2), speciation(3) and conflicts of interest between the sexes(4), and yet they are poorly understood. Matings inevitably have costs(5), and for females, the benefits of taking more than one mate are rarely obvious. One possible explanation is that females gain benefits because they can avoid using sperm from genetically incompatible males, or invest less in the offspring of such males(6,7). It has been shown that mating with more than one male can increase offspring viability(8-12), but we present the first clear demonstration that this occurs because females with several mates avoid the negative effects of genetic incompatibility(13). We show that in crickets, the eggs of females that mate only with siblings have decreased hatching success. However, if females mate with both a sibling and a non-sibling they avoid altogether the low egg viability associated with sibling matings. If similar effects occur in other species, inbreeding avoidance may be important in understanding the prevalence of multiple mating.	Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Tregenza, T (corresponding author), Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England.	T.Tregenza@leeds.ac.uk	Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222				Andersson Malte, 1994; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Keil A, 1998, ETHOLOGY, V104, P897; Lorenz MW, 1998, ARCH INSECT BIOCHEM, V38, P32, DOI 10.1002/(SICI)1520-6327(1998)38:1&lt;32::AID-ARCH4&gt;3.0.CO;2-X; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Markow T.A., 1982, P273; Markow TA, 1997, P NATL ACAD SCI USA, V94, P7756, DOI 10.1073/pnas.94.15.7756; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; OLSSON M, 1994, NATURE, V369, P528, DOI 10.1038/369528b0; Parker G.A., 1979, P123; QAYYUM H A, 1969, Pakistan Journal of Scientific Research, V21, P112; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P197, DOI 10.1007/BF00303211; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SIMMONS LW, 1986, ANIM BEHAV, V34, P1463, DOI 10.1016/S0003-3472(86)80217-2; SIMMONS LW, 1990, ANIM BEHAV, V40, P192, DOI 10.1016/S0003-3472(05)80683-9; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P313, DOI 10.1007/BF00299969; Stockley P, 1999, P ROY SOC B-BIOL SCI, V266, P1663, DOI 10.1098/rspb.1999.0829; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI 10.1111/j.1558-5646.1998.tb02252.x; Tregenza T, 1997, ANIM BEHAV, V54, P979, DOI 10.1006/anbe.1997.0500; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	30	414	423	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					71	73		10.1038/415071a	http://dx.doi.org/10.1038/415071a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780118	Green Accepted			2022-12-01	WOS:000173028800041
J	Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ				Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ			Complementary signaling pathways regulate the unfolded protein response and are required for C-elegans development	CELL			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; STRESS; KINASE; IRE1; ER; IDENTIFICATION	The unfolded protein response (UPR) is a transcriptional and translational intracellular signaling pathway activated by the accumulation of unfolded proteins in the lumen of the endoplasmic reticulum (ER). We have used C. elegans as a genetic model system to dissect UPR signaling in a multicellular organism. C. elegans requires ire-l-mediated splicing of xbp-1 mRNA for UPR gene transcription and survival upon ER stress. In addition, ire-1/xbp-1 acts with pek-1, a protein kinase that mediates translation attenuation, in complementary pathways that are essential for worm development and survival. We propose that UPR transcriptional activation by ire-1 as well as translational attenuation by pek-1 maintain ER homeostasis. The results demonstrate that the UPR and ER homeostasis are essential for metazoan development.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068304, Japan	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Kyoto University	Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.			Yoshida, Hiderou/0000-0002-5773-1408	NIAID NIH HHS [5R01 AI-42394-04] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042394] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; BRENNER S, 1974, GENETICS, V77, P71; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen PJ, 2000, DEV BIOL, V217, P77, DOI 10.1006/dbio.1999.9521; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall DH, 1997, J NEUROSCI, V17, P1033; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; KOLDIN B, 1995, NUCLEIC ACIDS RES, V23, P4162, DOI 10.1093/nar/23.20.4162; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; LEE K, 2002, IN PRESS GENES DEV; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; MORI K, 1993, CELL, V74, P743; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIGURDSON DC, 1984, GENETICS, V108, P331; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wyllie A.H., 1981, CELL DEATH BIOL PATH, P9; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	53	523	550	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					893	903		10.1016/S0092-8674(01)00612-2	http://dx.doi.org/10.1016/S0092-8674(01)00612-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779465	Bronze			2022-12-01	WOS:000173024200010
J	Washington, MT; Prakash, L; Prakash, S				Washington, MT; Prakash, L; Prakash, S			Yeast DNA polymerase eta utilizes an induced-fit mechanism of nucleotide incorporation	CELL			English	Article							PIGMENTOSUM VARIANT CELLS; THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; KINETIC MECHANISM; I KLENOW; CRYSTAL-STRUCTURE; BASE-PAIRS; FIDELITY; REPLICATION; BYPASS	DNA polymerase eta (Pol eta) is unique among eukaryotic DNA polymerases in its proficient ability to replicate through distorting DNA lesions, and Pol eta synthesizes DNA with a low fidelity. Here, we use pre-steady-state kinetics to investigate the mechanism of nucleotide incorporation by Pol eta and show that it utilizes an induced-fit mechanism to selectively incorporate the correct nucleotide. Pol eta discriminates poorly between the correct and incorrect nucleotide at both the initial nucleotide binding step and at the subsequent induced-fit conformational change step, which precedes the chemical step of phosphodiester bond formation. This property enables Pol eta to bypass lesions with distorted DNA geometries, and it bestows upon the enzyme a low fidelity.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Blocker Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.	sprakash@scms.utmb.edu	Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261; Washington, Todd/0000-0001-8680-2992	NIGMS NIH HHS [GM 19261] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Johnson KA, 1998, CURR OPIN BIOTECH, V9, P87, DOI 10.1016/S0958-1669(98)80089-X; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; KATI WM, 1992, J BIOL CHEM, V267, P25988; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; McDonald JP, 1997, GENETICS, V147, P1557; Minko IG, 2001, J BIOL CHEM, V276, P2517, DOI 10.1074/jbc.M007867200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	53	111	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					917	927		10.1016/S0092-8674(01)00613-4	http://dx.doi.org/10.1016/S0092-8674(01)00613-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779467	Bronze			2022-12-01	WOS:000173024200012
J	Bhalla, P; Pippa, S; Williams, G				Bhalla, P; Pippa, S; Williams, G			An inexpensive and edible aid for the diagnosis of puberty in the male: multispecies evaluation of an alternative orchidometer	BRITISH MEDICAL JOURNAL			English	Article									Univ Hosp Aintree, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AE, Merseyside, England	University of Liverpool	Williams, G (corresponding author), Univ Hosp Aintree, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AE, Merseyside, England.							Chen M, 2000, BRIT MED J, V321, P1565, DOI 10.1136/bmj.321.7276.1565; Chipkevitch E, 1996, J UROLOGY, V156, P2050, DOI 10.1016/S0022-5347(01)65433-8; Prader A, 1966, Triangle, V7, P240; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Williams TM, 1995, BRIT MED J, V311, P1700, DOI 10.1136/bmj.311.7021.1700	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1486	1486		10.1136/bmj.323.7327.1486	http://dx.doi.org/10.1136/bmj.323.7327.1486			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751366	Green Published			2022-12-01	WOS:000172979900027
J	Lee, WH; Boyer, TG				Lee, WH; Boyer, TG			BRCA1 and BRCA2 in breast cancer	LANCET			English	Article									Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.								0	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S5	S5		10.1016/S0140-6736(01)07018-0	http://dx.doi.org/10.1016/S0140-6736(01)07018-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784554	Bronze			2022-12-01	WOS:000172907200005
J	Zhang, QH; Piston, DW; Goodman, RH				Zhang, QH; Piston, DW; Goodman, RH			Regulation of corepressor function by nuclear NADH	SCIENCE			English	Article							CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; PROTEIN SIR2; TRANSFORMATION; TRANSCRIPTION; METASTASIS; CARCINOMA; CELLS; CTBP	The corepressor CtBP (carboxyl-terminal binding protein) is involved in transcriptional pathways important for development, cell cycle regulation, and transformation. We demonstrate that CtBP binding to cellular and viral transcriptional repressors is regulated by the nicotinamide adenine dinucleotides NAD(+) and NADH, with NADH being two to three orders of magnitude more effective. Levels of free nuclear nicotinamide adenine dinucleotides, determined using two-photon microscopy, correspond to the levels required for half-maximal CtBP binding and are considerably tower than those previously reported. Agents capable of increasing NADH levels stimulate CtBP binding to its partners in vivo and potentiate CtBP-mediated repression. We propose that this ability to detect changes in nuclear NAD(+)/NADH ratio allows CtBP to serve as a redox sensor for transcription.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NCI NIH HHS [R01 CA115468-05, K01 CA096561, R01 CA115468] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA096561, R01CA115468] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; French T, 1998, METHOD CELL BIOL, V56, P277, DOI 10.1016/S0091-679X(08)60431-8; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PHILIPPIDIS H, 1969, BIOCHEM J, V113, P651, DOI 10.1042/bj1130651; PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shigemori K, 1996, AM J PHYSIOL-LUNG C, V270, pL803, DOI 10.1152/ajplung.1996.270.5.L803; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zhang Q., UNPUB	22	474	485	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1895	1897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11847309				2022-12-01	WOS:000174299500040
J	Drake, MJ; Jakosky, BM				Drake, MJ; Jakosky, BM			Narrow horizons in astrobiology	NATURE			English	Editorial Material									Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Arizona; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Drake, MJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.							Gee H, 2001, NATURE, V409, P1079; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					733	734		10.1038/415733a	http://dx.doi.org/10.1038/415733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845181				2022-12-01	WOS:000173833900022
J	Sharon, D; Grinvald, A				Sharon, D; Grinvald, A			Dynamics and constancy in cortical spatiotemporal patterns of orientation processing	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SIMPLE CELLS; POSTSYNAPTIC POTENTIALS; THALAMIC INPUT; SELECTIVITY; INHIBITION; NEURONS; ORGANIZATION; EXCITATION	How does the high selectivity to stimulus orientation emerge in the visual cortex? Thalamic feedforward-dominated models of orientation selectivity predict constant selectivity during the visual response, whereas intracortical recurrent models predict dynamic improvement in selectivity. We imaged the cat visual cortex with voltage-sensitive dyes to measure orientation-tuning dynamics of a large neuronal population. Tuning-curve width did not narrow after response onset, whereas the difference between preferred and orthogonal responses (modulation depth) first increased, then declined. We identified a suppression of the evoked responses, referred to as the evoked deceleration-acceleration (DA) notch, which was larger for the orthogonal response, Furthermore, peak selectivity of the tuning curves was contemporaneous with the evoked DA notch. These findings suggest that in the cat brain, sustained visual cortical processing does not narrow orientation tuning; rather, intracortical interactions may amplify modulation depth and suppress the orthogonal response relatively more than the preferred, Thus, feedforward models and recurrent models of orientation selectivity must be combined.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Sharon, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Anderson Jessie Annie, COMMUNICATION; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STERKIN, UNPUB; Sterkin A., 1999, Society for Neuroscience Abstracts, V25, P784; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919	31	73	75	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					512	515		10.1126/science.1065916	http://dx.doi.org/10.1126/science.1065916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799249				2022-12-01	WOS:000173350700055
J	Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B				Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B			The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation	CELL			English	Article							VERTEBRATE LIMB DEVELOPMENT; PROMOTER REGION; BINDING-SITES; GENE PROMOTER; CHONDROCYTES; CBFA1; PROTEINS; SEQUENCE; LINEAGE; TISSUES	We have identified a novel zinc finger-containing transcription factor, called Osterix (Osx), that is specifically expressed in all developing bones. In Osx null mice, no bone formation occurs. In endochondral skeletal elements of Osx null mice, mesenchymal cells, together with osteoclasts and blood vessels, invade the mineralized cartilage matrix. However, the mesenchymal cells do not deposit bone matrix. Similarly, cells in the periosteum and in the condensed mesenchyme of membranous skeletal elements cannot differentiate into osteoblasts. These cells do, however, express Runx2/Cbfa1, another transcription factor required for bone formation. In contrast, Osx is not expressed in Runx2/Cbfa1 null mice. Thus, Osx acts downstream of Runx2/Cbfa1. Because Osx null preosteoblasts express typical chondrocyte marker genes, we propose that Runx2/Cbfa1-expressing preosteoblasts are still bipotential cells.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	de Crombrugghe, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Kunkel, Gary/0000-0002-4199-369X; Nakashima, Kazuhisa/0000-0003-0491-2149	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16672] Funding Source: Medline; NIAMS NIH HHS [P01 AR42919] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Ausubel F, 1995, SHORT PROTOCOLS MOL; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; CHEN JK, 1992, J BONE MINER RES, V7, P987; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; HOGAN B, 1994, MAIPULATING MOUSE EM; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1	35	2612	2740	6	223	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					17	29		10.1016/S0092-8674(01)00622-5	http://dx.doi.org/10.1016/S0092-8674(01)00622-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792318	Bronze			2022-12-01	WOS:000173280700005
J	Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M				Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M			Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry	NATURE			English	Article							YEAST; CHECKPOINT; DEGRADATION; PATHWAYS; LIGASE; DOMAIN; REPAIR	The recent abundance of genome sequence data has brought an urgent need for systematic proteomics to decipher the encoded protein networks that dictate cellular function(1). To date, generation of large-scale protein-protein interaction maps has relied on the yeast two-hybrid system, which detects binary interactions through activation of reporter gene expression(2-4). With the advent of ultrasensitive mass spectrometric protein identification methods, it is feasible to identify directly protein complexes on a proteome-wide scale(5,6). Here we report, using the budding yeast Saccharomyces cerevisiae as a test case, an example of this approach, which we term high-throughput mass spectrometric protein complex identification (HMS-PCI). Beginning with 10% of predicted yeast proteins as baits, we detected 3,617 associated proteins covering 25% of the yeast proteome. Numerous protein complexes were identified, including many new interactions in various signalling pathways and in the DNA damage response. Comparison of the HMS-PCI data set with interactions reported in the literature revealed an average threefold higher success rate in detection of known complexes compared with large-scale two-hybrid studies(3,4). Given the high degree of connectivity observed in this study, even partial HMS-PCI coverage of complex proteomes, including that of humans, should allow comprehensive identification of cellular networks.	MDS Proteom, Toronto, ON M9W 7H4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Figeys, D (corresponding author), MDS Proteom, 251 Attwell Dr, Toronto, ON M9W 7H4, Canada.		Moran, Michael/GYD-3631-2022; Podtelejnikov, Alexandre/B-6120-2017; Tyers, Michael/ABE-3194-2021; Hogue, Christopher W V/AAZ-3934-2020; Bader, Gary/C-1176-2009; Hogue, Christopher/B-6726-2008; Donaldson, Ian/A-2867-2009; Durocher, Daniel/A-7733-2010; Heilbut, Adrian M/J-9427-2012; Pawson, Tony J/E-4578-2013; Mann, Matthias/A-3454-2013	Podtelejnikov, Alexandre/0000-0002-8124-6584; Hogue, Christopher W V/0000-0002-3107-5246; Bader, Gary/0000-0003-0185-8861; Donaldson, Ian/0000-0002-4203-8328; Durocher, Daniel/0000-0003-3863-8635; Heilbut, Adrian M/0000-0002-8169-7967; Mann, Matthias/0000-0003-1292-4799; Figeys, Daniel/0000-0002-5373-7546; Bennett, Keiryn L./0000-0001-9356-7708				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen P, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1022, DOI 10.1186/GB-2000-1-3-REVIEWS1022]; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Marsolier MC, 2000, GENETICS, V154, P1523; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pawson T, 2000, GENE DEV, V14, P1027; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tyers M, 1999, P NATL ACAD SCI USA, V96, P12230, DOI 10.1073/pnas.96.22.12230; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	30	2820	2923	4	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					180	183		10.1038/415180a	http://dx.doi.org/10.1038/415180a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805837				2022-12-01	WOS:000173159300044
J	Nasrin, D; Collignon, PJ; Roberts, L; Wilson, EJ; Pilotto, LS; Douglas, RM				Nasrin, D; Collignon, PJ; Roberts, L; Wilson, EJ; Pilotto, LS; Douglas, RM			Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; CARRIAGE	Objective To examine the relation between use of antibiotics in a cohort of preschool children and nasal carriage of resistant strains of pneumococcus. Design and participants Prospective cohort study over two years of 461 children aged under 4 years living in Canberra, Australia. Main outcome measures Use of drugs, respiratory symptoms, and visits to doctors were documented in a daily diary by parents of the children during 25 months of observation. Isolates of pneumococci, which were cultured from nasal swabs collected approximately six monthly, were tested for antibiotic resistance. Results From the four swab collections 631 positive pneumococcal isolates from 461 children were found, of which 13.6% were resistant to penicillin. Presence of penicillin resistant pneumococci was significantly associated with children's use of a beta lactam antibiotic in the two months before each swab collection (odds ratio 2.03 (95% confidence interval 1.15 to 3.56, P = 0.01)). The odds ratio of the association remained >1 (though did not reach significance at the 0.05 level) for use in the six months before swab collection. The association was seen in children who received only penicillin or only cephalosporin antibiotics in that period. The odds ratio was 4.67 (1.29 to 17.09, P = 0.02) in children who had received both types of beta lactam in the two months before their nasal swab. The modelled odds of carrying penicillin resistant pneumococcus was 4% higher for each additional day 0 of use of beta lactam antibiotics in die six months before swab collection. Conclusions Reduction in beta lactam use could quickly reduce the carriage rates of penicillin resistant pneumococci in early childhood. In view of the propensity of these organisms to be spread among children in the community, the prevalence of penicillin resistant organisms may fall as a consequence.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Canberra Hosp, Infect Dis Unit, Canberra, ACT, Australia; Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia; Flinders Univ S Australia, Dept Gen Practice, Adelaide, SA 5001, Australia	Australian National University; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital; Flinders University South Australia	Nasrin, D (corresponding author), 9C-A Impiana Condo,1 Tasik Ampang, Ampang 68000, Selangor, Malaysia.		Collignon, Peter/U-4846-2019	Collignon, Peter/0000-0001-8648-9203				Arason VA, 1996, BMJ-BRIT MED J, V313, P387; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; DELMAR CB, 2000, COCHRANE DATABASE SY; DOUGLAS RM, 1986, AM J DIS CHILD, V140, P1183, DOI 10.1001/archpedi.1986.02140250109044; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Hennekens C., 1987, EPIDEMIOLOGY MED; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; LINARES J, 1992, CLIN INFECT DIS, V15, P99, DOI 10.1093/clinids/15.1.99; Low DE, 1998, JAMA-J AM MED ASSOC, V279, P394, DOI 10.1001/jama.279.5.394; NASRIN D, 2000, THESIS AUSTR NATL U; *NAT COMM CLIN LAB, 1994, M100S5 NCCLS; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; Turnidge JD, 1999, MED J AUSTRALIA, V170, P152, DOI 10.5694/j.1326-5377.1999.tb127710.x; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; [No title captured]	16	101	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2002	324	7328					28	30A		10.1136/bmj.324.7328.28	http://dx.doi.org/10.1136/bmj.324.7328.28			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510JV	11777803	Green Published, Bronze			2022-12-01	WOS:000173205700022
J	Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G				Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G			Carnivorous plants - Mass march of termites into the deadly trap	NATURE			English	Article							BORNEO		Univ Frankfurt, Inst Zool, Fachbereich Biol, D-60054 Frankfurt, Germany; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ Frankfurt, D-60325 Frankfurt, Germany; Forschungsinst Senckenberg, D-60325 Frankfurt, Germany	Goethe University Frankfurt; University of Wurzburg; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Merbach, MA (corresponding author), Univ Frankfurt, Inst Zool, Fachbereich Biol, Postfach 111932, D-60054 Frankfurt, Germany.		Fiala, Brigitte/I-3788-2016	Fiala, Brigitte/0000-0002-9625-1933				ADAMJUMAAT H, 1997, PERTANIKA J TROP AGR, V20, P121; Clarke C, 1997, NEPENTHES BORNEO; JONES DT, 1995, INSECT SOC, V42, P359, DOI 10.1007/BF01242164; KATO Y, 1993, J HOKKAIDO BRAIN RES, V6, P11; Miura T, 1997, INSECT SOC, V44, P267, DOI 10.1007/s000400050047; Moran JA, 1999, ANN BOT-LONDON, V83, P521, DOI 10.1006/anbo.1999.0857; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474	7	44	46	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					36	37		10.1038/415036a	http://dx.doi.org/10.1038/415036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780106				2022-12-01	WOS:000173028800029
J	Quaini, F; Urbanek, K; Beltrami, AP; Finato, N; Beltrami, CA; Nadal-Ginard, B; Kajstura, J; Leri, A; Anversa, P				Quaini, F; Urbanek, K; Beltrami, AP; Finato, N; Beltrami, CA; Nadal-Ginard, B; Kajstura, J; Leri, A; Anversa, P			Chimerism of the transplanted heart (Publication with Expression of Concern. See vol. 379, pg. 1870, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Publication with Expression of Concern							IN-SITU HYBRIDIZATION; STEM-CELLS; P-GLYCOPROTEIN; VENTRICULAR MYOCYTES; ENDOTHELIAL-CELLS; MUSCLE; ORIGIN; CHROMOSOME; MECHANISMS; EXPRESSION	Background: Cases in which a male patient receives a heart from a female donor provide an unusual opportunity to test whether primitive cells translocate from the recipient to the graft and whether cells with the phenotypic characteristics of those of the recipient ultimately reside in the donor heart. The Y chromosome can be used to detect migrated undifferentiated cells expressing stem-cell antigens and to discriminate between primitive cells derived from the recipient and those derived from the donor. Methods: We examined samples from the atria of the recipient and the atria and ventricles of the graft by fluorescence in situ hybridization to determine whether Y chromosomes were present in eight hearts from female donors implanted into male patients. Primitive cells bearing Y chromosomes that expressed c-kit, MDR1, and Sca-1 were also investigated. Results: Myocytes, coronary arterioles, and capillaries that had a Y chromosome made up 7 to 10 percent of those in the donor hearts and were highly proliferative. As compared with the ventricles of control hearts, the ventricles of the transplanted hearts had markedly increased numbers of cells that were positive for c-kit, MDR1, or Sca-1. The number of primitive cells was higher in the atria of the hosts and the atria of the donor hearts than in the ventricles of the donor hearts, and 12 to 16 percent of these cells contained a Y chromosome. Undifferentiated cells were negative for markers of bone marrow origin. Progenitor cells expressing MEF2, GATA-4, and nestin (which identify the cells as myocytes) and Flk1 (which identifies the cells as endothelial cells) were identified. Conclusions: Our results show a high level of cardiac chimerism caused by the migration of primitive cells from the recipient to the grafted heart. Putative stem cells and progenitor cells were identified in control myocardium and in increased numbers in transplanted hearts. (N Engl J Med 2002;346:5-15.) Copyright (C) 2002 Massachusetts Medical Society.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; Univ Udine, Dept Pathol, I-33100 Udine, Italy	New York Medical College; University of Udine	Anversa, P (corresponding author), New York Med Coll, Dept Med, Vosburgh Pavil, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu	Beltrami, Antonio/C-5291-2008; Mordwinkin, Nicholas M/A-4347-2010; Finato, Nicoletta/A-7351-2010; beltrami, carlo a/A-8026-2008	Beltrami, Antonio/0000-0002-0679-2710; Quaini, Federico/0000-0003-2377-4810	NHLBI NIH HHS [HL-65577, HL-66923, HL-65573, HL-39902, HL-38132] Funding Source: Medline; NIA NIH HHS [AG-17042, AG-15756] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066923, R01HL065577, R01HL038132, R01HL039902, R01HL065573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017042, R01AG015756] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami CA, 1997, J MOL CELL CARDIOL, V29, P2789, DOI 10.1006/jmcc.1997.0514; Bunting Kevin D., 2000, Blood, V96, P902; Byrne JG, 2000, J HEART LUNG TRANSPL, V19, P786, DOI 10.1016/S1053-2498(00)00130-3; Demetris A J, 1997, Ann Transplant, V2, P27; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; Frede S E, 1996, Transpl Immunol, V4, P227, DOI 10.1016/S0966-3274(96)80022-0; Fyfe B, 1996, CIRCULATION, V93, P1133, DOI 10.1161/01.CIR.93.6.1133; Gaetano C, 2001, CIRC RES, V88, pE38; Hafizi S, 1997, CURR OPIN CARDIOL, V12, P495, DOI 10.1097/00001573-199711000-00001; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hessel H, 1996, HISTOCHEM CELL BIOL, V106, P481, DOI 10.1007/s004180050067; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; HRUBAN RH, 1993, AM J PATHOL, V142, P975; Ichikawa N, 2000, LIVER TRANSPLANT, V6, P686, DOI 10.1053/jlts.2000.19029; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; KENNEDY LJ, 1971, NEW ENGL J MED, V285, P884, DOI 10.1056/NEJM197110142851603; Kitagawa-Sakakida S, 2000, J HEART LUNG TRANSPL, V19, P584, DOI 10.1016/S1053-2498(00)00105-4; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Miles C, 1997, DEVELOPMENT, V124, P537; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pauly RR, 1997, METHOD CELL BIOL, V52, P133, DOI 10.1016/S0091-679X(08)60377-5; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Triulzi DJ, 2001, TRANSFUSION, V41, P419, DOI 10.1046/j.1537-2995.2001.41030419.x; Wagoner LE, 1996, CIRCULATION, V93, P111, DOI 10.1161/01.CIR.93.1.111; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wollensak G, 1999, EXP EYE RES, V68, P341, DOI 10.1006/exer.1998.0611; Wu M, 2000, GENE DEV, V14, P301; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	39	945	1054	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					5	15		10.1056/NEJMoa012081	http://dx.doi.org/10.1056/NEJMoa012081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11777997	Bronze			2022-12-01	WOS:000173033600002
J	Parker, RA				Parker, RA			Caring for patients at the end of life: Reflections after 12 years of practice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Physicians have the privilege and authority to assist patients and their families at the end of life. Regardless of diagnosis, commonalities occur in the dying process, and palliative care benefits patients and families. This perspective chronicles my experience over 12 years caring for 95 patients at the end of life, illustrated in part with six vignettes. I describe interactions with families, discuss logistic issues around dying, examine the do-not-resuscitate issue, and highlight experiences with home visits. I also touch on how I communicate with the family after a death. I hope to express the significance of what I have learned while assisting patients and families at this critical juncture.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Healthcare Associates, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Parker, RA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Healthcare Associates, 1 Autumn St, Boston, MA 02215 USA.	raparker@caregroup.harvard.edu							0	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2002	136	1					72	75		10.7326/0003-4819-136-1-200201010-00012	http://dx.doi.org/10.7326/0003-4819-136-1-200201010-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510BF	11777365				2022-12-01	WOS:000173188300007
J	McPhee, S; Markowitz, AJ				McPhee, S; Markowitz, AJ			Psychological considerations, growth, and transcendence at the end of life - The art of the possible	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; Hall D, 1998, WITHOUT POEMS; Kenyon Jane, 1996, OTHERWISE NEW SELECT; Nouwen H. J. M., 1994, OUR GREATEST GIFT ME	4	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					3002	3002		10.1001/jama.286.23.3002	http://dx.doi.org/10.1001/jama.286.23.3002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502VY	11743842				2022-12-01	WOS:000172764500033
J	Goodner, B; Hinkle, G; Gattung, S; Miller, N; Blanchard, M; Qurollo, B; Goldman, BS; Cao, YW; Askenazi, M; Halling, C; Mullin, L; Houmiel, K; Gordon, J; Vaudin, M; Iartchouk, O; Epp, A; Liu, F; Wollam, C; Allinger, M; Doughty, D; Scott, C; Lappas, C; Markelz, B; Flanagan, C; Crowell, C; Gurson, J; Lomo, C; Sear, C; Strub, G; Cielo, C; Slater, S				Goodner, B; Hinkle, G; Gattung, S; Miller, N; Blanchard, M; Qurollo, B; Goldman, BS; Cao, YW; Askenazi, M; Halling, C; Mullin, L; Houmiel, K; Gordon, J; Vaudin, M; Iartchouk, O; Epp, A; Liu, F; Wollam, C; Allinger, M; Doughty, D; Scott, C; Lappas, C; Markelz, B; Flanagan, C; Crowell, C; Gurson, J; Lomo, C; Sear, C; Strub, G; Cielo, C; Slater, S			Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; ALPHA-PROTEOBACTERIA; ESCHERICHIA-COLI; DNA; PLASMID; TUMOR; TRANSFORMATION; EVOLUTION; SYMBIONT; EXPORT	Agrobacterium tumefaciens is a plant pathogen capable of transferring a defined segment of DNA to a host plant, generating a gall tumor. Replacing the transferred tumor-inducing genes with exogenous DNA allows the introduction of any desired gene into the plant. Thus, A. tumefaciens has been critical for the development of modern plant genetics and agricultural biotechnology. Here we describe the genome of A. tumefaciens strain C58, which has an unusual structure consisting of one circular and one linear chromosome. We discuss genome architecture and evolution and additional genes potentially involved in virulence and metabolic parasitism of host plants.	Cereon Genom LLC, Cambridge, MA 02139 USA; Univ Richmond, Dept Biol, Richmond, VA 23173 USA; Hiram Coll, Dept Biol, Hiram, OH 44234 USA; Monsanto Co, St Louis, MO 63167 USA	University of Richmond; Hiram College; Monsanto	Slater, S (corresponding author), Cereon Genom LLC, 45 Sidney St, Cambridge, MA 02139 USA.	steven.c.slater@cereon.com		Miller, Nora/0000-0003-0764-8881; Qurollo, Barbara/0000-0002-9849-2511; Askenazi, Manor/0000-0003-1646-833X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM061690] Funding Source: NIH RePORTER; NIGMS NIH HHS [R15 GM61690-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLARDETSERVENT A, 1993, J BACTERIOL, V175, P7869, DOI 10.1128/JB.175.24.7869-7874.1993; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bhat TK, 1998, BIODEGRADATION, V9, P343, DOI 10.1023/A:1008397506963; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Brassinga AKC, 2001, J BACTERIOL, V183, P1824, DOI 10.1128/JB.183.5.1824-1829.2001; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dessaux Y., 1998, RHIZOBIACEAE MOL BIO, P173, DOI DOI 10.1007/978-94-011-5060-6_9; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Goodner BW, 1999, J BACTERIOL, V181, P5160, DOI 10.1128/JB.181.17.5160-5166.1999; HAMILTON RH, 1971, EXPERIENTIA, V27, P229, DOI 10.1007/BF02145913; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Jumas-Bilak E, 1998, J BACTERIOL, V180, P2749, DOI 10.1128/JB.180.10.2749-2755.1998; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KRISHNAN M, 1991, J BACTERIOL, V173, P903, DOI 10.1128/jb.173.2.903-905.1991; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; LAPOINTE G, 1992, J BACTERIOL, V174, P2631, DOI 10.1128/jb.174.8.2631-2639.1992; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Li PL, 2000, J BACTERIOL, V182, P179, DOI 10.1128/JB.182.1.179-188.2000; Lyi SM, 1999, MOL MICROBIOL, V31, P339, DOI 10.1046/j.1365-2958.1999.01178.x; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; OTTEN L, 1992, MOL PLANT MICROBE IN, V5, P279, DOI 10.1094/MPMI-5-279; PARKE D, 1995, J BACTERIOL, V177, P3808, DOI 10.1128/jb.177.13.3808-3817.1995; Penyalver R, 2001, APPL ENVIRON MICROB, V67, P654, DOI 10.1128/AEM.67.2.654-664.2001; Plano GV, 2001, MOL MICROBIOL, V40, P284, DOI 10.1046/j.1365-2958.2001.02354.x; Purcell M, 1998, INFECT IMMUN, V66, P2245, DOI 10.1128/IAI.66.5.2245-2255.1998; ROSENBERG C, 1984, MOL GEN GENET, V196, P533, DOI 10.1007/BF00436205; SCHLUTER A, 1995, MOL GEN GENET, V247, P206, DOI 10.1007/BF00705651; Schuerman PL, 1997, APPL MICROBIOL BIOT, V47, P560, DOI 10.1007/s002530050973; SHAW CH, 1991, BIOESSAYS, V13, P25, DOI 10.1002/bies.950130105; SKARSTAD K, COMMUNICATION; Smith EF, 1907, SCIENCE, V25, P671, DOI 10.1126/science.25.643.671; Subramaniyan S, 2000, FEMS MICROBIOL LETT, V183, P1, DOI 10.1111/j.1574-6968.2000.tb08925.x; Suzuki K, 2000, GENE, V242, P331, DOI 10.1016/S0378-1119(99)00502-8; Suzuki K, 2001, DNA RES, V8, P141, DOI 10.1093/dnares/8.4.141; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Topping J F, 1995, Methods Mol Biol, V49, P63; Van Montagu M., 1979, DEV GENETICS, P71; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; WILLEMS A, 1993, INT J SYST BACTERIOL, V43, P305, DOI 10.1099/00207713-43-2-305; Willis LB, 1999, J BACTERIOL, V181, P4176, DOI 10.1128/JB.181.14.4176-4184.1999; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	62	492	1177	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2323	2328		10.1126/science.1066803	http://dx.doi.org/10.1126/science.1066803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743194				2022-12-01	WOS:000172817200038
J	Brownlee, M				Brownlee, M			Biochemistry and molecular cell biology of diabetic complications	NATURE			English	Review							PROTEIN-KINASE-C; GLYCATION END-PRODUCTS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIUM-DEPENDENT VASODILATION; ALDOSE REDUCTASE INHIBITION; GLUCOSE-MODIFIED PROTEINS; GROWTH-FACTOR-BETA; FACTOR-KAPPA-B; NITRIC-OXIDE; NERVE-CONDUCTION	Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation. Four main molecular mechanisms have been implicated in glucose-mediated vascular damage. All seem to reflect a single hyperglycaemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain. This integrating paradigm provides a new conceptual framework for future research and drug discovery.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Brownlee, M (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	brownlee@aecom.yu.edu						Abordo EA, 1996, IMMUNOL LETT, V53, P7, DOI 10.1016/0165-2478(96)02601-6; CHARONIS AS, 1990, DIABETES, V39, P807, DOI 10.2337/diabetes.39.7.807; Chen YQ, 1998, J BIOL CHEM, V273, P8225, DOI 10.1074/jbc.273.14.8225; Coppey LJ, 2001, BRIT J PHARMACOL, V134, P21, DOI 10.1038/sj.bjp.0704216; CRAVEN PA, 1994, J CLIN INVEST, V93, P311, DOI 10.1172/JCI116961; Craven PA, 1997, DIABETES, V46, P671, DOI 10.2337/diabetes.46.4.671; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; CRAVEN RP, IN PRESS METABOLISM; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; DU XD, IN PRESS J CLIN INVE; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; ENGERMAN RL, 1994, DIABETOLOGIA, V37, P141, DOI 10.1007/s001250050084; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; FEDEROFF HJ, 1993, DIABETES, V42, P509, DOI 10.2337/diabetes.42.4.509; Feener EP, 1996, CONTRIB NEPHROL, V118, P180; Ganz MB, 2000, AM J PHYSIOL-ENDOC M, V278, pE146, DOI 10.1152/ajpendo.2000.278.1.E146; Gerstein HC, 2000, LANCET, V355, P253; Giardino I, 1996, J CLIN INVEST, V97, P1422, DOI 10.1172/JCI118563; GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Glogowski EA, 1999, KIDNEY INT, V55, P486, DOI 10.1046/j.1523-1755.1999.00284.x; Goldberg HJ, 2000, DIABETES, V49, P863, DOI 10.2337/diabetes.49.5.863; Greene DA, 1999, NEUROLOGY, V53, P580, DOI 10.1212/WNL.53.3.580; HAITOGLOU CS, 1992, J BIOL CHEM, V267, P12404; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; HENNEKENS, 1990, ARCH OPHTHALMOL-CHIC, V108, P1234; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Hsueh Willa A., 1998, American Journal of Medicine, V105, p4S, DOI 10.1016/S0002-9343(98)00205-8; HUIJBERTS MSP, 1993, J CLIN INVEST, V92, P1407, DOI 10.1172/JCI116716; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Keogh RJ, 1997, METABOLISM, V46, P41, DOI 10.1016/S0026-0495(97)90165-7; KIRSTEIN M, 1992, J CLIN INVEST, V90, P439, DOI 10.1172/JCI115879; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; Lu M, 1998, J CLIN INVEST, V101, P1219, DOI 10.1172/JCI1277; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Nakamura S, 1997, DIABETES, V46, P895, DOI 10.2337/diabetes.46.5.895; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Phillips SL, 1999, DIABETES, V48, P2083, DOI 10.2337/diabetes.48.10.2083; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Quinn M, 1996, DIABETOLOGIA, V39, P940; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; SCHMIDT RF, 1996, ESPRIT CACID, V1, P1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; SKOLNIK EY, 1991, J EXP MED, V174, P931, DOI 10.1084/jem.174.4.931; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; Stitt AW, 1997, AM J PATHOL, V150, P523; STUDER RK, 1993, DIABETES, V42, P118, DOI 10.2337/diabetes.42.1.118; Suzuki K, 1998, J BIOCHEM-TOKYO, V123, P353; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; TSILIBARY EC, 1988, J BIOL CHEM, V263, P4302; Tsuji H, 1998, BIOCHEM BIOPH RES CO, V245, P583, DOI 10.1006/bbrc.1998.8489; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Williams B, 1997, DIABETES, V46, P1497, DOI 10.2337/diabetes.46.9.1497; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; WILSON DC, 1992, ACTA PAEDIATR, V81, P84, DOI 10.1111/j.1651-2227.1992.tb12087.x; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; XIA P, 1995, J CLIN INVEST, V96, P733, DOI 10.1172/JCI118117; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855	99	6283	6803	40	1238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					813	820		10.1038/414813a	http://dx.doi.org/10.1038/414813a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742414				2022-12-01	WOS:000172676200062
J	Hunt, GR; Corballis, MC; Gray, RD				Hunt, GR; Corballis, MC; Gray, RD			Laterality in tool manufacture by crows - Neural processing and not ecological factors may influence 'handedness' in these birds.	NATURE			English	Article							MANUAL LATERALITY; CALEDONIAN CROWS; HAND; SPECIALIZATION; PAN		Univ Auckland, Dept Psychol, Auckland 92019, New Zealand	University of Auckland	Hunt, GR (corresponding author), Univ Auckland, Dept Psychol, Auckland 92019, New Zealand.		Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Corballis, Michael/0000-0002-3126-6114				Bradshaw JL., 1993, EVOLUTION LATERAL AS; BYRNE RW, 1991, CORTEX, V27, P521, DOI 10.1016/S0010-9452(13)80003-2; Corballis M.C., 1991, LOPSIDED APE EVOLUTI; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; HARRIS LJ, 1989, CAN J PSYCHOL, V43, P369, DOI 10.1037/h0084228; Hopkins WD, 1996, PSYCHON B REV, V3, P449, DOI 10.3758/BF03214548; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; McGrew WC, 1997, INT J PRIMATOL, V18, P787, DOI 10.1023/A:1026347913888; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0	12	62	64	1	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					707	707		10.1038/414707a	http://dx.doi.org/10.1038/414707a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501GD	11742382	Bronze			2022-12-01	WOS:000172676200030
J	Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M				Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M			Chiral amplification of oligopeptides in two-dimensional crystalline self-assemblies on water	SCIENCE			English	Article							OLIGOMERIZATION; ARCHITECTURES; POLYPEPTIDES; INTERFACE; DESIGN	Differences in the two-dimensional packing arrangements of racemic and enantiomeric crystalline self-assemblies on the water surface of amphiphilic activated analogs of lysine and glutamic acid have been used to prepare oligopeptides of homochiral sequence and oligopeptides of single handedness from chiral nonracemic mixtures. The crystalline structures on the water surface were determined by grazing incidence x-ray diffraction and the diastereomeric composition of the oligopeptides by matrix-assisted laser desorption time-of-flight mass spectrometry with enantio-labeling. These results suggest that reactivity of ordered clusters at interfaces might have played a role in the generation of early homochiral biopolymers.	Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark; Univ Paris 06, Lab Chim Struct Organ & Biol, F-75252 Paris 05, France	Weizmann Institute of Science; Technical University of Denmark; UDICE-French Research Universities; Sorbonne Universite	Lahav, M (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	leslie.leiserowitz@weizmann.ac.il; isabelle.weissbuch@welzmann.ac.il; meir.lahav@weizmann.ac.il		Jensen, Torben Rene/0000-0002-4278-3221				ADDADI L, 1977, ISRAEL J CHEM, V15, P116; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BANIEL A, 1948, J ORG CHEM, V13, P791, DOI 10.1021/jo01164a001; Blocher M, 2001, HELV CHIM ACTA, V84, P842, DOI 10.1002/1522-2675(20010418)84:4<842::AID-HLCA842>3.0.CO;2-1; BLOUT ER, 1957, J AM CHEM SOC, V79, P749, DOI 10.1021/ja01560a068; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; Bonner WA, 1999, ORIGINS LIFE EVOL B, V29, P329, DOI 10.1023/A:1006511115735; BRACK A, 1981, ORIGINS LIFE EVOL B, V11, P135, DOI 10.1007/BF00928004; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1; Deamer DW, 1997, MICROBIOL MOL BIOL R, V61, P239, DOI 10.1128/.61.2.239-261.1997; FRANCK P, 2000, CHEM 21 CENTURY, P175, DOI DOI 10.1002/9783527612949.CH11; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Fukuda K, 2000, ADV COLLOID INTERFAC, V87, P113, DOI 10.1016/S0001-8686(99)00041-X; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; Kuzmenko I, 2001, CHEM REV, V101, P1659, DOI 10.1021/cr990038y; LAHAV M, 1976, J AM CHEM SOC, V98, P1620, DOI 10.1021/ja00422a078; MASON S, 1984, NATURE, V310, P546, DOI 10.1038/310546b0; Saghatelian A, 2001, NATURE, V409, P797, DOI 10.1038/35057238; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; SHEEHAN JC, 1952, J AM CHEM SOC, V74, P4726, DOI 10.1021/ja01138a528; SHIBATA A, 1991, LANGMUIR, V7, P2261, DOI 10.1021/la00058a047; Siegel JS, 1998, CHIRALITY, V10, P24, DOI 10.1002/(SICI)1520-636X(1998)10:1/2<24::AID-CHIR5>3.0.CO;2-Y; Weissbuch I, 1997, J AM CHEM SOC, V119, P933, DOI 10.1021/ja9613926; Weissbuch I, 2000, CHEM-EUR J, V6, P725, DOI 10.1002/(SICI)1521-3765(20000218)6:4<725::AID-CHEM725>3.3.CO;2-5; WEISSBUCH I, 1994, PER SUPRAMOL CHEM, V1, P173; Zhang LS, 1999, J AM CHEM SOC, V121, P3311, DOI 10.1021/ja983859d	28	161	163	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1266	1269		10.1126/science.1065625	http://dx.doi.org/10.1126/science.1065625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11786606				2022-12-01	WOS:000173926000035
J	Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P				Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P			Evolutionary biology - Performance constraints in decathletes	NATURE			English	Article							ENDURANCE		Univ Instelling Antwerp, Dept Biol, B-2610 Wilrijk, Belgium	University of Antwerp	Van Damme, R (corresponding author), Univ Instelling Antwerp, Dept Biol, Univ Pl 1, B-2610 Wilrijk, Belgium.		Wilson, Robbie S/F-1463-2011	Aerts, Peter/0000-0002-6867-5421; Van Damme, Raoul/0000-0002-4585-6940; Wilson, Robbie/0000-0002-0116-5427				Dohm MR, 1996, EVOLUTION, V50, P1688, DOI 10.1111/j.1558-5646.1996.tb03940.x; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garland Theodore Jr., 1994, P251; Gilchrist GW, 1996, EVOLUTION, V50, P1560, DOI 10.1111/j.1558-5646.1996.tb03928.x; LEVINS RICHARD, 1968; MCPEEK MA, 1996, AM NAT             S, V148, P124; RIVERO JLL, 1993, J APPL PHYSIOL, V75, P1758, DOI 10.1152/jappl.1993.75.4.1758; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; [No title captured]	10	127	127	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					755	756		10.1038/415755b	http://dx.doi.org/10.1038/415755b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845199				2022-12-01	WOS:000173833900036
J	van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB				van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB			Dietary patterns and risk for type 2 diabetes mellitus in US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; GLYCEMIC LOAD; PIMA-INDIANS; WOMEN; HEALTH; FIBER; FAT; REPRODUCIBILITY; QUESTIONNAIRE; CARBOHYDRATE	Background: The role of diet in the development of type 2 diabetes mellitus remains unsettled. Objective: To examine the association between major dietary patterns and risk for type 2 diabetes mellitus. Design: Prospective cohort study. Setting: United States. Participants: 42 504 male health professionals, 40 to 75 years of age, without diagnosed diabetes, cardiovascular disease, or cancer at baseline. Measurements: Using factor analysis based on data from food-frequency questionnaires, we identified and validated two major dietary patterns that we labeled "prudent" (characterized by higher consumption of vegetables, fruit, fish, poultry and whole grains) and "western" (characterized by higher consumption of red meat, processed meat, French fries, high-fat dairy products, refined grains, and sweets and desserts). Relative risks and 95% CIs were adjusted for potential confounders, including body mass index (BMI), physical activity, and cigarette smoking. Results: During 12 years of follow-up (466508 person-years), we documented 1321 cases of type 2 diabetes. The prudent dietary pattern score was associated with a modestly lower risk for type 2 diabetes (relative risk for extreme quintiles, 0.84 [CI, 0.70 to 1.00]). In contrast, the western dietary pattern score was associated with an increased risk for type 2 diabetes (relative risk, 1.59 [CI, 1.32 to 1.93]; P < 0.001 for trend). A high score for the western dietary pattern combined with low physical activity (relative risk comparing extreme quintiles of dietary pattern score and physical activity, 1.96 [CI, 1.35 to 2.84]) or obesity (relative risk for BMI greater than or equal to 30 kg/m(2) vs. <25 kg/m(2), 11.2 [CI, 8.07 to 15.6]) was associated with a particularly high risk for type 2 diabetes. Conclusion: Our findings suggest that a western dietary pattern is associated with a substantially increased risk for type 2 diabetes in men.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Netherlands National Institute for Public Health & the Environment	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Robles-Sardin, Alma E/M-7714-2015; van Dam, Rob M/F-9674-2010; Hu, Frank/C-1919-2013	Robles-Sardin, Alma E/0000-0003-2044-7793; van Dam, Rob M/0000-0002-7354-8734; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55075] Funding Source: Medline; NHLBI NIH HHS [HL 35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gittelsohn J, 1998, J NUTR, V128, P541, DOI 10.1093/jn/128.3.541; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Himsworth HP, 1935, CLIN SCI, V2, P117; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Johnson W. J., 1998, NUTR EPIDEMIOLOGY, P22, DOI [DOI 10.1093/ACPROF:OSO/9780195122978.003.11, 10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001]; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Kim J. O., 1978, FACTOR ANAL STAT MET; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Pratley RE, 1998, P NUTR SOC, V57, P175, DOI 10.1079/PNS19980029; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; *SAS I, 1989, SAS STAT US GUID VER; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; SWINBURN BA, 1991, J CLIN ENDOCR METAB, V73, P156, DOI 10.1210/jcem-73-1-156; *WHO STUD GROUP DI, 1995, DIAB MELL REP WHO ST; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337	33	584	592	1	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					201	209		10.7326/0003-4819-136-3-200202050-00008	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827496				2022-12-01	WOS:000173637400003
J	Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM				Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM			Structural identification of a bacterial quorum-sensing signal containing boron	NATURE			English	Article							ESCHERICHIA-COLI; VIBRIO-HARVEYI; EXPRESSION; BIOSYNTHESIS; SEQUENCE; SYSTEMS; FAMILY	Cell-cell communication in bacteria is accomplished through the exchange of extracellular signalling molecules called autoinducers. This process, termed quorum sensing, allows bacterial populations to coordinate gene expression. Community cooperation probably enhances the effectiveness of processes such as bioluminescence, virulence factor expression, antibiotic production and biofilm development(1-4). Unlike other autoinducers, which are specific to a particular species of bacteria, a recently discovered autoinducer (AI-2)(5) is produced by a large number of bacterial species. AI-2 has been proposed to serve as a 'universal' signal for inter-species communication(1,2,6,7). The chemical identity of AI-2 has, however, proved elusive. Here we present the crystal structure of an AI-2 sensor protein, LuxP, in a complex with autoinducer. The bound ligand is a furanosyl borate diester that bears no resemblance to previously characterized autoinducers. Our findings suggest that addition of naturally occurring borate to an AI-2 precursor generates active AI-2. Furthermore, they indicate a potential biological role for boron, an element required by a number of organisms but for unknown reasons.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Ecol Chim Polymeres & Mat, Lab Spectrometrie Masse Bioorgan, F-67087 Strasbourg, France	Princeton University; Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Noelle, POTIER/AAX-7633-2021	Bassler, Bonnie/0000-0002-0043-746X; POTIER, Noelle/0000-0002-6381-4365				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; BOESEKEN J, 1949, ADV CARBOHYD CHEM, V4, P189; Bowen H.J.M., 1966, TRACE ELEMENTS BIOCH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DUERRE JA, 1977, BIOCH ADENOSYLMETHIO, P43; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lewis HA, 2001, STRUCTURE, V9, P527, DOI 10.1016/S0969-2126(01)00613-X; LOOMIS WD, 1992, BIOFACTORS, V3, P229; MAZUREK M, 1963, CAN J CHEM, V41, P2403, DOI 10.1139/v63-354; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MILLER CH, 1968, J BIOL CHEM, V243, P92; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAGIONE ED, 1985, BIOCHEM J, V232, P335, DOI 10.1042/bj2320335; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schummer D, 1996, LIEBIGS ANN, P965; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2	31	1099	1200	15	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					545	549		10.1038/415545a	http://dx.doi.org/10.1038/415545a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823863				2022-12-01	WOS:000173564300051
J	Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF				Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF			Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; TETRATRICOPEPTIDE REPEAT; HEAVY-CHAIN; DOMAIN; GENE; RECONSTITUTION; EXPRESSION; COMPLEXES; MACHINES; RECEPTOR	The organization of myosin into motile cellular structures requires precise temporal and spatial regulation. Proteins containing a UCS (UNC-45/CRO1/She4p) domain are necessary for the incorporation of myosin into the contractite ring during cytokinesis and into thick filaments during muscle development. We report that the carboxyl-terminal regions of UNC-45 bound and exerted chaperone activity on the myosin head. The amino-terminal tetratricopeptide repeat domain of UNC-45 bound the molecular chaperone Hsp90. Thus, UNC-45 functions both as a molecular chaperone and as an Hsp90 co-chaperone for myosin, which can explain previous findings of altered assembly and decreased accumulation of myosin in UNC-45 mutants of Caenorhabditis elegans.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Epstein, HF (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	hepstein@bcm.tmc.edu	Hartl, F. Ulrich/Y-8206-2019; Hutagalung, Alex/AAH-5795-2021					Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; DELOZANNE A, 1987, J CELL BIOL, V105, P2999, DOI 10.1083/jcb.105.6.2999; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; MCNALLY EM, 1988, P NATL ACAD SCI USA, V85, P7270, DOI 10.1073/pnas.85.19.7270; PRICE MG, UNPUB; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WOLFFLONG VL, 1993, J BIOL CHEM, V268, P23162; Wong KCY, 2000, J CELL SCI, V113, P2421	26	195	197	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					669	671		10.1126/science.1066648	http://dx.doi.org/10.1126/science.1066648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809970				2022-12-01	WOS:000173560900042
J	Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC				Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC			RIM1 alpha forms a protein scaffold for regulating neurotransmitter release at the active zone	NATURE			English	Article							SYNAPTIC-VESICLE FUSION; C-ELEGANS; RAB3; UNC-13; FAMILY; PROBABILITY; EXOCYTOSIS; EFFECTOR	Neurotransmitters are released by synaptic vesicle fusion at the active zone(1,2). The active zone of a synapse mediates Ca2+-triggered neurotransmitter release, and integrates presynaptic signals in regulating this release. Much is known about the structure of active zones and synaptic vesicles, but the functional relation between their components is poorly understood(3). Here we show that RIM1alpha, an active zone protein that was identified as a putative effector for the synaptic vesicle protein Rab3A(4,5), interacts with several active zone molecules, including Munc13-1 (ref. 6) and alpha-liprins(7,8), to form a protein scaffold in the presynaptic nerve terminal. Abolishing the expression of RIM1alpha in mice shows that RIM1alpha is essential for maintaining normal probability of neurotransmitter release, and for regulating release during short-term synaptic plasticity. These data indicate that RIM1alpha has a central function in integrating active zone proteins and synaptic vesicles into a molecular scaffold that controls neurotransmitter release.	Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; COWAN WM, 2001, SYNAPSES; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	28	454	477	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					321	326		10.1038/415321a	http://dx.doi.org/10.1038/415321a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797009				2022-12-01	WOS:000173293500044
J	Percec, I; Bartolomei, MS				Percec, I; Bartolomei, MS			Genetics - Do X chromosomes set boundaries?	SCIENCE			English	Editorial Material							ENHANCER-BLOCKING ACTIVITY; INACTIVATION CENTER; METHYLATION; REGION; MOUSE; CTCF		Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Percec, I (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; Zhan HC, 2001, HUM GENET, V109, P471, DOI 10.1007/s004390100601	11	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					287	288		10.1126/science.1068663	http://dx.doi.org/10.1126/science.1068663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786631				2022-12-01	WOS:000173278600035
J	Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M				Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M			The motor domain determines the large step of myosin-V	NATURE			English	Article							LIGHT-CHAIN; ACTIN FILAMENT; MOVEMENT; FORCE; MECHANICS; MOLECULE; BINDING; LEVER; HEAD	Class-V myosin proceeds along actin filaments with large (similar to 36 nm) steps(1-3). Myosin-V has two heads, each of which consists of a motor domain and a long (23 nm) neck domain. In accordance with the widely accepted lever-arm model(4), it was suggested that myosin-V steps to successive (36 nm) target zones along the actin helical repeat by tilting its long neck (lever-arm)(5). To test this hypothesis, we measured the mechanical properties of single molecules of myosin-V truncation mutants with neck domains only one-sixth of the native length. Our results show that the processivity and step distance along actin are both similar to those of full-length myosin-V. Thus, the long neck domain is not essential for either the large steps or processivity of myosin-V. These results challenge the lever-arm model. We propose that the motor domain and/or the actomyosin interface enable myosin-V to produce large processive steps during translocation along actin.	JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignaling, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Div Biomol Imaging, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Massachusetts System; University of Massachusetts Worcester; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Yanagida, T (corresponding author), JST, ICORP, Single Mol Proc Project, 2-4-14 Senba Higashi, Osaka 5620035, Japan.		Yanagida, Toshio/D-1919-2009					Cooke R, 1999, CURR BIOL, V9, pR773, DOI 10.1016/S0960-9822(00)80010-X; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P751, DOI 10.1093/oxfordjournals.jbchem.a122928; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; STRYER L, 1995, BIOCHEMISTRY-US, P443; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; WAKABAYASHI K, 1992, SCIENCE, V258, P443, DOI 10.1126/science.1411537; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200	28	115	114	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					192	195		10.1038/415192a	http://dx.doi.org/10.1038/415192a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805840				2022-12-01	WOS:000173159300047
J	Larsen, PL; Clarke, CF				Larsen, PL; Clarke, CF			Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q	SCIENCE			English	Article							C-ELEGANS; INTERMEDIARY METABOLISM; DAUER LARVA; LONGEVITY; DIAPAUSE; MUTANT; DAF-2; GENES; CYCLE	The isoprenylated benzoquinone coenzyme Q is a redox-active lipid essential for electron transport in aerobic respiration. Here, we show that withdrawal of coenzyme Q (Q) from the diet of wild-type nematodes extends adult life-span by similar to 60%. The longevity of clk-1, daf-2, daf-12, and daf-16 mutants is also extended by a Q-less diet. These results establish the importance of Q in life-span determination. The findings suggest that Q and the daf-2 pathway intersect at the mitochondria and imply that a concerted production coupled with enhanced scavenging of reactive oxygen species contributes to the substantial life-span extension.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Larsen, PL (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 951569, Los Angeles, CA 90095 USA.							Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAGAN IVE, 2000, COENZYME Q MOL MECH; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2001, NAT GENET, V28, P102, DOI 10.1038/88797; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	24	199	214	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					120	123		10.1126/science.1064653	http://dx.doi.org/10.1126/science.1064653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778046				2022-12-01	WOS:000173143100047
J	Moine, H; Mandel, JL				Moine, H; Mandel, JL			Biomedicine - Do G quartets orchestrate fragile X pathology?	SCIENCE			English	Editorial Material									CNRS, UPR 9002, F-67084 Strasbourg, France; Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moine, H (corresponding author), CNRS, UPR 9002, F-67084 Strasbourg, France.		Moine, Herve/Q-2328-2016; Mandel, Jean Louis/Q-2668-2016	Moine, Herve/0000-0002-6250-7902; Mandel, Jean Louis/0000-0002-0535-6589				ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bardoni B, 2000, AM J MED GENET, V97, P153, DOI 10.1002/1096-8628(200022)97:2<153::AID-AJMG7>3.0.CO;2-M; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Deng JP, 2001, P NATL ACAD SCI USA, V98, P13665, DOI 10.1073/pnas.241374798; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Kooy RF, 2000, MOL MED TODAY, V6, P193, DOI 10.1016/S1357-4310(00)01674-9; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	13	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2487	2488		10.1126/science.1068352	http://dx.doi.org/10.1126/science.1068352			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752559				2022-12-01	WOS:000172927700035
J	Averhoff, F; Shapiro, CN; Bell, BP; Hyams, I; Burd, L; Deladisma, A; Simard, EP; Nalin, D; Kuter, B; Ward, C; Lundberg, M; Smith, N; Margolis, HS				Averhoff, F; Shapiro, CN; Bell, BP; Hyams, I; Burd, L; Deladisma, A; Simard, EP; Nalin, D; Kuter, B; Ward, C; Lundberg, M; Smith, N; Margolis, HS			Control of hepatitis A through routine vaccination of children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-WIDE OUTBREAK; TRANSMISSION; INFECTION	Context The impact of routine hepatitis A vaccination of children living in large communities with elevated disease rates has not been evaluated. Objective To determine the effect of routine vaccination of children on disease incidence in a community with recurrent hepatitis A epidemics. Design, Setting, and Participants Community-based demonstration project conducted from January 12, 1995, through December 31, 2000, in Butte County, California, among children aged 2 to 17 years. Intervention In 1995, vaccination was offered to children aged 2 to 12 years during vaccination clinics conducted on 2 occasions 6 to 12 months apart at most schools in the county. In 1996-2000, vaccine was distributed to community health care clinicians, who vaccinated eligible children without charge. Vaccine was also available at health department clinics, selected child care centers, and other sites. Main Outcome Measures Hepatitis A vaccination coverage, hepatitis A incidence, and vaccine effectiveness. Results During the study period, 29789 (66.2%) of an estimated 44982 eligible children received at least 1 vaccine dose; 17681 (89.3%) received a second dose. The number of hepatitis A cases among the entire county population declined 93.5% during the study period, from 57 cases in 1995 to 4 in 2000, the lowest number of cases reported in the county since hepatitis A surveillance began in 1966. The 2000 incidence rate of 1.9 per 100000 population was the lowest of any county in the state. Of the 245 cases reported during the 6-year period, 40 (16.3%) occurred among children 17 years of age or younger, of which 16 (40%) occurred in 1995 and only 1 in 2000. One of the 27 case patients eligible for vaccination had been vaccinated, having received the first dose 3 days before symptom onset. The estimated protective vaccine efficacy was 98% (95% confidence interval, 86%-100%). Conclusions In this population, hepatitis A vaccine was highly effective in preventing disease among recipients. Childhood vaccination appears to have decreased hepatitis A incidence among children and adults and controlled the disease in a community with recurrent epidemics.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Butte Cty Dept Publ Hlth, Oroville, CA USA; Calif Dept Hlth Serv, Immunizat Branch, Berkeley, CA 94704 USA; Merck Vaccine Div, West Point, PA USA; Merck Res Labs, West Point, PA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Health Care Services; Merck & Company; Merck & Company	Bell, BP (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G-37,1600 Clifton Rd, Atlanta, GA 30333 USA.		Simard, Edgar/G-4552-2010	Simard, Edgar/0000-0001-8093-2067				*AL DEP HLTH SOC S, 1993, STAT AL EP B, V18; ANDRE FE, 1992, VACCINE, V10, pS160, DOI 10.1016/0264-410X(92)90576-6; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; *CDCP, 1996, HEP SURV, P16; *CDCP, 1987, HEPATITIS SURVEILLAN, V51, P6; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P1; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P600; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; GILDON B, 1992, SOUTHERN MED J, V85, P9, DOI 10.1097/00007611-199201000-00004; GRECO D, 1986, INT J EPIDEMIOL, V15, P108, DOI 10.1093/ije/15.1.108; INNIS BL, 1994, JAMA-J AM MED ASSOC, V271, P1328, DOI 10.1001/jama.271.17.1328; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; MAJEED FA, 1992, EPIDEMIOL INFECT, V109, P167; MANN JM, 1982, PUBLIC HEALTH REP, V97, P516; McMahon BJ, 1996, ARCH PEDIAT ADOL MED, V150, P733, DOI 10.1001/archpedi.1996.02170320079014; NALIN DR, 1993, J HEPATOL, V18, pS51, DOI 10.1016/S0168-8278(05)80379-4; PAVIA AT, 1990, AM J EPIDEMIOL, V131, P1085, DOI 10.1093/oxfordjournals.aje.a115601; SAGLIOCCA L, 1988, EUR J EPIDEMIOL, V4, P470, DOI 10.1007/BF00146400; SHAW FE, 1986, AM J EPIDEMIOL, V123, P1057, DOI 10.1093/oxfordjournals.aje.a114334; SHAW FE, 1990, AM J PUBLIC HEALTH, V80, P1091, DOI 10.2105/AJPH.80.9.1091; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; VANBENEDEN C, 1998, INT C EM INF DIS M M; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; YANG NY, 1988, AM J EPIDEMIOL, V127, P599	25	97	101	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					2968	2973		10.1001/jama.286.23.2968	http://dx.doi.org/10.1001/jama.286.23.2968			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502VY	11743837	Bronze			2022-12-01	WOS:000172764500028
J	van Lommel, P; van Wees, R; Meyers, V; Elfferich, I				van Lommel, P; van Wees, R; Meyers, V; Elfferich, I			Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands	LANCET			English	Article							SYNCOPE	Background Some people report a near-death experience (NDE) after a life-threatening crisis. We aimed to establish the cause of this experience and assess factors that affected its frequency, depth, and content. Methods In a prospective study, we included 344 consecutive cardiac patients who were successfully resuscitated after cardiac arrest in ten Dutch hospitals. We compared demographic, medical, pharmacological, and psychological data between patients who reported NDE and patients who did not (controls) after resuscitation. In a longitudinal study of life changes after NDE, we compared the groups 2 and 8 years later. Findings 62 patients (18%) reported NDE, of whom 41 (12%) described a core experience. Occurrence of the experience was not associated with duration of cardiac arrest or unconsciousness, medication, or fear of death before cardiac arrest. Frequency of NDE was affected by how we defined NDE, the prospective nature of the research in older cardiac patients, age, surviving cardiac arrest in first myocardial infarction, more than one cardiopulmonary resuscitation (CPR) during stay in hospital, previous NDE, and memory problems after prolonged CPR. Depth of the experience was affected by sex, surviving CPR outside hospital, and fear before cardiac arrest. Significantly more patients who had an NDE, especially a deep experience, died within 30 days of CPR (p<0.0001). The process of transformation after NDE took several years, and differed from those of patients who survived cardiac arrest without NDE. Interpretation We do not know why so few cardiac patients report NDE after CPR, although age plays a part. With a purely physiological explanation such as cerebral anoxia for the experience, most patients who have been clinically dead should report one.	Hosp Rijnstate, Div Cardiol, NL-6800 TA Arnhem, Netherlands; Capelle AD, Ijssel, Netherlands	Rijnstate Hospital	van Lommel, P (corresponding author), Hosp Rijnstate, Div Cardiol, POB 9555, NL-6800 TA Arnhem, Netherlands.							AMINOFF MJ, 1988, ANN INTERN MED, V108, P791, DOI 10.7326/0003-4819-108-6-791; [Anonymous], 1998, MED PSYCHIAT, V1, P92; Appelby L., 1989, BMJ-BRIT MED J, V298, P976; Atwater P.M.H., 1988, COMING BACK LIFE AFT; Blackmore S., 1993, DYING LIVE SCI NEAR; CLUTE HL, 1990, ANESTHESIOLOGY, V73, P821, DOI 10.1097/00000542-199011000-00004; DICKEY W, 1992, BRIT HEART J, V67, P334; Greyson B, 2000, LANCET, V355, P460; GREYSON B, 1993, PSYCHIATRY, V56, P390; Greyson B, 1998, PERSPECT BIOL MED, V42, P14; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Grof S., 1977, HUMAN ENCOUNTER DEAT; Groth-Marnat G, 1998, J HUMANIST PSYCHOL, V38, P110, DOI 10.1177/00221678980383005; Jansen K. L. R, 1996, NEAR DEATH EXPERIENC, P265; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; MEDUNA LJ, 1950, CARBON DIOXIDE THERA; Morse M., 1996, NEAR DEATH EXPERIENC, P299; MORSE M, 1990, TRANSFORMED LIGHT; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Penfield W., 1958, EXCITABLE CORTEX CON; Ring K., 1984, HEADING OMEGA SEARCH; Ring K., 1980, LIFE DEATH SCI INVES; Ring K., 1999, MINDSIGHT NEAR DEATH; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; SABOM MB, 1988, LIGHT DEATH 1 DOCTOR, P37; SABORN M, 1982, RECOLLECTIONS DEATH; Schmied I, 1999, TODESNAHE INTERDISZI, P217; SCHOENBECK SB, 1991, J NEAR DEATH STUDIES, V9, P211; SCHROTERKUNHARD.M, 1999, TODESNAHE INTERDISZI, P65; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012	31	267	281	5	123	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2001	358	9298					2039	2045		10.1016/S0140-6736(01)07100-8	http://dx.doi.org/10.1016/S0140-6736(01)07100-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502BB	11755611				2022-12-01	WOS:000172722800013
J	Balter, M				Balter, M			Archaeology - Did plaster hold neolithic society together?	SCIENCE			English	News Item																		ROBERTS N, 1998, SCIENCE         1120, P1442	1	3	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2278	+		10.1126/science.294.5550.2278	http://dx.doi.org/10.1126/science.294.5550.2278			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503TT	11743181				2022-12-01	WOS:000172817200017
J	Bouchard, MJ; Wang, LH; Schneider, RJ				Bouchard, MJ; Wang, LH; Schneider, RJ			Calcium signaling by HBx protein in hepatitis B virus DNA replication	SCIENCE			English	Article							X-PROTEIN; TYROSINE PHOSPHORYLATION; ION-CHANNEL; MITOCHONDRIA; ACTIVATION; KINASE; CELLS; PYK2; SRC; INFECTION	Hepatitis B virus (HBV) infects more than 300 million people and is a leading cause of liver cancer and disease. The HBV HBx: protein is essential for infection; HBx activation of Src is important for HBV DNA replication. In our study, HBx activated cytosolic calcium-dependent proline-rich tyrosine kinase-2 (Pyk2), a Src kinase activator. HBx activation of HBV DNA replication was blocked by inhibiting Pyk2 or calcium signaling mediated by mitochondrial calcium channels, which suggests that HBx targets mitochondrial calcium regulation. Reagents that increased cytosolic calcium substituted for HBx protein in HBV DNA replication. Thus, alteration of cytosolic calcium was a fundamental requirement for HBV replication and was mediated by HBx protein.	NYU, Dept Microbiol, New York, NY 10016 USA	New York University	Schneider, RJ (corresponding author), NYU, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.			Schneider, Robert/0000-0001-5807-5564	NCI NIH HHS [F32CA-4476, R0ICA-565633] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Baron KT, 1997, EUR J PHARMACOL, V340, P295, DOI 10.1016/S0014-2999(97)01433-7; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Ganem D, 2001, HEPADNAVIRIDAE VIRUS, P2923; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Henkler F, 2001, J GEN VIROL, V82, P871, DOI 10.1099/0022-1317-82-4-871; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; NATOLI G, 1994, ONCOGENE, V9, P2837; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Takada S, 1999, ONCOGENE, V18, P6965, DOI 10.1038/sj.onc.1203188; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Zhao JH, 2000, J CELL SCI, V113, P3063; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	29	305	330	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2376	2378		10.1126/science.294.5550.2376	http://dx.doi.org/10.1126/science.294.5550.2376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743208				2022-12-01	WOS:000172817200053
J	Tong, AHY; Evangelista, M; Parsons, AB; Xu, H; Bader, GD; Page, N; Robinson, M; Raghibizadeh, S; Hogue, CWV; Bussey, H; Andrews, B; Tyers, M; Boone, C				Tong, AHY; Evangelista, M; Parsons, AB; Xu, H; Bader, GD; Page, N; Robinson, M; Raghibizadeh, S; Hogue, CWV; Bussey, H; Andrews, B; Tyers, M; Boone, C			Systematic genetic analysis with ordered arrays of yeast deletion mutants	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SYNTHETIC LETHAL; BUDDING YEAST; MORPHOGENESIS; MUTATIONS; SCREEN	In Saccharomyces cerevisiae, more than 80% of the similar to 6200 predicted genes are nonessential, implying that the genome is buffered from the phenotypic consequences of genetic perturbation. To evaluate function, we developed a method for systematic construction of double mutants, termed synthetic genetic array (SGA) analysis, in which a query mutation is crossed to an array of similar to 4700 deletion mutants. Inviable double-mutant meiotic progeny identify functional relationships between genes. SGA analysis of genes with roles in cytoskeletal organization (BNI1, ARP2, ARC40, BIM1), DNA synthesis and repair (SGS1, RAD27), or uncharacterized functions (BBC1, NBP2) generated a network of 291 interactions among 204 genes. Systematic application of this approach should produce a global map of gene function.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Virtek Engn Sci Inc, Toronto, ON M5R 2J7, Canada	University of Toronto; University of Toronto; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University	Andrews, B (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 100 Coll St, Toronto, ON M5S 1A8, Canada.		Tyers, Michael/ABE-3194-2021; Robinson, Mark D./O-2254-2019; Hogue, Christopher/B-6726-2008; Bader, Gary/C-1176-2009; Hogue, Christopher W V/AAZ-3934-2020; Robinson, Mark D/A-6432-2015	Robinson, Mark D./0000-0002-3048-5518; Bader, Gary/0000-0003-0185-8861; Hogue, Christopher W V/0000-0002-3107-5246; Robinson, Mark D/0000-0002-3048-5518				Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Chen CY, 1998, GENETICS, V150, P577; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; EVANGELISTA M, IN PRESS NATURE CELL; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kroll ES, 1996, GENETICS, V143, P95; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; MAIOLATESI M, COMMUNICATION; MOCHIDA J, COMMUNICATION; Mullen JR, 2001, GENETICS, V157, P103; NOVICK P, 1989, GENETICS, V121, P659; OOI SL, COMMUNICATION; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; TONG AJ, UNPUB; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wang TT, 1997, GENETICS, V147, P1595; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	29	1552	1586	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2364	2368		10.1126/science.1065810	http://dx.doi.org/10.1126/science.1065810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743205				2022-12-01	WOS:000172817200050
J	Arlettaz, R; Jones, G; Racey, PA				Arlettaz, R; Jones, G; Racey, PA			Effect of acoustic clutter on prey detection by bats	NATURE			English	Article							SPECIES MYOTIS-MYOTIS; LONG-EARED BATS; ECHOLOCATION SIGNALS; FEEDING-BEHAVIOR; GLEANING BAT; DISCRIMINATION; MOTHS; STRATEGY	Bats that capture animal prey from substrates often emit characteristic echolocation calls that are short-duration, frequency-modulated (FM) and broadband(1). Such calls seem to be suited to locating prey in uncluttered habitats, including flying prey, but may be less effective for finding prey among cluttered backgrounds because echoes reflecting from the substrate mask the acoustic signature of prey(2-4). Perhaps these call designs serve primarily for spatial orientation(5-7). Furthermore, it has been unclear whether the acoustic image conveyed by FM echoes enables fine texture discrimination(3,8,9), or whether gleaning bats that forage in echo-cluttering environments must locate prey by using other cues, such as prey-generated sounds(5-7,10-13). Here we show that two species of insectivorous gleaning bats perform badly when compelled to detect silent and immobile prey in clutter, but are very efficient at capturing noisy prey items among highly cluttered backgrounds, and both dead or live prey in uncluttered habitats. These findings suggest that the short, broadband FM echolocation calls associated with gleaning bats are not adapted to detecting prey in clutter.	Univ Bern, Inst Zool, Div Conservat Biol, CH-3012 Bern, Switzerland; Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Bern; University of Lausanne; University of Bristol; University of Aberdeen	Arlettaz, R (corresponding author), Univ Bern, Inst Zool, Div Conservat Biol, Baltzerstr 6, CH-3012 Bern, Switzerland.	raphael.arlettaz@nat.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Jones, Gareth/0000-0002-1904-3735				ANDERSON ME, 1993, ANIM BEHAV, V46, P1151, DOI 10.1006/anbe.1993.1304; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; BRIGHAM RM, 1995, ECOSCIENCE, V2, P276, DOI 10.1080/11956860.1995.11682294; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; FAURE PA, 1994, J COMP PHYSIOL A, V174, P651; FAURE PA, 1992, ANIM BEHAV, V44, P31, DOI 10.1016/S0003-3472(05)80751-1; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; HABERSETZER J, 1983, J COMP PHYSIOL, V152, P275, DOI 10.1007/BF00611192; Jensen ME, 2001, J EXP BIOL, V204, P199; Johnston DS, 2001, J MAMMAL, V82, P362, DOI 10.1644/1545-1542(2001)082<0362:IAPLVI>2.0.CO;2; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Norman AP, 1999, ANIM BEHAV, V57, P829, DOI 10.1006/anbe.1998.1028; Schmidt S, 2000, J COMP PHYSIOL A, V186, P975, DOI 10.1007/s003590000151; SCHMIDT S, 1988, NATURE, V331, P617, DOI 10.1038/331617a0; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHUMM A, 1991, BEHAV ECOL SOCIOBIOL, V28, P255; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; SIMMONS JA, 1988, J ACOUST SOC AM, V84, P551, DOI 10.1121/1.396832; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE	26	152	158	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					742	745		10.1038/414742a	http://dx.doi.org/10.1038/414742a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742397				2022-12-01	WOS:000172676200045
J	Michel, T; Reichhart, JM; Hoffmann, JA; Royet, J				Michel, T; Reichhart, JM; Hoffmann, JA; Royet, J			Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein	NATURE			English	Article							HOST-DEFENSE; INNATE IMMUNITY; ANTIFUNGAL; INFECTION; RECEPTORS; GENE; TLR4	Microbial infection activates two distinct intracellular signalling cascades in the immune-responsive fat body of Drosophila(1,2). Gram-positive bacteria and fungi predominantly induce the Toll signalling pathway, whereas Gram-negative bacteria activate the Imd pathway(3,4). Loss-of-function mutants in either pathway reduce the resistance to corresponding infections(4,5). Genetic screens have identified a range of genes involved in these intracellular signalling cascades(6-12), but how they are activated by microbial infection is largely unknown. Activation of the transmembrane receptor Toll requires a proteolytically cleaved form of an extracellular cytokine-like polypeptide, Spatzle(13), suggesting that Toll does not itself function as a bona fide recognition receptor of microbial patterns. This is in apparent contrast with the mammalian Toll-like receptors(14) and raises the question of which host molecules actually recognize microbial patterns to activate Toll through Spatzle. Here we present a mutation that blocks Toll activation by Gram-positive bacteria and significantly decreases resistance to this type of infection. The mutation semmelweis (seml) inactivates the gene encoding a peptidoglycan recognition protein (PGRP-SA). Interestingly, seml does not affect Toll activation by fungal infection, indicating the existence of a distinct recognition system for fungi to activate the Toll pathway.	Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Royet, J (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			Michel, Tatiana/0000-0002-0146-9236				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; CELINE LF, 1999, SEMMELWEIS IMAGINAIR; Franc NC, 2000, MICROBES INFECT, V2, P243, DOI 10.1016/S1286-4579(00)00304-X; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Turner M W, 2000, Rev Immunogenet, V2, P305; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	30	583	616	1	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					756	759		10.1038/414756a	http://dx.doi.org/10.1038/414756a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742401				2022-12-01	WOS:000172676200049
J	White, PD; Thomas, JM; Kangro, HO; Bruce-Jones, WDA; Amess, J; Crawford, DH; Grover, SA; Clare, AW				White, PD; Thomas, JM; Kangro, HO; Bruce-Jones, WDA; Amess, J; Crawford, DH; Grover, SA; Clare, AW			Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis	LANCET			English	Article							EPSTEIN-BARR-VIRUS; GLANDULAR FEVER; PSYCHIATRIC-DISORDERS; RISK-FACTORS; LIFE-EVENTS; SYMPTOMS; PERSONALITY; PERSISTENCE; RELIABILITY; DEPRESSION	Background Certain infections can trigger chronic fatigue syndromes (CFS) in a minority of people infected, but the reason is unknown. We describe some factors that predict or are associated with prolonged fatigue after infectious mononucleosis and contrast these factors with those that predicted mood disorders after the same infection. Methods We prospectively studied a cohort of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-tract infections until 6 months after clinical onset. We sought predictors of both acute and chronic fatigue syndromes and mood disorders from clinical, laboratory, and psychosocial measures. Findings An empirically defined fatigue syndrome 6 months after onset, which excluded comorbid psychiatric disorders, was most reliably predicted by a positive Monospot test at onset (odds ratio 2.1 [95% CI 1.4-3.3]) and lower physical fitness (0.35 [0.15-0.8]). Cervical lymphadenopathy and initial bed rest were associated with, or predicted, a fatigue syndrome up to 2 months after onset. By contrast, mood disorders were predicted by a premorbid psychiatric history (2.3 [1.4-3.9]), an emotional personality score (1.21 [1.11-1.35]), and social adversity (1.7 [1.0-2.9]). Definitions of CFS that included comorbid mood disorders were predicted by a mixture of those factors that predicted either the empirically defined fatigue syndrome or mood disorders. Interpretation The predictors of a prolonged fatigue syndrome after an infection differ with both definition and time, depending particularly on the presence or absence of comorbid mood disorders. The particular infection and its consequent immune reaction may have an early role, but physical deconditioning may also be important. By contrast, mood disorders are predicted by factors that predict mood disorders in general.	St Bartholomews & Royal London Sch Med & Dent, Dept Psychol Med, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Comp Sci, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Virol, London, England; St Bartholomews & Royal London Sch Med & Dent, Dept Haematol, London, England; Univ London St Georges Hosp, Sch Med, Dept Virol, London SW17 0RE, England; Univ Edinburgh, Dept Med Microbiol, Edinburgh, Midlothian, Scotland	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; St Georges University London; University of Edinburgh	White, PD (corresponding author), St Bartholomews Hosp, St Bartholomews & Royal London Sch Med, Dept Psychol Med, London EC1A 7BE, England.			White, Peter/0000-0002-8193-5355				Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; BERELOWITZ GJ, 1995, J VIRAL HEPATITIS, V2, P133, DOI 10.1111/j.1365-2893.1995.tb00018.x; Brown GW, 1989, LIFE EVENTS ILLNESS; BRUCEJONES WDA, 1994, PSYCHOL MED, V24, P651, DOI 10.1017/S003329170002780X; Buchwald DS, 2000, AM J MED, V109, P531, DOI 10.1016/S0002-9343(00)00560-X; Buckley L, 1999, J PSYCHOSOM RES, V46, P395, DOI 10.1016/S0022-3999(98)00120-2; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; CLARK MR, 1995, AM J MED, V98, P187, DOI 10.1016/S0002-9343(99)80403-3; COPE H, 1994, LANCET, V344, P864, DOI 10.1016/S0140-6736(94)92833-9; DALRYMPLE W, 1964, Postgrad Med, V35, P345; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eysenck HJ., 1975, MANUAL EYSENCK PERSO; FLEISHER GR, 1983, J CLIN MICROBIOL, V17, P619, DOI 10.1128/JCM.17.4.619-624.1983; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 2000, J NEUROL NEUROSUR PS, V69, P302, DOI 10.1136/jnnp.69.3.302; Harvey V P, 1970, J Sports Med Phys Fitness, V10, P185; HENLE W, 1974, HUM PATHOL, V5, P551, DOI 10.1016/S0046-8177(74)80006-7; HOTOPF M, 1996, J NEUROL NEUROSUR PS, V60, P495; Katon W, 1999, GEN HOSP PSYCHIAT, V21, P21, DOI 10.1016/S0163-8343(98)00068-1; KENDELL RE, 1968, BRIT J PSYCHIAT, V114, P767, DOI 10.1192/bjp.114.511.767; LAMBORE S, 1991, J FAM PRACTICE, V33, P33; LEE CL, 1968, AM J CLIN PATHOL, V49, P12; Lloyd Andrew R., 1998, American Journal of Medicine, V105, p7S, DOI 10.1016/S0002-9343(98)00157-0; *OFF POP CONS SURV, 1980, CLASS OCC COD IND; PERKINS DO, 1994, AM J PSYCHIAT, V151, P233; Ray C, 1995, BRIT J MED PSYCHOL, V68, P323, DOI 10.1111/j.2044-8341.1995.tb01839.x; RILEY MS, 1990, BRIT MED J, V301, P953, DOI 10.1136/bmj.301.6758.953; *ROYAL COLL, 1996, CHRON FAT SYNDR REP, P1; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622; Theorell T, 1999, PSYCHOSOM MED, V61, P304, DOI 10.1097/00006842-199905000-00009; THOMPSON DS, 1969, J AMER COLL HEALTH A, V17, P453; van der Werf SP, 2000, J PSYCHOSOM RES, V49, P373, DOI 10.1016/S0022-3999(00)00197-5; van Os J, 2001, BRIT J PSYCHIAT, V178, pS72, DOI 10.1192/bjp.178.40.s72; Vercoulen JHMM, 1998, J PSYCHOSOM RES, V45, P507, DOI 10.1016/S0022-3999(98)00023-3; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; Wessely S, 1998, CHRONIC FATIGUE ITS; WHITE PD, 1995, PSYCHOL MED, V25, P917, DOI 10.1017/S0033291700037405; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; WHITE PD, 1994, PERS INDIV DIFFER, V16, P801, DOI 10.1016/0191-8869(94)90223-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	112	113	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2001	358	9297					1946	1954		10.1016/S0140-6736(01)06961-6	http://dx.doi.org/10.1016/S0140-6736(01)06961-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500HZ	11747919				2022-12-01	WOS:000172622200012
J	Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG				Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG			Emergence of modern human behavior: Middle Stone Age engravings from South Africa	SCIENCE			English	Article							LUMINESCENCE	In the Eurasian Upper Paleotithic after about 35,000 years ago, abstract or depictional images provide evidence for cognitive abilities considered integral to modern human behavior. Here we report on two abstract representations engraved on pieces of red ochre recovered from the Middle Stone Age layers at Blombos Cave in South Africa. A mean date of 77,000 years was obtained for the layers containing the engraved ochres by thermoluminescence dating of burnt lithics, and the stratigraphic integrity was confirmed by an optically stimulated luminescence age of 70,000 years on an overlying dune. These engravings support the emergence of modern human behavior in Africa at least 35,000 years before the start of the Upper Paleolithic.	S African Museum, Iziko Museums Cape Town, ZA-8000 Cape Town, South Africa; SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; Univ Bergen, Ctr Dev Studies, N-5007 Bergen, Norway; CNRS, UMR 5808, Inst Prehist & Geol Quanternaire, F-33405 Talence, France; Univ Wales, Inst Geog & Earth Sci, Luminescence Dating Lab, Aberystwyth SY23 3DB, Dyfed, Wales; CEA, CNRS, UMR, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Bergen; Centre National de la Recherche Scientifique (CNRS); Aberystwyth University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Cape Town	Henshilwood, CS (corresponding author), S African Museum, Iziko Museums Cape Town, POB 61, ZA-8000 Cape Town, South Africa.		Duller, Geoffrey/AAR-7494-2020; Duller, Geoffrey A.T./D-5110-2015; Jacobs, Zenobia/B-2721-2012; Henshilwood, Christopher S/K-3806-2014	Duller, Geoffrey/0000-0002-2694-4590; Duller, Geoffrey A.T./0000-0002-2694-4590; Jacobs, Zenobia/0000-0001-5424-5837; Henshilwood, Christopher S/0000-0002-2818-293X; TRIBOLO, Chantal/0000-0003-0506-2430; Mercier, Norbert/0000-0002-6375-9108; Sealy, Judith/0000-0001-5071-8211				AIELLO L, 1998, ORIGIN DIVERSIFICATI; BAHN P, 1997, J ICE AGE; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; DEACON HJ, 1999, HUMAN BEGINNINGS S; DErrico F, 1997, J HUM EVOL, V33, P1, DOI 10.1006/jhev.1997.0141; Gibson K., 1996, MODELLING EARLY HUMA; Henshilwood C, 1997, CURR ANTHROPOL, V38, P890, DOI 10.1086/204678; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Joron J.-L., 1974, THESIS U PARIS SUD; Klein R.G., 1999, HUMAN CAREER; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mercier N., 1992, ANCIENT TL, V10, P28; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; *SCAND COL I, 1999, NAT COL SYST IND; Stringer C.B., 1996, CONT ISSUES HUMAN EV, V21, P115; VALLADAS H, 1992, QUATERNARY SCI REV, V11, P1, DOI 10.1016/0277-3791(92)90034-6; Vogel JC, 1999, J ARCHAEOL SCI, V26, P729, DOI 10.1006/jasc.1999.0450; VOGEL JC, 2000, HUMANITY AFRICAN NAI, P261; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; WATTS J, 1999, EVOLUTION CULTURE, P113; Willermet C. M., 1997, CONCEPTUAL ISSUES MO; WURZ S, 2000, THESIS STELLENBOSCH; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100	26	544	562	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1278	1280		10.1126/science.1067575	http://dx.doi.org/10.1126/science.1067575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522ZC	11786608				2022-12-01	WOS:000173926000039
J	Houchmandzadeh, B; Wieschaus, E; Leibler, S				Houchmandzadeh, B; Wieschaus, E; Leibler, S			Establishment of developmental precision and proportions in the early Drosophila embryo	NATURE			English	Article							DEPENDENT MANNER; BICOID PROTEIN; GAP GENES; HUNCHBACK; GRADIENT; STAUFEN	During embryonic development, orderly patterns of gene expression eventually assign each cell in the embryo its particular fate. For the anteroposterior axis of the Drosophila embryo, the first step in this process depends on a spatial gradient of the maternal morphogen Bicoid (Bcd). Positional information of this gradient is transmitted to downstream gap genes, each occupying a well defined spatial domain(1-4). We determined the precision of the initial process by comparing expression domains in different embryos. Here we show that the Bcd gradient displays a high embryo-to-embryo variability, but that this noise in the positional information is strongly decreased ('filtered') at the level of hunchback (hb) gene expression. In contrast to the Bcd gradient, the hb expression pattern already includes the information about the scale of the embryo. We show that genes known to interact directly with Hb are not responsible for its spatial precision, but that the maternal gene staufen may be crucial.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Grenoble 1, Spectrometrie Phys Lab, CNRS, F-38402 St Martin Dheres, France; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Princeton University	Wieschaus, E (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.		Houchmandzadeh, Bahram/F-9199-2012	Houchmandzadeh, Bahram/0000-0001-8104-2576				DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; HULSKAMP M, 1994, GENETICS, V138, P125; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; KOSSMAN D, 1908, DEV GENES EVOL, V208, P290; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Press W., 1992, NUMERICAL RECIPES, V2nd; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Segel I. H, 1993, ENZYME KINETICS; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	18	364	373	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					798	802		10.1038/415798a	http://dx.doi.org/10.1038/415798a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845210				2022-12-01	WOS:000173833900048
J	Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF				Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF			Unsuspected diversity among marine aerobic anoxygenic phototrophs	NATURE			English	Article							PHOTOSYNTHESIS GENE-CLUSTER; RHODOBACTER-CAPSULATUS; BACTERIOCHLOROPHYLL ALPHA; BACTERIA; ORGANIZATION; SUBUNIT; REGION	Aerobic, anoxygenic, phototrophic bacteria containing bacteriochlorophyll a (Bchla) require oxygen for both growth and Bchla synthesis(1-6). Recent reports suggest that these bacteria are widely distributed in marine plankton, and that they may account for up to 5% of surface ocean photosynthetic electron transport 7 and 11% of the total microbial community(8). Known planktonic anoxygenic phototrophs belong to only a few restricted groups within the Proteobacteria a-subclass. Here we report genomic analyses of the photosynthetic gene content and operon organization in naturally occurring marine bacteria. These photosynthetic gene clusters included some that most closely resembled those of Proteobacteria from the beta-subclass, which have never before been observed in marine environments. Furthermore, these photosynthetic genes were broadly distributed in marine plankton, and actively expressed in neritic bacterioplankton assemblages, indicating that the newly identified phototrophs were photosynthetically competent. Our data demonstrate that planktonic bacterial assemblages are not simply composed of one uniform, widespread class of anoxygenic phototrophs, as previously proposed(8); rather, these assemblages contain multiple, distantly related, photosynthetically active bacterial groups, including some unrelated to known and cultivated types.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Inst Genom Res, Rockville, MD 20850 USA; Marine Biotechnol Inst, Kamaishi Labs, Kamaishi, Iwate 0260001, Japan	Monterey Bay Aquarium Research Institute; J. Craig Venter Institute	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016; Suzuki, Marcelino/D-3329-2009; chen, qi/C-8585-2011	Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Suzuki, Marcelino/0000-0003-3868-6362; Heidelberg, John/0000-0003-0673-3224; Fraser, Claire/0000-0003-1462-2428				Achenbach LA, 2001, APPL ENVIRON MICROB, V67, P2922, DOI 10.1128/AEM.67.7.2922-2926.2001; Alberti M, 1995, ANOXYGENIC PHOTOSYNT, P1083; BAUER CE, 1991, MOL GEN GENET, V228, P433, DOI 10.1007/BF00260637; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; Choudhary M, 2000, NUCLEIC ACIDS RES, V28, P862, DOI 10.1093/nar/28.4.862; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenchel T, 2001, SCIENCE, V292, P2444, DOI 10.1126/science.1062799; Hahn FM, 1996, J BACTERIOL, V178, P619, DOI 10.1128/jb.178.3.619-624.1996; Harashima K., 1989, AEROBIC PHOTOSYNTHET; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Naylor GW, 1999, PHOTOSYNTH RES, V62, P121, DOI 10.1023/A:1006350405674; Petersen BL, 1998, HEREDITAS, V129, P131, DOI 10.1111/j.1601-5223.1998.00131.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	25	317	339	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					630	633		10.1038/415630a	http://dx.doi.org/10.1038/415630a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832943	hybrid			2022-12-01	WOS:000173709100043
J	Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY				Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY			The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE PLASMIDS; UNITED-STATES; QUINOLONE; CIPROFLOXACIN; BACTEREMIA; MUTATIONS; OUTBREAK; SEROVARS; HUMANS	Background Salmonella enterica: serotype choleraesuis is a cause of serious systemic infections. Because fluoroquinolones are the drug of choice for the treatment of severe salmonella infections, the emergence and dissemination of fluoroquinolone-resistant S. enterica serotype choleraesuis have clinical consequences. Methods: In Taiwan, a hospital-based surveillance system has been in place since 1987 to monitor the incidence of S. enterica serotype choleraesuis infections and the antimicrobial susceptibility of the isolates. We investigated the rapid emergence of fluoroquinolone resistance in this serotype in 2000 and 2001. Pigs in Taiwan were evaluated as a potential source of the resistant salmonella. Results: A total of 501 clinical isolates of S. enterica serotype choleraesuis were recovered in our hospital from 1987 through 2000. The proportion of total salmonella isolates made up by S. enterica serotype choleraesuis decreased from an average of 8.4 percent before 1995 to 2.7 percent in 1996 through 1998. During 1999 and 2000, this proportion increased significantly, to an average of 5.0 percent. Ciprofloxacin resistance in S. enterica serotype choleraesuis has been observed since 2000. In the third quarter of 2001, 60 percent of isolates were resistant to ciprofloxacin. Molecular typing indicated that the primary source of S. enterica serotype choleraesuis isolates was herds of swine. All the resistant isolates from humans and swine had mutations that led to the substitution of phenylalanine for serine at position 83 and asparagine for aspartic acid at position 87 in the gene for DNA gyrase A. Conclusions: This investigation in Taiwan indicates that fluoroquinolone-resistant S. enterica serotype choleraesuis can spread from swine to humans. The use of fluoroquinolones in food animals should be prohibited.	Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Tao Yuan, Taiwan; Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Chung Hsing University	Chiu, CH (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, 5 Pu Hsin St,Kweishan 333, Tao Yuan, Taiwan.	chchiu@adm.cgmh.org.tw						Bender JB, 2001, NEW ENGL J MED, V344, P189, DOI 10.1056/NEJM200101183440305; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Chiu CH, 1999, MICROBIOL IMMUNOL, V43, P899, DOI 10.1111/j.1348-0421.1999.tb01225.x; Chiu CH, 1999, INT J CLIN PRACT, V53, P161; Chu C, 2001, ANTIMICROB AGENTS CH, V45, P2299, DOI 10.1128/AAC.45.8.2299-2303.2001; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Farmer J. J. Iii, 1995, P438; Frost JA, 1996, J ANTIMICROB CHEMOTH, V37, P85, DOI 10.1093/jac/37.1.85; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; JACOBSON MA, 1989, ANN INTERN MED, V110, P1027, DOI 10.7326/0003-4819-110-12-1027; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; McDonald Lawrence Clifford, 2001, Journal of Microbiology Immunology and Infection, V34, P97; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Archives, 2000, M7A5 NCCLS, P1; National Heart L.a.B.I, 2000, PRACTICAL GUIDE IDEN, P1; Olsen SJ, 2001, NEW ENGL J MED, V344, P1572, DOI 10.1056/NEJM200105243442102; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; Su LH, 2000, J HOSP INFECT, V46, P110, DOI 10.1053/jhin.2000.0815; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Wiuff C, 2000, MICROB DRUG RESIST, V6, P11, DOI 10.1089/mdr.2000.6.11	31	200	210	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					413	419		10.1056/NEJMoa012261	http://dx.doi.org/10.1056/NEJMoa012261			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832529				2022-12-01	WOS:000173686400004
J	Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK				Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK			Diagnostic testing fails the test - The pitfalls of patents are illustrated by the case of haemochromatosis.	NATURE			English	Editorial Material							GENE; HEMOCHROMATOSIS		Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; George Mason Univ, Sch Law, Arlington, VA 22201 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; George Mason University; University of Pennsylvania; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NHGRI NIH HHS [R01 HG002034-01A1S2, R01 HG002034-03, R01 HG002034-01A1S1, R01 HG002034, R01 HG002034-01A1, R01 HG002034-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gochee PA, 2001, CURR OPIN HEMATOL, V8, P98, DOI 10.1097/00062752-200103000-00007; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Merz JF, 1999, CLIN CHEM, V45, P324; Pointon JJ, 2000, GENET TEST, V4, P151, DOI 10.1089/10906570050114867; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Thomas SM, 1996, NATURE, V380, P387, DOI 10.1038/380387a0; Thomas SM, 1997, NATURE, V388, P709, DOI 10.1038/41853; Thorstensen K, 2000, GENET TEST, V4, P371, DOI 10.1089/109065700750065117; Wadman M, 2001, NATURE, V413, P443, DOI 10.1038/35097228	12	97	98	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					577	579		10.1038/415577a	http://dx.doi.org/10.1038/415577a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832913	Green Accepted			2022-12-01	WOS:000173709100016
J	Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG				Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG			Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; RAPID PROGRESSION; SURVIVAL; ADULTS; KIGALI; RWANDA; WOMEN; PREDICTORS; MORTALITY	Objectives To estimate the rate of progression from seroconversion to symptomatic disease in adults infected with HIV-1, and to establish whether the background level of signs and symptoms commonly associated with HIV-1 in uninfected controls are likely to affect progression rates. Design Longitudinal, prospective cohort study of people infected with HIV-1 and randomly selected subjects negative for HIV-1 antibodies identified during population studies. Setting Study clinic with basic medical care in rural Uganda. Subjects 275 patients infected with HIV-1 (107 prevalent cases and 168 incident cases) and 246 controls negative for HIV-1 antibodies. Main outcome measures Signs and symptoms of HIV disease, as determined by stages 2 and 3 of the World Health Organization clinical staging system. Results The median time front seroconversion to WHO stage 2 was 25.4 months and to stage 3 was 45.5 months. 43% of the participants infected with HIV-1 had signs or symptoms by two years after seroconversion. The most common clinical conditions used to define progression of disease were weight loss, mucocutaneous manifestations, bacterial infections, chronic fever, and chronic diarrhoea. Although the rates of these conditions (apart from minor weight loss) were significantly higher in the participants infected with HIV-1, they were also relatively frequent. in the control group. Herpes zoster, oral candidiasis, and pulmonary tuberculosis were not common events in the control group and therefore were more indicative of infection with HIV-1. Conclusions Disease progression associated with infection with HIV-1 seems to be rapid in rural Uganda. This is most likely due to the high prevalence of conditions in the general population that could be taken as symptoms and signs of infection with HIV-1.	Uganda Virus Res Inst, Programme AIDS, MRC, Entebbe, Uganda	Uganda Virus Research Institute	Morgan, D (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Mayanja, Billy/AAL-5087-2021					ANZALA OA, 1995, J INFECT DIS, V171, P686, DOI 10.1093/infdis/171.3.686; Brettle RP, 1996, INT J STD AIDS, V7, P110, DOI 10.1258/0956462961917302; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; HOLMBERG SD, 1995, AM J EPIDEMIOL, V141, P395, DOI 10.1093/oxfordjournals.aje.a117441; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KERLIKOWSKE KM, 1994, AIDS, V8, P963, DOI 10.1097/00002030-199407000-00014; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; MANN JM, 1986, LANCET, V2, P707; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MILLER WC, 1995, J ACQ IMMUN DEF SYND, V9, P408; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; NAGELKERKE NJD, 1990, AIDS, V4, P743, DOI 10.1097/00002030-199008000-00005; NGALY B, 1988, NEW ENGL J MED, V319, P1123, DOI 10.1056/NEJM198810273191704; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221	20	83	84	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					193	196		10.1136/bmj.324.7331.193	http://dx.doi.org/10.1136/bmj.324.7331.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809639	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000173604800013
J	Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S				Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S			Chronic fatigue syndrome: a step towards agreement	LANCET			English	Editorial Material									Act ME, London EC4V 5AA, England; Univ Washington, Harborview Med Ctr, Chron Fatigue Cooperat Res Ctr, Seattle, WA 98195 USA; Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; Guys Kings & St Thomas Sch Med, Dept Psychol Med, London, England	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Edinburgh; University of London; King's College London	Clark, C (corresponding author), Act ME, 4 Deans Court,St Pauls Churchyard, London EC4V 5AA, England.		Wessely, Simon C/A-8713-2008	sharpe, michael/0000-0002-6474-9980				*ROY COLL PHYS PSY, 1996, CHRON FAT SYNDR; Straus SE, 1996, BRIT MED J, V313, P831; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; 1996, LANCET, V348, P971	4	18	20	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					97	98		10.1016/S0140-6736(02)07336-1	http://dx.doi.org/10.1016/S0140-6736(02)07336-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809249				2022-12-01	WOS:000173212400006
J	Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH				Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH			Distinct effects of T-bet in T(H)1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells	SCIENCE			English	Article							INTERFERON-GAMMA; TARGETED DISRUPTION; RECEPTOR DEFICIENCY; LEISHMANIA-MAJOR; MICE; INFECTION; STAT1; GENE; ACTIVATION; EXPRESSION	T-bet is a member of the T-box family of transcription factors that appears to regulate lineage commitment in CD4 T helper (T-H) lymphocytes in part by activating the hallmark T(H)1 cytokine, interferon-gamma (IFN-gamma), IFN-gamma is aLso produced by natural killer (NK) cells and most prominently by CD8 cytotoxic T cells, and is vital. for the control of microbial pathogens. Although T-bet is expressed in all these cell types, it is required for control of IFN-gamma production in CD4 and NK cells, but not in CD8 cells. This difference is aLso apparent in the function of these cell subsets. Thus, the regulation of a single cytokine, IFN-gamma, is controlled by distinct transcriptional mechanisms within the T cell lineage.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Washington University (WUSTL)	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.		Satoskar, Abhay/AAB-7748-2019					Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; COICO R, 1994, PROTOCOLS IMMUNOLOGY; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Monteforte GM, 2000, J IMMUNOL, V164, P5890, DOI 10.4049/jimmunol.164.11.5890; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; SZABO S, UNPUB; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2	30	933	1010	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					338	342		10.1126/science.1065543	http://dx.doi.org/10.1126/science.1065543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786644				2022-12-01	WOS:000173278600053
J	Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM				Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM			Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna	NATURE			English	Article							SINGLE-MOLECULE; SPECIFICITY; AZOBENZENE; PROBES; DESIGN	Increasingly detailed structural(1) and dynamic(2,3) studies are highlighting the precision with which biomolecules execute often complex tasks at the molecular scale. The efficiency and versatility of these processes have inspired many attempts to mimic or harness them. To date, biomolecules have been used to perform computational operations(4) and actuation(5), to construct artificial transcriptional loops that behave like simple circuit elements(6,7) and to direct the assembly of nanocrystals(8). Further development of these approaches requires new tools for the physical and chemical manipulation of biological systems. Biomolecular activity has been triggered optically through the use of chromophores(9-14), but direct electronic control over biomolecular 'machinery' in a specific and fully reversible manner has not yet been achieved. Here we demonstrate remote electronic control over the hybridization behaviour of DNA molecules, by inductive coupling of a radio-frequency magnetic field to a metal nanocrystal covalently linked to DNA(15). Inductive coupling to the nanocrystal increases the local temperature of the bound DNA, thereby inducing denaturation while leaving surrounding molecules relatively unaffected. Moreover, because dissolved biomolecules dissipate heat in less than 50 picoseconds (ref. 16), the switching is fully reversible. Inductive heating of macroscopic samples is widely used(17-19), but the present approach should allow extension of this concept to the control of hybridization and thus of a broad range of biological functions on the molecular scale.	MIT, Media Lab, Cambridge, MA 02139 USA; MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; Engenos, Waltham, MA 02451 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jacobson, JM (corresponding author), MIT, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Jacobson, Joseph/0000-0002-1332-3197; Zhang, Shuguang/0000-0002-3856-3752				Asanuma H, 1999, TETRAHEDRON LETT, V40, P7995, DOI 10.1016/S0040-4039(99)01547-6; Ashkenazi G, 1997, BIOSENS BIOELECTRON, V12, P85, DOI 10.1016/S0956-5663(97)87054-6; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; HAMADSCHIFFERLI K, 2001, MAT RES SOC P; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; Hermanson G. T., 2010, BIOCONJUGATE TECHNIQ; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; Liu D, 1997, BIOORG MED CHEM LETT, V7, P2677, DOI 10.1016/S0960-894X(97)10044-0; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; McAdams HH, 2000, CURR BIOL, V10, pR318, DOI 10.1016/S0960-9822(00)00440-1; Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895; Orfeuil M., 1987, ELECT PROCESS HEATIN; Probst JC, 2000, METHODS, V22, P271, DOI 10.1006/meth.2000.1079; REARDON JE, 1984, BIOCHEMISTRY-US, V23, P3849, DOI 10.1021/bi00312a009; Schimmel P. R., 1980, BIOPHYSICAL CHEM; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Telford JR, 1998, ACCOUNTS CHEM RES, V31, P755, DOI 10.1021/ar970078t; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e; Zinn S., 1988, ELEMENTS INDUCTION H	30	317	335	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					152	155		10.1038/415152a	http://dx.doi.org/10.1038/415152a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805829				2022-12-01	WOS:000173159300036
J	Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D				Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D			Sitosterol-beta-glucoside as primer for cellulose synthesis in plants	SCIENCE			English	Article							MOLECULAR DIRECTIONALITY; SYNTHASE; ARABIDOPSIS; ENDO-1,4-BETA-GLUCANASE; BIOSYNTHESIS; HERBICIDES; KORRIGAN	Cellulose synthesis in plants requires beta -1,4-glucan chain initiation, elongation, and termination. The process of chain elongation is likely to be distinct from the process of chain initiation. We demonstrate that a CesA glucosyltransferase initiates glucan polymerization by using sitosterol-beta -glucoside (SG) as primer. Cotton fiber membranes synthesize sitosterol-cellodextrins (SCDs) from SG and uridine 5'-diphosphate-glucose (UDP-Glc) under conditions that also favor cellulose synthesis. The cellulase encoded by the Korrigan (Kor) gene, required for cellulose synthesis in plants, may function to cleave SG from the growing polymer chain.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Delmer, D (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	dpdelmer@ucdavis.edu						BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BULONE V, 1995, PLANT J, V8, P213, DOI 10.1046/j.1365-313X.1995.08020213.x; CALLAGHAN T, 1988, PLANT PHYSIOL, V86, P1104, DOI 10.1104/pp.86.4.1104; Cantatore JL, 2000, BIOCHEM SOC T, V28, P748, DOI 10.1042/BST0280748; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; ELBEIN AD, 1975, LIPIDS, V10, P427, DOI 10.1007/BF02532449; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; FUJINO Y, 1979, BIOCHIM BIOPHYS ACTA, V574, P94; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; PENG L, UNPUB; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Perrin RM, 2001, CURR BIOL, V11, pR213, DOI 10.1016/S0960-9822(01)00108-7; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Sabba RP, 1999, WEED SCI, V47, P757, DOI 10.1017/S004317450009144X; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schrick K, 2000, GENE DEV, V14, P1471; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6	25	296	336	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					147	150		10.1126/science.1064281	http://dx.doi.org/10.1126/science.1064281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778054				2022-12-01	WOS:000173143100055
J	Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D				Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D			IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; STRESS; ER; REQUIRES; COORDINATION; INDUCTION; CLEAVAGE; PATHWAY; ATF6	The unfolded protein response (UPR), caused by stress, matches the folding capacity of endoplasmic reticulum (ER) to the load of client proteins in the organelle(1,2). In yeast, processing of HAC1 mRNA by activated Ire1 leads to synthesis of the transcription factor Hac1 and activation of the UPR3. The responses to activated IRE1 in metazoans are less well understood. Here we demonstrate that mutations in either ire-1 or the transcription-factor-encoding xbp-1 gene abolished the UPR in Caenorhabditis elegans. Mammalian XBP-1 is essential for immunoglobulin secretion and development of plasma cells(4), and high levels of XBP-1 messenger RNA are found in specialized secretory cells(5). Activation of the UPR causes IRE1-dependent splicing of a small intron from the XBP-1 mRNA both in C. elegans and mice. The protein encoded by the processed murine XBP-1 mRNA accumulated during the UPR, whereas the protein encoded by unprocessed mRNA did not. Purified mouse IRE1 accurately cleaved XBP-1 mRNA in vitro, indicating that XBP-1 mRNA is a direct target of IRE1 endonucleolytic activity. Our findings suggest that physiological ER load regulates a developmental decision in higher eukaryotes.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Ron, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	ron@saturn.med.nyu.edu	Longo, Kenneth A/A-5631-2010; Urano, Fumihiko/AAF-4492-2020	Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974				Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; CLARK SG, 1994, GENETICS, V137, P987; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shamu CE, 1998, CURR BIOL, V8, pR121, DOI 10.1016/S0960-9822(98)70986-8; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	21	2014	2097	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					92	96		10.1038/415092a	http://dx.doi.org/10.1038/415092a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780124				2022-12-01	WOS:000173028800047
J	Chandler, WL; Jelacic, S; Boster, DR; Ciol, MA; Williams, GD; Watkins, SL; Igarashi, T; Tarr, PI				Chandler, WL; Jelacic, S; Boster, DR; Ciol, MA; Williams, GD; Watkins, SL; Igarashi, T; Tarr, PI			Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	XVIIIth Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 06-12, 2001	PARIS, FRANCE	Int Soc Thrombosis & Haemostasis			TISSUE-PLASMINOGEN ACTIVATOR; ESCHERICHIA-COLI O157-H7; FIBRINOLYTIC THERAPY; INHIBITOR TYPE-1; FRAGMENT 1+2; D-DIMER; PLASMA; HISTOPATHOLOGY; IMMUNOASSAY; DEGRADATION	Background: The hemolytic-uremic syndrome is a thrombotic complication of Escherichia coli O157:H7 infection. It is not known whether the coagulation abnormalities precede, and potentially cause, this disorder. Methods: In 53 children infected with E. coli O157:H7, we measured a panel of markers indicating activation of the clotting cascade and renal function within four days after the onset of illness. These markers were measured again in as many as possible of the 16 children in whom the hemolytic-uremic syndrome developed. Results: The children in whom the hemolytic-uremic syndrome subsequently developed had significantly higher median plasma concentrations of prothrombin fragment 1+2, tissue plasminogen activator (t-PA) antigen, t-PA-plasminogen-activator inhibitor type 1 (PAI-1) complex, and d-dimer than children with uncomplicated infection. These abnormalities preceded the development of azotemia and thrombocytopenia. When the hemolytic-uremic syndrome developed, the urinary concentrations of beta(2)-microglobulin and N-acetyl-beta -glucosaminidase rose significantly (P=0.03 for both increases); the plasma concentrations of t-PA antigen, t-PA-PAI-1 complex, d-dimer, and plasmin-antiplasmin complex also increased significantly. The concentration of t-PA antigen correlated with that of the t-PA-PAI-1 complex in a linear regression model (squared correlation coefficient, 0.80; P<0.001). Conclusions: In the hemolytic-uremic syndrome, thrombin generation (probably due to accelerated thrombogenesis) and inhibition of fibrinolysis precede renal injury and may be the cause of such injury. (N Engl J Med 2002;346:23-32.) Copyright (C) 2002 Massachusetts Medical Society.	Childrens Hosp & Reg Med Ctr, Div Gastroenterol, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo	Tarr, PI (corresponding author), Childrens Hosp & Reg Med Ctr, Div Gastroenterol, CH-24,4800 Sand Point Way NE, Seattle, WA 98105 USA.			Ciol, Marcia/0000-0001-6406-4706; Jelacic, Srdjan/0000-0002-6617-9870	NIDDK NIH HHS [1RO1DK52081] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052081] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDERMAN MH, 1983, NEW ENGL J MED, V309, P1213, DOI 10.1056/NEJM198311173092004; BELL BP, 1997, PEDIATRICS, V100, P127; BERGSTEIN JM, 1992, NEW ENGL J MED, V327, P755, DOI 10.1056/NEJM199209103271102; BRENNER B, 1990, CIRCULATION, V81, P1818, DOI 10.1161/01.CIR.81.6.1818; Chandler WL, 2000, CLIN CHEM, V46, P38; Chandler WL, 2000, HAEMOSTASIS, V30, P204; Chandler WL, 1997, CIRCULATION, V96, P761; CHART H, 1991, LANCET, V337, P437, DOI 10.1016/0140-6736(91)91222-G; COLDING H, 1992, APMIS, V100, P119, DOI 10.1111/j.1699-0463.1992.tb00849.x; ELMS MJ, 1983, THROMB HAEMOSTASIS, V50, P591; EVRIN PE, 1972, SCAND J CLIN LAB INV, V29, P69, DOI 10.3109/00365517209081057; HABIB R, 1992, HEMOLYTIC UREMIC SYN, P315; Hayashi M, 1997, ACTA OBSTET GYN SCAN, V76, P590, DOI 10.3109/00016349709024590; HOLVOET P, 1986, THROMB HAEMOSTASIS, V56, P124; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; KATZ J, 1971, J PEDIATR-US, V78, P426, DOI 10.1016/S0022-3476(71)80222-6; KNECHT MF, 1992, THROMB RES, V67, P213, DOI 10.1016/0049-3848(92)90140-6; MONNENS L, 1982, CLIN NEPHROL, V17, P284; Nakao H, 2000, J NAT TOXINS, V9, P299; Nevard CHF, 1997, THROMB HAEMOSTASIS, V78, P1450; OKAMOTO K, 1992, HAEMOSTASIS, V22, P17; PELZER H, 1991, THROMB HAEMOSTASIS, V65, P153; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; RIELLA MC, 1976, NEPHRON, V17, P188, DOI 10.1159/000180723; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; Tsai HM, 2001, PEDIATR RES, V49, P653, DOI 10.1203/00006450-200105000-00008; Van Geet C, 1998, KIDNEY INT, V54, P1324, DOI 10.1046/j.1523-1755.1998.00103.x; VANDEKAR NCAJ, 1994, PEDIATR RES, V36, P257, DOI 10.1203/00006450-199408000-00019; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	29	157	166	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					23	32		10.1056/NEJMoa011033	http://dx.doi.org/10.1056/NEJMoa011033			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11777999				2022-12-01	WOS:000173033600004
J	Gestwicki, JE; Kiessling, LL				Gestwicki, JE; Kiessling, LL			Inter-receptor communication through arrays of bacterial chemoreceptors	NATURE			English	Article							SINGLE CYTOPLASMIC DOMAIN; ESCHERICHIA-COLI; KINASE ACTIVATION; CHEMOTAXIS; COMPLEX; DIMER; SENSITIVITY; MECHANISM; LOCATION; LATTICE	The sensing mechanisms of chemotactic bacteria allow them to respond sensitively to stimuli. Escherichia coli, for example, respond to changes in chemoattractant concentration of less than 10% over a range spanning six orders of magnitude(1,2). Sensitivity over this range depends on a nonlinear relationship between ligand concentration and output response(3). At low ligand concentrations, substantial amplification of the chemotactic signal is required; however, the mechanism responsible for this amplification remains unclear. Here we demonstrate that inter-receptor communication within a lattice(4,5) acts to amplify and integrate sensory information. Synthetic multivalent ligands that interact through the low-abundance, galactose-sensing receptor Trg stabilize large clusters of chemoreceptors and markedly enhance signal output from these enforced clusters. On treatment with multivalent ligands, the response to the attractant serine is amplified by at least 100-fold. This amplification requires a full complement of chemoreceptors; deletion of the aspartate (Tar) or dipeptide (Tap) receptors diminishes the amplification of the serine response. These results demonstrate that the entire array is involved in sensing. This mode of information exchange has general implications for the processing of signals by cellular receptors.	Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA.		Kiessling, Laura L/A-4074-2008	Kiessling, Laura/0000-0001-6829-1500				ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2000, J BACTERIOL, V182, P6499, DOI 10.1128/JB.182.22.6499-6502.2000; Gestwicki JE, 2000, CHEM BIOL, V7, P583, DOI 10.1016/S1074-5521(00)00002-8; Gestwicki JE, 2001, BIOORGAN MED CHEM, V9, P2387, DOI 10.1016/S0968-0896(01)00162-6; HAZELBAU.GL, 1969, P NATL ACAD SCI USA, V64, P1300, DOI 10.1073/pnas.64.4.1300; HAZELBAUER GL, 1981, J BACTERIOL, V145, P35, DOI 10.1128/JB.145.1.35-42.1981; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matsuuchi L, 2001, CURR OPIN IMMUNOL, V13, P270, DOI 10.1016/S0952-7915(00)00215-6; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; SAGER BM, 1988, ANAL BIOCHEM, V173, P271, DOI 10.1016/0003-2697(88)90189-3; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SLOCUM MK, 1983, J BACTERIOL, V155, P565, DOI 10.1128/JB.155.2.565-577.1983; Tatsuno I, 1996, SCIENCE, V274, P423, DOI 10.1126/science.274.5286.423; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; YEH JI, 1993, J BIOL CHEM, V268, P9787; Yin CC, 2000, NAT CELL BIOL, V2, P669, DOI 10.1038/35023625	30	205	207	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					81	84		10.1038/415081a	http://dx.doi.org/10.1038/415081a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780121				2022-12-01	WOS:000173028800044
J	Rojstaczer, S; Sterling, SM; Moore, NJ				Rojstaczer, S; Sterling, SM; Moore, NJ			Human appropriation of photosynthesis products	SCIENCE			English	Article							GLOBAL CARBON-CYCLE; FORESTS; ECOSYSTEMS; STORAGE	Previous global estimates of the human impact on terrestrial photosynthesis products depended heavily on extrapolation from plot-scale measurements. Here, we estimated this impact with the use of recent data, many of which were collected at global and continental scales. Monte Carlo techniques that incorporate known and estimated error in our parameters provided estimates of uncertainty. We estimate that humans appropriate 10 to 55% of terrestrial photosynthesis products. This broad range reflects uncertainty in key parameters and makes it difficult to ascertain whether we are approaching crisis levels in our use of the planet's resources. Improved estimates will require high-resolution global measures within agricultural lands and tropical forests.	Duke Univ, Ctr Hydrol Sci, Durham, NC 27708 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University; Duke University	Rojstaczer, S (corresponding author), Duke Univ, Ctr Hydrol Sci, Durham, NC 27708 USA.		Noojipady, Praveen/B-2511-2010					AJTAY GL, 1979, GLOBAL CARBON CYCLE, P00129; ARMENTANO TV, 1980, CAN J FOREST RES, V10, P53, DOI 10.1139/x80-009; BROWN C, 1999, GFPOSWP03 FAO; BROWN S, 1992, INTERCIENCIA, V17, P8; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; FAO, 1995, FOR RES ASS 1990 GLO; *FAO, 1990, 1989 FAO PROD YB; *FAO, 1992, FOR RES TROP ZON MAI; Haberl H, 1997, AMBIO, V26, P143; LIETH H, 1973, HUM ECOL, V1, P303, DOI 10.1007/BF01536729; PANDEY D, 1997, GCPINT628UK FAO FOOD; Pandey D, 1995, 128 FAO; Pimentel D., 1996, FOOD ENERGY SOC; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Scharpenberg R., 1998, GLOBAL FIBRE SUPPLY; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITTAKER RH, 1973, HUM ECOL, V1, P357, DOI 10.1007/BF01536732; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; WRIGHT DH, 1990, AMBIO, V19, P189; [No title captured]	23	173	196	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2549	2552		10.1126/science.1064375	http://dx.doi.org/10.1126/science.1064375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752576				2022-12-01	WOS:000172927700059
J	Roth, JP; Yoder, JC; Won, TJ; Mayer, JM				Roth, JP; Yoder, JC; Won, TJ; Mayer, JM			Application of the Marcus cross relation to hydrogen atom transfer reactions	SCIENCE			English	Article							COUPLED ELECTRON-TRANSFER; PROTON; RADICALS; ABSTRACTION; COMPLEXES; RATES; DNA	The transfer of a hydrogen atom-a proton and an electron-is a fundamental process in chemistry and biology. A variety of hydrogen atom transfer reactions, involving iron complexes, phenols, hydroxylamines, (BuOOH)-Bu-t, toluene, and related radicals, are shown to follow the Marcus cross relation. Thus, the Marcus theory formalism based on ground-state energetics and self-exchange rates, originally developed for electron transfer processes, is also valuable for hydrogen atom transfer. Compounds that undergo slow proton transfer (C-H bonds) or slow electron transfer (cobalt complexes) also undergo slow hydrogen atom transfer. Limitations of this approach are also discussed.	Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mayer, JM (corresponding author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.	mayer@chem.washington.edu	Roth, Justine/B-5488-2013		NIGMS NIH HHS [2 R01 GM50422-05, 1 F32 GM63383-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050422, F32GM063383] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERY WJ, 1980, ANNU REV PHYS CHEM, V31, P227, DOI 10.1146/annurev.pc.31.100180.001303; AVILA DV, 1995, J AM CHEM SOC, V117, P2929, DOI 10.1021/ja00115a029; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; Baskin S., 1997, OXIDANTS ANTIOXIDANT; Bordwell FG, 1996, J AM CHEM SOC, V118, P10819, DOI 10.1021/ja961469q; Borgis D, 1996, J PHYS CHEM-US, V100, P1118, DOI 10.1021/jp9522324; Cabelli DE, 2001, ORGANOMETALLICS, V20, P3729, DOI 10.1021/om0102089; COHEN AO, 1968, J PHYS CHEM-US, V72, P4249, DOI 10.1021/j100858a052; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Donahue NM, 1998, J PHYS CHEM A, V102, P3923, DOI 10.1021/jp980372i; FISCHER H, 1984, LANDOLTBORNSTEIN, V13; FISCHER H, 1984, LANDOLTBORNSTEIN, V18; Iordanova N, 2001, J AM CHEM SOC, V123, P3723, DOI 10.1021/ja0100524; KOCHI JK, 1973, FREE RADICALS, V1, P69; KREILICK RW, 1966, J AM CHEM SOC, V88, P2645, DOI 10.1021/ja00964a004; KRISTJANSDOTTIR SS, 1991, J AM CHEM SOC, V113, P4366, DOI 10.1021/ja00011a070; Lee E, 2000, J PHYS CHEM B, V104, P6894, DOI 10.1021/jp000167e; Lee ISH, 2001, J AM CHEM SOC, V123, P7492, DOI 10.1021/ja004232+; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Marcus RA, 1997, J PHYS CHEM A, V101, P4072, DOI 10.1021/jp963722e; Mayer Jean Francois, UNPUB; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; Mijs W.J., 1986, ORGANIC SYNTHESIS OX; Olah GA., 1995, HYDROCARBON CHEM; Roth JP, 1999, INORG CHEM, V38, P2760, DOI 10.1021/ic990251c; Roth JP, 2000, J AM CHEM SOC, V122, P5486, DOI 10.1021/ja9941328; RUSSELL GA, 1973, FREE RADICALS, V1, P283; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; SUTIN N, 1983, PROG INORG CHEM, V30, P441, DOI 10.1002/9780470166314.ch9; Tanko JM, 2001, J AM CHEM SOC, V123, P5808, DOI 10.1021/ja005730l; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Weatherly SC, 2001, J AM CHEM SOC, V123, P1236, DOI 10.1021/ja003788u; YODER JC, UNPUB; ZAVELOVICH EB, 1974, CHEM PHYS LETT, V29, P212, DOI 10.1016/0009-2614(74)85015-3	34	181	181	10	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2524	2526		10.1126/science.1066130	http://dx.doi.org/10.1126/science.1066130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752572				2022-12-01	WOS:000172927700051
J	Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L				Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L			Carbonaceous meteorites as a source of sugar-related organic compounds for the early Earth	NATURE			English	Article							MURCHISON METEORITE; MASS SPECTROMETRY; CARBOXYLIC-ACIDS; AMINO-ACIDS; CHROMATOGRAPHY; DERIVATIVES; EVOLUTION; COMETS	The much-studied Murchison meteorite is generally used as the standard reference for organic compounds in extraterrestrial material. Amino acids and other organic compounds(1) important in contemporary biochemistry are thought to have been delivered to the early Earth by asteroids and comets, where they may have played a role in the origin of life(2-4). Polyhydroxylated compounds (polyols) such as sugars, sugar alcohols and sugar acids are vital to all known lifeforms-they are components of nucleic acids (RNA, DNA), cell membranes and also act as energy sources. But there has hitherto been no conclusive evidence for the existence of polyols in meteorites, leaving a gap in our understanding of the origins of biologically important organic compounds on Earth. Here we report that a variety of polyols are present in, and indigenous to, the Murchison and Murray meteorites in amounts comparable to amino acids. Analyses of water extracts indicate that extraterrestrial processes including photolysis and formaldehyde chemistry could account for the observed compounds. We conclude from this that polyols were present on the early Earth and therefore at least available for incorporation into the first forms of life.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ G DAnnunzio, IRSPS, I-65127 Pescara, Italy	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; G d'Annunzio University of Chieti-Pescara	Cooper, G (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	gcooper@mail.arc.nasa.gov						AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; Amelung W, 1996, SOIL BIOL BIOCHEM, V28, P1631, DOI 10.1016/S0038-0717(96)00248-9; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; BRIMACOMBE JS, 1972, CARBOHYDRATES CHEM B, P479; Bruijn J.M.de, 1986, SUGAR TECHN REV, V13, P21; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI C, V30, P1582; COLEMAN ML, 1978, ANAL CHEM, V50, P1594, DOI 10.1021/ac50033a056; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; DEGENS ET, 1962, NATURWISSENSCHAFTEN, V49, P605, DOI 10.1007/BF01178050; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; GILBART J, 1987, EUR J CLIN MICROBIOL, V6, P715, DOI 10.1007/BF02013084; HAYES JM, 1967, GEOCHIM COSMOCHIM AC, V31, P1395, DOI 10.1016/0016-7037(67)90019-1; Hollis JM, 2000, ASTROPHYS J, V540, pL107, DOI 10.1086/312881; Irvine WM, 1999, SPACE SCI REV, V90, P203, DOI 10.1023/A:1005258300558; Jungclaus G. A., 1976, Meteoritics, V11, P231, DOI 10.1111/j.1945-5100.1976.tb00324.x; KAPLAN IR, 1963, GEOCHIM COSMOCHIM AC, V27, P805, DOI 10.1016/0016-7037(63)90045-0; Langenbeck W, 1942, NATURWISSENSCHAFTEN, V30, P30, DOI 10.1007/BF01475765; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; LOWENDAHL L, 1976, TAPPI, V59, P118; McDonald GD, 1996, ICARUS, V122, P107, DOI 10.1006/icar.1996.0112; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PETERSSO.G, 1970, TETRAHEDRON, V26, P3413, DOI 10.1016/S0040-4020(01)92918-7; Pigman W., 1972, CARBOHYDRATES CHEM A, V1, P165; WEBER AL, 1992, J MOL EVOL, V35, P1, DOI 10.1007/BF00160255; Zolensky M., 1988, METEORITES EARLY SOL, P114	29	315	320	5	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					879	883		10.1038/414879a	http://dx.doi.org/10.1038/414879a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780054	Green Published			2022-12-01	WOS:000172813300037
J	Roger, T; David, J; Glauser, MP; Calandra, T				Roger, T; David, J; Glauser, MP; Calandra, T			MIF regulates innate immune responses through modulation of Toll-like receptor 4	NATURE			English	Article							MIGRATION-INHIBITORY FACTOR; BINDING-PROTEIN; CUTTING EDGE; LIPOPOLYSACCHARIDE-BINDING; LETHAL ENDOTOXEMIA; MACROPHAGE; GENE; LPS; EXPRESSION; ACTIVATION	Macrophages are pivotal effector cells of the innate immune system, which is vital for recognizing and eliminating invasive microbial pathogens(1,2). When microbial products bind to pathogen-recognition receptors, macrophages become activated and release a broad array of cytokines(3) that orchestrate the host innate and adaptive immune responses. Initially identified as a T-cell cytokine(4,5), macrophage migration inhibitory factor (MIF) is also a macrophage cytokine and an important mediator of inflammation and sepsis(6-12). Here we report that MIF is an essential regulator of macrophage responses to endotoxin (lipopolysaccharide) and Gram-negative bacteria. Compared with wild-type cells, MIF-deficient macrophages are hyporesponsive to lipopolysaccharide and Gram-negative bacteria, as shown by a profound reduction in the activity of NF-kappaB and the production of tumour-necrosis factor-alpha. This reduction is due to a downregulation of Toll-like receptor 4 (TLR4), the signal-transducing molecule of the lipopolysaccharide receptor complex, and is associated with decreased activity of transcription factor PU.1, which is required for optimal expression of the Tlr4 gene in myeloid cells. These findings identify an important role for MIF in innate immunity and provide a molecular basis for the resistance of MIF-dercient mice to endotoxic shock.	CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard T.H. Chan School of Public Health	Calandra, T (corresponding author), CHU Vaudois, Dept Internal Med, Div Infect Dis, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.		Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Calandra, Thierry/0000-0003-3051-1285				Adachi Y, 1999, J ENDOTOXIN RES, V5, P139, DOI 10.1179/096805199101531642; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Heine H, 1999, J IMMUNOL, V162, P6971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Le Roy D, 1999, J IMMUNOL, V162, P7454; Matsumura I, 2000, BLOOD, V96, P2440; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	30	471	502	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					920	924		10.1038/414920a	http://dx.doi.org/10.1038/414920a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780066				2022-12-01	WOS:000172813300049
J	de Groot, BL; Grubmuller, H				de Groot, BL; Grubmuller, H			Water permeation across biological membranes: Mechanism and dynamics of aquaporin-1 and GlpF	SCIENCE			English	Article							MOLECULAR-DYNAMICS; GLYCEROL FACILITATOR; CHANNEL; RECONSTITUTION; LIPOSOMES; VERSION; PORE	"Real time" molecular dynamics simulations of water permeation through human aquaporin-1 (AQP1) and the bacterial glycerol facilitator GlpF are presented. We obtained time-resolved, atomic-resolution models of the permeation mechanism across these highly selective membrane channels. Both proteins act as two-stage filters: Conserved fingerprint [asparagine-proline-alanine (NPA)] motifs form a selectivity-determining region; a second (aromatic/arginine) region is proposed to function as a proton filter. Hydrophobic regions near the NPA motifs are rate-limiting water barriers. In AQP1, a fine-tuned water dipole rotation during passage is essential for water selectivity. In GlpF, a glycerol-mediated "induced fit" gating motion is proposed to generate selectivity for glycerol over water.	Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany	Max Planck Society	Grubmuller, H (corresponding author), Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, Fassberg 11, D-37077 Gottingen, Germany.	hgrubmu@gwdg.de						Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERENDSEN HJC, COMMUNICATION; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; Deen PMT, 1998, CURR OPIN CELL BIOL, V10, P435, DOI 10.1016/S0955-0674(98)80055-0; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; ENGEL A, IN PRESS INT REV CYT; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; JUNG JS, 1994, J BIOL CHEM, V269, P14648; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; MAUREL C, 1994, J BIOL CHEM, V269, P11869; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; SHI LB, 1994, J BIOL CHEM, V269, P10417; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1	39	775	793	6	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2001	294	5550					2353	2357		10.1126/science.1062459	http://dx.doi.org/10.1126/science.1062459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743202				2022-12-01	WOS:000172817200047
J	Thompson, JR; Gerald, PF; Willoughby, MLN; Armstrong, BK				Thompson, JR; Gerald, PF; Willoughby, MLN; Armstrong, BK			Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study	LANCET			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; NEURAL-TUBE DEFECTS; COLORECTAL-CANCER; COMMON MUTATION; RISK-FACTORS; LEUKEMIA; GENE; SUSCEPTIBILITY; DEFICIENCY; CHILDREN	Background Acute lymphoblastic leukaemia is the most common childhood cancer in more-developed countries but it has few recognised risk factors or preventive measures. We aimed to determine and assess the risk factors associated with this disease. Methods From 1984 to 1992, we investigated known and suspected risk factors for common acute lymphoblastic leukaemia diagnosed in a population-based case-control study of children aged 0-14 years in Western Australia. 83 children in the study group came from the sole referral centre for paediatric cancer in the state and 166 controls matched for age and sex were recruited through a postal survey of people randomly selected from the state electoral roll. We interviewed mothers of 83 study and 166 control children (82% and 74%, respectively, of those eligible). Fathers completed a self-administered questionnaire. Findings We recorded a protective association between iron or folate supplementation in pregnancy and risk of common acute lymphoblastic leukaemia in the child (odds ratio 0.37 [95% CI 0.21-0.65]; p=0.001). For iron alone, the odds ratio was 0.75 (0.37-1.51); only one mother took folate without iron. Further analyses of folate use with or without iron (0.40; 0.21-0.73) showed that the protective effect varies little by time of first use of supplements or for how long they were taken. The association was not weakened by adjustment for potentially confounding variables. Interpretation Our results, though unexpected, suggest that folate supplementation in pregnancy reduces the risk of common acute lymphoblastic leukaemia in the child.	Canc Fdn Western Australia, Perth, WA, Australia; Univ Newcastle, Royal Newcastle Hosp, Sch Populat Hlth Sci, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; Princess Margaret Hosp, Dept Haematol & Oncol, Perth, WA, Australia; New S Wales Canc Council, Sydney, NSW, Australia	University of Newcastle; Cancer Council New South Wales	Thompson, JR (corresponding author), Canc Fdn Western Australia, Perth, WA, Australia.	rickthom@iinet.net.au	Armstrong, Bruce K/K-9464-2015	Armstrong, Bruce K/0000-0001-8940-7525				ARUNDEL SE, 1986, J EPIDEMIOL COMMUN H, V40, P30, DOI 10.1136/jech.40.1.30; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Bower C, 1997, AUST NZ J OBSTET GYN, V37, P267; BUCKLEY JD, 1994, LEUKEMIA, V8, P856; BUNIN GR, 1993, NEW ENGL J MED, V329, P536, DOI 10.1056/NEJM199308193290804; Chen J, 1996, CANCER RES, V56, P4862; CNATTINGIUS S, 1995, J NATL CANCER I, V87, P908, DOI 10.1093/jnci/87.12.908; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Esteller M, 1997, CARCINOGENESIS, V18, P2307, DOI 10.1093/carcin/18.12.2307; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GREAVES MF, 1988, LEUKEMIA, V2, P120; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; KAYE SA, 1991, CANCER-AM CANCER SOC, V68, P1351, DOI 10.1002/1097-0142(19910915)68:6<1351::AID-CNCR2820680627>3.0.CO;2-J; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; KINLEN L, 1988, LANCET, V2, P1323; LOWENGART RA, 1987, J NATL CANCER I, V79, P39; Ma J, 1997, CANCER RES, V57, P1098; MILLER RW, 1963, NEW ENGL J MED, V268, P393, DOI 10.1056/NEJM196302212680801; Parkin DM, 1998, IARC SCI PUBLICATION, V144; Petridou E, 1997, BRIT J CANCER, V76, P1241, DOI 10.1038/bjc.1997.541; Roman E, 1997, BRIT J CANCER, V76, P406, DOI 10.1038/bjc.1997.399; ROSS JA, 1994, EPIDEMIOL REV, V16, P243, DOI 10.1093/oxfordjournals.epirev.a036153; Rozen R, 1999, AM J MED GENET, V83, P142, DOI 10.1002/(SICI)1096-8628(19990312)83:2<142::AID-AJMG12>3.0.CO;2-Y; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Taylor GM, 1996, LEUKEMIA, P210; Ullen H, 1997, CANCER LETT, V114, P215, DOI 10.1016/S0304-3835(97)04666-1; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANSTEENSELMOLL HA, 1985, INT J EPIDEMIOL, V14, P555, DOI 10.1093/ije/14.4.555; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298	31	183	186	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2001	358	9297					1935	1940		10.1016/S0140-6736(01)06959-8	http://dx.doi.org/10.1016/S0140-6736(01)06959-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500HZ	11747917				2022-12-01	WOS:000172622200010
J	Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M				Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M			Protein nanoarrays generated by dip-pen nanolithography	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; FABRICATION; ADSORPTION; PARALLEL; PATTERNS	Dip-pen nanolithography was used to construct arrays of proteins with 100- to 350-nanometer features. These nanoarrays exhibit almost no detectable nonspecific binding of proteins to their passivated portions even in complex mixtures of proteins, and therefore provide the opportunity to study a variety of surface-mediated biological recognition processes. For example, reactions involving the protein features and antigens in complex solutions can be screened easily by atomic force microscopy. As further proof-of-concept, these arrays were used to study cellular adhesion at the submicrometer scale.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Ctr Nanofabricat & Mol Self Assembly, Evanston, IL 60208 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu; mmrksich@midway.uchicago.edu	Park, So-Jung/F-9471-2017; Mirkin, Chad A/E-3911-2010; Mrksich, Milan/G-2469-2011; Lee, KiBum/F-3702-2012; Lee, Ki-Bum/G-7503-2015	Mirkin, Chad/0000-0002-6634-7627; Mrksich, Milan/0000-0002-4964-796X; LEE, Ki-Bum/0000-0002-8164-0047				Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Bergman AA, 1998, LANGMUIR, V14, P6785, DOI 10.1021/la980642o; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4; BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Kenseth JR, 2001, LANGMUIR, V17, P4105, DOI 10.1021/la0100744; KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572; LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038; MacBeath G, 2000, SCIENCE, V289, P1760; Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775; Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n; Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9; Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198	23	1027	1080	1	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1702	1705		10.1126/science.1067172	http://dx.doi.org/10.1126/science.1067172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11834780				2022-12-01	WOS:000174212900043
J	Theissen, G				Theissen, G			Secret life of genes	NATURE			English	Editorial Material									Univ Jena, Lehrstuhl Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Theissen, G (corresponding author), Univ Jena, Lehrstuhl Genet, Philosophenweg 12, D-07743 Jena, Germany.							Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Graur D., 2000, FUNDAMENTALS MOL EVO; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631	4	61	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					741	741		10.1038/415741a	http://dx.doi.org/10.1038/415741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845189	Bronze			2022-12-01	WOS:000173833900028
J	Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M				Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M			Adult-onset primary open-angle glaucoma caused by mutations in optineurin	SCIENCE			English	Article							LOW-TENSION GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; NECROSIS-FACTOR-ALPHA; CYTOCHROME P4501B1; IDENTIFICATION; PREVALENCE; PROTEIN; REGION; LOCUS; 2P21	Primary open-angle glaucoma (POAG) affects 33 million individuals worldwide and is a leading cause of blindness. In a study of 54 families with autosomal dominantly inherited adult-onset POAG, we identified the causative gene on chromosome 10p14 and designated it OPTN (for "optineurin"). Sequence alterations in OPTN were found in 16.7% of families with hereditary POAG, including individuals with normal intraocular pressure. The OPTN gene codes for a conserved 66-kilodalton protein of unknown function that has been implicated in the tumor necrosis factor-alpha signaling pathway and that interacts with diverse proteins including Huntingtin, Ras-associated protein RABB, and transcription factor IIIA. Optineurin is expressed in trabecular meshwork, nonpigmented ciliary epithelium, retina, and brain, and we speculate that it plays a neuroprotective role.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Moorfields Eye Hosp, Glaucoma Res Unit, London EC1V 2PD, England; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Vis Res Program UHN, Dept Ophthalmol, Toronto, ON M5T 2S8, Canada; Univ Eye Specialists, Chicago, IL 60611 USA; New York Eye & Ear Infirm, Valhalla, NY 10003 USA; New York Med Coll, Valhalla, NY 10003 USA; Int Glaucoma Assoc, London SE5 9HQ, England	University of Connecticut; St Georges University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Connecticut; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA.		Quill, Barry/O-2614-2014	Quill, Barry/0000-0002-0578-5703	NATIONAL EYE INSTITUTE [R01EY009947] Funding Source: NIH RePORTER; NEI NIH HHS [EY-09947] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; GROSSKREUTZ C, 1994, INT OPHTHALMOL CLIN, V34, P173, DOI 10.1097/00004397-199403430-00016; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; REZAIE T, UNPUB; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tezel G, 2000, J NEUROSCI, V20, P8693; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; WERNER EB, 1996, GLAUCOMAS, V2, pCH36; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V	21	807	873	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1077	1079		10.1126/science.1066901	http://dx.doi.org/10.1126/science.1066901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834836				2022-12-01	WOS:000173793000067
J	Smetacek, V				Smetacek, V			Balance: Mind-grasping gravity - Is the mind's balance, and hence its functioning, derived from that of the body?	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; HECK D, 2001, SPEKTRUM WISSENS OCT, P36; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Ramachandran V. S., 1999, PHANTOMS BRAIN PROBI	4	6	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					481	481		10.1038/415481a	http://dx.doi.org/10.1038/415481a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823838	Bronze			2022-12-01	WOS:000173564300026
J	Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW				Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW			Activation of orphan receptors by the hormone relaxin	SCIENCE			English	Article							THYROTROPIN RECEPTORS; BINDING; CELLS; IDENTIFICATION; CRYPTORCHIDISM; GONADOTROPIN; INSULIN; PEPTIDE; GROWTH; INSL3	Relaxin is a hormone important for the growth and remodeling of reproductive and other tissues during pregnancy. Although binding sites for relaxin are widely distributed, the nature of its receptor has been elusive. Here, we demonstrate that two orphan heterotrimeric guanine nucleotide binding protein (G protein)-coupled receptors, LGR7 and LGR8, are capable of mediating the action of relaxin through an adenosine 3',5'-monophosphate (cAMP)-dependent pathway distinct from that of the structurally related insulin and insulin-like growth factor family ligand. Treatment of antepartum mice with the soluble ligand-binding region of LGR7 caused parturition delay. The wide and divergent distribution of the two relaxin receptors implicates their roles in reproductive, brain, renal, cardiovascular, and other functions.	Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Hsueh, AJW (corresponding author), Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA.				NICHD NIH HHS [HD23273] Funding Source: Medline; NIDDK NIH HHS [DK58534] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023273, R01HD023273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK058534] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARTSCH O, 2001, MOL HUM REPROD, V7, P799; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; BATHGATE RA, 2001, J BIOL CHEM, V31, P31; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAVOREN JB, 1985, BIOL REPROD, V33, P37, DOI 10.1095/biolreprod33.1.37; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; GEDDES BJ, 1995, J NEUROENDOCRINOL, V7, P411, DOI 10.1111/j.1365-2826.1995.tb00777.x; HSU CJ, 1985, ENDOCRINOLOGY, V116, P2029, DOI 10.1210/endo-116-5-2029; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; HWANG JJ, 1989, ENDOCRINOLOGY, V125, P260, DOI 10.1210/endo-125-1-260; Min G, 1996, BIOL REPROD, V55, P1243, DOI 10.1095/biolreprod55.6.1243; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; OSHEROFF PL, 1992, P NATL ACAD SCI USA, V89, P2384, DOI 10.1073/pnas.89.6.2384; OSHEROFF PL, 1991, P NATL ACAD SCI USA, V88, P6413, DOI 10.1073/pnas.88.15.6413; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; SHERWOOD CD, 1974, ARCH BIOCHEM BIOPHYS, V160, P185, DOI 10.1016/S0003-9861(74)80025-1; SHERWOOD OD, 1994, PHYSL REPRODUCTION, V1, P861; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	25	643	681	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					671	674		10.1126/science.1065654	http://dx.doi.org/10.1126/science.1065654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809971				2022-12-01	WOS:000173560900043
J	Moore, JP				Moore, JP			On the trail of two trials	NATURE			English	Editorial Material									Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.								0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					365	366		10.1038/415365a	http://dx.doi.org/10.1038/415365a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807523				2022-12-01	WOS:000173433600020
J	Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS				Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS			Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NMDA RECEPTOR; ION CHANNELS; K(V)LQT1; YOTIAO; HEART; FORM	Sympathetic nervous system (SNS) regulation of cardiac action potential duration (APD) is mediated by beta adrenergic receptor (betaAR) activation, which increases the stow outward potassium ion current (I-Ks). Mutations in two human I-Ks channel subunits, hKCNQ1 and hKCNE1, prolong APD and cause inherited cardiac arrhythmias known as LQTS (long QT syndrome). We show that PAR modulation of I-Ks requires targeting of adenosine 3',5'-monophosphate (cAMP)dependent protein kinase (PKA) and protein phosphatase 1 (PP1) to hKCNQ1 through the targeting protein yotiao. Yotiao binds to hKCNQ1 by a leucine zipper motif, which is disrupted by an LQTS mutation (hKCNQ1-G589D). Identification of the hKCNQ1 macromolecular complex provides a mechanism for SNS modulation of cardiac APD through I-Ks.	Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Kurokawa, Junko/ABF-7557-2021; Kurokawa, Junko/Q-6287-2017	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908	NHLBI NIH HHS [R01-HL68093, R01-HL61503, R01-HL56810-05, R01-HL56180, R01-HL44365-07, P01HL67849-01] Funding Source: Medline; NIAID NIH HHS [R01-AI39794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067849, R01HL044365, R01HL056180, R01HL056810, R01HL061503, R01HL068093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An RH, 1999, J PHYSIOL-LONDON, V516, P19, DOI 10.1111/j.1469-7793.1999.019aa.x; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Feliciello A, 1999, FEBS LETT, V464, P174, DOI 10.1016/S0014-5793(99)01585-9; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; GULICK J, 1991, J BIOL CHEM, V266, P9180; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 2000, CARDIAC ELECTROPHYSI, pCH11; Lin JW, 1998, J NEUROSCI, V18, P2017; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MARX SO, UNPUB; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Paavonen KJ, 2001, HEART, V86, P39, DOI 10.1136/heart.86.1.39; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schwartz PJ, 2001, CIRCULATION, V103, P89; Scott JN, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0600-72; Towbin JA, 2001, DRUG METAB DISPOS, V29, P574; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069	20	545	576	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					496	499		10.1126/science.1066843	http://dx.doi.org/10.1126/science.1066843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799244				2022-12-01	WOS:000173350700050
J	Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME				Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME			Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors	SCIENCE			English	Article							D-ASPARTATE RECEPTOR; INCREASES TYROSINE PHOSPHORYLATION; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; CELL-CONTACT; SUBUNIT 2B; KINASES; ACTIVATION; GROWTH; SITES	Protein-protein interactions and calcium entry through the N-methyl-D-aspartate (NMDA)-type glutamate receptor regulate synaptic development and plasticity in the central nervous system. The EphB receptor tyrosine kinases are localized at excitatory synapses where they cluster and associate with NMDA receptors. We identified a mechanism whereby EphBs modulate NMDA receptor function. EphrinB2 activation of EphB in primary cortical neurons potentiates NMDA receptor-dependent influx of calcium. Treatment of cells with ephrinB2 led to NMDA receptor tyrosine phosphorylation through activation of the Src family of tyrosine kinases. These ephrinB2-dependent events result in enhanced NMDA receptor-dependent gene expression. Our findings indicate that ephrin-B2 stimulation of EphB modulates the functional consequences of NMDA receptor activation and suggest a mechanism whereby activity-independent and activity-dependent signals converge to regulate the development and remodeling of synaptic connections.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@tch.harvard.edu		Dalva, Matthew/0000-0002-7737-8787	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017512, R01NS012651, R01NS045500] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS12651, R01 NS045500, NS17512] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DALVA MB, UNPUB; Di Luca M, 2001, NEUROREPORT, V12, P1301, DOI 10.1097/00001756-200105080-00049; Ellis C, 1996, ONCOGENE, V12, P1727; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; TAKASU MA, UNPUB; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; [No title captured]	32	389	410	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					491	495		10.1126/science.1065983	http://dx.doi.org/10.1126/science.1065983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799243				2022-12-01	WOS:000173350700049
J	Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB				Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB			Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase	NATURE			English	Article							INCREASES GLUCOSE-UPTAKE; SKELETAL-MUSCLE; INSULIN; COA; MECHANISM; OBESITY; STRESS; MICE	Leptin is a hormone secreted by adipocytes that plays a pivotal role in regulating food intake, energy expenditure and neuroendocrine function(1). Leptin stimulates the oxidation of fatty acids(2) and the uptake of glucose(3,4), and prevents the accumulation of lipids in nonadipose tissues, which can lead to functional impairments known as "lipotoxicity''(5). The signalling pathways that mediate the metabolic effects of leptin remain undefined. The 5'-AMP-activated protein kinase (AMPK) potently stimulates fatty-acid oxidation in muscle by inhibiting the activity of acetyl coenzyme A carboxylase (ACC)(6,7). AMPK is a heterotrimeric enzyme that is conserved from yeast to humans and functions as a 'fuel gauge' to monitor the status of cellular energy(6). Here we show that leptin selectively stimulates phosphorylation and activation of the alpha2 catalytic subunit of AMPK (alpha2 AMPK) in skeletal muscle, thus establishing a previously unknown signalling pathway for leptin. Early activation of AMPK occurs by leptin acting directly on muscle, whereas later activation depends on leptin functioning through the hypothalamic-sympathetic nervous system axis. In parallel with its activation of AMPK, leptin suppresses the activity of ACC, thereby stimulating the oxidation of fatty acids in muscle. Blocking AMPK activation inhibits the phosphorylation of ACC stimulated by leptin. Our data identify AMPK as a principal mediator of the effects of leptin on fatty-acid metabolism in muscle.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Cellular Stress Grp, London W12 0NN, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Imperial College London	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@caregroup.harvard.edu	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Minokoshi, Yasuhiko/0000-0002-7119-4805				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AKAIKE N, 1981, SCIENCE, V213, P1252, DOI 10.1126/science.6267696; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; MARTIN WH, 1990, AM J PHYSIOL, V259, pH1402, DOI 10.1152/ajpheart.1990.259.5.H1402; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Oakes ND, 1999, J LIPID RES, V40, P1155; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STAFFORD IL, 1990, J NEUROSCI, V10, P91; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4	29	1544	1633	3	159	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					339	343		10.1038/415339a	http://dx.doi.org/10.1038/415339a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797013				2022-12-01	WOS:000173293500048
J	White, TW				White, TW			Unique and redundant connexin contributions to lens development	SCIENCE			English	Article							MOLECULAR-FEATURES; ALPHA(3) CONNEXIN; MICE; DIFFERENTIATION; EYE	Connexin genes encode intercellular channels that help to coordinate development. In mice, the targeted deletion of different connexins produces disparate effects on ocular growth and differentiation in the tens, and the need for multiple channel subunits is poorly understood. Knockout of Cx46 causes a loss of homeostasis and cataracts. Deletion of Cx50 results in reduced ocular growth and cataracts. Targeted replacement of Cx50 with Cx46 by genetic knock-in corrected defects in cellular differentiation and prevented cataracts, but did not restore normal growth. These data show that intrinsic properties of Cx50 were required for cellular growth, whereas nonspecific restoration of communication by Cx46 maintained differentiation.	SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	White, TW (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.		White, Thomas/GPG-4026-2022; White, Thomas W./R-3605-2019	White, Thomas/0000-0002-3285-7434; 	NATIONAL EYE INSTITUTE [R01EY002430, R01EY013163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037751] Funding Source: NIH RePORTER; NEI NIH HHS [EY02430, EY13163] Funding Source: Medline; NIGMS NIH HHS [GM37751] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Hopperstad MG, 2000, BIOPHYS J, V79, P1954, DOI 10.1016/S0006-3495(00)76444-7; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; WHITE T, UNPUB; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2000, BRAIN RES REV, V32, P130, DOI 10.1016/S0165-0173(99)00072-7; Wride MA, 1996, DIFFERENTIATION, V61, P77, DOI 10.1046/j.1432-0436.1996.6120077.x	15	192	196	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					319	320		10.1126/science.1067582	http://dx.doi.org/10.1126/science.1067582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786642				2022-12-01	WOS:000173278600047
J	Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR				Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR			ATP-bound states of GroEL captured by cryo-electron microscopy	CELL			English	Article							OLIGOMERIC CHAPERONIN GROEL; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; ESCHERICHIA-COLI; KINETIC-ANALYSIS; PROTEIN; BINDING; CYCLE; MECHANISM; POLYPEPTIDE	The chaperonin GroEL drives its protein-folding cycle by cooperatively binding ATP to one of its two rings, priming that ring to become folding-active upon GroES binding, while simultaneously discharging the previous folding chamber from the opposite ring. The GroEL-ATP structure, determined by cryo-EM and atomic structure fitting, shows that the intermediate domains rotate downward, switching their intersubunit salt bridge contacts from substrate binding to ATP binding domains. These observations, together with the effects of ATP binding to a GroEL-GroES-ADP complex, suggest structural models for the ATP-induced reduction in affinity for polypeptide and for cooperativity. The model for cooperativity, based on switching of intersubunit salt bridge interactions around the GroEL ring, may provide general insight into cooperativity in other ring complexes and molecular machines.	Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of London; Birkbeck University London; Imperial College London; Howard Hughes Medical Institute; Yale University; Yale University	Ranson, NA (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.		Roseman, Alan/AAE-6689-2019	Roseman, Alan/0000-0002-4783-2619; Ranson, Neil/0000-0002-3640-5275				Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Roseman AM, 2001, J STRUCT BIOL, V135, P115, DOI 10.1006/jsbi.2001.4374; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; STANIFORTH RA, 1994, BIOCHEM J, V300, P651, DOI 10.1042/bj3000651; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1998, J AM CHEM SOC, V120, P13262, DOI 10.1021/ja983136u	46	232	233	2	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					869	879		10.1016/S0092-8674(01)00617-1	http://dx.doi.org/10.1016/S0092-8674(01)00617-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779463	Bronze			2022-12-01	WOS:000173024200008
J	Malin, MC; Caplinger, MA; Davis, SD				Malin, MC; Caplinger, MA; Davis, SD			Observational evidence for an active surface reservoir of solid carbon dioxide on mars	SCIENCE			English	Article							RESIDUAL CO2 FROST; SOUTH POLAR-CAP; SUMMER TEMPERATURES; ASTRONOMICAL THEORY; CHAOTIC OBLIQUITY; WATER-VAPOR; INSOLATION	High-resolution images of the south polar residual cap of Mars acquired in 1999 and 2001 show changes in the configuration of pits, intervening ridges, and isolated mounds. Escarpments have retreated 1 to 3 meters in 1 martian year, changes that are an order of magnitude larger than can be explained by the sublimation of water ice, but close to what is expected for sublimation of carbon dioxide ice. These observations support a 35-year-old conjecture that Mars has a large surface reservoir of solid carbon dioxide. The erosion implies that this reservoir is not in equilibrium with the present environment and that global climate change is occurring on Mars.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.							BRIGGS GA, 1974, ICARUS, V23, P167, DOI 10.1016/0019-1035(74)90004-9; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; DZURISIN D, 1975, J GEOPHYS RES, V80, P3286, DOI 10.1029/JB080i023p03286; FANALE FP, 1974, J GEOPHYS RES, V79, P3397, DOI 10.1029/JC079i024p03397; FANALE FP, 1976, ICARUS, V28, P172; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Hess S. L., 1977, Journal of Geophysical Research, V82, P4559, DOI 10.1029/JS082i028p04559; HESS SL, 1976, SCIENCE, V194, P1352, DOI 10.1126/science.194.4271.1352; HESS SL, 1976, SCIENCE, V194, P78, DOI 10.1126/science.194.4260.78; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1984, ICARUS, V57, P322, DOI 10.1016/0019-1035(84)90121-0; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin M. C., 1991, International Journal of Imaging Systems and Technology, V3, P76, DOI 10.1002/ima.1850030205; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MURRAY BC, 1973, SCIENCE, V182, P437, DOI 10.1126/science.182.4111.437; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; MURRAY BC, 1973, SCIENCE, V180, P638, DOI 10.1126/science.180.4086.638; NEUGEBAUER G, 1971, ASTRON J, V76, P719, DOI 10.1086/111189; PAIGE DA, 1985, SCIENCE, V228, P1160, DOI 10.1126/science.228.4704.1160; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; SODERBLOM LA, 1973, J GEOPHYS RES, V78, P4197, DOI 10.1029/JB078i020p04197; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; WARD WR, 1973, SCIENCE, V181, P260, DOI 10.1126/science.181.4096.260; ZUREK RW, 1982, ICARUS, V50, P288, DOI 10.1016/0019-1035(82)90127-0	36	116	116	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2146	2148		10.1126/science.1066416	http://dx.doi.org/10.1126/science.1066416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11768358				2022-12-01	WOS:000172647700045
J	Stern, V				Stern, V			Gynaecological examinations post-Ledward - a private matter	LANCET			English	Editorial Material							CHAPERONES				Stern, V (corresponding author), 30 Goldhurst Terrace, London NW6 3HU, England.	vivien.stern@bushinternet.com						Bignell CJ, 1999, BMJ-BRIT MED J, V319, P137, DOI 10.1136/bmj.319.7203.137; JONES RH, 1983, J ROY COLL GEN PRACT, V33, P25; Morrow J, 1999, BMJ-BRIT MED J, V319, P1266; *ROYAL COLL OBST G, 1997, INT EX REP WORK PART; Torrance CJ, 1999, BRIT MED J, V319, P159, DOI 10.1136/bmj.319.7203.159; Webb R, 1996, CAN FAM PHYSICIAN, V42, P54; WRIGHT O, 2000, TIMES           1221, P5; 2000, REPORT INQUIRY QUALI	8	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1896	1898		10.1016/S0140-6736(01)06892-1	http://dx.doi.org/10.1016/S0140-6736(01)06892-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741649				2022-12-01	WOS:000172463000033
J	Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK				Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK			Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease	NATURE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CD4(+) T-CELLS; CUTTING EDGE; LYMPHOCYTES; TH1; ENCEPHALOMYELITIS; THERAPY; ANTIGEN; SUBSETS	Activation of naive CD4(+) T-helper cells results in the development of at least two distinct effector populations, Th1 and Th2 cells(1-3). Th1 cells produce cytokines (interferon (IFN)-gamma, interleukin (IL)-2, tumour-necrosis factor (TNF)-alpha and lymphotoxin) that are commonly associated with cell-mediated immune responses against intracellular pathogens, delayed-type hypersensitivity reactions 4, and induction of organ-specific autoimmune diseases(5). Th2 cells produce cytokines (IL-4, IL-10 and IL-13) that are crucial for control of extracellular helminthic infections and promote atopic and allergic diseases(4). Although much is known about the functions of these two subsets of T-helper cells, there are few known surface molecules that distinguish between them(6). We report here the identification and characterization of a transmembrane protein, Tim-3, which contains an immunoglobulin and a mucin-like domain and is expressed on differentiated Th1 cells. In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages. Tim-3 may have an important role in the induction of autoimmune diseases by regulating macrophage activation and/or function.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 95305 USA; VA Hlth Care Syst, Palo Alto, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Stanford University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Sobel, Raymond/0000-0002-0477-9002				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; GORDON EJ, 1995, J NEUROIMMUNOL, V62, P153, DOI 10.1016/0165-5728(95)00120-2; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Jourdan P, 1998, J IMMUNOL, V160, P4153; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LACK G, 1994, J IMMUNOL, V152, P2546; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; MCINTIRE JJ, 2001, NATURE IMMUNOL, V2, P1019; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Tran EH, 1998, J IMMUNOL, V161, P3767; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Zingoni A, 1998, J IMMUNOL, V161, P547	24	1119	1304	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					536	541		10.1038/415536a	http://dx.doi.org/10.1038/415536a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823861				2022-12-01	WOS:000173564300049
J	Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW				Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW			DNA reveals high dispersal synchronizing the population dynamics of Canada lynx	NATURE			English	Article							GENE FLOW; MICROSATELLITE LOCI; DIFFERENTIATION; MIGRATION; PATTERNS	Population dynamics of Canada lynx (Lynx canadensis) have been of interest to ecologists for nearly sixty years(1-4). Two competing hypotheses concerning lynx population dynamics and large-scale spatial synchrony are currently debated. The first suggests that dispersal is substantial among lynx populations(5), and the second proposes that lynx at the periphery of their range exist in small, isolated patches that maintain cycle synchrony via correlation with extrinsic environmental factors(2). Resolving the nature of lynx population dynamics and dispersal is important both to ecological theory and to the conservation of threatened lynx populations: the lack of knowledge about connectivity between populations at the southern periphery of the lynx's geographic range delayed their legal listing in the United States(6). We test these competing hypotheses using microsatellite DNA markers and lynx samples from 17 collection sites in the core and periphery of the lynx's geographic range. Here we show high gene flow despite separation by distances greater than 3,100 km, supporting the dispersal hypothesis. We therefore suggest that management actions in the contiguous United States should focus on maintaining connectivity with the core of the lynx's geographic range.	Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA; USDA, USFS, Rocky Mt Res Stn, Missoula, MT 59801 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Schwartz, MK (corresponding author), Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA.		Schwartz, Michael K/C-3184-2014; Mills, L. Scott/K-2458-2012	Schwartz, Michael K/0000-0003-3521-3367; Mills, L. Scott/0000-0001-8771-509X				BERTHIER P, IN PRESS GENETICS; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cattadori IM, 2000, J ANIM ECOL, V69, P620, DOI 10.1046/j.1365-2656.2000.00421.x; Cornuet JM, 1999, GENETICS, V153, P1989; Ehrich D, 2001, MOL ECOL, V10, P481, DOI 10.1046/j.1365-294x.2001.01229.x; Elton C, 1942, J ANIM ECOL, V11, P215, DOI 10.2307/1358; Forbes SH, 1997, CONSERV BIOL, V11, P1226, DOI 10.1046/j.1523-1739.1997.96296.x; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; MANUEL S, IN PRESS CONS BIOL; McKelvey Kevin S., 2000, P207; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mowat Garth, 2000, P265; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Predavec M, 2001, OECOLOGIA, V126, P216, DOI 10.1007/s004420000516; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Ruggiero Leonard F., 2000, P443; SCHWARTZ MK, UNPUB MOL ECOL; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S., 1984, THEORY GENE FREQUENC; 2000, FED REG, V65, P15051	28	124	128	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					520	522		10.1038/415520a	http://dx.doi.org/10.1038/415520a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823858	Green Published			2022-12-01	WOS:000173564300045
J	Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A				Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A			Faithful expression of imprinted genes in cloned mice	SCIENCE			English	Article									Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Inst Technol, Ctr Gene Res, Kanagawa 2268501, Japan; CREST, JST, Saitama 3320012, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591100, Japan	National Institute of Infectious Diseases (NIID); Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokai University	Ishino, F (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	fishino@bio.titech.ac.jp; aogura@nih.go.jp	Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601				Dean W, 1998, DEVELOPMENT, V125, P2273; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Ogura A, 2000, MOL REPROD DEV, V57, P55, DOI 10.1002/1098-2795(200009)57:1&lt;55::AID-MRD8&gt;3.0.CO;2-W; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206	6	156	172	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					297	297		10.1126/science.295.5553.297	http://dx.doi.org/10.1126/science.295.5553.297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786635				2022-12-01	WOS:000173278600039
J	McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G				McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G			Resource-based niches provide a basis for plant species diversity and dominance in arctic tundra	NATURE			English	Article							ALASKAN TUNDRA; AMINO-ACIDS; COMPETITION; NITROGEN; GROWTH; TREES	Ecologists have long been intrigued by the ways co-occurring species divide limiting resources. Such resource partitioning, or niche differentiation, may promote species diversity by reducing competition(1,2). Although resource partitioning is an important determinant of species diversity and composition in animal communities(3), its importance in structuring plant communities has been difficult to resolve(4). This is due mainly to difficulties in studying how plants compete for belowground resources(5). Here we provide evidence from a N-15-tracer field experiment showing that plant species in a nitrogen-limited, arctic tundra community were differentiated in timing, depth and chemical form of nitrogen uptake, and that species dominance was strongly correlated with uptake of the most available soil nitrogen forms. That is, the most productive species used the most abundant nitrogen forms, and less productive species used less abundant forms. To our knowledge, this is the first documentation that the composition of a plant community is related to partitioning of differentially available forms of a single limiting resource.	US EPA, Corvallis, OR 97333 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; US Forest Serv, Inst Pacific Isl Forestry, USDA, Honolulu, HI 96813 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Appalachian Mt Club, Gorham, NH 03581 USA	United States Environmental Protection Agency; Kansas State University; United States Department of Agriculture (USDA); United States Forest Service; Marine Biological Laboratory - Woods Hole; University of Alaska System; University of Alaska Fairbanks	McKane, RB (corresponding author), US EPA, Corvallis, OR 97333 USA.	mckane.bob@epa.gov	Giblin, Anne/AAV-6838-2020; Nadelhoffer, Knute/AAE-7744-2020; Laundre, James/P-1968-2016	Giblin, Anne/0000-0003-3851-2178; Nadelhoffer, Knute/0000-0001-9775-894X; Laundre, James/0000-0002-2061-8655; Rastetter, Edward/0000-0002-8620-5431; Kwiatkowski, Bonnie/0000-0003-0158-9753				[Anonymous], 1975, COMMUNITIES ECOSYSTE; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bliss L C, 1992, ARCTIC ECOSYSTEMS CH, P59, DOI DOI 10.1016/B978-0-12-168250-7.50010-9; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; FLANAGAN LB, 1992, PLANT CELL ENVIRON, V15, P831, DOI 10.1111/j.1365-3040.1992.tb02150.x; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kielland K, 1995, BIOGEOCHEMISTRY, V31, P85, DOI 10.1007/BF00000940; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; MCNAUGHTON SJ, 1970, SCIENCE, V167, P131, DOI 10.1126/science.167.3915.131; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; PARRISH JAD, 1976, ECOLOGY, V57, P1281, DOI 10.2307/1935052; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; RIEGER S, 1979, EXPLORATORY SOIL SUR; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1986, ECOLOGY, V67, P660, DOI 10.2307/1937690; SHAVER GR, 1975, ECOLOGY, V56, P401, DOI 10.2307/1934970; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Tilman D., 1982, Monographs in Population Biology, pi	26	639	687	14	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					68	71		10.1038/415068a	http://dx.doi.org/10.1038/415068a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780117				2022-12-01	WOS:000173028800040
J	Reich, DS; Mechler, F; Victor, JD				Reich, DS; Mechler, F; Victor, JD			Independent and redundant information in nearby cortical neurons	SCIENCE			English	Article							VISUAL-CORTEX; SPIKE TRAINS; DISCHARGE	In the primary visual cortex (V1), nearby neurons are tuned to similar stimulus features, and, depending on the manner and time scale over which neuronal signals are analyzed, the resulting redundancy may mitigate deleterious effects of response variability. We estimated information rates in the short-time scale responses of clusters of up to six simultaneously recorded nearby neurons in monkey V1. Responses were almost independent if we kept track of which neuron fired each spike but were redundant if we summed responses over the cluster. Redundancy was independent of cluster size. Summing neuronal responses to reduce variability discards potentially useful information, and the discarded information increases with cluster size.	Rockefeller Univ, Biophys Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Rockefeller University; Cornell University	Reich, DS (corresponding author), Rockefeller Univ, Biophys Lab, 1230 York Ave, New York, NY 10021 USA.		Victor, Jonathan D./D-2931-2009; Reich, Daniel S./E-5701-2010	Victor, Jonathan D./0000-0002-9293-0111; Reich, Daniel S./0000-0002-2628-4334	NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NEI NIH HHS [EY07138, EY9314] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; De Angelo J, 1999, Expert Opin Pharmacother, V1, P19; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; Reich DS, 2001, J NEUROPHYSIOL, V85, P305, DOI 10.1152/jn.2001.85.1.305; Reich DS, 2000, J NEUROSCI, V20, P1964; REICH DS, 2001, THESIS ROCKEFELLER U; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	21	204	207	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2566	2568		10.1126/science.1065839	http://dx.doi.org/10.1126/science.1065839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752580				2022-12-01	WOS:000172927700064
J	Kuo, HC; Cheng, CF; Clark, RB; Lin, JJC; Lin, JLC; Hoshijima, M; Nguyen-Tran, VTB; Gu, YS; Ikeda, Y; Chu, PH; Ross, J; Giles, WR; Chien, KR				Kuo, HC; Cheng, CF; Clark, RB; Lin, JJC; Lin, JLC; Hoshijima, M; Nguyen-Tran, VTB; Gu, YS; Ikeda, Y; Chu, PH; Ross, J; Giles, WR; Chien, KR			A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I-to and confers susceptibility to ventricular tachycardia	CELL			English	Article							TRANSIENT OUTWARD CURRENT; SUDDEN CARDIAC DEATH; K+ CHANNEL; HEART-FAILURE; MOUSE HEARTS; EXPRESSION; MYOCYTES; SUBUNIT; MICE; REPOLARIZATION	KChIP2, a gene encoding three auxiliary subunits of Kv4.2 and Kv4.3, is preferentially expressed in the adult heart, and its expression is downregulated in cardiac hypertrophy. Mice deficient for KChIP2 exhibit normal cardiac structure and function but display a prolonged elevation in the ST segment on the electrocardiogram. The KChIP2(-/-) mice are highly susceptible to the induction of cardiac arrhythmias. Single-cell analysis revealed a substrate for arrhythmogenesis, including a complete absence of transient outward potassium current, It., and a marked increase in action potential duration. These studies demonstrate that a defect in KChIP2 is sufficient to confer a marked genetic susceptibility to arrhythmias, establishing a novel genetic pathway for ventricular tachycardia via a loss of the transmural gradient of I-to.	Univ Calif San Diego, Sch Med, UCSD Salk Program Mol Med, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of Calgary; University of Iowa	Chien, KR (corresponding author), Univ Calif San Diego, Sch Med, UCSD Salk Program Mol Med, Inst Mol Med, La Jolla, CA 92093 USA.		gu, yu/GSD-4507-2022; CHENG, Ching-Feng/AAB-8861-2019; Chu, Pao-Hsien/P-5249-2019	CHENG, Ching-Feng/0000-0003-0104-0146; Chu, Pao-Hsien/0000-0003-0361-6348; Ikeda, Yasuhiro/0000-0002-2970-7304; Nguyen-Tran, Van/0000-0001-5678-1908				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Antzelevitch C, 2001, CURR OPIN CARDIOL, V16, P1, DOI 10.1097/00001573-200101000-00001; Antzelevitch C, 2001, EUR HEART J, V22, P356, DOI 10.1053/euhj.2000.2461; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Berul CI, 1997, J CLIN INVEST, V99, P570, DOI 10.1172/JCI119197; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; ELSHERIF N, 2000, CARDIAC ELECTROPHYSI, P662; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Giese KP, 1998, LEARN MEMORY, V5, P257; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; TOMITA F, 1994, CIRC RES, V75, P296, DOI 10.1161/01.RES.75.2.296; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wickenden AD, 1999, CIRC RES, V85, P1067; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	33	357	366	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 14	2001	107	6					801	813		10.1016/S0092-8674(01)00588-8	http://dx.doi.org/10.1016/S0092-8674(01)00588-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747815	Bronze			2022-12-01	WOS:000172771800012
J	Norio, P; Schildkraut, CL				Norio, P; Schildkraut, CL			Visualization of DNA replication on individual Epstein-Barr virus episomes	SCIENCE			English	Article							DIHYDROFOLATE-REDUCTASE DOMAIN; HIGH-RESOLUTION; FIBER-FISH; SITES; HYBRIDIZATION; INITIATION; ORIGIN; GENOME; PAUSE; FORKS	The duplication of the mammalian genome is an organized event, but there is limited information about the precision of the duplication program at specific genetic loci. We developed an approach that allows DNA replication events to be visualized in individual DNA molecules. Studying the latent replication of Epstein-Barr virus episomes, we show that different initiation sites are used to commence DNA replication from a specific portion of the viral genome (zone), whereas termination does not seem to be genomically defined. We conclude that initiation zones and pausing sites are major organizers of the duplication program, but initiation, fork progression, and termination of replication can vary in each molecule.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Norio, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NCI NIH HHS [P30CA13330] Funding Source: Medline; NIGMS NIH HHS [GM45751] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; HUBERMAN JA, 1966, P NATL ACAD SCI USA, V55, P599, DOI 10.1073/pnas.55.3.599; HUBERMAN JA, 1968, J MOL BIOL, V32, P327, DOI 10.1016/0022-2836(68)90013-2; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kalejta RF, 1996, MOL CELL BIOL, V16, P4923; Kieff E., 1996, FIELDS VIROLOGY, P2343; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NORIO P, UNPUB; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; van de Rijke FM, 2000, J HISTOCHEM CYTOCHEM, V48, P743, DOI 10.1177/002215540004800602; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; Yates J.L, 1996, DNA REPLICATION EUKA, P751; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	24	115	120	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2361	2364		10.1126/science.1064603	http://dx.doi.org/10.1126/science.1064603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743204				2022-12-01	WOS:000172817200049
J	Wang, ZR; Kiledjian, M				Wang, ZR; Kiledjian, M			Functional link between the mammalian exosome and mRNA decapping	CELL			English	Article							MESSENGER-RNA DEGRADATION; PROTEIN COMPLEX; ENDORIBONUCLEASE ACTIVITY; ENDONUCLEOLYTIC CLEAVAGE; SACCHAROMYCES-CEREVISIAE; CAP STRUCTURE; YEAST-CELLS; STABILITY; TURNOVER; TRANSLATION	Mechanistic understanding of mammalian mRNA turnover remains incomplete. We demonstrate that the 3' to 5' exoribonuclease decay pathway is a major contributor to mRNA decay both in cells and in cell extract. An exoribonuclease-dependent scavenger decapping activity was identified that follows decay of the mRNA and hydrolyzes the residual cap. The decapping activity is associated with a subset:Of the exosome proteins in vivo, implying a higher-order degradation complex consisting of exoribonucleases and a decapping activity, which together coordinate the decay of an mRNA. These findings indicate that following deadenylation of mammal mRNA, degradation proceeds by a coupled 3' to 5' exoribonucleolytic activity and subsequent hydrolysis of the cap structure by a scavenger decapping activity.	Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	kiledjia@biology.rutgers.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051611] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51611] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brewer G, 1998, J BIOL CHEM, V273, P34770, DOI 10.1074/jbc.273.52.34770; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; BROWN BD, 1993, GENE DEV, V7, P1620, DOI 10.1101/gad.7.8.1620; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; DRUMMOND DR, 1985, NUCLEIC ACIDS RES, V13, P7375, DOI 10.1093/nar/13.20.7375; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; FURUICHI Y, 1989, METHOD ENZYMOL, V180, P164; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; GELPI C, 1990, CLIN EXP IMMUNOL, V81, P59; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GREEN MR, 1983, CELL, V32, P681, DOI 10.1016/0092-8674(83)90054-5; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Kiledjian M, 1999, METHODS, V17, P84, DOI 10.1006/meth.1998.0710; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; NUSS DL, 1975, CELL, V6, P21, DOI 10.1016/0092-8674(75)90069-0; NUSS DL, 1977, J BIOL CHEM, V252, P2815; REIMER G, 1986, J IMMUNOL, V137, P3802; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHOENBERG DR, 1997, MRNA METABOLISM POST, P217; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; STOECKLE MY, 1989, MOL CELL BIOL, V9, P4738, DOI 10.1128/MCB.9.11.4738; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Wang ZR, 2000, EMBO J, V19, P295, DOI 10.1093/emboj/19.2.295; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WICKENS MP, 1983, J MOL BIOL, V163, P1, DOI 10.1016/0022-2836(83)90027-X; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhang S, 1999, MOL CELL BIOL, V19, P7568; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706	57	200	208	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					751	762		10.1016/S0092-8674(01)00592-X	http://dx.doi.org/10.1016/S0092-8674(01)00592-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747811	Bronze			2022-12-01	WOS:000172771800008
J	Gandon, S; Mackinnon, MJ; Nee, S; Read, AF				Gandon, S; Mackinnon, MJ; Nee, S; Read, AF			Imperfect vaccines and the evolution of pathogen virulence	NATURE			English	Article								Vaccines rarely provide full protection from disease. Nevertheless, partially effective (imperfect) vaccines may be used to protect both individuals and whole populations(1-3). We studied the potential impact of different types of imperfect vaccines on the evolution of pathogen virulence (induced host mortality) and the consequences for public health. Here we show that vaccines designed to reduce pathogen growth rate and/or toxicity diminish selection against virulent pathogens. The subsequent evolution leads to higher levels of intrinsic virulence and hence to more severe disease in unvaccinated individuals. This evolution can erode any population-wide benefits such that overall mortality rates are unaffected, or even increase, with the level of vaccination coverage. In contrast, infection-blocking vaccines induce no such effects, and can even select for lower virulence. These findings have policy implications for the development and use of vaccines that are not expected to provide full immunity, such as candidate vaccines for malaria(4).	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Gandon, S (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	Sylvain.Gandon@ed.ac.uk	Mackinnon, Margaret/L-3155-2013; GANDON, Sylvain/AHC-0976-2022	Mackinnon, Margaret/0000-0003-1279-9625; GANDON, Sylvain/0000-0003-2624-7856				ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Caswell H., 2001, MATRIX POPULATION MO, V2nd; *CDC, 2000, MROB MORTAL WKLY REP, V46, P1094; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; DIECKMANN U, 2001, VIRULENCE MANAGEMENT; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; GUPTA S, 1997, P ROY SOC LOND B BIO, V266, P1435; HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6; Hoffman SL, 1996, MALARIA VACCINE DEV; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; MCLEAN AR, 1995, P ROY SOC B-BIOL SCI, V261, P389, DOI 10.1098/rspb.1995.0164; MCLEAN SA, 1993, P ROY SOC LOND B BIO, V256, P9; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Regoes RR, 2000, EVOLUTION, V54, P64, DOI 10.1111/j.0014-3820.2000.tb00008.x; Ronce O, 2001, EVOLUTION, V55, P1520, DOI 10.1111/j.0014-3820.2001.tb00672.x; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Witter RL, 1997, ACTA VET HUNG, V45, P251; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Zuckerman AJ, 2000, LANCET, V355, P1382, DOI 10.1016/S0140-6736(00)02132-2	30	442	449	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					751	756		10.1038/414751a	http://dx.doi.org/10.1038/414751a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742400	Green Published			2022-12-01	WOS:000172676200048
J	Cartron, JP				Cartron, JP			Rh-deficiency syndrome	LANCET			English	Article									Inst Natl Transfus Sanguine, INSERM, U76, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Cartron, JP (corresponding author), Inst Natl Transfus Sanguine, INSERM, U76, 6 Rue Alexandre Cabanel, F-75015 Paris, France.								0	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S57	S57		10.1016/S0140-6736(01)07069-6	http://dx.doi.org/10.1016/S0140-6736(01)07069-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784606	Bronze			2022-12-01	WOS:000172907200057
J	Lewin, S; Meyer, IH				Lewin, S; Meyer, IH			Torture, ill-treatment, and sexual identity	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Columbia Univ, Mailman Sch Publ Hlth, Div Sociomed Sci, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University	Lewin, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.		Meyer, Ilan H/A-2142-2009					ALTMAN D, 1997, HLTH HUMAN RIGHTS, V2, P15; *AM PSYCH ASS, 2001, GAY LESB BIS ISS; *AMN INT, 2001, CRIM HAT CONSP SIL T; *AMN INT, 2001, EGYPT REL CHILD IMPR; Meyer IH, 2001, AM J PUBLIC HEALTH, V91, P856, DOI 10.2105/AJPH.91.6.856	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1899	1900		10.1016/S0140-6736(01)06894-5	http://dx.doi.org/10.1016/S0140-6736(01)06894-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497NU	11741651				2022-12-01	WOS:000172463000035
J	Gelber, AC; Wigley, FM				Gelber, AC; Wigley, FM			Disease severity as a predictor of outcome in scleroderma	LANCET			English	Editorial Material							SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; TRIAL		Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University	Wigley, FM (corresponding author), Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA.							Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Bryan C, 1999, ARTHRITIS RHEUM-US, V42, P2660, DOI 10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N; Clements PJ, 1999, ARTHRITIS RHEUM-US, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7; Geirsson AJ, 2001, ANN RHEUM DIS, V60, P1117, DOI 10.1136/ard.60.12.1117; LOPEZOVEJERO JA, 1979, NEW ENGL J MED, V300, P1417, DOI 10.1056/NEJM197906213002505; Medsger TA, 2000, CURR OPIN RHEUMATOL, V12, P545, DOI 10.1097/00002281-200011000-00012; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; WIGLEY FM, 1994, ANN INTERN MED, V120, P199, DOI 10.7326/0003-4819-120-3-199402010-00004	11	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					277	279		10.1016/S0140-6736(02)07535-9	http://dx.doi.org/10.1016/S0140-6736(02)07535-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830191				2022-12-01	WOS:000173588100005
J	Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G				Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G			Male displays adjusted to female's response - Macho courtship by the satin bowerbird is tempered to avoid frightening the female.	NATURE			English	Article							PTILONORHYNCHUS-VIOLACEUS; THREAT REDUCTION; TRAITS		Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Patricelli, GL (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	borgia@umail.umd.edu	Patricelli, Gail L/L-3730-2017	Uy, J. Albert C./0000-0002-8437-5525; Patricelli, Gail/0000-0003-3397-8390				Andersson Malte, 1994; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, EMU, V95, P1, DOI 10.1071/MU9950001; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; BORGIA G, 1995, AM SCI, V83, P542; Borgia G., 1979, SEXUAL SELECTION REP, P27; Mateos C, 1999, BEHAV ECOL SOCIOBIOL, V45, P235, DOI 10.1007/s002650050558; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994	9	213	215	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					279	280		10.1038/415279a	http://dx.doi.org/10.1038/415279a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796996				2022-12-01	WOS:000173293500031
J	Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK				Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK			Recognition of the rotavirus mRNA 3 ' consensus by an asymmetric NSP3 homodimer	CELL			English	Article							POLY(A) BINDING-PROTEIN; ANGSTROM RESOLUTION; CONSENSUS SEQUENCE; CRYSTAL-STRUCTURE; 3 END; TRANSLATION; DOMAINS; NS34; DNA; EQUIVALENT	Rotaviruses, the cause of life-threatening diarrhea in humans and cattle, utilize a functional homolog of poly(A) binding protein (PABP) known as nonstructural protein 3 (NSP3) for translation of viral mRNAs. NSP3 binds to viral mRNA 3' consensus sequences and circularizes the mRNA via interactions with eIF4G. The X-ray structure of the NSP3 RNA binding domain bound to a rotaviral mRNA 3' end has been determined. NSP3 is a novel, heart-shaped homodimer with a medial RNA binding cleft. The homodimer is asymmetric, and contains two similar N-terminal segments plus two structurally different C-terminal segments that intertwine to create a tunnel enveloping the mRNA 31 end. Biophysical studies demonstrate high affinity binding leading to increased thermal stability and slow dissociation kinetics, consistent with NSP3 function.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Rockefeller Univ, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Burley, Stephen/0000-0002-2487-9713				Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BICAN P, 1982, J VIROL, V43, P1113, DOI 10.1128/JVI.43.3.1113-1117.1982; BOTH GW, 1984, NUCLEIC ACIDS RES, V12, P1621, DOI 10.1093/nar/12.3.1621; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN GM, 1985, LANCET, V2, P1123; Deardorff JA, 1997, J MOL BIOL, V269, P67, DOI 10.1006/jmbi.1997.1013; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; EIDEN JJ, 1993, VIROLOGY, V196, P298, DOI 10.1006/viro.1993.1479; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Estes M.K., 1996, FIELDS VIROLOGY, P1625; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; King DA, 1999, NAT STRUCT BIOL, V6, P64; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Miller RT, 1996, FASEB J, V10, P171, DOI 10.1096/fasebj.10.1.8566539; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; QIAN Y, 1991, VIROLOGY, V184, P752, DOI 10.1016/0042-6822(91)90446-I; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SILVERSTEIN SC, 1976, ANNU REV BIOCHEM, V45, P375, DOI 10.1146/annurev.bi.45.070176.002111; Valdar WSJ, 2001, PROTEINS, V42, P108; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	45	84	90	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					71	81		10.1016/S0092-8674(01)00632-8	http://dx.doi.org/10.1016/S0092-8674(01)00632-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792322	Bronze			2022-12-01	WOS:000173280700009
J	Toth, LJ; Assad, JA				Toth, LJ; Assad, JA			Dynamic coding of behaviourally relevant stimuli in parietal cortex	NATURE			English	Article							PRIMATE PREFRONTAL CORTEX; NEURAL ACTIVITY; AREA LIP; MOTOR; TRANSFORMATIONS; REPRESENTATION; SELECTIVITY; MOVEMENTS; MACAQUES; SPACE	A general function of cerebral cortex is to allow the flexible association of sensory stimuli with specific behaviours. Many neurons in parietal(1,2), prefrontal(3,4) and motor(5-7) cortical areas are activated both by particular movements and by sensory cues that trigger these movements, suggesting a role in linking sensation to action. For example, neurons in the lateral intraparietal area (LIP) encode both the location of visual stimuli and the direction of saccadic eye movements(8,9). LIP is not believed to encode nonspatial stimulus attributes such as colour(10,11). Here we investigated whether LIP would encode colour if colour was behaviourally linked to the eye movement. We trained monkeys to make an eye movement in one of two directions based alternately on the colour or location of a visual cue. When cue colour was relevant for directing eye movement, we found a substantial fraction of LIP neurons selective for cue colour. However, when cue location was relevant, colour selectivity was virtually absent in LIP. These results demonstrate that selectivity of cortical neurons can change as a function of the required behaviour.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Toth, LJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Toth, Louis/0000-0003-4986-7046				ABRAMSON N, 1963, INFORMATION THEORY C; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	22	208	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					165	168		10.1038/415165a	http://dx.doi.org/10.1038/415165a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805833				2022-12-01	WOS:000173159300040
J	Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD				Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD			Superoxide activates mitochondrial uncoupling proteins	NATURE			English	Article							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; FATTY-ACIDS; RAT; NUCLEOTIDES; EXPRESSION; GENERATION; GENE; MICE; UCP2	Uncoupling protein 1 (UCP1) diverts energy from ATP synthesis to thermogenesis in the mitochondria of brown adipose tissue by catalysing a regulated leak of protons across the inner membrane(1,2). The functions of its homologues, UCP2 and UCP3, in other tissues are debated(3,4). UCP2 and UCP3 are present at much lower abundance than UCP1, and the uncoupling with which they are associated is not significantly thermogenic(5,6). Mild uncoupling would, however, decrease the mitochondrial production of reactive oxygen species, which are important mediators of oxidative damage(7,8). Here we show that superoxide increases mitochondrial proton conductance through effects on UCP1, UCP2 and UCP3. Superoxide-induced uncoupling requires fatty acids and is inhibited by purine nucleotides. It correlates with the tissue expression of UCPs, appears in mitochondria from yeast expressing UCP1, and is absent in skeletal muscle mitochondria from UCP3 knockout mice. Our findings indicate that the interaction of superoxide with UCPs may be a mechanism for decreasing the concentrations of reactive oxygen species inside mitochondria.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; GlaxoSmithKline, Dept Comparat Genome, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Dept Vasc Biol, Harlow CM19 5AW, Essex, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; GlaxoSmithKline; GlaxoSmithKline	Brand, MD (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		Clapham, John/AAK-4715-2020; St-Pierre, Julie/AGB-3651-2022; Brand, Martin D/A-9423-2012; Cadenas, Susana/D-1523-2016	St-Pierre, Julie/0000-0002-2815-7099; Brand, Martin D/0000-0003-4418-6153; Roussel, Damien/0000-0002-8865-5428; Cadenas, Susana/0000-0003-0726-0369				Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BATHGATE B, 1992, MOL MICROBIOL, V6, P363, DOI 10.1111/j.1365-2958.1992.tb01479.x; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 2001, BIOCHEM SOC T, V29, P763; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pastore D, 2000, FEBS LETT, V470, P88, DOI 10.1016/S0014-5793(00)01292-8; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Stuart JA, 2001, BBA-BIOENERGETICS, V1504, P144, DOI 10.1016/S0005-2728(00)00243-7; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	30	1079	1128	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					96	99		10.1038/415096a	http://dx.doi.org/10.1038/415096a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780125				2022-12-01	WOS:000173028800048
J	Kerp, H				Kerp, H			Palaeobotany - Atmospheric CO2 from fossil plant cuticles	NATURE			English	Article							PERMIAN PALEOBOTANY; PALYNOLOGY		Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany	University of Munster	Kerp, H (corresponding author), Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany.		Kerp, Hans/AAJ-1102-2020					BARTHEL M., 1980, SCHRIFTENREIHE GEOLO, V16, P49; Boy J.A., 1982, Z DTSCH GEOL GES, V133, P607; KERP H, 1993, REV PALAEOBOT PALYNO, V78, P1, DOI 10.1016/0034-6667(93)90014-L; KERP JHF, 1988, REV PALAEOBOT PALYNO, V54, P249, DOI 10.1016/0034-6667(88)90017-6; LIPPOLT HJ, 1989, JB GEOL PALAONT MH, P553; Naugolnykh SV, 1996, REV PALAEOBOT PALYNO, V91, P35, DOI 10.1016/0034-6667(95)00066-6; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Poole I, 2000, NEW PHYTOL, V145, P511, DOI 10.1046/j.1469-8137.2000.00589.x; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041	9	7	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					38	38		10.1038/415038a	http://dx.doi.org/10.1038/415038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780108	Bronze			2022-12-01	WOS:000173028800031
J	Baden, LR; Horowitz, G; Jacoby, H; Eliopoulos, GM				Baden, LR; Horowitz, G; Jacoby, H; Eliopoulos, GM			Quinolones and false-positive urine screening for opiates by immunoassay technology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPPY SEED INGESTION; ANTIBACTERIAL ACTIVITY; PHARMACOKINETICS; TUBERCULOSIS; OFLOXACIN; MORPHINE; CODEINE; LEVOFLOXACIN; PENETRATION; PEFLOXACIN	Context Millions of assays are performed each year to monitor for substance abuse in various settings. When common medications cross-react with frequently used testing assays, false-positive results can lead to invalid conclusions. Objective To evaluate cross-reactivity of quinolone antimicrobials in common opiate screening assays and to assess the in vivo implications of this phenomenon. Design, Setting, and Participants The reactivity of 13 quinolones (levofloxacin, ofloxacin, pefloxacin, enoxacin, moxifloxacin, gatifloxacin, trovafloxacin, sparfloxacin, lomefloxacin, ciprofloxacin, clinafloxacin, norfloxacin, and nalidixic acid) was tested in 5 commercial opiate screening assays from September 1998 to March 1999. In 6 healthy volunteers, we confirmed the cross-reactivity of levofloxacin or ofloxacin with these opiate screening assays. Main Outcome Measure Opiate assay activity (threshold for positive result, 300 ng/mL of morphine). Results Nine of the quinolones caused assay results above the threshold for a positive result in at least 1 of the assays. Four of the assay systems caused false-positive results for at least 1 quinolone. Eleven of the 13 compounds caused some opiate activity by at least 1 assay system. At least 1 compound caused opiate assay activity in all 5 assay systems. Levofloxacin, oflaxacin, and perfloxacin were most likely to lead to a false-positive opiate result. Positive results were obtained in urine from all 6 volunteers. Conclusion Greater attention to the cross-reactivity of quinolones with immunoassays for opiates is needed to minimize the potential for invalid test interpretation.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St,PBB-A400, Boston, MA 02115 USA.	lbaden@partners.org						ANDRIOLE V, 1998, QUINOLONES; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BAILEY GS, 1996, ENV HLTH PERSPECT, V1, P5; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; BORNER K, 1993, DRUGS, V45, P303; Bron NJ, 1996, J ANTIMICROB CHEMOTH, V38, P1023, DOI 10.1093/jac/38.6.1023; Catrou PG, 1996, AM J CLIN PATHOL, V105, P527; Chien SC, 1997, ANTIMICROB AGENTS CH, V41, P1562, DOI 10.1128/AAC.41.7.1562; de Paula M, 1998, CLIN CHEM LAB MED, V36, P241, DOI 10.1515/CCLM.1998.041; ELSOHLY HN, 1988, J FORENSIC SCI, V33, P347; File TM, 1997, ANTIMICROB AGENTS CH, V41, P1965, DOI 10.1128/AAC.41.9.1965; GJERDE H, 1990, FORENSIC SCI INT, V44, P179, DOI 10.1016/0379-0738(90)90248-W; GUIBERT J, 1989, PATHOL BIOL, V37, P406; HAYES LW, 1987, CLIN CHEM, V33, P806; HENDEE WR, 1987, JAMA-J AM MED ASSOC, V257, P3110; HOFFKEN G, 1985, ANTIMICROB AGENTS CH, V27, P375, DOI 10.1128/AAC.27.3.375; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; KARABALUT N, 2000, QUINOLONE ANTIMICROB, P202; KOHNO S, 1992, CHEST, V102, P1815, DOI 10.1378/chest.102.6.1815; Meatherall R, 1997, THER DRUG MONIT, V19, P98, DOI 10.1097/00007691-199702000-00019; MONK JP, 1987, DRUGS, V33, P346, DOI 10.2165/00003495-198733040-00003; MONTAY G, 1984, ANTIMICROB AGENTS CH, V25, P463, DOI 10.1128/AAC.25.4.463; NAKASHIMA M, 1995, ANTIMICROB AGENTS CH, V39, P2635, DOI 10.1128/AAC.39.12.2635; *NAT COMM CLIN LAB, 1997, M100S7 NAT COMM CLIN; Paul BD, 1999, CLIN CHEM, V45, P510; PAUL BD, 1985, J ANAL TOXICOL, V9, P222, DOI 10.1093/jat/9.5.222; PETTITT BC, 1987, CLIN CHEM, V33, P1251; SALERNO C, 1990, THER DRUG MONIT, V12, P210; SELAVKA CM, 1991, J FORENSIC SCI, V36, P685; SLOOP G, 1995, J ANAL TOXICOL, V19, P554, DOI 10.1093/jat/19.7.554; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TREVILLA PH, 1995, J ANAL TOXICOL, V19, P200, DOI 10.1093/jat/19.3.200; Wise R, 1999, ANTIMICROB AGENTS CH, V43, P1508, DOI 10.1128/AAC.43.6.1508; WISE R, 1984, ANTIMICROB AGENTS CH, V26, P17, DOI 10.1128/AAC.26.1.17; YEW WW, 1990, J ANTIMICROB CHEMOTH, V26, P227, DOI 10.1093/jac/26.2.227; 2001, MED LETT DRUGS THER, V43, P87; 1998, MED LETT DRUGS THER, V40, P33; 1997, FED REG, V62, P51118; 1995, FED REG, V60, P57587; 1988, FED REG, V53, P11979	41	44	48	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2001	286	24					3115	3119		10.1001/jama.286.24.3115	http://dx.doi.org/10.1001/jama.286.24.3115			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505QM	11754677	Bronze			2022-12-01	WOS:000172927100029
J	Jin, QL; He, SY				Jin, QL; He, SY			Role of the Hrp pilus in type III protein secretion in Pseudomonas syringae	SCIENCE			English	Article							AVR PROTEINS; EXPRESSION; PROMOTER; VECTORS; CLONING; TOMATO; COLI	Bacterial surface appendages called pili and needle-like filaments are associated with protein and/or DNA transfer to recipient plant, human, or bacterial cells during pathogenesis or conjugation. Although it has long been suspected that pili function as a conduit for protein or DNA transfer, direct evidence has been lacking. The Hrp pilus of Pseudomonas syringae is assembled by the type III secretion system. We used an in situ immunogold labeling procedure to visualize the extrusion of an effector protein, AvrPto, from the tip of the Hrp pilus, providing direct evidence that a bacterial pilus can function as a conduit for protein delivery.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	He, SY (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu		He, Sheng Yang/0000-0003-1308-498X				BRINTON CC, 1964, P NATL ACAD SCI USA, V52, P776, DOI 10.1073/pnas.52.3.776; Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; EMERSON SU, 1970, SCIENCE, V169, P190, DOI 10.1126/science.169.3941.190; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; HUANG HC, 1991, MOL PLANT MICROBE IN, V4, P469, DOI 10.1094/MPMI-4-469; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jin QL, 2001, MOL MICROBIOL, V40, P1129, DOI 10.1046/j.1365-2958.2001.02455.x; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Koebnik R, 2001, TRENDS MICROBIOL, V9, P586, DOI 10.1016/S0966-842X(01)02255-7; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SHEN H, 1993, J BACTERIOL, V175, P5916, DOI 10.1128/JB.175.18.5916-5924.1993; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; YEN KM, 1991, J BACTERIOL, V173, P5328, DOI 10.1128/jb.173.17.5328-5335.1991	22	151	160	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2556	2558		10.1126/science.1066397	http://dx.doi.org/10.1126/science.1066397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752577				2022-12-01	WOS:000172927700061
J	Meier, DE; Back, AL; Morrison, RS				Meier, DE; Back, AL; Morrison, RS			The inner life of physicians and care of the seriously ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOCTOR-PATIENT COMMUNICATION; ASSISTED SUICIDE; MEDICAL-STUDENTS; PALLIATIVE CARE; PERSONAL GROWTH; NATIONAL SURVEY; SEXUAL CONTACT; STRESS; DEATH; COUNTERTRANSFERENCE	Seriously ill persons are emotionally vulnerable during the typically protracted course of an illness. Physicians respond to such patients' needs and emotions with emotions of their own, which may reflect a need to rescue the patient, a sense of failure and frustration when the patient's illness progresses, feelings of powerlessness against illness and its associated losses, grief, fear of becoming ill oneself, or a desire to separate from and avoid patients to escape these feelings. These emotions can affect both the quality of medical care and the physician's own sense of well-being, since unexamined emotions may also lead to physician distress, disengagement, burnout, and poor judgment. In this article, which is intended for the practicing, nonpsychiatric clinician, we describe a model for increasing physician self-awareness, which includes identifying and working with emotions that may affect patient care. Our approach is based on the standard medical model of risk factors, signs and symptoms, differential diagnosis, and intervention. Although it is normal to have feelings arising from the care of patients, physicians should take an active role in identifying and controlling those emotions.	CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, New York, NY 10029 USA; Univ Washington, Sch Med, Dept Med Hist & Eth, Dept Med,VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Meier, DE (corresponding author), CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, Box 1070, New York, NY 10029 USA.							BALINT M, 1972, DOCTOR HIST PATIENT; BECKMAN H, 1990, J GEN INTERN MED, V5, P42, DOI 10.1007/BF02602308; BENOLIEL JQ, 1987, OMEGA-J DEATH DYING, V18, P341, DOI 10.2190/4Y6G-XQAP-0XYN-LRW9; Billings C V, 1992, Am Nurse, V24, P2; Billings JA, 1997, JAMA-J AM MED ASSOC, V278, P733, DOI 10.1001/jama.278.9.733; BILLINGS JA, 1985, OUTPATIENT MANAGEMEN, P309; BLACKSHAW SL, 1994, AM J PSYCHIAT, V151, P293; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Block S, 1998, ACAD MED, V73, P763, DOI 10.1097/00001888-199807000-00012; BLOCK S, 2001, MANAGING DEATH ICU T, P183; Block SD, 1996, ACAD PSYCHIATR, V20, P65, DOI 10.1007/BF03341552; BLOCK SD, 1995, PSYCHOSOMATICS, V36, P445, DOI 10.1016/S0033-3182(95)71625-5; BRADSHAW S, 1976, B MENNINGER CLIN, V40, P665; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; BREWSTER JM, 1986, JAMA-J AM MED ASSOC, V255, P1913, DOI 10.1001/jama.255.14.1913; Buckman R., 1992, BREAK BAD NEWS GUIDE; BUTLER RN, 1975, AM J PSYCHIAT, V132, P893; CAINE ED, 1993, JAMA-J AM MED ASSOC, V270, P875, DOI 10.1001/jama.270.7.875; Casarett D, 2001, ANN INTERN MED, V134, P208, DOI 10.7326/0003-4819-134-3-200102060-00012; Charon R, 2000, ANN INTERN MED, V132, P63, DOI 10.7326/0003-4819-132-1-200001040-00011; Charon R, 2001, ANN INTERN MED, V134, P83, DOI 10.7326/0003-4819-134-1-200101020-00024; CLARKE PJ, 1981, AM J ORTHOPSYCHIAT, V51, P71, DOI 10.1111/j.1939-0025.1981.tb01349.x; Crouch M, 1986, Fam Med, V18, P93; DEBBIE, 1988, JAMA-J AM MED ASSOC, V259, P272; Dozor R B, 1992, Fam Med, V24, P538; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; Farber NJ, 1997, ARCH INTERN MED, V157, P2291, DOI 10.1001/archinte.157.20.2291; FREEBORN DK, 2000, PERMANENTE J, V2, P22; Friedman E, 1990, Healthc Forum J, V33, P9; GABBARD GO, 1995, JAMA-J AM MED ASSOC, V273, P1445, DOI 10.1001/jama.273.18.1445; GARTRELL N, 1986, AM J PSYCHIAT, V143, P1126; GARTRELL NK, 1992, WESTERN J MED, V157, P139; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; GORDON GH, 1986, J GEN INTERN MED, V1, P228, DOI 10.1007/BF02596188; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; Gorlin R, 2001, CAMB Q HEALTHC ETHIC, V10, P7, DOI 10.1017/S0963180101001037; Gundersen L, 2001, ANN INTERN MED, V135, P145, DOI 10.7326/0003-4819-135-2-200107170-00023; Hendin H, 2000, AM J PSYCHIAT, V157, P2022, DOI 10.1176/appi.ajp.157.12.2022; HENDIN H, 1981, AM J PSYCHOTHER, V35, P469, DOI 10.1176/appi.psychotherapy.1981.35.4.469; HOWELLS K, 1982, SOC SCI MED, V16, P1421, DOI 10.1016/0277-9536(82)90137-X; Hurwitz B, 2000, LANCET, V356, P2086, DOI 10.1016/S0140-6736(00)03412-7; JECKER NS, 1995, WESTERN J MED, V163, P287; Liossi C, 1997, PALLIATIVE MED, V11, P455, DOI 10.1177/026921639701100605; Lubitz R M, 1996, JAMA, V275, P414, DOI 10.1001/jama.275.5.414; MALTSBERGER JT, 1974, ARCH GEN PSYCHIAT, V30, P625; Manian FA, 2001, ARCH INTERN MED, V161, P801, DOI 10.1001/archinte.161.6.801; MARSHALL AA, 1995, AM J GASTROENTEROL, V90, P4; MARTIN AR, 1986, J GEN INTERN MED, V1, P252, DOI 10.1007/BF02596195; Martin C A, 1987, Hosp J, V3, P121, DOI 10.1300/J011v03n02_07; MARTIN MJ, 1981, MAYO CLIN PROC, V56, P35; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; MCCUE JD, 1982, NEW ENGL J MED, V306, P458, DOI 10.1056/NEJM198202253060805; MCCUE JD, 1985, NEW ENGL J MED, V312, P449, DOI 10.1056/NEJM198502143120725; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; MEIER D, 2000, ETHNICAL DILEMMAS, P180; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; Mengel MB, 1987, FAM SYST MED, V5, P176; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; MILES SH, 1994, JAMA-J AM MED ASSOC, V271, P1786, DOI 10.1001/jama.271.22.1786; MODESTIN J, 1987, BRIT J MED PSYCHOL, V60, P379, DOI 10.1111/j.2044-8341.1987.tb02757.x; Muskin PR, 1998, JAMA-J AM MED ASSOC, V279, P323, DOI 10.1001/jama.279.4.323; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; NOVACK DH, 1997, MED ENCOUNTER, V13, P2; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PICK IB, 1985, INT J PSYCHOANAL, V66, P157; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Prendergast T J, 1997, New Horiz, V5, P62; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; PUCINSKI J, 1985, BR J HOSP PSYCHIAT, V33, P90; QUILL TE, 1983, ANN INTERN MED, V98, P228, DOI 10.7326/0003-4819-98-2-228; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; QUILL TE, 1991, NEW ENGL J MED, V324, P691, DOI 10.1056/NEJM199103073241010; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; QUILL TE, 1989, ANN INTERN MED, V111, P51, DOI 10.7326/0003-4819-111-1-51; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Rabow MW, 2001, WESTERN J MED, V174, P66, DOI 10.1136/ewjm.174.1.66; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Schon DA, 1987, ED REFLECTIVE PRACTI; SMITH JW, 1986, JAMA-J AM MED ASSOC, V255, P1155, DOI 10.1001/jama.255.9.1155; SMITH RC, 1988, PSYCHOSOMATICS, V29, P392, DOI 10.1016/S0033-3182(88)72339-7; SNIBBE JR, 1989, PSYCHOL REP, V65, P775, DOI 10.2466/pr0.1989.65.3.775; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; STRASBURGER LH, 1992, AM J PSYCHOTHER, V46, P544, DOI 10.1176/appi.psychotherapy.1992.46.4.544; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; VALIANT GE, 1972, NEW ENGL J MED, V287, P372; von Gunten CF, 2000, JAMA-J AM MED ASSOC, V284, P3051, DOI 10.1001/jama.284.23.3051; Weiner EL, 2001, WESTERN J MED, V174, P19, DOI 10.1136/ewjm.174.1.19; WEISMAN AD, 1974, REALIZATION DEATH; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; YARNEY G, 2001, BRIT MED J, V322, P252; ZINN WM, 1988, JAMA-J AM MED ASSOC, V259, P3296, DOI 10.1001/jama.259.22.3296	95	406	415	2	39	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2001	286	23					3007	3014		10.1001/jama.286.23.3007	http://dx.doi.org/10.1001/jama.286.23.3007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502VY	11743845				2022-12-01	WOS:000172764500036
J	Kojouri, K; Vesely, SK; George, JN				Kojouri, K; Vesely, SK; George, JN			Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							INDUCED IMMUNE THROMBOCYTOPENIA; HYPERSENSITIVITY	Background: Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is thought to be uncommon and to have a good prognosis. Objective: To describe the frequency, clinical features, and longterm outcomes of quinine-associated TTP-HUS. Design: Case series. Setting: Hospitals in central-western Oklahoma. Patients: 225 consecutive patients with TTP-HUS, 1989-2000. Measurements: Presenting features and clinical outcomes. Results: Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome was associated with quinine in 17 patients. Four patients died, and 7 survivors currently have chronic renal failure. Since 1 July 1995, 132 patients with clinically suspected TTP-HUS were explicitly asked about drug exposure. Fourteen (11%) had taken quinine, and 7 had taken other drugs associated with TTP-HUS. Neurologic abnormalities were as severe in patients with quinine-associated TTP-HUS as in the 118 patients who had not taken quinine. Conclusions: Quinine is a common cause of drug-associated TTP-HUS and can cause death and chronic renal failure. When the disorder is described as TTP-HUS rather than only as HUS, the severity of neurologic abnormalities and the occasional absence of renal failure are emphasized. if recurrent disease is to be prevented, clinicians must recognize quinine as a possible cause.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Hematol Oncol Sect, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	George, JN (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Hematol Oncol Sect, Box 26901, Oklahoma City, OK 73190 USA.	Jim-George@OUHSC.edu		Vesely, Sara/0000-0003-3448-0156				BARR E, 1990, BRIT MED J, V301, P323, DOI 10.1136/bmj.301.6747.323; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Crum NF, 2000, SOUTHERN MED J, V93, P726; Farver DK, 1999, ANN PHARMACOTHER, V33, P32, DOI 10.1345/aph.18172; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; GOTTSCHALL JL, 1994, AM J HEMATOL, V47, P283, DOI 10.1002/ajh.2830470407; GOTTSCHALL JL, 1991, BLOOD, V77, P306; Kedia RK, 1999, POSTGRAD MED J, V75, P429, DOI 10.1136/pgmj.75.885.429; Kojouri K, 2000, J Okla State Med Assoc, V93, P519; Medina PJ, 2001, CURR OPIN HEMATOL, V8, P286, DOI 10.1097/00062752-200109000-00004; Moake JL, 1998, THROMBOSIS HEMORRHAG, P583; NAYLOR JR, 1994, AGE AGEING, V23, P418, DOI 10.1093/ageing/23.5.418; Rock GA, 2000, BRIT J HAEMATOL, V109, P496, DOI 10.1046/j.1365-2141.2000.01941.x; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Schattner A, 1998, AM J MED, V104, P488, DOI 10.1016/S0002-9343(98)00082-5; STRONCEK DF, 1992, BLOOD, V80, P241; 1994, FED REG, V59, P43234	18	87	93	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1047	1051		10.7326/0003-4819-135-12-200112180-00008	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747383				2022-12-01	WOS:000172759700004
J	Ren, DJ; Navarro, B; Xu, HX; Yue, LX; Shi, Q; Clapham, DE				Ren, DJ; Navarro, B; Xu, HX; Yue, LX; Shi, Q; Clapham, DE			A prokaryotic voltage-gated sodium channel	SCIENCE			English	Article							FLAGELLAR MOTORS; CA2+ CHANNELS; ION CHANNELS; SELECTIVITY; TETRODOTOXIN; PERMEATION; MUTATIONS; DRIVEN; LOCUS; SITE	The pore-forming subunits of canonical voltage-gated sodium and calcium channels are encoded by four repeated domains of six-transmembrane (6TM) segments. We expressed and characterized a bacterial ion channel (NaChBac) from Bacillus halodurans that is encoded by one 6TM segment. The sequence, especially in the pore region, is similar to that of voltage-gated calcium channels. The expressed channel was activated by voltage and was blocked by calcium channel blockers. However, the channel was selective for sodium. The identification of NaChBac as a functionally expressed bacterial voltage-sensitive ion-selective channel provides insight into both voltage-dependent activation and divalent cation selectivity.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Ctr Int Fis, Lab Biofis, Bogota, Colombia	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; ATSUMI T, 1992, NATURE, V355, P182, DOI 10.1038/355182a0; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BIOCHEM BIOPH RES CO, V281, P741, DOI 10.1006/bbrc.2001.4408; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Krulwich TA, 2001, BBA-BIOENERGETICS, V1505, P158, DOI 10.1016/S0005-2728(00)00285-1; NAVARRO B, UNPUB; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SKRYMA R, 1994, AM J PHYSIOL, V267, pC544, DOI 10.1152/ajpcell.1994.267.2.C544; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Triggle DJ, 1999, EUR J PHARMACOL, V375, P311, DOI 10.1016/S0014-2999(99)00329-5; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yorimitsu T, 2001, BBA-BIOENERGETICS, V1505, P82, DOI 10.1016/S0005-2728(00)00279-6	32	360	372	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2372	2375		10.1126/science.1065635	http://dx.doi.org/10.1126/science.1065635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743207				2022-12-01	WOS:000172817200052
J	Gani, R; Leach, S				Gani, R; Leach, S			Transmission potential of smallpox in contemporary populations	NATURE			English	Article							IMPACT	Despite eradication(1), smallpox still presents a risk to public health whilst laboratory stocks of virus remain(2,3). One factor crucial to any assessment of this risk is R-0, the average number of secondary cases infected by each primary case. However, recently applied estimates have varied too widely (R-0 from 1.5 to >20) to be of practical use, and often appear to disregard contingent factors such as socio-economic conditions and herd immunity(4-8). Here we use epidemic modelling(9) to show a more consistent derivation of R0. In isolated pre-twentieth century populations(10-12) with negligible herd immunity, the numbers of cases initially rose exponentially, with an R-0 between 3.5 and 6. Before outbreak controls were applied, smallpox also demonstrated similar levels of transmission in 30 sporadic outbreaks in twentieth century Europe(1), taking into account pre-existing vaccination levels(13,14) (about 50%) and the role of hospitals in doubling early transmission. Should smallpox recur, such estimates of transmission potential (R-0 from 3.5 to 6) predict a reasonably rapid epidemic rise before the implementation of public health interventions, because little residual herd immunity exists now that vaccination has ceased.	Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England		Leach, S (corresponding author), Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England.	steve.leach@camr.org.uk						ANDERSON R M, 1991; ARITA I, 1986, J HYG-CAMBRIDGE, V96, P459, DOI 10.1017/S0022172400066249; Creighton C., 1891, HIST EPIDEMICS BRITA, V2; Dietz K, 2000, NATURE, V408, P513, DOI 10.1038/35046270; DIXON C.W, 1962, SMALLPOX; Duncan CJ, 1996, J THEOR BIOL, V183, P447, DOI 10.1006/jtbi.1996.0234; Fenner F., 1988, SMALLPOX ITS ERADICA; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HENDERSON DA, 1994, VACCINES, P13; KOPLAN JP, 1978, TROP GEOGR MED, V30, P355; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; MACK TM, 1972, AM J EPIDEMIOL, V95, P157, DOI 10.1093/oxfordjournals.aje.a121380; MELTZER MI, IN PRESS EMERG INFEC, V7; MOODY J, 1980, 1 BURF BURF SCH TOLS; OTOOLE T, 1999, EMERG INFECT DIS, V4, P488; *REG GEN, 1870, ANN REP REG GEN 1869; WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669; *WHO, 1999, FUT RES SMALLP VIR R; World Health Organization, 1970, HLTH ASP CHEM BIOL W; 1999, NATURE, V399, P628	24	192	195	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					748	751		10.1038/414748a	http://dx.doi.org/10.1038/414748a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742399				2022-12-01	WOS:000172676200047
J	Kuhn, G; Hijri, M; Sanders, IR				Kuhn, G; Hijri, M; Sanders, IR			Evidence for the evolution of multiple genomes in arbuscular mycorrhizal fungi	NATURE			English	Article							INTERNAL TRANSCRIBED SPACERS; SCUTELLOSPORA-CASTANEA; GIGASPORA-MARGARITA; SEXUAL REPRODUCTION; GENETIC DIVERSITY; GLOMUS-MOSSEAE; RIBOSOMAL DNA; SEQUENCES; GLOMALES; SPORES	Ancient asexuals directly contradict the evolutionary theories that explain why organisms should evolve a sexual life history(1,2). The mutualistic, arbuscular mycorrhizal fungi are thought to have been asexual for approximately 400 million years(3,4). In the absence of sex, highly divergent descendants of formerly allelic nucleotide sequences are thought to evolve in a genome(2). In mycorrhizal fungi, where individual offspring receive hundreds of nuclei from the parent, it has been hypothesized that a population of genetically different nuclei should evolve within one individual(5,6). Here we use DNA-DNA fluorescent in situ hybridization to show that genetically different nuclei co-exist in individual arbuscular mycorrhizal fungi. We also show that the population genetics techniques(4) used in other organisms are unsuitable for detecting recombination because the assumptions and underlying processes do not rt the fungal genomic structure shown here. Instead we used a phylogenetic approach to show that the within-individual genetic variation that occurs in arbuscular mycorrhizal fungi probably evolved through accumulation of mutations in an essentially clonal genome, with some infrequent recombination events. We conclude that mycorrhizal fungi have evolved to be multi-genomic.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland	University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Inst Ecol, Biol Bldg, CH-1015 Lausanne, Switzerland.		Hijri, Mohamed/ABC-5969-2021; Sanders, Ian R/T-9988-2017; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; Sanders, Ian R/0000-0002-9591-8214; 				Antoniolli ZI, 2000, MYCOL RES, V104, P708, DOI 10.1017/S0953756299001860; Clapp JP, 2001, NEW PHYTOL, V149, P539, DOI 10.1046/j.1469-8137.2001.00060.x; Giovannetti M, 2001, NEW PHYTOL, V151, P717, DOI 10.1046/j.0028-646x.2001.00216.x; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Hijri M, 1999, FUNGAL GENET BIOL, V26, P141, DOI 10.1006/fgbi.1998.1112; HOELZEL AR, 1991, MOL GENETIC ECOLOGY, P1; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Lanfranco L, 1999, MOL ECOL, V8, P37, DOI 10.1046/j.1365-294X.1999.00535.x; LloydMacgilp SA, 1996, NEW PHYTOL, V133, P103, DOI 10.1111/j.1469-8137.1996.tb04346.x; MAYNARDSMITH J, 1986, NATURE, V324, P300; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Redecker D, 1999, FUNGAL GENET BIOL, V28, P238, DOI 10.1006/fgbi.1999.1173; Redecker D, 1997, APPL ENVIRON MICROB, V63, P1756, DOI 10.1128/AEM.63.5.1756-1761.1997; Rosendahl S, 1997, MOL ECOL, V6, P821, DOI 10.1046/j.1365-294X.1997.d01-213.x; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Sanders IR, 1996, NEW PHYTOL, V133, P123, DOI 10.1111/j.1469-8137.1996.tb04348.x; Sanders IR, 1999, NATURE, V399, P737, DOI 10.1038/21544; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; vanGemeren IA, 1997, GENE, V198, P43, DOI 10.1016/S0378-1119(97)00290-4; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; White TJ., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	24	211	226	0	74	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2001	414	6865					745	748		10.1038/414745a	http://dx.doi.org/10.1038/414745a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742398	Green Published			2022-12-01	WOS:000172676200046
J	Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA				Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA			Role of nucleoporin induction in releasing an mRNA nuclear export block	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; PORE COMPLEX; MATRIX PROTEIN; NUP98; BIOGENESIS; EXPRESSION; TRANSPORT; DOMAIN; SITE; RAN	Signal-mediated nuclear import and export proceed through the nuclear pore complex (NPC). Some NPC components, such as the nucleoporins (Nups) Nup98 and Nup96, are also associated with the nuclear interior. Nup98 is a target of the vesicular stomatitis virus (VSV) matrix (M) protein-mediated inhibition of messenger RNA (mRNA) nuclear export. Here, Nup98 and Nup96 were found to be up-regulated by interferon (IFN). M protein-mediated inhibition of mRNA nuclear export was reversed when cells were treated with IFN-gamma or transfected with a complementary DNA (cDNA) encoding Nup98 and Nup96. Thus, increased Nup98 and Nup96 expression constitutes an IFN-mediated mechanism that reverses M protein-mediated inhibition of gene expression.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Canc Ctr, Miami, FL 33136 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; University of Miami; University of Miami	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA.		Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; 	NIAID NIH HHS [AI28900, AI46503, AI48204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046503, P01AI048204, R01AI028900] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahuja HG, 2001, GENE CHROMOSOME CANC, V30, P410, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1108>3.0.CO;2-9; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; CHILAKAMARTI V, 2001, P NATL ACAD SCI USA, V98, P6674; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIELDS BN, 1996, FUNDAMENTAL VIROLOGY, P561; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; YANG SD, 1995, MOL IMMUNOL, V32, P733, DOI 10.1016/0161-5890(95)00035-D	27	131	141	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1523	1525		10.1126/science.1067861	http://dx.doi.org/10.1126/science.1067861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11809937				2022-12-01	WOS:000173981300053
J	Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA				Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA			Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; COGNITIVE PERFORMANCE; COBALAMIN DEFICIENCY; UNITED-STATES; POPULATION; SERUM; FOLATE; VITAMIN-B12; ROTTERDAM	Background: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. Methods: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B(sub 12) and B(sub 6). Results: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. Conclusions: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease. (N Engl J Med 2002;346:476-83.) Copyright (C) 2002 Massachusetts Medical Society.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Tufts University; United States Department of Agriculture (USDA); Boston University	Wolf, PA (corresponding author), Boston Univ, Sch Med, Dept Neurol Neurol Epidemiol & Genet, 715 Albany St,B-608, Boston, MA 02118 USA.		Wilson, Peter W.F./J-2455-2016; Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Wolf, Philip/0000-0002-3628-301X	NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NIA NIH HHS [5R01-AG16495-02, 5R01-AG08122-11] Funding Source: Medline; NINDS NIH HHS [5R01-NS17950-19, R01 NS017950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016495, R01AG008122] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P143; [Anonymous], 1996, FED REGISTER, V61, P8781; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BELL IR, 1992, ACTA PSYCHIAT SCAND, V86, P386, DOI 10.1111/j.1600-0447.1992.tb03285.x; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Bots ML, 1997, J INTERN MED, V242, P339, DOI 10.1046/j.1365-2796.1997.00239.x; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chao CL, 2000, CIRCULATION, V101, P485, DOI 10.1161/01.CIR.101.5.485; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; COLE MG, 1984, AGE AGEING, V13, P101, DOI 10.1093/ageing/13.2.101; Cox DR., 1984, ANAL SURVIVAL DATA; Diaz-Arrastia R, 1998, ARCH NEUROL-CHICAGO, V55, P1407, DOI 10.1001/archneur.55.11.1407; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Fassbender K, 1999, LANCET, V353, P1586; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HORNE DW, 1988, CLIN CHEM, V34, P2357; IKEDA T, 1990, ACTA PSYCHIAT SCAND, V82, P327, DOI 10.1111/j.1600-0447.1990.tb01395.x; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; KARNAZE DS, 1987, ARCH INTERN MED, V147, P429, DOI 10.1001/archinte.147.3.429; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lehmann M, 1999, DEMENT GERIATR COGN, V10, P12, DOI 10.1159/000017092; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LEVITT AJ, 1992, ACTA PSYCHIAT SCAND, V86, P301, DOI 10.1111/j.1600-0447.1992.tb03270.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; McCann SM, 1997, EXP GERONTOL, V32, P431, DOI 10.1016/S0531-5565(96)00154-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nilsson K, 1996, EUR J CLIN INVEST, V26, P853, DOI 10.1111/j.1365-2362.1996.tb02129.x; ORDOVAS JM, 1987, J LIPID RES, V28, P371; Perry DJ, 1999, BEST PRACT RES CL HA, V12, P451, DOI 10.1053/beha.1999.0036; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; Riggs KM, 1996, AM J CLIN NUTR, V63, P306, DOI 10.1093/ajcn/63.3.306; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; SHIN YS, 1983, CLIN CHIM ACTA, V127, P77, DOI 10.1016/0009-8981(83)90077-3; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Wald DS, 2001, ARCH INTERN MED, V161, P695, DOI 10.1001/archinte.161.5.695; Wang HX, 2001, NEUROLOGY, V56, P1188, DOI 10.1212/WNL.56.9.1188; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Welty FK, 1998, ARTERIOSCL THROM VAS, V18, P1745, DOI 10.1161/01.ATV.18.11.1745; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x	56	2550	2675	7	280	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					476	483		10.1056/NEJMoa011613	http://dx.doi.org/10.1056/NEJMoa011613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844848				2022-12-01	WOS:000173815300003
J	Watanabe, N; Mitchison, TJ				Watanabe, N; Mitchison, TJ			Single-molecule speckle analysis of Aactin filament turnover in lamellipodia	SCIENCE			English	Article							ACTIN POLYMERIZATION; ARP2/3 COMPLEX; LEADING-EDGE; BARBED ENDS; CELLS; DYNAMICS; FIBROBLASTS; JASPLAKINOLIDE; MICROTUBULES; ADF/COFILIN	Lamellipodia are thin, veil-like extensions at the edge of cells that contain a dynamic array of actin filaments. We describe an approach for analyzing spatial regulation of actin polymerization and depolymerization in vivo in which we tracked single molecules of actin fused to the green fluorescent protein. Polymerization and the lifetime of actin filaments in lamellipodia were measured with high spatial precision. Basal polymerization and depolymerization occurred throughout lamellipodia with largely constant kinetics, and polymerization was promoted within one micron of the lamellipodium tip. Most of the actin filaments in the lamellipodium were generated by polymerization away from the tip.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Watanabe, N (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.				NIGMS NIH HHS [GM48027] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HITCHCOCKDEGREG.SE, 1988, BIOCHEMISTRY-US, V27, P9183; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakagawa H, 2001, J CELL SCI, V114, P1555; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Tardy Y, 1995, BIOPHYS J, V69, P1674, DOI 10.1016/S0006-3495(95)80085-8; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417	31	349	353	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1083	1086		10.1126/science.1067470	http://dx.doi.org/10.1126/science.1067470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834838				2022-12-01	WOS:000173793000069
J	Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD				Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD			Development - Parthenogenetic stem cells in nonhuman primates	SCIENCE			English	Article							EMBRYOS		Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Adv Cell Technol, Worcester, MA 01605 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Wake Forest University; Wake Forest Baptist Medical Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic	Grant, KA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lanza, Robert/0000-0002-3047-3074; Vrana, Kent/0000-0003-4902-7733; West, Michael/0000-0002-4842-5468; Cibelli, Jose/0000-0002-2176-3854	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011997, T32AA007565] Funding Source: NIH RePORTER; NIAAA NIH HHS [P50-AA11997, T32-AA07565] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Boediono A, 1999, MOL REPROD DEV, V53, P159, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;159::AID-MRD5&gt;3.0.CO;2-X; Carroll J, 2001, SEMIN CELL DEV BIOL, V12, P37, DOI 10.1006/scdb.2000.0215; FUKUI Y, 1992, MOL REPROD DEV, V33, P357, DOI 10.1002/mrd.1080330318; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253	8	240	270	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					819	819		10.1126/science.1065637	http://dx.doi.org/10.1126/science.1065637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823632				2022-12-01	WOS:000173733000034
J	Hua, W; Chung, J; Gelles, J				Hua, W; Chung, J; Gelles, J			Distinguishing inchworm and hand-over-hand processive kinesin movement by neck rotation measurements	SCIENCE			English	Article							STIMULATED ATP HYDROLYSIS; DIMERIC KINESIN; MICROTUBULE MOVEMENT; HEADED KINESIN; MOTOR; DERIVATIVES; MOLECULES; MECHANISM; BINDING; KIF1A	The motor enzyme kinesin makes hundreds of unidirectional 8-nanometer steps without detaching from or freely sliding along the microtubule on which it moves. We investigated the kinesin stepping mechanism by immobilizing a Drosophila kinesin derivative through the carboxyl-terminal end of the neck coiled-coil domain and measuring orientations of microtubules moved by single enzyme molecules at submicromolar adenosine triphosphate concentrations. The kinesin-mediated microtubule-surface linkage was sufficiently torsionally stiff (greater than or equal to2.0+/-0.9 x 10(-20) Newton meters per radian(2)) that stepping by the hypothesized symmetric hand-over-hand mechanism would produce 180degrees rotations of the microtubule relative to the immobilized kinesin neck. In fact, there were no rotations, a finding that is inconsistent with symmetric hand-over-hand movement, An alternative "inch-worm" mechanism is consistent with our experimental results.	Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA.							BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BLOCK SM, 1995, BIOPHYS J, V68, P23055; Chung J.-H., UNPUB; CROSS RA, 1995, J MUSCLE RES CELL M, V16, P91, DOI 10.1007/BF00122526; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, UNPUB; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Young EC, 1998, BIOCHEMISTRY-US, V37, P3467, DOI 10.1021/bi972172n; YOUNG EC, 1995, J BIOL CHEM, V270, P3926, DOI 10.1074/jbc.270.8.3926	31	165	170	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					844	848		10.1126/science.1063089	http://dx.doi.org/10.1126/science.1063089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823639				2022-12-01	WOS:000173733000042
J	Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G				Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G			Partitioning of the matrix fraction of the Golgi apparatus during mitosis in animal cells	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; HELA-CELLS; IN-VIVO; TRANSPORT; PROTEIN; COMPLEX; GM130; DYNAMICS; PATHWAY; REVEALS	The Golgi apparatus is partitioned during mitosis in animal cells by a process of fragmentation, dispersal, and reassembly in each daughter cell. We fractionated the Golgi apparatus in vivo using the drug brefeldin A or a dominant-negative mutant of the Sar1p protein. After these treatments, Golgi enzymes moved back to the endoplasmic reticulum, leaving behind a matrix of Golgi structural proteins. Under these conditions, cells still entered and exited mitosis normally, and their Golgi matrix partitioned in a manner very similar to that of the complete organelle. Thus, the matrix may be the partitioning unit of the Golgi apparatus and may carry the Golgi enzyme-containing membranes into the daughter cells.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Taguchi, Tomohiko/I-5014-2019	Taguchi, Tomohiko/0000-0003-0464-6370				BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Jokitalo E, 2001, J CELL BIOL, V154, P317, DOI 10.1083/jcb.200104073; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Miles S, 2001, J CELL BIOL, V155, P543, DOI 10.1083/jcb.200103104; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Prescott AR, 2001, TRAFFIC, V2, P321, DOI 10.1034/j.1600-0854.2001.002005321.x; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; ROWE T, 1995, METHOD ENZYMOL, V257, P49; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yoshimura S, 2001, J CELL SCI, V114, P4105; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	27	103	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					848	851		10.1126/science.1068064	http://dx.doi.org/10.1126/science.1068064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823640				2022-12-01	WOS:000173733000043
J	Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG				Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG			Structure of the cell-puncturing device of bacteriophage T4	NATURE			English	Article							TAIL LYSOZYME; BASEPLATE; PROGRAM; PROTEIN	Bacteriophage T4 has a very efficient mechanism for infecting cells(1). The key component of this process is the baseplate, located at the end of the phage tail, which regulates the interaction of the tail fibres and the DNA ejection machine(2). A complex of gene product (gp) 5 (63K) and gp27 (44K), the central part of the baseplate, is required to penetrate the outer cell membrane of Escherichia coli and to disrupt the intermembrane peptidoglycan layer, promoting subsequent entry of phage DNA into the host. We present here a crystal structure of the (gp5-gp27)(3) 321K complex, determined to 2.9 Angstrom resolution and fitted into a cryoelectron microscopy map at 17 Angstrom resolution of the baseplate-tail tube assembly. The carboxy-terminal domain of gp5 is a triple-stranded beta-helix that forms an equilateral triangular prism, which acts as a membrane-puncturing needle. The middle lysozyme domain of gp5, situated on the periphery of the prism, serves to digest the peptidoglycan layer. The amino-terminal, antiparallel beta-barrel domain of gp5 is inserted into a cylinder formed by three gp27 monomers, which may serve as a channel for DNA ejection.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow, Russia; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Tokyo Institute of Technology	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Kanamaru, Shuji/R-4049-2017; Leiman, Petr G/E-5120-2010	Kanamaru, Shuji/0000-0002-2765-531X; Leiman, Petr G/0000-0002-9091-0918; Chipman, Paul/0000-0003-3652-4087; Kostyuchenko, Victor/0000-0001-9751-307X				BOVA R, 1990, NUCLEIC ACIDS RES, V18, P3046, DOI 10.1093/nar/18.10.3046; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; EISERLING FA, 1994, MOL BIOL BACTERIOP T, V4, P209; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Kanamaru S, 1999, J BACTERIOL, V181, P2739, DOI 10.1128/JB.181.9.2739-2744.1999; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOSIG G, 1989, New Biologist, V1, P171; MURZIN AG, 1992, CURR OPIN STRUC BIOL, V2, P895; NAKAGAWA H, 1985, J VIROL, V54, P460, DOI 10.1128/JVI.54.2.460-466.1985; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; SHELDRICK GM, 2001, INT TABLES CRYSTALLO, VF, P734; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Takeda S, 1998, BBA-PROTEIN STRUCT M, V1384, P243, DOI 10.1016/S0167-4838(98)00016-8; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; VANDERSLICE RW, 1974, VIROLOGY, V60, P265, DOI 10.1016/0042-6822(74)90384-5	23	299	307	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					553	557		10.1038/415553a	http://dx.doi.org/10.1038/415553a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823865				2022-12-01	WOS:000173564300053
J	Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P				Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P			Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study	LANCET			English	Article							GROWTH-ASSOCIATED PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR CELLS; SYNAPSIN I; SCG10; MICE; L1; REPRESSOR; SYSTEM; GAP-43	Background Identification of genes and characterisation of their function is an essential step towards understanding complex pathophysiological abnormalities in Down's syndrome. We did a study to investigate abnormalities in gene expression in human neuronal stem cells and progenitor cells from Down's syndrome and control post-mortem human fetal tissue. Methods Indexing-based differential display PCR was done on neuronal precursor cells derived from the cortex of a fetus with Down's syndrome, and findings were compared with those of two control samples. Findings were validated against neurosphere preparations from three independent Down's syndrome fetuses and five independent controls by real-time quantitative PCR. Findings Results of differential display PCR analysis showed that SCG10-a neuron-specific growth-associated protein regulated by the neuron-restrictive silencer factor REST-was almost undetectable in the Down's syndrome sample. This finding was validated by real-time PCR. We also found that other genes regulated by the REST transcription factor were selectively repressed, whereas non-REST-regulated genes with similar functions were unaffected. Changes in expression of several key developmental genes in the Down's syndrome stem-cell and progenitor-cell pool correlated with striking changes in neuron morphology after differentiation. Interpretation Our findings suggest a link between dysregulation of the REST transcription factor and some of the neurological deficits seen in Down's syndrome. Experimental REST downregulation has been shown to trigger apoptosis, which could account for the striking and selective loss of neurons in the differentiated Down's syndrome cell preparations.	Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England; UK Human Genome Mapping Project Resource Ctr, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 1TN, England; Univ Cambridge, MRC, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England; UCL, Dept Obstet & Gynaecol, London WC1E 6BT, England; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Anat, Madison, WI USA; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Neurol, Madison, WI USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bahn, S (corresponding author), Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England.	sabine.bahn@bbsrc.ac.uk		Caldwell, Maeve/0000-0001-7442-711X				CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CROME L, 1972, PATHOLOGY MENTAL RET, P200; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Haydar TF, 2000, J NEUROSCI, V20, P4156; HAYES A, 1993, PEDIATR CLIN N AM, V40, P523; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; HOOK EG, 1982, DOWN SYNDROME ADV BI; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Mahadeva H, 1998, J MOL BIOL, V284, P1391, DOI 10.1006/jmbi.1998.2292; OKAZAKI T, 1995, NEUROBIOL AGING, V16, P883, DOI 10.1016/0197-4580(95)02001-2; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palm K, 1998, J NEUROSCI, V18, P1280; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Saito Y, 2000, ACTA NEUROPATHOL, V100, P654, DOI 10.1007/s004010000230; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957	24	167	174	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					310	315		10.1016/S0140-6736(02)07497-4	http://dx.doi.org/10.1016/S0140-6736(02)07497-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830198				2022-12-01	WOS:000173588100012
J	Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T				Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T			Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin	CELL			English	Article							LIM-KINASE 1; COFILIN PHOSPHORYLATION; DEPOLYMERIZING FACTOR; DROSOPHILA BRISTLES; FILAMENT DYNAMICS; BINDING PROTEIN; CELL POLARITY; GENE; EXPRESSION; BUNDLES	The ADF (actin-depolymerizing factor)/cofilin family is a stimulus-responsive mediator of actin dynamics. In contrast to the mechanisms of inactivation of ADF/cofilin by kinases such as LIM-kinase 1 (LIMK1), much less is known about its reactivation through dephosphorylation. Here we report Slingshot (SSH), a family of phosphatases that have the property of F actin binding. In Drosophila, loss of ssh function dramatically increased levels of both F actin and phospho-cofilin (P cofilin) and disorganized epidermal cell morphogenesis. In mammalian cells, human SSH homologs (hSSHs) suppressed LIMK1-induced actin reorganization. Furthermore, SSH and the hSSHs dephosphorylated P cofilin in cultured cells and in cell-free assays. Our results strongly suggest that the SSH family plays a pivotal role in actin dynamics by reactivating ADF/cofilin in vivo.	Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol Corp, CREST, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; Kyoto University; Tohoku University; Japan Science & Technology Agency (JST)	Uemura, T (corresponding author), Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan.	tuemura@virus.kyoto-u.ac.jp	Mizuno, Kensaku/G-8631-2015; Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; UEMURA, Tadashi/0000-0001-7204-3606				ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; COHEN P, 1990, ADV SEC MESS PHOSPH, V24, P230; Cong JL, 2001, DEVELOPMENT, V128, P2793; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; DeRosier DJ, 2000, J CELL BIOL, V148, P1; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; Geng W, 2000, GENETICS, V156, P1817; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HAY BA, 1994, DEVELOPMENT, V120, P2121; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MITCHELL HK, 1990, DEV GENET, V11, P133, DOI 10.1002/dvg.1020110203; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; OVERTON J, 1967, J MORPHOL, V122, P367, DOI 10.1002/jmor.1051220406; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; ROBERTSON HM, 1988, GENETICS, V118, P461; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tilney LG, 2000, J CELL SCI, V113, P1255; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Toshima JY, 2001, J BIOL CHEM, V276, P43471, DOI 10.1074/jbc.M104620200; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yahara I, 1996, CELL STRUCT FUNCT, V21, P421, DOI 10.1247/csf.21.421; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	71	525	552	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					233	246		10.1016/S0092-8674(01)00638-9	http://dx.doi.org/10.1016/S0092-8674(01)00638-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832213	Bronze			2022-12-01	WOS:000173521300010
J	Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR				Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR			A hydrogen-based subsurface microbial community dominated by methanogens	NATURE			English	Article							ECOSYSTEMS; DEEP; INDICATOR; DIVERSITY; BACTERIA; ENERGY	The search for extraterrestrial life may be facilitated if ecosystems can be found on Earth that exist under conditions analogous to those present on other planets or moons. It has been proposed, on the basis of geochemical and thermodynamic considerations, that geologically derived hydrogen might support subsurface microbial communities on Mars and Europa in which methanogens form the base of the ecosystem(1-5). Here we describe a unique subsurface microbial community in which hydrogen-consuming, methane-producing Archaea far outnumber the Bacteria. More than 90% of the 16S ribosomal DNA sequences recovered from hydrothermal waters circulating through deeply buried igneous rocks in Idaho are related to hydrogen-using methanogenic microorganisms. Geochemical characterization indicates that geothermal hydrogen, not organic carbon, is the primary energy source for this methanogen-dominated microbial community. These results demonstrate that hydrogen-based methanogenic communities do occur in Earth's subsurface, providing an analogue for possible subsurface microbial ecosystems on other planets.	US Geol Survey, Columbia, SC 29210 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; US Geol Survey, Idaho Falls, ID 83402 USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Idaho National Laboratory; United States Department of the Interior; United States Geological Survey	Chapelle, FH (corresponding author), US Geol Survey, Columbia, SC 29210 USA.	dlovley@microbio.umass.edu	Bradley, Paul M./AAC-2451-2020	Bradley, Paul M./0000-0001-7522-8606				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; BOSTON PJ, 1992, ICARUS, V95, P300, DOI 10.1016/0019-1035(92)90045-9; Carr MH, 1996, CIBA F SYMP, V202, P249; Chapelle FH, 1997, ENVIRON SCI TECHNOL, V31, P2873, DOI 10.1021/es970085c; Embree G. F., 1982, IDAHO BUREAU MINES G, V26, P333; Farmer JD., 2000, GSA TODAY, V10, P1; Fisk MR, 1999, J GEOPHYS RES-PLANET, V104, P11805, DOI 10.1029/1999JE900010; Fry NK, 1997, APPL ENVIRON MICROB, V63, P1498, DOI 10.1128/AEM.63.4.1498-1504.1997; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Knobel LL, 1999, 99246 US GEOL SURV; LILLEY MD, 2001, LPI CONTRIBUTION, V1088; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McCollom TM, 1999, J GEOPHYS RES-PLANET, V104, P30729, DOI 10.1029/1999JE001126; McKay CP, 2001, WILEY S ECO, P315; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; PICARD C, 1992, APPL ENVIRON MICROB, V58, P2717, DOI 10.1128/AEM.58.9.2717-2722.1992; PIERCE KL, 1982, GEOL SOC AM MEM, V179; Shock EL, 1996, CIBA F SYMP, V202, P40; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; SUGISAKI R, 1986, J GEOPHYS RES-SOLID, V91, P2296, DOI 10.1029/JB091iB12p12296; WAKITA H, 1980, SCIENCE, V210, P188, DOI 10.1126/science.210.4466.188	26	318	347	9	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					312	315		10.1038/415312a	http://dx.doi.org/10.1038/415312a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797006				2022-12-01	WOS:000173293500041
J	Sigala, N; Logothetis, NK				Sigala, N; Logothetis, NK			Visual categorization shapes feature selectivity in the primate temporal cortex	NATURE			English	Article							INFEROTEMPORAL CORTEX; RHESUS-MONKEYS; RECOGNITION; SIMILARITY; REPRESENTATION; EXPERTISE; IMAGES; EYE	The way that we perceive and interact with objects depends on our previous experience with them. For example, a bird expert is more likely to recognize a bird as a sparrow, a sandpiper or a cockatiel than a non-expert(1). Neurons in the inferior temporal cortex have been shown to be important in the representation of visual objects; however, it is unknown which object features are represented and how these representations are affected by categorization training. Here we show that feature selectivity in the macaque inferior temporal cortex is shaped by categorization of objects on the basis of their visual features. Specifically, we recorded from single neurons while monkeys performed a categorization task with two sets of parametric stimuli. Each stimulus set consisted of four varying features, but only two of the four were important for the categorization task (diagnostic features). We found enhanced neuronal representation of the diagnostic features relative to the non-diagnostic ones. These findings demonstrate that stimulus features important for categorization are instantiated in the activity of single units (neurons) in the primate inferior temporal cortex.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Sigala, N (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	natasha.sigala@tuebingen.mpg.de	Sigala, Natasha/ABH-3181-2020; Sigala, Natasha/K-1750-2013; Logothetis, Nikos/U-9282-2019	Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; 				BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SIGALA N, 2001, J COGNITIVE NEUROSCI, V14, P1; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x	20	417	421	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					318	320		10.1038/415318a	http://dx.doi.org/10.1038/415318a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511YC	11797008				2022-12-01	WOS:000173293500043
J	Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG				Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG			Dendroaspis natriuretic peptide: endogenous or dubious?	LANCET			English	Editorial Material							SEQUENCE-ANALYSIS; BRAIN; PRECURSOR; CLONING; MEMBER; FAMILY		Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	University of Otago	Richards, AM (corresponding author), Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, POB 4345, Christchurch, New Zealand.			Cameron, Vicky/0000-0003-3147-683X				Collins E, 2000, J CARDIOVASC PHARM, V35, P614, DOI 10.1097/00005344-200004000-00015; Fabrega E, 2001, AM J GASTROENTEROL, V96, P2724; Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089; Lisy O, 1999, KIDNEY INT, V56, P502, DOI 10.1046/j.1523-1755.1999.00573.x; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; OIKAWA S, 1984, NATURE, V309, P724, DOI 10.1038/309724a0; Schirger JA, 1999, MAYO CLIN PROC, V74, P126, DOI 10.4065/74.2.126; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1989, BIOCHEM BIOPH RES CO, V159, P1427, DOI 10.1016/0006-291X(89)92269-9; SUDOH T, 1988, NATURE, V332, P76	11	30	34	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					5	6		10.1016/S0140-6736(02)07270-7	http://dx.doi.org/10.1016/S0140-6736(02)07270-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809176				2022-12-01	WOS:000173143500005
J	Smith, O				Smith, O			Development - A SAC of crumbs and stardust	SCIENCE			English	Article																		Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a	2	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2498	2498		10.1126/science.294.5551.2498	http://dx.doi.org/10.1126/science.294.5551.2498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752566				2022-12-01	WOS:000172927700043
J	Tanis, BC; van den Bosch, MAAJ; Kemmeren, JM; Cats, VM; Helmerhorst, FM; Algra, A; van der Graaf, Y; Rosendaal, FR				Tanis, BC; van den Bosch, MAAJ; Kemmeren, JM; Cats, VM; Helmerhorst, FM; Algra, A; van der Graaf, Y; Rosendaal, FR			Oral contraceptives and the risk of myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL CASE-CONTROL; ACTIVATED PROTEIN-C; V LEIDEN MUTATION; YOUNG-WOMEN; VENOUS THROMBOSIS; CARDIOVASCULAR-DISEASE; PROGESTAGEN; RESISTANCE; INCREASES	Background: An association between the use of oral contraceptives and the risk of myocardial infarction has been found in some, but not all, studies. We investigated this association, according to the type of progestagen included in third-generation (i.e., desogestrel or gestodene) and second-generation (i.e., levonorgestrel) oral contraceptives, the dose of estrogen, and the presence or absence of prothrombotic mutations. Methods: In a nationwide, population-based, case-control study, we identified and enrolled 248 women 18 through 49 years of age who had had a first myocardial infarction between 1990 and 1995 and 925 control women who had not had a myocardial infarction and who were matched for age, calendar year of the index event, and area of residence. Subjects supplied information on oral-contraceptive use and major cardiovascular risk factors. An analysis for factor V Leiden and the G20210A mutation in the prothrombin gene was conducted in 217 patients and 763 controls. Results: The odds ratio for myocardial infarction among women who used any type of combined oral contraceptive, as compared with nonusers, was 2.0 (95 percent confidence interval, 1.5 to 2.8). The adjusted odds ratio was 2.5 (95 percent confidence interval, 1.5 to 4.1) among women who used second-generation oral contraceptives and 1.3 (95 percent confidence interval, 0.7 to 2.5) among those who used third-generation oral contraceptives. Among women who used oral contraceptives, the odds ratio was 2.1 (95 percent confidence interval, 1.5 to 3.0) for those without a prothrombotic mutation and 1.9 (95 percent confidence interval, 0.6 to 5.5) for those with a mutation. Conclusions: The risk of myocardial infarction was increased among women who used second-generation oral contraceptives. The results with respect to the use of third-generation oral contraceptives were inconclusive but suggested that the risk was lower than the risk associated with second-generation oral contraceptives. The risk of myocardial infarction was similar among women who used oral contraceptives whether or not they had a prothrombotic mutation. (N Engl J Med 2001;345:1787-93.) Copyright (C) 2001 Massachusetts Medical Society.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Ctr Hemostasis & Thrombosis Res, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Obstet Gynecol & Reprod Med, Leiden, Netherlands; Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Bldg 1,C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.							BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; BOYCE J, 1963, LANCET, V1, P111, DOI 10.1016/S0140-6736(63)91117-6; *CENTR BUR STAT, 1998, STAT JB 1998, P491; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; FARLEY TMM, 1995, LANCET, V346, P1582; FOTHERBY K, 1994, CONTRACEPTION, V49, P1, DOI 10.1016/0010-7824(94)90106-6; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GODSLAND IF, 1990, NEW ENGL J MED, V323, P1375, DOI 10.1056/NEJM199011153232003; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; Herings RMC, 1999, LANCET, V354, P1478; Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8; Jick H, 1996, LANCET, V347, P627, DOI 10.1016/S0140-6736(96)91334-3; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; JICK H, 1978, JAMA-J AM MED ASSOC, V240, P2548, DOI 10.1001/jama.240.23.2548; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lewis MA, 1996, BRIT MED J, V312, P88; MANN JI, 1975, BMJ-BRIT MED J, V2, P241, DOI 10.1136/bmj.2.5965.241; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; ROBINSON GE, 1994, BRIT J OBSTET GYNAEC, V101, P1036, DOI 10.1111/j.1471-0528.1994.tb13578.x; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; SARTWELL PE, 1982, EPIDEMIOL REV, V4, P95, DOI 10.1093/oxfordjournals.epirev.a036253; SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034; Spitzer WO, 1996, BRIT MED J, V312, P83; STADEL BV, 1981, NEW ENGL J MED, V305, P612, DOI 10.1056/NEJM198109103051104; THOROGOOD M, 1990, AM J OBSTET GYNECOL, V163, P274, DOI 10.1016/0002-9378(90)90567-Q; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0	30	261	266	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1787	1793		10.1056/NEJMoa003216	http://dx.doi.org/10.1056/NEJMoa003216			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752354	Green Published			2022-12-01	WOS:000172794800001
J	Saltiel, AR; Kahn, CR				Saltiel, AR; Kahn, CR			Insulin signalling and the regulation of glucose and lipid metabolism	NATURE			English	Review							GLYCOGEN-SYNTHASE KINASE-3; RECEPTOR SUBSTRATE 1; PROTEIN-KINASE; MICE LACKING; PHOSPHATIDYLINOSITOL 3-KINASE; TARGETED DISRUPTION; PHOSPHOINOSITIDE 3-KINASE; DIABETES-MELLITUS; TYROSINE PHOSPHORYLATION; HEPATIC GLUCONEOGENESIS	The epidemic of type 2 diabetes and impaired glucose tolerance is one of the main causes of morbidity and mortality worldwide. In both disorders, tissues such as muscle, fat and liver become less responsive or resistant to insulin. This state is also linked to other common health problems, such as obesity, polycystic ovarian disease, hyperlipidaemia, hypertension and atherosclerosis. The pathophysiology of insulin resistance involves a complex network of signalling pathways, activated by the insulin receptor, which regulates intermediary metabolism and its organization in cells. But recent studies have shown that numerous other hormones and signalling events attenuate insulin action, and are important in type 2 diabetes.	Univ Michigan, Sch Med, Dept Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Saltiel, AR (corresponding author), Univ Michigan, Sch Med, Dept Med, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu; c.ronald.kahn@joslin.harvard.edu	Saltiel, Alan/L-3632-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Saltiel, Alan/0000-0002-9726-9828				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1999, J PEDIATR ENDOCR MET, V12, P475; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bergman RN, 1997, RECENT PROG HORM RES, V52, P359; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Craparo A, 1997, J BIOL CHEM, V272, P11663; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hwang JH, 2001, J APPL PHYSIOL, V90, P1267, DOI 10.1152/jappl.2001.90.4.1267; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kessler A, 2001, AM J PHYSIOL-ENDOC M, V280, pE65, DOI 10.1152/ajpendo.2001.280.1.E65; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI200111559; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Patti Mary-Elizabeth, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P89; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; PONS S, 1995, MOL CELL BIOL, V15, P4453; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stern MP, 2000, J CLIN INVEST, V106, P323, DOI 10.1172/JCI10725; Sutherland C, 1996, PHILOS T ROY SOC B, V351, P191, DOI 10.1098/rstb.1996.0016; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wada T, 1999, ENDOCRINOLOGY, V140, P4585, DOI 10.1210/en.140.10.4585; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; ZIEGLER SF, 1993, ONCOGENE, V8, P663; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	100	3583	3779	42	1405	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					799	806		10.1038/414799a	http://dx.doi.org/10.1038/414799a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742412	Green Published			2022-12-01	WOS:000172676200060
J	El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS				El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS			The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (vol 404, pg 398, 2000)	NATURE			English	Correction							HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; DUODENAL-ULCER DISEASE; ACID-SECRETION; STOMACH-CANCER; RECEPTOR; GENE; CELLS; RISK; ASSOCIATION	Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease(1). The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion(2), whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy(3), which are presumptive precursors of gastric cancer(4). Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are in near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA-protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine(5) and a powerful inhibitor of gastric acid secretion(6,7). Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.					Lissowska, Jolanta/AAH-3252-2020; El-Omar, Emad/AAT-7780-2021; Young, Howard/A-6350-2008	Lissowska, Jolanta/0000-0003-2695-5799; Bream, Jay/0000-0002-9149-7643; El-Omar, Emad/0000-0002-0011-3924; Young, Howard/0000-0002-3118-5111				Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; BIDWELL JL, CYTOKINE GENE POLYM; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; CORREA P, 1992, CANCER RES, V52, P6735; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; RUIZ B, 1994, AM J GASTROENTEROL, V89, P533; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; SIPPONEN P, 1994, SCAND J GASTROENTERO, V29, P24, DOI 10.3109/00365529409105356; STOCKBRUEGGER RW, 1984, SCAND J GASTROENTERO, V19, P355, DOI 10.1080/00365521.1984.12005735; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wolfe M M, 1992, Gastroenterology, V102, P2177; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yu CR, 1996, J IMMUNOL, V157, P126; [No title captured]	32	227	231	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					99	+		10.1038/35083631	http://dx.doi.org/10.1038/35083631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11808612	Bronze			2022-12-01	WOS:000169644900053
J	Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R				Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R		Children's Canc Grp	Expression of p53 and prognosis in children with malignant gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE ASTROCYTOMAS; LONG-TERM SURVIVAL; GLIOBLASTOMA-MULTIFORME; CLINICAL-IMPLICATIONS; EGFR AMPLIFICATION; GENE AMPLIFICATION; CANCER-THERAPY; MUTATIONS; OVEREXPRESSION; DELETION	Background: The prognosis of children with high-grade gliomas is uncertain, even when clinical and histologic findings are considered. We investigated whether mutations in the TP53 gene or the degree of expression of p53 protein in high-grade gliomas is associated with progression-free survival in children with these tumors. Methods: Paraffin-embedded specimens of malignant gliomas from children treated in the Children's Cancer Group study CCG-945 were assessed by mutational analysis of TP53 (121 specimens) and immunohistochemical analysis of p53 (115 specimens). For mutational studies, areas of tissue that contained malignant glioma were isolated by microdissection, and the DNA was subjected to polymerase-chain-reaction-based amplification and sequencing of TP53 exons 5, 6, 7, and 8. Immunohistochemical analysis was performed with the use of a microwave-enhanced antigen retrieval and an antibody that bound both wild-type and mutant p53. Results: We found a significant association between overexpression of p53 and outcome; this association was independent of histologic features, age, sex, the extent of resection, and tumor location. The rate (+/-SE) of progression-free survival at five years was 44+/-6 percent in the group of 74 patients whose tumors had low levels of expression of p53 and 17+/-6 percent in the group of 41 patients whose tumors had overexpression of p53 (P<0.001). A nonsignificant association was observed between mutations in TP53 and outcome. Conclusions: Overexpression of p53 in malignant gliomas during childhood is strongly associated with an adverse outcome, independently of clinical prognostic factors and histologic findings.	Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Childrens Oncol Grp, Arcadia, CA USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; NYU, Med Ctr, Dept Pediat, New York, NY 10016 USA; Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Oncology Group (COG); University System of Ohio; Ohio State University; St Jude Children's Research Hospital; New York University; University of Southern California	Pollack, IF (corresponding author), Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave, Pittsburgh, PA 15213 USA.	pollaci@chplink.chp.edu			NATIONAL CANCER INSTITUTE [P30CA021765, U10CA013539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037704] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA13539] Funding Source: Medline; NINDS NIH HHS [NS01810, NS37704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boyett J., 1998, P ASCO, V17, p526a; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brown JM, 1999, CANCER RES, V59, P1391; Campbell JW, 1996, NEUROSURGERY, V38, P258, DOI 10.1097/00006123-199602000-00006; CHANDLER KL, 1993, NEUROSURGERY, V32, P716, DOI 10.1227/00006123-199305000-00003; Collins VP, 1999, SEMIN CANCER BIOL, V9, P267, DOI 10.1006/scbi.1999.0132; Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121; DANKS RA, 1995, NEUROSURGERY, V37, P246, DOI 10.1227/00006123-199508000-00009; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Dixon W.J., 1969, INTRO STAT ANAL; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; FINLAY JL, 1995, J CLIN ONCOL, V13, P112, DOI 10.1200/JCO.1995.13.1.112; FULTS D, 1992, CANCER RES, V52, P674; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; Galanis E, 1998, INT J ONCOL, V13, P717; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GOH HS, 1995, CANCER RES, V55, P5217; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HE J, 1995, CANCER RES, V55, P4833; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ichimura K, 2000, CANCER RES, V60, P417; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; JAMES CD, 1988, CANCER RES, V48, P5546; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Kim SH, 1999, J UROLOGY, V162, P1512, DOI 10.1016/S0022-5347(05)68350-4; KINZLER KW, 1994, NEW ENGL J MED, V331, P49, DOI 10.1056/NEJM199407073310113; KLEIHUES P, 1993, INT HISTOLOGICAL CLA, V21, P11; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LANG FF, 1994, ONCOGENE, V9, P949; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LITOFSKY NS, 1994, NEUROSURGERY, V34, P967, DOI 10.1227/00006123-199406000-00003; Liu WG, 1997, CANCER RES, V57, P5254; Louis DN, 1997, BRAIN PATHOL, V7, P755, DOI 10.1111/j.1750-3639.1997.tb01062.x; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; NAZZARO JM, 1990, J NEUROSURG, V73, P331, DOI 10.3171/jns.1990.73.3.0331; Newcomb EW, 2000, HUM PATHOL, V31, P115, DOI 10.1016/S0046-8177(00)80207-5; POLLACK IF, 1994, NEW ENGL J MED, V331, P1500, DOI 10.1056/NEJM199412013312207; Pollack IF, 1997, CANCER RES, V57, P304; Pollack IF, 2001, CANCER RES, V61, P7404; Quinn DI, 2000, CANCER RES, V60, P1585; Raffel C, 1999, CLIN CANCER RES, V5, P4085; RASHEED BKA, 1994, CANCER RES, V54, P1324; RASHEED BKA, 1995, ONCOGENE, V10, P2243; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; RUSCH V, 1995, CANCER RES, V55, P5038; SALCMAN M, 1994, NEUROSURGERY, V34, P213, DOI 10.1227/00006123-199402000-00002; SALFORD LG, 1988, J NEUROSURG, V69, P506, DOI 10.3171/jns.1988.69.4.0506; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SPOSTO R, 1989, J NEURO-ONCOL, V7, P165, DOI 10.1007/BF00165101; Sung T, 2000, BRAIN PATHOL, V10, P249, DOI 10.1111/j.1750-3639.2000.tb00258.x; Sure U, 1997, J NEUROPATH EXP NEUR, V56, P782; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; VONDEIMLING A, 1993, BRAIN PATHOL, V3, P19; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wu TT, 1996, MODERN PATHOL, V9, P199; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	58	207	212	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					420	427		10.1056/NEJMoa012224	http://dx.doi.org/10.1056/NEJMoa012224			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832530				2022-12-01	WOS:000173686400005
J	Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML				Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML			Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTION FACTOR; EXPRESSION; FACTOR-1-ALPHA; HOMEOSTASIS; HIF-1-ALPHA; PROTEIN-1; SUBUNIT; EPAS1	The hypoxia-inducible factors (HIFs) 1alpha and 2alpha are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress. This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel-Lindau (VHL tumor suppressor) ubiquitin ligase. We now show that hypoxic induction of the COOH-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD. Inhibitors of Fe(II)- and 2-oxoglutarate-dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator. Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity. Full induction of HIF-1alpha and -2alpha, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degradation and COOH-terminal transactivation domains, respectively.	Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia; CSIRO Hlth Sci & Nutr, Parkville, Vic 3052, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Whitelaw, ML (corresponding author), Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia.		Lando, David/AAH-3052-2019; Lando, David/A-2546-2010; Peet, Daniel/AAE-6698-2020	Lando, David/0000-0001-5783-8769; Peet, Daniel/0000-0002-6085-8936				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lopaticki S, 1998, J MASS SPECTROM, V33, P950, DOI 10.1002/(SICI)1096-9888(199810)33:10<950::AID-JMS704>3.3.CO;2-1; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, GENE DEV, V14, P1893; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wallis TP, 2001, PROTEIN SCI, V10, P2251, DOI 10.1110/ps.15401; WANG QP, 1991, J BIOL CHEM, V266, P14004; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	28	1193	1279	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					858	861		10.1126/science.1068592	http://dx.doi.org/10.1126/science.1068592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823643				2022-12-01	WOS:000173733000046
J	Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE				Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE			Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators	NATURE			English	Article							J-COUPLINGS; PROTEINS; BINDING; NMR; CBP; SPECIFICITY; ACTIVATION; DYNAMICS; PROGRAMS; COMPLEX	Nuclear hormone receptors are ligand-activated transcription factors that regulate the expression of genes that are essential for development, reproduction and homeostasis(1). The hormone response is mediated through recruitment of p160 receptor coactivators and the general transcriptional coactivator CBP/p300, which function synergistically to activate transcription(2). These coactivators exhibit intrinsic histone acetyltransferase activity, function in the remodelling of chromatin, and facilitate the recruitment of RNA polymerase II and the basal transcription machinery(3). The activities of the p160 coactivators are dependent on CBP. Both coactivators are essential for proper cell-cycle control, differentiation and apoptosis, and are implicated in cancer and other diseases(4-7). To elucidate the molecular basis of assembling the multiprotein activation complex, we undertook a structural and thermodynamic analysis of the interaction domains of CBP and the activator for thyroid hormone and retinoid receptors(8). Here we show that although the isolated domains are intrinsically disordered, they combine with high affinity to form a cooperatively folded helical heterodimer. Our study uncovers a unique mechanism, called 'synergistic folding', through which p160 coactivators recruit CBP/p300 to allow transmission of the hormonal signal to the transcriptional machinery.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Howard Hughes Medical Institute	Wright, PE (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Dyson, Jane/D-4160-2011	Evans, Ronald/0000-0002-9986-5965; Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BAX A, 1994, METHOD ENZYMOL, V239, P79; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Goodman RH, 2000, GENE DEV, V14, P1553; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li C, 1997, P NATL ACAD SCI USA, V94, P2278, DOI 10.1073/pnas.94.6.2278; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	30	336	347	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					549	553		10.1038/415549a	http://dx.doi.org/10.1038/415549a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823864				2022-12-01	WOS:000173564300052
J	Williams, JH; Friedman, WE				Williams, JH; Friedman, WE			Identification of diploid endosperm in an early angiosperm lineage	NATURE			English	Article							3 GENOMIC COMPARTMENTS; EXTANT GYMNOSPERMS; PHYLOGENY; EMBRYOLOGY; GNETALES; ORIGIN; PLANTS; GENES; ROOT	In flowering plants, the developmental and genetic basis for the establishment of an embryo-nourishing tissue differs from all other lineages of seed plants. Among extant nonflowering seed plants (conifers, cycads, Ginkgo, Gnetales), a maternally derived haploid tissue (female gametophyte) is responsible for the acquisition of nutrients from the maternal diploid plant, and the ultimate provisioning of the embryo. In flowering plants, a second fertilization event, contemporaneous with the fusion of sperm and egg to yield a zygote, initiates a genetically biparental and typically triploid embryo-nourishing tissue called endosperm. For over a century, triploid biparental endosperm has been viewed as the ancestral condition in extant flowering plants(1-3). Here we report diploid biparental endosperm in Nuphar polysepalum, a basal angiosperm. We show that diploid endosperms are common among early angiosperm lineages and may represent the ancestral condition among flowering plants. If diploid endosperm is plesiomorphic, the triploid endosperms of the vast majority of flowering plants must have evolved from a diploid condition through the developmental modification of the unique fertilization process that initiates endosperm.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.	ned@colorado.edu	Williams, Joseph Hill/E-2227-2011	Williams, Joseph/0000-0002-1206-5667; Friedman, William Edward/0000-0003-0374-3427				Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Battaglia E, 1989, ANN BOT, V47, P7; BATYGINA T B, 1982, Botanicheskii Zhurnal (St. Petersburg), V67, P1179; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Feild TS, 2000, INT J PLANT SCI, V161, P705, DOI 10.1086/314293; FRIEDMAN WE, 1995, P NATL ACAD SCI USA, V92, P3913, DOI 10.1073/pnas.92.9.3913; Friedman WE, 2001, CURR OPIN PLANT BIOL, V4, P14, DOI 10.1016/S1369-5266(00)00129-1; Friedman WE, 2001, EVOLUTION, V55, P217; Galati BG, 1985, B SOC ARGENT BOT, V24, P9; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Johri B.M., 1992, COMP EMBRYOLOGY ANGI; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Orban I, 1998, BOT J LINN SOC, V126, P339, DOI 10.1006/bojl.1997.0157; PALSER BF, 1975, ANN MO BOT GARD, V62, P621, DOI 10.2307/2395269; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; Solntseva MP, 1981, COMP EMBRYOLOGY FLOW, P51; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stebbins G.L., 1974, FLOWERING PLANTS EVO; Swamy BGL., 1964, J INDIAN BOT SOC, V43, P391; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; VANMIEGROET F, 1992, CAN J BOT, V70, P1991; Wilson M. F., 1983, MATE CHOICE PLANTS T; Winter A. N., 1991, BOT ZH, V76, P1716; Winter AN, 1991, BOT ZH, V76; YOSHIDA OSAMU, 1962, J COLL ARTS SCI CHIBA UNIV NAT SCI SER, V3, P459; [No title captured]	30	116	123	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					522	526		10.1038/415522a	http://dx.doi.org/10.1038/415522a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823859				2022-12-01	WOS:000173564300046
J	Ernst, MO; Banks, MS				Ernst, MO; Banks, MS			Humans integrate visual and haptic information in a statistically optimal fashion	NATURE			English	Article							TEXTURE-PERCEPTION; IDEAL OBSERVERS; TOUCH; PSYCHOPHYSICS; DISCREPANCY; DOMINANCE; VISION; SLANT	When a person looks at an object while exploring it with their hand, vision and touch both provide information for estimating the properties of the object. Vision frequently dominates the integrated visual-haptic percept, for example when judging size, shape or position(1-3), but in some circumstances the percept is clearly affected by haptics(4-7). Here we propose that a general principle, which minimizes variance in the final estimate, determines the degree to which vision or haptics dominates. This principle is realized by using maximum-likelihood estimation(8-15) to combine the inputs. To investigate cue combination quantitatively, we first measured the variances associated with visual and haptic estimation of height. We then used these measurements to construct a maximum-likelihood integrator. This model behaved very similarly to humans in a visual-haptic task. Thus, the nervous system seems to combine visual and haptic information in a fashion that is similar to a maximum-likelihood integrator. Visual dominance occurs when the variance associated with visual estimation is lower than that associated with haptic estimation.	Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ernst, MO (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	marc.ernst@tuebingen.mpg.de		Ernst, Marc/0000-0003-4197-8569				Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Clark J.J., 1990, DATA FUSION SENSORY; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; FESTINGE.L, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024766; GHARAMANI Z, 1997, SELF ORG COMPUTATION, P117; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; HELLER MA, 1983, PERCEPTION, V12, P607, DOI 10.1068/p120607; HELLER MA, 1982, PERCEPT PSYCHOPHYS, V31, P339, DOI 10.3758/BF03202657; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; POWER RP, 1980, PERCEPTION, V9, P457, DOI 10.1068/p090457; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Schrater PR, 2000, INT J COMPUT VISION, V40, P73, DOI 10.1023/A:1026557704054; SINGER G, 1969, PERCEPT PSYCHOPHYS, V5, P315, DOI 10.3758/BF03209572; Tastevin J, 1937, ENCEPHALE, V32, P57; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Warren D. H., 1991, PSYCHOL TOUCH, P119; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638	25	2761	2793	20	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					429	433		10.1038/415429a	http://dx.doi.org/10.1038/415429a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514HR	11807554				2022-12-01	WOS:000173433600050
J	Keenan, SP				Keenan, SP			Weaning protocols: here to stay	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DURATION; TRIAL; TIME		Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada		Keenan, SP (corresponding author), Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada.							BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; COHEN IL, 1991, CRIT CARE MED, V19, P1278, DOI 10.1097/00003246-199110000-00010; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Henneman E, 2001, CRIT CARE MED, V29, P297, DOI 10.1097/00003246-200102000-00013; Horst HM, 1998, ARCH SURG-CHICAGO, V133, P483, DOI 10.1001/archsurg.133.5.483; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Vitacca M, 2001, AM J RESP CRIT CARE, V164, P225, DOI 10.1164/ajrccm.164.2.2008160; Wood G, 1995, Respir Care, V40, P219; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	12	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					186	187		10.1016/S0140-6736(02)07465-2	http://dx.doi.org/10.1016/S0140-6736(02)07465-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812550				2022-12-01	WOS:000173350800006
J	Bond, DR; Holmes, DE; Tender, LM; Lovley, DR				Bond, DR; Holmes, DE; Tender, LM; Lovley, DR			Electrode-reducing microorganisms that harvest energy from marine sediments	SCIENCE			English	Article							MICROBIAL FUEL-CELLS; 16S RIBOSOMAL-RNA; DESULFUROMONAS-ACETOXIDANS; FE(III) REDUCTION; GEN-NOV; OXIDATION; BACTERIUM; AQUIFER	Energy in the form of electricity can be harvested from marine sediments by placing a graphite electrode (the anode) in the anoxic zone and connecting it to a graphite cathode in the overlying aerobic water. We report a specific enrichment of microorganisms of the family Geobacteraceae on energy-harvesting anodes, and we show that these microorganisms can conserve energy to support their growth by oxidizing organic compounds with an electrode serving as the sole electron acceptor. This finding not only provides a method for extracting energy from organic matter, but also suggests a strategy for promoting the bioremediation of organic contaminants in subsurface environments.	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	University of Massachusetts System; University of Massachusetts Amherst; United States Department of Defense; United States Navy; Naval Research Laboratory	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.			Bond, Daniel/0000-0001-8083-7107; saravanan, s/0000-0003-1269-1243				EMDE R, 1989, APPL MICROBIOL BIOT, V32, P170, DOI 10.1007/BF00165883; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley D.R., 2000, PROKARYOTES; LOVLEY DR, 1994, NATURE, V370, P128, DOI 10.1038/370128a0; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lovley DR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P3; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Park DH, 2000, APPL ENVIRON MICROB, V66, P1292, DOI 10.1128/AEM.66.4.1292-1297.2000; PFENNIG N, 1976, ARCH MICROBIOL, V110, P3, DOI 10.1007/BF00416962; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; ROLLER SD, 1984, J CHEM TECH BIOT B, V34, P3; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018	17	1037	1166	33	732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					483	485		10.1126/science.1066771	http://dx.doi.org/10.1126/science.1066771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799240				2022-12-01	WOS:000173350700046
J	Walker, GJ; Hayward, NK				Walker, GJ; Hayward, NK			p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse	LANCET			English	Editorial Material							GERMLINE MUTATIONS; INK4A LOCUS; CDK4; RAS		Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Hayward, NK (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia.		hayward, nicholas k/C-1367-2015; Walker, Graeme J/C-2548-2012; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; Walker, Graeme J/0000-0002-9392-8769; 				Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Pollock PM, 2000, CLIN LAB MED, V20, P667; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	15	9	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					7	8		10.1016/S0140-6736(02)07271-9	http://dx.doi.org/10.1016/S0140-6736(02)07271-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809177				2022-12-01	WOS:000173143500006
J	Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M				Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M			Combined functional genomic maps of the C-elegans DNA damage response	SCIENCE			English	Article							PROTEIN; YEAST; INTERFERENCE; CHECKPOINTS; PATHWAY; REPAIR; LENGTH; RNA	Many human cancers originate from defects in the DNA damage response (DDR). Although much is known about this process, it is likely that additional DDR genes remain to be discovered. To identify such genes, we used a strategy that combines protein-protein interaction mapping and large-scale phenotypic analysis in Caenorhabditis elegans. Together, these approaches identified 12 worm DDR orthologs and 11 novel DDR genes. One of these is the putative ortholog of hBCL3, a gene frequently altered in chronic lymphocytic leukemia. Thus, the combination of functional genomic mapping approaches in model organisms may facilitate the identification and characterization of genes involved in cancer and, perhaps, other human diseases.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Vidal, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Reboul, Jerome/P-9103-2016	Reboul, Jerome/0000-0002-5513-4546; Vaglio, Philippe/0000-0003-2900-5596; Gartner, Anton/0000-0003-4639-9902	NATIONAL CANCER INSTITUTE [P01CA080111, R33CA081658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA80111-02, 7 R33 CA81658-02] Funding Source: Medline; NHGRI NIH HHS [5R01HG01715-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Cai RL, 2000, J BIOL CHEM, V275, P27909; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dernburg AF, 2000, GENE DEV, V14, P1578; di Fagagna FD, 1999, NAT GENET, V23, P76; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Sternberg PW, 2001, CELL, V105, P173, DOI 10.1016/S0092-8674(01)00308-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	225	232	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					127	131		10.1126/science.1065986	http://dx.doi.org/10.1126/science.1065986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778048				2022-12-01	WOS:000173143100049
J	Sharp, MD; Pogliano, K				Sharp, MD; Pogliano, K			Rote of cell-specific SpoIIIE assembly in polarity of DNA transfer	SCIENCE			English	Article							BACILLUS-SUBTILIS SPORULATION; MECHANISM; DIVISION; BACTERIA; PROTEIN	SpoIIIE mediates postseptational chromosome partitioning in Bacillus subtilis, but the mechanism controlling the direction of DNA transfer remains obscure. Here, we demonstrated that SpoIIIE acts as a DNA exporter: When SpoIIIE was synthesized in the larger of the two cells necessary for sporulation, the mother cell, DNA was translocated into the smaller forespore; however, when it was synthesized in the forespore, DNA was translocated into the mother cell. Furthermore, the DNA-tracking domain of SpoIIIE inhibited SpoIIIE complex assembly in the forespore. Thus, during sporulation, chromosome partitioning is controlled by the preferential assembly of SpoIIIE in one daughter cell.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.			Pogliano, Kit/0000-0002-7868-3345	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057045-02, R01 GM057045-04, GM-57045, R01 GM057045-03, R01 GM057045] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; POGLIANO J, IN PRESS J BACTERIOL; POGLIANO K, 1995, MOL MICROBIOL, V18, P459, DOI 10.1111/j.1365-2958.1995.mmi_18030459.x; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161	11	78	79	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					137	139		10.1126/science.1066274	http://dx.doi.org/10.1126/science.1066274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778051	Green Accepted			2022-12-01	WOS:000173143100052
J	Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR				Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR			Identification of a host protein essential for assembly of immature HIV-1 capsids	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNASE-L INHIBITOR; RETROVIRAL MORPHOGENESIS; VIF PROTEIN; TYPE-1; CELLS; PATHWAY; NEF; INFECTIVITY; EXPRESSION	To form an immature HIV-1 capsid, 1,500 HIV-1 Gag (p55) polypeptides must assemble properly along the host cell plasma membrane. Insect cells and many higher eukaryotic cell types support efficient capsid assembly 1, but yeast(2) and murine cells(3,4) do not, indicating that host machinery is required for immature HIV-1 capsid formation. Additionally, in a cell-free system that reconstitutes HIV-1 capsid formation, post-translational assembly events require ATP and a subcellular fraction(5), suggesting a requirement for a cellular ATP-binding protein. Here we identify such a protein (HP68), described previously as an RNase L inhibitor(6), and demonstrate that it associates post-translationally with HIV-1 Gag in a cell-free system and human T cells infected with HIV-1. Using a dominant negative mutant of HP68 in mammalian cells and depletion-reconstitution experiments in the cell-free system, we demonstrate that HP68 is essential for post-translational events in immature HIV-1 capsid assembly. Furthermore, in cells the HP68-Gag complex is associated with HIV-1 Vif, which is involved in virion morphogenesis and infectivity. These findings support a critical role for HP68 in posttranslational events of HIV-1 assembly and reveal a previously unappreciated dimension of host-viral interaction.	Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Rutgers State University New Brunswick	Lingappa, JR (corresponding author), Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA.		Lingappa, Jairam/N-7760-2017	Firestein, Bonnie/0000-0002-1679-3565				BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Boulanger P, 1996, CURR TOP MICROBIOL, V214, P237; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Cohen EA, 1996, CURR TOP MICROBIOL, V214, P219; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; HOCKLEY DJ, 1994, J GEN VIROL, V75, P2985, DOI 10.1099/0022-1317-75-11-2985; Hynes G, 1996, ELECTROPHORESIS, V17, P1720, DOI 10.1002/elps.1150171109; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; JOWETT JBM, 1992, J GEN VIROL, V73, P3079, DOI 10.1099/0022-1317-73-12-3079; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LINGAPPA JR, 1994, J CELL BIOL, V125, P99, DOI 10.1083/jcb.125.1.99; Lingappa JR, 1997, J CELL BIOL, V136, P567, DOI 10.1083/jcb.136.3.567; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Martinand C, 1999, J VIROL, V73, P290, DOI 10.1128/JVI.73.1.290-296.1999; MORGAN PJ, 1989, J NEUROENDOCRINOL, V1, P1, DOI 10.1111/j.1365-2826.1989.tb00068.x; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; SALEHZADA T, 1991, J BIOL CHEM, V266, P5808; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Singh AR, 2001, VIROLOGY, V279, P257, DOI 10.1006/viro.2000.0706; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	30	189	214	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					88	92		10.1038/415088a	http://dx.doi.org/10.1038/415088a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780123				2022-12-01	WOS:000173028800046
J	Petersdorf, EW; Hansen, JA; Martin, PJ; Woolfrey, A; Malkki, M; Gooley, T; Storer, B; Mickelson, E; Smith, A; Anasetti, C				Petersdorf, EW; Hansen, JA; Martin, PJ; Woolfrey, A; Malkki, M; Gooley, T; Storer, B; Mickelson, E; Smith, A; Anasetti, C			Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DONOR MARROW TRANSPLANTATION; UNRELATED DONORS; HLA-C; LYMPHOCYTES-T; MOLECULES; LEUKEMIA; COMPATIBILITY; ENGRAFTMENT; ASSOCIATION; EXPERIENCE	Background: Successful engraftment of hematopoietic stem cells from unrelated donors is influenced by disparities between the donor and recipient for HLA-A, B, and C alleles. Disparities between HLA sequence polymorphisms that are serologically detectable are termed antigen mismatches, whereas those that can be identified only by DNA-based typing methods are termed allele mismatches. Whether both kinds of polymorphisms are important in transplantation is not known. We tested the hypothesis that allele mismatches that are detectable only at the DNA level are less immunogenic than those that are serologically detectable and thereby are associated with a lower risk of graft failure after hematopoietic-cell transplantation. Methods: We used DNA sequencing to define the HLA-A, B, and C alleles in 471 patients who received bone marrow from unrelated donors for the treatment of chronic myeloid leukemia after myeloablative conditioning therapy. The odds ratios for graft failure were determined for recipients of transplants from donors with a single class I allele mismatch, a single class I antigen mismatch, or two or more class I mismatches, as compared with those with no mismatch. Results: A single HLA allele mismatch did not increase the risk of graft failure, whereas a single antigen mismatch significantly increased the risk. The risk was also increased if the recipient was HLA homozygous at the mismatched class I locus or if the donor had two or more class I mismatches. Conclusions: HLA class I antigen mismatches that are serologically detectable confer an enhanced risk of graft failure after hematopoietic-cell transplantation. Transplants from donors with a single class I allele mismatch that is not serologically detectable may be used without an increased risk of graft failure. (N Engl J Med 2001;345:1794-800.) Copyright (C) 2001 Massachusetts Medical Society.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA USA; Seattle Canc Care Alliance, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance	Petersdorf, EW (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.				NCI NIH HHS [CA18029, CA72978, CA15704] Funding Source: Medline; NIAID NIH HHS [AI33484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015704, R29CA072978, P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANASETTI C, 1989, NEW ENGL J MED, V320, P197, DOI 10.1056/NEJM198901263200401; ANASETTI C, 1994, TRANSFUS SCI, V15, P221, DOI 10.1016/0955-3886(94)90134-1; Anasetti C., 1999, HEMATOPOIETIC CELL T, P904; BEATTY PG, 1991, TRANSPLANTATION, V51, P443, DOI 10.1097/00007890-199102000-00034; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BUNCE M, 1997, GENETIC DIVERSITY HL, V1, P83; DAUSSET J, 1954, C R SOC BIOL, V146, P1539; Davies SM, 2000, BLOOD, V96, P4096; DUPONT B, 1980, HISTOCOMPATIBILITY T, P229; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; FLEISCHHAUER K, 1990, NEW ENGL J MED, V323, P1818, DOI 10.1056/NEJM199012273232607; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KERNAN NA, 1987, TRANSPLANTATION, V43, P842, DOI 10.1097/00007890-198743060-00014; Klein J, 2000, NEW ENGL J MED, V343, P1504; Marsh S. G. E., 2001, Tissue Antigens, V57, P236; McGlave PB, 2000, BLOOD, V95, P2219, DOI 10.1182/blood.V95.7.2219.007k27_2219_2225; Neisig A, 1998, J IMMUNOL, V160, P171; OPELZ G, 1994, NEW ENGL J MED, V330, P816, DOI 10.1056/NEJM199403243301203; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Petersdorf EW, 1997, BLOOD, V89, P1818, DOI 10.1182/blood.V89.5.1818.1818_1818_1823; Petersdorf EW, 1998, BLOOD, V92, P3515, DOI 10.1182/blood.V92.10.3515.422k49_3515_3520; Petersdorf EW, 1996, P NATL ACAD SCI USA, V93, P15358, DOI 10.1073/pnas.93.26.15358; PETERSDORF EW, 1995, BLOOD, V86, P1606, DOI 10.1182/blood.V86.4.1606.bloodjournal8641606; Petersdorf EW, 2001, BRIT J HAEMATOL, V112, P988, DOI 10.1046/j.1365-2141.2001.02655.x; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Schreuder GMT, 1999, HUM IMMUNOL, V60, P1157, DOI 10.1016/S0198-8859(99)00111-1; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Valiante N M, 1997, Biol Blood Marrow Transplant, V3, P229; VANROOD JJ, 1963, J CLIN INVEST, V42, P1382	33	221	230	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2001	345	25					1794	U4		10.1056/NEJMoa011826	http://dx.doi.org/10.1056/NEJMoa011826			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503JF	11752355	Bronze			2022-12-01	WOS:000172794800002
J	Payne, MY				Payne, MY			Too young to be having a heart attack	LANCET			English	Article											Payne, MY (corresponding author), 75 Keel Court, Heathsville, VA 22473 USA.	mpayne@crosslink.net							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S64	S64		10.1016/S0140-6736(01)07076-3	http://dx.doi.org/10.1016/S0140-6736(01)07076-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784613	Bronze			2022-12-01	WOS:000172907200064
J	Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L				Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L			Brief report: Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; HUMAN EMBRYOS; SINGLE CELLS; ANEUPLOIDY; DIAGNOSIS; AMPLIFICATION		Melbourne IVF, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Wilton, L (corresponding author), Melbourne IVF, 320 Victoria Parade, Melbourne, Vic 3002, Australia.							COONEN E, 1994, HUM REPROD, V9, P533, DOI 10.1093/oxfordjournals.humrep.a138540; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Edgar DH, 2000, HUM REPROD, V15, P175, DOI 10.1093/humrep/15.1.175; Fung J, 2000, HUM GENET, V107, P615, DOI 10.1007/s004390000416; Gardner D.K, 2000, HDB VITRO FERTILIZAT, P205; Gianaroli L, 1999, FERTIL STERIL, V72, P837, DOI 10.1016/S0015-0282(99)00377-5; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Kahraman S, 2000, HUM REPROD, V15, P2003, DOI 10.1093/humrep/15.9.2003; Munne S, 1999, HUM REPROD, V14, P2191, DOI 10.1093/humrep/14.9.2191; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Voullaire L, 1999, PRENATAL DIAG, V19, P846, DOI 10.1002/(SICI)1097-0223(199909)19:9<846::AID-PD657>3.0.CO;2-#; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wells D, 1999, NUCLEIC ACIDS RES, V27, P1214, DOI 10.1093/nar/27.4.1214	14	123	154	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1537	1541		10.1056/NEJMoa011052	http://dx.doi.org/10.1056/NEJMoa011052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794220				2022-12-01	WOS:000172265200004
J	Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM				Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM			Promotion of prescription drugs to consumers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Spending on prescription drugs is the fastest growing component of the health care budget. There is public concern about the possibility that direct-to-consumer advertising of prescription drugs will result in inappropriate prescribing and higher costs of care. Guidelines issued in 1997 by the Food and Drug Administration (FDA) regarding advertising to consumers through electronic media are considered by some to be responsible for unleashing a flood of direct-to-consumer advertising. Methods: Using data on spending for promotional purposes and sales of prescription drugs, we examined industrywide trends for various types of promotion. We also tracked the relation between promotional efforts and sales over time. Finally, we documented the variation in direct-to-consumer advertising among and within five therapeutic classes of drugs and compared the variation in the intensity of such advertising with variation in the intensity of promotion to health care professionals. Results: Annual spending on direct-to-consumer advertising for prescription drugs tripled between 1996 and 2000, when it reached nearly $2.5 billion. Despite this increase, such advertising accounts for only 15 percent of the money spent on drug promotion and is highly concentrated on a subgroup of products. Within a therapeutic class, there is marked variation in the intensity of direct-to-consumer advertising, and the amount of such advertising for specific products fluctuates over time. The initial surge in direct-to-consumer advertising preceded the 1997 FDA guidelines that clarified the rules for electronic direct-to-consumer advertising, and thus the 1997 guidelines may not have been the most important reason for the overall increase. Conclusions: Although the use of direct-to-consumer advertising has grown disproportionately to other forms of promotion, it continues to account for a small proportion of total promotional efforts. Nevertheless, physicians must assist patients in evaluating health-related information obtained through direct advertising. (N Engl J Med 2002;346:498-505.) Copyright (C) 2002 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184; Donohue, Julie/0000-0003-2418-6017				[Anonymous], 2001, PREVENTION MAGAZINE, P46; BERNDT ER, 2001, LONG SHADOW PATIENT; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; *J KAIS FAM FDN, 2001, PRESCR DRUG TRENDS C; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; *NIH CAR MAN, 2001, PRESCR DRUG EXP 2000; PASTORE M, 2001, HEALTHCARE WEB ADVER; *PHARM RES MAN AM, 2000, IND PROF 2000; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	10	282	287	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					498	505		10.1056/NEJMsa012075	http://dx.doi.org/10.1056/NEJMsa012075			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521AE	11844852				2022-12-01	WOS:000173815300007
J	Myneni, SCB				Myneni, SCB			Formation of stable chlorinated hydrocarbons in weathering plant material	SCIENCE			English	Article							ABSORPTION	Though several chlorinated organic compounds produced by humans are carcinogenic and toxic, some are also produced by the biotic and abiotic processes in the environment. In situ x-ray spectroscopy data indicate that natural organic matter in soils, sediments, and natural waters contain stable, less volatile organic compounds with chlorinated phenolic and aliphatic groups as the principal Cl forms. These compounds are formed at rapid rates from the transformation of inorganic Cl during humification of plant material and, thus, play a critical role in the cycling of Cl and of several major and trace elements in the environment and may influence human health.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Myneni, SCB (corresponding author), Princeton Univ, Dept Geosci, 151 Guyot Hall, Princeton, NJ 08544 USA.							ASPLUND G, 1991, ENVIRON SCI TECHNOL, V25, P1347; CARLSEN L, 1992, ORG GEOCHEM, V18, P477, DOI 10.1016/0146-6380(92)90110-J; DEJONG E, 1994, APPL ENVIRON MICROB, V60, P271, DOI 10.1128/AEM.60.1.271-277.1994; GRIBBLE GW, 1994, J CHEM EDUC, V71, P907, DOI 10.1021/ed071p907; HOEKSTRA EJ, 1995, CHEM BRIT, V31, P127; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Neidleman SL., 1986, BIOHALOGENATION PRIN; PERERA RCC, 1987, J CHEM PHYS, V86, P4824, DOI 10.1063/1.452675; PERERA RCC, 1991, PHYS REV A, V43, P3609, DOI 10.1103/PhysRevA.43.3609; Porter G, 1996, PURE APPL CHEM, V68, P1683, DOI 10.1351/pac199668091683; Prospero JM, 1999, P NATL ACAD SCI USA, V96, P3396, DOI 10.1073/pnas.96.7.3396; Rompel A, 1997, J AM CHEM SOC, V119, P4465, DOI 10.1021/ja9610951; Salisbury F.B., 1992, PLANT PHYSIOL, V4th ed.; Schwarzenbach RP, 1993, ENV ORGANIC CHEM; SHADLE SE, 1995, J AM CHEM SOC, V117, P2259, DOI 10.1021/ja00113a015; SMITH TA, 1994, J AM CHEM SOC, V116, P3836, DOI 10.1021/ja00088a020; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Stohr J, 2013, SPRINGE SER SURF SCI	19	141	153	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1039	1041		10.1126/science.1067153	http://dx.doi.org/10.1126/science.1067153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799203				2022-12-01	WOS:000173793000056
J	Rich, TH; Vickers-Rich, P; Gangloff, RA				Rich, TH; Vickers-Rich, P; Gangloff, RA			Polar dinosaurs	SCIENCE			English	Editorial Material							VICTORIA		Museum Victoria, Melbourne, Vic 3001, Australia; Monash Univ, Dept Earth Sci, Clayton, Vic 3800, Australia; Univ Alaska Museum, Fairbanks, AK 99775 USA	Museum Victoria; Monash University; University of Alaska System; University of Alaska Fairbanks	Rich, TH (corresponding author), Museum Victoria, POB 666E, Melbourne, Vic 3001, Australia.							Case Judd A., 1998, Journal of Vertebrate Paleontology, V18, p32A; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CLEMENS WA, 1993, GEOLOGY, V21, P503, DOI 10.1130/0091-7613(1993)021<0503:PIOATV>2.3.CO;2; DELAPPARENT AF, 1962, NORSK POLARINST ARBO, V14; DOUGLAS JG, 1982, PALAEOGEOGR PALAEOCL, V39, P171, DOI 10.1016/0031-0182(82)90021-9; GANGLOFF RA, 1998, DAKOTERRA, V5, P79; Gasparini Zulma, 1996, Memoirs of the Queensland Museum, V39, P583; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; Hammer William R., 1999, National Science Museum Monographs, V15, P211; Hotton N., 1980, COLD LOOK WARM BLOOD, P311; Laplace P. S., 1798, TRAITE MECANIQUE CEL, V2; PARRISH JT, 1988, GEOLOGY, V16, P22, DOI 10.1130/0091-7613(1988)016<0022:LCTVAN>2.3.CO;2; Pasch Anne D., 2001, P219; RICH TH, 2000, DINOSAURS DARKNESS; RICH TH, 1997, DINOSAUR ENCY, P562; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1	16	75	79	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					979	980		10.1126/science.1068920	http://dx.doi.org/10.1126/science.1068920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834803				2022-12-01	WOS:000173793000030
J	Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ				Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ			Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1	NATURE			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; FARNESYLTRANSFERASE INHIBITORS; N-RAS; NF1; GENE; CELLS; GAP; IMPAIRMENT; DROSOPHILA	Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans(1). Mice carrying a heterozygous null mutation of the Nf1 gene (Nf1(+/-)) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity(3,4), adenylyl cyclase modulation(5,6) and microtubule binding(7), it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1(+/-) mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1(+/-) mice have increased GABA (gamma-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.	Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychol, Los Angeles, CA 90095 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT)	Silva, AJ (corresponding author), Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA.		Kucherlapati, Raju/ABC-8807-2021; Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Stern, Joel N.H./0000-0002-1259-2256; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Chorvatova A, 2000, ENDOCRINOLOGY, V141, P684, DOI 10.1210/en.141.2.684; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gibbs JB, 1997, CURR OPIN CHEM BIOL, V1, P197, DOI 10.1016/S1367-5931(97)80010-5; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muthalif MM, 2000, HYPERTENSION, V35, P457, DOI 10.1161/01.HYP.35.1.457; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.3.CO;2-A; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; TONG J, 2000, SOC NEUR ABSTR; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Xu HM, 1997, BRAIN RES, V759, P149, DOI 10.1016/S0006-8993(97)00328-4; YAN N, 1995, CANCER RES, V55, P3569	30	416	428	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					526	530		10.1038/nature711	http://dx.doi.org/10.1038/nature711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793011				2022-12-01	WOS:000173564300047
J	Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA				Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA			Genome sequence of the plant pathogen Ralstonia solanacearum	NATURE			English	Article							SYMBIONT SINORHIZOBIUM-MELILOTI; PSEUDOMONAS-SOLANACEARUM; SECRETION APPARATUS; ESCHERICHIA-COLI; PROTEINS; VIRULENCE; GENES; BACTERIA; HRP; IDENTIFICATION	Ralstonia solanacearum is a devastating, soil-borne plant pathogen with a global distribution and an unusually wide host range. It is a model system for the dissection of molecular determinants governing pathogenicity. We present here the complete genome sequence and its analysis of strain GMI1000. The 5.8-megabase (Mb) genome is organized into two replicons: a 3.7-Mb chromosome and a 2.1-Mb megaplasmid. Both replicons have a mosaic structure providing evidence for the acquisition of genes through horizontal gene transfer. Regions containing genetically mobile elements associated with the percentage of G+C bias may have an important function in genome evolution. The genome encodes many proteins potentially associated with a role in pathogenicity. In particular, many putative attachment factors were identified. The complete repertoire of type III secreted effector proteins can be studied. Over 40 candidates were identified. Comparison with other genomes suggests that bacterial plant pathogens and animal pathogens harbour distinct arrays of specialized type III-dependent effectors.	INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Fdn Jean Dausset, CEPH, F-75010 Paris, France; CNRS, LMGM, F-31062 Toulouse, France; INRA, URGV, F-91057 Evry, France; INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; INRA, Unite Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Foundation Jean Dausset-CEPH; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Boucher, CA (corresponding author), INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, BP27, F-31326 Castanet Tolosan, France.	boucher@toulouse.inra.fr	Arlat, Matthieu/CAH-3310-2022; Thébault, Patricia/AAD-1105-2020; Gaspin, Christine/B-6756-2015; Gouzy, Jerome/AAH-4977-2020	Thébault, Patricia/0000-0003-2276-4573; Gouzy, Jerome/0000-0001-5695-4557; Cunnac, Sebastien/0000-0002-3695-491X; Arlat, Matthieu/0000-0001-6196-4856; Lavie, Muriel/0000-0003-3308-811X; Genin, Stephane/0000-0003-2498-2400; Chandler, Michael/0000-0002-0292-6662; CHOISNE, Nathalie/0000-0001-6024-1664				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 1996, PLANT CELL, V8, P1683, DOI 10.1105/tpc.8.10.1683; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; Boucher C. A., 1988, Molecular Plant-Microbe Interactions, V1, P282, DOI 10.1094/MPMI-1-282; BRUMBLEY SM, 1993, J BACTERIOL, V175, P5477, DOI 10.1128/JB.175.17.5477-5487.1993; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Ezra D, 2000, MOL PLANT MICROBE IN, V13, P683, DOI 10.1094/MPMI.2000.13.6.683; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; FISCHER RA, 1922, J R STAT SOC, V85, P87; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; GRANADA GA, 1983, CAN J MICROBIOL, V29, P433, DOI 10.1139/m83-070; Gueneron M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/j.1365-2958.2000.01870.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYWARD A. C., 2000, ENCY MICROBIOLOGY, V4, P32; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karp PD, 1999, NUCLEIC ACIDS RES, V27, P55, DOI 10.1093/nar/27.1.55; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Leach JE, 1996, ANNU REV PHYTOPATHOL, V34, P153, DOI 10.1146/annurev.phyto.34.1.153; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Matthysse AG, 2000, BBA-GENE STRUCT EXPR, V1490, P208, DOI 10.1016/S0167-4781(99)00250-X; Merlin C, 1997, MOL GEN GENET, V253, P499; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; ROSENBERG C, 1982, J BACTERIOL, V150, P402, DOI 10.1128/JB.150.1.402-406.1982; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith E. F., 1896, US DEP AGR DIV VEG P, P1; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thebaut P, 2000, JOBIM C P, P361; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x	47	698	1400	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					497	502		10.1038/415497a	http://dx.doi.org/10.1038/415497a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823852	Bronze			2022-12-01	WOS:000173564300038
J	Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG				Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG			Systems analysis of Ran transport	SCIENCE			English	Article							PORE COMPLEX PROTEIN; BINDING PROTEIN; NUCLEAR IMPORT; RCC1; GTPASE; NTF2; ACTIVATION; MECHANISM; BETA; P62	The separate components of nucleocytoplasmic transport have been well characterized, including the key regulatory rote of Ran, a guanine nucleotide triphosphatase. However, the overall system behavior in intact cells is difficult to analyze because the dynamics of these components are interdependent. We used a combined experimental and computational approach to study Ran transport in vivo. The resulting model provides the first quantitative picture of Ran flux between the nuclear and cytoplasmic compartments in eukaryotic cells. The model predicts that the Ran exchange factor RCC1, and not the flux capacity of the nuclear pore complex (NPC), is the crucial regulator of steady-state flux across the NPC. Moreover, it provides the first estimate of the total in vivo flux (520 molecules per NPC per second and predicts that the transport system is robust.	Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Connecticut, Ctr Hlth, Ctr Biomed Imaging Technol, Farmington, CT 06030 USA	University of Virginia; University of Virginia; University of Connecticut	Macara, IG (corresponding author), Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.			Loew, Leslie/0000-0002-1851-4646	NCRR NIH HHS [NCRR-RR13186] Funding Source: Medline; NIGMS NIH HHS [GM-50526, NIH-GM-20438] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; CLARKE PR, 1995, J CELL SCI, V108, P1217; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Fink C, 1998, BIOPHYS J, V75, P1648, DOI 10.1016/S0006-3495(98)77607-6; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Schaff JC, 2000, METHOD ENZYMOL, V321, P1; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Smith W, 1998, PIANO KEYBOARD, V1, P8	21	150	156	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					488	491		10.1126/science.1064732	http://dx.doi.org/10.1126/science.1064732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799242				2022-12-01	WOS:000173350700048
J	Donaldson, GC; Keatinge, WR				Donaldson, GC; Keatinge, WR			Excess winter mortality: influenza or cold stress? Observational study	BRITISH MEDICAL JOURNAL			English	Article							DISEASE		Univ London Queen Mary & Westfield Coll, Div Biomed Sci, London E1 4NS, England	University of London; Queen Mary University London	Keatinge, WR (corresponding author), Univ London Queen Mary & Westfield Coll, Div Biomed Sci, Mile End Rd, London E1 4NS, England.		Donaldson, Gavin/M-7992-2017	Donaldson, Gavin/0000-0002-5538-4190				Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1986, BRIT MED J, V293, P732, DOI 10.1136/bmj.293.6549.732-a; KHAW KT, 1995, BRIT MED J, V310, P1559, DOI 10.1136/bmj.310.6994.1559	5	65	68	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					89	90		10.1136/bmj.324.7329.89	http://dx.doi.org/10.1136/bmj.324.7329.89			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786453	Bronze, Green Published			2022-12-01	WOS:000173325400018
J	van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP				van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP			Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study	LANCET			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; INTIMA-MEDIA THICKNESS; BINDING CASSETTE TRANSPORTER-1; GROWTH EVALUATION STATIN; ATHEROSCLEROSIS RISK; TANGIER-DISEASE; HDL CHOLESTEROL; CAROTID-ARTERY; ABC1 GENE	Background Decreased concentrations of HDL cholesterol are associated with increased cardiovascular risk. These concentrations are directly related to cholesterol efflux from cells-the first step and a key process in reverse cholesterol transport. Cholesterol efflux is mediated by the ATP-binding cassette A1 transporter (ABCA1), the rate-limiting step in the production of HDL. We aimed to assess the relation between cholesterol efflux, HDL concentrations, and arterial-wall changes in individuals with impaired ABCA1 function. Methods We investigated 30 individuals from families with ABCA1 mutations, and 110 controls matched for age, sex, and ethnic origin. We measured concentrations of HDL cholesterol in plasma and intima-media thickness of the carotid arteries by B-mode ultrasonography in all participants, We also measured cholesterol efflux from skin fibroblasts in nine individuals with ABCA1 mutations and in ten controls. Findings Individuals with ABCA1 mutations had lower amounts of cholesterol efflux, lower HDL cholesterol concentrations, and-greater intima-media thicknesses than controls. An intima-media thickness at the upper limit of normal (0.80 mm) was reached by age 55 years in the ABCA1 heterozygotes, and at age 80 years in unaffected controls (p<0.0001). Additionally, strong positive correlations were seen between HDL cholesterol concentrations and cholesterol efflux (r=0.90, p=0.001), and negative correlations between apolipoprotein-Al-mediated (r=-0.61, p=0.030) and HDL-particle-mediated (r=-0.60, p=0.018) efflux and intima-media thickness in the ABCA1 mutation carriers. Interpretation These results show a direct relation between ABCA1-mediated cellular cholesterol efflux and arterial-wall thickness, and therefore suggest that increasing efflux could inhibit atherosclerosis progression before the manifestation of symptomatic cardiovascular disease.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Expt Hematol, NL-1105 AZ Amsterdam, Netherlands; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; Xenon Genet, Vancouver, BC, Canada; Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Internal Med, NL-2300 RA Leiden, Netherlands; Univ Groningen Hosp, Dept Internal Med, NL-9713 EZ Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Clee, Susanne/F-7312-2010; Kastelein, John/AAF-7950-2020; van Dam, Marjel/AFT-3071-2022; Clee, Susanne/AAC-4278-2020; Hayden, Michael R/D-8581-2011; Brooks-Wilson, Angela/E-9399-2012	Clee, Susanne/0000-0001-7946-688X; Hayden, Michael R/0000-0001-5159-1419; Brooks-Wilson, Angela/0000-0003-1009-6408; van Dam, Marjel/0000-0001-9802-7516				Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOTS ML, 1992, HYPERTENSION, V19, P717, DOI 10.1161/01.HYP.19.6.717; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chambless LE, 1996, ULTRASOUND MED BIOL, V22, P545, DOI 10.1016/0301-5629(96)00039-7; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Clee SM, 2001, CIRCULATION, V103, P1198; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; de Groot E, 1998, ULTRASOUND MED BIOL, V24, P825, DOI 10.1016/S0301-5629(98)00037-4; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glomset J A, 1973, Adv Lipid Res, V11, P1; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; MILLER GJ, 1975, LANCET, V1, P16; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Owen JS, 1999, LANCET, V354, P1402, DOI 10.1016/S0140-6736(99)00297-4; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Smilde TJ, 2000, EUR J CLIN INVEST, V30, P473; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; STOK WJ, 2001, 3 C PULS WAV AN LOND; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983	31	169	172	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					37	41		10.1016/S0140-6736(02)07277-X	http://dx.doi.org/10.1016/S0140-6736(02)07277-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809185				2022-12-01	WOS:000173143500014
J	Yan, H; Zhang, XP; Shen, ZY; Seeman, NC				Yan, H; Zhang, XP; Shen, ZY; Seeman, NC			A robust DNA mechanical device controlled by hybridization topology	NATURE			English	Article							DOUBLE-CROSSOVER MOLECULES; LIGATION; DESIGN	Controlled mechanical movement in molecular-scale devices has been realized in a variety of systems-catenanes and rotaxanes(1-3), chiroptical molecular switches(4), molecular ratchets(5) and DNA(6)- by exploiting conformational changes triggered by changes in redox potential or temperature, reversible binding of small molecules or ions, or irradiation. The incorporation of such devices into arrays(7,8) could in principle lead to complex structural states suitable for nanorobotic applications, provided that individual devices can be addressed separately. But because the triggers commonly used tend to act equally on all the devices that are present, they will need to be localized very tightly. This could be readily achieved with devices that are controlled individually by separate and device-specific reagents. A trigger mechanism that allows such specific control is the reversible binding of DNA strands, thereby 'fuelling' conformational changes in a DNA machine(9). Here we improve upon the initial prototype system that uses this mechanism but generates by-products(9), by demonstrating a robust sequence-dependent rotary DNA device operating in a four-step cycle. We show that DNA strands control and fuel our device cycle by inducing the interconversion between two robust topological motifs, paranemic crossover (PX) DNA(10,11) and its topoisomer JX(2) DNA, in which one strand end is rotated relative to the other by 180 degrees. We expect that a wide range of analogous yet distinct rotary devices can be created by changing the control strands and the device sequences to which they bind.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.							Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Pease AR, 2001, ACCOUNTS CHEM RES, V34, P433, DOI 10.1021/ar000178q; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2001, NANO LETT, V1, P22, DOI 10.1021/nl000182v; Shen Z, 1999, THESIS NEW YORK U; Sun WQ, 1999, J MOL BIOL, V294, P683, DOI 10.1006/jmbi.1999.3155; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yang XP, 1998, J AM CHEM SOC, V120, P9779, DOI 10.1021/ja9817601; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	16	623	644	7	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					62	65		10.1038/415062a	http://dx.doi.org/10.1038/415062a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780115				2022-12-01	WOS:000173028800038
J	Silver, DL; Montell, DJ				Silver, DL; Montell, DJ			Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila	CELL			English	Article							FOCAL ADHESION KINASE; JAK-STAT PATHWAY; CONSTITUTIVE ACTIVATION; IN-VIVO; PROTEIN; GENE; MIGRATION; OOGENESIS; ENCODES; C/EBP	The JAK/STAT signaling pathway, renowned for its effects on cell proliferation and survival, is constitutively active in various human cancers, including ovarian. We have found that JAK and STAT are required to convert the border cells in the Drosophila ovary from stationary, epithelial cells to migratory, invasive cells. The ligand for this pathway, Unpaired (UPD), is expressed by two central cells within the migratory cell cluster. Mutations in upd or jak cause defects in migration and a reduction in the number of cells recruited to the cluster. Ectopic expression of either UPD or JAK is sufficient to induce extra epithelial cells to migrate. Thus, a localized signal activates the JAK/ STAT pathway in neighboring epithelial cells, causing them to become invasive.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Silver, Debra/0000-0001-9189-844X	NIGMS NIH HHS [GM 46425] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R29GM046425] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010; DAMELL JE, 1997, SCIENCE, V277, P1630; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Han DD, 2000, DEVELOPMENT, V127, P573; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jinks TM, 2000, MOL CELL, V5, P581, DOI 10.1016/S1097-2765(00)80451-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu YR, 1999, DEVELOPMENT, V126, P1869; Liu YR, 2001, DEVELOPMENT, V128, P321; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; MCGREGOR JR, 2002, IN PRESS DEVELOPMENT; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Montell DJ, 2001, MECH DEVELOP, V105, P19, DOI 10.1016/S0925-4773(01)00393-8; Montell DJ, 1999, DEVELOPMENT, V126, P3035; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Rorth P, 2000, MOL CELL, V6, P23; RORTH P, 1992, GENE DEV, V6, P2299, DOI 10.1101/gad.6.12a.2299; Rorth P, 1998, DEVELOPMENT, V125, P1049; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Spradling Allan C., 1993, P1; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	51	227	229	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					831	841		10.1016/S0092-8674(01)00607-9	http://dx.doi.org/10.1016/S0092-8674(01)00607-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779460	Bronze			2022-12-01	WOS:000173024200005
J	Al-Shahi, R; Will, RG; Warlow, CP				Al-Shahi, R; Will, RG; Warlow, CP			Amount of research interest in rare and common neurological conditions: bibliometric study	BRITISH MEDICAL JOURNAL			English	Article									Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Warlow, CP (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.			Al-Shahi Salman, Rustam/0000-0002-2108-9222				Frankel S, 1989, Health Trends, V21, P56; Global Forum for Health Research, 2000, 10 90 REP HLTH RES; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; WARLOW CP, 2001, BRAINS DIS NERVOUS S	5	18	18	3	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2001	323	7327					1461	1462		10.1136/bmj.323.7327.1461	http://dx.doi.org/10.1136/bmj.323.7327.1461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506PA	11751355	Green Submitted, Green Published			2022-12-01	WOS:000172979900015
J	Eagles, JM				Eagles, JM			SAD - help arrives with the dawn?	LANCET			English	Editorial Material							WINTER DEPRESSION; LIGHT; SIMULATION		Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland		Eagles, JM (corresponding author), Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland.							Ando K, 1996, BIOL PSYCHIAT, V39, P22, DOI 10.1016/0006-3223(95)00109-3; Avery DH, 2001, BIOL PSYCHIAT, V50, P205, DOI 10.1016/S0006-3223(01)01200-8; Brainard GC, 2001, J NEUROSCI, V21, P6405; Eagles JM, 1999, BRIT J PSYCHIAT, V175, P472, DOI 10.1192/bjp.175.5.472; Lewy AJ, 1998, ARCH GEN PSYCHIAT, V55, P890, DOI 10.1001/archpsyc.55.10.890; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lingjaerde O, 1998, ACTA PSYCHIAT SCAND, V98, P73, DOI 10.1111/j.1600-0447.1998.tb10045.x; Michalak EE, 2001, BRIT J PSYCHIAT, V179, P31, DOI 10.1192/bjp.179.1.31; TERMAN M, 1989, BIOL PSYCHIAT, V25, P966, DOI 10.1016/0006-3223(89)90276-X; THOMPSON C, 2001, SEASONAL AFFECTIVE D, P151	10	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2100	2100		10.1016/S0140-6736(01)07232-4	http://dx.doi.org/10.1016/S0140-6736(01)07232-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784620				2022-12-01	WOS:000172905800005
J	Pepperberg, DR; Crouch, RK				Pepperberg, DR; Crouch, RK			An illuminating new step in visual-pigment regeneration	LANCET			English	Editorial Material									Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina	Pepperberg, DR (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.							Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/ng0501-92; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	14	15	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2098	2099		10.1016/S0140-6736(01)07231-2	http://dx.doi.org/10.1016/S0140-6736(01)07231-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784619				2022-12-01	WOS:000172905800004
J	Garcia, LR; Mehta, P; Sternberg, PW				Garcia, LR; Mehta, P; Sternberg, PW			Regulation of distinct muscle behaviors controls the C. elegans male's copulatory spicules during mating	CELL			English	Article							LEVAMISOLE RESISTANCE; SYNAPTIC-TRANSMISSION; GENE-TRANSFER; MUTANTS; MUTATIONS; G(Q)ALPHA; ENCODES; CELLS; INTERACTS	We demonstrate through cell ablation, molecular genetic, and pharmacological approaches that during C. elegans male mating behavior, the male inserts his copulatory spicules into the hermaphrodite by regulating periodic and prolonged spicule muscle contractions. Distinct cholinergic neurons use different ACh receptors and calcium channels in the spicule muscles to mediate these contractile behaviors. The PCB and PCC sensory neurons facilitate periodic contraction through muscle-encoded UNC-68 ryanodine receptor calcium channels. The SPC motor neurons trigger prolonged contraction through EGL-19 L-type voltage-gated calcium channels. The male gonad then lengthens the duration of EGL-19-mediated prolonged muscle contraction. This regulation of muscle contraction provides a paradigm to explain how animals initiate, monitor, and maintain a behavioral motor program.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu						ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; FINNEY D J, 1971, P333; Fleming JT, 1997, J NEUROSCI, V17, P5843; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller LM, 1996, GENETICS, V143, P1181; Moerman Donald G., 1997, Cold Spring Harbor Monograph Series, V33, P417; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TRENT C, 1983, GENETICS, V104, P619; TRIBUT F, 1994, J EXP BIOL, V186, P325; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475	43	81	82	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					777	788		10.1016/S0092-8674(01)00600-6	http://dx.doi.org/10.1016/S0092-8674(01)00600-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747813	Bronze			2022-12-01	WOS:000172771800010
J	Feldman, KA; Enscore, RE; Lathrop, SL; Matyas, BT; McGuill, M; Schriefer, ME; Stiles-Enos, D; Dennis, DT; Petersen, LR; Hayes, EB				Feldman, KA; Enscore, RE; Lathrop, SL; Matyas, BT; McGuill, M; Schriefer, ME; Stiles-Enos, D; Dennis, DT; Petersen, LR; Hayes, EB			An outbreak of primary pneumonic tularemia on martha's vineyard	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: In the summer of 2000, an outbreak of primary pneumonic tularemia occurred on Martha's Vineyard, Massachusetts. The only previously reported outbreak of pneumonic tularemia in the United States also occurred on the island in 1978. Methods: We conducted a case-control study of adults with pneumonic tularemia and investigated the environment to identify risk factors for primary pneumonic tularemia. Patients with confirmed cases were residents of or visitors to Martha's Vineyard who had symptoms suggestive of primary pneumonic tularemia, were ill between May 15 and October 31, 2000, and had a positive laboratory test for tularemia. Controls were adults who had spent at least 15 days on Martha's Vineyard between May 15 and September 28, 2000. Results: We identified 15 patients with tularemia; 11 of these cases were primary pneumonic tularemia. Francisella tularensis type A was isolated from blood and lung tissue of the one man who died. Patients were more likely than controls to have used a lawn mower or brush cutter in the two weeks before the illness (odds ratio, 9.2; 95 percent confidence interval, 1.6 to 68.0) and during the summer (odds ratio, undefined; 95 percent confidence interval, 1.8 to (infinity)). Lawn mowing and brush cutting remained significant risk factors after adjustment for other potentially confounding variables. Only one patient reported being exposed to a rabbit while cutting brush. Of 40 trapped animals, 1 striped skunk and 1 Norway rat were seropositive for antibodies against F. tularensis. Conclusions: Study of this outbreak of primary pneumonic tularemia implicates lawn mowing and brush cutting as risk factors for this infection. (N Engl J Med 2001;345:1601-6.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Ft Collins, CO 80522 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Ft Collins, CO 80522 USA; Massachusetts Dept Publ Hlth, Boston, MA USA; Marthas Vineyard Hosp, Oak Bluffs, MA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health	Feldman, KA (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, POB 2087,Rampart Rd, Ft Collins, CO 80522 USA.			Enscore, Russell/0000-0002-1290-1100				[Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; AYRES JC, 1948, NEW ENGL J MED, V238, P187, DOI 10.1056/NEJM194802052380606; Belding DL, 1941, NEW ENGL J MED, V224, P1085, DOI 10.1056/NEJM194106262242602; BELL J F, 1975, Journal of Wildlife Diseases, V11, P421; BELL JF, 1979, CRC HDB SERIES ZOO A, V2, P161; BROWN SL, 1980, J CLIN MICROBIOL, V11, P146, DOI 10.1128/JCM.11.2.146-148.1980; DAHLSTRAND S, 1971, Scandinavian Journal of Infectious Diseases, V3, P7; DEAN A, 1995, EPI INFO VERSION 6 W; DENNIS DT, 1999, INFECT DIS; DENNIS DT, 1998, MAXCY ROSENAU LAST P, P354; HALSTED CC, 1978, PEDIATRICS, V61, P660; Hopla CE, 1994, HDB ZOONOSES, P113; Hornick R. B., 1998, BACTERIAL INFECT HUM, P823; Jellison W.L., 1974, TULAREMIA N AM 1930; LENHART SW, 1997, DHHS PUBLICATION; MARTONE WJ, 1979, JAMA-J AM MED ASSOC, V242, P2315, DOI 10.1001/jama.242.21.2315; MCCARTHY VP, 1990, PEDIATR INFECT DIS J, V9, P298, DOI 10.1097/00006454-199004000-00018; MCDOWELL JW, 1964, TULAREMIA; MEHTA C, 1992, STATXACT VERSION 4 0; Murin S, 2000, CLIN CHEST MED, V21, P121, DOI 10.1016/S0272-5231(05)70012-5; PARKER RR, 1951, NATL I HLTH B, V193, P1; PENN RL, 1995, MANDELL DOUGLAS BENN, V2, P2060; PITTMAN B, 1977, J CLIN MICROBIOL, V5, P621; POMANSKAIA L. A., 1957, Journal of Microbiology, Epidemiology and Immunobiology, V28, P597; *SAS I, 1996, SAS VERS 6 12; SMITH CN, 1946, BIOL CONTROL AM DOG; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; Williams J, 1998, LANCET, V351, P1697, DOI 10.1016/S0140-6736(97)10444-5; 1993, MMWR MORB MORTAL WKL, V42, P1	29	198	205	0	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2001	345	22					1601	1606		10.1056/NEJMoa011374	http://dx.doi.org/10.1056/NEJMoa011374			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496EU	11757506				2022-12-01	WOS:000172383900003
J	Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE				Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE			Regulatory role of SGT1 in early R gene-mediated plant defenses	SCIENCE			English	Article							DISEASE RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; EDS1; DEGRADATION; EXPRESSION; PROTEINS	Animal SGT1 is a component of Skp1-Cullin-F-box protein (SCF) ubiquitin ligases that target regulatory proteins for degradation. Mutations in one (SGT1b) of two highly homologous Arabidopsis SGT1 genes disable early plant defenses conferred by multiple resistance (R) genes. Loss of SGT1b function in resistance is not compensated for by SGT1a. R genes differ in their requirements for SGT1b and a second resistance signaling gene, RAR1, that was previously implicated as an SGT1 interactor. Moreover, SGT1b and RAR1 contribute additively to RPP5-mediated pathogen recognition. These data imply both operationally distinct and cooperative functions of SGT1 and RAR1 in plant disease resistance.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society	Parker, JE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	parker@mpiz-koeln.mpg.de	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Austin, Mark/0000-0003-4943-7265				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Andrade MA, 2001, PLANT MOL BIOL, V46, P603, DOI 10.1023/A:1010650809272; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Inohara N, 2000, J BIOL CHEM, V275, P27823; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MUSKETT P, IN PRESS PLANT CELL; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6	23	331	369	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2077	2080		10.1126/science.1067747	http://dx.doi.org/10.1126/science.1067747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847308				2022-12-01	WOS:000174450500050
J	Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ				Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ			Role of Escherichia coli curli operons in directing amyloid fiber formation	SCIENCE			English	Article							THIN AGGREGATIVE FIMBRIAE; FIBRONECTIN-BINDING CURLI; SALMONELLA-ENTERITIDIS; ALZHEIMERS-DISEASE; SURFACE ORGANELLES; PEPTIDES; CSGB	Amyloid is associated with debilitating human ailments including Alzheimer's and prion diseases. Biochemical, biophysical, and imaging analyses revealed that fibers produced by Escherichia coli called curli were amyloid. The CsgA curlin subunit, purified in the absence of the CsgB nucleator, adopted a soluble, unstructured form that upon prolonged incubation assembled into fibers that were indistinguishable from curli. In vivo, curli biogenesis was dependent on the nucleation-precipitation machinery requiring the CsgE and CsgF chaperone-like and nucleator proteins, respectively. Unlike eukaryotic amyloid formation, curli biogenesis is a productive pathway, requiring a specific assembly machinery.	Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Karolinska Inst, Dept Microbiol, S-171777 Stockholm, Sweden; Karolinska Inst, Tumorbiol Ctr, S-171777 Stockholm, Sweden	Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Karolinska Institutet	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, Box 8230, St Louis, MO 63110 USA.		Hammar, Mats/R-7908-2019	Hammar, Mats/0000-0002-4593-7273; Chapman, Matthew/0000-0002-2645-1294	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010502, R01AI029549, R01AI048689, R37AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48689, F32 AI010502, AI29549, R37 AI029549, 1 F32 AI10502-01A1, R01 AI048689, R01 AI029549, F32 AI010502-03] Funding Source: Medline; NIA NIH HHS [NIA P50 AG05681-17, P50 AG005681] Funding Source: Medline; NIDDK NIH HHS [R01 DK051406, DK51406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; CHAPMAN M, UNPUB; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; HUESER JE, 1987, J MUSCLE RES CELL M, V8, P303; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, INFECT AGENT DIS, V2, P272; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998	17	897	934	7	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					851	855		10.1126/science.1067484	http://dx.doi.org/10.1126/science.1067484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823641	Green Accepted			2022-12-01	WOS:000173733000044
J	Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ				Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ			Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin	NATURE			English	Article							ELECTRON-DENSITY MAPS; BORDETELLA-PERTUSSIS; BACILLUS-ANTHRACIS; X-RAY; PHOSPHORYLASE-KINASE; CATALYTIC MECHANISM; PEPTIDE COMPLEX; EDEMA FACTOR; BINDING; DOMAIN	Oedema factor, a calmodulin-activated adenylyl cyclase, is important in the pathogenesis of anthrax. Here we report the X-ray structures of oedema factor with and without bound calmodulin. Oedema factor shares no significant structural homology with mammalian adenylyl cyclases or other proteins. In the active site, 39-deoxy-ATP and a single metal ion are well positioned for catalysis with histidine 351 as the catalytic base. This mechanism differs from the mechanism of two-metal-ion catalysis proposed for mammalian adenylyl cyclases. Four discrete regions of oedema factor form a surface that recognizes an extended conformation of calmodulin, which is very different from the collapsed conformation observed in other structures of calmodulin bound to effector peptides. On calmodulin binding, an oedema factor helical domain of relative molecular mass 15,000 undergoes a 15 Angstrom translation and a 30degrees rotation away from the oedema factor catalytic core, which stabilizes a disordered loop and leads to enzyme activation. These allosteric changes provide the first molecular details of how calmodulin modulates one of its targets.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Boston Biomed Res Inst, Watertown, MA 02472 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	University of Chicago; University of Chicago; Boston Biomedical Research Institute; Tufts University	Tang, WJ (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.	bohm@bbri.org; wtang@midway.uchicago.edu	Drum, Chester/A-6089-2015	Drum, Chester/0000-0001-6327-4584; Grabarek, Zenon/0000-0002-3636-5701; Tang, Wei-Jen/0000-0002-8267-8995				BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drum CL, 2001, ACTA CRYSTALLOGR D, V57, P1881, DOI 10.1107/S0907444901014937; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eldik LV, 1998, CALMODULIN SIGNAL TR; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FARRAR YJK, 1993, J BIOL CHEM, V268, P4120; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1991, EMBO J, V10, P1683, DOI 10.1002/j.1460-2075.1991.tb07692.x; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LABRUYERE E, 1990, BIOCHEMISTRY-US, V29, P4922, DOI 10.1021/bi00472a024; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; MUNIER H, 1995, ARCH BIOCHEM BIOPHYS, V320, P224, DOI 10.1016/0003-9861(95)90004-7; MUNIER H, 1992, J BIOL CHEM, V267, P9816; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	51	332	348	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					396	402		10.1038/415396a	http://dx.doi.org/10.1038/415396a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807546				2022-12-01	WOS:000173433600041
J	Jackson, BE; McInerney, MJ				Jackson, BE; McInerney, MJ			Anaerobic microbial metabolism can proceed close to thermodynamic limits	NATURE			English	Article							SYNTROPHIC ASSOCIATION; BENZOATE DEGRADATION; ENERGETICS; BACTERIUM; OXIDATION; GROWTH	Many fermentative bacteria obtain energy for growth by reactions in which the change in free energy (DeltaG') is less than that needed to synthesize ATP(1-4). These bacteria couple substrate metabolism directly to ATP synthesis, however, by classical phosphoryl transfer reactions(4,5). An explanation for the energy economy of these organisms is that biological systems conserve energy in discrete amounts(3,)4, with a minimum, biochemically convertible energy value of about -20 kJ mol(-1) (refs(1-3)). This concept predicts that anaerobic substrate decay ceases before the minimum free energy value is reached, and several studies support this prediction(1,6-9). Here we show that metabolism by syntrophic associations, in which the degradation of a substrate by one species is thermodynamically possible only through removal of the end product by another species(1), can occur at values close to thermodynamic equilibrium (DeltaG' approximate to0 kJ mol(-1)). The free energy remaining when substrate metabolism halts is not constant; it depends on the terminal electron-accepting reaction and the amount of energy required for substrate activation. Syntrophic associations metabolize near thermodynamic equilibrium, indicating that bacteria operate extremely efficient catabolic systems.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	McInerney, MJ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, 770 Van Vleet Oval, Norman, OK 73019 USA.	mcinerney@ou.edu	McInerney, Michael J/E-6215-2012					AUBURGER G, 1992, APPL MICROBIOL BIOT, V37, P789, DOI 10.1007/BF00174847; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Christensen TH, 2000, J CONTAM HYDROL, V45, P165, DOI 10.1016/S0169-7722(00)00109-1; COUTTS DAP, 1987, J APPL BACTERIOL, V62, P251, DOI 10.1111/j.1365-2672.1987.tb02406.x; Cramer W.A., 1990, ENERGY TRANSDUCTION; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; DWYER DF, 1988, APPL ENVIRON MICROB, V54, P1354, DOI 10.1128/AEM.54.6.1354-1359.1988; Elshahed MS, 2001, APPL ENVIRON MICROB, V67, P1728, DOI 10.1128/AEM.67.4.1728-1738.2001; Harwood CS, 1997, J BACTERIOL, V179, P301, DOI 10.1128/jb.179.2.301-309.1997; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1111/j.1574-6976.1998.tb00380.x; JACKSON BE, 1999, THESIS U OKLAHOMA; JETTEN MSM, 1991, FEMS MICROBIOL LETT, V84, P313, DOI 10.1111/j.1574-6968.1991.tb04616.x; KAISER JL, 1982, ARCH MICROBIOL, V133, P384; Kleerebezem R, 2000, BIOTECHNOL BIOENG, V67, P529, DOI 10.1002/(SICI)1097-0290(20000305)67:5<529::AID-BIT4>3.0.CO;2-Q; MALONEY PC, 1983, J BACTERIOL, V153, P1461, DOI 10.1128/JB.153.3.1461-1470.1983; McInerney M.J., 1981, BIOMASS CONVERS PROC, P277, DOI DOI 10.1007/978-1-4757-0301-6_15; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B., 1988, NAT REV MICROBIOL, P5; Schocke L, 1997, MICROBIOL-UK, V143, P2345, DOI 10.1099/00221287-143-7-2345; Scholten JCM, 2000, APPL ENVIRON MICROB, V66, P2934, DOI 10.1128/AEM.66.7.2934-2942.2000; Seiler W., 1980, ATMOS TECHNOL, V12, P40; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P82, DOI 10.1007/BF00291279; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thauer R. K., 1984, S SOC GEN MICROBIOL, P123; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Warikoo V, 1996, APPL ENVIRON MICROB, V62, P26, DOI 10.1128/AEM.62.1.26-32.1996; WOFFORD NQ, 1986, J BACTERIOL, V167, P179, DOI 10.1128/jb.167.1.179-185.1986; [No title captured]	30	187	197	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					454	456		10.1038/415454a	http://dx.doi.org/10.1038/415454a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807560				2022-12-01	WOS:000173433600056
J	Raji, A				Raji, A			The body politic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					286	286		10.1001/jama.287.3.286	http://dx.doi.org/10.1001/jama.287.3.286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790190				2022-12-01	WOS:000173294700001
J	Glasauer, S; Langley, S; Beveridge, TJ				Glasauer, S; Langley, S; Beveridge, TJ			Intracellular iron minerals in a dissimilatory iron-reducing bacterium	SCIENCE			English	Article							REDUCTION; FE3O4; FE3S4	Among prokaryotes, there are few examples of controlled mineral formation; the formation of crystalline iron oxides and sulfides [magnetite (Fe3O4) or greigite (Fe3S4)] by magnetotactic bacteria is an exception. Shewanella putrefaciens CN32, a Gram-negative, facultative anaerobic bacterium that is capable of dissimilatory iron reduction, produced microscopic intracellular grains of iron oxide minerals during growth on two-line ferrihydrite in a hydrogen-argon atmosphere. The minerals, formed at iron concentrations found in the soil and sedimentary environments where these bacteria are active, could represent an unexplored pathway for the cycling of iron by bacteria.	Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	University of Guelph	Glasauer, S (corresponding author), Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada.		Glasauer, Susan/AAY-6599-2021					BAUMINGER ER, 1980, BIOCHIM BIOPHYS ACTA, V623, P237, DOI 10.1016/0005-2795(80)90252-4; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; BEVERIDGE TJ, 1989, BACTERIA NATURE, V3, P1; Cornell RM., 1997, IRON OXIDES STRUCTUR, V39, P1499, DOI [10.1016/S0010-938X(97)00096-6, DOI 10.1016/S0010-938X(97)00096-6]; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; KUTERBACH DA, 1982, SCIENCE, V218, P695, DOI 10.1126/science.218.4573.695; MEYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; STEIFEL EI, 1979, NATURE, V279, P81; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; Vainshtein MB, 1998, MICROBIOLOGY+, V67, P670	16	125	137	6	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					117	119		10.1126/science.1066577	http://dx.doi.org/10.1126/science.1066577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778045				2022-12-01	WOS:000173143100046
J	Skjaerven, R; Wilcox, AJ; Lie, RT				Skjaerven, R; Wilcox, AJ; Lie, RT			The interval between pregnancies and the risk of preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; PRE-ECLAMPSIA; PRETERM DELIVERY; PATERNITY; WOMEN; ABORTION; SMOKING; DONOR	Background: The risk of preeclampsia is generally lower in second pregnancies than in first pregnancies, but not if the mother has a new partner for the second pregnancy. One explanation is that the risk is reduced with repeated maternal exposure and adaptation to specific antigens from the same partner. However, the difference in risk might instead be explained by the interval between births. A longer interbirth interval may be associated with both a change of partner and a higher risk of preeclampsia. Methods: We used data from the Medical Birth Registry of Norway, a population-based registry that includes births that occurred between 1967 and 1998. We studied 551,478 women who had two or more singleton deliveries and 209,423 women who had three or more singleton deliveries. Results: Preeclampsia occurred during 3.9 percent of first pregnancies, 1.7 percent of second pregnancies, and 1.8 percent of third pregnancies when the woman had the same partner. The risk in a second or third pregnancy was directly related to the time that had elapsed since the preceding delivery, and when the interbirth interval was 10 years or more, the risk approximated that among nulliparous women. After adjustment for the presence or absence of a change of partner, maternal age, and year of delivery, the odds ratio for preeclampsia for each one-year increase in the interbirth interval was 1.12 (95 percent confidence interval, 1.11 to 1.13). In unadjusted analyses, a pregnancy involving a new partner was associated with higher risk of preeclampsia, but after adjustment for the interbirth interval, the risk of preeclampsia was reduced (odds ratio for preeclampsia with a change of partner, 0.73; 95 percent confidence interval, 0.66 to 0.81). Conclusions: The protective effect of previous pregnancy against preeclampsia is transient. After adjustment for the interval between births, a change of partner is not associated with an increased risk of preeclampsia. (N Engl J Med 2002;346:33-8.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Med Stat, N-5021 Bergen, Norway; Univ Bergen, Med Birth Registry Norway, Locus Registry Based Epidemiol, N-5021 Bergen, Norway; NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Skjaerven, R (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Med Stat, Armauer Hansens Bldg, N-5021 Bergen, Norway.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027, Z01ES049027] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], CHESLEYS HYPERTENSIV; Basso O, 1998, INT J EPIDEMIOL, V27, P642, DOI 10.1093/ije/27.4.642; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Dekker GA, 1999, SEMIN PERINATOL, V23, P24, DOI 10.1016/S0146-0005(99)80057-3; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; DUFFUS GM, 1968, LANCET, V1, P994; Eras JL, 2000, EPIDEMIOLOGY, V11, P36, DOI 10.1097/00001648-200001000-00009; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; FEENEY JG, 1980, EUR J OBSTET GYN R B, V11, P35, DOI 10.1016/0028-2243(80)90051-9; Fu HS, 2000, J BIOSOC SCI, V32, P63, DOI 10.1017/S0021932000000638; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Haug K, 1998, ACTA PAEDIATR, V87, P1023, DOI 10.1080/080352598750031310; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Need J A, 1976, Perspect Nephrol Hypertens, V5, P169; NEED JA, 1975, BRIT MED J, V1, P548, DOI 10.1136/bmj.1.5957.548; NEED JA, 1983, J REPROD IMMUNOL, V5, P329, DOI 10.1016/0165-0378(83)90242-5; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBILLARD PY, 1993, J REPROD IMMUNOL, V24, P1, DOI 10.1016/0165-0378(93)90032-D; Robillard PY, 1999, EUR J OBSTET GYN R B, V84, P37, DOI 10.1016/S0301-2115(98)00250-4; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Smith GN, 1997, AM J OBSTET GYNECOL, V177, P455, DOI 10.1016/S0002-9378(97)70215-1; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Tubbergen P, 1999, J REPROD IMMUNOL, V45, P81, DOI 10.1016/S0165-0378(99)00040-6; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	28	268	280	1	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					33	38		10.1056/NEJMoa011379	http://dx.doi.org/10.1056/NEJMoa011379			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11778000	Bronze			2022-12-01	WOS:000173033600005
J	Fong, YW; Zhou, Q				Fong, YW; Zhou, Q			Stimulatory effect of splicing factors on transcriptional elongation	NATURE			English	Article							RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; C-TERMINAL DOMAIN; HIV-1 TAT; P-TEFB; TAT-SF1; PURIFICATION; AFFINITY; PROTEIN; U2	Transcription and pre-mRNA splicing are tightly coupled gene expression events in eukaryotic cells(1,2). An interaction between the carboxy-terminal domain of the largest subunit of RNA polymerase (Pol) II and components of the splicing machinery is postulated to mediate this coupling(3-5). Here, we show that splicing factors function directly to promote transcriptional elongation, demonstrating that transcription is more intimately coupled to splicing than previously thought. The spliceosomal U small nuclear ribonucleoproteins (snRNPs) interact with human transcription elongation factor TAT-SF1 (refs 6-9) and strongly stimulate polymerase elongation when directed to an intron-free human immunodeficiency virus-1 (HIV-1) template. This effect is likely to be mediated through the binding of TAT-SF1 to elongation factor P-TEFb(10), a proposed component of the transcription elongation complex(11,12). Inclusion of splicing signals in the nascent transcript further stimulates transcription, supporting the notion that the recruitment of U snRNPs near the elongating polymerase is important for transcription. Because the TAT-SF1-UsnRNP complex also stimulates splicing in vitro, it may serve as a dual-function factor to couple transcription and splicing and to facilitate their reciprocal activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; BACH M, 1990, METHOD ENZYMOL, V181, P232; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Blencowe BJ, 1999, METH MOL B, V118, P275; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hirose Y, 2000, GENE DEV, V14, P1415; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kim JB, 1999, MOL CELL BIOL, V19, P5960; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Perriman R, 2000, GENE DEV, V14, P97; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	30	271	276	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					929	933		10.1038/414929a	http://dx.doi.org/10.1038/414929a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780068				2022-12-01	WOS:000172813300051
J	Kane, B				Kane, B			Cancer chemotherapy: Teaching old drugs new tricks	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1107	1110		10.7326/0003-4819-135-12-200112180-00035	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747409				2022-12-01	WOS:000172759700027
J	Thompson, JB; Kindt, JH; Drake, B; Hansma, HG; Morse, DE; Hansma, PK				Thompson, JB; Kindt, JH; Drake, B; Hansma, HG; Morse, DE; Hansma, PK			Bone indentation recovery time correlates with bond reforming time	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; COLLAGEN CROSS-LINKS; SCANNING ELECTRON; FIBRILS; TITIN; IMMUNOGLOBULIN; MICROCRACKING; STRENGTH; DOMAINS; CORNEA	Despite centuries of work, dating back to Galileo(1), the molecular basis of bone's toughness and strength remains largely a mystery. A great deal is known about bone microsctructure(2-5) and the microcracks(6,7) that are precursors to its fracture, but little is known about the basic mechanism for dissipating the energy of an impact to keep the bone from fracturing. Bone is a nanocomposite of hydroxyapatite crystals and an organic matrix. Because rigid crystals such as the hydroxyapatite crystals cannot dissipate much energy, the organic matrix, which is mainly collagen, must be involved. A reduction in the number of collagen cross links has been associated with reduced bone strength(8-10) and collagen is molecularly elongated ('pulled') when bovine tendon is strained(11). Using an atomic force microscope(12-16), a molecular mechanistic origin for the remarkable toughness of another biocomposite material, abalone nacre, has been found(12). Here we report that bone, like abalone nacre, contains polymers with 'sacrircial bonds' that both protect the polymer backbone and dissipate energy. The time needed for these sacrificial bonds to reform after pulling correlates with the time needed for bone to recover its toughness as measured by atomic force microscope indentation testing. We suggest that the sacrificial bonds found within or between collagen molecules may be partially responsible for the toughness of bone.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Thompson, JB (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	jbthomp@physics.ucsb.edu						ASCENZI A, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90040-L; Bigi A, 1997, BIOMATERIALS, V18, P657, DOI 10.1016/S0142-9612(96)00156-1; BURSTEIN AH, 1975, J BONE JOINT SURG AM, V57, P956, DOI 10.2106/00004623-197557070-00013; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Charras GT, 2001, ULTRAMICROSCOPY, V86, P85, DOI 10.1016/S0304-3991(00)00076-0; CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736; Currey JD., 1984, MECH ADAPTATIONS BON; Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z; EINBINDER J, 1951, J BIOL CHEM, V188, P335; El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.3.CO;2-C; FULLWOOD NJ, 1995, CURR EYE RES, V14, P529, DOI 10.3109/02713689508998399; GREENE E.C., 1963, AM PHILOS SOC, V2, P227; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Lin H, 1999, BIOCHEMISTRY-US, V38, P9956, DOI 10.1021/bi990800q; Miyagawa A, 2000, JPN J OPHTHALMOL, V44, P591, DOI 10.1016/S0021-5155(00)00272-0; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Paige MF, 2001, MICRON, V32, P355, DOI 10.1016/S0968-4328(00)00038-X; Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0; Reilly GC, 1999, J EXP BIOL, V202, P543; REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Williams K.R., 2000, MECH TESTING BONE BO, P567; Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127	30	381	397	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2001	414	6865					773	776		10.1038/414773a	http://dx.doi.org/10.1038/414773a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501GD	11742405				2022-12-01	WOS:000172676200053
J	Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK				Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK			Ecology - Is coral bleaching really adaptive?	NATURE			English	Article							HYPOTHESIS		Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia	University of Queensland	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia.		Hoegh-Guldberg, Ove/H-6169-2011; Jones, Ross/N-4651-2013; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Jones, Ross/0000-0003-1661-4149; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Baker, Andrew/0000-0002-7866-2587				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4	7	84	89	6	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					601	602		10.1038/415601a	http://dx.doi.org/10.1038/415601a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832932				2022-12-01	WOS:000173709100032
J	Gaudet, J; Mango, SE				Gaudet, J; Mango, SE			Regulation of organogenesis by the Caenorhabditis elegans, FoxA protein PHA-41	SCIENCE			English	Article							HEAVY-CHAIN ISOFORMS; C-ELEGANS; FORK HEAD; DROSOPHILA EMBRYO; GENE-EXPRESSION; CELL LINEAGE; IDENTIFICATION; LOCALIZATION; HNF-3-BETA; HOMOLOG	The pha-4 locus encodes a forkhead box A (FoxA/HNF3) transcription factor homolog that specifies organ identity for Caenorhabditis elegans pharyngeal cells. We used microarrays to identify pharyngeal genes and analyzed those genes to determine which were direct PHA-4 targets. Our data suggest that PHA-4 directly activates most or all pharyngeal genes. Furthermore, the relative affinity of PHA-4 for different TRTTKRY (R=A/G, K=T/G, Y=T/C) elements modulates the onset of gene expression, providing a mechanism to activate pharyngeal genes at different developmental stages. We suggest that direct transcriptional regulation of entire gene networks may be a common feature of organ identity genes.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056264] Funding Source: Medline; ODCDC CDC HHS [CCSG 2P30CA42014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ODCDC CDC HHS		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; AVERY L, 1993, GENETICS, V133, P897; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; IP YT, 1992, J CELL SCI, P33; JURGENS G, 1988, ROUX ARCH DEV BIOL, V197, P345, DOI 10.1007/BF00375954; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x; MANGO SE, 1994, DEVELOPMENT, V120, P3019; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; Schnabel R., 1997, C ELEGANS, P361; Shibata Y, 2000, GENETICS, V154, P635; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	31	299	302	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					821	825		10.1126/science.1065175	http://dx.doi.org/10.1126/science.1065175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823633				2022-12-01	WOS:000173733000035
J	Seidemann, E; Arieli, A; Grinvald, A; Slovin, H				Seidemann, E; Arieli, A; Grinvald, A; Slovin, H			Dynamics of depolarization and hyperpolarization in the frontal cortex and saccade goat	SCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; EYE FIELDS; ELECTRICAL-STIMULATION; SUPERIOR COLLICULUS; VISUAL-CORTEX; MOVEMENTS; MICROSTIMULATION; REVEAL; MONKEY; SIGNAL	The frontal eye field and neighboring area 8Ar of the primate cortex are involved in programming and execution of saccades. Electrical microstimulation in these regions elicits short-latency contralateral saccades. To determine how spatiotemporal dynamics of microstimulation-evoked activity are converted into saccade plans, we used a combination of real-time optical imaging and microstimulation in behaving monkeys. Short stimulation trains evoked a rapid and widespread wave of depolarization followed by unexpected large and prolonged hyperpolarization. During this hyperpolarization saccades are almost exclusively ipsilateral, suggesting an important role for hyperpolarization in determining saccade goal.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Grodetsky Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Seidemann, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eyal.seidemann@weizmann.ac.il		Slovin, Hamutal/0000-0001-6350-8141; Seidemann, Eyal/0000-0003-2841-5948				ALBOWITZ B, 1993, EUR J NEUROSCI, V5, P1349, DOI 10.1111/j.1460-9568.1993.tb00921.x; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; DOBELLE WH, 1979, NEUROSURGERY, V5, P521, DOI 10.1227/00006123-197910000-00022; Ferrier D, 1875, PHILOS T R SOC LON B, V165, P433, DOI DOI 10.1098/RSTL.1875.0016; GOLDBERG ME, 1986, EXP BRAIN RES, V61, P579; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; PETERSEN CCH, 2001, SOC NEUR ABSTR, V27; PREUSS TM, 1991, J COMP NEUROL, V310, P475, DOI 10.1002/cne.903100403; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; SCHALL JD, 1995, REV NEUROSCIENCE, V6, P63; Schall JD, 1997, CEREBR CORT, V12, P527; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SCHLAG J, 1990, TRENDS NEUROSCI, V13, P410, DOI 10.1016/0166-2236(90)90122-Q; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; SEIDEMANN DE, 1999, SOC NEUR ABSTR, V25, P784; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Slovin H, 2000, EUR J NEUROSCI, V12, P126; Slovin H., 1999, Society for Neuroscience Abstracts, V25, P784; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X	28	105	105	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					862	865		10.1126/science.1066641	http://dx.doi.org/10.1126/science.1066641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823644	Green Submitted			2022-12-01	WOS:000173733000047
J	Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D				Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D			FtsK is a DNA motor protein that activates chromosome dimer resolution by switching the catalytic state of the XerC and XerD recombinases	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; TOPOLOGICAL SELECTIVITY; DIF; TERMINUS; LOCALIZATION; SEGREGATION; TRANSPORT; SEPTUM	FtsK acts at the bacterial division septum to couple chromosome segregation with cell division. We demonstrate that a truncated FtsK derivative, FtsK(50C), uses ATP hydrolysis to translocate along duplex DNA as a multimer in vitro, consistent with FtsK having an in vivo role in pumping DNA through the closing division septum. FtsK(50C) also promotes a complete Xer recombination reaction between dif sites by switching the state of activity of the XerCD recombinases so that XerD makes the first pair of strand exchanges to form Holliday junctions that are then resolved by XerC. The reaction between directly repeated dif sites in circular DNA leads to the formation of uncatenated circles and is equivalent to the formation of chromosome monomers from dimers.	Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England; Univ Lausanne, Lab Anal Ultrastruct, CH-1015 Lausanne, Switzerland	University of Oxford; University of Lausanne	Sherratt, D (corresponding author), Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England.	sherratt@bioch.ox.ac.uk	Barre, François-Xavier/F-6767-2019; Stasiak, Andrzej/E-5551-2010	Stasiak, Andrzej/0000-0002-0398-1989; Aussel, Laurent/0000-0001-5239-4556				ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ARCISZEWSKA LK, 1995, EMBO J, V14, P2112, DOI 10.1002/j.1460-2075.1995.tb07203.x; Barre F.-X., 2002, MOBILE DNA, P149; Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; BLAKELY G, 1991, NEW BIOL, V3, P789; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Colloms SD, 1997, CELL, V88, P855, DOI 10.1016/S0092-8674(00)81931-5; COLLOMS SD, 1990, J BACTERIOL, V172, P6973, DOI 10.1128/jb.172.12.6973-6980.1990; Colloms SD, 1996, EMBO J, V15, P1172, DOI 10.1002/j.1460-2075.1996.tb00456.x; Cornet F, 1996, GENE DEV, V10, P1152, DOI 10.1101/gad.10.9.1152; Diez AA, 1997, J BACTERIOL, V179, P5878, DOI 10.1128/jb.179.18.5878-5883.1997; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hallet B, 1999, MOL CELL, V4, P949, DOI 10.1016/S1097-2765(00)80224-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; Kilbride E, 1999, J MOL BIOL, V289, P1219, DOI 10.1006/jmbi.1999.2864; KUEMPEL PL, 1991, NEW BIOL, V3, P799; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; Niki H, 2000, GENE DEV, V14, P212; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Perals K, 2000, MOL MICROBIOL, V36, P33, DOI 10.1046/j.1365-2958.2000.01847.x; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Recchia GD, 1999, MOL MICROBIOL, V34, P1146, DOI 10.1046/j.1365-2958.1999.01668.x; Sherratt DJ, 2001, CURR OPIN MICROBIOL, V4, P653, DOI 10.1016/S1369-5274(01)00265-X; SOGO JM, 1987, ELECTRON MICROS, P61; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Yu XC, 1998, J BACTERIOL, V180, P6424; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	41	255	261	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					195	205		10.1016/S0092-8674(02)00624-4	http://dx.doi.org/10.1016/S0092-8674(02)00624-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832210	Bronze			2022-12-01	WOS:000173521300007
J	Stegmeier, F; Visintin, R; Amon, A				Stegmeier, F; Visintin, R; Amon, A			Separase, polo kinase, the kinetochore protein Slk19 and Spo12 function in a network that controls Cdc14 localization during early anaphase	CELL			English	Article							SINGLE-DIVISION MEIOSIS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC EXIT; PHOSPHATASE CDC14; CYCLIN DESTRUCTION; SISTER CHROMATIDS; PROMOTING COMPLEX; MITOSIS; PHOSPHORYLATION	In budding yeast, the phosphatase Cdc14, a key regulator of exit from mitosis, is released from its inhibitor Cfi1/Net1 in the nucleolus during anaphase. A signaling cascade, known as the mitotic exit network (MEN), controls this release. We have identified a regulatory network, the FEAR (Cdc fourteen early anaphase release) network that promotes Cdc14 release from the nucleolus during early anaphase. The FEAR network is comprised of the polo kinase CdG5, the separase Esp1, the kinetochore-associated protein Slk19, and Spo12. We also show that the FEAR network initiates Cdc14 release from Cfi1/Net1 during early anaphase, and MEN maintains Cdc14 in the released state during late anaphase. We propose that one function of Cdc14 released by the FEAR network is to stimulate MEN activity.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.		Visintin, Rosella/J-9690-2012	Amon, Angelika/0000-0001-9837-0314; Visintin, Rosella/0000-0001-6758-9946	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056800, R29GM056800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cueille N, 2001, J CELL SCI, V114, P2649; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KLAPHOLZ S, 1980, GENETICS, V96, P589; Lee SE, 2001, J CELL SCI, V114, P2345; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; PARKES V, 1992, NUCLEIC ACIDS RES, V20, P5617, DOI 10.1093/nar/20.21.5617; Severin F, 2001, J CELL BIOL, V155, P711, DOI 10.1083/jcb.200104096; SHARON G, 1990, GENETICS, V125, P487; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, YEAST, V10, P451, DOI 10.1002/yea.320100404; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, CURR OPIN CELL BIOL, V13, P754, DOI 10.1016/S0955-0674(00)00279-9; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	45	366	377	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					207	220		10.1016/S0092-8674(02)00618-9	http://dx.doi.org/10.1016/S0092-8674(02)00618-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832211	Bronze			2022-12-01	WOS:000173521300008
J	Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M				Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M			Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; GLYCOSYLATION REACTIONS; TRANSMEMBRANE MOVEMENT; BIOSYNTHESIS; TRANSPORT; CLONING; GLYCOPROTEINS; TOPOGRAPHY	N-linked glycosylation of proteins in eukaryotic cells follows a highly conserved pathway. The tetradecasaccharide substrate (Glc(3)Man(9)GlcNAc(2)) is first assembled at the membrane of the endoplasmic reticulum (ER) as a dolichylpyrophosphate (DolPP)-linked intermediate, and then transferred to nascent polypeptide chains in the lumen of the ER1. The assembly of the oligosaccharide starts on the cytoplasmic side of the ER membrane with the synthesis of a Man(5)GlcNAc(2)-PP-Dol intermediate. This lipid-linked intermediate is then translocated across the membrane so that the oligosaccharides face the lumen of the ER, where the biosynthesis of Glc(3)Man(9)GlcNAc(2)-PP-Dol continues to completion. The fully assembled oligosaccharide is transferred to selected asparagine residues of target proteins. The transmembrane movement of lipid-linked Man(5)GlcNAc(2) oligosaccharide is of fundamental importance in this biosynthetic pathway, and similar processes involving phospholipids and glycolipids are essential in all types of cells(2-4). The process is predicted to be catalysed by proteins, termed flippases, which to date have remained elusive(2-4). Here we provide evidence that yeast RFT1 encodes an evolutionarily conserved protein required for the translocation of Man(5)GlcNAc(2)-PP-Dol from the cytoplasmic to the lumenal leaflet of the ER membrane.	Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641				ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; BUGG TDH, 1994, FEMS MICROBIOL LETT, V119, P255; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Christine Guthrie G.R.F, 1991, METHOD ENZYMOL, V194, P3; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Davidson EA, 2001, BIOCHIMIE, V83, P601, DOI 10.1016/S0300-9084(01)01316-5; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; HANOVER JA, 1979, J BIOL CHEM, V254, P9237; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2056, DOI 10.1021/bi00551a008; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; ORLEAN P, 1991, METHOD ENZYMOL, V194, P682; PEREZ M, 1986, J BIOL CHEM, V261, P6822; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Wach A, 1998, METHOD MICROBIOL, V26, P67; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	28	200	205	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					447	450		10.1038/415447a	http://dx.doi.org/10.1038/415447a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807558				2022-12-01	WOS:000173433600054
J	Lewis, JD; Brown, A; Localio, AR; Schwartz, JS				Lewis, JD; Brown, A; Localio, AR; Schwartz, JS			Initial evaluation of rectal bleeding in young persons: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CONTRAST BARIUM-ENEMA; COLORECTAL-CANCER; FLEXIBLE SIGMOIDOSCOPY; GENERAL-PRACTICE; COLONOSCOPIC POLYPECTOMY; ASYMPTOMATIC ADULTS; PREDICTIVE-VALUE; LARGE-BOWEL; FOLLOW-UP; POLYPS	Background: Evaluation of rectal bleeding in young patients is a frequent diagnostic challenge. Objective: To determine the relative cost-effectiveness of alternative diagnostic strategies for young patients with rectal bleeding. Design: Cost-effectiveness analysis using a Markov model. Data Sources: Probability estimates were based on published medical literature. Cost estimates were based on Medicare reimbursement rates and published medical literature. Target Population: Persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding. Time Horizon: The patient's lifetime. Perspective: Modified societal perspective. Interventions: Diagnostic strategies included no evaluation, colonoscopy, flexible sigmoidoscopy, barium enema, anoscopy, or any feasible combination of these procedures. Outcome Measures: Life expectancy and costs, Results of Base-Case Analysis: For 35-year-old patients, the no-evaluation strategy yielded the least life expectancy. The incremental cost-effectiveness of flexible sigmoidoscopy compared with no evaluation or with any strategy incorporating anoscopy (followed by further evaluation if no anal disease was found on anoscopy) was less than $5300 per year of life gained. A strategy of flexible sigmoidoscopy plus barium enema yielded the greatest life expectancy, with an incremental cost of $23 918 per additional life-year gained compared with flexible sigmoidoscopy alone. Results of Sensitivity Analysis: As patient age at presentation of rectal bleeding increased, evaluation of the entire colon became more cost-effective. The incremental cost-effectiveness of flexible sigmoidoscopy plus barium enema compared with colonoscopy was sensitive to estimates of the sensitivity of the tests. In a probabilistic sensitivity analysis comparing flexible sigmoidoscopy with anoscopy followed by flexible sigmoidoscopy if needed, the middle 95th percentile of the distribution of the incremental cost-effectiveness ratios ranged from flexible sigmoidoscopy yielding an increased life expectancy at reduced cost to $52 158 per year of life. gained (mean, $11 461 per year of life saved). Conclusions: Evaluation of the colon of persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding increases the life expectancy at a cost comparable to that of colon cancer screening.	Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lewis, JD (corresponding author), Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Blockley Hall,9th Floor,423 Guardian Dr, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002589] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-K08-DK02589-0] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOSTA JA, 1994, AM SURGEON, V60, P903; [Anonymous], 1992, CANC INCIDENCE 5 CON; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BRAND EJ, 1980, ANN SURG, V192, P111, DOI 10.1097/00000658-198007000-00019; CHAPUIS PH, 1985, BRIT MED J, V290, P1546, DOI 10.1136/bmj.290.6481.1546; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; DENT OF, 1986, DIS COLON RECTUM, V29, P243, DOI 10.1007/BF02553027; FARQUHARSON SM, 1994, LANCET, V344, P751, DOI 10.1016/S0140-6736(94)92241-1; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; FIJTEN GH, 1994, BRIT J GEN PRACT, V44, P320; FIJTEN GH, 1993, FAM PRACT, V10, P283, DOI 10.1093/fampra/10.3.283; Fine KD, 1999, AM J GASTROENTEROL, V94, P3202, DOI 10.1016/S0002-9270(99)00578-X; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GOULSTON KJ, 1986, LANCET, V2, P261; GUILLEM JG, 1987, ANN SURG, V206, P606; Helfand M, 1997, JAMA-J AM MED ASSOC, V277, P44, DOI 10.1001/jama.277.1.44; HIXSON LJ, 1989, EUR J RADIOL, V9, P254; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; HOFF G, 1986, SCAND J GASTROENTERO, V21, P848, DOI 10.3109/00365528609011129; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; IRVINE EJ, 1988, GUT, V29, P1188, DOI 10.1136/gut.29.9.1188; JARAMILLO E, 1992, GASTROINTEST RADIOL, V17, P81, DOI 10.1007/BF01888514; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; KORETZ RL, 1993, ANN INTERN MED, V118, P63, DOI 10.7326/0003-4819-118-1-199301010-00011; KORKIS AM, 1995, DIGEST DIS SCI, V40, P1520, DOI 10.1007/BF02285201; LEWIS J, IN PRESS DIG DIS SCI; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; MAKELA JT, 1993, SCAND J GASTROENTERO, V28, P1062, DOI 10.3109/00365529309098310; MANT A, 1989, DIS COLON RECTUM, V32, P191, DOI 10.1007/BF02554525; Metcalf JV, 1996, BRIT J GEN PRACT, V46, P161; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; PROVENZALE D, 1990, ANN INTERN MED, V113, P760, DOI 10.7326/0003-4819-113-10-760; RAFTERY TL, 1980, AM SURGEON, V46, P600; REX DK, 1990, GASTROENTEROLOGY, V98, P855, DOI 10.1016/0016-5085(90)90007-N; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Ries L, 1998, SEER CANC STAT REV 1; ROSEN L, 1993, DIS COLON RECTUM, V36, P1126, DOI 10.1007/BF02052261; Shennak MM, 1997, DIS COLON RECTUM, V40, P208, DOI 10.1007/BF02054990; SHINYA H, 1982, SURG CLIN N AM, V62, P897; SINGARAM C, 1995, AM J GASTROENTEROL, V90, P146; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; STANILAND JR, 1976, GASTROENTEROLOGY, V70, P22; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Talley NJ, 1998, AM J GASTROENTEROL, V93, P2179; THOENI RF, 1983, RADIOLOGY, V146, P603, DOI 10.1148/radiology.146.3.6600844; VENTURA S, 1996, BIRTHS DEATHS US 199; Waye J D, 1993, Gastroenterologist, V1, P158; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; WAYE JD, 1988, AM J GASTROENTEROL, V83, P120; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; 1999, MMWR MORB MORTAL WKL, V48, P116	60	29	31	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					99	110		10.7326/0003-4819-136-2-200201150-00007	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790061				2022-12-01	WOS:000173333900002
J	Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J				Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J		UK Neonatgal Staffing Study Grp	Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation	LANCET			English	Article							BIRTH; MORTALITY	Background UK recommendations suggest that large neonatal intensive-care units (NICUs) have better outcomes than small units, although this suggestion remains unproven. We assessed whether patient volume, staffing levels, and workload are associated with risk-adjusted outcomes, and with costs or staff wellbeing. Methods 186 UK NICUs were stratified according to volume of patients, nursing provision, and neonatal consultant provision. Primary outcomes were hospital mortality, mortality or cerebral damage, and nosocomial bacteraemia. We studied 13 515 infants of all birthweights consecutively admitted to 54 randomly selected NICUs. Multiple logistic regression analyses were done with every primary outcome as the dependent variable. Staff wellbeing and stress were assessed by anonymous mental health index (MHI)-5 questionnaires. Findings Data were available for 13 334 (99%) infants. High-volume NICUs treated the sickest infants and had highest crude mortality. Risk-adjusted mortality and mortality or cerebral damage were unrelated to patient volume or staffing provision; however, nosocomial bacteraemia was less frequent in NICUs with low neonatal consultant provision (odds ratio 0.65, 95% Cl 0.43-0.98). Mortality was raised with increasing workload in all types of NICUs. Infants admitted at full capacity versus half capacity were about 50% more likely to die, but there was wide uncertainty around this estimate. Most staff had MHI-5 scores that suggested good mental health. Interpretation The implications of this report for staffing policy, medicolegal risk management, and ethical practice remain to be tested. Centralisation of only the sickest infants could improve efficiency, provided that this does not create excessive workload for staff. Assessment of increased staffing levels that are closer to those in adult intensive care might be appropriate.	Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Sheffield, ScHARR, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, ScHARR, Sheffield Hlth Econ Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Sydney, Westmead & New Childrens Hosp, Sydney, NSW 2006, Australia	University of Aberdeen; University of Sheffield; University of Sheffield; University of Sydney	Tucker, J (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland.	j.s.tucker@abdn.ac.uk	McCabe, Christopher/E-2051-2016; Marlow, Neil/D-2918-2009; Parry, Gareth/CAF-6975-2022	Marlow, Neil/0000-0001-5890-2953; 				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *BRIT ASS PER MED, 1996, STAND HOSP PROV NEON; Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; COCKBURN F, 1993, LANCET, V342, P193; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Field D, 1999, ARCH DIS CHILD-FETAL, V80, pF111, DOI 10.1136/fn.80.2.F111; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; GOLDFRAD C, 2000, J EPIDEMIOL COMMUN H, pA9; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; McCabe CJ, 1996, BRIT J PSYCHIAT, V169, P517, DOI 10.1192/bjp.169.4.516; MCFARLANE A, 2000, BIRTH COUNTS STAT PR, P544; Mugford M, 1998, ARCH DIS CHILD-FETAL, V78, pF179; Murphy MK., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [10.3310/hta2030, DOI 10.3310/HTA2030]; *NHS CTR REV DISS, 1996, EFFECTIVE HLTH CARE, V2, P1; O'Neill C, 2000, J PUBLIC HEALTH MED, V22, P108, DOI 10.1093/pubmed/22.1.108; Parmanum J, 2000, BMJ-BRIT MED J, V321, P727, DOI 10.1136/bmj.321.7263.727; Parry GJ, 1998, BRIT MED J, V316, P1931, DOI 10.1136/bmj.316.7149.1931; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; PICKERING J, 1993, ARCH DIS CHILD-FETAL, V68, P539; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Redshaw M., 1996, DELIVERING NEONATAL; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; SEPKOWITZ S, 1993, LANCET, V342, P938, DOI 10.1016/0140-6736(93)91992-U; *SOC SERV COMM, 1980, PER NEON MORT 2 REP; Tarnow-Mordi W, 2000, ARCH DIS CHILD-FETAL, V82, pF118; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; TarnowMordi W, 1997, LANCET, V350, P66, DOI 10.1016/S0140-6736(05)66269-1; TARNOWMORDI W, 2002, RISK ADJUSTED OUTCOM; TARNOWMORDI WO, 1997, SEMIN NEONATOL, V2, P171; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tucker J, 1999, ARCH DIS CHILD-FETAL, V80, pF233, DOI 10.1136/fn.80.3.F233; UKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P33; WHEELER RHB, 1995, ARCH DIS CHILD, V73, pF32; *WORK GROUP NEON I, 1995, NEON INT CAR ACC AV; 1986, LANCET, V1, P777	39	194	196	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					99	107						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809250				2022-12-01	WOS:000173212400007
J	Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G				Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G			Functional organization of the yeast proteome by systematic analysis of protein complexes	NATURE			English	Article							LARGE-SCALE ANALYSIS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; GENOMIC ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; SUBUNITS; PURIFICATION; GENERATION; NETWORK	Most cellular processes are carried out by multiprotein complexes. The identification and analysis of their components provides insight into how the ensemble of expressed proteins (proteome) is organized into functional units. We used tandem-affinity purification (TAP) and mass spectrometry in a large-scale approach to characterize multiprotein complexes in Saccharomyces cerevisiae. We processed 1,739 genes, including 1,143 human orthologues of relevance to human biology, and purified 589 protein assemblies. Bioinformatic analysis of these assemblies defined 232 distinct multiprotein complexes and proposed new cellular roles for 344 proteins, including 231 proteins with no previous functional annotation. Comparison of yeast and human complexes showed that conservation across species extends from single proteins to their molecular environment. Our analysis provides an outline of the eukaryotic proteome as a network of protein complexes at a level of organization beyond binary interactions. This higher-order map contains fundamental biological information and offers the context for a more reasoned and informed approach to drug discovery.	Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; CNRS, CGM, F-91198 Gif Sur Yvette, France	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Gavin, AC (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	anne-claude.gavin@cellzome.com; giulio.superti-furga@cellzome.com	Kuster, Bernhard/Q-6031-2016; Bork, Peer/F-1813-2013; Schultz, Joerg/B-9346-2008; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Kuster, Bernhard/0000-0002-9094-1677; Bork, Peer/0000-0002-2627-833X; Superti-Furga, Giulio/0000-0002-0570-1768; Drewes, Gerard/0000-0003-0575-6766; Gavin, Anne-Claude/0000-0003-4917-2340; Krause, Roland/0000-0001-9938-7126; Bauch, Angela/0000-0002-8712-4414; Seraphin, Bertrand/0000-0002-5168-1921				Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	46	3685	3842	2	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					141	147		10.1038/415141a	http://dx.doi.org/10.1038/415141a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805826				2022-12-01	WOS:000173159300033
J	Arnold, KE; Owens, IPF; Marshall, NJ				Arnold, KE; Owens, IPF; Marshall, NJ			Fluorescent signaling in parrots	SCIENCE			English	Article							PIGMENTS		Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University of Glasgow; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Queensland	Arnold, KE (corresponding author), Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	K.Arnold@bio.gla.ac.uk	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Owens, Ian PF/F-1392-2010; Arnold, Kathryn E/F-8683-2016	Arnold, Kathryn E/0000-0002-6485-6065; Owens, Ian/0000-0001-6080-3321; Marshall, Justin/0000-0001-9006-6713				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Boles WE, 1990, BIRDS INT, V3, P76; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X	5	112	115	6	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					92	92		10.1126/science.295.5552.92	http://dx.doi.org/10.1126/science.295.5552.92			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778040				2022-12-01	WOS:000173143100038
J	Feskanich, D; Singh, V; Willett, WC; Colditz, GA				Feskanich, D; Singh, V; Willett, WC; Colditz, GA			Vitamin A intake and hip fractures among postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETINOIC ACID; HYPERVITAMINOSIS-A; CAROTENOID DATABASE; PROSPECTIVE COHORT; DIETARY-INTAKE; BETA-CAROTENE; BONE; SUPPLEMENTATION; VEGETABLES; RESORPTION	Context Ingestion of toxic amounts of vitamin A affects bone remodeling and can have adverse skeletal effects in animals. The possibility has been raised that long-term high vitamin A intake could contribute to fracture risk in humans. Objective To assess the relationship between high vitamin A intake from foods and supplements and risk of hip fracture among postmenopausal women. Design Prospective analysis begun in 1980 with 18 years of follow-up within the Nurses' Health Study. Setting General community of registered nurses within 11 US states. Participants A total of 72337 postmenopausal women aged 34 to 77 years. Main Outcome Measures Incident hip fractures resulting from low or moderate trauma, analyzed by quintiles of vitamin A intake and by use of multivitamins and vitamin A supplements, assessed at baseline and updated during follow-up. Results From 1980 to 1998, 603 incident hip fractures resulting from low or moderate trauma were identified. After controlling for confounding factors, women in the highest quintile of total vitamin A intake (greater than or equal to 3000 mug/d of retinol equivalents [RE]) had a significantly elevated relative risk (RR) of hip fracture (RR, 1.48; 95% confidence interval [CI], 1.05-2.07; P for trend =.003) compared with women in the lowest quintile of intake (<1250 <mu>g/d of RE). This increased risk was attributable primarily to retinol (RR, 1.89; 95% CI, 1.33-2.68; P for trend <.001 comparing <greater than or equal to>2000 mug/d vs <500 <mu>g/d). The association of high retinol intake with hip fracture was attenuated among women using postmenopausal estrogens. Beta carotene did not contribute significantly to fracture risk (RR, 1.22; 95% CI, 0.90-1.66; P for trend=.10 comparing greater than or equal to 6300 mug/d vs <2550 <mu>g/d). Women currently taking a specific vitamin A supplement had a nonsignificant 40% increased risk of hip fracture (RR, 1.40; 95% CI, 0.99-1.99) compared with those not taking that supplement, and, among women not taking supplemental vitamin A, retinol from food was significantly associated with fracture risk (RR, 1.69; 95% CI, 1.05-2.74; P for trend =.05 comparing greater than or equal to 1000 mug/d vs <400 <mu>g/d). Conclusions Long-term intake of a diet high in retinol may promote the development of osteoporotic hip fractures in women. The amounts of retinol in fortified foods and vitamin supplements may need to be reassessed.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Roche Vitamins Inc, Human Nutr Res, Parsippany, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Roche Holding	Feskanich, D (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	diane.feskanich@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Hijleh G, 1997, EUR J MORPHOL, V35, P327, DOI 10.1076/ejom.35.5.327.13088; [Anonymous], 1999, NUTR REV, V57, P192; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1456, DOI 10.1001/archopht.1993.01090110014001; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; CHUGAHUJA JK, 1993, J AM DIET ASSOC, V93, P318, DOI 10.1016/0002-8223(93)91559-9; CLARK L, 1971, J COMP PATHOL, V81, P365, DOI 10.1016/0021-9975(71)90024-7; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DIGIOVANNA JJ, 1995, ARCH DERMATOL, V131, P1263, DOI 10.1001/archderm.131.11.1263; *FOOD NUTR BOARD I, IN PRESS DIET REF IN; FORSYTH KS, 1989, LIFE SCI, V45, P2149, DOI 10.1016/0024-3205(89)90081-7; FRAME B, 1974, ANN INTERN MED, V80, P44, DOI 10.7326/0003-4819-80-1-44; FREUDENHEIM JL, 1986, AM J CLIN NUTR, V44, P863, DOI 10.1093/ajcn/44.6.863; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; HEYWOOD R, 1985, TOXICOLOGY, V36, P91, DOI 10.1016/0300-483X(85)90043-5; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; Kindmark A, 1998, ACTA DERM-VENEREOL, V78, P266; KOCHHAR DM, 1984, TERATOGEN CARCIN MUT, V4, P377, DOI 10.1002/tcm.1770040407; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; MCGUIRE J, 1987, Dermatologica (Basel), V175, P169; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; METZ AL, 1985, J NUTR, V115, P929, DOI 10.1093/jn/115.7.929; Michaud DS, 1998, CANCER EPIDEM BIOMAR, V7, P283; MOORE T, 1945, BIOCHEM J, V39, P222, DOI 10.1042/bj0390222; MOORE T, 1979, INT J VITAM NUTR RES, V49, P14; Nierenberg DW, 1997, AM J CLIN NUTR, V66, P315, DOI 10.1093/ajcn/66.2.315; Okada Natsuko, 1994, Journal of Dermatology (Tokyo), V21, P308; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P259; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SHARMAN IM, 1985, BMJ-BRIT MED J, V290, P95, DOI 10.1136/bmj.290.6462.95; SOWERS MR, 1990, J CLIN EPIDEMIOL, V43, P693, DOI 10.1016/0895-4356(90)90040-V; TOGARI A, 1991, GEN PHARMACOL, V22, P287, DOI 10.1016/0306-3623(91)90450-K; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT W, 1998, NUTR EPIDEMIOLOGY, P125; WOLBACH SB, 1947, J BONE JOINT SURG, V29, P171; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632	41	273	290	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					47	54		10.1001/jama.287.1.47	http://dx.doi.org/10.1001/jama.287.1.47			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754708	Bronze			2022-12-01	WOS:000172978500025
J	Chien, YC; Chen, JY; Liu, MY; Yang, HI; Hsu, MM; Chen, CJ; Yang, CS				Chien, YC; Chen, JY; Liu, MY; Yang, HI; Hsu, MM; Chen, CJ; Yang, CS			Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-POSITIVE PERSONS; WUZHOU-CITY; CHINA; DNASE	Background It is probable but unproven that Epstein-Barr virus (EBV) has a role in nasopharyngeal carcinoma. We determined whether antibodies against EBV are present before the development of nasopharyngeal carcinoma. Methods A total of 9699 men were enrolled between 1984 and 1986. Blood samples were examined for IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV-specific DNase. During 131,981 person-years of follow-up, 22 pathologically confirmed new cases of nasopharyngeal carcinoma that were diagnosed more than one year after recruitment were ascertained through linkage with the National Cancer Registry of Taiwan. Results The cumulative risk of nasopharyngeal carcinoma per 100,000 person-years was 11.2 for subjects who tested positive for neither serologic marker, 45.0 for those who had one marker, and 371.0 for those who had both markers. After adjustment for age and the presence or absence of a family history of nasopharyngeal carcinoma, the relative risk of nasopharyngeal carcinoma was 32.8 for subjects with both markers (95 percent confidence interval, 7.3 to 147.2; P<0.001) and 4.0 for subjects with one marker (95 percent confidence interval, 1.6 to 10.2; P=0.003), as compared with subjects with neither marker. The longer the duration of follow-up, the greater the difference in the cumulative incidence of nasopharyngeal carcinoma between seropositive and seronegative subjects. Conclusions IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV DNase are predictive of nasopharyngeal carcinoma. (N Engl J Med 2001;345:1877-82.) Copyright (C) 2001 Massachusetts Medical Society.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 100, Taiwan; Natl Taipei Coll Nursing, Dept Gen Educ, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chien, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, 1 Jen Ai Rd,Sec 1, Taipei 100, Taiwan.		Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Jen-Yang/D-2085-2010	Yang, Hwai-I/0000-0002-3433-942X; 				[Anonymous], 1997, IARC MONOGRAPHS EVAL, V70, P47; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; CHEN KP, 1979, COLOR ATLAS CANC MOR; CHENG SZD, 1991, MACROMOLECULES, V24, P150, DOI 10.1021/ma00001a024; DETHE G, 1975, INT J CANCER, V16, P713, DOI 10.1002/ijc.2910160503; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE W, 1970, J NATL CANCER I, V44, P225; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; JEANNEL D, 1999, INFECT HUMAN CANC, P125; Lin Y-H, 1997, CHINESE J PUBLIC HLT, V16, P466; Liu MY, 1997, J MED VIROL, V52, P262, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;262::AID-JMV5&gt;3.0.CO;2-0; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; WARA WM, 1975, CANCER, V35, P1313, DOI 10.1002/1097-0142(197505)35:5<1313::AID-CNCR2820350510>3.0.CO;2-B; Yu MC, 1996, CANC EPIDEMIOLOGY PR, P603; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1983, INTERVIROLOGY, V20, P190, DOI 10.1159/000149391; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204; ZONG YS, 1992, CANCER, V69, P3, DOI 10.1002/1097-0142(19920101)69:1&lt;3::AID-CNCR2820690104&gt;3.0.CO;2-7	19	320	330	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2001	345	26					1877	1882		10.1056/NEJMoa011610	http://dx.doi.org/10.1056/NEJMoa011610			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TY	11756578				2022-12-01	WOS:000172932700003
J	Chabriere, E; Vernede, C; Guigliarelli, B; Charon, MH; Hatchikian, EC; Fontecilla-Camps, JC				Chabriere, E; Vernede, C; Guigliarelli, B; Charon, MH; Hatchikian, EC; Fontecilla-Camps, JC			Crystal structure of the free radical intermediate of pyruvate : ferredoxin oxidoreductase	SCIENCE			English	Article							PYRUVATEFERREDOXIN OXIDOREDUCTASE; PYROCOCCUS-FURIOSUS; THIAMINE ACTION; MECHANISM; ARCHAEON; CRYSTALLOGRAPHY; DIPHOSPHATE; BACTERIUM; BONDS	In anaerobic organisms, the decarboxylation of pyruvate, a crucial component of intermediary metabolism, is catalyzed by the metalloenzyme pyruvate: ferredoxin oxidoreductase (PFOR) resulting in the generation of tow potential electrons and the subsequent acetylation of coenzyme A (CoA). PFOR is the only enzyme for which a stable acetyl thiamine diphosphate (ThDP)-based free radical reaction intermediate has been identified. The 1.87 Angstrom -resolution structure of the radical form of PFOR from Desulfovibrio africanus shows that, despite currently accepted ideas, the thiazole ring of the ThDP cofactor is markedly bent, indicating a drastic reduction of its aromaticity. In addition, the bond connecting the acetyl group to ThDP is unusually tong, probably of the one-electron type already described for several cation radicals but not yet found in a biological system. Taken together, our data, along with evidence from the literature, suggest that acetyl-CoA synthesis by PFOR proceeds via a condensation mechanism involving acetyl (PFOR-based) and thiyl (CoA-based) radicals.	Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Cristallog & Cristallogenese Prot Lab, F-38027 Grenoble 1, France; CNRS, Inst Biol Struct & Microbiol, Unite Bioenerget & Ingn Prot, F-13402 Marseille, France; Univ Henri Poincare, Lab Cristallog & Modelisat Mat Mineraux & Biol, CNRS, Unite Mixte Rech 7036, F-54506 Vandoeuvre Les Nancy, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Fontecilla-Camps, JC (corresponding author), Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Cristallog & Cristallogenese Prot Lab, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	juan@lccp.ibs.fr						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLETTA G, 1990, J AM CHEM SOC, V112, P8144, DOI 10.1021/ja00178a044; BELLVILE DJ, 1985, J AM CHEM SOC, V107, P4978, DOI 10.1021/ja00303a025; BENNETT JE, 1971, T FARADAY SOC, V67, P1587, DOI 10.1039/tf9716701587; Bock AK, 1996, EUR J BIOCHEM, V237, P35, DOI 10.1111/j.1432-1033.1996.0035n.x; Bock AK, 1997, FEBS LETT, V414, P209, DOI 10.1016/S0014-5793(97)00998-8; Bouchev VF, 1999, J AM CHEM SOC, V121, P3724, DOI 10.1021/ja984057l; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; BRESLOW R, 1962, ANN NY ACAD SCI, V98, P445, DOI 10.1111/j.1749-6632.1962.tb30565.x; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton RD, 1996, J AM CHEM SOC, V118, P5655, DOI 10.1021/ja960378q; CAMMACK R, 1980, FEBS LETT, V118, P271, DOI 10.1016/0014-5793(80)80236-5; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; DOCAMPO R, 1987, J BIOL CHEM, V262, P12417; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; KERSCHER L, 1982, TRENDS BIOCHEM SCI, V7, P371, DOI 10.1016/0968-0004(82)90118-9; Kletzin A, 1996, J BACTERIOL, V178, P248, DOI 10.1128/jb.178.1.248-257.1996; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maslak P, 1995, J AM CHEM SOC, V117, P12380, DOI 10.1021/ja00155a002; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Reed LJ, 1998, PROTEIN SCI, V7, P220, DOI 10.1002/pro.5560070125; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; SMITH ET, 1994, BIOCHEMISTRY-US, V33, P1008, DOI 10.1021/bi00170a020; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tersteegen A, 1997, EUR J BIOCHEM, V244, P862, DOI 10.1111/j.1432-1033.1997.00862.x; Vernede X, 1999, J APPL CRYSTALLOGR, V32, P505, DOI 10.1107/S0021889899002678; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; Zhang Q, 1996, J BIOCHEM-TOKYO, V120, P587	37	117	121	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2001	294	5551					2559	2563		10.1126/science.1066198	http://dx.doi.org/10.1126/science.1066198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752578				2022-12-01	WOS:000172927700062
J	McCarl, BA; Schneider, UA				McCarl, BA; Schneider, UA			Climate change - Greenhouse gas mitigation in US agriculture and forestry	SCIENCE			English	Editorial Material									Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA; Iowa State Univ, Ctr Agr & Rural Dev, Ames, IA 50011 USA	Texas A&M University System; Texas A&M University College Station; Iowa State University	Schneider, UA (corresponding author), Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA.		McCarl, Bruce A/E-9445-2011; Schneider, Uwe A/M-7342-2016	Schneider, Uwe A/0000-0002-6833-9292				CHANG CC, 1992, AM J AGR ECON, V74, P38, DOI 10.2307/1242988; *INT PAN CLIM CHAN, 1991, CLIM CHANG IPCC SCI; Lal R., 1998, POTENTIAL US CROPLAN, P128; McCarl B. A., 2000, REV AGR ECON, V22, P134, DOI 10.1111/1058-195.t01-1-00011; Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069; SCHNEIDER U, 2000, THESIS TEXAS A M U; Weyant JP, 1999, ENERG J, pVII	7	205	218	6	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2481	2482		10.1126/science.1064193	http://dx.doi.org/10.1126/science.1064193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752558				2022-12-01	WOS:000172927700031
J	Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB				Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB			Crystal structure of an Eph receptor-ephrin complex	NATURE			English	Article							LIGAND-BINDING; TRANSMEMBRANE LIGANDS; TYROSINE KINASES; SAM DOMAIN; NUK; DIMERIZATION; ATTACHMENT; PROTEINS; BRAIN; AXONS	The Eph family of receptor tyrosine kinases and their membrane-anchored ephrin ligands are important in regulating cell-cell interactions as they initiate a unique bidirectional signal transduction cascade whereby information is communicated into both the Eph-expressing and the ephrin-expressing cells. Initially identified as regulators of axon pathfinding and neuronal cell migration, Ephs and ephrins are now known to have roles in many other cell-cell interactions, including those of vascular endothelial cells and specialized epithelia(1,2). Here we report the crystal structure of the complex formed between EphB2 and ephrin-B2, determined at 2.7 Angstrom resolution. Each Eph receptor binds an ephrin ligand through an expansive dimerization interface dominated by the insertion of an extended ephrin loop into a channel at the surface of the receptor. Two Eph-Ephrin dimers then join to form a tetramer, in which each ligand interacts with two receptors and each receptor interacts with two ligands. The Eph and ephrin molecules are precisely positioned and orientated in these complexes, promoting higher-order clustering and the initiation of bidirectional signalling.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Brookhaven National Laboratory; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Henkemeyer, Mark/0000-0002-7525-1061				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BRUNGER AT, 1993, XPLOR V 3 1 MANUAL; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Hockley D, 1998, JAVA REP, V3, P6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8	29	261	274	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					933	938		10.1038/414933a	http://dx.doi.org/10.1038/414933a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780069				2022-12-01	WOS:000172813300052
J	Cross, HF; Haarbrink, M; Egerton, G; Yazdanbakhsh, M; Taylor, MJ				Cross, HF; Haarbrink, M; Egerton, G; Yazdanbakhsh, M; Taylor, MJ			Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood	LANCET			English	Article							ADVERSE REACTIONS; ONCHOCERCIASIS; INTERLEUKIN-6; BACTERIA	Wolbachia bacteria seem to have evolved as essential endosymbionts of their filarial nematode hosts. Studies in mice have suggested that these bacteria are associated with systemic inflammatory reactions to filarial chemotherapy. We took blood samples from 15 Indonesian patients before and after treatment with diethylcarbamazine far Brugia malayi infection, and recorded the severity of any post-treatment inflammatory reactions. Blood from all three patients with severe adverse reactions and from one of six with moderate reactions was positive for Wolbachia DNA 4-48 h after diethylcarbamazine treatment. We suggest that these severe inflammatory reactions are associated with the release of endosymbionts into the blood after treatment for filariasis.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Liverpool School of Tropical Medicine; University of Liverpool; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Taylor, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.		Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Taylor, Mark/0000-0003-3396-9275				Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Haarbrink M, 2000, J INFECT DIS, V182, P564, DOI 10.1086/315735; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; TURNER PF, 1994, J INFECT DIS, V169, P1071, DOI 10.1093/infdis/169.5.1071	5	94	99	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1873	1875		10.1016/S0140-6736(01)06899-4	http://dx.doi.org/10.1016/S0140-6736(01)06899-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741630				2022-12-01	WOS:000172463000016
J	Vogelstein, B; Alberts, B; Shine, K				Vogelstein, B; Alberts, B; Shine, K			Genetics - Please don't call it cloning!	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Kimmel Canc Ctr, Baltimore, MD 21231 USA; Natl Acad Sci, Washington, DC 20418 USA; CNR, Washington, DC 20418 USA; Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Vogelstein, B (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA.							Kennedy D, 2001, SCIENCE, V294, P745, DOI 10.1126/science.294.5543.745; National Research Council, 2001, STEM CELLS FUT REG M; National Research Council, 2002, SCI MED ASP HUM REPR	3	71	72	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1237	1237		10.1126/science.1070247	http://dx.doi.org/10.1126/science.1070247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847324				2022-12-01	WOS:000173926000021
J	Verweij, M; van den Hoven, M				Verweij, M; van den Hoven, M			Influenza vaccination rates and informed consent in Dutch nursing homes: Survey of nursing home physicians	BRITISH MEDICAL JOURNAL			English	Article									Univ Utrecht, Ctr Bioeth & Hlth Law, NL-3584 CS Utrecht, Netherlands	Utrecht University	Verweij, M (corresponding author), Univ Utrecht, Ctr Bioeth & Hlth Law, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.			Verweij, Marcel/0000-0001-9169-1852				BEAUCHAMP H, 1994, PRINCIPLES BIOMEDICA; Drinka PJ, 1997, J FAM PRACTICE, V45, P509; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Nicholson KG, 2000, LANCET, V355, P83, DOI 10.1016/S0140-6736(99)00310-4; Verweij M, 2001, BIOETHICS, V15, P536, DOI 10.1111/1467-8519.00260	5	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					328	328		10.1136/bmj.324.7333.328	http://dx.doi.org/10.1136/bmj.324.7333.328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834559	Green Published, Bronze			2022-12-01	WOS:000173866300017
J	Provencio, I; Rollag, MD; Castrucci, AM				Provencio, I; Rollag, MD; Castrucci, AM			Anatomy: Photoreceptive net in the mammalian retina - This mesh of cells may explain how some blind mice can still tell day from night.	NATURE			English	Article									Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Circadian Res Ctr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.		Castrucci, Ana Maria L/C-3296-2014	Castrucci, Ana Maria/0000-0002-2065-8198; Provencio, Ignacio/0000-0003-1175-920X				Berson DM, 2001, INVEST OPHTH VIS SCI, V42, pS113; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Rollag MD, 2000, METHOD ENZYMOL, V316, P291	7	340	355	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	493		10.1038/415493a	http://dx.doi.org/10.1038/415493a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823848	Bronze			2022-12-01	WOS:000173564300033
J	Weeks, SJ; Currie, B; Bakun, A				Weeks, SJ; Currie, B; Bakun, A			Satellite imaging - Massive emissions of toxic gas in the Atlantic	NATURE			English	Article									Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa; Univ Cape Town, IRD, IDYLE Project, Dept Oceanog, ZA-7701 Rondebosch, South Africa; Natl Marine Res & Informat Ctr, Swakopmund, Namibia	University of Cape Town; University of Cape Town	Weeks, SJ (corresponding author), Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa.		Weeks, Scarla J/E-8632-2013	Weeks, Scarla J/0000-0002-0579-7069; Bakun, Andrew/0000-0002-4366-3846				BAILEY GW, 1985, S AFRICAN J MARINE S, V3, P197; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; MASRIERA J, 1990, MAR BIOL, V104, P175, DOI 10.1007/BF01313256; Tyrrell T, 1999, J GEOPHYS RES-OCEANS, V104, P3223, DOI 10.1029/1998JC900052; WOOSTER WS, 1963, SEA, V2, P253	5	92	95	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	494		10.1038/415493b	http://dx.doi.org/10.1038/415493b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823847				2022-12-01	WOS:000173564300034
J	Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD				Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD			Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study	LANCET			English	Article							ACUTE MOUNTAIN-SICKNESS; OPERATION EVEREST-II; LUNG LYMPH-FLOW; SIMULATED ALTITUDE; GAS-EXCHANGE; SEA-LEVEL; EXERCISE; EDEMA; HUMANS; SHEEP	Background High altitude pulmonary oedema (RAPE) that is severe enough to require urgent medical care is infrequent. We hypothesised that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort. Methods We assessed 262 consecutive climbers of Monte Rosa (4559 m), before ascent and about 24 h later on the summit 1 h after arriving, by clinical examination, electrocardiography, oximetry, spirometry, carbon monoxide transfer, and closing volume. A chest radiograph was taken at altitude. Findings Only one climber was evacuated for HAPE, but 40 (15%) of 262 climbers had chest rales or interstitial oedema on radiograph after ascent. Of 37 of these climbers, 34 (92%) showed increased closing volume. Of the 197 climbers without oedema, 146 (74%) had an increase in closing volume at altitude. With no change in vital capacity, forced expiratory volume in 1 s and forced expiratory flow at 25-75% of forced vital capacity increased slightly at altitude, without evidence of oedema. If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. Interpretation The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.	San Raffaele Univ Sci Inst, Resp Med Unit, I-20132 Milan, Italy; Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093 USA; Univ Ferrara, Club Alpino Italiano & Pulm Div, I-44100 Ferrara, Italy	Vita-Salute San Raffaele University; University of California System; University of California San Diego; University of Ferrara	Cremona, G (corresponding author), San Raffaele Univ Sci Inst, Resp Med Unit, Via Olgettina 60, I-20132 Milan, Italy.		Cremona, George/ABI-2752-2020	Asnaghi, Roberto/0000-0001-9746-6955	NHLBI NIH HHS [HL 07212, HL 17731] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007212, P01HL017731] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COATES G, 1984, J CLIN INVEST, V74, P133, DOI 10.1172/JCI111393; DEAL EC, 1980, AM REV RESPIR DIS, V121, P621; DEMEDTS M, 1974, B PHYSIO-PATHOL RESP, V10, P11; Eldridge MW, 1996, J APPL PHYSIOL, V81, P911, DOI 10.1152/jappl.1996.81.2.911; FASULES JW, 1985, CIRCULATION, V72, P957, DOI 10.1161/01.CIR.72.5.957; GALE GE, 1985, J APPL PHYSIOL, V58, P978, DOI 10.1152/jappl.1985.58.3.978; GRAY GW, 1973, J APPL PHYSIOL, V35, P227, DOI 10.1152/jappl.1973.35.2.227; GUY HJ, 1976, AM REV RESPIR DIS, V113, P737; HACKETT PH, 1976, LANCET, V2, P1149; HARKEN AH, 1976, ANN SURG, V184, P183, DOI 10.1097/00000658-197608000-00009; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Maggiorini M, 1999, HYPOXIA NEXT MILLENN, P408; NEWMAN JH, 1988, J APPL PHYSIOL, V64, P2125, DOI 10.1152/jappl.1988.64.5.2125; OBRODOVICH H, 1986, AM REV RESPIR DIS, V134, P862, DOI 10.1164/arrd.1986.134.5.862; Podolsky A, 1996, J APPL PHYSIOL, V81, P922, DOI 10.1152/jappl.1996.81.2.922; Rahn H., 1955, GRAPHICAL ANAL RESP; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SCHAFFARTZIK W, 1992, J APPL PHYSIOL, V72, P1657, DOI 10.1152/jappl.1992.72.5.1657; Scherrer U, 1999, ADV EXP MED BIOL, V474, P93; SINGH I, 1965, LANCET, V1, P229; Steinacker JM, 1998, EUR RESPIR J, V11, P643; VISWANATHAN R, 1969, AM REV RESPIR DIS, V100, P334, DOI 10.1164/arrd.1969.100.3.334; VISWANATHAN R, 1978, RESPIRATION, V36, P216, DOI 10.1159/000193953; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1992, INT J SPORTS MED, V13, P54; WEST JB, 1995, PULMONARY PATHOPHYSI	29	138	146	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					303	309		10.1016/S0140-6736(02)07496-2	http://dx.doi.org/10.1016/S0140-6736(02)07496-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830197				2022-12-01	WOS:000173588100011
J	Hibberd, JM; Quick, WP				Hibberd, JM; Quick, WP			Characteristics of C-4 photosynthesis in stems and petioles of C-3 flowering plants	NATURE			English	Article							DISSOLVED INORGANIC CARBON; PHOTORESPIRATORY ENZYMES; BUNDLE-SHEATH; METABOLISM; GROWTH; LOCALIZATION; RHIZOSPHERE; TOBACCO; LEAVES; CELLS	Most plants are known as C-3 plants because the first product of photosynthetic CO2 fixation is a three-carbon compound(1). C-4 plants, which use an alternative pathway in which the first product is a four-carbon compound, have evolved independently many times and are found in at least 18 families(2,3). In addition to differences in their biochemistry, photosynthetic organs of C-4 plants show alterations in their anatomy and ultrastructure(4). Little is known about whether the biochemical or anatomical characteristics of C-4 photosynthesis evolved first. Here we report that tobacco, a typical C-3 plant, shows characteristics of C-4 photosynthesis in cells of stems and petioles that surround the xylem and phloem, and that these cells are supplied with carbon for photosynthesis from the vascular system and not from stomata. These photosynthetic cells possess high activities of enzymes characteristic of C-4 photosynthesis, which allow the decarboxylation of four-carbon organic acids from the xylem and phloem, thus releasing CO2 for photosynthesis. These biochemical characteristics of C-4 photosynthesis in cells around the vascular bundles of stems of C-3 plants might explain why C-4 photosynthesis has evolved independently many times.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Sheffield, Robert Hill Inst, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Cambridge; University of Sheffield	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk						Ashton AR., 1990, METH PLANT BIOCH, V3, P39, DOI DOI 10.1016/B978-0-12-461013-2.50010-1; BENZIONI A, 1971, PHYSIOL PLANTARUM, V24, P288, DOI 10.1111/j.1399-3054.1971.tb03493.x; CALVIN M, 1951, SYM SOC EXP BIOL, V5, P284; Cramer MD, 1999, NEW PHYTOL, V142, P441, DOI 10.1046/j.1469-8137.1999.00415.x; Cramer MD, 1999, J EXP BOT, V50, P79, DOI 10.1093/jexbot/50.330.79; Esau K., 1965, PLANT ANATOMY; Gao ZF, 1996, PLANT PHYSIOL BIOCH, V34, P807; Gerendas J, 1999, J EXP BOT, V50, P1101, DOI 10.1093/jexbot/50.336.1101; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hibberd JM, 1999, PLANT CELL ENVIRON, V22, P937, DOI 10.1046/j.1365-3040.1999.00462.x; KEELEY JE, 1984, NATURE, V310, P694, DOI 10.1038/310694a0; Keeley JE, 1998, BOT REV, V64, P121, DOI 10.1007/BF02856581; Kinsman EA, 1998, DEVELOPMENT, V125, P1815; Lea PJ., 1999, PLANT BIOCH MOL BIOL; Monson RK, 1999, C4 PLANT BIOL, P377, DOI [10.1016/B978-012614440-6/50012-4, DOI 10.1016/B978-012614440-6/50012-4]; MOORE PD, 1982, NATURE, V310, P696; Nilsen Erik T., 1995, P223, DOI 10.1016/B978-012276460-8/50012-6; Pate J.S., 1975, TRANSPORT PLANTS, P451, DOI 10.1007/978-3-642-66161-7_19; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P139, DOI 10.1111/j.1365-3040.1991.tb01330.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; RAWSTHORNE S, 1988, PLANTA, V173, P298, DOI 10.1007/BF00401016; RAWSTHORNE S, 1988, PLANTA, V176, P527, DOI 10.1007/BF00397660; RAWSTHORNE S, 1992, PLANT J, V2, P267, DOI 10.1111/j.1365-313X.1992.00267.x; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Sage RF, 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; SCHAAF J, 1995, PLANT PHYSIOL, V108, P949, DOI 10.1104/pp.108.3.949; THOMAS JC, 1992, PLANT PHYSIOL, V98, P626, DOI 10.1104/pp.98.2.626; Vuorinen AH, 1995, J PLANT PHYSIOL, V147, P236, DOI 10.1016/S0176-1617(11)81510-5; WALKER RP, 1995, PLANTA, V196, P58, DOI 10.1007/BF00193217	30	296	333	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					451	454		10.1038/415451a	http://dx.doi.org/10.1038/415451a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807559	Green Accepted			2022-12-01	WOS:000173433600055
J	Perakis, SS; Hedin, LO				Perakis, SS; Hedin, LO			Nitrogen loss from unpolluted South American forests mainly via dissolved organic compounds	NATURE			English	Article							CARBON SEQUESTRATION; TEMPERATE FOREST; ECOSYSTEMS; SOIL; DEPOSITION; SATURATION; PATTERNS; STORAGE; FLUXES	Conceptual(1-4) and numerical(5-8) models of nitrogen cycling in temperate forests assume that nitrogen is lost from these ecosystems predominantly by way of inorganic forms, such as nitrate and ammonium ions. Of these, nitrate is thought to be particularly mobile, being responsible for nitrogen loss to deep soil and stream waters. But human activities-such as fossil fuel combustion, fertilizer production and land-use change-have substantially altered the nitrogen cycle over large regions(9), making it difficult to separate natural aspects of nitrogen cycling from those induced by human perturbations(10). Here we report stream chemistry data from 100 unpolluted primary forests in temperate South America. Although the sites exhibit a broad range of environmental factors that influence ecosystem nutrient cycles(11-13) (such as climate, parent material, time of ecosystem development, topography and biotic diversity), we observed a remarkably consistent pattern of nitrogen loss across all forests. In contrast to findings from forests in polluted regions, streamwater nitrate concentrations are exceedingly low, such that nitrate to ammonium ratios were less than unity, and dissolved organic nitrogen is responsible for the majority of nitrogen losses from these forests. We therefore suggest that organic nitrogen losses should be considered in models of forest nutrient cycling, which could help to explain observations of nutrient limitation in temperate forest ecosystems.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Perakis, SS (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, 3200 SW Jefferson Way, Corvallis, OR 97331 USA.	sperakis@usgs.gov						Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; AGUILAR R, 1985, SOIL SCI SOC AM J, V49, P695, DOI 10.2136/sssaj1985.03615995004900030034x; ALABACK PB, 1991, REV CHIL HIST NAT, V64, P399; ALMEYDA AE, 1958, RECOPILACION DATOS C; Campbell JL, 2000, BIOGEOCHEMISTRY, V49, P123, DOI 10.1023/A:1006383731753; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Goodale CL, 2000, ECOSYSTEMS, V3, P433, DOI 10.1007/s100210000039; GORHAM E, 1961, GEOL SOC AM BULL, V72, P795, DOI 10.1130/0016-7606(1961)72[795:FISOMI]2.0.CO;2; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Jenny H., 1941, FACTORS SOIL FORMATI; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; Mcdowell WH, 1998, WATER AIR SOIL POLL, V105, P175, DOI 10.1023/A:1005032904590; McGuire AD, 1997, GLOBAL BIOGEOCHEM CY, V11, P173, DOI 10.1029/97GB00059; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Nodvin SC, 1995, WATER AIR SOIL POLL, V85, P1647, DOI 10.1007/BF00477216; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Schimel DS, 1997, P NATL ACAD SCI USA, V94, P8280, DOI 10.1073/pnas.94.16.8280; SOLLINS P, 1980, ECOL MONOGR, V50, P261, DOI 10.2307/2937252; STODDARD JL, 1994, ADV CHEM SER, V237, P223; Tamm CO, 1991, J ECOL, DOI DOI 10.2307/2260680; Veblen Thomas T., 1996, P293; VILLAGRAM C, 1993, QUATERNARY LAKE DIST; Vitousek PM, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P432; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weathers KC, 2000, ECOSYSTEMS, V3, P590, DOI 10.1007/s100210000051	31	498	584	3	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					416	419		10.1038/415416a	http://dx.doi.org/10.1038/415416a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807551				2022-12-01	WOS:000173433600046
J	Zasloff, M				Zasloff, M			Antimicrobial peptides of multicellular organisms	NATURE			English	Review							HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; BETA-DEFENSIN; HOST-DEFENSE; IN-VITRO; ANTIBACTERIAL PEPTIDE; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; INSECT IMMUNITY; EXPRESSION	Multicellular organisms live, by and large, harmoniously with microbes. The cornea of the eye of an animal is almost always free of signs of infection. The insect flourishes without lymphocytes or antibodies. A plant seed germinates successfully in the midst of soil microbes. How is this accomplished? Both animals and plants possess potent, broad-spectrum antimicrobial peptides, which they use to fend off a wide range of microbes, including bacteria, fungi, viruses and protozoa. What sorts of molecules are they? How are they employed by animals in their defence? As our need for new antibiotics becomes more pressing, could we design anti-infective drugs based on the design principles these molecules teach us?	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Zasloff, M (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW, Washington, DC 20007 USA.	maz5@georgetown.edu	akbari, mohammad/O-4200-2017; Abrams, William R/A-5782-2008					AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; BULET P, 1993, J BIOL CHEM, V268, P14893; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Fehlbaum P, 2000, P NATL ACAD SCI USA, V97, P12723, DOI 10.1073/pnas.220424597; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giacometti A, 2000, DIAGN MICR INFEC DIS, V38, P115, DOI 10.1016/S0732-8893(00)00175-9; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Groisman EA, 1998, BIOESSAYS, V20, P96, DOI 10.1002/(SICI)1521-1878(199801)20:1<96::AID-BIES13>3.0.CO;2-3; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Hamuro Y, 1999, J AM CHEM SOC, V121, P12200, DOI 10.1021/ja992728p; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; ROMEO D, 1988, J BIOL CHEM, V263, P9573; Russell JP, 1996, INFECT IMMUN, V64, P1565, DOI 10.1128/IAI.64.5.1565-1568.1996; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shinnar A.E., 1996, P 14 PEPT AM S COL O, P189; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Ulvatne H, 2001, SCAND J INFECT DIS, V33, P507, DOI 10.1080/00365540110026692; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff Michael, 2001, P261	74	6490	6870	91	2255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					389	395		10.1038/415389a	http://dx.doi.org/10.1038/415389a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807545				2022-12-01	WOS:000173433600040
J	Beldade, P; Brakefield, PM; Long, AD				Beldade, P; Brakefield, PM; Long, AD			Contribution of Distal-less to quantitative variation in butterfly eyespots	NATURE			English	Article							DROSOPHILA-MELANOGASTER; BRISTLE NUMBER; BICYCLUS-ANYNANA; EVOLUTION; PATTERNS; WINGS; GENETICS; POLYMORPHISMS; LOCUS	The colour patterns decorating butterfly wings provide ideal material to study the reciprocal interactions between evolution and development. They are visually compelling products of selection, often with a clear adaptive value, and are amenable to a detailed developmental characterization(1). Research on wing-pattern evolution and development has focused on the eyespots of the tropical butterfly Bicyclus anynana(2). There is quantitative variation for several features of eyespot morphology(3-5) but the actual genes contributing to such variation are unknown. On the other hand, studies of gene expression patterns in wing primordia have implicated different developmental pathways in eyespot formation(6-11). To link these two sets of information we need to identify which genes within the implicated pathways contribute to the quantitative variation accessible to natural selection. Here we begin to bridge this gap by demonstrating linkage between DNA polymorphisms in the candidate gene Distal-less (Dll) and eyespot size in B. anynana.	Leiden Univ, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92612 USA	Leiden University; Leiden University - Excl LUMC; University of California System; University of California Irvine	Beldade, P (corresponding author), Leiden Univ, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.		Beldade, Patrícia/E-1970-2011	Beldade, Patrícia/0000-0001-7831-979X; Long, Tony/0000-0002-5007-8514				Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 1999, BIOESSAYS, V21, P391, DOI 10.1002/(SICI)1521-1878(199905)21:5&lt;391::AID-BIES6&gt;3.0.CO;2-Q; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CARROLL SB, 1994, DEVELOPMENT, P217; Doerge RW, 1996, GENETICS, V142, P285; EDWARDS MD, 1987, GENETICS, V116, P113; Falconer DS, 1996, INTRO QUANTITATIVE G; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; LANDER ES, 1989, GENETICS, V121, P185; Long AD, 2000, GENETICS, V154, P1255; LONG AD, 1995, GENETICS, V139, P1273; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Marec F, 1996, INT J INSECT MORPHOL, V25, P205, DOI 10.1016/0020-7322(96)00009-8; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Monteiro A, 1997, GENETICS, V146, P287; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI 10.2307/2410374; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Nijhout HF, 1991, DEV EVOLUTION BUTTER; Palopoli MF, 1996, CURR OPIN GENET DEV, V6, P502, DOI 10.1016/S0959-437X(96)80074-8; PANGANIBAN G, 1994, CURR BIOL, V4, P671, DOI 10.1016/S0960-9822(00)00151-2; Robinson R., 1971, LEPIDOPTERA GENETICS; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wijngaarden PJ, 2000, HEREDITY, V85, P471, DOI 10.1046/j.1365-2540.2000.00786.x	30	108	111	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					315	318		10.1038/415315a	http://dx.doi.org/10.1038/415315a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797007				2022-12-01	WOS:000173293500042
J	Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH				Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH			Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study	LANCET			English	Article							NITRIC-OXIDE SYNTHESIS; L-ARGININE; ENDOGENOUS INHIBITOR; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; HEMODIALYSIS; SYNTHASE; IMPROVES; SERUM	Background The plasma concentration of asymmetrical dimethylarginine (ADMA), an inhibitor of nitric-oxide synthase, which has been linked to endothelial dysfunction and atherosclerosis in the general population, is raised in patients with end-stage renal disease and could contribute to the high cardiovascular risk in patients with chronic renal failure. We investigated the relation between cardiovascular risk factors and plasma ADMA concentration in a cohort of haemodialysis patients (n=225), and tested the predictive power of ADMA for mortality and cardiovascular outcomes. Methods Patients had standard dialysis three times a week. We accurately recorded cardiovascular events over a mean follow-up of 33.4 months (SID 14.6); these events were reviewed by a panel of physicians. We identified correlates of plasma ADMA by univariate and multivariate analyses. Findings On univariate analysis, ADMA concentration in plasma was directly related to concentrations of fibrinogen and L-arginine in plasma, duration of dialysis treatment, and serum cholesterol concentration, and was inversely related to serum albumin concentration. On multivariate analysis, only plasma fibrinogen (p=0.0001) and serum albumin (p=0.04) concentrations were independently related to plasma ADMA concentration (multiple r=0.44, p=0.0001). 83 patients died, 53 (64%) by cardiovascular causes. In a Cox's proportional-hazards model, plasma ADMA ranked as the second factor predicting overall mortality (hazard ratio 1.26, 95% CI 1.11-1.41, p=0.0001) and cardiovascular events (1.17, 1.04-1.33, p=0.008). Interpretation In haemodialysis patients, plasma ADMA is a strong and independent predictor of overall mortality and cardiovascular outcome. These findings lend support to the hypothesis that accumulation of ADMA is an important risk factor for cardiovascular disease in chronic renal failure.	Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pahrmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Hosp San Raffaele, Lab Cromatog & Tecn Separaz, I-20132 Milan, Italy; Univ Catania, Dept Internal Med, I-95124 Catania, Italy; CNR, Ctr Clin Physiol, Reggio Di Calabria, Italy; CNR, Renal Unit, Reggio Di Calabria, Italy	Hannover Medical School; University of Hamburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Boger, RH (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	boeger@uke.uni-hamburg.de	Zoccali, Carmine/B-9445-2009; Cataliotti, Alessandro/G-7607-2012; Malatino, Lorenzo/I-7319-2018; fermo, isabella/AAN-3999-2020	Cataliotti, Alessandro/0000-0001-5476-8523; Malatino, Lorenzo/0000-0003-2944-2729; fermo, isabella/0000-0003-2947-1933; Bode-Boger, Stefanie/0000-0002-5132-6591; Zoccali, Carmine/0000-0002-6616-1996				Anderstam B, 1997, J AM SOC NEPHROL, V8, P1437; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Boger RH, 1997, CIRCULATION, V96, P1282, DOI 10.1161/01.CIR.96.4.1282; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Boger RH, 1998, J AM COLL CARDIOL, V32, P1336, DOI 10.1016/S0735-1097(98)00375-1; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; CAYATTE AJ, 1994, ARTERIOSCLER THROMB, V14, P753, DOI 10.1161/01.ATV.14.5.753; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; DREXLER H, 1991, LANCET, V338, P1546, DOI 10.1016/0140-6736(91)92372-9; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Hand MF, 1998, KIDNEY INT, V53, P1068, DOI 10.1046/j.1523-1755.1998.00851.x; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kari JA, 1997, KIDNEY INT, V52, P468, DOI 10.1038/ki.1997.354; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Levey AS, 1998, AM J KIDNEY DIS, V32, pS5, DOI 10.1053/ajkd.1998.v32.pm9820463; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MacAllister RJ, 1996, NEPHROL DIAL TRANSPL, V11, P2449, DOI 10.1093/oxfordjournals.ndt.a027213; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NIH, 1997, US REN DAT SYST 1997; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; VALLANCE P, 1992, LANCET, V339, P572; YU XJ, 1994, LIFE SCI, V54, P753, DOI 10.1016/0024-3205(94)00443-9; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.454; Zoccali C, 1999, J HYPERTENS, V17, P1751, DOI 10.1097/00004872-199917120-00013	29	898	925	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2113	2117		10.1016/S0140-6736(01)07217-8	http://dx.doi.org/10.1016/S0140-6736(01)07217-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784625				2022-12-01	WOS:000172905800009
J	Oh, K; Jeong, KS; Moore, JS				Oh, K; Jeong, KS; Moore, JS			Folding-driven synthesis of oligomers	NATURE			English	Article							VIRTUAL COMBINATORIAL LIBRARIES; MOLECULES; POLYMERS	The biological function of biomacromolecules such as DNA and enzymes depends on their ability to perform and control molecular association, catalysis, self-replication or other chemical processes. In the case of proteins in particular, the dependence of these functions on the three-dimensional protein conformation is long known(1) and has inspired the development of synthetic oligomers and polymers with the capacity to fold in a controlled manner(2-7), but it remains challenging to design these so-called 'foldamers' so that they are capable of inducing or controlling chemical processes and interactions(8,9). Here we show that the stability gained from folding can be used to control the synthesis of oligomers from short chain segments reversibly ligated through an imine metathesis reaction. That is, folding shifts the ligation equilibrium(10-13) in favour of conformationally ordered sequences, so that oligomers having the most stable solution structures form preferentially. Crystallization has previously been used to shift an equilibrium in order to indirectly influence the synthesis of small molecules(14), but the present approach to selectively prepare macromolecules with stable conformations directly connects folding and synthesis, emphasizing molecular function rather than structure in polymer synthesis.	Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Moore, JS (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.			Jeong, Kyu-Sung/0000-0003-1023-1796				Berl V, 2000, NATURE, V407, P720, DOI 10.1038/35037545; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GOODMAN M, 1969, P NATL ACAD SCI USA, V64, P444, DOI 10.1073/pnas.64.2.444; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huc I, 1997, P NATL ACAD SCI USA, V94, P2106, DOI 10.1073/pnas.94.6.2106; Katz TJ, 2000, ANGEW CHEM INT EDIT, V39, P1921, DOI 10.1002/1521-3773(20000602)39:11<1921::AID-ANIE1921>3.0.CO;2-F; Kirshenbaum K, 1999, CURR OPIN STRUC BIOL, V9, P530, DOI 10.1016/S0959-440X(99)80075-X; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Moore JS, 2000, ORG LETT, V2, P915, DOI 10.1021/ol0055723; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Prince RB, 1999, J AM CHEM SOC, V121, P3114, DOI 10.1021/ja983995i; Stigers KD, 1999, CURR OPIN CHEM BIOL, V3, P714, DOI 10.1016/S1367-5931(99)00030-7; TOTH G, 1974, TETRAHEDRON LETT, V15, P735; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; WOODWARD RB, 1952, J AM CHEM SOC, V74, P4223, DOI 10.1021/ja01137a001; ZHANG JS, 1994, J AM CHEM SOC, V116, P4227, DOI 10.1021/ja00089a012	20	161	161	0	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					889	893		10.1038/414889a	http://dx.doi.org/10.1038/414889a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780057				2022-12-01	WOS:000172813300040
J	Huelsenbeck, JP; Ronquist, F; Nielsen, R; Bollback, JP				Huelsenbeck, JP; Ronquist, F; Nielsen, R; Bollback, JP			Evolution - Bayesian inference of phylogeny and its impact on evolutionary biology	SCIENCE			English	Review							MAXIMUM-LIKELIHOOD-ESTIMATION; AMINO-ACID SITES; MARKOV-CHAINS; SEQUENCES; GENE; SUBSTITUTION; MODELS; RATES; SELECTION; TREES	As a discipline, phylogenetics is becoming transformed by a flood of molecular data. These data allow broad questions to be asked about the history of life, but also present difficult statistical and computational problems. Bayesian inference of phyto logeny brings a new perspective to a number of outstanding issues in evolutionary biology, including the analysis of large phylogenetic trees and complex evolutionary models and the detection of the footprint of natural selection in DNA sequences.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Uppsala Univ, Evolutionary Biol Ctr, Dept Syst Zool, SE-75236 Uppsala, Sweden; Cornell Univ, Dept Biometr, Ithaca, NY 14853 USA	University of Rochester; Uppsala University; Cornell University	Huelsenbeck, JP (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.		Nielsen, Rasmus/D-4405-2009; Ronquist, Fredrik/Q-2013-2015; Huelsenbeck, John P/C-6398-2013	Nielsen, Rasmus/0000-0003-0513-6591; Ronquist, Fredrik/0000-0002-3929-251X; 				Atrian S, 1998, J MOL EVOL, V47, P211, DOI 10.1007/PL00006378; Beerli P, 1999, GENETICS, V152, P763; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Clayton DG, 1996, MARKOV CHAIN MONTE C; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1968, THESIS U CHIGAGO; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; GELMAN A, 1995, BAYASIAN DATA ANAL; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Jukes T. H., 1969, MAMMALIAN PROTEIN ME; KUHNER MK, 1995, GENETICS, V140, P1421; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Losos Jonathan B., 1994, P60; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2000, GENETICS, V154, P931; NIELSEN R, IN PRESS P PAC S BIO; Nielsen R. D., UNPUB; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2001, MOL BIOL EVOL, V18, P376, DOI 10.1093/oxfordjournals.molbev.a003813; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	40	2102	2186	4	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2001	294	5550					2310	2314		10.1126/science.1065889	http://dx.doi.org/10.1126/science.1065889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503TT	11743192	Green Submitted			2022-12-01	WOS:000172817200036
J	Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA				Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA			Chameleon radiation by oceanic dispersal	NATURE			English	Article							HISTORICAL BIOGEOGRAPHY; INDIAN-OCEAN; MADAGASCAR; PHYLOGENY; VOLCANISM; REPTILIA; BREAKUP; SKULL	Historical biogeography is dominated by vicariance methods that search for a congruent pattern of fragmentation of ancestral distributions produced by shared Earth history(1-3). A focus of vicariant studies has been austral area relationships and the break-up of the supercontinent Gondwana(3-5). Chameleons are one of the few extant terrestrial vertebrates thought to have biogeographic patterns that are congruent with the Gondwanan break-up of Madagascar and Africa(6,7). Here we show, using molecular and morphological evidence for 52 chameleon taxa, support for a phylogeny and area cladogram that does not fit a simple vicariant history. Oceanic dispersal-not Gondwanan breakup-facilitated species radiation, and the most parsimonious biogeographic hypothesis supports a Madagascan origin for chameleons, with multiple 'out-of-Madagascar' dispersal events to Africa, the Seychelles, the Comoros archipelago, and possibly Reunion Island. Although dispersal is evident in other Indian Ocean terrestrial animal groups(8-16), our study finds substantial out-of-Madagascar species radiation, and further highlights the importance of oceanic dispersal as a potential precursor for speciation.	Amer Museum Nat Hist, New York, NY 10024 USA; SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	American Museum of Natural History (AMNH); Texas State University System; Texas State University San Marcos; University of Michigan System; University of Michigan	Raxworthy, CJ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	rax@amnh.edu						[Anonymous], 1981, SYSTEMATICS BIOGEORA; ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; BLANC C P, 1972, P501; Brown J.H., 1998, BIOGEOGRAPHY; Caccone A, 1999, MOL PHYLOGENET EVOL, V12, P1, DOI 10.1006/mpev.1998.0594; CRISCI JV, 1991, SYST ZOOL, V40, P152, DOI 10.2307/2992254; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Fisher BL, 1996, COLLOQ SEMI, P457; FROST DR, 1989, MISC PUBL U KANSAS M, V81, P1; Griswold Charles E., 2000, P345; Hay WW, 1999, GEOL S AM S, P1; HILLENIUS D, 1978, Beaufortia, V28, P9; HOFMAN A, 1991, Amphibia-Reptilia, V12, P245, DOI 10.1163/156853891X00428; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; KLAVER C, 1986, BONN ZOOL MONOGR, V22, P1; Kluge A. G., 1995, MISC PUBL MUS ZOOL, V183, P1; Mausfeld P, 2000, MOL PHYLOGENET EVOL, V17, P11, DOI 10.1006/mpev.2000.0809; MOODY S, 1980, Vestnik Ustredniho Ustavu Geologickeho, V55, P85; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; RIEPPEL O, 1992, J HERPETOL, V26, P77, DOI 10.2307/1565027; RIEPPEL O, 1987, ZOOL J LINN SOC-LOND, V89, P41, DOI 10.1111/j.1096-3642.1987.tb01343.x; Rieppel O, 1997, J ZOOL, V243, P351, DOI 10.1111/j.1469-7998.1997.tb02788.x; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Trueman JWH, 1998, SYST BIOL, V47, P733, DOI 10.1080/106351598260725; Yoder AD, 1996, COLLOQ SEMI, P245	30	247	258	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					784	787		10.1038/415784a	http://dx.doi.org/10.1038/415784a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845207	Green Published			2022-12-01	WOS:000173833900044
J	Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA				Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA			RNA helicase MUT-14-dependent gene silencing triggered in C-elegans by short antisense RNAs	SCIENCE			English	Article							GERM-LINE DEVELOPMENT; MESSENGER-RNA; UNWINDING RNA; INTERFERENCE; REQUIREMENTS; POLYMERASE; TRANSGENE	Posttranscriptional gene silencing in Caenorhabditis elegans results from exposure to double-stranded RNA (dsRNA), a phenomenon designated as RNA interference (RNAi), or from co-suppression, in which transgenic DNA leads to silencing of both the transgene and the endogenous gene. Here we show that single-stranded RNA oligomers of antisense polarity can also be potent inducers of gene silencing. As is the case for co-suppression, antisense RNAs act independently of the RNAi genes rde-1 and rde-4 but require the mutator/RNAi gene mut-7 and a putative DEAD box RNA helicase, mut-14. Our data favor the hypothesis that gene silencing is accomplished by RNA primer extension using the mRNA as template, leading to dsRNA that is subsequently degraded.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Tijsterman, Marcel/H-5663-2018	Tijsterman, Marcel/0000-0001-8465-9002; Ketting, Rene/0000-0001-6161-5621				Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELBASHIR SM, IN PRESS EMBO J; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	119	213	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					694	697		10.1126/science.1067534	http://dx.doi.org/10.1126/science.1067534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809977				2022-12-01	WOS:000173560900050
J	Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR				Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR			A calcium sensor in the sodium channel modulates cardiac excitability	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; ST-SEGMENT ELEVATION; BRUGADA-SYNDROME; SLOW INACTIVATION; PROTEIN-KINASE; NA+ CHANNEL; CALMODULIN; ARRHYTHMIAS; DEATH; MECHANISM	Sodium channels are principal molecular determinants responsible for myocardial conduction and maintenance of the cardiac rhythm. Calcium ions (Ca2+) have a fundamental role in the coupling of cardiac myocyte excitation and contraction, yet mechanisms whereby intracellular Ca2+ may directly modulate Na channel function have yet to be identified. Here we show that calmodulin (CaM), a ubiquitous Ca2+-sensing protein, binds to the carboxy-terminal 'IQ' domain(1) of the human cardiac Na channel (hH1) in a Ca2+-dependent manner. This binding interaction significantly enhances slow inactivation-a channel-gating process linked to life-threatening idiopathic ventricular arrhythmias(2,3). Mutations targeted to the IQ domain disrupted CaM binding and eliminated Ca2+/CaM-dependent slow inactivation, whereas the gating effects of Ca2+/CaM were restored by intracellular application of a peptide modelled after the IQ domain. A naturally occurring mutation (A1924T) in the IQ domain altered hH1 function in a manner characteristic of the Brugada arrhythmia syndrome(4,5), but at the same time inhibited slow inactivation induced by Ca2+/CaM, yielding a clinically benign (arrhythmia free) phenotype.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37232 USA.		Roden, Dan/ABD-5412-2021; Kupershmidt, Sabina/AAO-5464-2021	Kupershmidt, Sabina/0000-0002-8119-2723				Aimond F, 1999, CARDIOVASC RES, V42, P402, DOI 10.1016/S0008-6363(99)00070-X; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Balser JR, 1999, CIRC RES, V85, P872, DOI 10.1161/01.RES.85.9.872; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; CLUSIN WT, 1983, LANCET, V1, P272, DOI 10.1016/S0140-6736(83)91688-4; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIDIEGO JM, 1994, CIRCULATION, V89, P1839, DOI 10.1161/01.CIR.89.4.1839; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; James P, 1996, GENETICS, V144, P1425; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 1998, BIOPHYS J, V74, P2945, DOI 10.1016/S0006-3495(98)78001-4; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; RUDY B, 1978, J PHYSL, V238, P1; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wilde A, 1999, CIRCULATION, V99, P722; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	30	175	186	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					442	447		10.1038/415442a	http://dx.doi.org/10.1038/415442a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807557				2022-12-01	WOS:000173433600053
J	Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J				Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J			Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FALLING ASLEEP; EPISODES; ATTACKS; DRIVERS; PRAMIPEXOLE; ROPINIROLE; ACCIDENTS	Context Somnolence is a recognized adverse effect of dopamine agonists. Two new dopamine agonists, pramipexole and ropinirole, have been reported to cause sudden-onset sleep spells in patients with Parkinson disease (PD) while they were driving. The frequency of these spells and whether driving should be restricted has yet to be established. Objective To determine the frequency of and predictors for sudden-onset sleep and, particularly, episodes of falling asleep while driving among patients with PD. Design, Setting, and Participants Prospective survey conducted between January and April 2000 in 18 clinics directed by members of the Canadian Movement Disorders Group; 638 consecutive highly functional PD patients without dementia were enrolled, of whom 420 were currently drivers. Main Outcome Measures Excessive daytime sleepiness and sudden-onset sleep as assessed by the Epworth Sleepiness Scale and the Inappropriate Sleep Composite Score. The latter score, designed for this study, addressed falling asleep in unusual circumstances. The 2 scales were combined in 3 separate formats dozing off, sudden unexpected sleep, and sudden blank spells. Results Excessive daytime sleepiness was present overall in 327 (51 %) of the 638 patients and in 213 (51%) of the 420 drivers. Patients taking a variety of different dopamine agonists had no differences in Epworth sleepiness scores, in the composite score, or in the risk of failing asleep while driving. Sixteen patients (3.8%) had experienced at least 1 episode of sudden onset of sleep while driving (after the diagnosis of PD); in 3 (0.7%), it occurred without warning. The 2 risk factors associated with failing asleep at the wheel were the Epworth Sleepiness Scale score (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.06-1.24) and the Inappropriate Sleep Composite Score (OR, 2.54; 95% CI, 1.76-3.66). A standard Epworth Sleepiness Scale score of 7 or higher predicted 75% of episodes of sleep behind the wheel at a specificity of 50% (exclusion of the question related to driving provided 70% sensitivity and 52% specificity), whereas a score of 1 on the Inappropriate Sleep Composite Score generated a sensitivity of 52% and specificity of 82%. Conclusions Excessive daytime sleepiness is common even in patients with PD who are independent and do not have dementia. Sudden-onset sleep without warning is infrequent. The Epworth score has adequate sensitivity for predicting prior episodes of failing asleep while driving and its specificity can be increased by use of the Inappropriate Sleep Composite Score. It is unknown if routinely performing these assessments could be more effective in predicting future risk for these rare sleep attacks. Patients should be warned not to drive if they doze in unusual circumstances.	Univ Manitoba, Dept Med, Div Neurol, Winnipeg, MB, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada; Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	University of Manitoba; University of Toronto; University of Toronto; University of Alberta; University of Sherbrooke; University of British Columbia	Hobson, DE (corresponding author), Winnipeg Clin, 425 St Mary Ave, Winnipeg, MB R3C ON2, Canada.	dhobson@cc.umanitoba.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667; Martin, WR Wayne/0000-0002-3416-691X				Arnulf I, 2000, NEUROLOGY, V55, P281, DOI 10.1212/WNL.55.2.281; DRACHMAN DA, 1988, ANN NEUROL, V24, P787, DOI 10.1002/ana.410240614; EBERSBACH G, 2000, MOV DISORD S3, V15, P89; FACTOR SA, 1990, MOVEMENT DISORD, V5, P280, DOI 10.1002/mds.870050404; Ferreira JJ, 2000, LANCET, V355, P1333, DOI 10.1016/S0140-6736(00)02119-X; Ferreira JJ, 2000, MOV DISORD S3, V15, P128; Ferreira JJ, 2000, MOV DISORD S3, V15, P187; FERREIRA JJ, 2000, MOVEMENT DISORD, V15, P129; Frucht S, 2000, NEUROLOGY, V54, P276; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Gottwald MD, 1997, ANN PHARMACOTHER, V31, P1205, DOI 10.1177/106002809703101014; Hauser RA, 2000, MOVEMENT DISORD, V15, P658, DOI 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N; Hobson DE, 1999, CAN J NEUROL SCI, V26, pS27, DOI 10.1017/S0317167100000068; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HOMANN CN, 2000, MOVEMENT DISORD, V15, P108; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Horne JA, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00222.x; ITOI A, 1993, CAND RIVERS AVOID FA; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Karlsen K, 1999, MOVEMENT DISORD, V14, P237, DOI 10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.3.CO;2-O; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Maycock G, 1997, ACCIDENT ANAL PREV, V29, P453, DOI 10.1016/S0001-4575(97)00024-9; Montastruc JL, 2000, MOVEMENT DISORD, V15, P361, DOI 10.1002/1531-8257(200003)15:2<361::AID-MDS1034>3.0.CO;2-J; Natl Ctr Sleep Disorders Res Working Grp, 1999, AM FAM PHYSICIAN, V59, P937; NAUSIEDA PA, 1987, HDB PARKINSONS DISEA, P371; Olanow CW, 2000, MOVEMENT DISORD, V15, P212, DOI 10.1002/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6; PALADINI D, 2000, MOV DISORD S3, V15, P130; Parkinson Study Group, 2000, JAMA, V284, P1931; Partinen R, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160564; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Ryan M, 2000, PHARMACOTHERAPY, V20, P724, DOI 10.1592/phco.20.7.724.35181; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schapira AHV, 2000, LANCET, V355, P1332, DOI 10.1016/S0140-6736(00)02118-8; Schwab R.S., 1969, 3 S PARKINSONS DIS, P152; STIASNY K, 2000, MOV DISORD S3, V15, P114; Stocchi F, 1998, J NEUROL, V245, pS15, DOI 10.1007/PL00007731; Tracik F, 2001, MOVEMENT DISORD, V16, P500, DOI 10.1002/mds.1083	38	410	432	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					455	463		10.1001/jama.287.4.455	http://dx.doi.org/10.1001/jama.287.4.455			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798367	Bronze			2022-12-01	WOS:000173401900022
J	Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A				Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A			Detection of carbonates in dust shells around evolved stars	NATURE			English	Article							INTERSTELLAR SILICATE MINERALOGY; PLANETARY-NEBULA; ISO SPECTRUM; NGC-6302; ICE; BODIES; STEPS; DISKS	Carbonates on large Solar System bodies like Earth and Mars 1,2 (the latter represented by the meteorite ALH84001) form through the weathering of silicates in a watery (CO3)(2-) solution. The presence of carbonates in interplanetary dust particles and asteroids (again, represented by meteorites) is not completely understood, but has been attributed to aqueous alteration on a large parent body, which was subsequently shattered into smaller pieces. Despite efforts(3-5), the presence of carbonates outside the Solar System has hitherto not been established(6,7). Here we report the discovery of the carbonates calcite and dolomite in the dust shells of evolved stars, where the conditions are too primitive for the formation of large parent bodies with liquid water. These carbonates, therefore, are not formed by aqueous alteration, but perhaps through processes on the surfaces of dust or ice grains or gas phase condensation. The presence of carbonates which did not form by aqueous alteration suggests that some of the carbonates found in Solar System bodies no longer provide direct evidence that liquid water was present on large parent bodies early in the history of the Solar System(8).	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Univ Jena, Inst Astrophys & Univ Observ, D-07745 Jena, Germany; Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Heverlee, Belgium; Georgia Tech, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; ESA, ESTEC, Solar Syst Div, NL-2201 AZ Noordwijk, Netherlands; UCL, Dept Phys & Astron, London WC1E 6BT, England; Rutherford Appleton Lab, Dept Space Sci, Didcot OX11 0QX, Oxon, England	University of Amsterdam; Friedrich Schiller University of Jena; KU Leuven; University System of Georgia; Georgia Institute of Technology; European Space Agency; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Kemper, F (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.	ciska@science.uva.nl	Kemper, Francisca/AAZ-8274-2020; Henning, Thomas K/O-4372-2018; Barlow, Michael J/A-5638-2009	Kemper, Francisca/0000-0003-2743-8240; Henning, Thomas K/0000-0002-1493-300X; Barlow, Michael J/0000-0002-3875-1171				BERTIE JE, 1969, J CHEM PHYS, V50, P4501, DOI 10.1063/1.1670922; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; CORRADI RLM, 1993, ASTRON ASTROPHYS, V269, P462; Endress M, 1996, NATURE, V379, P701, DOI 10.1038/379701a0; GILLETT FC, 1973, ASTROPHYS J, V183, P87, DOI 10.1086/152211; Gonzalez-Alfonso E, 1999, ASTROPHYS J, V525, P845, DOI 10.1086/307909; Henning T, 1996, ASTRON ASTROPHYS, V311, P291; JAGER C, 1994, ASTRON ASTROPHYS, V292, P641; Jager C, 1998, ASTRON ASTROPHYS, V339, P904; Keane JV, 2001, ASTRON ASTROPHYS, V376, P254, DOI 10.1051/0004-6361:20010936; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Koike C, 2000, ASTRON ASTROPHYS, V363, P1115; KOIKE C, 1999, P 32 ISAS LUN PLAN S, V32, P175, DOI DOI 10.1051/0004-6361:20053256; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; LESTER DF, 1984, ASTROPHYS J, V281, pL67, DOI 10.1086/184287; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Molster FJ, 1999, NATURE, V401, P563, DOI 10.1038/44085; Molster FJ, 2001, ASTRON ASTROPHYS, V372, P165, DOI 10.1051/0004-6361:20010465; PAYNE HE, 1988, ASTROPHYS J, V326, P368, DOI 10.1086/166098; PENMAN JM, 1976, MON NOT R ASTRON SOC, V176, P539, DOI 10.1093/mnras/176.3.539; POPE KO, 1996, LUNAR PLANET SCI, V27, P1045; Pottasch SR, 1999, ASTRON ASTROPHYS, V347, P975; RIETMEIJER FJM, 1985, NATURE, V313, P293, DOI 10.1038/313293a0; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Scott ERD, 1998, METEORIT PLANET SCI, V33, P709, DOI 10.1111/j.1945-5100.1998.tb01677.x; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361	28	85	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					295	297		10.1038/415295a	http://dx.doi.org/10.1038/415295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797000				2022-12-01	WOS:000173293500035
J	Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA				Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA		MIRAGE Study Grp	Risk of dementia among white and African American relatives of patients with Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-E GENOTYPE; FAMILIAL AGGREGATION; HEAD-INJURY; AGE; METAANALYSIS; ASSOCIATION; POPULATION; DIAGNOSIS; MIRAGE; STATEMENT	Context Evidence exists that the incidence of Alzheimer disease (AD), as well as risk attributable to specific genetic factors such as apolipoprotein E (APOE) genotype, may vary considerably among ethnic groups. Family studies of probands with AD offer an opportunity to evaluate lifetime risk of dementia among relatives of these probands. Objective To compare lifetime dementia risk estimates among relatives of white and African American probands with probable or definite AD. Design and Setting Risk analysis using data collected by questionnaire and supplemental records between May 1991 and March 2001 at 17 medical centers contributing to the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study. Participants A total of 17639 first-degree biological relatives and 2474 spouses of 2339 white AD probands, and 2281 first-degree biological relatives and 257 spouses of 255 African American AD probands. Main Outcome Measures Cumulative risk of dementia by age 85 years, stratified by ethnicity and sex of relatives and by APOE genotype of probands. Results Cumulative risk of dementia in first-degree biological relatives of African American AD probands by age 85 years was 43.7% (SE, 3.1%), and the corresponding risk in first-degree biological relatives of white AD probands was 26.9% (SE, 0.8%), yielding a relative risk (RR) of 1.6 (95% confidence interval [CI], 1.4-1.9; P<.001). The risk in spouses of African American AD probands of 18.5% (SE, 8.4%) was also higher than the risk in white spouses of 10.4% (SE, 1.7%) but did not reach statistical significance (RR, 1.8; 95% CI, 0.5-6.0; P=.34), likely due to the smaller sample size of African Americans. The proportional increase in risk of dementia among white first-degree biological relatives compared with white spouses of 2.6 (95% CI, 2.1-3.2) was similar to that of 2.4 (95% CI, 1.3-4.4) in African American first-degree biological relatives compared with African American spouses. Female first-degree biological relatives of probands had a higher risk of developing dementia than did their male counterparts, among whites (31.2% vs 20.4%; RR, 1.5; 95% CI, 1.3-1.7; P<.001) as well as among African Americans, although this was not significant among African Americans (46.7% vs 40.1%; RR, 1.2; 95% CI, 0.9-1.7, P=.30). The patterns of risk among first-degree biological relatives stratified by APOE genotype of the probands were similar in white families and African American families. Conclusion First-degree relatives of African Americans with AD have a higher cumulative risk of dementia than do those of whites with AD. However, in this study, the additional risk of dementia conferred by being a first-degree relative, by being female, or by the probability of having an APOE epsilon4 allele appeared similar in African American and white families. These data provide estimates of dementia risk that can be used to offer counseling to family members of patients with AD.	Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; Morehouse Sch Med, Dept Pharmacol, Atlanta, GA 30310 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA	Boston University; Boston University; Boston University; Boston University; Boston University; University of Alabama System; University of Alabama Birmingham; Morehouse School of Medicine; Morehouse School of Medicine; Mayo Clinic; Medical University of South Carolina	Green, RC (corresponding author), Boston Univ, Sch Med, Genet Program, 715 Albany St,L-320, Boston, MA 02118 USA.		Farrer, Lindsay/AAS-1035-2020	Cupples, L. Adrienne/0000-0003-0273-7965; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009029, P30AG013846] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG/AG02213] Funding Source: Medline; NIA NIH HHS [AG13846, AG09029] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BALLARD EL, 1993, GERONTOLOGIST, V33, P561, DOI 10.1093/geront/33.4.561; BELGRAVE LL, 1993, GERONTOLOGIST, V33, P379, DOI 10.1093/geront/33.3.379; Brodaty H, 1995, ALZ DIS ASSOC DIS, V9, P182; Connell CM, 1997, GERONTOLOGIST, V37, P355, DOI 10.1093/geront/37.3.355; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; Demissie S, 2001, NEUROEPIDEMIOLOGY, V20, P105, DOI 10.1159/000054768; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P72, DOI 10.1001/archneur.57.1.72; Devi G, 1999, NEUROLOGY, V53, P789, DOI 10.1212/WNL.53.4.789; Devi G, 1998, GENET EPIDEMIOL, V15, P215, DOI 10.1002/(SICI)1098-2272(1998)15:3<215::AID-GEPI1>3.0.CO;2-3; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1994, NEUROLOGY, V44, P652, DOI 10.1212/WNL.44.4.652; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GRAFFRADFORD N, IN PRESS ARCH NEUROL; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; LOVESTONE S, 1995, INT J GERIATR PSYCH, V10, P1; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; McConnell LM, 1998, NAT MED, V4, P757, DOI 10.1038/nm0798-757; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; RELKIN NR, 1996, NEUROL ALERT, V14, P58; Sahota A, 1997, ANN NEUROL, V42, P659, DOI 10.1002/ana.410420418; Sayi JG, 1997, E AFR MED J, V74, P668; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; *US BUR CENS, 1991, CENS POP HOUS 1990 S; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	40	250	254	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					329	336		10.1001/jama.287.3.329	http://dx.doi.org/10.1001/jama.287.3.329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790212	Bronze			2022-12-01	WOS:000173294700027
J	Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L				Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L			Stage-specific transcription of distinct repertoires of a multigene family during plasmodium life cycle	SCIENCE			English	Article							YOELII RHOPTRY PROTEIN; MALARIA PARASITE; RODENT MALARIA; FALCIPARUM; VIVAX; GENE; IDENTIFICATION; MEROZOITES; SELECTION; INVASION	Members of a multigene family in the rodent malaria parasite Plasmodium yoelii yoelli code for 235-kilodalton proteins (Py235) that are located in the merozoite apical complex, are implicated in virulence, and may determine red blood cell specificity. We show that distinct subsets of py235 genes are expressed in sporozoites and hepatic and erythrocytic stages, Antibodies to Py235 inhibited sporozoite invasion of hepatocytes, The switch in expression profile occurred immediately after transition from one stage to another, The results suggest that this differential expression is driven by strong biological requirements and provide evidence that hepatic and erythrocytic merozoites differ.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Univ Paris 05, Hop Cochin, Inst Cochin Genet Mol, Dept Immunol,INSERM,U445, F-75014 Paris, France; Natl Museum Nat Hist, Lab Biol Parasitaire, F-75231 Paris, France; Inst Pasteur, Unite Parasitol Biomed, F-75724 Paris 15, France	MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Preiser, PR (corresponding author), Natl Inst Med Res, Div Parasitol, Ridgeway, London NW7 1AA, England.		Holder, Anthony A/A-7554-2013; Snounou, Georges/F-3352-2011; Costa, Fabio/E-1181-2012; Preiser, Peter R/A-2201-2011; Renia, Laurent/E-2117-2011	Holder, Anthony A/0000-0002-8490-6058; Snounou, Georges/0000-0002-6133-6398; Costa, Fabio/0000-0001-9969-7300; Renia, Laurent/0000-0003-0349-1557; Khan, Shahid/0000-0002-0533-4670; , Peter/0000-0003-4331-7000	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2000, MOL BIOCHEM PARASIT, V108, P257, DOI 10.1016/S0166-6851(00)00219-X; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; KEEN J, 1990, MOL BIOCHEM PARASIT, V42, P241, DOI 10.1016/0166-6851(90)90167-K; KEEN JK, 1994, MOL BIOCHEM PARASIT, V65, P171, DOI 10.1016/0166-6851(94)90125-2; Khan SM, 2001, MOL BIOCHEM PARASIT, V114, P197, DOI 10.1016/S0166-6851(01)00253-5; Landau Irene, 1998, P401; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; Narum DL, 2001, MOL BIOCHEM PARASIT, V112, P193, DOI 10.1016/S0166-6851(00)00363-7; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Owen CA, 1999, MOL BIOCHEM PARASIT, V99, P183, DOI 10.1016/S0166-6851(99)00015-8; Preiser PR, 1998, EXP PARASITOL, V89, P50, DOI 10.1006/expr.1998.4259; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; PREISER PR, UNPUB; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; RENIA L, UNPUB; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Sinha KA, 1996, MOL BIOCHEM PARASIT, V76, P329, DOI 10.1016/0166-6851(95)02546-4; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Thompson J, 1999, MOL MICROBIOL, V31, P253, DOI 10.1046/j.1365-2958.1999.01167.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001	33	59	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					342	345		10.1126/science.1064938	http://dx.doi.org/10.1126/science.1064938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786645				2022-12-01	WOS:000173278600054
J	Fehr, E; Gachter, S				Fehr, E; Gachter, S			Altruistic punishment in humans	NATURE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; HANDICAP	Human cooperation is an evolutionary puzzle. Unlike other creatures, people frequently cooperate with genetically unrelated strangers, often in large groups, with people they will never meet again, and when reputation gains are small or absent. These patterns of cooperation cannot be explained by the nepotistic motives associated with the evolutionary theory of kin selection and the selfish motives associated with signalling theory or the theory of reciprocal altruism. Here we show experimentally that the altruistic punishment of defectors is a key motive for the explanation of cooperation. Altruistic punishment means that individuals punish, although the punishment is costly for them and yields no material gain. We show that cooperation flourishes if altruistic punishment is possible, and breaks down if it is ruled out. The evidence indicates that negative emotions towards defectors are the proximate mechanism behind altruistic punishment. These results suggest that future study of the evolution of human cooperation should include a strong focus on explaining altruistic punishment.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ St Gallen, FEW HSG, CH-9000 St Gallen, Switzerland	University of Zurich; University of St Gallen	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.		Osuna, Luis E/A-5858-2010; Gachter, Simon/C-9787-2009	Gachter, Simon/0000-0002-7182-8505				Alexander RD, 1987, BIOL MORAL SYSTEMS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod Robert K., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BOYD R, IN PRESS EVOLUTION C; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; FISCHBACHER U, 1999, 21 U ZUR I EMP RES E; Frank R.H., 1988, PASSIONS REASON STRA; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heckathorn DD., 1989, RATION SOC, V1, P78, DOI [10.1177/1043463189001001006, DOI 10.1177/1043463189001001006]; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; HIRSHLEIFER J, 1987, LATEST BEST ESSAYS E; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; NOWAK MA, 1995, SCI AM, V272, P76, DOI 10.1038/scientificamerican0695-76; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Richerson P. J., 1998, INDOCTRINABILITY IDE, P71; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Smuts B. B., 1987, PRIMATE SOC; Sober E., 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	28	3329	3406	28	1145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					137	140		10.1038/415137a	http://dx.doi.org/10.1038/415137a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509PR	11805825				2022-12-01	WOS:000173159300032
J	Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP				Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP			Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							S-TRANSFERASE-THETA; LUNG-CANCER; HOMOZYGOUS DELETION; GESTATIONAL-AGE; PRETERM BIRTH; SUSCEPTIBILITY; CYP1A1; OUTCOMES; SMOKERS; RISK	Context Little is known about genetic susceptibility to cigarette smoke in relation to adverse pregnancy outcomes. Objective To investigate whether the association between maternal cigarette smoking and infant birth weight differs by polymorphisms of 2 maternal metabolic genes: CYP1A1 and GSTT1. Design, Setting, and Participants Case-control study conducted in 1998-2000 among 741 mothers (174 ever smokers and 567 never smokers) who delivered singleton live births at Boston Medical Center. A total of 207 cases were preterm or low-birth-weight infants and 534 were non-low-birth-weight, full-term infants (control). Main Outcome Measure Birth weight, gestation, fetal growth by smoking status and CYP1A1 Mspl (AA vs Aa and aa, where Aa and as were combined because of small numbers of as and similar results), and GSTT1 (present vs absent) genotypes. Results Without consideration of genotype, continuous maternal smoking during pregnancy was associated with a mean reduction of 377 g (SE, 89 g) in birth weight (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.2-3.7). When CYP1A1 genotype was considered, the estimated reduction in birth weight was 252 g (SE, 111 g) for the AA genotype group (n = 75; OR, 1.3; 95% CI, 0.6-2.6); but was 520 g (SE, 124 g) for the Aa/aa genotype group (n=43 for Aa, n=6 for aa; OR, 3.2; 95% CI, 1.6-6.4). When GSTT1 genotype was considered, the estimated reduction in birth weight was 285 g (SE, 99 g) (OR, 1.7; 95% CI, 0.9-3.2) and 642 g (SE, 154 g) (OR, 3.5; 95% Cl, 1.5-8.3) for the present and absent genotype groups, respectively. When both CYP1A1 and GSTT1 genotypes were considered, the,greatest reduction in birth weight was found among smoking mothers with the CYP1A1 Aa/aa and GSTT1 absent genotypes (-1285 g; SE, 234 g; P<.001). Among never smokers,, genotype did not independently confer an adverse effect. A similar pattern emerged in analyses stratified by maternal ethnicity and in analyses for gestation. Conclusions In our study, maternal CYP1A1 and GSTT1 genotypes modified the association between maternal cigarette smoking and infant birth weight, suggesting an interaction between metabolic genes and cigarette smoking.	Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Beijing Med Univ, Ctr Ecogenet & Reprod Hlth, Beijing 100083, Peoples R China	Boston University; Boston University; Boston Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Peking University	Wang, XB (corresponding author), Boston Univ, Sch Med, Dept Pediat, 91 E Concord St,Matern 4, Boston, MA 02118 USA.		Wang, Guoying/F-8908-2011	Zuckerman, Barry/0000-0002-0044-2592; Bauchner, Howard/0000-0002-8368-9805				ALEXANDROV K, 1992, CANCER RES, V52, P6248; Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3; BARTSCH H, 1995, PHARMACOGENETICS, V5, pS84, DOI 10.1097/00008571-199512001-00007; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; DOLANMULLEN P, 1994, AM J OBSTET GYNECOL, V171, P1328, DOI 10.1016/0002-9378(94)90156-2; EVERSON RB, 1988, J NATL CANCER I, V80, P567, DOI 10.1093/jnci/80.8.567; Fennell TR, 2000, CANCER EPIDEM BIOMAR, V9, P705; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; HAYASHI S, 1992, JPN J CANCER RES, V83, P866, DOI 10.1111/j.1349-7006.1992.tb01992.x; Hellerstedt WL, 1997, AM J PUBLIC HEALTH, V87, P591, DOI 10.2105/AJPH.87.4.591; Ishibe N, 1997, CANCER EPIDEM BIOMAR, V6, P1075; KATOH T, 1995, CARCINOGENESIS, V16, P655, DOI 10.1093/carcin/16.3.655; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; KRAMER MS, 1987, PEDIATRICS, V80, P502; LANDI MT, 1994, PHARMACOGENETICS, V4, P242, DOI 10.1097/00008571-199410000-00002; Meis PJ, 1997, PAEDIATR PERINAT EP, V11, P287, DOI 10.1111/j.1365-3016.1997.tb00006.x; NAKACHI K, 1993, CANCER RES, V53, P2994; National Research Council, 1983, POL AR HYDR EV SOURC, P197; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Peacock JL, 1998, INT J EPIDEMIOL, V27, P647, DOI 10.1093/ije/27.4.647; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Perera FP, 1999, ENVIRON HEALTH PERSP, V107, P451, DOI 10.1289/ehp.99107s3451; Pollack H, 2000, AM J PUBLIC HEALTH, V90, P395, DOI 10.2105/AJPH.90.3.395; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Sambrook J., 1989, MOL CLONING LAB MANU; SCHRODER KR, 1995, ARCH TOXICOL, V69, P505, DOI 10.1007/s002040050205; TIMBRELL JA, 1991, PRINCIPLES BIOCH TOX; Umbach DM, 2000, AM J EPIDEMIOL, V152, P701, DOI 10.1093/aje/152.8.701; *US DEP HHS, 1990, HLTH BEN SMOK CESS R, P367; Wang XB, 2000, AM J EPIDEMIOL, V152, P693, DOI 10.1093/aje/152.8.693; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978; Wang XB, 1995, NEW ENGL J MED, V333, P1744, DOI 10.1056/NEJM199512283332606; WIENCKE JK, 1995, CANCER EPIDEM BIOMAR, V4, P253; Xu XP, 1998, AM J IND MED, V33, P157, DOI 10.1002/(SICI)1097-0274(199802)33:2<157::AID-AJIM7>3.3.CO;2-V; Xu XP, 1996, CANCER EPIDEM BIOMAR, V5, P687	42	436	455	2	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					195	202		10.1001/jama.287.2.195	http://dx.doi.org/10.1001/jama.287.2.195			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779261	Bronze			2022-12-01	WOS:000173114900021
J	Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R				Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R			Tumstatin, an endothelial cell-specific inhibitor of protein synthesis	SCIENCE			English	Article							CAP-DEPENDENT INITIATION; ALPHA(V)BETA(3) INTEGRIN; PHOSPHORYLATION; RAPAMYCIN; KINASE; ANGIOGENESIS; TRANSLATION; TARGET	Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions as an endothelial cell-specific inhibitor of protein synthesis. Through a requisite interaction with alphaV beta3 integrin, tumstatin inhibits activation of focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-binding protein 1. These results establish a rote for integrins in mediating ceti-specific inhibition of cap-dependent protein synthesis and suggest a potential mechanism for tumstatin's selective effects on endothelial cells.	Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Pharmacol, Boston, MA 02215 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1V6, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; McGill University; McGill University	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA.	rkalluri@caregroup.harvard.edu	Kahn, Ronald/AAY-2435-2021; Kalluri, Raghu/E-2677-2015	Kahn, Ronald/0000-0002-7583-9228; Kalluri, Raghu/0000-0002-2190-547X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051711] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL66105] Funding Source: Medline; NIDDK NIH HHS [DK-55001, DK-51711] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beretta L, 1996, J VIROL, V70, P8993, DOI 10.1128/JVI.70.12.8993-8996.1996; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Bushell M, 1999, FEBS LETT, V451, P332, DOI 10.1016/S0014-5793(99)00614-6; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; LIVELY JC, UNPUB; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SUDHAKAR A, UNPUB; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433	26	356	408	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					140	143		10.1126/science.1065298	http://dx.doi.org/10.1126/science.1065298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778052				2022-12-01	WOS:000173143100053
J	Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA				Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA			Satellite tagging - Expanded niche for white sharks	NATURE			English	Article							TRACKING; TAGS		Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Point Reyes Bird Observ, Stinson Beach, CA 94970 USA	Stanford University; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz	Boustany, AM (corresponding author), Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.							Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fischer W., 1984, FAO SPECIES IDENTIFI, P1; Goldman KJ, 1996, GREAT WHITE SHARKS, P111, DOI 10.1016/B978-012415031-7/50012-4; Hill Roger D., 1994, P227; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Taylor L., 1985, Memoirs of the Southern California Academy of Sciences, V9, P41; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	12	180	185	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					35	36		10.1038/415035b	http://dx.doi.org/10.1038/415035b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780105				2022-12-01	WOS:000173028800028
J	Kiger, AA; Jones, DL; Schulz, C; Rogers, MB; Fuller, MT				Kiger, AA; Jones, DL; Schulz, C; Rogers, MB; Fuller, MT			Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue	SCIENCE			English	Article							DROSOPHILA SPERMATOGENESIS; PROTEIN; KINASE; PROLIFERATION; MELANOGASTER; EXPRESSION; ENCODES; OVARY; FATE; EYE	Stem cells generate many differentiated, short-lived cell types, such as blood, skin, and sperm, throughout adult life. Stem cells maintain a tong-term capacity to divide, producing daughter cells that either self-renew or initiate differentiation. Although the surrounding microenvironment or "niche" influences stem cell fate decisions, few signals that emanate from the niche to specify stem cell self-renewal have been identified. Here we demonstrate that the apical hub cells in the Drosophila testis act as a cellular niche that supports stem cell self-renewal. Hub cells express the ligand Unpaired (Upd), which activates the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway in adjacent germ cells to specify self-renewal and continual maintenance of the germ line stem cell population.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Fuller, Margaret T/0000-0002-3804-4987	NICHD NIH HHS [HD07493] Funding Source: Medline; NIDDK NIH HHS [P01-DK53074] Funding Source: Medline; NIGMS NIH HHS [R01 GM078176, GM07790-22] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078176, T32GM007790] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Gonczy P, 1996, DEVELOPMENT, V122, P2437; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jones D. B., UNPUB; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; KIGER AA, UNPUB; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li M., UNPUB; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; LUSCHNIG S, UNPUB; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	25	505	531	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2542	2545		10.1126/science.1066707	http://dx.doi.org/10.1126/science.1066707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11752574				2022-12-01	WOS:000172927700057
J	Cao, YX; Bonizzi, G; Seagroves, TN; Greten, FR; Johnson, R; Schmidt, EV; Karin, M				Cao, YX; Bonizzi, G; Seagroves, TN; Greten, FR; Johnson, R; Schmidt, EV; Karin, M			IKK alpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development	CELL			English	Article							NF-KAPPA-B; MICE LACKING; LIVER DEGENERATION; BREAST-CANCER; KINASE-ALPHA; BETA SUBUNIT; CELL-GROWTH; ACTIVATION; PHOSPHORYLATION; DIFFERENTIATION	To identify functions of the IKK alpha subunit of I kappaB kinase that require catalytic activity, we generated an Ikk alpha (AA) knockin allele containing alanines instead of serines in the activation loop. Ikk alpha (AA/AA) mice are healthy and fertile, but females display a severe lactation defect due to impaired proliferation of mammary epithelia[ cells. IKK alpha. activity is required for NF-kappaB activation in mammary epithelial cells during pregnancy and in response to RANK ligand but not TNF alpha. IKK alpha and NF-kappaB activation are also required for optimal cyclin Dl induction. Defective RANK signaling or cyclin D1 expression results in the same phenotypic effect as the Ikk alpha (AA) mutation, which is completely suppressed by a mammary specific cyclin D1 transgene. Thus, IKK alpha is a critical intermediate in a pathway that controls mammary epithelial proliferation in response to RANK signaling via cyclin D1.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Childrens Serv, Charlestown, MA 02129 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Bonizzi, Giuseppina/AAD-9042-2022; Johnson, Randall/AAM-1189-2021; Seagroves, Tiffany/AAE-3278-2019; Greten, Florian R/AAF-5196-2020	Johnson, Randall/0000-0002-4084-6639; Seagroves, Tiffany/0000-0002-6937-943X; Greten, Florian R/0000-0002-3928-6080				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Delhase M, 1999, COLD SPRING HARB SYM, V64, P491, DOI 10.1101/sqb.1999.64.491; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Geymayer S, 2000, FASEB J, V14, P1159, DOI 10.1096/fasebj.14.9.1159; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GILMORE TD, 1999, DNA ALTERATIONS CANC; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Nishimura T, 2000, AM J REPROD IMMUNOL, V43, P351, DOI 10.1111/j.8755-8920.2000.430604.x; PULLAN SE, 1997, EPITHELIAL CELL CULT, P97; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	50	389	409	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2001	107	6					763	775		10.1016/S0092-8674(01)00599-2	http://dx.doi.org/10.1016/S0092-8674(01)00599-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	502ZC	11747812	Bronze			2022-12-01	WOS:000172771800009
J	Adini, Y; Sagi, D; Tsodyks, M				Adini, Y; Sagi, D; Tsodyks, M			Context-enabled learning in the human visual system	NATURE			English	Article							SYNAPTIC PLASTICITY; CORTEX; DISCRIMINATION; EXPERIENCE; NEURONS; VISION	Training was found to improve the performance of humans on a variety of visual perceptual tasks(1,2). However, the ability to detect small changes in the contrast of simple visual stimuli could not be improved by repetition(3). Here we show that the performance of this basic task could be modified after the discrimination of the stimulus contrast was practised in the presence of similar laterally placed stimuli, suggesting a change in the local neuronal circuit involved in the task. On the basis of a combination of hebbian and anti-hebbian synaptic learning rules compatible with our results, we propose a mechanism of plasticity in the visual cortex that is enabled by a change in the context.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sagi, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	dov.sagi@weizmann.ac.il	Sagi, Dov/A-5454-2008; tsodyks, misha/J-4430-2013	Sagi, Dov/0000-0002-8446-9230; Tsodyks, Misha/0000-0002-5661-4349				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Adini Y, 2001, J OPT SOC AM A, V18, P2228, DOI 10.1364/JOSAA.18.002228; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Gabor D., 1946, IEEE J I ELECT ENG, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; LEGGE GE, 1981, VISION RES, V21, P457, DOI 10.1016/0042-6989(81)90092-4; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; POLLEN DA, 1983, IEEE T SYST MAN CYB, V13, P907, DOI 10.1109/TSMC.1983.6313086; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Zenger B, 2002, PERCEPTUAL LEARNING, P177; Zenger-Landolt B, 2001, VISION RES, V41, P3663, DOI 10.1016/S0042-6989(01)00175-4	31	128	130	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					790	793		10.1038/415790a	http://dx.doi.org/10.1038/415790a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845209				2022-12-01	WOS:000173833900046
J	Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC				Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC			Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule	SCIENCE			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASES; ADHESION MOLECULES; BINDING; DOMAINS; POTENT; RHINOVIRUS; INHIBITION; NONPEPTIDE	The protein-protein interaction between leukocyte functional antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is critical to lymphocyte and immune system function. Here, we report on the transfer of the contiguous, nonlinear epitope of ICAM-1, responsible for its association with LFA-1, to a small-molecule framework. These LFA-1 antagonists bound LFA-1, blocked binding of ICAM-1, and inhibited a mixed lymphocyte reaction (MLR) with potency significantly greater than that of cyclosporine A. Furthermore, in comparison to an antibody to LFA-1, they exhibited significant anti-inflammatory effects in vivo. These results demonstrate the utility of small-molecule mimics of nonlinear protein epitopes and the protein epitopes themselves as leads in the identification of novel pharmaceutical agents.	Genentech Inc, Dept Bioorgan Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Small Mol Pharmacol, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Technol, San Francisco, CA 94080 USA; Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding	Gadek, TR (corresponding author), Genentech Inc, Dept Bioorgan Chem, 1 DNA Way, San Francisco, CA 94080 USA.							ADLER M, 1993, BIOCHEMISTRY-US, V32, P282, DOI 10.1021/bi00052a036; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BODARY SC, UNPUB; BURDICK DJ, 1999, Patent No. 9949856; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CONNOLLY MK, 1994, CLIN IMMUNOL IMMUNOP, V72, P198, DOI 10.1006/clin.1994.1130; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; Fisher KL, 1997, MOL BIOL CELL, V8, P501, DOI 10.1091/mbc.8.3.501; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; GRANLUND H, 2000, CURR OPIN ANTIINFLAM, V2, P332; KAKIMOTO K, 1992, CELL IMMUNOL, V142, P326, DOI 10.1016/0008-8749(92)90294-Y; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kelly TA, 1999, J IMMUNOL, V163, P5173; Liu G, 2001, EXPERT OPIN THER PAT, V11, P1383, DOI 10.1517/13543776.11.9.1383; Liu G, 2001, J MED CHEM, V44, P1202, DOI 10.1021/jm000503f; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5077, DOI 10.1021/ja00091a008; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5069, DOI 10.1021/ja00091a007; MCDOWELL RS, 1992, J AM CHEM SOC, V114, P9245, DOI 10.1021/ja00050a001; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; NAKAKURA EK, 1993, TRANSPLANTATION, V55, P412; OppenheimerMarks N, 1996, CLIN IMMUNOL IMMUNOP, V79, P203, DOI 10.1006/clin.1996.0069; SPRAGG JH, 1996, MOL MED SCI, P131; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Werther WA, 1996, J IMMUNOL, V157, P4986	25	143	159	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1086	1089		10.1126/science.295.5557.1086	http://dx.doi.org/10.1126/science.295.5557.1086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834839				2022-12-01	WOS:000173793000070
J	Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M				Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M			Mechanism of force generation by myosin heads in skeletal muscle	NATURE			English	Article							STRIATED-MUSCLE; ISOMETRIC CONTRACTION; FINE-STRUCTURE; POWER STROKE; LIGHT-CHAIN; FIBERS; FROG; ACTIN; MOTOR; CONFORMATION	Muscles generate force and shortening in a cyclical interaction between the myosin head domains projecting from the myosin filaments and the adjacent actin filaments. Although many features of the dynamic performance of muscle are determined by the rates of attachment and detachment of myosin and actin 1, the primary event in force generation is thought to be a conformational change or 'working stroke' in the actin-bound myosin head(2-8). According to this hypothesis, the working stroke is much faster than attachment or detachment, but can be observed directly in the rapid force transients that follow step displacement of the filaments(3). Although many studies of the mechanism of muscle contraction(9-13) have been based on this hypothesis, the alternative view-that the fast force transients are caused by fast components of attachment and detachment(14-17) has not been excluded definitively. Here we show that measurements of the axial motions of the myosin heads at angstrom resolution by a new X-ray interference technique(18) rule out the rapid attachment/detachment hypothesis, and provide compelling support for the working stroke model of force generation.	Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England; Univ Florence, I-50134 Florence, Italy; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of London; King's College London; University of Florence; European Synchrotron Radiation Facility (ESRF)	Irving, M (corresponding author), Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England.	malcolm.irving@kcl.ac.uk	Sun, Yin-Biao/F-9988-2018	Sun, Yin-Biao/0000-0002-4992-8198; LINARI, MARCO/0000-0001-6512-4897; RECONDITI, MASSIMO/0000-0001-5065-924X; Narayanan, Theyencheri/0000-0003-1957-1041	Telethon [625] Funding Source: Medline	Telethon(Fondazione Telethon)		BOESECKE P, 1995, REV SCI INSTRUM, V66, P1636; BRENNER B, 1991, P NATL ACAD SCI USA, V88, P10490, DOI 10.1073/pnas.88.23.10490; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1981, J PHYSIOL-LONDON, V317, pP12; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; Piazzesi G, 1999, J PHYSIOL-LONDON, V514, P305, DOI 10.1111/j.1469-7793.1999.305ae.x; PODOLSKY RJ, 1973, COLD SPRING HARB SYM, V37, P661, DOI 10.1101/SQB.1973.037.01.080; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SJOSTROM M, 1977, J MOL BIOL, V109, P49, DOI 10.1016/S0022-2836(77)80045-4; THORSON J, 1969, BIOPHYS J, V9, P360, DOI 10.1016/S0006-3495(69)86392-7	30	116	119	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					659	662		10.1038/415659a	http://dx.doi.org/10.1038/415659a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832949	Green Published			2022-12-01	WOS:000173709100051
J	Nenner, F				Nenner, F			The knapsack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					417	418		10.1001/jama.287.4.417	http://dx.doi.org/10.1001/jama.287.4.417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798342				2022-12-01	WOS:000173401900001
J	Reardon, DC; Cougle, JR				Reardon, DC; Cougle, JR			Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABORTION; WOMEN		Elliot Inst, Springfield, IL 62791 USA		Reardon, DC (corresponding author), Elliot Inst, POB 7348, Springfield, IL 62791 USA.			Reardon, David/0000-0002-4478-6231				COSTELLO EJ, 1982, J CLIN PSYCHOL, V38, P340, DOI 10.1002/1097-4679(198204)38:2<340::AID-JCLP2270380220>3.0.CO;2-D; JONES EF, 1992, DEMOGRAPHY, V29, P113, DOI 10.2307/2061366; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735	4	87	89	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					151	152		10.1136/bmj.324.7330.151	http://dx.doi.org/10.1136/bmj.324.7330.151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514ZH	11799033	Green Published, Bronze			2022-12-01	WOS:000173470600020
J	Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI				Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI			A selective advantage to immigrant genes in a Daphnia metapopulation	SCIENCE			English	Article							INBREEDING DEPRESSION; SUBDIVIDED POPULATIONS; DELETERIOUS MUTATIONS; CYCLICAL PARTHENOGEN; ROCK POOLS; EXTINCTION; LOAD; CONSEQUENCES; ENVIRONMENT; DIVERSITY	Immigrants to habitats occupied by conspecific organisms are usually expected to be competitively inferior, because residents may be locally adapted. If residents are inbred, however, mating between immigrants and residents results in offspring that may enjoy a fitness advantage from hybrid vigor. We demonstrate this effect experimentally in a natural Daphnia metapopulation in which genetic bottlenecks and local inbreeding are common. We estimate that in this metapopulation, hybrid vigor amplifies the rate of gene flow several times more than would be predicted from the nominal migration rate. This can affect the persistence of local populations and the entire metapopulation.	Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; Tvarminne Zool Stn, SF-10900 Hango, Finland; Univ Fribourg, Dept Biol, Unite Ecol & Evolut, CH-1700 Fribourg, Switzerland; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland	University of Basel; University of Fribourg; University of Texas System; University of Texas Austin; University of Helsinki	Ebert, D (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.		Ebert, Dieter/P-6134-2019; Haag, Christoph/B-6488-2009; Ebert, Dieter/B-5502-2009	Ebert, Dieter/0000-0003-2653-3772; Haag, Christoph/0000-0002-8817-1431; Ebert, Dieter/0000-0003-2653-3772				As S, 1992, ECOLOGICAL PRINCIPLE, P201; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; BRYANT EH, 1990, AM NAT, V136, P542, DOI 10.1086/285112; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1990, NATURE, V347, P380, DOI 10.1038/347380a0; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Darwin CR, 1876, EFFECTS CROSS SELF F; De Meester L, 1999, P ROY SOC B-BIOL SCI, V266, P2471; DEMEESTER L, 1993, OECOLOGIA, V96, P80, DOI 10.1007/BF00318033; Deng HW, 1997, GENETICS, V147, P147; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; Hebert PDN, 1993, METHODOLOGIES ALLOZY; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; JONES CS, 1995, P ROY SOC B-BIOL SCI, V260, P251, DOI 10.1098/rspb.1995.0088; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.1111/j.1558-5646.1994.tb02188.x, 10.2307/2410240]; LYNCH M, 1994, AM NAT, V144, P242, DOI 10.1086/285673; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Mayr E, 1963, ANIMAL SPECIES EVOLU; Olivieri Isabelle, 1997, P293, DOI 10.1016/B978-012323445-2/50017-1; PAJUNEN VI, 1986, ANN ZOOL FENN, V23, P131; PAJUNEN VI, UNPUB; Pamilo P, 1999, HEREDITAS, V130, P257, DOI 10.1111/j.1601-5223.1999.00257.x; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SINNOCK P, 1970, AM NAT, V104, P469, DOI 10.1086/282681; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; WILSON CC, 1992, ECOLOGY, V73, P1462, DOI 10.2307/1940690; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	38	191	195	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					485	488		10.1126/science.1067485	http://dx.doi.org/10.1126/science.1067485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799241	Green Submitted			2022-12-01	WOS:000173350700047
J	Ford, ES; Giles, WH; Dietz, WH				Ford, ES; Giles, WH; Dietz, WH			Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; DIABETES-MELLITUS; AFRICAN-AMERICANS; SYNDROME-X; RISK; ATHEROSCLEROSIS; PREVENTION; MORTALITY; EXERCISE; WHITES	Context The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) highlights the importance of treating patients with the metabolic syndrome to prevent cardiovascular disease. Limited information is available about the prevalence of the metabolic syndrome in the United States, however. Objective To estimate the prevalence of the metabolic syndrome in the United States as defined by the ATP III report. Design, Setting, and Participants Analysis of data on 8814 men and women aged 20 years or older from the Third National Health and Nutrition Examination Survey (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian US population. Main Outcome Measures Prevalence of the metabolic syndrome as defined by ATP III (greater than or equal to3 of the following abnormalities): waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dL (1.69 mmol/L); high-density lipoprotein cholesterol level of less than 40 mg/dL (1.04 mmol/L) in men and 50 mg/dL (1.29 mmol/L) in women; blood pressure of at least 130/85 mm Hg; or serum glucose level of at least 110 mg/dL (6.1 mmol/L). Results The unadjusted and age-adjusted prevalences of the metabolic syndrome were 21.8% and 23.7%, respectively. The prevalence increased from 6.7% among participants aged 20 through 29 years to 43.5% and 42.0% for participants aged 60 through 69 years and aged at least 70 years, respectively. Mexican Americans had the highest age-adjusted prevalence of the metabolic syndrome (31.9%). The age-adjusted prevalence was similar for men (24.0%) and women (23.4%). However, among African Americans, women had about a 57% higher prevalence than men did and among Mexican Americans, women had about a 26% higher prevalence than men did. Using 2000 census data, about 47 million US residents have the metabolic syndrome. Conclusions These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent. The large numbers of US residents with the metabolic syndrome may have important implications for the health care sector.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 1600 Clifton Rd NE,Mailstop E-17, Atlanta, GA 30333 USA.	esf2@cdc.gov						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], VITAL HLTH STAT; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; *CDCP, 1996, 3RD NATL HLTH NUTR E; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Haffner SM, 1997, DIABETES, V46, P63, DOI 10.2337/diabetes.46.1.63; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Hulthe J, 2000, ARTERIOSCL THROM VAS, V20, P2140, DOI 10.1161/01.ATV.20.9.2140; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Liese AD, 1997, ANN EPIDEMIOL, V7, P407, DOI 10.1016/S1047-2797(97)00047-1; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; *NIH, 2001, 013670 NIH; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Schmidt MI, 1996, DIABETES CARE, V19, P414, DOI 10.2337/diacare.19.5.414; SHAH BV, 1997, SUDAAN USERS MANUAL; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	23	4828	5257	9	346	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					356	359		10.1001/jama.287.3.356	http://dx.doi.org/10.1001/jama.287.3.356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790215	Bronze			2022-12-01	WOS:000173294700030
J	Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR				Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR			Fibulin-5/DANCE is essential for elastogenesis in vivo	NATURE			English	Article							EXTRACELLULAR-MATRIX; ELASTIN; ARTERIES	The elastic fibre system has a principal role in the structure and function of various types of organs that require elasticity, such as large arteries, lung and skin(1,2). Although elastic fibres are known to be composed of microfibril proteins (for example, fibrillins and latent transforming growth factor (TGF)-beta -binding proteins) and polymerized elastin, the mechanism of their assembly and development is not well understood. Here we report that fibulin-5 (also known as DANCE), a recently discovered integrin ligand(3), is an essential determinant of elastic fibre organization. fibulin-5(-/-) mice generated by gene targeting exhibit a severely disorganized elastic fibre system throughout the body. fibulin-5(-/-) mice survive to adulthood, but have a tortuous aorta with loss of compliance, severe emphysema, and loose skin (cutis laxa). These tissues contain fragmented elastin without an increase of elastase activity, indicating defective development of elastic fibres. Fibulin-5 interacts directly with elastic fibres in vitro, and serves as a ligand for cell surface integrins alphav beta3, alphav beta5 and alpha9 beta1 through its aminoterminal domain. Thus, fibulin-5 may provide anchorage of elastic fibres to cells, thereby acting to stabilize and organize elastic fibres in the skin, lung and vasculature.	Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Inst Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068501, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kyoto University; Kyoto University	Chien, KR (corresponding author), Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA.		CHENG, Ching-Feng/AAB-8861-2019; Honjo, Tasuku/N-4470-2016; Hinek, Aleksander/V-8790-2019; Nakamura, Tomoyuki/AAX-9340-2020	CHENG, Ching-Feng/0000-0003-0104-0146; Minamisawa, Susumu/0000-0003-4728-2116; takada, yoshikazu/0000-0001-5481-9589; Ikeda, Yasuhiro/0000-0002-2970-7304				Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Dietz HC, 2000, MATRIX BIOL, V19, P481, DOI 10.1016/S0945-053X(00)00101-3; DOBRIN PB, 1990, J SURG RES, V48, P116, DOI 10.1016/0022-4804(90)90202-D; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FAZIO MJ, 1989, CUTIS, V43, P437; FEIGENBAUM H, 1995, ECOCARDIOGRAPHY; LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; PIQUETTE CA, 2000, TXB RESP MED, P1187; RAPAPORT E, 2000, TXB RESP MED, P1631; Robb BW, 1999, MOL BIOL CELL, V10, P3595, DOI 10.1091/mbc.10.11.3595; Robert L, 1998, GERONTOLOGY, V44, P307, DOI 10.1159/000022034; ROSE JR, 1993, FASEB J, V7, pA1208, DOI 10.1096/fasebj.7.13.8405806; SENIOR RM, 1998, PULMONARY DIS DISORD, P659; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	23	472	513	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					171	175		10.1038/415171a	http://dx.doi.org/10.1038/415171a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805835				2022-12-01	WOS:000173159300042
J	Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN				Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN			Germ cell survival through carbohydrate-mediated interaction with Sertoli cells	SCIENCE			English	Article							ALPHA-D-MANNOSIDASE; SPERM PLASMA-MEMBRANES; LINKED OLIGOSACCHARIDES; BIOSYNTHESIS; EXPRESSION; EPIDIDYMIS	Spermatogenesis is a precisely regulated process in which the germ cells closely interact with Sertoli cells. The molecular basis of this cell-cell adhesion is unknown. Here, we demonstrate that targeted disruption of Man2a2, a gene encoding alpha -mannosidase IIx (MX), an enzyme that forms intermediate asparagine-linked carbohydrates (N-glycans), results in Man2a2 null mates that are largely infertile. The Man2a2 null spermatogenic cells fail to adhere to Sertoli cells and are prematurely released from the testis to epididymis. We identified an N-glycan structure that plays a key role in germ cell-Sertoli cell adhesion and showed that a specific carbohydrate was required for spermatogenesis.	Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA; Burnham Inst, Stem Cell Program, La Jolla, CA 92037 USA; Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido, Japan; Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; Tohoku Univ, Dept Urol, Sendai, Miyagi 980, Japan; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Hokkaido University; Keio University; Tohoku University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia	Fukuda, MN (corresponding author), Burnham Inst, Glycobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Moremen, Kelley/AAD-4661-2019; Millan, Jose Luis/B-6580-2008; Nishimura, Shinichiro/F-5277-2011		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA071932, R01CA042595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42595, CA71932] Funding Source: Medline; NCRR NIH HHS [RR05351] Funding Source: Medline; NICHD NIH HHS [U54 HD035041, HD05863] Funding Source: Medline; NIGMS NIH HHS [GM47533] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAMA T, UNPUB; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEPHILIP RM, 1987, BIOL REPROD, V37, P1271, DOI 10.1095/biolreprod37.5.1271; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Hiramoto S, 1997, BIOCHEM BIOPH RES CO, V241, P439, DOI 10.1006/bbrc.1997.7768; Igdoura SA, 1999, EUR J CELL BIOL, V78, P441, DOI 10.1016/S0171-9335(99)80071-5; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; KERR JB, 1995, MICROSC RES TECHNIQ, V32, P364, DOI 10.1002/jemt.1070320503; KOHNO S, 1983, J REPROD IMMUNOL, V5, P339, DOI 10.1016/0165-0378(83)90243-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MOREMEN KW, 2000, COMPREHENSIVE HDB, P81; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P138; Oh-eda M, 2001, EUR J BIOCHEM, V268, P1280, DOI 10.1046/j.1432-1327.2001.01992.x; Panter KE, 1999, J NAT TOXINS, V8, P53; SKUDLAREK MD, 1991, BIOCHEM J, V277, P213, DOI 10.1042/bj2770213; STAMENKOVIC I, 1992, CELL, V68, P1003, DOI 10.1016/0092-8674(92)90071-J; TAKAHASHI N, 1992, HDB ENDOGLYCOSIDASES, P199; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; TULSIANI DRP, 1989, J CELL BIOL, V109, P1257, DOI 10.1083/jcb.109.3.1257; TULSIANI DRP, 1990, BIOL REPROD, V42, P843, DOI 10.1095/biolreprod42.5.843; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936	28	115	118	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					124	127		10.1126/science.1065570	http://dx.doi.org/10.1126/science.1065570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778047				2022-12-01	WOS:000173143100048
J	Schwetz, BA				Schwetz, BA			Breast tissue ablation device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2002	287	1					33	33		10.1001/jama.287.1.33-b	http://dx.doi.org/10.1001/jama.287.1.33-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506NK	11754690				2022-12-01	WOS:000172978500005
J	Jagust, W				Jagust, W			Untangling vascular dementia	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE		Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA	University of California System; University of California Davis	Jagust, W (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.		Jagust, William/ABE-6426-2020					Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1974, LANCET, V2, P207; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476	11	39	40	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2097	2098		10.1016/S0140-6736(01)07230-0	http://dx.doi.org/10.1016/S0140-6736(01)07230-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784618				2022-12-01	WOS:000172905800003
J	Leveille, SG; Ling, S; Hochberg, MC; Resnick, HE; Bandeen-Roche, KJ; Won, A; Guralnik, JM				Leveille, SG; Ling, S; Hochberg, MC; Resnick, HE; Bandeen-Roche, KJ; Won, A; Guralnik, JM			Widespread musculoskeletal pain and the progression of disability in older disabled women	ANNALS OF INTERNAL MEDICINE			English	Article							GENERAL-POPULATION; OSTEO-ARTHRITIS; UNITED-STATES; OSTEOARTHRITIS; KNEE; PREVALENCE; HEALTH; HIP; FIBROMYALGIA; ASSOCIATION	Background: Widespread musculoskeletal pain is a poorly understood but common problem in older adults. Little is known about the progression of disability related to this condition. Objective: To determine whether widespread musculoskeletal pain increases the risk for worsening disability in older women with disabilities. Design: Prospective cohort study. Setting: The Women's Health and Aging Study. Participants: 1002 community-dwelling women 65 years of age or older with disability. Measurements: Widespread musculoskeletal pain was defined as pain in the upper and lower extremities and axial pain with moderate or severe pain in at least one of the three regions. Worsening disability was defined as progression from no or mild difficulty to severe difficulty or inability to perform activities of daily living (ADLs), walk one-quarter mile, or lift 10 lbs. Results: At baseline, 24% of participants had widespread pain and 25% had no pain or only mild pain in a single site. Women with widespread pain were 2.5 to 3.5 times more likely to have severe difficulty with ADLs, walking, or lifting at baseline compared with women who had no or mild pain. In women without severe difficulty initially, widespread pain nearly doubled the risk for progression to severe difficulty in each of the tasks, after adjustment for age, body mass index, comorbid illness, and other confounders. Conclusion: Widespread musculoskeletal pain is frequent among community-dwelling older women with disability and appears to predict the progression of disability. Efforts to better understand the cause of this pain and its treatment might reduce the overall burden of disability.	Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Univ Maryland, Baltimore, MD 21201 USA; Maryland Vet Affairs Hlth Care Syst, Baltimore, MD USA; NIA, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Leveille, SG (corresponding author), Hebrew Rehabil Ctr Aged, Res & Training Inst, 1200 Ctr St, Boston, MA 02131 USA.	leveille@mall.hrca.harvard.edu			NIA NIH HHS [N01-AG12112] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG012112] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennett Robert, 1998, Current Opinion in Rheumatology, V10, P95, DOI 10.1097/00002281-199803000-00002; Brattberg G, 1996, PAIN, V67, P29, DOI 10.1016/0304-3959(96)03047-3; Cooper C, 1996, J RHEUMATOL, V23, P1938; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; CROFT P, 1993, J RHEUMATOL, V20, P710; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; FELSON DT, 1995, J RHEUMATOL, V22, P7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIED LP, 2000, WOMENS HLTH AGING ST; GURALNIK JM, 2001, WOMENS HLTH AGING ST; Hirsch R, 1996, ANN RHEUM DIS, V55, P25, DOI 10.1136/ard.55.1.25; HOCHBERG MC, 1989, SEMIN ARTHRITIS RHEU, V18, P4, DOI 10.1016/0049-0172(89)90008-5; HOCHBERG MC, 1995, J RHEUMATOL, V22, P2291; Kasper JD, 1999, ANN EPIDEMIOL, V9, P498, DOI 10.1016/S1047-2797(99)00026-5; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWLESS JF, 1982, STAT MODELS METHODS, P376; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Leveille SG, 1999, J GERONTOL A-BIOL, V54, pM487, DOI 10.1093/gerona/54.10.M487; Lichtenstein MJ, 1998, J GERONTOL A-BIOL, V53, pM361; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; *NAT CTR HLTH STAT, 1999, HLTH AG CHARTB; NORRIS JT, 1987, J AM GERIATR SOC, V35, P989, DOI 10.1111/j.1532-5415.1987.tb04001.x; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Scudds RJ, 2000, J GERONTOL A-BIOL, V55, pM393, DOI 10.1093/gerona/55.7.M393; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Won A, 1999, J AM GERIATR SOC, V47, P936, DOI 10.1111/j.1532-5415.1999.tb01287.x	34	141	143	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2001	135	12					1038	1046		10.7326/0003-4819-135-12-200112180-00007	http://dx.doi.org/10.7326/0003-4819-135-12-200112180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502TW	11747382				2022-12-01	WOS:000172759700003
J	Hendry, JH; Booth, C; Potten, CS				Hendry, JH; Booth, C; Potten, CS			Endothelial cells and radiation gastrointestinal syndrome	SCIENCE			English	Editorial Material							FIBROBLAST GROWTH-FACTOR; INTESTINAL CRYPTS; CLONOGEN CONTENT; IN-VIVO; DEDUCTION; SURVIVAL; DEATH; ASSAY; MICE		Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England; EpiStem Ltd, Manchester, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Hendry, JH (corresponding author), Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England.							FUKS Z, 1994, CANCER RES, V54, P2582; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; ROBERTS SA, 1995, RADIAT RES, V141, P303, DOI 10.2307/3579007; ROBERTS SA, 1994, INT J RADIAT BIOL, V65, P477, DOI 10.1080/09553009414550551; TEE PG, 1995, CANCER RES, V55, P298; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; WITHERS HR, 1993, RADIOTHER ONCOL, V26, P238	11	12	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1411A	1411A						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11826850				2022-12-01	WOS:000172240500002
J	Cyranoski, D				Cyranoski, D			Japanese forum urges rethink over patents	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-01	WOS:000173433600009
J	Cyranoski, D				Cyranoski, D			Satellite set to keep track of whales	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-01	WOS:000173433600010
